OrphaCode,DisorderName,GeneSymbol,GeneName,GeneLocus
166024,Multiple epiphyseal dysplasia-macrocephaly-facial dysmorphism syndrome,KIF7,kinesin family member 7,15q26.1
93,Aspartylglucosaminuria,AGA,aspartylglucosaminidase,4q34.3
166035,Brachydactyly-short stature-retinitis pigmentosa syndrome,CWC27,CWC27 spliceosome associated cyclophilin,5q12.3
585,Multiple sulfatase deficiency,SUMF1,sulfatase modifying factor 1,3p26.1
118,Beta-mannosidosis,MANBA,mannosidase beta,4q24
166063,Pontocerebellar hypoplasia type 4,TSEN54,tRNA splicing endonuclease subunit 54,17q25.1
166078,Von Willebrand disease type 1,VWF,von Willebrand factor,12p13.31
166073,Pontocerebellar hypoplasia type 6,RARS2,"arginyl-tRNA synthetase 2, mitochondrial",6q15
166084,Von Willebrand disease type 2A,VWF,von Willebrand factor,12p13.31
333,Farber disease,ASAH1,N-acylsphingosine amidohydrolase 1,8p22
349,Fucosidosis,FUCA1,alpha-L-fucosidase 1,1p36.11
166090,Von Willebrand disease type 2M,VWF,von Willebrand factor,12p13.31
166087,Von Willebrand disease type 2B,VWF,von Willebrand factor,12p13.31
366,Glycogen storage disease due to glycogen debranching enzyme deficiency,AGL,"amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase",1p21.2
166093,Von Willebrand disease type 2N,VWF,von Willebrand factor,12p13.31
368,Glycogen storage disease due to muscle glycogen phosphorylase deficiency,PYGM,"glycogen phosphorylase, muscle associated",11q13.1
166096,Von Willebrand disease type 3,VWF,von Willebrand factor,12p13.31
166100,Autosomal dominant otospondylomegaepiphyseal dysplasia,COL2A1,collagen type II alpha 1 chain,12q13.11
166100,Autosomal dominant otospondylomegaepiphyseal dysplasia,COL11A2,collagen type XI alpha 2 chain,6p21.32
371,Glycogen storage disease due to muscle phosphofructokinase deficiency,PFKM,"phosphofructokinase, muscle",12q13.11
166105,FASTKD2-related infantile mitochondrial encephalomyopathy,FASTKD2,FAST kinase domains 2,2q33.3
369,Glycogen storage disease due to liver glycogen phosphorylase deficiency,PYGL,glycogen phosphorylase L,14q22.1
447,Paroxysmal nocturnal hemoglobinuria,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,Xp22.2
166108,Birk-Barel syndrome,KCNK9,potassium two pore domain channel subfamily K member 9,8q24.3
166119,Isolated osteopoikilosis,LEMD3,LEM domain containing 3,12q14.3
166260,Dentinogenesis imperfecta type 2,DSPP,dentin sialophosphoprotein,4q22.1
166265,Dentinogenesis imperfecta type 3,DSPP,dentin sialophosphoprotein,4q22.1
166272,Odontochondrodysplasia,TRIP11,thyroid hormone receptor interactor 11,14q32.12
576,Mucolipidosis type II,GNPTAB,N-acetylglucosamine-1-phosphate transferase subunits alpha and beta,12q23.2
812,Sialidosis type 1,NEU1,neuraminidase 1,6p21.33
166282,Hereditary sick sinus syndrome,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
166282,Hereditary sick sinus syndrome,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,15q24.1
166282,Hereditary sick sinus syndrome,MYH6,myosin heavy chain 6,14q11.2
166282,Hereditary sick sinus syndrome,GNB2,G protein subunit beta 2,7q22.1
578,Mucolipidosis type IV,MCOLN1,mucolipin TRP cation channel 1,19p13.2
166286,Porokeratotic eccrine ostial and dermal duct nevus,GJB2,gap junction protein beta 2,13q12.11
461,Recessive X-linked ichthyosis,FLG,filaggrin,1q21.3
461,Recessive X-linked ichthyosis,STS,steroid sulfatase,Xp22.31
584,Mucopolysaccharidosis type 7,GUSB,glucuronidase beta,7q11.21
166412,Hot water reflex epilepsy,SLC1A1,solute carrier family 1 member 1,9p24.2
95,Friedreich ataxia,FXN,frataxin,9q21.11
586,Cystic fibrosis,SERPINA1,serpin family A member 1,14q32.13
586,Cystic fibrosis,SLC26A9,solute carrier family 26 member 9,1q32.1
586,Cystic fibrosis,SLC6A14,solute carrier family 6 member 14,Xq23
586,Cystic fibrosis,SLC9A3,solute carrier family 9 member A3,5p15.33
586,Cystic fibrosis,CEACAM3,CEA cell adhesion molecule 3,19q13.2
586,Cystic fibrosis,CEACAM6,CEA cell adhesion molecule 6,19q13.2
586,Cystic fibrosis,EDNRA,endothelin receptor type A,4q31.22-q31.23
586,Cystic fibrosis,GSTM3,glutathione S-transferase mu 3,1p13.3
586,Cystic fibrosis,HMOX1,heme oxygenase 1,22q12.3
586,Cystic fibrosis,GCLC,glutamate-cysteine ligase catalytic subunit,6p12.1
586,Cystic fibrosis,HFE,homeostatic iron regulator,6p22.2
586,Cystic fibrosis,CFTR,CF transmembrane conductance regulator,7q31.2
586,Cystic fibrosis,TGFB1,transforming growth factor beta 1,19q13.2
586,Cystic fibrosis,DCTN4,dynactin subunit 4,5q33.1
586,Cystic fibrosis,CLCA4,chloride channel accessory 4,1p22.3
586,Cystic fibrosis,STX1A,syntaxin 1A,7q11.23
586,Cystic fibrosis,KCNN4,potassium calcium-activated channel subfamily N member 4,19q13.31
586,Cystic fibrosis,MIF,macrophage migration inhibitory factor,22q11.23
586,Cystic fibrosis,SLC11A1,solute carrier family 11 member 1,2q35
550,MELAS,MT-TQ,mitochondrially encoded tRNA-Gln (CAA/G),mitochondria
550,MELAS,MT-CO1,mitochondrially encoded cytochrome c oxidase I,mitochondria
550,MELAS,MT-CO2,mitochondrially encoded cytochrome c oxidase II,mitochondria
550,MELAS,MT-CO3,mitochondrially encoded cytochrome c oxidase III,mitochondria
550,MELAS,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,mitochondria
550,MELAS,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,mitochondria
550,MELAS,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,mitochondria
550,MELAS,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,mitochondria
550,MELAS,MT-TL1,mitochondrially encoded tRNA-Leu (UUA/G) 1,mitochondria
550,MELAS,MT-TW,mitochondrially encoded tRNA-Trp (UGA/G),mitochondria
550,MELAS,MT-TH,mitochondrially encoded tRNA-His (CAU/C),mitochondria
550,MELAS,MT-TS1,mitochondrially encoded tRNA-Ser (UCN) 1,mitochondria
550,MELAS,MT-TS2,mitochondrially encoded tRNA-Ser (AGU/C) 2,mitochondria
550,MELAS,MT-TF,mitochondrially encoded tRNA-Phe (UUU/C),mitochondria
269,Facioscapulohumeral dystrophy,DNMT3B,DNA methyltransferase 3 beta,20q11.21
269,Facioscapulohumeral dystrophy,DUX4,double homeobox 4,4q35.2
269,Facioscapulohumeral dystrophy,DUX4L1,double homeobox 4 like 1 (pseudogene),4q35.2
269,Facioscapulohumeral dystrophy,FRG1,FSHD region gene 1,4q35.2
269,Facioscapulohumeral dystrophy,SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,18p11.32
269,Facioscapulohumeral dystrophy,SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,18p11.32
480,Kearns-Sayre syndrome,MT-ATP8,mitochondrially encoded ATP synthase membrane subunit 8,mitochondria
480,Kearns-Sayre syndrome,RRM2B,ribonucleotide reductase regulatory TP53 inducible subunit M2B,8q22.3
480,Kearns-Sayre syndrome,MT-TL1,mitochondrially encoded tRNA-Leu (UUA/G) 1,mitochondria
551,MERRF,MT-TP,mitochondrially encoded tRNA-Pro (CCN),mitochondria
551,MERRF,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,mitochondria
551,MERRF,MT-TL1,mitochondrially encoded tRNA-Leu (UUA/G) 1,mitochondria
551,MERRF,MT-TK,mitochondrially encoded tRNA-Lys (AAA/G),mitochondria
551,MERRF,MT-RNR1,mitochondrially encoded 12S rRNA,mitochondria
551,MERRF,MT-TQ,mitochondrially encoded tRNA-Gln (CAA/G),mitochondria
551,MERRF,MT-TH,mitochondrially encoded tRNA-His (CAU/C),mitochondria
551,MERRF,MT-TS1,mitochondrially encoded tRNA-Ser (UCN) 1,mitochondria
551,MERRF,MT-TS2,mitochondrially encoded tRNA-Ser (AGU/C) 2,mitochondria
551,MERRF,MT-TF,mitochondrially encoded tRNA-Phe (UUU/C),mitochondria
597,Central core disease,RYR1,ryanodine receptor 1,19q13.2
163746,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease,SOX10,SRY-box transcription factor 10,22q13.1
684,Paramyotonia congenita of Von Eulenburg,SCN4A,sodium voltage-gated channel alpha subunit 4,17q23.3
163931,Acrodermatitis continua of Hallopeau,IL36RN,interleukin 36 receptor antagonist,2q14.1
163931,Acrodermatitis continua of Hallopeau,AP1S3,adaptor related protein complex 1 subunit sigma 3,2q36.1
163927,Pustulosis palmaris et plantaris,IL36RN,interleukin 36 receptor antagonist,2q14.1
163927,Pustulosis palmaris et plantaris,AP1S3,adaptor related protein complex 1 subunit sigma 3,2q36.1
163937,"X-linked intellectual disability, Najm type",CASK,calcium/calmodulin dependent serine protein kinase,Xp11.4
614,Thomsen and Becker disease,CLCN1,chloride voltage-gated channel 1,7q34
163966,"X-linked dominant chondrodysplasia, Chassaing-Lacombe type",HDAC6,histone deacetylase 6,Xp11.23
163976,"X-linked intellectual disability, Van Esch type",POLA1,"DNA polymerase alpha 1, catalytic subunit",Xp22.11-p21.3
163956,"X-linked intellectual disability, Nascimento type",UBE2A,ubiquitin conjugating enzyme E2 A,Xq24
324,Fabry disease,GLA,galactosidase alpha,Xq22.1
163985,Hyperekplexia-epilepsy syndrome,ARHGEF9,Cdc42 guanine nucleotide exchange factor 9,Xq11.1
778,Rett syndrome,MECP2,methyl-CpG binding protein 2,Xq28
307,Juvenile myoclonic epilepsy,CILK1,ciliogenesis associated kinase 1,6p12.1
307,Juvenile myoclonic epilepsy,CACNB4,calcium voltage-gated channel auxiliary subunit beta 4,2q23.3
307,Juvenile myoclonic epilepsy,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,5q34
307,Juvenile myoclonic epilepsy,EFHC1,EF-hand domain containing 1,6p12.2
307,Juvenile myoclonic epilepsy,GABRD,gamma-aminobutyric acid type A receptor subunit delta,1p36.33
307,Juvenile myoclonic epilepsy,KCNQ3,potassium voltage-gated channel subfamily Q member 3,8q24.22
307,Juvenile myoclonic epilepsy,JRK,Jrk helix-turn-helix protein,8q24.3
307,Juvenile myoclonic epilepsy,CLCN2,chloride voltage-gated channel 2,3q27.1
1941,Juvenile absence epilepsy,EFHC1,EF-hand domain containing 1,6p12.2
892,Von Hippel-Lindau disease,CCND1,cyclin D1,11q13.3
892,Von Hippel-Lindau disease,VHL,von Hippel-Lindau tumor suppressor,3p25.3
731,Autosomal recessive polycystic kidney disease,DZIP1L,DAZ interacting zinc finger protein 1 like,3q22.3
731,Autosomal recessive polycystic kidney disease,PKHD1,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,6p12.3-p12.2
164736,Familial advanced sleep-phase syndrome,PER3,period circadian regulator 3,1p36.23
164736,Familial advanced sleep-phase syndrome,CSNK1D,casein kinase 1 delta,17q25.3
164736,Familial advanced sleep-phase syndrome,PER2,period circadian regulator 2,2q37.3
138,CHARGE syndrome,SEMA3E,semaphorin 3E,7q21.11
138,CHARGE syndrome,CHD7,chromodomain helicase DNA binding protein 7,8q12.2
803,Amyotrophic lateral sclerosis,CCNF,cyclin F,16p13.3
803,Amyotrophic lateral sclerosis,TAF15,TATA-box binding protein associated factor 15,17q12
803,Amyotrophic lateral sclerosis,ANXA11,annexin A11,10q22.3
803,Amyotrophic lateral sclerosis,CFAP410,cilia and flagella associated protein 410,21q22.3
803,Amyotrophic lateral sclerosis,GLE1,GLE1 RNA export mediator,9q34.11
803,Amyotrophic lateral sclerosis,NEK1,NIMA related kinase 1,4q33
803,Amyotrophic lateral sclerosis,GLT8D1,glycosyltransferase 8 domain containing 1,3p21.1
803,Amyotrophic lateral sclerosis,CHCHD10,coiled-coil-helix-coiled-coil-helix domain containing 10,22q11.23
803,Amyotrophic lateral sclerosis,DAO,D-amino acid oxidase,12q24.11
803,Amyotrophic lateral sclerosis,ATXN2,ataxin 2,12q24.12
803,Amyotrophic lateral sclerosis,CHMP2B,charged multivesicular body protein 2B,3p11.2
803,Amyotrophic lateral sclerosis,SOD1,superoxide dismutase 1,21q22.11
803,Amyotrophic lateral sclerosis,TREM2,triggering receptor expressed on myeloid cells 2,6p21.1
803,Amyotrophic lateral sclerosis,VAPB,VAMP associated protein B and C,20q13.32
803,Amyotrophic lateral sclerosis,VCP,valosin containing protein,9p13.3
803,Amyotrophic lateral sclerosis,NEFH,neurofilament heavy chain,22q12.2
803,Amyotrophic lateral sclerosis,OPTN,optineurin,10p13
803,Amyotrophic lateral sclerosis,DCTN1,dynactin subunit 1,2p13.1
803,Amyotrophic lateral sclerosis,TARDBP,TAR DNA binding protein,1p36.22
803,Amyotrophic lateral sclerosis,FIG4,FIG4 phosphoinositide 5-phosphatase,6q21
803,Amyotrophic lateral sclerosis,FUS,FUS RNA binding protein,16p11.2
803,Amyotrophic lateral sclerosis,ANG,angiogenin,14q11.2
803,Amyotrophic lateral sclerosis,MATR3,matrin 3,5q31.2
803,Amyotrophic lateral sclerosis,PRPH,peripherin,12q13.12
803,Amyotrophic lateral sclerosis,PON1,paraoxonase 1,7q21.3
803,Amyotrophic lateral sclerosis,PON2,paraoxonase 2,7q21.3
803,Amyotrophic lateral sclerosis,PON3,paraoxonase 3,7q21.3
803,Amyotrophic lateral sclerosis,SQSTM1,sequestosome 1,5q35.3
803,Amyotrophic lateral sclerosis,UBQLN2,ubiquilin 2,Xp11.21
803,Amyotrophic lateral sclerosis,C9ORF72,C9orf72-SMCR8 complex subunit,9p21.2
803,Amyotrophic lateral sclerosis,PFN1,profilin 1,17p13.2
803,Amyotrophic lateral sclerosis,TBK1,TANK binding kinase 1,12q14.2
803,Amyotrophic lateral sclerosis,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,12q13.13
803,Amyotrophic lateral sclerosis,PPARGC1A,PPARG coactivator 1 alpha,4p15.2
803,Amyotrophic lateral sclerosis,ERBB4,erb-b2 receptor tyrosine kinase 4,2q34
803,Amyotrophic lateral sclerosis,UNC13A,unc-13 homolog A,19p13.11
100,Ataxia-telangiectasia,ATM,ATM serine/threonine kinase,11q22.3
399,Huntington disease,HTT,huntingtin,4p16.3
399,Huntington disease,SLC2A3,solute carrier family 2 member 3,12p13.31
501,Lafora disease,EPM2A,"EPM2A glucan phosphatase, laforin",6q24.3
501,Lafora disease,NHLRC1,NHL repeat containing E3 ubiquitin protein ligase 1,6p22.3
567,22q11.2 deletion syndrome,TBX1,T-box transcription factor 1,22q11.21
567,22q11.2 deletion syndrome,TBX1,T-box transcription factor 1,22q11.21
567,22q11.2 deletion syndrome,ARVCF,ARVCF delta catenin family member,22q11.21
567,22q11.2 deletion syndrome,GP1BB,glycoprotein Ib platelet subunit beta,22q11.21
567,22q11.2 deletion syndrome,UFD1,ubiquitin recognition factor in ER associated degradation 1,22q11.21
567,22q11.2 deletion syndrome,HIRA,histone cell cycle regulator,22q11.21
567,22q11.2 deletion syndrome,COMT,catechol-O-methyltransferase,22q11.21
567,22q11.2 deletion syndrome,JMJD1C,jumonji domain containing 1C,10q21.3
567,22q11.2 deletion syndrome,RREB1,ras responsive element binding protein 1,6p24.3
567,22q11.2 deletion syndrome,SEC24C,"SEC24 homolog C, COPII coat complex component",10q22.2
232,Sickle cell anemia,HBB,hemoglobin subunit beta,11p15.4
536,Systemic lupus erythematosus,BANK1,B cell scaffold protein with ankyrin repeats 1,4q24
536,Systemic lupus erythematosus,PXK,PX domain containing serine/threonine kinase like,3p14.3
536,Systemic lupus erythematosus,IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),14q32.33
536,Systemic lupus erythematosus,CTLA4,cytotoxic T-lymphocyte associated protein 4,2q33.2
536,Systemic lupus erythematosus,TREX1,three prime repair exonuclease 1,3p21.31
536,Systemic lupus erythematosus,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
536,Systemic lupus erythematosus,IL10,interleukin 10,1q32.1
536,Systemic lupus erythematosus,MECP2,methyl-CpG binding protein 2,Xq28
536,Systemic lupus erythematosus,FCGR3B,Fc fragment of IgG receptor IIIb,1q23.3
536,Systemic lupus erythematosus,C4A,complement C4A (Chido/Rodgers blood group),6p21.33
536,Systemic lupus erythematosus,C4B,complement C4B (Chido/Rodgers blood group),6p21.33
536,Systemic lupus erythematosus,CR2,complement C3d receptor 2,1q32.2
536,Systemic lupus erythematosus,IRF5,interferon regulatory factor 5,7q32.1
536,Systemic lupus erythematosus,PDCD1,programmed cell death 1,2q37.3
536,Systemic lupus erythematosus,PTPN22,protein tyrosine phosphatase non-receptor type 22,1p13.2
536,Systemic lupus erythematosus,STAT4,signal transducer and activator of transcription 4,2q32.2-q32.3
536,Systemic lupus erythematosus,FCGR2B,Fc fragment of IgG receptor IIb,1q23.3
536,Systemic lupus erythematosus,DNASE1,deoxyribonuclease 1,16p13.3
536,Systemic lupus erythematosus,BLK,"BLK proto-oncogene, Src family tyrosine kinase",8p23.1
536,Systemic lupus erythematosus,ITGAM,integrin subunit alpha M,16p11.2
536,Systemic lupus erythematosus,KIAA0319L,KIAA0319 like,1p34.3
536,Systemic lupus erythematosus,JAZF1,JAZF zinc finger 1,7p15.2-p15.1
536,Systemic lupus erythematosus,TNIP1,TNFAIP3 interacting protein 1,5q33.1
536,Systemic lupus erythematosus,TNFAIP3,TNF alpha induced protein 3,6q23.3
536,Systemic lupus erythematosus,UBE2L3,ubiquitin conjugating enzyme E2 L3,22q11.21
536,Systemic lupus erythematosus,TNFSF4,TNF superfamily member 4,1q25.1
536,Systemic lupus erythematosus,SPP1,secreted phosphoprotein 1,4q22.1
536,Systemic lupus erythematosus,IRAK1,interleukin 1 receptor associated kinase 1,Xq28
536,Systemic lupus erythematosus,ETS1,"ETS proto-oncogene 1, transcription factor",11q24.3
536,Systemic lupus erythematosus,TLR7,toll like receptor 7,Xp22.2
166002,Multiple epiphyseal dysplasia due to collagen 9 anomaly,COL9A1,collagen type IX alpha 1 chain,6q13
166002,Multiple epiphyseal dysplasia due to collagen 9 anomaly,COL9A2,collagen type IX alpha 2 chain,1p34.2
166002,Multiple epiphyseal dysplasia due to collagen 9 anomaly,COL9A3,collagen type IX alpha 3 chain,20q13.33
534,Oculocerebrorenal syndrome of Lowe,OCRL,OCRL inositol polyphosphate-5-phosphatase,Xq26.1
165991,Exercise-induced hyperinsulinism,SLC16A1,solute carrier family 16 member 1,1p13.2
652,Multiple endocrine neoplasia type 1,CDKN1B,cyclin dependent kinase inhibitor 1B,12p13.1
652,Multiple endocrine neoplasia type 1,CDKN1A,cyclin dependent kinase inhibitor 1A,6p21.2
652,Multiple endocrine neoplasia type 1,CDKN2B,cyclin dependent kinase inhibitor 2B,9p21.3
652,Multiple endocrine neoplasia type 1,CDKN2C,cyclin dependent kinase inhibitor 2C,1p32.3
652,Multiple endocrine neoplasia type 1,MEN1,menin 1,11q13
908,Fragile X syndrome,FMR1,fragile X messenger ribonucleoprotein 1,Xq27.3
47,X-linked agammaglobulinemia,BTK,Bruton tyrosine kinase,Xq22.1
905,Wilson disease,ATP7B,ATPase copper transporting beta,13q14.3
792,X-linked retinoschisis,RS1,retinoschisin 1,Xp22.13
827,Stargardt disease,CNGB3,cyclic nucleotide gated channel subunit beta 3,8q21.3
827,Stargardt disease,PRPH2,peripherin 2,6p21.1
827,Stargardt disease,ABCA4,ATP binding cassette subfamily A member 4,1p22.1
827,Stargardt disease,ELOVL4,ELOVL fatty acid elongase 4,6q14.1
827,Stargardt disease,PROM1,prominin 1,4p15.32
906,Wiskott-Aldrich syndrome,WAS,WASP actin nucleation promoting factor,Xp11.23
906,Wiskott-Aldrich syndrome,WIPF1,WAS/WASL interacting protein family member 1,2q31.1
904,Williams syndrome,STX1A,syntaxin 1A,7q11.23
904,Williams syndrome,TBL2,transducin beta like 2,7q11.23
904,Williams syndrome,GTF2IRD2,GTF2I repeat domain containing 2,7q11.23
904,Williams syndrome,VPS37D,VPS37D subunit of ESCRT-I,7q11.23
904,Williams syndrome,FKBP6,FKBP prolyl isomerase family member 6 (inactive),7q11.23
904,Williams syndrome,RFC2,replication factor C subunit 2,7q11.23
904,Williams syndrome,NCF1,neutrophil cytosolic factor 1,7q11.23
904,Williams syndrome,TMEM270,transmembrane protein 270,7q11.23
904,Williams syndrome,EIF4H,eukaryotic translation initiation factor 4H,7q11.23
904,Williams syndrome,DNAJC30,DnaJ heat shock protein family (Hsp40) member C30,7q11.23
904,Williams syndrome,METTL27,methyltransferase like 27,7q11.23
904,Williams syndrome,BUD23,BUD23 rRNA methyltransferase and ribosome maturation factor,7q11.23
904,Williams syndrome,BAZ1B,bromodomain adjacent to zinc finger domain 1B,7q11.23
904,Williams syndrome,CLIP2,CAP-Gly domain containing linker protein 2,7q11.23
904,Williams syndrome,ELN,elastin,7q11.23
904,Williams syndrome,GTF2I,general transcription factor IIi,7q11.23
904,Williams syndrome,GTF2IRD1,GTF2I repeat domain containing 1,7q11.23
904,Williams syndrome,LIMK1,LIM domain kinase 1,7q11.23
280,Wolf-Hirschhorn syndrome,PIGG,phosphatidylinositol glycan anchor biosynthesis class G (EMM blood group),4p16.3
280,Wolf-Hirschhorn syndrome,CPLX1,complexin 1,4p16.3
280,Wolf-Hirschhorn syndrome,CTBP1,C-terminal binding protein 1,4p16.3
280,Wolf-Hirschhorn syndrome,NSD2,nuclear receptor binding SET domain protein 2,4p16.3
280,Wolf-Hirschhorn syndrome,NELFA,negative elongation factor complex member A,4p16.3
280,Wolf-Hirschhorn syndrome,LETM1,leucine zipper and EF-hand containing transmembrane protein 1,4p16.3
15,Achondroplasia,FGFR3,fibroblast growth factor receptor 3,4p16.3
96,Ataxia with vitamin E deficiency,TTPA,alpha tocopherol transfer protein,8q12.3
101,Dentatorubral pallidoluysian atrophy,ATN1,atrophin 1,12p13.31
276,T-B+ severe combined immunodeficiency due to gamma chain deficiency,IL2RG,interleukin 2 receptor subunit gamma,Xq13.1
481,Kennedy disease,AR,androgen receptor,Xq12
664,Ornithine transcarbamylase deficiency,OTC,ornithine transcarbamylase,Xp11.4
394,Homocystinuria due to cystathionine beta-synthase deficiency,CBS,cystathionine beta-synthase,21q22.3
508,Donohue syndrome,INSR,insulin receptor,19p13.2
163596,Hb Bart's hydrops fetalis,HBA2,hemoglobin subunit alpha 2,16p13.3
163596,Hb Bart's hydrops fetalis,HBA1,hemoglobin subunit alpha 1,16p13.3
429,Hypochondroplasia,FGFR3,fibroblast growth factor receptor 3,4p16.3
104,Leber hereditary optic neuropathy,NDUFS2,NADH:ubiquinone oxidoreductase core subunit S2,1q23.3
104,Leber hereditary optic neuropathy,DNAJC30,DnaJ heat shock protein family (Hsp40) member C30,7q11.23
104,Leber hereditary optic neuropathy,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,mitochondria
104,Leber hereditary optic neuropathy,MT-CO1,mitochondrially encoded cytochrome c oxidase I,mitochondria
104,Leber hereditary optic neuropathy,MT-CO3,mitochondrially encoded cytochrome c oxidase III,mitochondria
104,Leber hereditary optic neuropathy,MT-CYB,mitochondrially encoded cytochrome b,mitochondria
104,Leber hereditary optic neuropathy,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,mitochondria
104,Leber hereditary optic neuropathy,MT-ND2,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2,mitochondria
104,Leber hereditary optic neuropathy,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,mitochondria
104,Leber hereditary optic neuropathy,MT-ND4L,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L,mitochondria
104,Leber hereditary optic neuropathy,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,mitochondria
104,Leber hereditary optic neuropathy,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,mitochondria
2182,Hydrocephalus with stenosis of the aqueduct of Sylvius,L1CAM,L1 cell adhesion molecule,Xq28
163634,Maffucci syndrome,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
163634,Maffucci syndrome,IDH1,isocitrate dehydrogenase (NADP(+)) 1,2q34
163717,Familial mesial temporal lobe epilepsy,CPA6,carboxypeptidase A6,8q13.2
649,Norrie disease,NDP,norrin cystine knot growth factor NDP,Xp11.3
163727,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome,TBC1D24,TBC1 domain family member 24,16p13.3
163721,Rolandic epilepsy-speech dyspraxia syndrome,SRPX2,sushi repeat containing protein X-linked 2,Xq22.1
163721,Rolandic epilepsy-speech dyspraxia syndrome,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,16p13.2
163684,Leukoencephalopathy-dystonia-motor neuropathy syndrome,SCP2,sterol carrier protein 2,1p32.3
163681,CNTNAP2-related developmental and epileptic encephalopathy,CNTNAP2,contactin associated protein 2,7q35-q36.1
379,Chronic granulomatous disease,CYBB,cytochrome b-245 beta chain,Xp21.1-p11.4
379,Chronic granulomatous disease,NCF1,neutrophil cytosolic factor 1,7q11.23
379,Chronic granulomatous disease,NCF2,neutrophil cytosolic factor 2,1q25.3
379,Chronic granulomatous disease,CYBA,cytochrome b-245 alpha chain,16q24.2
379,Chronic granulomatous disease,NCF4,neutrophil cytosolic factor 4,22q12.3
379,Chronic granulomatous disease,CYBC1,cytochrome b-245 chaperone 1,17q25.3
16,Blue cone monochromatism,OPN1MW,"opsin 1, medium wave sensitive",Xq28
16,Blue cone monochromatism,OPN1LW,"opsin 1, long wave sensitive",Xq28
644,NARP syndrome,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,mitochondria
163699,Alveolar soft tissue sarcoma,TFE3,transcription factor binding to IGHM enhancer 3,Xp11.23
163699,Alveolar soft tissue sarcoma,ASPSCR1,"ASPSCR1 tether for SLC2A4, UBX domain containing",17q25.3
637,Full NF2-related schwannomatosis,NF2,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",22q12.2
163696,Action myoclonus-renal failure syndrome,SCARB2,scavenger receptor class B member 2,4q21.1
181,X-linked hypohidrotic ectodermal dysplasia,EDA,ectodysplasin A,Xq13.1
181,X-linked hypohidrotic ectodermal dysplasia,EDA2R,ectodysplasin A2 receptor,Xq12
163693,2p21 microdeletion syndrome,SLC3A1,solute carrier family 3 member 1,2p21
163693,2p21 microdeletion syndrome,PREPL,prolyl endopeptidase like,2p21
163693,2p21 microdeletion syndrome,CAMKMT,calmodulin-lysine N-methyltransferase,2p21
163693,2p21 microdeletion syndrome,PPM1B,"protein phosphatase, Mg2+/Mn2+ dependent 1B",2p21
163690,Hypotonia-cystinuria syndrome,SLC3A1,solute carrier family 3 member 1,2p21
163690,Hypotonia-cystinuria syndrome,PREPL,prolyl endopeptidase like,2p21
337,Fibrodysplasia ossificans progressiva,ACVR1,activin A receptor type 1,2q24.1
377,Gorlin syndrome,PTCH1,patched 1,9q22.32
377,Gorlin syndrome,SUFU,SUFU negative regulator of hedgehog signaling,10q24.32
377,Gorlin syndrome,PTCH2,patched 2,1p34.1
648,Noonan syndrome,RRAS,RAS related,19q13.33
648,Noonan syndrome,MRAS,muscle RAS oncogene homolog,3q22.3
648,Noonan syndrome,SPRED2,sprouty related EVH1 domain containing 2,2p14
648,Noonan syndrome,RRAS2,RAS related 2,11p15.2
648,Noonan syndrome,PTPN11,protein tyrosine phosphatase non-receptor type 11,12q24.13
648,Noonan syndrome,CBL,Cbl proto-oncogene,11q23.3
648,Noonan syndrome,SOS1,SOS Ras/Rac guanine nucleotide exchange factor 1,2p22.1
648,Noonan syndrome,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
648,Noonan syndrome,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",3p25.2
648,Noonan syndrome,NRAS,"NRAS proto-oncogene, GTPase",1p13.2
648,Noonan syndrome,RIT1,Ras like without CAAX 1,1q22
648,Noonan syndrome,LZTR1,leucine zipper like post translational regulator 1,22q11.21
648,Noonan syndrome,RASA2,RAS p21 protein activator 2,3q23
648,Noonan syndrome,SOS2,SOS Ras/Rho guanine nucleotide exchange factor 2,14q21.3
648,Noonan syndrome,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
281,Monosomy 5p syndrome,SEMA5A,semaphorin 5A,5p15.31
281,Monosomy 5p syndrome,CTNND2,catenin delta 2,5p15.2
752,"46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",HSD17B3,hydroxysteroid 17-beta dehydrogenase 3,9q22.32
510,Lesch-Nyhan syndrome,HPRT1,hypoxanthine phosphoribosyltransferase 1,Xq26.2-q26.3
524,Li-Fraumeni syndrome,CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
524,Li-Fraumeni syndrome,MDM2,MDM2 proto-oncogene,12q15
524,Li-Fraumeni syndrome,TP53,tumor protein p53,17p13.1
524,Li-Fraumeni syndrome,CHEK2,checkpoint kinase 2,22q12.1
640,Hereditary neuropathy with liability to pressure palsies,PMP22,peripheral myelin protein 22,17p12
640,Hereditary neuropathy with liability to pressure palsies,PMP22,peripheral myelin protein 22,17p12
60,Alpha-1-antitrypsin deficiency,SERPINA1,serpin family A member 1,14q32.13
895,Waardenburg syndrome type 2,KITLG,KIT ligand,12q21.32
895,Waardenburg syndrome type 2,TYR,tyrosinase,11q14.3
895,Waardenburg syndrome type 2,SNAI2,snail family transcriptional repressor 2,8q11.21
895,Waardenburg syndrome type 2,SOX10,SRY-box transcription factor 10,22q13.1
895,Waardenburg syndrome type 2,MITF,melanocyte inducing transcription factor,3p13
895,Waardenburg syndrome type 2,EDNRB,endothelin receptor type B,13q22.3
896,Waardenburg syndrome type 3,PAX3,paired box 3,2q36.1
857,Townes-Brocks syndrome,SALL1,spalt like transcription factor 1,16q12.1
857,Townes-Brocks syndrome,DACT1,dishevelled binding antagonist of beta catenin 1,14q23.1
894,Waardenburg syndrome type 1,PAX3,paired box 3,2q36.1
682,Hyperkalemic periodic paralysis,SCN4A,sodium voltage-gated channel alpha subunit 4,17q23.3
800,Schwartz-Jampel syndrome,HSPG2,heparan sulfate proteoglycan 2,1p36.12
628,Diastrophic dysplasia,SLC26A2,solute carrier family 26 member 2,5q32
681,Hypokalemic periodic paralysis,SCN4A,sodium voltage-gated channel alpha subunit 4,17q23.3
681,Hypokalemic periodic paralysis,CACNA1S,calcium voltage-gated channel subunit alpha1 S,1q32.1
681,Hypokalemic periodic paralysis,KCNE3,potassium voltage-gated channel subfamily E regulatory subunit 3,11q13.4
107,BOR syndrome,SIX1,SIX homeobox 1,14q23.1
107,BOR syndrome,EYA1,EYA transcriptional coactivator and phosphatase 1,8q13.3
107,BOR syndrome,SIX5,SIX homeobox 5,19q13.32
774,Hereditary hemorrhagic telangiectasia,ACVRL1,activin A receptor like type 1,12q13.13
774,Hereditary hemorrhagic telangiectasia,SMAD4,SMAD family member 4,18q21.2
774,Hereditary hemorrhagic telangiectasia,ENG,endoglin,9q34.11
774,Hereditary hemorrhagic telangiectasia,GDF2,growth differentiation factor 2,10q11.22
794,Saethre-Chotzen syndrome,FGFR3,fibroblast growth factor receptor 3,4p16.3
794,Saethre-Chotzen syndrome,FGFR2,fibroblast growth factor receptor 2,10q26.13
794,Saethre-Chotzen syndrome,TWIST1,twist family bHLH transcription factor 1,7p21.1
2869,Peutz-Jeghers syndrome,STK11,serine/threonine kinase 11,19p13.3
893,WAGR syndrome,WT1,WT1 transcription factor,11p13
893,WAGR syndrome,PAX6,paired box 6,11p13
893,WAGR syndrome,BDNF,brain derived neurotrophic factor,11p14.1
912,Zellweger syndrome,PEX11B,peroxisomal biogenesis factor 11 beta,1q21.1
912,Zellweger syndrome,PEX2,peroxisomal biogenesis factor 2,8q21.13
912,Zellweger syndrome,PEX1,peroxisomal biogenesis factor 1,7q21.2
912,Zellweger syndrome,PEX10,peroxisomal biogenesis factor 10,1p36.32
912,Zellweger syndrome,PEX12,peroxisomal biogenesis factor 12,17q12
912,Zellweger syndrome,PEX13,peroxisomal biogenesis factor 13,2p15
912,Zellweger syndrome,PEX14,peroxisomal biogenesis factor 14,1p36.22
912,Zellweger syndrome,PEX16,peroxisomal biogenesis factor 16,11p11.2
912,Zellweger syndrome,PEX19,peroxisomal biogenesis factor 19,1q23.2
912,Zellweger syndrome,PEX26,peroxisomal biogenesis factor 26,22q11.21
912,Zellweger syndrome,PEX3,peroxisomal biogenesis factor 3,6q24.2
912,Zellweger syndrome,PEX5,peroxisomal biogenesis factor 5,12p13.31
912,Zellweger syndrome,PEX6,peroxisomal biogenesis factor 6,6p21.1
53,Albers-Schönberg osteopetrosis,CLCN7,chloride voltage-gated channel 7,16p13.3
14,Abetalipoproteinemia,MTTP,microsomal triglyceride transfer protein,4q23
167,Chédiak-Higashi syndrome,LYST,lysosomal trafficking regulator,1q42.3
207,Crouzon syndrome,FGFR2,fibroblast growth factor receptor 2,10q26.13
207,Crouzon syndrome,ERF,ETS2 repressor factor,19q13.2
201,Cowden syndrome,PTEN,phosphatase and tensin homolog,10q23.31
201,Cowden syndrome,USF3,upstream transcription factor family member 3,3q13.2
201,Cowden syndrome,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
201,Cowden syndrome,SDHB,succinate dehydrogenase complex iron sulfur subunit B,1p36.13
201,Cowden syndrome,SDHD,succinate dehydrogenase complex subunit D,11q23.1
201,Cowden syndrome,SDHC,succinate dehydrogenase complex subunit C,1q23.3
201,Cowden syndrome,SEC23B,"SEC23 homolog B, COPII coat complex component",20p11.23
201,Cowden syndrome,AKT1,AKT serine/threonine kinase 1,14q32.33
201,Cowden syndrome,KLLN,"killin, p53 regulated DNA replication inhibitor",10q23
192,Coffin-Lowry syndrome,RPS6KA3,ribosomal protein S6 kinase A3,Xp22.12
169808,Mild hemophilia A,F8,coagulation factor VIII,Xq28
169802,Severe hemophilia A,F8,coagulation factor VIII,Xq28
169805,Moderate hemophilia A,F8,coagulation factor VIII,Xq28
562,McCune-Albright syndrome,GNAS,GNAS complex locus,20q13.32
565,Menkes disease,ATP7A,ATPase copper transporting alpha,Xq21.1
474,Jeune syndrome,KIAA0753,KIAA0753,17p13.1
474,Jeune syndrome,DYNC2LI1,dynein cytoplasmic 2 light intermediate chain 1,2p21
474,Jeune syndrome,IFT80,intraflagellar transport 80,3q25.33
474,Jeune syndrome,DYNC2H1,dynein cytoplasmic 2 heavy chain 1,11q22.3
474,Jeune syndrome,TTC21B,tetratricopeptide repeat domain 21B,2q24.3
474,Jeune syndrome,WDR19,WD repeat domain 19,4p14
474,Jeune syndrome,IFT140,intraflagellar transport 140,16p13.3
474,Jeune syndrome,DYNC2I1,dynein 2 intermediate chain 1,7q36.3
474,Jeune syndrome,IFT172,intraflagellar transport 172,2p23.3
474,Jeune syndrome,DYNC2I2,dynein 2 intermediate chain 2,9q34.11
474,Jeune syndrome,CEP120,centrosomal protein 120,5q23.2
540,Familial hemophagocytic lymphohistiocytosis,PRF1,perforin 1,10q22.1
540,Familial hemophagocytic lymphohistiocytosis,STX11,syntaxin 11,6q24.2
540,Familial hemophagocytic lymphohistiocytosis,UNC13D,unc-13 homolog D,17q25.3
540,Familial hemophagocytic lymphohistiocytosis,STXBP2,syntaxin binding protein 2,19p13.2
568,"Microphthalmia, Lenz type",BCOR,BCL6 corepressor,Xp11.4
568,"Microphthalmia, Lenz type",NAA10,"N-alpha-acetyltransferase 10, NatA catalytic subunit",Xq28
564,Meckel syndrome,TXNDC15,thioredoxin domain containing 15,5q31.1
564,Meckel syndrome,TMEM107,transmembrane protein 107,17p13.1
564,Meckel syndrome,TCTN1,tectonic family member 1,12q24.11
564,Meckel syndrome,TMEM237,transmembrane protein 237,2q33.1
564,Meckel syndrome,RPGRIP1,RPGR interacting protein 1,14q11.2
564,Meckel syndrome,CEP290,centrosomal protein 290,12q21.32
564,Meckel syndrome,TMEM67,transmembrane protein 67,8q22.1
564,Meckel syndrome,MKS1,MKS transition zone complex subunit 1,17q22
564,Meckel syndrome,RPGRIP1L,RPGRIP1 like,16q12.2
564,Meckel syndrome,CC2D2A,coiled-coil and C2 domain containing 2A,4p15.32
564,Meckel syndrome,TMEM216,transmembrane protein 216,11q13.1
564,Meckel syndrome,TCTN3,tectonic family member 3,10q24.1
564,Meckel syndrome,TCTN2,tectonic family member 2,12q24.31
564,Meckel syndrome,B9D1,B9 domain containing 1,17p11.2
564,Meckel syndrome,B9D2,B9 domain containing 2,19q13.2
564,Meckel syndrome,TMEM231,transmembrane protein 231,16q23.1
564,Meckel syndrome,CSPP1,centrosome and spindle pole associated protein 1,8q13.1-q13.2
289,Ellis Van Creveld syndrome,DYNC2LI1,dynein cytoplasmic 2 light intermediate chain 1,2p21
289,Ellis Van Creveld syndrome,GLI1,GLI family zinc finger 1,12q13.3
289,Ellis Van Creveld syndrome,EVC2,EvC ciliary complex subunit 2,4p16.2
289,Ellis Van Creveld syndrome,EVC,EvC ciliary complex subunit 1,4p16.2
289,Ellis Van Creveld syndrome,PRKACA,protein kinase cAMP-activated catalytic subunit alpha,19p13.12
289,Ellis Van Creveld syndrome,PRKACB,protein kinase cAMP-activated catalytic subunit beta,1p31.1
258,Laminin subunit alpha 2-related congenital muscular dystrophy,LAMA2,laminin subunit alpha 2,6q22.33
1646,Chromosome Y microdeletion syndrome,AZF1,azoospermia factor 1,Yq11
1646,Chromosome Y microdeletion syndrome,USP9Y,ubiquitin specific peptidase 9 Y-linked,Yq11.221
1646,Chromosome Y microdeletion syndrome,DAZ1,deleted in azoospermia 1,Yq11.223
1646,Chromosome Y microdeletion syndrome,DAZ2,deleted in azoospermia 2,Yq11.223
1646,Chromosome Y microdeletion syndrome,DAZ3,deleted in azoospermia 3,Yq11.23
1646,Chromosome Y microdeletion syndrome,DAZ4,deleted in azoospermia 4,Yq11.23
1646,Chromosome Y microdeletion syndrome,DDX3Y,DEAD-box helicase 3 Y-linked,Yq11.221
1646,Chromosome Y microdeletion syndrome,RBMY1A1,RNA binding motif protein Y-linked family 1 member A1,Yq11.223
1646,Chromosome Y microdeletion syndrome,TSPY1,testis specific protein Y-linked 1,Yp11.2
169464,Primary CD59 deficiency,CD59,CD59 molecule (CD59 blood group),11p13
87,Apert syndrome,FGFR2,fibroblast growth factor receptor 2,10q26.13
97,Familial paroxysmal ataxia,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
169467,Recurrent Neisseria infections due to factor D deficiency,CFD,complement factor D,19p13.3
313,Lamellar ichthyosis,SULT2B1,sulfotransferase family 2B member 1,19q13.33
313,Lamellar ichthyosis,ASPRV1,aspartic peptidase retroviral like 1,2p13.3
313,Lamellar ichthyosis,SDR9C7,short chain dehydrogenase/reductase family 9C member 7,12q13.3
313,Lamellar ichthyosis,ABCA12,ATP binding cassette subfamily A member 12,2q35
313,Lamellar ichthyosis,ALOX12B,"arachidonate 12-lipoxygenase, 12R type",17p13.1
313,Lamellar ichthyosis,ALOXE3,arachidonate epidermal lipoxygenase 3,17p13.1
313,Lamellar ichthyosis,TGM1,transglutaminase 1,14q12
313,Lamellar ichthyosis,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19p13.12
313,Lamellar ichthyosis,NIPAL4,NIPA like domain containing 4,5q33.3
313,Lamellar ichthyosis,LIPN,lipase family member N,10q23.31
169799,Mild hemophilia B,F9,coagulation factor IX,Xq27.1
169796,Moderate hemophilia B,F9,coagulation factor IX,Xq27.1
169793,Severe hemophilia B,F9,coagulation factor IX,Xq27.1
1000,Ocular albinism with late-onset sensorineural deafness,AP3D1,adaptor related protein complex 3 subunit delta 1,19p13.3
171430,Severe congenital nemaline myopathy,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
171430,Severe congenital nemaline myopathy,NEB,nebulin,2q23.3
171430,Severe congenital nemaline myopathy,KLHL40,kelch like family member 40,3p22.1
171430,Severe congenital nemaline myopathy,KLHL41,kelch like family member 41,2q31.1
171430,Severe congenital nemaline myopathy,LMOD3,leiomodin 3,3p14.1
171433,Intermediate nemaline myopathy,TPM3,tropomyosin 3,1q21.3
171433,Intermediate nemaline myopathy,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
171433,Intermediate nemaline myopathy,NEB,nebulin,2q23.3
171433,Intermediate nemaline myopathy,KLHL41,kelch like family member 41,2q31.1
171436,Typical nemaline myopathy,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
171436,Typical nemaline myopathy,CFL2,cofilin 2,14q13.1
171436,Typical nemaline myopathy,TPM2,tropomyosin 2,9p13.3
171436,Typical nemaline myopathy,NEB,nebulin,2q23.3
171436,Typical nemaline myopathy,KLHL41,kelch like family member 41,2q31.1
171436,Typical nemaline myopathy,LMOD3,leiomodin 3,3p14.1
171439,Childhood-onset nemaline myopathy,TPM2,tropomyosin 2,9p13.3
171439,Childhood-onset nemaline myopathy,MYPN,myopalladin,10q21.3
171439,Childhood-onset nemaline myopathy,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
171439,Childhood-onset nemaline myopathy,TPM3,tropomyosin 3,1q21.3
171439,Childhood-onset nemaline myopathy,NEB,nebulin,2q23.3
171439,Childhood-onset nemaline myopathy,KBTBD13,kelch repeat and BTB domain containing 13,15q22.31
171439,Childhood-onset nemaline myopathy,KLHL41,kelch like family member 41,2q31.1
171445,Muscle filaminopathy,FLNC,filamin C,7q32.1
171607,X-linked spastic paraplegia type 34,SPG34,spastic paraplegia 34 (autosomal dominant),reserved
2771,Bruck syndrome,PLOD2,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",3q24
2771,Bruck syndrome,FKBP10,FKBP prolyl isomerase 10,17q21.2
171612,Autosomal dominant spastic paraplegia type 37,SPG37,spastic paraplegia 37 (autosomal dominant),8p21.2-q13.3
171612,Autosomal dominant spastic paraplegia type 37,KPNA3,karyopherin subunit alpha 3,13q14.2
171617,Autosomal dominant spastic paraplegia type 38,SPG38,"spastic paraplegia 38 (autosomal dominant, Silver syndrome)",4p16-p15
1349,Mitochondrial DNA-related cardiomyopathy and hearing loss,MT-TK,mitochondrially encoded tRNA-Lys (AAA/G),mitochondria
171622,Autosomal recessive spastic paraplegia type 32,SPG32,spastic paraplegia 32 (autosomal recessive),14q12-q21
171629,Autosomal recessive spastic paraplegia type 35,FA2H,fatty acid 2-hydroxylase,16q23.1
861,Treacher-Collins syndrome,POLR1B,RNA polymerase I subunit B,2q14.1
861,Treacher-Collins syndrome,TCOF1,treacle ribosome biogenesis factor 1,5q32-q33.1
861,Treacher-Collins syndrome,POLR1D,RNA polymerase I and III subunit D,13q12.2
861,Treacher-Collins syndrome,POLR1C,RNA polymerase I and III subunit C,6p21.1
308,Progressive myoclonic epilepsy type 1,CSTB,cystatin B,21q22.3
308,Progressive myoclonic epilepsy type 1,SCARB2,scavenger receptor class B member 2,4q21.1
308,Progressive myoclonic epilepsy type 1,PRICKLE1,prickle planar cell polarity protein 1,12q12
199,Cornelia de Lange syndrome,SMC1A,structural maintenance of chromosomes 1A,Xp11.22
199,Cornelia de Lange syndrome,NIPBL,NIPBL cohesin loading factor,5p13.2
199,Cornelia de Lange syndrome,SMC3,structural maintenance of chromosomes 3,10q25.2
199,Cornelia de Lange syndrome,HDAC8,histone deacetylase 8,Xq13.1
199,Cornelia de Lange syndrome,RAD21,RAD21 cohesin complex component,8q24.11
199,Cornelia de Lange syndrome,BRD4,bromodomain containing 4,19p13.12
930,Idiopathic achalasia,CRLF1,cytokine receptor like factor 1,19p12
930,Idiopathic achalasia,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",6p21.32
930,Idiopathic achalasia,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",6p21.32
930,Idiopathic achalasia,NOS1,nitric oxide synthase 1,12q24.22
1727,22q11.2 duplication syndrome,TBX1,T-box transcription factor 1,22q11.21
169079,Cernunnos-XLF deficiency,NHEJ1,non-homologous end joining factor 1,2q35
168984,CLAPO syndrome,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
169100,Immunodeficiency due to CD25 deficiency,IL2RA,interleukin 2 receptor subunit alpha,10p15.1
169095,Severe combined immunodeficiency due to FOXN1 deficiency,FOXN1,forkhead box N1,17q11.2
169082,Combined immunodeficiency due to CD3gamma deficiency,CD3G,CD3 gamma subunit of T-cell receptor complex,11q23.3
169085,Susceptibility to respiratory infections associated with CD8alpha chain mutation,CD8A,CD8 subunit alpha,2p11.2
168829,Primary peritoneal carcinoma,BRCA1,BRCA1 DNA repair associated,17q21.31
753,"46,XY difference of sex development due to 5-alpha-reductase 2 deficiency",SRD5A2,steroid 5 alpha-reductase 2,2p23.1
868,Triose phosphate-isomerase deficiency,TPI1,triosephosphate isomerase 1,12p13.31
218,Darier disease,ATP2A2,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,12q24.11
168796,"Heart-hand syndrome, Slovenian type",LMNA,lamin A/C,1q22
1465,Coffin-Siris syndrome,ARID2,AT-rich interaction domain 2,12q12
1465,Coffin-Siris syndrome,SMARCB1,SWI/SNF related BAF chromatin remodeling complex subunit B1,22q11.23
1465,Coffin-Siris syndrome,SMARCA4,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4,19p13.2
1465,Coffin-Siris syndrome,ARID1B,AT-rich interaction domain 1B,6q25.3
1465,Coffin-Siris syndrome,ARID1A,AT-rich interaction domain 1A,1p36.11
1465,Coffin-Siris syndrome,SMARCE1,SWI/SNF related BAF chromatin remodeling complex subunit E1,17q21.2
1465,Coffin-Siris syndrome,SOX11,SRY-box transcription factor 11,2p25.2
1465,Coffin-Siris syndrome,SOX4,SRY-box transcription factor 4,6p22.3
1465,Coffin-Siris syndrome,DPF2,double PHD fingers 2,11q13.1
1465,Coffin-Siris syndrome,SMARCD1,SWI/SNF related BAF chromatin remodeling complex subunit D1,12q13.12
1465,Coffin-Siris syndrome,SMARCC2,SWI/SNF related BAF chromatin remodeling complex subunit C2,12q13.2
168953,Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement,FGFR1,fibroblast growth factor receptor 1,8p11.23
168950,Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement,PDGFRB,platelet derived growth factor receptor beta,5q32
168947,Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement,PDGFRA,platelet derived growth factor receptor alpha,4q12
168940,Chronic eosinophilic leukemia,FIP1L1,factor interacting with PAPOLA and CPSF1,4q12
168940,Chronic eosinophilic leukemia,PDGFRA,platelet derived growth factor receptor alpha,4q12
2609,Isolated complex I deficiency,TMEM126B,transmembrane protein 126B,11q14.1
2609,Isolated complex I deficiency,NDUFAF8,NADH:ubiquinone oxidoreductase complex assembly factor 8,17q25.3
2609,Isolated complex I deficiency,TIMMDC1,translocase of inner mitochondrial membrane domain containing 1,3q13.33
2609,Isolated complex I deficiency,NDUFB11,NADH:ubiquinone oxidoreductase subunit B11,Xp11.3
2609,Isolated complex I deficiency,NDUFA6,NADH:ubiquinone oxidoreductase subunit A6,22q13.2
2609,Isolated complex I deficiency,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,mitochondria
2609,Isolated complex I deficiency,MT-ND2,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2,mitochondria
2609,Isolated complex I deficiency,MT-ND3,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3,mitochondria
2609,Isolated complex I deficiency,NDUFAF2,NADH:ubiquinone oxidoreductase complex assembly factor 2,5q12.1
2609,Isolated complex I deficiency,NDUFS1,NADH:ubiquinone oxidoreductase core subunit S1,2q33.3
2609,Isolated complex I deficiency,NDUFS2,NADH:ubiquinone oxidoreductase core subunit S2,1q23.3
2609,Isolated complex I deficiency,NDUFS3,NADH:ubiquinone oxidoreductase core subunit S3,11p11.2
2609,Isolated complex I deficiency,NDUFS4,NADH:ubiquinone oxidoreductase subunit S4,5q11.2
2609,Isolated complex I deficiency,NDUFS6,NADH:ubiquinone oxidoreductase subunit S6,5p15.33
2609,Isolated complex I deficiency,NDUFS7,NADH:ubiquinone oxidoreductase core subunit S7,19p13.3
2609,Isolated complex I deficiency,NDUFS8,NADH:ubiquinone oxidoreductase core subunit S8,11q13.2
2609,Isolated complex I deficiency,NDUFV1,NADH:ubiquinone oxidoreductase core subunit V1,11q13.2
2609,Isolated complex I deficiency,NDUFV2,NADH:ubiquinone oxidoreductase core subunit V2,18p11.22
2609,Isolated complex I deficiency,NDUFA1,NADH:ubiquinone oxidoreductase subunit A1,Xq24
2609,Isolated complex I deficiency,NDUFAF4,NADH:ubiquinone oxidoreductase complex assembly factor 4,6q16.1
2609,Isolated complex I deficiency,NDUFAF5,NADH:ubiquinone oxidoreductase complex assembly factor 5,20p12.1
2609,Isolated complex I deficiency,NDUFA11,NADH:ubiquinone oxidoreductase subunit A11,19p13.3
2609,Isolated complex I deficiency,NDUFAF3,NADH:ubiquinone oxidoreductase complex assembly factor 3,3p21.31
2609,Isolated complex I deficiency,NUBPL,"NUBP iron-sulfur cluster assembly factor, mitochondrial",14q12
2609,Isolated complex I deficiency,FOXRED1,FAD dependent oxidoreductase domain containing 1,11q24.2
2609,Isolated complex I deficiency,NDUFAF1,NADH:ubiquinone oxidoreductase complex assembly factor 1,15q15.1
2609,Isolated complex I deficiency,NDUFB9,NADH:ubiquinone oxidoreductase subunit B9,8q24.13
2609,Isolated complex I deficiency,NDUFB3,NADH:ubiquinone oxidoreductase subunit B3,2q33.1
2609,Isolated complex I deficiency,NDUFB10,NADH:ubiquinone oxidoreductase subunit B10,16p13.3
626,Large/giant congenital melanocytic nevus,ZEB2,zinc finger E-box binding homeobox 2,2q22.3
626,Large/giant congenital melanocytic nevus,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
626,Large/giant congenital melanocytic nevus,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",3p25.2
626,Large/giant congenital melanocytic nevus,ALK,ALK receptor tyrosine kinase,2p23.2-p23.1
626,Large/giant congenital melanocytic nevus,NRAS,"NRAS proto-oncogene, GTPase",1p13.2
626,Large/giant congenital melanocytic nevus,SOX5,SRY-box transcription factor 5,12p12.1
626,Large/giant congenital melanocytic nevus,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
773,Refsum disease,PHYH,phytanoyl-CoA 2-hydroxylase,10p13
773,Refsum disease,PEX7,peroxisomal biogenesis factor 7,6q23.3
169154,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency,IL7R,interleukin 7 receptor,5p13.2
169150,Immunodeficiency due to a late component of complement deficiency,C5,complement C5,9q33.2
169150,Immunodeficiency due to a late component of complement deficiency,C6,complement C6,5p13.1
169150,Immunodeficiency due to a late component of complement deficiency,C7,complement C7,5p13.1
169150,Immunodeficiency due to a late component of complement deficiency,C8A,complement C8 alpha chain,1p32.2
169150,Immunodeficiency due to a late component of complement deficiency,C8B,complement C8 beta chain,1p32.2
169150,Immunodeficiency due to a late component of complement deficiency,C8G,complement C8 gamma chain,9q34.3
169150,Immunodeficiency due to a late component of complement deficiency,C9,complement C9,5p13.1
169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,CD3D,CD3 delta subunit of T-cell receptor complex,11q23.3
169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,CD3E,CD3 epsilon subunit of T-cell receptor complex,11q23.3
169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,CD247,CD247 molecule,1q24.2
169157,T-B+ severe combined immunodeficiency due to CD45 deficiency,PTPRC,protein tyrosine phosphatase receptor type C,1q31.3-q32.1
1947,Northern epilepsy,CLN8,CLN8 transmembrane ER and ERGIC protein,8p23.3
169147,Immunodeficiency due to a classical component pathway complement deficiency,C2,complement C2,6p21.33
169147,Immunodeficiency due to a classical component pathway complement deficiency,C4A,complement C4A (Chido/Rodgers blood group),6p21.33
169147,Immunodeficiency due to a classical component pathway complement deficiency,C4B,complement C4B (Chido/Rodgers blood group),6p21.33
169147,Immunodeficiency due to a classical component pathway complement deficiency,C1QA,complement C1q A chain,1p36.12
169147,Immunodeficiency due to a classical component pathway complement deficiency,C1QB,complement C1q B chain,1p36.12
169147,Immunodeficiency due to a classical component pathway complement deficiency,C1QC,complement C1q C chain,1p36.12
169147,Immunodeficiency due to a classical component pathway complement deficiency,C1S,complement C1s,12p13.31
169147,Immunodeficiency due to a classical component pathway complement deficiency,C1R,complement C1r,12p13.31
169142,Recurrent infections due to specific granule deficiency,CEBPE,CCAAT enhancer binding protein epsilon,14q11.2
169142,Recurrent infections due to specific granule deficiency,SMARCD2,SWI/SNF related BAF chromatin remodeling complex subunit D2,17q23.3
596,X-linked centronuclear myopathy,MTM1,myotubularin 1,Xq28
610,Bethlem muscular dystrophy,COL6A1,collagen type VI alpha 1 chain,21q22.3
610,Bethlem muscular dystrophy,COL6A2,collagen type VI alpha 2 chain,21q22.3
610,Bethlem muscular dystrophy,COL6A3,collagen type VI alpha 3 chain,2q37.3
610,Bethlem muscular dystrophy,COL12A1,collagen type XII alpha 1 chain,6q13-q14.1
169186,Autosomal recessive centronuclear myopathy,TTN,titin,2q31.2
169186,Autosomal recessive centronuclear myopathy,SPEG,striated muscle enriched protein kinase,2q35
169186,Autosomal recessive centronuclear myopathy,RYR1,ryanodine receptor 1,19q13.2
169186,Autosomal recessive centronuclear myopathy,BIN1,bridging integrator 1,2q14.3
464,Incontinentia pigmenti,IKBKG,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,Xq28
169189,Autosomal dominant centronuclear myopathy,RYR1,ryanodine receptor 1,19q13.2
169189,Autosomal dominant centronuclear myopathy,DNM2,dynamin 2,19p13.2
169189,Autosomal dominant centronuclear myopathy,MYF6,myogenic factor 6,12q21.31
169189,Autosomal dominant centronuclear myopathy,BIN1,bridging integrator 1,2q14.3
169189,Autosomal dominant centronuclear myopathy,MTMR14,myotubularin related protein 14,3p25.3
44,Neonatal adrenoleukodystrophy,PEX2,peroxisomal biogenesis factor 2,8q21.13
44,Neonatal adrenoleukodystrophy,PEX1,peroxisomal biogenesis factor 1,7q21.2
44,Neonatal adrenoleukodystrophy,PEX10,peroxisomal biogenesis factor 10,1p36.32
44,Neonatal adrenoleukodystrophy,PEX12,peroxisomal biogenesis factor 12,17q12
44,Neonatal adrenoleukodystrophy,PEX13,peroxisomal biogenesis factor 13,2p15
44,Neonatal adrenoleukodystrophy,PEX14,peroxisomal biogenesis factor 14,1p36.22
44,Neonatal adrenoleukodystrophy,PEX16,peroxisomal biogenesis factor 16,11p11.2
44,Neonatal adrenoleukodystrophy,PEX19,peroxisomal biogenesis factor 19,1q23.2
44,Neonatal adrenoleukodystrophy,PEX26,peroxisomal biogenesis factor 26,22q11.21
44,Neonatal adrenoleukodystrophy,PEX3,peroxisomal biogenesis factor 3,6q24.2
44,Neonatal adrenoleukodystrophy,PEX5,peroxisomal biogenesis factor 5,12p13.31
44,Neonatal adrenoleukodystrophy,PEX6,peroxisomal biogenesis factor 6,6p21.1
44,Neonatal adrenoleukodystrophy,PEX11B,peroxisomal biogenesis factor 11 beta,1q21.1
56,Alkaptonuria,HGD,"homogentisate 1,2-dioxygenase",3q13.33
963,Acromegaly,AIP,AHR interacting HSP90 co-chaperone,11q13.2
963,Acromegaly,GPR101,G protein-coupled receptor 101,Xq26.3
1059,Blue rubber bleb nevus,TEK,TEK receptor tyrosine kinase,9p21.2
22,Succinic semialdehyde dehydrogenase deficiency,ALDH5A1,aldehyde dehydrogenase 5 family member A1,6p22.3
29,Mevalonic aciduria,MVK,mevalonate kinase,12q24.11
245,Nager syndrome,SF3B4,splicing factor 3b subunit 4,1q21.2
30,Hereditary orotic aciduria,UMPS,uridine monophosphate synthetase,3q21.2
36,Acrocallosal syndrome,GLI3,GLI family zinc finger 3,7p14.1
36,Acrocallosal syndrome,KIF7,kinesin family member 7,15q26.1
915,Aarskog-Scott syndrome,FGD1,"FYVE, RhoGEF and PH domain containing 1",Xp11.22
2614,Nail-patella syndrome,LMX1B,LIM homeobox transcription factor 1 beta,9q33.3
33,Isovaleric acidemia,IVD,isovaleryl-CoA dehydrogenase,15q15.1
819,Smith-Magenis syndrome,DEAF1,DEAF1 transcription factor,11p15.5
819,Smith-Magenis syndrome,RAI1,retinoic acid induced 1,17p11.2
819,Smith-Magenis syndrome,FLII,FLII actin remodeling protein,17p11.2
819,Smith-Magenis syndrome,IQSEC2,IQ motif and Sec7 domain ArfGEF 2,Xp11.22
168615,Hereditary persistence of alpha-fetoprotein,AFP,alpha fetoprotein,4q13.3
168612,Congenital deficiency in alpha-fetoprotein,AFP,alpha fetoprotein,4q13.3
1452,Cleidocranial dysplasia,RUNX2,RUNX family transcription factor 2,6p21.1
168629,Autosomal thrombocytopenia with normal platelets,IKZF5,IKAROS family zinc finger 5,10q26.13
168629,Autosomal thrombocytopenia with normal platelets,ETV6,ETS variant transcription factor 6,12p13.2
168629,Autosomal thrombocytopenia with normal platelets,MASTL,microtubule associated serine/threonine kinase like,10p12.1
168629,Autosomal thrombocytopenia with normal platelets,CYCS,"cytochrome c, somatic",7p15.3
168629,Autosomal thrombocytopenia with normal platelets,ANKRD26,ankyrin repeat domain containing 26,10p12.1
168624,"Familial scaphocephaly syndrome, McGillivray type",FGFR2,fibroblast growth factor receptor 2,10q26.13
193,Cohen syndrome,VPS13B,vacuolar protein sorting 13 homolog B,8q22.2
1334,Chronic mucocutaneous candidiasis,CLEC7A,C-type lectin domain containing 7A,12p13.2
1334,Chronic mucocutaneous candidiasis,IL17RA,interleukin 17 receptor A,22q11.1
1334,Chronic mucocutaneous candidiasis,IL17F,interleukin 17F,6p12.2
1334,Chronic mucocutaneous candidiasis,TRAF3IP2,TRAF3 interacting protein 2,6q21
1334,Chronic mucocutaneous candidiasis,IL17RC,interleukin 17 receptor C,3p25.3
168583,Hereditary North American Indian childhood cirrhosis,UTP4,UTP4 small subunit processome component,16q22.1
1369,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome,TKFC,triokinase and FMN cyclase,11q12.2
1369,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome,SLC25A4,solute carrier family 25 member 4,4q35.1
1369,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome,AGK,acylglycerol kinase,7q34
168577,Hereditary cryohydrocytosis with reduced stomatin,SLC2A1,solute carrier family 2 member 1,1p34.2
168593,Sudden infant death-dysgenesis of the testes syndrome,TSPYL1,TSPY like 1,6q22.1
168588,Hyperandrogenism due to cortisone reductase deficiency,H6PD,hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,1p36.22
168588,Hyperandrogenism due to cortisone reductase deficiency,HSD11B1,hydroxysteroid 11-beta dehydrogenase 1,1q32.2
168601,Congenital enteropathy due to enteropeptidase deficiency,TMPRSS15,transmembrane serine protease 15,21q21.1
168598,Methionine adenosyltransferase I/III deficiency,MAT1A,methionine adenosyltransferase 1A,10q22.3
168606,Seborrhea-like dermatitis with psoriasiform elements,ZNF750,zinc finger protein 750,17q25.3
1154,Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome,PIEZO2,piezo type mechanosensitive ion channel component 2,18p11.22-p11.21
168558,"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency",CYP11A1,cytochrome P450 family 11 subfamily A member 1,15q24.1
168563,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",DHH,desert hedgehog signaling molecule,12q13.12
124,Diamond-Blackfan anemia,RPL18,ribosomal protein L18,19q13.33
124,Diamond-Blackfan anemia,RPS27,ribosomal protein S27,1q21.3
124,Diamond-Blackfan anemia,RPL27,ribosomal protein L27,17q21.31
124,Diamond-Blackfan anemia,RPS15A,ribosomal protein S15a,16p12.3
124,Diamond-Blackfan anemia,TSR2,TSR2 ribosome maturation factor,Xp11.22
124,Diamond-Blackfan anemia,RPL35,ribosomal protein L35,9q33.3
124,Diamond-Blackfan anemia,RPL8,ribosomal protein L8,8q24.3
124,Diamond-Blackfan anemia,HEATR3,HEAT repeat containing 3,16q12.1
124,Diamond-Blackfan anemia,RPL31,ribosomal protein L31,2q11.2
124,Diamond-Blackfan anemia,RPL9,ribosomal protein L9,4p14
124,Diamond-Blackfan anemia,ADA2,adenosine deaminase 2,22q11.1
124,Diamond-Blackfan anemia,RPS20,ribosomal protein S20,8q12.1
124,Diamond-Blackfan anemia,RPS19,ribosomal protein S19,19q13.2
124,Diamond-Blackfan anemia,RPS24,ribosomal protein S24,10q22.3
124,Diamond-Blackfan anemia,GATA1,GATA binding protein 1,Xp11.23
124,Diamond-Blackfan anemia,RPS17,ribosomal protein S17,15q25.2
124,Diamond-Blackfan anemia,RPS7,ribosomal protein S7,2p25.3
124,Diamond-Blackfan anemia,RPL5,ribosomal protein L5,1p22.1
124,Diamond-Blackfan anemia,RPL11,ribosomal protein L11,1p36.11
124,Diamond-Blackfan anemia,RPL35A,ribosomal protein L35a,3q29
124,Diamond-Blackfan anemia,RPS10,ribosomal protein S10,6p21.31
124,Diamond-Blackfan anemia,RPS26,ribosomal protein S26,12q13.2
124,Diamond-Blackfan anemia,RPL26,ribosomal protein L26,17p13.1
124,Diamond-Blackfan anemia,RPL15,ribosomal protein L15,3p24.2
124,Diamond-Blackfan anemia,RPS29,ribosomal protein S29,14q21.3
124,Diamond-Blackfan anemia,RPS28,ribosomal protein S28,19p13.2
168566,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3,TSFM,"Ts translation elongation factor, mitochondrial",12q14.1
1310,Caffey disease,COL1A1,collagen type I alpha 1 chain,17q21.33
168569,H syndrome,SLC29A3,solute carrier family 29 member 3,10q22.1
168572,Native American myopathy,STAC3,SH3 and cysteine rich domain 3,12q13.3
125,Bloom syndrome,BLM,BLM RecQ like helicase,15q26.1
90,Argininemia,ARG1,arginase 1,6q23.2
1065,Aniridia-cerebellar ataxia-intellectual disability syndrome,ITPR1,"inositol 1,4,5-trisphosphate receptor type 1",3p26.1
1065,Aniridia-cerebellar ataxia-intellectual disability syndrome,PAX6,paired box 6,11p13
168454,"Spondyloepimetaphyseal dysplasia, Geneviève type",NANS,N-acetylneuraminate synthase,9q22.33
1146,Distal arthrogryposis type 1,NALCN,"sodium leak channel, non-selective",13q32.3-q33.1
1146,Distal arthrogryposis type 1,TNNI2,"troponin I2, fast skeletal type",11p15.5
1146,Distal arthrogryposis type 1,TNNT3,"troponin T3, fast skeletal type",11p15.5
1146,Distal arthrogryposis type 1,TPM2,tropomyosin 2,9p13.3
1146,Distal arthrogryposis type 1,MYH3,myosin heavy chain 3,17p13.1
1146,Distal arthrogryposis type 1,MYBPC1,myosin binding protein C1,12q23.2
1143,Neurogenic arthrogryposis multiplex congenita,SCYL2,SCY1 like pseudokinase 2,12q23.1
1143,Neurogenic arthrogryposis multiplex congenita,COL25A1,collagen type XXV alpha 1 chain,4q25
1143,Neurogenic arthrogryposis multiplex congenita,ERGIC1,endoplasmic reticulum-golgi intermediate compartment 1,5q35.1
1147,Sheldon-Hall syndrome,NALCN,"sodium leak channel, non-selective",13q32.3-q33.1
1147,Sheldon-Hall syndrome,TNNI2,"troponin I2, fast skeletal type",11p15.5
1147,Sheldon-Hall syndrome,TNNT3,"troponin T3, fast skeletal type",11p15.5
1147,Sheldon-Hall syndrome,TPM2,tropomyosin 2,9p13.3
1147,Sheldon-Hall syndrome,MYH3,myosin heavy chain 3,17p13.1
246,Postaxial acrofacial dysostosis,DHODH,dihydroorotate dehydrogenase (quinone),16q22.2
1775,Dyskeratosis congenita,NPM1,nucleophosmin 1,5q35.1
1775,Dyskeratosis congenita,DKC1,dyskerin pseudouridine synthase 1,Xq28
1775,Dyskeratosis congenita,TERT,telomerase reverse transcriptase,5p15.33
1775,Dyskeratosis congenita,TERC,telomerase RNA component,3q26.2
1775,Dyskeratosis congenita,TINF2,TERF1 interacting nuclear factor 2,14q12
1775,Dyskeratosis congenita,NOP10,NOP10 ribonucleoprotein,15q14
1775,Dyskeratosis congenita,NHP2,NHP2 ribonucleoprotein,5q35.3
1775,Dyskeratosis congenita,USB1,U6 snRNA biogenesis phosphodiesterase 1,16q21
1775,Dyskeratosis congenita,WRAP53,WD repeat containing antisense to TP53,17p13.1
1775,Dyskeratosis congenita,CTC1,CST telomere replication complex component 1,17p13.1
1775,Dyskeratosis congenita,RTEL1,regulator of telomere elongation helicase 1,20q13.33
1775,Dyskeratosis congenita,PARN,poly(A)-specific ribonuclease,16p13.12
1775,Dyskeratosis congenita,TYMS,thymidylate synthetase,18p11.32
1764,Familial dysautonomia,ELP1,elongator complex protein 1,9q31.3
235,Dubowitz syndrome,LIG4,DNA ligase 4,13q33.3
235,Dubowitz syndrome,NSUN2,NOP2/Sun RNA methyltransferase 2,5p15.31
239,Dyggve-Melchior-Clausen disease,DYM,dymeclin,18q21.1
395,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,MTHFR,methylenetetrahydrofolate reductase,1p36.22
147,Carbamoyl-phosphate synthetase 1 deficiency,CPS1,carbamoyl-phosphate synthase 1,2q34
23,Argininosuccinic aciduria,ASL,argininosuccinate lyase,7q11.21
45,Adenosine monophosphate deaminase deficiency,AMPD1,adenosine monophosphate deaminase 1,1p13.2
45,Adenosine monophosphate deaminase deficiency,AMPD3,adenosine monophosphate deaminase 3,11p15.4
226,Dihydropteridine reductase deficiency,QDPR,quinoid dihydropteridine reductase,4p15.32
1556,Cutis marmorata telangiectatica congenita,GNA11,G protein subunit alpha 11,19p13.3
1556,Cutis marmorata telangiectatica congenita,ARL6IP6,ARF like GTPase 6 interacting protein 6,2q23.3
1496,Corpus callosum agenesis-neuronopathy syndrome,SLC12A6,solute carrier family 12 member 6,15q14
417,Neonatal severe primary hyperparathyroidism,TRPV6,transient receptor potential cation channel subfamily V member 6,7q34
417,Neonatal severe primary hyperparathyroidism,CASR,calcium sensing receptor,3q13.33-q21.1
2248,Hypoplastic left heart syndrome,GJA1,gap junction protein alpha 1,6q22.31
2248,Hypoplastic left heart syndrome,NKX2-5,NK2 homeobox 5,5q35.1
2140,Congenital diaphragmatic hernia,LONP1,"lon peptidase 1, mitochondrial",19p13.2
2140,Congenital diaphragmatic hernia,ZFPM2,"zinc finger protein, FOG family member 2",8q23
2140,Congenital diaphragmatic hernia,GATA6,GATA binding protein 6,18q11.2
2116,Hartnup disease,CLTRN,"collectrin, amino acid transport regulator",Xp22.2
2116,Hartnup disease,SLC6A19,solute carrier family 6 member 19,5p15.33
2118,Hawkinsinuria,HPD,4-hydroxyphenylpyruvate dioxygenase,12q24.31
351,Galactosialidosis,CTSA,cathepsin A,20q13.12
2020,Congenital fiber-type disproportion myopathy,MAP3K20,mitogen-activated protein kinase kinase kinase 20,2q31.1
2020,Congenital fiber-type disproportion myopathy,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
2020,Congenital fiber-type disproportion myopathy,SELENON,selenoprotein N,1p36.11
2020,Congenital fiber-type disproportion myopathy,TPM2,tropomyosin 2,9p13.3
2020,Congenital fiber-type disproportion myopathy,TPM3,tropomyosin 3,1q21.3
2020,Congenital fiber-type disproportion myopathy,MYL2,myosin light chain 2,12q24.11
2020,Congenital fiber-type disproportion myopathy,ITGA7,integrin subunit alpha 7,12q13.2
2020,Congenital fiber-type disproportion myopathy,HACD1,3-hydroxyacyl-CoA dehydratase 1,10p12.33
2053,Freeman-Sheldon syndrome,NALCN,"sodium leak channel, non-selective",13q32.3-q33.1
2053,Freeman-Sheldon syndrome,MYH3,myosin heavy chain 3,17p13.1
1933,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",SUCLA2,succinate-CoA ligase ADP-forming subunit beta,13q14.2
1880,Ebstein malformation of the tricuspid valve,MYH7,myosin heavy chain 7,14q11.2
1885,Isolated ectopia lentis,FBN1,fibrillin 1,15q21.1
1885,Isolated ectopia lentis,ADAMTSL4,ADAMTS like 4,1q21.2
635,Neuroblastoma,MYCN,"MYCN proto-oncogene, bHLH transcription factor",2p24.3
635,Neuroblastoma,LMO1,LIM domain only 1,11p15.4
635,Neuroblastoma,PHOX2B,paired like homeobox 2B,4p13
635,Neuroblastoma,ALK,ALK receptor tyrosine kinase,2p23.2-p23.1
635,Neuroblastoma,HACE1,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,6q16.3
635,Neuroblastoma,LIN28B,lin-28 homolog B,6q16.3-q21
2612,Linear nevus sebaceus syndrome,HRAS,"HRas proto-oncogene, GTPase",11p15.5
2612,Linear nevus sebaceus syndrome,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
2612,Linear nevus sebaceus syndrome,NRAS,"NRAS proto-oncogene, GTPase",1p13.2
2635,Metatropic dysplasia,TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
606,Proximal myotonic myopathy,CNBP,CCHC-type zinc finger nucleic acid binding protein,3q21.3
705,Pendred syndrome,SLC26A4,solute carrier family 26 member 4,7q22.3
705,Pendred syndrome,KCNJ10,potassium inwardly rectifying channel subfamily J member 10,1q23.2
705,Pendred syndrome,FOXI1,forkhead box I1,5q35.1
2801,Juvenile Paget disease,TNFRSF11B,TNF receptor superfamily member 11b,8q24.12
2801,Juvenile Paget disease,TNFRSF11A,TNF receptor superfamily member 11a,18q21.33
2785,Osteopetrosis with renal tubular acidosis,CA2,carbonic anhydrase 2,8q21.2
2744,Horizontal gaze palsy with progressive scoliosis,DCC,DCC netrin 1 receptor,18q21.2
2744,Horizontal gaze palsy with progressive scoliosis,ROBO3,roundabout guidance receptor 3,11q24.2
2746,Opsismodysplasia,INPPL1,inositol polyphosphate phosphatase like 1,11q13.4
2971,Peroxisomal acyl-CoA oxidase deficiency,ACOX1,acyl-CoA oxidase 1,17q25.1
2970,Prune belly syndrome,CHRM3,cholinergic receptor muscarinic 3,1q43
744,Proteus syndrome,AKT1,AKT serine/threonine kinase 1,14q32.33
2903,Familial spontaneous pneumothorax,FLCN,folliculin,17p11.2
2901,Neuralgic amyotrophy,SEPTIN9,septin 9,17q25.3
718,Isolated Pierre Robin sequence,SOX9,SRY-box transcription factor 9,17q24.3
3071,Costello syndrome,HRAS,"HRas proto-oncogene, GTPase",11p15.5
763,Pycnodysostosis,CTSK,cathepsin K,1q21.3
2301,Congenital short bowel syndrome,FLNA,filamin A,Xq28
2301,Congenital short bowel syndrome,CLMP,CXADR like cell adhesion molecule,11q24.1
469,Hereditary fructose intolerance,ALDOB,"aldolase, fructose-bisphosphate B",9q31.1
2308,Jacobsen syndrome,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",11q24.3
2318,Joubert syndrome with oculorenal defect,CEP290,centrosomal protein 290,12q21.32
2318,Joubert syndrome with oculorenal defect,CC2D2A,coiled-coil and C2 domain containing 2A,4p15.32
2318,Joubert syndrome with oculorenal defect,TMEM216,transmembrane protein 216,11q13.1
2318,Joubert syndrome with oculorenal defect,TMEM237,transmembrane protein 237,2q33.1
2318,Joubert syndrome with oculorenal defect,TMEM138,transmembrane protein 138,11q12.2
2318,Joubert syndrome with oculorenal defect,ZNF423,zinc finger protein 423,16q12.1
2318,Joubert syndrome with oculorenal defect,TMEM231,transmembrane protein 231,16q23.1
2253,Foveal hypoplasia-presenile cataract syndrome,PAX6,paired box 6,11p13
180188,Isolated congenital breast hypoplasia/aplasia,PTPRF,protein tyrosine phosphatase receptor type F,1p34.2
502,Trichorhinophalangeal syndrome type 2,RAD21,RAD21 cohesin complex component,8q24.11
502,Trichorhinophalangeal syndrome type 2,TRPS1,transcriptional repressor GATA binding 1,8q23.3
502,Trichorhinophalangeal syndrome type 2,EXT1,exostosin glycosyltransferase 1,8q24.11
477,KID syndrome,GJB2,gap junction protein beta 2,13q12.11
477,KID syndrome,GJB6,gap junction protein beta 6,13q12.11
506,Leigh syndrome,IARS2,"isoleucyl-tRNA synthetase 2, mitochondrial",1q41
2377,Laurence-Moon syndrome,PNPLA6,"patatin like domain 6, lysophospholipase",19p13.2
2466,MASA syndrome,L1CAM,L1 cell adhesion molecule,Xq28
560,Marshall syndrome,COL11A1,collagen type XI alpha 1 chain,1p21.1
570,Moebius syndrome,PLXND1,plexin D1,3q22.1
570,Moebius syndrome,REV3L,"REV3 like, DNA directed polymerase zeta catalytic subunit",6q21
179494,Obesity due to leptin receptor gene deficiency,LEPR,leptin receptor,1p31.3
287,Classical Ehlers-Danlos syndrome,COL5A2,collagen type V alpha 2 chain,2q32.2
287,Classical Ehlers-Danlos syndrome,COL5A1,collagen type V alpha 1 chain,9q34.3
287,Classical Ehlers-Danlos syndrome,COL1A1,collagen type I alpha 1 chain,17q21.33
1020,Early-onset autosomal dominant Alzheimer disease,ABCA7,ATP binding cassette subfamily A member 7,19p13.3
1020,Early-onset autosomal dominant Alzheimer disease,TREM2,triggering receptor expressed on myeloid cells 2,6p21.1
1020,Early-onset autosomal dominant Alzheimer disease,PSEN1,presenilin 1,14q24.2
1020,Early-onset autosomal dominant Alzheimer disease,PSEN2,presenilin 2,1q42.13
1020,Early-onset autosomal dominant Alzheimer disease,APP,amyloid beta precursor protein,21q21.3
1020,Early-onset autosomal dominant Alzheimer disease,SORL1,sortilin related receptor 1,11q24.1
1020,Early-onset autosomal dominant Alzheimer disease,TOMM40,translocase of outer mitochondrial membrane 40,19q13.32
54,X-linked recessive ocular albinism,AP3D1,adaptor related protein complex 3 subunit delta 1,19p13.3
54,X-linked recessive ocular albinism,GPR143,G protein-coupled receptor 143,Xp22.2
154,Familial isolated dilated cardiomyopathy,TAF1A,"TATA-box binding protein associated factor, RNA polymerase I subunit A",1q41
154,Familial isolated dilated cardiomyopathy,GET3,"guided entry of tail-anchored proteins factor 3, ATPase",19p13.13
154,Familial isolated dilated cardiomyopathy,VEZF1,vascular endothelial zinc finger 1,17q22
154,Familial isolated dilated cardiomyopathy,RPL3L,ribosomal protein L3 like,16p13.3
154,Familial isolated dilated cardiomyopathy,MYBPC3,myosin binding protein C3,11p11.2
154,Familial isolated dilated cardiomyopathy,JPH2,junctophilin 2,20q13.12
154,Familial isolated dilated cardiomyopathy,PPCS,phosphopantothenoylcysteine synthetase,1p34.2
154,Familial isolated dilated cardiomyopathy,CAP2,cyclase associated actin cytoskeleton regulatory protein 2,6p22.3
154,Familial isolated dilated cardiomyopathy,LMOD2,leiomodin 2,7q31.32
154,Familial isolated dilated cardiomyopathy,ABCC9,ATP binding cassette subfamily C member 9,12p12.1
154,Familial isolated dilated cardiomyopathy,ACTC1,actin alpha cardiac muscle 1,15q14
154,Familial isolated dilated cardiomyopathy,PSEN1,presenilin 1,14q24.2
154,Familial isolated dilated cardiomyopathy,PSEN2,presenilin 2,1q42.13
154,Familial isolated dilated cardiomyopathy,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
154,Familial isolated dilated cardiomyopathy,SDHA,succinate dehydrogenase complex flavoprotein subunit A,5p15.33
154,Familial isolated dilated cardiomyopathy,SGCD,sarcoglycan delta,5q33.2-q33.3
154,Familial isolated dilated cardiomyopathy,TAFAZZIN,"tafazzin, phospholipid-lysophospholipid transacylase",Xq28
154,Familial isolated dilated cardiomyopathy,TCAP,titin-cap,17q12
154,Familial isolated dilated cardiomyopathy,TNNI3,"troponin I3, cardiac type",19q13.42
154,Familial isolated dilated cardiomyopathy,TNNT2,"troponin T2, cardiac type",1q32.1
154,Familial isolated dilated cardiomyopathy,TPM1,tropomyosin 1,15q22.2
154,Familial isolated dilated cardiomyopathy,TTN,titin,2q31.2
154,Familial isolated dilated cardiomyopathy,CRYAB,crystallin alpha B,11q23.1
154,Familial isolated dilated cardiomyopathy,CSRP3,cysteine and glycine rich protein 3,11p15.1
154,Familial isolated dilated cardiomyopathy,DES,desmin,2q35
154,Familial isolated dilated cardiomyopathy,DMD,dystrophin,Xp21.2-p21.1
154,Familial isolated dilated cardiomyopathy,DSG2,desmoglein 2,18q12.1
154,Familial isolated dilated cardiomyopathy,FKTN,fukutin,9q31.2
154,Familial isolated dilated cardiomyopathy,LDB3,LIM domain binding 3,10q23.2
154,Familial isolated dilated cardiomyopathy,DOLK,dolichol kinase,9q34.11
154,Familial isolated dilated cardiomyopathy,MYH6,myosin heavy chain 6,14q11.2
154,Familial isolated dilated cardiomyopathy,MYH7,myosin heavy chain 7,14q11.2
154,Familial isolated dilated cardiomyopathy,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",3p25.2
154,Familial isolated dilated cardiomyopathy,TMPO,thymopoietin,12q23.1
154,Familial isolated dilated cardiomyopathy,TNNC1,"troponin C1, slow skeletal and cardiac type",3p21.1
154,Familial isolated dilated cardiomyopathy,VCL,vinculin,10q22.2
154,Familial isolated dilated cardiomyopathy,ACTN2,actinin alpha 2,1q43
154,Familial isolated dilated cardiomyopathy,FHL2,four and a half LIM domains 2,2q12.2
154,Familial isolated dilated cardiomyopathy,PLN,phospholamban,6q22.31
154,Familial isolated dilated cardiomyopathy,BAG3,BAG cochaperone 3,10q26.11
154,Familial isolated dilated cardiomyopathy,RBM20,RNA binding motif protein 20,10q25.2
154,Familial isolated dilated cardiomyopathy,NEXN,nexilin F-actin binding protein,1p31.1
154,Familial isolated dilated cardiomyopathy,TXNRD2,thioredoxin reductase 2,22q11.21
154,Familial isolated dilated cardiomyopathy,GATAD1,GATA zinc finger domain containing 1,7q21.2
154,Familial isolated dilated cardiomyopathy,MYPN,myopalladin,10q21.3
154,Familial isolated dilated cardiomyopathy,LAMA4,laminin subunit alpha 4,6q21
154,Familial isolated dilated cardiomyopathy,PRDM16,PR/SET domain 16,1p36.32
154,Familial isolated dilated cardiomyopathy,ANKRD1,ankyrin repeat domain 1,10q23.31
154,Familial isolated dilated cardiomyopathy,LMNA,lamin A/C,1q22
154,Familial isolated dilated cardiomyopathy,DSP,desmoplakin,6p24.3
154,Familial isolated dilated cardiomyopathy,HAND2,heart and neural crest derivatives expressed 2,4q34.1
154,Familial isolated dilated cardiomyopathy,BAG5,BAG cochaperone 5,14q32.33
154,Familial isolated dilated cardiomyopathy,C10ORF71,chromosome 10 open reading frame 71,10q11.23
84,Fanconi anemia,RAD51,RAD51 recombinase,15q15.1
84,Fanconi anemia,MAD2L2,mitotic arrest deficient 2 like 2,1p36.22
84,Fanconi anemia,BRCA1,BRCA1 DNA repair associated,17q21.31
84,Fanconi anemia,XRCC2,X-ray repair cross complementing 2,7q36.1
84,Fanconi anemia,RFWD3,ring finger and WD repeat domain 3,16q23.1
84,Fanconi anemia,BRCA2,BRCA2 DNA repair associated,13q13.1
84,Fanconi anemia,BRIP1,BRCA1 interacting DNA helicase 1,17q23.2
84,Fanconi anemia,ERCC4,"ERCC excision repair 4, endonuclease catalytic subunit",16p13.12
84,Fanconi anemia,FANCA,FA complementation group A,16q24.3
84,Fanconi anemia,FANCB,FA complementation group B,Xp22.2
84,Fanconi anemia,FANCC,FA complementation group C,9q22.32
84,Fanconi anemia,FANCD2,FA complementation group D2,3p25.3
84,Fanconi anemia,FANCE,FA complementation group E,6p21.31
84,Fanconi anemia,FANCF,FA complementation group F,11p14.3
84,Fanconi anemia,FANCG,FA complementation group G,9p13.3
84,Fanconi anemia,FANCL,FA complementation group L,2p16.1
84,Fanconi anemia,FANCM,FA complementation group M,14q21.2
84,Fanconi anemia,FANCI,FA complementation group I,15q26.1
84,Fanconi anemia,PALB2,partner and localizer of BRCA2,16p12.2
84,Fanconi anemia,RAD51C,RAD51 paralog C,17q22
84,Fanconi anemia,SLX4,SLX4 structure-specific endonuclease subunit,16p13.3
84,Fanconi anemia,UBE2T,ubiquitin conjugating enzyme E2 T,1q32.1
816,Sjögren-Larsson syndrome,ALDH3A2,aldehyde dehydrogenase 3 family member A2,17p11.2
821,Sotos syndrome,NSD1,nuclear receptor binding SET domain protein 1,5q35.3
821,Sotos syndrome,APC2,APC regulator of WNT signaling pathway 2,19p13.3
3204,Stormorken-Sjaastad-Langslet syndrome,ORAI1,ORAI calcium release-activated calcium modulator 1,12q24.31
3204,Stormorken-Sjaastad-Langslet syndrome,STIM1,stromal interaction molecule 1,11p15.4
3205,Sturge-Weber syndrome,GNAQ,G protein subunit alpha q,9q21.2
3320,Thrombocytopenia-absent radius syndrome,RBM8A,RNA binding motif protein 8A,1q21.1
887,VACTERL/VATER association,HOXD13,homeobox D13,2q31.1
909,Cerebrotendinous xanthomatosis,CYP27A1,cytochrome P450 family 27 subfamily A member 1,2q35
3447,Weaver syndrome,NSD1,nuclear receptor binding SET domain protein 1,5q35.3
3447,Weaver syndrome,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,7q36.1
3447,Weaver syndrome,SUZ12,SUZ12 polycomb repressive complex 2 subunit,17q11.2
1422,Chondrodysplasia-difference of sex development syndrome,HHAT,hedgehog acyltransferase,1q32.2
178469,Autosomal dominant non-syndromic intellectual disability,KCNQ2,potassium voltage-gated channel subfamily Q member 2,20q13.33
178469,Autosomal dominant non-syndromic intellectual disability,ERBB4,erb-b2 receptor tyrosine kinase 4,2q34
178469,Autosomal dominant non-syndromic intellectual disability,BRSK2,BR serine/threonine kinase 2,11p15.5
178469,Autosomal dominant non-syndromic intellectual disability,MED12L,mediator complex subunit 12L,3q25.1
178469,Autosomal dominant non-syndromic intellectual disability,SLC6A1,solute carrier family 6 member 1,3p25.3
178469,Autosomal dominant non-syndromic intellectual disability,SETD1B,"SET domain containing 1B, histone lysine methyltransferase",12q24.31
178469,Autosomal dominant non-syndromic intellectual disability,CLTC,clathrin heavy chain,17q23.1
178469,Autosomal dominant non-syndromic intellectual disability,ITSN1,intersectin 1,21q22.11
178469,Autosomal dominant non-syndromic intellectual disability,PRICKLE2,prickle planar cell polarity protein 2,3p14.1
178469,Autosomal dominant non-syndromic intellectual disability,HIVEP2,HIVEP zinc finger 2,6q24.2
178469,Autosomal dominant non-syndromic intellectual disability,KDM5B,lysine demethylase 5B,1q32.1
178469,Autosomal dominant non-syndromic intellectual disability,GABBR1,gamma-aminobutyric acid type B receptor subunit 1,6p22.1
178469,Autosomal dominant non-syndromic intellectual disability,DPYSL2,dihydropyrimidinase like 2,8p21.2
178469,Autosomal dominant non-syndromic intellectual disability,SET,SET nuclear proto-oncogene,9q34.11
178469,Autosomal dominant non-syndromic intellectual disability,ARF3,ARF GTPase 3,12q13.12
178469,Autosomal dominant non-syndromic intellectual disability,CACNA1I,calcium voltage-gated channel subunit alpha1 I,22q13.1
178469,Autosomal dominant non-syndromic intellectual disability,RAB11A,"RAB11A, member RAS oncogene family",15q22.31
178469,Autosomal dominant non-syndromic intellectual disability,PPP3CA,protein phosphatase 3 catalytic subunit alpha,4q24
178469,Autosomal dominant non-syndromic intellectual disability,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,5q33.2
178469,Autosomal dominant non-syndromic intellectual disability,KCNQ5,potassium voltage-gated channel subfamily Q member 5,6q13
178469,Autosomal dominant non-syndromic intellectual disability,DLL1,delta like canonical Notch ligand 1,6q27
178469,Autosomal dominant non-syndromic intellectual disability,SCN8A,sodium voltage-gated channel alpha subunit 8,12q13.13
178469,Autosomal dominant non-syndromic intellectual disability,TAOK1,TAO kinase 1,17q11.2
178469,Autosomal dominant non-syndromic intellectual disability,TRPM3,transient receptor potential cation channel subfamily M member 3,9q21.12-q21.13
178469,Autosomal dominant non-syndromic intellectual disability,NBEA,neurobeachin,13q13.3
178469,Autosomal dominant non-syndromic intellectual disability,CIC,capicua transcriptional repressor,19q13.2
178469,Autosomal dominant non-syndromic intellectual disability,CSNK2B,casein kinase 2 beta,6p21.33
178469,Autosomal dominant non-syndromic intellectual disability,ASH1L,ASH1 like histone lysine methyltransferase,1q22
178469,Autosomal dominant non-syndromic intellectual disability,SEMA6B,semaphorin 6B,19p13.3
178469,Autosomal dominant non-syndromic intellectual disability,CUX1,cut like homeobox 1,7q22.1
178469,Autosomal dominant non-syndromic intellectual disability,YWHAZ,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,8q22.3
178469,Autosomal dominant non-syndromic intellectual disability,TCF4,transcription factor 4,18q21.2
178469,Autosomal dominant non-syndromic intellectual disability,CTNND2,catenin delta 2,5p15.2
178469,Autosomal dominant non-syndromic intellectual disability,KIRREL3,kirre like nephrin family adhesion molecule 3,11q24.2
178469,Autosomal dominant non-syndromic intellectual disability,DOCK8,dedicator of cytokinesis 8,9p24.3
178469,Autosomal dominant non-syndromic intellectual disability,MBD5,methyl-CpG binding domain protein 5,2q23.1
178469,Autosomal dominant non-syndromic intellectual disability,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,12p13.1
178469,Autosomal dominant non-syndromic intellectual disability,CDH15,cadherin 15,16q24.3
178469,Autosomal dominant non-syndromic intellectual disability,KIF1A,kinesin family member 1A,2q37.3
178469,Autosomal dominant non-syndromic intellectual disability,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,9q34.3
178469,Autosomal dominant non-syndromic intellectual disability,DYNC1H1,dynein cytoplasmic 1 heavy chain 1,14q32.31
178469,Autosomal dominant non-syndromic intellectual disability,CACNG2,calcium voltage-gated channel auxiliary subunit gamma 2,22q12.3
178469,Autosomal dominant non-syndromic intellectual disability,EPB41L1,erythrocyte membrane protein band 4.1 like 1,20q11.23
178469,Autosomal dominant non-syndromic intellectual disability,DEAF1,DEAF1 transcription factor,11p15.5
178469,Autosomal dominant non-syndromic intellectual disability,EEF1A2,eukaryotic translation elongation factor 1 alpha 2,20q13.33
178469,Autosomal dominant non-syndromic intellectual disability,CAMK2A,calcium/calmodulin dependent protein kinase II alpha,5q32
178469,Autosomal dominant non-syndromic intellectual disability,CAMK2B,calcium/calmodulin dependent protein kinase II beta,7p13
178461,X-linked myopathy with postural muscle atrophy,FHL1,four and a half LIM domains 1,Xq26.3
178464,Hereditary myopathy with early respiratory failure,TTN,titin,2q31.2
178396,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation,SERPINA1,serpin family A member 1,14q32.13
178400,Distal myopathy with anterior tibial onset,DYSF,dysferlin,2p13.2
178389,Osteopetrosis-hypogammaglobulinemia syndrome,TNFRSF11A,TNF receptor superfamily member 11a,18q21.33
62,Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3,SGCA,sarcoglycan alpha,17q21.33
178364,Syndromic microphthalmia type 5,OTX2,orthodenticle homeobox 2,14q22.3
715,Glycogen storage disease due to muscle phosphorylase kinase deficiency,PHKA1,phosphorylase kinase regulatory subunit alpha 1,Xq13.1
715,Glycogen storage disease due to muscle phosphorylase kinase deficiency,PHKG1,phosphorylase kinase catalytic subunit gamma 1,7p11.2
178377,Osteosclerosis-developmental delay-craniosynostosis syndrome,LRP5,LDL receptor related protein 5,11q13.2
348,"Fructose-1,6-bisphosphatase deficiency",FBP1,fructose-bisphosphatase 1,9q22.32
178345,Aromatase excess syndrome,CYP19A1,cytochrome P450 family 19 subfamily A member 1,15q21.2
178355,Smith-McCort dysplasia,DYM,dymeclin,18q21.1
178355,Smith-McCort dysplasia,RAB33B,"RAB33B, member RAS oncogene family",4q31.1
178338,UV-sensitive syndrome,ERCC6,"ERCC excision repair 6, chromatin remodeling factor",10q11.23
178338,UV-sensitive syndrome,ERCC8,"ERCC excision repair 8, CSA ubiquitin ligase complex subunit",5q12.1
178338,UV-sensitive syndrome,UVSSA,UV stimulated scaffold protein A,4p16.3
178342,Inflammatory myofibroblastic tumor,TPM3,tropomyosin 3,1q21.3
178342,Inflammatory myofibroblastic tumor,ALK,ALK receptor tyrosine kinase,2p23.2-p23.1
178342,Inflammatory myofibroblastic tumor,RANBP2,RAN binding protein 2,2q13
178342,Inflammatory myofibroblastic tumor,CLTC,clathrin heavy chain,17q23.1
178342,Inflammatory myofibroblastic tumor,CARS1,cysteinyl-tRNA synthetase 1,11p15.4
178342,Inflammatory myofibroblastic tumor,TPM4,tropomyosin 4,19p13.12-p13.11
117,Behçet disease,IL10,interleukin 10,1q32.1
117,Behçet disease,HLA-B,"major histocompatibility complex, class I, B",6p21.33
117,Behçet disease,FAS,Fas cell surface death receptor,10q23.31
117,Behçet disease,UBAC2,UBA domain containing 2,13q32.3
117,Behçet disease,IL23R,interleukin 23 receptor,1p31.3
117,Behçet disease,MEFV,"MEFV innate immunity regulator, pyrin",16p13.3
117,Behçet disease,STAT4,signal transducer and activator of transcription 4,2q32.2-q32.3
117,Behçet disease,C4A,complement C4A (Chido/Rodgers blood group),6p21.33
117,Behçet disease,IL12A,interleukin 12A,3q25.33
117,Behçet disease,TLR4,toll like receptor 4,9q33.1
117,Behçet disease,CCR1,C-C motif chemokine receptor 1,3p21.31
117,Behçet disease,KLRC4,killer cell lectin like receptor C4,12p13.2
117,Behçet disease,IL12A-AS1,IL12A antisense RNA 1,3q25.33
117,Behçet disease,ERAP1,endoplasmic reticulum aminopeptidase 1,5q15
117,Behçet disease,IFNGR1,interferon gamma receptor 1,6q23.3
178509,Perry syndrome,DCTN1,dynactin subunit 1,2p13.1
178506,"Brain calcification, Rajab type",FARSB,phenylalanyl-tRNA synthetase subunit beta,2q36.1
177926,Bleeding disorder in hemophilia A carriers,F8,coagulation factor VIII,Xq28
177929,Bleeding disorder in hemophilia B carriers,F9,coagulation factor IX,Xq27.1
177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,SNORD115@,"small nucleolar RNA, C/D box 115 cluster",15q11.2
177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,SNRPN,small nuclear ribonucleoprotein polypeptide N,15q11.2
177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,MAGEL2,MAGE family member L2,15q11.2
177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,NDN,"necdin, MAGE family member",15q11.2
177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,OCA2,OCA2 melanosomal transmembrane protein,15q12-q13.1
177901,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1,SNORD116@,"small nucleolar RNA, C/D box 116 cluster",15q11.2
423,Malignant hyperthermia of anesthesia,CACNA1S,calcium voltage-gated channel subunit alpha1 S,1q32.1
423,Malignant hyperthermia of anesthesia,RYR1,ryanodine receptor 1,19q13.2
177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,SNORD115@,"small nucleolar RNA, C/D box 115 cluster",15q11.2
177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,SNRPN,small nuclear ribonucleoprotein polypeptide N,15q11.2
177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,MAGEL2,MAGE family member L2,15q11.2
177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,NDN,"necdin, MAGE family member",15q11.2
177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,OCA2,OCA2 melanosomal transmembrane protein,15q12-q13.1
177904,Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2,SNORD116@,"small nucleolar RNA, C/D box 116 cluster",15q11.2
177907,Prader-Willi syndrome due to translocation,SNRPN,small nuclear ribonucleoprotein polypeptide N,15q11.2
177910,Prader-Willi syndrome due to imprinting mutation,SNORD115@,"small nucleolar RNA, C/D box 115 cluster",15q11.2
177910,Prader-Willi syndrome due to imprinting mutation,SNRPN,small nuclear ribonucleoprotein polypeptide N,15q11.2
177910,Prader-Willi syndrome due to imprinting mutation,MAGEL2,MAGE family member L2,15q11.2
177910,Prader-Willi syndrome due to imprinting mutation,NDN,"necdin, MAGE family member",15q11.2
177910,Prader-Willi syndrome due to imprinting mutation,SNORD116@,"small nucleolar RNA, C/D box 116 cluster",15q11.2
388,Hirschsprung disease,ATP7A,ATPase copper transporting alpha,Xq21.1
388,Hirschsprung disease,ABCD1,ATP binding cassette subfamily D member 1,Xq28
388,Hirschsprung disease,ERBB2,erb-b2 receptor tyrosine kinase 2,17q12
388,Hirschsprung disease,ERBB3,erb-b2 receptor tyrosine kinase 3,12q13.2
388,Hirschsprung disease,SMO,"smoothened, frizzled class receptor",7q32.1
388,Hirschsprung disease,RET,ret proto-oncogene,10q11.21
388,Hirschsprung disease,ECE1,endothelin converting enzyme 1,1p36.12
388,Hirschsprung disease,EDN3,endothelin 3,20q13.32
388,Hirschsprung disease,EDNRB,endothelin receptor type B,13q22.3
388,Hirschsprung disease,GDNF,glial cell derived neurotrophic factor,5p13.2
388,Hirschsprung disease,NRTN,neurturin,19p13.3
388,Hirschsprung disease,SEMA3C,semaphorin 3C,7q21.11
388,Hirschsprung disease,SEMA3D,semaphorin 3D,7q21.11
388,Hirschsprung disease,SREBF1,sterol regulatory element binding transcription factor 1,17p11.2
178333,Åland Islands eye disease,CACNA1F,calcium voltage-gated channel subunit alpha1 F,Xp11.23
760,Purine nucleoside phosphorylase deficiency,PNP,purine nucleoside phosphorylase,14q11.2
270,Oculopharyngeal muscular dystrophy,PABPN1,poly(A) binding protein nuclear 1,14q11.2
244,Primary ciliary dyskinesia,NME5,NME/NM23 family member 5,5q31.2
244,Primary ciliary dyskinesia,DNAH1,dynein axonemal heavy chain 1,3p21.1
244,Primary ciliary dyskinesia,TTC12,tetratricopeptide repeat domain 12,11q23.2
244,Primary ciliary dyskinesia,NEK10,NIMA related kinase 10,3p24.1
244,Primary ciliary dyskinesia,DNAAF6,PIH1 domain containing 3,Xq22.3
244,Primary ciliary dyskinesia,CFAP221,cilia and flagella associated protein 221,2q14.2
244,Primary ciliary dyskinesia,SPEF2,sperm flagellar 2,5p13.2
244,Primary ciliary dyskinesia,DNAJB13,DnaJ heat shock protein family (Hsp40) member B13,11q13.4
244,Primary ciliary dyskinesia,ODAD4,outer dynein arm docking complex subunit 4,17q21.2
244,Primary ciliary dyskinesia,MCIDAS,multiciliate differentiation and DNA synthesis associated cell cycle protein,5q11.2
244,Primary ciliary dyskinesia,GAS2L2,growth arrest specific 2 like 2,17q12
244,Primary ciliary dyskinesia,OFD1,OFD1 centriole and centriolar satellite protein,Xp22.2
244,Primary ciliary dyskinesia,DNAH11,dynein axonemal heavy chain 11,7p15.3
244,Primary ciliary dyskinesia,DNAH5,dynein axonemal heavy chain 5,5p15.2
244,Primary ciliary dyskinesia,DNAI1,dynein axonemal intermediate chain 1,9p13.3
244,Primary ciliary dyskinesia,NME8,NME/NM23 family member 8,7p14.1
244,Primary ciliary dyskinesia,DNAI2,dynein axonemal intermediate chain 2,17q25.1
244,Primary ciliary dyskinesia,DNAAF2,dynein axonemal assembly factor 2,14q21.3
244,Primary ciliary dyskinesia,RSPH9,radial spoke head component 9,6p21.1
244,Primary ciliary dyskinesia,RSPH4A,radial spoke head component 4A,6q22.1
244,Primary ciliary dyskinesia,DNAAF1,dynein axonemal assembly factor 1,16q24.1
244,Primary ciliary dyskinesia,CCDC39,coiled-coil domain 39 molecular ruler complex subunit,3q26.33
244,Primary ciliary dyskinesia,CCDC40,coiled-coil domain 40 molecular ruler complex subunit,17q25.3
244,Primary ciliary dyskinesia,DNAL1,dynein axonemal light chain 1,14q24.3
244,Primary ciliary dyskinesia,DNAAF3,dynein axonemal assembly factor 3,19q13.42
244,Primary ciliary dyskinesia,DNAAF19,dynein axonemal assembly factor 19,17q21.31
244,Primary ciliary dyskinesia,DNAAF5,dynein axonemal assembly factor 5,7p22.3
244,Primary ciliary dyskinesia,HYDIN,HYDIN axonemal central pair apparatus protein,16q22.2
244,Primary ciliary dyskinesia,DNAAF11,dynein axonemal assembly factor 11,8q24.22
244,Primary ciliary dyskinesia,ODAD1,outer dynein arm docking complex subunit 1,19q13.33
244,Primary ciliary dyskinesia,DRC1,dynein regulatory complex subunit 1,2p23.3
244,Primary ciliary dyskinesia,ODAD2,outer dynein arm docking complex subunit 2,10p12.1
244,Primary ciliary dyskinesia,DNAAF4,dynein axonemal assembly factor 4,15q21.3
244,Primary ciliary dyskinesia,RSPH1,radial spoke head component 1,21q22.3
244,Primary ciliary dyskinesia,ZMYND10,zinc finger MYND-type containing 10,3p21.31
244,Primary ciliary dyskinesia,CFAP298,cilia and flagella associated protein 298,21q22.11
244,Primary ciliary dyskinesia,DRC2,dynein regulatory complex subunit 2,12q13.12
244,Primary ciliary dyskinesia,SPAG1,sperm associated antigen 1,8q22.2
244,Primary ciliary dyskinesia,CCNO,cyclin O,5q11.2
244,Primary ciliary dyskinesia,ODAD3,outer dynein arm docking complex subunit 3,19p13.2
244,Primary ciliary dyskinesia,RSPH3,radial spoke head 3,6q25.3
244,Primary ciliary dyskinesia,DRC4,dynein regulatory complex subunit 4,16q24.3
244,Primary ciliary dyskinesia,RPGR,retinitis pigmentosa GTPase regulator,Xp11.4
244,Primary ciliary dyskinesia,CFAP74,cilia and flagella associated protein 74,1p36.33
244,Primary ciliary dyskinesia,STK36,serine/threonine kinase 36,2q35
244,Primary ciliary dyskinesia,FOXJ1,forkhead box J1,17q25.1
244,Primary ciliary dyskinesia,DNAH9,dynein axonemal heavy chain 9,17p12
244,Primary ciliary dyskinesia,LRRC56,leucine rich repeat containing 56,11p15.5
244,Primary ciliary dyskinesia,CFAP300,cilia and flagella associated protein 300,11q22.1
178307,Reticulate acropigmentation of Kitamura,ADAM10,ADAM metallopeptidase domain 10,15q21.3
805,Tuberous sclerosis complex,IFNG,interferon gamma,12q15
805,Tuberous sclerosis complex,TSC1,TSC complex subunit 1,9q34.13
805,Tuberous sclerosis complex,TSC2,TSC complex subunit 2,16p13.3
178145,Moderate multiminicore disease with hand involvement,RYR1,ryanodine receptor 1,19q13.2
791,Retinitis pigmentosa,SCAPER,S-phase cyclin A associated protein in the ER,15q24.3
791,Retinitis pigmentosa,IFT88,intraflagellar transport 88,13q12.11
791,Retinitis pigmentosa,REEP6,receptor accessory protein 6,19p13.3
791,Retinitis pigmentosa,ARHGEF18,Rho/Rac guanine nucleotide exchange factor 18,19p13.2
791,Retinitis pigmentosa,BBS1,Bardet-Biedl syndrome 1,11q13.2
791,Retinitis pigmentosa,KIAA1549,KIAA1549,7q34
791,Retinitis pigmentosa,TMEM216,transmembrane protein 216,11q13.1
791,Retinitis pigmentosa,IFT43,intraflagellar transport 43,14q24.3
791,Retinitis pigmentosa,AHI1,Abelson helper integration site 1,6q23.3
791,Retinitis pigmentosa,AGBL5,AGBL carboxypeptidase 5,2p23.3
791,Retinitis pigmentosa,CC2D2A,coiled-coil and C2 domain containing 2A,4p15.32
791,Retinitis pigmentosa,ABCA4,ATP binding cassette subfamily A member 4,1p22.1
791,Retinitis pigmentosa,PRCD,photoreceptor disc component,17q25.1
791,Retinitis pigmentosa,PRPF3,pre-mRNA processing factor 3,1q21.2
791,Retinitis pigmentosa,PRPF31,pre-mRNA processing factor 31,19q13.42
791,Retinitis pigmentosa,PRPF8,pre-mRNA processing factor 8,17p13.3
791,Retinitis pigmentosa,PRPH2,peripherin 2,6p21.1
791,Retinitis pigmentosa,RDH12,retinol dehydrogenase 12,14q24.1
791,Retinitis pigmentosa,RGR,retinal G protein coupled receptor,10q23.1
791,Retinitis pigmentosa,RHO,rhodopsin,3q22.1
791,Retinitis pigmentosa,RLBP1,retinaldehyde binding protein 1,15q26.1
791,Retinitis pigmentosa,ROM1,retinal outer segment membrane protein 1,11q12.3
791,Retinitis pigmentosa,RP1,RP1 axonemal microtubule associated,8q11.23-q12.1
791,Retinitis pigmentosa,RP2,RP2 activator of ARL3 GTPase,Xp11.3
791,Retinitis pigmentosa,RP9,RP9 pre-mRNA splicing factor,7p14.3
791,Retinitis pigmentosa,RPE65,retinoid isomerohydrolase RPE65,1p31.3
791,Retinitis pigmentosa,RPGR,retinitis pigmentosa GTPase regulator,Xp11.4
791,Retinitis pigmentosa,SAG,S-antigen visual arrestin,2q37.1
791,Retinitis pigmentosa,BBS2,Bardet-Biedl syndrome 2,16q13
791,Retinitis pigmentosa,BEST1,bestrophin 1,11q12.3
791,Retinitis pigmentosa,CA4,carbonic anhydrase 4,17q23.1
791,Retinitis pigmentosa,CERKL,CERK like autophagy regulator,2q31.3
791,Retinitis pigmentosa,TTC8,tetratricopeptide repeat domain 8,14q31.3
791,Retinitis pigmentosa,TULP1,TUB like protein 1,6p21.31
791,Retinitis pigmentosa,USH2A,usherin,1q41
791,Retinitis pigmentosa,CLRN1,clarin 1,3q25.1
791,Retinitis pigmentosa,CNGA1,cyclic nucleotide gated channel subunit alpha 1,4p12
791,Retinitis pigmentosa,CRB1,crumbs cell polarity complex component 1,1q31.3
791,Retinitis pigmentosa,CRX,cone-rod homeobox,19q13.33
791,Retinitis pigmentosa,ARL6,ARF like GTPase 6,3q11.2
791,Retinitis pigmentosa,FSCN2,"fascin actin-bundling protein 2, retinal",17q25.3
791,Retinitis pigmentosa,HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8p11.21-p11.1
791,Retinitis pigmentosa,IMPDH1,inosine monophosphate dehydrogenase 1,7q32.1
791,Retinitis pigmentosa,MERTK,"MER proto-oncogene, tyrosine kinase",2q13
791,Retinitis pigmentosa,NR2E3,nuclear receptor subfamily 2 group E member 3,15q23
791,Retinitis pigmentosa,NRL,neural retina leucine zipper,14q11.2-q12
791,Retinitis pigmentosa,OFD1,OFD1 centriole and centriolar satellite protein,Xp22.2
791,Retinitis pigmentosa,PDE6A,phosphodiesterase 6A,5q32
791,Retinitis pigmentosa,PDE6B,phosphodiesterase 6B,4p16.3
791,Retinitis pigmentosa,SEMA4A,semaphorin 4A,1q22
791,Retinitis pigmentosa,CNGB1,cyclic nucleotide gated channel subunit beta 1,16q21
791,Retinitis pigmentosa,TOPORS,"TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase",9p21.1
791,Retinitis pigmentosa,PROM1,prominin 1,4p15.32
791,Retinitis pigmentosa,LRAT,lecithin retinol acyltransferase,4q32.1
791,Retinitis pigmentosa,EYS,eyes shut homolog,6q12
791,Retinitis pigmentosa,IDH3B,isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta,20p13
791,Retinitis pigmentosa,SPATA7,spermatogenesis associated 7,14q31.3
791,Retinitis pigmentosa,GUCA1B,guanylate cyclase activator 1B,6p21.1
791,Retinitis pigmentosa,KLHL7,kelch like family member 7,7p15.3
791,Retinitis pigmentosa,SNRNP200,small nuclear ribonucleoprotein U5 subunit 200,2q11.2
791,Retinitis pigmentosa,PCARE,photoreceptor cilium actin regulator,2p23.2
791,Retinitis pigmentosa,PDE6G,phosphodiesterase 6G,17q25.3
791,Retinitis pigmentosa,IMPG2,interphotoreceptor matrix proteoglycan 2,3q12.3
791,Retinitis pigmentosa,FAM161A,FAM161 centrosomal protein A,2p15
791,Retinitis pigmentosa,ZNF513,zinc finger protein 513,2p23.3
791,Retinitis pigmentosa,CDHR1,cadherin related family member 1,10q23.1
791,Retinitis pigmentosa,DHDDS,dehydrodolichyl diphosphate synthase subunit,1p36.11
791,Retinitis pigmentosa,PRPF6,pre-mRNA processing factor 6,20q13.33
791,Retinitis pigmentosa,MAK,male germ cell associated kinase,6p24.2
791,Retinitis pigmentosa,RBP3,retinol binding protein 3,10q11.22
791,Retinitis pigmentosa,CFAP418,cilia and flagella associated protein 418,8q22.1
791,Retinitis pigmentosa,IFT140,intraflagellar transport 140,16p13.3
791,Retinitis pigmentosa,ZNF408,zinc finger protein 408,11p11.2
791,Retinitis pigmentosa,ARL2BP,ARF like GTPase 2 binding protein,16q13
791,Retinitis pigmentosa,NEK2,NIMA related kinase 2,1q32.3
791,Retinitis pigmentosa,IFT172,intraflagellar transport 172,2p23.3
791,Retinitis pigmentosa,TUB,TUB bipartite transcription factor,11p15.4
791,Retinitis pigmentosa,KIZ,kizuna centrosomal protein,20p11.23
791,Retinitis pigmentosa,SLC7A14,solute carrier family 7 member 14,3q26.2
791,Retinitis pigmentosa,PRPF4,pre-mRNA splicing tri-snRNP complex factor PRPF4,9q32
791,Retinitis pigmentosa,RP1L1,RP1 like 1,8p23.1
791,Retinitis pigmentosa,AHR,aryl hydrocarbon receptor,7p21.1
791,Retinitis pigmentosa,COQ8B,coenzyme Q8B,19q13.2
791,Retinitis pigmentosa,IMPG1,interphotoreceptor matrix proteoglycan 1,6q14.1
791,Retinitis pigmentosa,IDH3A,isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha,15q25.1
791,Retinitis pigmentosa,DHX38,DEAH-box helicase 38,16q22.2
791,Retinitis pigmentosa,ARL3,ARF like GTPase 3,10q24.32
791,Retinitis pigmentosa,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",1p34.1
2131,Alternating hemiplegia of childhood,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
2131,Alternating hemiplegia of childhood,ATP1A2,ATPase Na+/K+ transporting subunit alpha 2,1q23.2
2131,Alternating hemiplegia of childhood,ATP1A3,ATPase Na+/K+ transporting subunit alpha 3,19q13.2
2131,Alternating hemiplegia of childhood,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
2131,Alternating hemiplegia of childhood,SLC2A1,solute carrier family 2 member 1,1p34.2
2131,Alternating hemiplegia of childhood,MT-TL2,mitochondrially encoded tRNA-Leu (CUN) 2,mitochondria
2131,Alternating hemiplegia of childhood,SLC1A3,solute carrier family 1 member 3,5p13.2
2131,Alternating hemiplegia of childhood,RHOBTB2,Rho related BTB domain containing 2,8p21.3
713,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,PGK1,phosphoglycerate kinase 1,Xq21.1
57,Glycogen storage disease due to aldolase A deficiency,ALDOA,"aldolase, fructose-bisphosphate A",16p11.2
2334,Autosomal dominant keratitis,PAX6,paired box 6,11p13
46,Adenylosuccinate lyase deficiency,ADSL,adenylosuccinate lyase,22q13.1
3166,Sialuria,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,9p13.3
2882,Sitosterolemia,ABCG5,ATP binding cassette subfamily G member 5,2p21
2882,Sitosterolemia,ABCG8,ATP binding cassette subfamily G member 8,2p21
900,Granulomatosis with polyangiitis,HLA-DPA1,"major histocompatibility complex, class II, DP alpha 1",6p21.32
900,Granulomatosis with polyangiitis,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",6p21.32
900,Granulomatosis with polyangiitis,CTLA4,cytotoxic T-lymphocyte associated protein 4,2q33.2
900,Granulomatosis with polyangiitis,PTPN22,protein tyrosine phosphatase non-receptor type 22,1p13.2
900,Granulomatosis with polyangiitis,PRTN3,proteinase 3,19p13.3
171695,Parkinsonian-pyramidal syndrome,SNCA,synuclein alpha,4q22.1
171695,Parkinsonian-pyramidal syndrome,FBXO7,F-box protein 7,22q12.3
134,Beta-ketothiolase deficiency,ACAT1,acetyl-CoA acetyltransferase 1,11q22.3
171700,Diffuse panbronchiolitis,MUCL3,mucin like 3,6p21.33
171700,Diffuse panbronchiolitis,MUC5B,"mucin 5B, oligomeric mucus/gel-forming",11p15.5
171703,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome,EOMES,eomesodermin,3p24.1
171706,Short stature-delayed bone age due to thyroid hormone metabolism deficiency,SECISBP2,SECIS binding protein 2,9q22.2
171709,Male infertility due to globozoospermia,C2CD6,C2 calcium dependent domain containing 6,2q33.1
171709,Male infertility due to globozoospermia,GGN,gametogenetin,19q13.2
171709,Male infertility due to globozoospermia,SEPTIN4,septin 4,17q22
171709,Male infertility due to globozoospermia,GOPC,golgi associated PDZ and coiled-coil motif containing,6q22.1
171709,Male infertility due to globozoospermia,ZPBP,zona pellucida binding protein,7p12.2
171709,Male infertility due to globozoospermia,SPATA16,spermatogenesis associated 16,3q26.31
171709,Male infertility due to globozoospermia,DPY19L2,dpy-19 like 2,12q14.2
171709,Male infertility due to globozoospermia,PICK1,protein interacting with PRKCA 1,22q13.1
171723,White sponge nevus,KRT4,keratin 4,12q13.13
171723,White sponge nevus,KRT13,keratin 13,17q21.2
171680,Lissencephaly due to TUBA1A mutation,TUBA1A,tubulin alpha 1a,12q13.12
171690,Metabolic myopathy due to lactate transporter defect,SLC16A1,solute carrier family 16 member 1,1p13.2
171863,Autosomal dominant spastic paraplegia type 42,SLC33A1,solute carrier family 33 member 1,3q25.31
171871,Renal pseudohypoaldosteronism type 1,NR3C2,nuclear receptor subfamily 3 group C member 2,4q31.23
171866,"Spondyloepimetaphyseal dysplasia, aggrecan type",ACAN,aggrecan,15q26.1
171881,Cap myopathy,MYPN,myopalladin,10q21.3
171881,Cap myopathy,TPM2,tropomyosin 2,9p13.3
171881,Cap myopathy,TPM3,tropomyosin 3,1q21.3
2512,Autosomal recessive primary microcephaly,WARS1,tryptophanyl-tRNA synthetase 1,14q32.2
2512,Autosomal recessive primary microcephaly,SARS1,seryl-tRNA synthetase 1,1p13.3
2512,Autosomal recessive primary microcephaly,CIT,citron rho-interacting serine/threonine kinase,12q24.23
2512,Autosomal recessive primary microcephaly,NUP37,nucleoporin 37,12q23.2
2512,Autosomal recessive primary microcephaly,NCAPD3,non-SMC condensin II complex subunit D3,11q25
2512,Autosomal recessive primary microcephaly,CENPE,centromere protein E,4q24
2512,Autosomal recessive primary microcephaly,COPB2,COPI coat complex subunit beta 2,3q23
2512,Autosomal recessive primary microcephaly,PDCD6IP,programmed cell death 6 interacting protein,3p22.3
2512,Autosomal recessive primary microcephaly,TRAPPC10,trafficking protein particle complex subunit 10,21q22.3
2512,Autosomal recessive primary microcephaly,MCM7,minichromosome maintenance complex component 7,7q22.1
2512,Autosomal recessive primary microcephaly,METTL5,"methyltransferase 5, N6-adenosine",2q31.1
2512,Autosomal recessive primary microcephaly,TRAPPC14,trafficking protein particle complex subunit 14,7q22.1
2512,Autosomal recessive primary microcephaly,KIF14,kinesin family member 14,1q32.1
2512,Autosomal recessive primary microcephaly,TAF13,TATA-box binding protein associated factor 13,1p13.3
2512,Autosomal recessive primary microcephaly,PYCR2,pyrroline-5-carboxylate reductase 2,1q42.12
2512,Autosomal recessive primary microcephaly,CDK5RAP2,CDK5 regulatory subunit associated protein 2,9q33.2
2512,Autosomal recessive primary microcephaly,CPAP,centrosome assembly and centriole elongation protein,13q12.12-q12.13
2512,Autosomal recessive primary microcephaly,ASPM,assembly factor for spindle microtubules,1q31.3
2512,Autosomal recessive primary microcephaly,MCPH1,microcephalin 1,8p23.1
2512,Autosomal recessive primary microcephaly,STIL,STIL centriolar assembly protein,1p33
2512,Autosomal recessive primary microcephaly,WDR62,WD repeat domain 62,19q13.12
2512,Autosomal recessive primary microcephaly,CEP152,centrosomal protein 152,15q21.1
2512,Autosomal recessive primary microcephaly,CEP63,centrosomal protein 63,3q22.2
2512,Autosomal recessive primary microcephaly,CEP135,centrosomal protein 135,4q12
2512,Autosomal recessive primary microcephaly,KNL1,kinetochore scaffold 1,15q15.1
2512,Autosomal recessive primary microcephaly,PHC1,polyhomeotic homolog 1,12p13.31
2512,Autosomal recessive primary microcephaly,CDK6,cyclin dependent kinase 6,7q21.2
2512,Autosomal recessive primary microcephaly,SASS6,SAS-6 centriolar assembly protein,1p21.2
2512,Autosomal recessive primary microcephaly,MFSD2A,"MFSD2 lysolipid transporter A, lysophospholipid",1p34.2
2512,Autosomal recessive primary microcephaly,ANKLE2,ankyrin repeat and LEM domain containing 2,12q24.33
171876,Generalized pseudohypoaldosteronism type 1,SCNN1A,sodium channel epithelial 1 subunit alpha,12p13.31
171876,Generalized pseudohypoaldosteronism type 1,SCNN1B,sodium channel epithelial 1 subunit beta,16p12.2
171876,Generalized pseudohypoaldosteronism type 1,SCNN1G,sodium channel epithelial 1 subunit gamma,16p12.2
797,Sarcoidosis,BTNL2,butyrophilin like 2,6p21.32
797,Sarcoidosis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
171829,6q16 microdeletion syndrome,SIM1,SIM bHLH transcription factor 1,6q16.3
171851,MEDNIK syndrome,AP1B1,adaptor related protein complex 1 subunit beta 1,22q12.2
171851,MEDNIK syndrome,AP1S1,adaptor related protein complex 1 subunit sigma 1,7q22.1
171848,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome,ABHD12,"abhydrolase domain containing 12, lysophospholipase",20p11.21
3303,Tetralogy of Fallot,KDR,kinase insert domain receptor,4q12
3303,Tetralogy of Fallot,ZFPM2,"zinc finger protein, FOG family member 2",8q23
3303,Tetralogy of Fallot,GATA4,GATA binding protein 4,8p23.1
3303,Tetralogy of Fallot,JAG1,jagged canonical Notch ligand 1,20p12.2
3303,Tetralogy of Fallot,NKX2-5,NK2 homeobox 5,5q35.1
3303,Tetralogy of Fallot,GATA5,GATA binding protein 5,20q13.33
3303,Tetralogy of Fallot,GJA5,gap junction protein alpha 5,1q21.2
3303,Tetralogy of Fallot,NKX2-6,NK2 homeobox 6,8p21.2
3303,Tetralogy of Fallot,GDF1,growth differentiation factor 1,19p13.11
3303,Tetralogy of Fallot,CITED2,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2,6q24.1
3303,Tetralogy of Fallot,GATA6,GATA binding protein 6,18q11.2
3303,Tetralogy of Fallot,FLT4,fms related receptor tyrosine kinase 4,5q35.3
3303,Tetralogy of Fallot,TBX1,T-box transcription factor 1,22q11.21
200418,Immunodeficiency with factor I anomaly,CFI,complement factor I,4q25
730,Autosomal dominant polycystic kidney disease,GANAB,glucosidase II alpha subunit,11q12.3
730,Autosomal dominant polycystic kidney disease,NEK8,NIMA related kinase 8,17q11.2
730,Autosomal dominant polycystic kidney disease,ALG9,"ALG9 alpha-1,2-mannosyltransferase",11q23.1
730,Autosomal dominant polycystic kidney disease,DNAJB11,DnaJ heat shock protein family (Hsp40) member B11,3q27.3
730,Autosomal dominant polycystic kidney disease,ALG5,ALG5 dolichyl-phosphate beta-glucosyltransferase,13q13.3
730,Autosomal dominant polycystic kidney disease,PKD1,"polycystin 1, transient receptor potential channel interacting",16p13.3
730,Autosomal dominant polycystic kidney disease,PKD2,"polycystin 2, transient receptor potential cation channel",4q22.1
730,Autosomal dominant polycystic kidney disease,BICC1,BicC family RNA binding protein 1,10q21.1
730,Autosomal dominant polycystic kidney disease,IFT140,intraflagellar transport 140,16p13.3
200421,Immunodeficiency with factor H anomaly,CFH,complement factor H,1q31.3
486,Autosomal dominant severe congenital neutropenia,TCIRG1,"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3",11q13.2
486,Autosomal dominant severe congenital neutropenia,ELANE,"elastase, neutrophil expressed",19p13.3
486,Autosomal dominant severe congenital neutropenia,GFI1,growth factor independent 1 transcriptional repressor,1p22.1
486,Autosomal dominant severe congenital neutropenia,CLPB,ClpB family mitochondrial disaggregase,11q13.4
486,Autosomal dominant severe congenital neutropenia,SRP19,signal recognition particle 19,5q22.2
98,Autosomal recessive spastic ataxia of Charlevoix-Saguenay,SACS,sacsin molecular chaperone,13q12.12
330,Congenital factor XII deficiency,F12,coagulation factor XII,5q35.3
828,Stickler syndrome,BMP4,bone morphogenetic protein 4,14q22.2
199340,"Muscular dystrophy, Selcen type",BAG3,BAG cochaperone 3,10q26.11
199337,Pancreatic insufficiency-anemia-hyperostosis syndrome,COX4I2,cytochrome c oxidase subunit 4I2,20q11.21
234,Dubin-Johnson syndrome,ABCC2,ATP binding cassette subfamily C member 2,10q24.2
199348,Thiamine-responsive encephalopathy,SLC19A3,solute carrier family 19 member 3,2q36.3
3287,Takayasu arteritis,HLA-B,"major histocompatibility complex, class I, B",6p21.33
3287,Takayasu arteritis,IL12B,interleukin 12B,5q33.3
3287,Takayasu arteritis,MLX,MAX dimerization protein MLX,17q21.2
199343,EAST syndrome,KCNJ10,potassium inwardly rectifying channel subfamily J member 10,1q23.2
2800,Extramammary Paget disease,ERBB2,erb-b2 receptor tyrosine kinase 2,17q12
199326,"Isolated autosomal dominant hypomagnesemia, Glaudemans type",KCNA1,potassium voltage-gated channel subfamily A member 1,12p13.32
199332,Endocrine-cerebro-osteodysplasia syndrome,CILK1,ciliogenesis associated kinase 1,6p12.1
199329,"Congenital myopathy, Paradas type",DYSF,dysferlin,2p13.2
2665,Congenital mesoblastic nephroma,ETV6,ETS variant transcription factor 6,12p13.2
2665,Congenital mesoblastic nephroma,NTRK3,neurotrophic receptor tyrosine kinase 3,15q25.3
3463,Wolfram syndrome,WFS1,wolframin ER transmembrane glycoprotein,4p16.1
3463,Wolfram syndrome,CISD2,CDGSH iron sulfur domain 2,4q24
199354,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy,HTRA1,HtrA serine peptidase 1,10q26.13
199351,Adult-onset dystonia-parkinsonism,PLA2G6,phospholipase A2 group VI,22q13.1
356,Gerstmann-Straussler-Scheinker syndrome,PRNP,prion protein (Kanno blood group),20p13
466,Fatal familial insomnia,PRNP,prion protein (Kanno blood group),20p13
3452,Whipple disease,IRF4,interferon regulatory factor 4,6p25.3
199285,Hereditary hypercarotenemia and vitamin A deficiency,BCO1,beta-carotene oxygenase 1,16q23.2
2102,GTP cyclohydrolase I deficiency,GCH1,GTP cyclohydrolase 1,14q22.2
3002,Immune thrombocytopenia,FCGR2C,Fc gamma receptor IIc (gene/pseudogene),1q23.3
199318,15q13.3 microdeletion syndrome,CHRNA7,cholinergic receptor nicotinic alpha 7 subunit,15q13.3
274,Bernard-Soulier syndrome,GP1BA,glycoprotein Ib platelet subunit alpha,17p13.2
274,Bernard-Soulier syndrome,GP1BB,glycoprotein Ib platelet subunit beta,22q11.21
274,Bernard-Soulier syndrome,GP9,glycoprotein IX platelet,3q21.3
1195,Congenital atransferrinemia,TF,transferrin,3q22.1
199302,Isolated cleft lip,TP63,tumor protein p63,3q28
199302,Isolated cleft lip,IRF6,interferon regulatory factor 6,1q32.2
199302,Isolated cleft lip,NECTIN1,nectin cell adhesion molecule 1,11q23.3
199302,Isolated cleft lip,MSX1,msh homeobox 1,4p16.2
199306,Cleft lip/palate,ARHGAP29,Rho GTPase activating protein 29,1p22.1
199306,Cleft lip/palate,TP63,tumor protein p63,3q28
199306,Cleft lip/palate,BMP4,bone morphogenetic protein 4,14q22.2
199306,Cleft lip/palate,COBLL1,cordon-bleu WH2 repeat protein like 1,2q24.3
199306,Cleft lip/palate,RIC1,"RIC1 homolog, RAB6A GEF complex partner 1",9p24.1
199306,Cleft lip/palate,NECTIN1,nectin cell adhesion molecule 1,11q23.3
199306,Cleft lip/palate,ARHGEF38,Rho guanine nucleotide exchange factor 38,4q24
199306,Cleft lip/palate,CDH1,cadherin 1,16q22.1
199306,Cleft lip/palate,IRF6,interferon regulatory factor 6,1q32.2
199306,Cleft lip/palate,PDGFRA,platelet derived growth factor receptor alpha,4q12
199306,Cleft lip/palate,MSX1,msh homeobox 1,4p16.2
199306,Cleft lip/palate,DLG1,discs large MAGUK scaffold protein 1,3q29
199306,Cleft lip/palate,DLX4,distal-less homeobox 4,17q21.33
926,Acatalasemia,CAT,catalase,11p13
199296,Congenital isolated ACTH deficiency,TBX19,T-box transcription factor 19,1q24.2
1675,Dihydropyrimidine dehydrogenase deficiency,DPYD,dihydropyrimidine dehydrogenase,1p21.3
189427,Cushing syndrome due to bilateral macronodular adrenocortical disease,KDM1A,lysine demethylase 1A,1p36.12
189427,Cushing syndrome due to bilateral macronodular adrenocortical disease,GNAS,GNAS complex locus,20q13.32
189427,Cushing syndrome due to bilateral macronodular adrenocortical disease,ARMC5,armadillo repeat containing 5,16p11.2
976,Adenine phosphoribosyltransferase deficiency,APRT,adenine phosphoribosyltransferase,16q24.3
3129,Sarcosinemia,SARDH,sarcosine dehydrogenase,9q34.2
415,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,SLC25A15,solute carrier family 25 member 15,13q14.11
13,6-pyruvoyl-tetrahydropterin synthase deficiency,PTS,6-pyruvoyltetrahydropterin synthase,11q23.1
171,Primary sclerosing cholangitis,SEMA4D,semaphorin 4D,9q22.2
171,Primary sclerosing cholangitis,GPR35,G protein-coupled receptor 35,2q37.3
171,Primary sclerosing cholangitis,MST1,macrophage stimulating 1,3p21.31
171,Primary sclerosing cholangitis,TCF4,transcription factor 4,18q21.2
199247,Corticosteroid-binding globulin deficiency,SERPINA6,serpin family A member 6,14q32.13
199241,Pulmonary capillary hemangiomatosis,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,15q15.1
189466,Familial isolated hypoparathyroidism due to impaired PTH secretion,PTH,parathyroid hormone,11p15.3
189466,Familial isolated hypoparathyroidism due to impaired PTH secretion,AIRE,autoimmune regulator,21q22.3
17,Fatal infantile lactic acidosis with methylmalonic aciduria,SUCLG1,succinate-CoA ligase GDP/ADP-forming subunit alpha,2p11.2
3006,Pyridoxine-dependent-developmental and epileptic encephalopathy,ALDH7A1,aldehyde dehydrogenase 7 family member A1,5q23.2
3006,Pyridoxine-dependent-developmental and epileptic encephalopathy,PLPBP,pyridoxal phosphate binding protein,8p11.23
3111,Rotor syndrome,SLCO1B1,solute carrier organic anion transporter family member 1B1,12p12.1
3111,Rotor syndrome,SLCO1B3,solute carrier organic anion transporter family member 1B3,12p12.2
2382,Lennox-Gastaut syndrome,CUX2,cut like homeobox 2,12q24.11-q24.12
2382,Lennox-Gastaut syndrome,SCN1A,sodium voltage-gated channel alpha subunit 1,2q24.3
2382,Lennox-Gastaut syndrome,MAPK10,mitogen-activated protein kinase 10,4q21.3
2382,Lennox-Gastaut syndrome,CHD2,chromodomain helicase DNA binding protein 2,15q26.1
2382,Lennox-Gastaut syndrome,DNM1,dynamin 1,9q34.11
2382,Lennox-Gastaut syndrome,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,15q12
2382,Lennox-Gastaut syndrome,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
2382,Lennox-Gastaut syndrome,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
1934,Early infantile developmental and epileptic encephalopathy,DMXL2,Dmx like 2,15q21.2
1934,Early infantile developmental and epileptic encephalopathy,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,9q34.3
1934,Early infantile developmental and epileptic encephalopathy,SLC32A1,solute carrier family 32 member 1,20q11.23
1934,Early infantile developmental and epileptic encephalopathy,NEUROD2,neuronal differentiation 2,17q12
1934,Early infantile developmental and epileptic encephalopathy,GRM7,glutamate metabotropic receptor 7,3p26.1
1934,Early infantile developmental and epileptic encephalopathy,CASK,calcium/calmodulin dependent serine protein kinase,Xp11.4
1934,Early infantile developmental and epileptic encephalopathy,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
1934,Early infantile developmental and epileptic encephalopathy,CDKL5,cyclin dependent kinase like 5,Xp22.13
1934,Early infantile developmental and epileptic encephalopathy,ARX,aristaless related homeobox,Xp21.3
1934,Early infantile developmental and epileptic encephalopathy,PNKP,polynucleotide kinase 3'-phosphatase,19q13.33
1934,Early infantile developmental and epileptic encephalopathy,GNAO1,G protein subunit alpha o1,16q13
1934,Early infantile developmental and epileptic encephalopathy,PIGQ,phosphatidylinositol glycan anchor biosynthesis class Q,16p13.3
1934,Early infantile developmental and epileptic encephalopathy,SIK1,salt inducible kinase 1,21q22.3
1934,Early infantile developmental and epileptic encephalopathy,SCN1B,sodium voltage-gated channel beta subunit 1,19q13.11
1934,Early infantile developmental and epileptic encephalopathy,SLC25A22,solute carrier family 25 member 22,11p15.5
1934,Early infantile developmental and epileptic encephalopathy,KCNA1,potassium voltage-gated channel subfamily A member 1,12p13.32
1934,Early infantile developmental and epileptic encephalopathy,TRIM8,tripartite motif containing 8,10q24.32
1934,Early infantile developmental and epileptic encephalopathy,PIGP,phosphatidylinositol glycan anchor biosynthesis class P,21q22.13
1942,Epilepsy with myoclonic-atonic seizures,SLC2A1,solute carrier family 2 member 1,1p34.2
1942,Epilepsy with myoclonic-atonic seizures,SYNGAP1,synaptic Ras GTPase activating protein 1,6p21.32
1942,Epilepsy with myoclonic-atonic seizures,NEXMIF,neurite extension and migration factor,Xq13.3
1942,Epilepsy with myoclonic-atonic seizures,SCN1A,sodium voltage-gated channel alpha subunit 1,2q24.3
1942,Epilepsy with myoclonic-atonic seizures,CHD2,chromodomain helicase DNA binding protein 2,15q26.1
1942,Epilepsy with myoclonic-atonic seizures,SLC6A1,solute carrier family 6 member 1,3p25.3
1942,Epilepsy with myoclonic-atonic seizures,AP2M1,adaptor related protein complex 2 subunit mu 1,3q27.1
267,Calpain-3-related limb-girdle muscular dystrophy R1,CAPN3,calpain 3,15q15.1
186,Primary biliary cholangitis,IL12RB1,interleukin 12 receptor subunit beta 1,19p13.11
186,Primary biliary cholangitis,SPIB,Spi-B transcription factor,19q13.33
186,Primary biliary cholangitis,IL12A,interleukin 12A,3q25.33
186,Primary biliary cholangitis,IRF5,interferon regulatory factor 5,7q32.1
186,Primary biliary cholangitis,TNPO3,transportin 3,7q32.1
186,Primary biliary cholangitis,MMEL1,membrane metalloendopeptidase like 1,1p36.32
186,Primary biliary cholangitis,POU2AF1,POU class 2 homeobox associating factor 1,11q23.1
186,Primary biliary cholangitis,TNFSF15,TNF superfamily member 15,9q32
397,Giant cell arteritis,PTPN22,protein tyrosine phosphatase non-receptor type 22,1p13.2
397,Giant cell arteritis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
397,Giant cell arteritis,HLA-B,"major histocompatibility complex, class I, B",6p21.33
397,Giant cell arteritis,P4HA2,prolyl 4-hydroxylase subunit alpha 2,5q31.1
2398,Multiple symmetric lipomatosis,MFN2,mitofusin 2,1p36.22
131,Budd-Chiari syndrome,F5,coagulation factor V,1q24.2
131,Budd-Chiari syndrome,JAK2,Janus kinase 2,9p24.1
131,Budd-Chiari syndrome,CALR,calreticulin,19p13.13
654,Nephroblastoma,BRCA2,BRCA2 DNA repair associated,13q13.1
654,Nephroblastoma,GPC3,glypican 3,Xq26.2
654,Nephroblastoma,CTR9,"CTR9 homolog, Paf1/RNA polymerase II complex component",11p15.4
654,Nephroblastoma,TRIM28,tripartite motif containing 28,19q13.43
654,Nephroblastoma,TRIM28,tripartite motif containing 28,19q13.43
654,Nephroblastoma,REST,RE1 silencing transcription factor,4q12
654,Nephroblastoma,TRIP13,thyroid hormone receptor interactor 13,5p15.33
654,Nephroblastoma,POU6F2,POU class 6 homeobox 2,7p14.1
654,Nephroblastoma,WT1,WT1 transcription factor,11p13
654,Nephroblastoma,WT1,WT1 transcription factor,11p13
654,Nephroblastoma,H19,H19 imprinted maternally expressed transcript,11p15.5
654,Nephroblastoma,DIS3L2,DIS3 like 3'-5' exoribonuclease 2,2q37.1
2587,Myeloperoxidase deficiency,MPO,myeloperoxidase,17q22
3389,Tuberculosis,SLC11A1,solute carrier family 11 member 1,2q35
2897,Pityriasis rubra pilaris,CARD14,caspase recruitment domain family member 14,17q25.3
2312,Transient familial neonatal hyperbilirubinemia,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2q37.1
183707,Infantile LAD-like disease due to RAC2 deficiency,RAC2,Rac family small GTPase 2,22q13.1
2314,Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency,STAT3,signal transducer and activator of transcription 3,17q21.2
183675,Recurrent infections associated with rare immunoglobulin isotypes deficiency,IGHG2,immunoglobulin heavy constant gamma 2 (G2m marker),14q32.33
183675,Recurrent infections associated with rare immunoglobulin isotypes deficiency,IGKC,immunoglobulin kappa constant,2p11.2
2177,Hydranencephaly,NDE1,nudE neurodevelopment protein 1,16p13.11
2380,Legg-Calvé-Perthes disease,COL2A1,collagen type II alpha 1 chain,12q13.11
897,Waardenburg-Shah syndrome,SOX10,SRY-box transcription factor 10,22q13.1
897,Waardenburg-Shah syndrome,EDN3,endothelin 3,20q13.32
897,Waardenburg-Shah syndrome,EDNRB,endothelin receptor type B,13q22.3
897,Waardenburg-Shah syndrome,MITF,melanocyte inducing transcription factor,3p13
808,Seckel syndrome,DNA2,DNA replication helicase/nuclease 2,10q21.3
808,Seckel syndrome,NUP85,nucleoporin 85,17q25.1
808,Seckel syndrome,ATR,ATR checkpoint kinase,3q23
808,Seckel syndrome,CPAP,centrosome assembly and centriole elongation protein,13q12.12-q12.13
808,Seckel syndrome,PCNT,pericentrin,21q22.3
808,Seckel syndrome,CEP152,centrosomal protein 152,15q21.1
808,Seckel syndrome,RBBP8,"RB binding protein 8, endonuclease",18q11.2
808,Seckel syndrome,ATRIP,ATR interacting protein,3p21.31
808,Seckel syndrome,TRAIP,TRAF interacting protein,3p21.31
808,Seckel syndrome,PLK4,polo like kinase 4,4q28.1
808,Seckel syndrome,CENPE,centromere protein E,4q24
3027,Caudal regression syndrome,VANGL1,VANGL planar cell polarity protein 1,1p13.1
3027,Caudal regression syndrome,FUZ,fuzzy planar cell polarity protein,19q13.33
676,Autosomal dominant hereditary chronic pancreatitis,CASR,calcium sensing receptor,3q13.33-q21.1
676,Autosomal dominant hereditary chronic pancreatitis,PRSS1,serine protease 1,7q34
676,Autosomal dominant hereditary chronic pancreatitis,PRSS2,serine protease 2,7q34
676,Autosomal dominant hereditary chronic pancreatitis,CTRC,chymotrypsin C,1p36.21
676,Autosomal dominant hereditary chronic pancreatitis,CPA1,carboxypeptidase A1,7q32.2
676,Autosomal dominant hereditary chronic pancreatitis,TRPV6,transient receptor potential cation channel subfamily V member 6,7q34
643,Giant axonal neuropathy,GAN,gigaxonin,16q23.2
634,Netherton syndrome,SPINK5,serine peptidase inhibitor Kazal type 5,5q32
140,Campomelic dysplasia,SOX9,SRY-box transcription factor 9,17q24.3
2828,Young-onset Parkinson disease,SYNJ1,synaptojanin 1,21q22.11
2828,Young-onset Parkinson disease,SNCA,synuclein alpha,4q22.1
2828,Young-onset Parkinson disease,PINK1,PTEN induced kinase 1,1p36.12
2828,Young-onset Parkinson disease,UCHL1,ubiquitin C-terminal hydrolase L1,4p13
2828,Young-onset Parkinson disease,HTRA2,HtrA serine peptidase 2,2p13.1
2828,Young-onset Parkinson disease,PODXL,podocalyxin like,7q32.3
2828,Young-onset Parkinson disease,LRRK2,leucine rich repeat kinase 2,12q12
2828,Young-onset Parkinson disease,PRKN,parkin RBR E3 ubiquitin protein ligase,6q26
2828,Young-onset Parkinson disease,PARK7,Parkinsonism associated deglycase,1p36.23
2828,Young-onset Parkinson disease,VPS13C,vacuolar protein sorting 13 homolog C,15q22.2
2828,Young-onset Parkinson disease,DNAJC6,DnaJ heat shock protein family (Hsp40) member C6,1p31.3
642,Hereditary sensory and autonomic neuropathy type 4,NTRK1,neurotrophic receptor tyrosine kinase 1,1q23.1
627,Nance-Horan syndrome,NHS,NHS actin remodeling regulator,Xp22.2-p22.13
638,Neurofibromatosis-Noonan syndrome,MAP2K2,mitogen-activated protein kinase kinase 2,19p13.3
638,Neurofibromatosis-Noonan syndrome,NF1,neurofibromin 1,17q11.2
326,Congenital factor V deficiency,F5,coagulation factor V,1q24.2
526,Liddle syndrome,SCNN1B,sodium channel epithelial 1 subunit beta,16p12.2
526,Liddle syndrome,SCNN1G,sodium channel epithelial 1 subunit gamma,16p12.2
526,Liddle syndrome,SCNN1A,sodium channel epithelial 1 subunit alpha,12p13.31
215,Congenital stationary night blindness,RHO,rhodopsin,3q22.1
215,Congenital stationary night blindness,SAG,S-antigen visual arrestin,2q37.1
215,Congenital stationary night blindness,CABP4,calcium binding protein 4,11q13.2
215,Congenital stationary night blindness,CACNA1F,calcium voltage-gated channel subunit alpha1 F,Xp11.23
215,Congenital stationary night blindness,GNAT1,G protein subunit alpha transducin 1,3p21.31
215,Congenital stationary night blindness,GRM6,glutamate metabotropic receptor 6,5q35.3
215,Congenital stationary night blindness,NYX,nyctalopin,Xp11.4
215,Congenital stationary night blindness,PDE6B,phosphodiesterase 6B,4p16.3
215,Congenital stationary night blindness,CACNA2D4,calcium voltage-gated channel auxiliary subunit alpha2delta 4,12p13.33
215,Congenital stationary night blindness,TRPM1,transient receptor potential cation channel subfamily M member 1,15q13.3
215,Congenital stationary night blindness,SLC24A1,solute carrier family 24 member 1,15q22.31
215,Congenital stationary night blindness,GPR179,G protein-coupled receptor 179,17q12
215,Congenital stationary night blindness,LRIT3,"leucine rich repeat, Ig-like and transmembrane domains 3",4q25
215,Congenital stationary night blindness,GRK1,G protein-coupled receptor kinase 1,13q34
215,Congenital stationary night blindness,GNB3,G protein subunit beta 3,12p13.31
342,Familial Mediterranean fever,MEFV,"MEFV innate immunity regulator, pyrin",16p13.3
180,Choroideremia,CHM,CHM Rab escort protein,Xq21.2
327,Congenital factor VII deficiency,F7,coagulation factor VII,13q34
373,Simpson-Golabi-Behmel syndrome,GPC3,glypican 3,Xq26.2
373,Simpson-Golabi-Behmel syndrome,GPC4,glypican 4,Xq26.2
403,Familial hyperaldosteronism type I,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8q24.3
403,Familial hyperaldosteronism type I,CYP11B2,cytochrome P450 family 11 subfamily B member 2,8q24.3
146,Differentiated thyroid carcinoma,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
146,Differentiated thyroid carcinoma,EIF1AX,eukaryotic translation initiation factor 1A X-linked,Xp22.12
146,Differentiated thyroid carcinoma,PPARG,peroxisome proliferator activated receptor gamma,3p25.2
146,Differentiated thyroid carcinoma,RET,ret proto-oncogene,10q11.21
146,Differentiated thyroid carcinoma,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
146,Differentiated thyroid carcinoma,CCDC6,coiled-coil domain containing 6,10q21.2
146,Differentiated thyroid carcinoma,TFG,trafficking from ER to golgi regulator,3q12.2
146,Differentiated thyroid carcinoma,TPR,"translocated promoter region, nuclear basket protein",1q31.1
146,Differentiated thyroid carcinoma,TRIM24,tripartite motif containing 24,7q33-q34
146,Differentiated thyroid carcinoma,TRIM27,tripartite motif containing 27,6p22.1
146,Differentiated thyroid carcinoma,TRIM33,tripartite motif containing 33,1p13.2
146,Differentiated thyroid carcinoma,ERC1,ELKS/RAB6-interacting/CAST family member 1,12p13.33
146,Differentiated thyroid carcinoma,FOXE1,forkhead box E1,9q22.33
146,Differentiated thyroid carcinoma,GOLGA5,golgin A5,14q32.12
146,Differentiated thyroid carcinoma,HRAS,"HRas proto-oncogene, GTPase",11p15.5
146,Differentiated thyroid carcinoma,NTRK1,neurotrophic receptor tyrosine kinase 1,1q23.1
146,Differentiated thyroid carcinoma,PAX8,paired box 8,2q14.1
146,Differentiated thyroid carcinoma,PCM1,pericentriolar material 1,8p22
146,Differentiated thyroid carcinoma,ETV6,ETS variant transcription factor 6,12p13.2
146,Differentiated thyroid carcinoma,NKX2-1,NK2 homeobox 1,14q13.3
146,Differentiated thyroid carcinoma,ALK,ALK receptor tyrosine kinase,2p23.2-p23.1
146,Differentiated thyroid carcinoma,NRAS,"NRAS proto-oncogene, GTPase",1p13.2
146,Differentiated thyroid carcinoma,NTRK3,neurotrophic receptor tyrosine kinase 3,15q25.3
146,Differentiated thyroid carcinoma,NCOA4,nuclear receptor coactivator 4,10q11.22
146,Differentiated thyroid carcinoma,DIRC3,disrupted in renal carcinoma 3,2q35
146,Differentiated thyroid carcinoma,NDUFA13,NADH:ubiquinone oxidoreductase subunit A13,19p13.11
146,Differentiated thyroid carcinoma,TERT,telomerase reverse transcriptase,5p15.33
146,Differentiated thyroid carcinoma,GAS8-AS1,GAS8 antisense RNA 1,16q24.3
146,Differentiated thyroid carcinoma,LPAR4,lysophosphatidic acid receptor 4,Xq21.1
1331,Familial prostate cancer,CDH1,cadherin 1,16q22.1
1331,Familial prostate cancer,MSMB,microseminoprotein beta,10q11.22
1331,Familial prostate cancer,RAD51D,RAD51 paralog D,17q12
1331,Familial prostate cancer,ATM,ATM serine/threonine kinase,11q22.3
1331,Familial prostate cancer,SRD5A2,steroid 5 alpha-reductase 2,2p23.1
1331,Familial prostate cancer,RNASEL,ribonuclease L,1q25.3
1331,Familial prostate cancer,BRCA1,BRCA1 DNA repair associated,17q21.31
1331,Familial prostate cancer,BRCA2,BRCA2 DNA repair associated,13q13.1
1331,Familial prostate cancer,CHEK2,checkpoint kinase 2,22q12.1
1331,Familial prostate cancer,ELAC2,elaC ribonuclease Z 2,17p12
1331,Familial prostate cancer,EPHB2,EPH receptor B2,1p36.12
1331,Familial prostate cancer,NBN,nibrin,8q21.3
1331,Familial prostate cancer,HNF1B,HNF1 homeobox B,17q12
1331,Familial prostate cancer,HOXB13,homeobox B13,17q21.32
1331,Familial prostate cancer,MSR1,macrophage scavenger receptor 1,8p22
847,X-linked alpha-thalassemia-intellectual disability syndrome,ATRX,ATRX chromatin remodeler,Xq21.1
2268,ICF syndrome,DNMT3B,DNA methyltransferase 3 beta,20q11.21
2268,ICF syndrome,ZBTB24,zinc finger and BTB domain containing 24,6q21
2268,ICF syndrome,CDCA7,cell division cycle associated 7,2q31.1
2268,ICF syndrome,HELLS,"helicase, lymphoid specific",10q23.33
2268,ICF syndrome,UHRF1,ubiquitin like with PHD and ring finger domains 1,19p13.3
475,Isolated Joubert syndrome,CEP120,centrosomal protein 120,5q23.2
475,Isolated Joubert syndrome,PIBF1,progesterone immunomodulatory binding factor 1,13q21.33-q22.1
475,Isolated Joubert syndrome,OFD1,OFD1 centriole and centriolar satellite protein,Xp22.2
475,Isolated Joubert syndrome,TCTN3,tectonic family member 3,10q24.1
475,Isolated Joubert syndrome,PDE6D,phosphodiesterase 6D,2q37.1
475,Isolated Joubert syndrome,KIAA0753,KIAA0753,17p13.1
475,Isolated Joubert syndrome,IFT74,intraflagellar transport 74,9p21.2
475,Isolated Joubert syndrome,B9D2,B9 domain containing 2,19q13.2
475,Isolated Joubert syndrome,TCTN2,tectonic family member 2,12q24.31
475,Isolated Joubert syndrome,AHI1,Abelson helper integration site 1,6q23.3
475,Isolated Joubert syndrome,TMEM67,transmembrane protein 67,8q22.1
475,Isolated Joubert syndrome,MKS1,MKS transition zone complex subunit 1,17q22
475,Isolated Joubert syndrome,ARL13B,ARF like GTPase 13B,3q11.1-q11.2
475,Isolated Joubert syndrome,INPP5E,inositol polyphosphate-5-phosphatase E,9q34.3
475,Isolated Joubert syndrome,TCTN1,tectonic family member 1,12q24.11
475,Isolated Joubert syndrome,B9D1,B9 domain containing 1,17p11.2
475,Isolated Joubert syndrome,TMEM237,transmembrane protein 237,2q33.1
475,Isolated Joubert syndrome,CEP41,centrosomal protein 41,7q32.2
475,Isolated Joubert syndrome,CPLANE1,ciliogenesis and planar polarity effector complex subunit 1,5p13.2
475,Isolated Joubert syndrome,CSPP1,centrosome and spindle pole associated protein 1,8q13.1-q13.2
475,Isolated Joubert syndrome,KIAA0586,KIAA0586,14q23.1
475,Isolated Joubert syndrome,CEP104,centrosomal protein 104,1p36.32
475,Isolated Joubert syndrome,KATNIP,katanin interacting protein,16p12.1
475,Isolated Joubert syndrome,SUFU,SUFU negative regulator of hedgehog signaling,10q24.32
475,Isolated Joubert syndrome,ARMC9,armadillo repeat containing 9,2q37.1
475,Isolated Joubert syndrome,CBY1,"chibby 1, beta catenin antagonist",22q13.1
475,Isolated Joubert syndrome,HYLS1,HYLS1 centriolar and ciliogenesis associated,11q24.2
475,Isolated Joubert syndrome,TOGARAM1,TOG array regulator of axonemal microtubules 1,14q21.2
475,Isolated Joubert syndrome,TMEM218,transmembrane protein 218,11q24.2
475,Isolated Joubert syndrome,ARL3,ARF like GTPase 3,10q24.32
392,Holt-Oram syndrome,TBX5,T-box transcription factor 5,12q24.21
86,Familial abdominal aortic aneurysm,COL3A1,collagen type III alpha 1 chain,2q32.2
243,"46,XX gonadal dysgenesis",NR5A1,nuclear receptor subfamily 5 group A member 1,9q33.3
243,"46,XX gonadal dysgenesis",FIGLA,folliculogenesis specific bHLH transcription factor,2p13.3
243,"46,XX gonadal dysgenesis",MRPS22,mitochondrial ribosomal protein S22,3q23
243,"46,XX gonadal dysgenesis",FSHR,follicle stimulating hormone receptor,2p16.3
243,"46,XX gonadal dysgenesis",BMP15,bone morphogenetic protein 15,Xp11.22
243,"46,XX gonadal dysgenesis",PSMC3IP,PSMC3 interacting protein,17q21.2
243,"46,XX gonadal dysgenesis",NUP107,nucleoporin 107,12q15
243,"46,XX gonadal dysgenesis",BNC1,basonuclin zinc finger protein 1,15q25.2
243,"46,XX gonadal dysgenesis",ZSWIM7,zinc finger SWIM-type containing 7,17p12
243,"46,XX gonadal dysgenesis",POLR3H,RNA polymerase III subunit H,22q13.2
243,"46,XX gonadal dysgenesis",MSH4,mutS homolog 4,1p31.1
243,"46,XX gonadal dysgenesis",SPIDR,scaffold protein involved in DNA repair,8q11.21
136,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy,NOTCH3,notch receptor 3,19p13.12
48,Congenital bilateral absence of vas deferens,ADGRG2,adhesion G protein-coupled receptor G2,Xp22.13
48,Congenital bilateral absence of vas deferens,CFTR,CF transmembrane conductance regulator,7q31.2
528,Congenital generalized lipodystrophy,PPARG,peroxisome proliferator activated receptor gamma,3p25.2
528,Congenital generalized lipodystrophy,FOS,"Fos proto-oncogene, AP-1 transcription factor subunit",14q24.3
275,Severe combined immunodeficiency due to DCLRE1C deficiency,DCLRE1C,DNA cross-link repair 1C,10p13
184,Cherubism,SH3BP2,SH3 domain binding protein 2,4p16.3
71,Chylomicron retention disease,SAR1B,secretion associated Ras related GTPase 1B,5q31.1
1949,Self-limited neonatal epilepsy,KCNQ2,potassium voltage-gated channel subfamily Q member 2,20q13.33
1949,Self-limited neonatal epilepsy,KCNQ3,potassium voltage-gated channel subfamily Q member 3,8q24.22
189,Hidrotic ectodermal dysplasia,GJB6,gap junction protein beta 6,13q12.11
1473,Uveal coloboma-cleft lip and palate-intellectual disability,YAP1,Yes1 associated transcriptional regulator,11q22.1
1344,Isolated atrial standstill,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
1344,Isolated atrial standstill,NPPA,natriuretic peptide A,1p36.22
182050,MYH9-related syndromic thrombocytopenia,MYH9,myosin heavy chain 9,22q12.3
3103,Roberts syndrome,ESCO2,establishment of sister chromatid cohesion N-acetyltransferase 2,8p21.1
181428,Familial Hyperalphalipoproteinemia,CETP,cholesteryl ester transfer protein,16q13
181428,Familial Hyperalphalipoproteinemia,APOC3,apolipoprotein C3,11q23.3
181428,Familial Hyperalphalipoproteinemia,SCARB1,scavenger receptor class B member 1,12q24.31
709,Peters plus syndrome,B3GLCT,beta 3-glucosyltransferase,13q12.3
776,Lujan-Fryns syndrome,MED12,mediator complex subunit 12,Xq13.1
776,Lujan-Fryns syndrome,ZDHHC9,zDHHC palmitoyltransferase 9,Xq26.1
776,Lujan-Fryns syndrome,UPF3B,UPF3B regulator of nonsense mediated mRNA decay,Xq24
902,Werner syndrome,WRN,WRN RecQ like helicase,8p12
888,Van der Woude syndrome,IRF6,interferon regulatory factor 6,1q32.2
888,Van der Woude syndrome,GRHL3,grainyhead like transcription factor 3,1p36.11
871,Hereditary progressive cardiac conduction defect,SCN1B,sodium voltage-gated channel beta subunit 1,19q13.11
871,Hereditary progressive cardiac conduction defect,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
871,Hereditary progressive cardiac conduction defect,NKX2-5,NK2 homeobox 5,5q35.1
871,Hereditary progressive cardiac conduction defect,TRPM4,transient receptor potential cation channel subfamily M member 4,19q13.33
1587,Monosomy 13q14 syndrome,RB1,RB transcriptional corepressor 1,13q14.2
1627,Deletion 5q35 syndrome,NKX2-5,NK2 homeobox 5,5q35.1
1627,Deletion 5q35 syndrome,NSD1,nuclear receptor binding SET domain protein 1,5q35.3
500,Noonan syndrome with multiple lentigines,PTPN11,protein tyrosine phosphatase non-receptor type 11,12q24.13
500,Noonan syndrome with multiple lentigines,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
500,Noonan syndrome with multiple lentigines,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",3p25.2
233,Duane retraction syndrome,CHN1,chimerin 1,2q31.1
233,Duane retraction syndrome,MAFB,MAF bZIP transcription factor B,20q12
233,Duane retraction syndrome,SALL4,spalt like transcription factor 4,20q13.2
2495,Meningioma,SMARCB1,SWI/SNF related BAF chromatin remodeling complex subunit B1,22q11.23
2495,Meningioma,PDGFB,platelet derived growth factor subunit B,22q13.1
2495,Meningioma,SUFU,SUFU negative regulator of hedgehog signaling,10q24.32
2495,Meningioma,NF2,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",22q12.2
2495,Meningioma,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
2495,Meningioma,AKT1,AKT serine/threonine kinase 1,14q32.33
2495,Meningioma,TERT,telomerase reverse transcriptase,5p15.33
2495,Meningioma,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
2495,Meningioma,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
2495,Meningioma,SMARCE1,SWI/SNF related BAF chromatin remodeling complex subunit E1,17q21.2
2495,Meningioma,TRAF7,TNF receptor associated factor 7,16p13.3
2495,Meningioma,SMO,"smoothened, frizzled class receptor",7q32.1
569,Familial or sporadic hemiplegic migraine,SCN1A,sodium voltage-gated channel alpha subunit 1,2q24.3
569,Familial or sporadic hemiplegic migraine,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
569,Familial or sporadic hemiplegic migraine,ATP1A2,ATPase Na+/K+ transporting subunit alpha 2,1q23.2
569,Familial or sporadic hemiplegic migraine,PRRT2,proline rich transmembrane protein 2,16p11.2
240,Léri-Weill dyschondrosteosis,SHOX,SHOX homeobox,Xp22.33 and Yp11.32
2311,Autosomal recessive spondylocostal dysostosis,TBX6,T-box transcription factor 6,16p11.2
2311,Autosomal recessive spondylocostal dysostosis,DLL3,delta like canonical Notch ligand 3,19q13.2
2311,Autosomal recessive spondylocostal dysostosis,MESP2,mesoderm posterior bHLH transcription factor 2,15q26.1
2311,Autosomal recessive spondylocostal dysostosis,LFNG,LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,7p22.3
2311,Autosomal recessive spondylocostal dysostosis,HES7,hes family bHLH transcription factor 7,17p13.1
2311,Autosomal recessive spondylocostal dysostosis,RIPPLY2,ripply transcriptional repressor 2,6q14.2
358,Gitelman syndrome,SLC12A3,solute carrier family 12 member 3,16q13
358,Gitelman syndrome,CLCNKB,chloride voltage-gated channel Kb,1p36.13
242,"46,XY complete gonadal dysgenesis",DHX37,DEAH-box helicase 37,12q24.31
242,"46,XY complete gonadal dysgenesis",WT1,WT1 transcription factor,11p13
242,"46,XY complete gonadal dysgenesis",SOX9,SRY-box transcription factor 9,17q24.3
242,"46,XY complete gonadal dysgenesis",SRY,sex determining region Y,Yp11.2
242,"46,XY complete gonadal dysgenesis",DHH,desert hedgehog signaling molecule,12q13.12
242,"46,XY complete gonadal dysgenesis",NR5A1,nuclear receptor subfamily 5 group A member 1,9q33.3
242,"46,XY complete gonadal dysgenesis",NR0B1,nuclear receptor subfamily 0 group B member 1,Xp21.2
242,"46,XY complete gonadal dysgenesis",CBX2,chromobox 2,17q25.3
242,"46,XY complete gonadal dysgenesis",MAP3K1,mitogen-activated protein kinase kinase kinase 1,5q11.2
242,"46,XY complete gonadal dysgenesis",DMRT1,doublesex and mab-3 related transcription factor 1,9p24.3
2052,Fraser syndrome,FRAS1,Fraser extracellular matrix complex subunit 1,4q21.21
2052,Fraser syndrome,FREM2,FRAS1 related extracellular matrix 2,13q13.3
2052,Fraser syndrome,GRIP1,glutamate receptor interacting protein 1,12q14.3
1358,Carey-Fineman-Ziter syndrome,MYMX,"myomixer, myoblast fusion factor",6p21.1
1358,Carey-Fineman-Ziter syndrome,MYMK,"myomaker, myoblast fusion factor",9q34.2
111,Barth syndrome,TAFAZZIN,"tafazzin, phospholipid-lysophospholipid transacylase",Xq28
1308,C syndrome,CD96,CD96 molecule,3q13.13-q13.2
150,Nasopharyngeal carcinoma,NFKBIA,NFKB inhibitor alpha,14q13.2
133,Chronic beryllium disease,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",6p21.32
1552,Currarino syndrome,MNX1,motor neuron and pancreas homeobox 1,7q36.3
624,Familial multiple nevi flammei,GNAQ,G protein subunit alpha q,9q21.2
3000,Familial peripheral male-limited precocious puberty,LHCGR,luteinizing hormone/choriogonadotropin receptor,2p16.3
920,Ablepharon macrostomia syndrome,TWIST2,twist family bHLH transcription factor 2,2q37.3
7,3C syndrome,VPS35L,VPS35 endosomal protein sorting factor like,16p12.3
7,3C syndrome,DPYSL5,dihydropyrimidinase like 5,2p23.3
7,3C syndrome,WASHC5,WASH complex subunit 5,8q24.13
7,3C syndrome,CCDC22,CCC complex scaffolding subunit CCDC22,Xp11.23
931,Isolated acheiropodia,LMBR1,limb development membrane protein 1,7q36.3
869,Triple A syndrome,TRAPPC11,trafficking protein particle complex subunit 11,4q35.1
869,Triple A syndrome,AAAS,aladin WD repeat nucleoporin,12q13.13
869,Triple A syndrome,GMPPA,GDP-mannose pyrophosphorylase A,2q35
2297,Insulin-resistance syndrome type A,INSR,insulin receptor,19p13.2
921,Abruzzo-Erickson syndrome,TBX22,T-box transcription factor 22,Xq21.1
31,Oxoglutaric aciduria,OGDH,oxoglutarate dehydrogenase,7p13
37,Acrodermatitis enteropathica,SLC39A4,solute carrier family 39 member 4,8q24.3
950,Acrodysostosis,PDE4D,phosphodiesterase 4D,5q11.2-q12.1
950,Acrodysostosis,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,17q24.2
955,Hajdu-Cheney syndrome,NOTCH2,notch receptor 2,1p12
952,"Acrofacial dysostosis, Weyers type",EVC,EvC ciliary complex subunit 1,4p16.2
952,"Acrofacial dysostosis, Weyers type",EVC2,EvC ciliary complex subunit 2,4p16.2
952,"Acrofacial dysostosis, Weyers type",CTNNB1,catenin beta 1,3p22.1
1713,17p11.2 microduplication syndrome,RAI1,retinoic acid induced 1,17p11.2
1762,Proximal Xq28 duplication syndrome,MECP2,methyl-CpG binding protein 2,Xq28
1878,TRIM32-related limb-girdle muscular dystrophy R8,TRIM32,tripartite motif containing 32,9q33.1
1946,Amelocerebrohypohidrotic syndrome,SLC13A5,solute carrier family 13 member 5,17p13.1
1946,Amelocerebrohypohidrotic syndrome,ROGDI,rogdi atypical leucine zipper,16p13.3
2604,Familial visceral myopathy,ACTG2,"actin gamma 2, smooth muscle",2p13.1
156,Carnitine palmitoyl transferase 1A deficiency,CPT1A,carnitine palmitoyltransferase 1A,11q13.3
2598,Mitochondrial myopathy and sideroblastic anemia,PUS1,pseudouridine synthase 1,12q24.33
2598,Mitochondrial myopathy and sideroblastic anemia,YARS2,tyrosyl-tRNA synthetase 2,12p11.21
1072,Ankyloblepharon filiforme adnatum-cleft palate syndrome,TP63,tumor protein p63,3q28
1053,Vein of Galen aneurysmal malformation,EPHB4,EPH receptor B4,7q22.1
1052,Mosaic variegated aneuploidy syndrome,TRIP13,thyroid hormone receptor interactor 13,5p15.33
1052,Mosaic variegated aneuploidy syndrome,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,15q15.1
1052,Mosaic variegated aneuploidy syndrome,CEP57,centrosomal protein 57,11q21
1052,Mosaic variegated aneuploidy syndrome,BUB1,BUB1 mitotic checkpoint serine/threonine kinase,2q13
1052,Mosaic variegated aneuploidy syndrome,BUB3,BUB3 mitotic checkpoint protein,10q26.13
1040,Metaphyseal anadysplasia,MMP13,matrix metallopeptidase 13,11q22.2
1040,Metaphyseal anadysplasia,MMP13,matrix metallopeptidase 13,11q22.2
1040,Metaphyseal anadysplasia,MMP9,matrix metallopeptidase 9,20q13.12
1106,Microphthalmia with limb anomalies,SMOC1,SPARC related modular calcium binding 1,14q24.1
990,Agnathia-holoprosencephaly-situs inversus syndrome,OTX2,orthodenticle homeobox 2,14q22.3
990,Agnathia-holoprosencephaly-situs inversus syndrome,PRRX1,paired related homeobox 1,1q24.2
994,Fetal akinesia deformation sequence,SLC18A3,solute carrier family 18 member A3,10q11.23
994,Fetal akinesia deformation sequence,MYOD1,myogenic differentiation 1,11p15.1
994,Fetal akinesia deformation sequence,RAPSN,receptor associated protein of the synapse,11p11.2
994,Fetal akinesia deformation sequence,DOK7,docking protein 7,4p16.3
994,Fetal akinesia deformation sequence,MUSK,muscle associated receptor tyrosine kinase,9q31.3
994,Fetal akinesia deformation sequence,NUP88,nucleoporin 88,17p13.2
994,Fetal akinesia deformation sequence,GLDN,gliomedin,15q21.2
994,Fetal akinesia deformation sequence,KIF21A,kinesin family member 21A,12q12
994,Fetal akinesia deformation sequence,MAGEL2,MAGE family member L2,15q11.2
994,Fetal akinesia deformation sequence,TUBA1A,tubulin alpha 1a,12q13.12
51,Aicardi-Goutières syndrome,LSM11,"LSM11, U7 small nuclear RNA associated",5q33.3
51,Aicardi-Goutières syndrome,RNU7-1,"RNA, U7 small nuclear 1",12p13.31
51,Aicardi-Goutières syndrome,SAMHD1,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1,20q11.23
51,Aicardi-Goutières syndrome,RNASEH2A,ribonuclease H2 subunit A,19p13.13
51,Aicardi-Goutières syndrome,RNASEH2B,ribonuclease H2 subunit B,13q14.3
51,Aicardi-Goutières syndrome,RNASEH2C,ribonuclease H2 subunit C,11q13.1
51,Aicardi-Goutières syndrome,ADAR,adenosine deaminase RNA specific,1q21.3
51,Aicardi-Goutières syndrome,TREX1,three prime repair exonuclease 1,3p21.31
51,Aicardi-Goutières syndrome,IFIH1,interferon induced with helicase C domain 1,2q24.2
978,ADULT syndrome,TP63,tumor protein p63,3q28
988,Tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome,SHH,sonic hedgehog signaling molecule,7q36.3
988,Tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome,LMBR1,limb development membrane protein 1,7q36.3
983,Testicular regression syndrome,DHX37,DEAH-box helicase 37,12q24.31
970,Hereditary sensory and autonomic neuropathy type 2,SCN9A,sodium voltage-gated channel alpha subunit 9,2q24.3
970,Hereditary sensory and autonomic neuropathy type 2,WNK1,WNK lysine deficient protein kinase 1,12p13.33
970,Hereditary sensory and autonomic neuropathy type 2,RETREG1,reticulophagy regulator 1,5p15.1
970,Hereditary sensory and autonomic neuropathy type 2,KIF1A,kinesin family member 1A,2q37.3
40,"Acromesomelic dysplasia, Maroteaux type",NPR2,natriuretic peptide receptor 2,9p13.3
969,Acromicric dysplasia,FBN1,fibrillin 1,15q21.1
969,Acromicric dysplasia,LTBP3,latent transforming growth factor beta binding protein 3,11q13.1
974,Adams-Oliver syndrome,NOTCH1,notch receptor 1,9q34.3
974,Adams-Oliver syndrome,ARHGAP31,Rho GTPase activating protein 31,3q13.32-q13.33
974,Adams-Oliver syndrome,DOCK6,dedicator of cytokinesis 6,19p13.2
974,Adams-Oliver syndrome,RBPJ,recombination signal binding protein for immunoglobulin kappa J region,4p15.2
974,Adams-Oliver syndrome,EOGT,EGF domain specific O-linked N-acetylglucosamine transferase,3p14.1
974,Adams-Oliver syndrome,DLL4,delta like canonical Notch ligand 4,15q15.1
972,Hereditary continuous muscle fiber activity,KCNA1,potassium voltage-gated channel subfamily A member 1,12p13.32
959,Acro-renal-ocular syndrome,SALL4,spalt like transcription factor 4,20q13.2
968,"Acromesomelic dysplasia, Hunter-Thompson type",GDF5,growth differentiation factor 5,20q11.22
1031,Enamel-renal syndrome,FAM20A,FAM20A golgi associated secretory pathway pseudokinase,17q24.2
64,Alström syndrome,ALMS1,ALMS1 centrosome and basal body associated protein,2p13.1
139396,X-linked cerebral adrenoleukodystrophy,ABCD1,ATP binding cassette subfamily D member 1,Xq28
139399,Adrenomyeloneuropathy,ABCD1,ATP binding cassette subfamily D member 1,Xq28
139406,Encephalopathy due to prosaposin deficiency,PSAP,prosaposin,10q22.1
701,Alopecia universalis,HR,HR lysine demethylase and nuclear receptor corepressor,8p21.3
1010,Autosomal dominant palmoplantar keratoderma and congenital alopecia,GJA1,gap junction protein alpha 1,6q22.31
1001,2q37 microdeletion syndrome,HDAC4,histone deacetylase 4,2q37.3
59,Allan-Herndon-Dudley syndrome,SLC16A2,solute carrier family 16 member 2,Xq13.2
127,Borjeson-Forssman-Lehmann syndrome,PHF6,PHD finger protein 6,Xq26.2
1263,Boomerang dysplasia,FLNB,filamin B,3p14.3
1234,Bartsocas-Papas syndrome,RIPK4,receptor interacting serine/threonine kinase 4,21q22.3
1231,Barber-Say syndrome,TWIST2,twist family bHLH transcription factor 2,2q37.3
1229,Congenital intrauterine infection-like syndrome,OCLN,occludin,5q13.2
109,Bannayan-Riley-Ruvalcaba syndrome,PTEN,phosphatase and tensin homolog,10q23.31
1239,Behr syndrome,OPA1,OPA1 mitochondrial dynamin like GTPase,3q29
115,Congenital contractural arachnodactyly,FBN2,fibrillin 2,5q23.3
137625,Glycogen storage disease due to muscle and heart glycogen synthase deficiency,GYS1,glycogen synthase 1,19q13.33
137608,Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome,PTEN,phosphatase and tensin homolog,10q23.31
1299,Branchioskeletogenital syndrome,CDH11,cadherin 11,16q21
1300,Autosomal dominant popliteal pterygium syndrome,IRF6,interferon regulatory factor 6,1q32.2
137634,Overgrowth-macrocephaly-facial dysmorphism syndrome,RNF135,ring finger protein 135,17q11.2
1297,Branchio-oculo-facial syndrome,TFAP2A,transcription factor AP-2 alpha,6p24.3
137639,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome,POLR3A,RNA polymerase III subunit A,10q22.3
1276,Brachydactyly-arterial hypertension syndrome,PDE3A,phosphodiesterase 3A,12p12.2
1275,Brachydactyly-elbow wrist dysplasia syndrome,MACROH2A1,macroH2A.1 histone,5q31.1
1275,Brachydactyly-elbow wrist dysplasia syndrome,PITX1,paired like homeodomain 1,5q31.1
1270,Bowen-Conradi syndrome,EMG1,EMG1 N1-specific pseudouridine methyltransferase,12p13.31
137605,Legius syndrome,SPRED1,sprouty related EVH1 domain containing 1,15q14
1168,Ataxia-oculomotor apraxia type 1,APTX,aprataxin,9p21.1
137834,Frank-Ter Haar syndrome,SH3PXD2B,SH3 and PX domains 2B,5q35.1
137831,X-linked intellectual disability-cerebellar hypoplasia syndrome,OPHN1,oligophrenin 1,Xq12
1170,Autosomal recessive cerebelloparenchymal disorder type 3,PMPCA,"peptidase, mitochondrial processing subunit alpha",9q34.3
1175,X-linked progressive cerebellar ataxia,GJB1,gap junction protein beta 1,Xq13.1
1180,Ataxia-hypogonadism-choroidal dystrophy syndrome,PNPLA6,"patatin like domain 6, lysophospholipase",19p13.2
1173,Cerebellar ataxia-hypogonadism syndrome,PNPLA6,"patatin like domain 6, lysophospholipase",19p13.2
1173,Cerebellar ataxia-hypogonadism syndrome,RNF216,ring finger protein 216,7p22.1
137681,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,GFM1,G elongation factor mitochondrial 1,3q25.32
137675,Histiocytoid cardiomyopathy,MT-CYB,mitochondrially encoded cytochrome b,mitochondria
137678,Spondyloepiphyseal dysplasia with metatarsal shortening,COL2A1,collagen type II alpha 1 chain,12q13.11
137754,Aminoacylase 1 deficiency,ACY1,aminoacylase 1,3p21.2
1145,Infantile-onset X-linked spinal muscular atrophy,UBA1,ubiquitin like modifier activating enzyme 1,Xp11.3
137776,Lethal congenital contracture syndrome type 2,ERBB3,erb-b2 receptor tyrosine kinase 3,12q13.2
1149,Kuskokwim syndrome,FKBP10,FKBP prolyl isomerase 10,17q21.2
1159,Progressive pseudorheumatoid dysplasia,CCN6,cellular communication network factor 6,6q21
137783,Lethal congenital contracture syndrome type 3,PIP5K1C,phosphatidylinositol-4-phosphate 5-kinase type 1 gamma,19p13.3
137783,Lethal congenital contracture syndrome type 3,MYBPC1,myosin binding protein C1,12q23.2
1215,Autosomal dominant optic atrophy plus syndrome,OPA1,OPA1 mitochondrial dynamin like GTPase,3q29
1216,Autosomal dominant congenital benign spinal muscular atrophy,TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
1225,Baller-Gerold syndrome,RECQL4,RecQ like helicase 4,8q24.3
1226,Bamforth-Lazarus syndrome,FOXE1,forkhead box E1,9q22.33
137888,Auriculocondylar syndrome,GNAI3,G protein subunit alpha i3,1p13.3
137888,Auriculocondylar syndrome,PLCB4,phospholipase C beta 4,20p12.3-p12.2
137888,Auriculocondylar syndrome,EDN1,endothelin 1,6p24.1
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,AURKC,aurora kinase C,19q13.43
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,DNHD1,dynein heavy chain domain 1,11p15.4
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,CFAP47,cilia and flagella associated protein 47,Xp21.1
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,DNAH10,dynein axonemal heavy chain 10,12q24.31
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,AKAP3,A-kinase anchoring protein 3,12p13.32
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,CFAP61,cilia and flagella associated protein 61,20p11.23
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,ARMC12,armadillo repeat containing 12,6p21.31
137893,Male infertility due to large-headed multiflagellar polyploid spermatozoa,IFT74,intraflagellar transport 74,9p21.2
1186,Infantile-onset spinocerebellar ataxia,TWNK,twinkle mtDNA helicase,10q24.31
137898,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,DARS2,"aspartyl-tRNA synthetase 2, mitochondrial",1q25.1
1187,Lethal ataxia with deafness and optic atrophy,PRPS1,phosphoribosyl pyrophosphate synthetase 1,Xq22.3
1190,Atelosteogenesis type I,FLNB,filamin B,3p14.3
137908,Hypotonia with lactic acidemia and hyperammonemia,MRPS22,mitochondrial ribosomal protein S22,3q23
1200,Burn-McKeown syndrome,POLR1A,RNA polymerase I subunit A,2p11.2
1200,Burn-McKeown syndrome,TXNL4A,thioredoxin like 4A,18q23
141258,Tessier number 4 facial cleft,SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1 like,22q11.23
1458,CODAS syndrome,LONP1,"lon peptidase 1, mitochondrial",19p13.2
1454,Joubert syndrome with hepatic defect,TMEM67,transmembrane protein 67,8q22.1
1454,Joubert syndrome with hepatic defect,RPGRIP1L,RPGRIP1 like,16q12.2
1454,Joubert syndrome with hepatic defect,CC2D2A,coiled-coil and C2 domain containing 2A,4p15.32
1454,Joubert syndrome with hepatic defect,INPP5E,inositol polyphosphate-5-phosphatase E,9q34.3
190,Coats disease,NDP,norrin cystine knot growth factor NDP,Xp11.3
1429,Benign hereditary chorea,NKX2-1,NK2 homeobox 1,14q13.3
1429,Benign hereditary chorea,ADCY5,adenylate cyclase 5,3q21.1
1426,Greenberg dysplasia,LBR,lamin B receptor,1q42.12
1427,Autosomal recessive otospondylomegaepiphyseal dysplasia,COL11A2,collagen type XI alpha 2 chain,6p21.32
1435,Xq21 microdeletion syndrome,POU3F4,POU class 3 homeobox 4,Xq21.1
155878,Submucosal cleft palate,GRHL3,grainyhead like transcription factor 3,1p36.11
155878,Submucosal cleft palate,UBB,ubiquitin B,17p11.2
1490,Corneal dystrophy-perceptive deafness syndrome,SLC4A11,solute carrier family 4 member 11,20p13
1486,Lethal congenital contracture syndrome type 1,GLE1,GLE1 RNA export mediator,9q34.11
141276,Tessier number 7 facial cleft,PTCH2,patched 2,1p34.1
141276,Tessier number 7 facial cleft,SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1 like,22q11.23
1466,COFS syndrome,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19q13.32
1466,COFS syndrome,ERCC6,"ERCC excision repair 6, chromatin remodeling factor",10q11.23
1466,COFS syndrome,ERCC5,"ERCC excision repair 5, endonuclease",13q33.1
1466,COFS syndrome,ERCC1,"ERCC excision repair 1, endonuclease non-catalytic subunit",19q13.32
141291,Cleft lip and alveolus,MSX1,msh homeobox 1,4p16.2
141291,Cleft lip and alveolus,TP63,tumor protein p63,3q28
141291,Cleft lip and alveolus,IRF6,interferon regulatory factor 6,1q32.2
141291,Cleft lip and alveolus,NECTIN1,nectin cell adhesion molecule 1,11q23.3
1410,Uncombable hair syndrome,PADI3,peptidyl arginine deiminase 3,1p36.13
1410,Uncombable hair syndrome,TGM3,transglutaminase 3,20p13
1412,Tarsal-carpal coalition syndrome,NOG,noggin,17q22
1416,Familial calcium pyrophosphate deposition,TNFRSF11B,TNF receptor superfamily member 11b,8q24.12
1416,Familial calcium pyrophosphate deposition,ANKH,ANKH inorganic pyrophosphate transport regulator,5p15.2
1394,Cerebrofaciothoracic dysplasia,TMCO1,transmembrane and coiled-coil domains 1,1q24.1
1401,CHAND syndrome,RIPK4,receptor interacting serine/threonine kinase 4,21q22.3
141074,External auditory canal aplasia/hypoplasia,TSHZ1,teashirt zinc finger homeobox 1,18q22.3
174,"Metaphyseal chondrodysplasia, Schmid type",COL10A1,collagen type X alpha 1 chain,6q22.1
1425,Desbuquois syndrome,CSGALNACT1,chondroitin sulfate N-acetylgalactosaminyltransferase 1,8p21.3
1425,Desbuquois syndrome,CANT1,calcium activated nucleotidase 1,17q25.3
1425,Desbuquois syndrome,XYLT1,xylosyltransferase 1,16p12.3
156728,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",MATN3,matrilin 3,2p24.1
163,Hereditary hyperferritinemia-cataract syndrome,FTL,ferritin light chain,19q13.33
1366,Autosomal recessive palmoplantar keratoderma and congenital alopecia,LSS,lanosterol synthase,21q22.3
1393,Cerebrocostomandibular syndrome,SNRPB,small nuclear ribonucleoprotein polypeptides B and B1,20p13
157820,Cold-induced sweating syndrome,KLHL7,kelch like family member 7,7p15.3
157820,Cold-induced sweating syndrome,CRLF1,cytokine receptor like factor 1,19p12
157820,Cold-induced sweating syndrome,CLCF1,cardiotrophin like cytokine factor 1,11q13.2
157798,Serrated polyposis syndrome,RNF43,ring finger protein 43,17q22
1388,Catel-Manzke syndrome,TGDS,"TDP-glucose 4,6-dehydratase",13q32.1
157801,Mesoaxial synostotic syndactyly with phalangeal reduction,BHLHA9,basic helix-loop-helix family member a9,17p13.3
1387,Cataract-intellectual disability-hypogonadism syndrome,RAB3GAP1,RAB3 GTPase activating protein catalytic subunit 1,2q21.3
1387,Cataract-intellectual disability-hypogonadism syndrome,RAB3GAP2,RAB3 GTPase activating non-catalytic protein subunit 2,1q41
157791,Epithelioid hemangioendothelioma,TFE3,transcription factor binding to IGHM enhancer 3,Xp11.23
157791,Epithelioid hemangioendothelioma,CAMTA1,calmodulin binding transcription activator 1,1p36.31-p36.23
157791,Epithelioid hemangioendothelioma,YAP1,Yes1 associated transcriptional regulator,11q22.1
157791,Epithelioid hemangioendothelioma,WWTR1,WW domain containing transcription regulator 1,3q25.1
157794,Hereditary mixed polyposis syndrome,BMPR1A,bone morphogenetic protein receptor type 1A,10q23.2
157794,Hereditary mixed polyposis syndrome,GREM1,"gremlin 1, DAN family BMP antagonist",15q13.3
157769,Situs ambiguus,PKD1L1,"polycystin 1 like 1, transient receptor potential channel interacting",7p12.3
157769,Situs ambiguus,ZIC3,Zic family member 3,Xq26.3
157769,Situs ambiguus,ACVR2B,activin A receptor type 2B,3p22.2
157769,Situs ambiguus,LEFTY2,left-right determination factor 2,1q42.12
157769,Situs ambiguus,NODAL,nodal growth differentiation factor,10q22.1
157769,Situs ambiguus,CFAP53,cilia and flagella associated protein 53,18q21.1
157769,Situs ambiguus,MMP21,matrix metallopeptidase 21,10q26.2
157769,Situs ambiguus,NODAL,nodal growth differentiation factor,10q22.1
157769,Situs ambiguus,CIROP,ciliated left-right organizer metallopeptidase,14q11.2
157769,Situs ambiguus,DNAH9,dynein axonemal heavy chain 9,17p12
157769,Situs ambiguus,CFC1,"cryptic, EGF-CFC family member 1",2q21.1
157716,Late infantile CACH syndrome,EIF2B1,eukaryotic translation initiation factor 2B subunit alpha,12q24.31
157716,Late infantile CACH syndrome,EIF2B2,eukaryotic translation initiation factor 2B subunit beta,14q24.3
157716,Late infantile CACH syndrome,EIF2B3,eukaryotic translation initiation factor 2B subunit gamma,1p34.1
157716,Late infantile CACH syndrome,EIF2B4,eukaryotic translation initiation factor 2B subunit delta,2p23.3
157716,Late infantile CACH syndrome,EIF2B5,eukaryotic translation initiation factor 2B subunit epsilon,3q27.1
157719,Juvenile or adult CACH syndrome,EIF2B1,eukaryotic translation initiation factor 2B subunit alpha,12q24.31
157719,Juvenile or adult CACH syndrome,EIF2B2,eukaryotic translation initiation factor 2B subunit beta,14q24.3
157719,Juvenile or adult CACH syndrome,EIF2B3,eukaryotic translation initiation factor 2B subunit gamma,1p34.1
157719,Juvenile or adult CACH syndrome,EIF2B4,eukaryotic translation initiation factor 2B subunit delta,2p23.3
157719,Juvenile or adult CACH syndrome,EIF2B5,eukaryotic translation initiation factor 2B subunit epsilon,3q27.1
157713,Congenital or early infantile CACH syndrome,EIF2B1,eukaryotic translation initiation factor 2B subunit alpha,12q24.31
157713,Congenital or early infantile CACH syndrome,EIF2B2,eukaryotic translation initiation factor 2B subunit beta,14q24.3
157713,Congenital or early infantile CACH syndrome,EIF2B3,eukaryotic translation initiation factor 2B subunit gamma,1p34.1
157713,Congenital or early infantile CACH syndrome,EIF2B4,eukaryotic translation initiation factor 2B subunit delta,2p23.3
157713,Congenital or early infantile CACH syndrome,EIF2B5,eukaryotic translation initiation factor 2B subunit epsilon,3q27.1
1377,Cataract-microcornea syndrome,CRYAA,crystallin alpha A,21q22.3
1377,Cataract-microcornea syndrome,CRYBA4,crystallin beta A4,22q12.1
1377,Cataract-microcornea syndrome,CRYBB2,crystallin beta B2,22q11.23
1377,Cataract-microcornea syndrome,CRYGC,crystallin gamma C,2q33.3
1377,Cataract-microcornea syndrome,CRYGD,crystallin gamma D,2q33.3
1377,Cataract-microcornea syndrome,GJA8,gap junction protein alpha 8,1q21.2
1377,Cataract-microcornea syndrome,CRYBB1,crystallin beta B1,22q12.1
1377,Cataract-microcornea syndrome,MAF,MAF bZIP transcription factor,16q23.2
157215,Hereditary hypophosphatemic rickets with hypercalciuria,SLC34A3,solute carrier family 34 member 3,9q34.3
157215,Hereditary hypophosphatemic rickets with hypercalciuria,SLC34A1,solute carrier family 34 member 1,5q35.3
1328,Camurati-Engelmann disease,TGFB1,transforming growth factor beta 1,19q13.2
1338,Heart defect-tongue hamartoma-polysyndactyly syndrome,WDPCP,WD repeat containing planar cell polarity effector,2p15
1340,Cardiofaciocutaneous syndrome,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
1340,Cardiofaciocutaneous syndrome,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
1340,Cardiofaciocutaneous syndrome,MAP2K1,mitogen-activated protein kinase kinase 1,15q22.31
1340,Cardiofaciocutaneous syndrome,MAP2K2,mitogen-activated protein kinase kinase 2,19p13.3
2856,Persistent Müllerian duct syndrome,AMH,anti-Mullerian hormone,19p13.3
2856,Persistent Müllerian duct syndrome,AMHR2,anti-Mullerian hormone receptor type 2,12q13.13
1766,Dysequilibrium syndrome,VLDLR,very low density lipoprotein receptor,9p24.2
1766,Dysequilibrium syndrome,WDR81,WD repeat domain 81,17p13.3
1766,Dysequilibrium syndrome,CA8,carbonic anhydrase 8,8q12.1
1766,Dysequilibrium syndrome,ATP8A2,ATPase phospholipid transporting 8A2,13q12.13
1766,Dysequilibrium syndrome,TUBB2B,tubulin beta 2B class IIb,6p25.2
1777,Temtamy syndrome,C12ORF57,chromosome 12 open reading frame 57,12p13.31
1772,"45,X/46,XY mixed gonadal dysgenesis",SRY,sex determining region Y,Yp11.2
1782,Dysosteosclerosis,TNFRSF11A,TNF receptor superfamily member 11a,18q21.33
1782,Dysosteosclerosis,TCIRG1,"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3",11q13.2
1782,Dysosteosclerosis,SLC29A3,solute carrier family 29 member 3,10q22.1
1788,"Acrofacial dysostosis, Rodríguez type",SF3B4,splicing factor 3b subunit 4,1q21.2
859,Transcobalamin deficiency,TCN2,transcobalamin 2,22q12.2
139441,Hypomyelination with atrophy of basal ganglia and cerebellum,TUBB4A,tubulin beta 4A class IVa,19p13.3
139441,Hypomyelination with atrophy of basal ganglia and cerebellum,UFM1,ubiquitin fold modifier 1,13q13.3
139447,Progressive cavitating leukoencephalopathy,NDUFV2,NADH:ubiquinone oxidoreductase core subunit V2,18p11.22
1573,Hypotrichosis with juvenile macular degeneration,CDH3,cadherin 3,16q22.1
726,Alpers-Huttenlocher syndrome,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
139455,Autosomal recessive bestrophinopathy,BEST1,bestrophin 1,11q12.3
139466,SERKAL syndrome,WNT4,Wnt family member 4,1p36.12
1596,Distal deletion 15q syndrome,MCTP2,multiple C2 and transmembrane domain containing 2,15q26.2
139471,Microphthalmia with brain and digit anomalies,BMP4,bone morphogenetic protein 4,14q22.2
139474,17q11.2 microduplication syndrome,NF1,neurofibromin 1,17q11.2
1617,Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion,NR4A2,nuclear receptor subfamily 4 group A member 2,2q24.1
1617,Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion,TBR1,T-box brain transcription factor 1,2q24.2
1606,1p36 deletion syndrome,RERE,arginine-glutamic acid dipeptide repeats,1p36.23
1606,1p36 deletion syndrome,PRKCZ,protein kinase C zeta,1p36.33
1606,1p36 deletion syndrome,UBE4B,ubiquitination factor E4B,1p36.22
1606,1p36 deletion syndrome,MMP23B,matrix metallopeptidase 23B,1p36.33
1606,1p36 deletion syndrome,GABRD,gamma-aminobutyric acid type A receptor subunit delta,1p36.33
1606,1p36 deletion syndrome,SKI,SKI proto-oncogene,1p36.33-p36.32
1606,1p36 deletion syndrome,KCNAB2,potassium voltage-gated channel subfamily A regulatory beta subunit 2,1p36.31
1606,1p36 deletion syndrome,PRDM16,PR/SET domain 16,1p36.32
1606,1p36 deletion syndrome,CASZ1,castor zinc finger 1,1p36.22
1606,1p36 deletion syndrome,SPEN,spen family transcriptional repressor,1p36.21-p36.13
1606,1p36 deletion syndrome,PDPN,podoplanin,1p36.21
1606,1p36 deletion syndrome,LUZP1,leucine zipper protein 1,1p36.12
1606,1p36 deletion syndrome,HSPG2,heparan sulfate proteoglycan 2,1p36.12
139480,Autosomal recessive spastic paraplegia type 39,PNPLA6,"patatin like domain 6, lysophospholipase",19p13.2
139485,Autosomal recessive ataxia due to ubiquinone deficiency,COQ8A,coenzyme Q8A,1q42.13
139515,Charcot-Marie-Tooth disease type 4J,FIG4,FIG4 phosphoinositide 5-phosphatase,6q21
139512,Neuropathy with hearing impairment,GJB3,gap junction protein beta 3,1p34.3
139525,Distal hereditary motor neuropathy type 2,HSPB1,heat shock protein family B (small) member 1,7q11.23
139525,Distal hereditary motor neuropathy type 2,HSPB8,heat shock protein family B (small) member 8,12q24.23
139525,Distal hereditary motor neuropathy type 2,HSPB3,heat shock protein family B (small) member 3,5q11.2
139525,Distal hereditary motor neuropathy type 2,FBXO38,F-box protein 38,5q32
1658,Absence of fingerprints-congenital milia syndrome,SMARCAD1,SNF2 related chromatin remodeling ATPase with DExD box 1,4q22.3
139536,Distal hereditary motor neuropathy type 5,REEP1,receptor accessory protein 1,2p11.2
139536,Distal hereditary motor neuropathy type 5,BSCL2,"BSCL2 lipid droplet biogenesis associated, seipin",11q12.3
139536,Distal hereditary motor neuropathy type 5,GARS1,glycyl-tRNA synthetase 1,7p14.3
139557,X-linked distal spinal muscular atrophy type 3,ATP7A,ATPase copper transporting alpha,Xq21.1
1662,Restrictive dermopathy,ZMPSTE24,zinc metallopeptidase STE24,1p34.2
1662,Restrictive dermopathy,LMNA,lamin A/C,1q22
139552,"Distal hereditary motor neuropathy, Jerash type",SIGMAR1,sigma non-opioid intracellular receptor 1,9p13.3
139583,X-linked hereditary sensory and autonomic neuropathy with deafness,AIFM1,apoptosis inducing factor mitochondria associated 1,Xq26.1
1667,Wolcott-Rallison syndrome,EIF2AK3,eukaryotic translation initiation factor 2 alpha kinase 3,2p11.2
139578,Mutilating hereditary sensory neuropathy with spastic paraplegia,CCT5,chaperonin containing TCP1 subunit 5,5p15.2
139589,Distal hereditary motor neuropathy type 7,DCTN1,dynactin subunit 1,2p13.1
139589,Distal hereditary motor neuropathy type 7,SLC5A7,solute carrier family 5 member 7,2q12.3
140917,Stapes ankylosis with broad thumbs and toes,NOG,noggin,17q22
140922,Titin-related limb-girdle muscular dystrophy R10,TTN,titin,2q31.2
1545,Crisponi syndrome,CRLF1,cytokine receptor like factor 1,19p12
1545,Crisponi syndrome,CLCF1,cardiotrophin like cytokine factor 1,11q13.2
140905,Hyperlipidemia due to hepatic triacylglycerol lipase deficiency,LIPC,"lipase C, hepatic type",15q21.3
1540,Jackson-Weiss syndrome,FGFR2,fibroblast growth factor receptor 2,10q26.13
140908,Brachydactyly type B2,NOG,noggin,17q22
140952,Syndactyly-telecanthus-anogenital and renal malformations syndrome,CCNQ,cyclin Q,Xq28
140957,Autosomal dominant macrothrombocytopenia,TUBA8,tubulin alpha 8,22q11.21
140957,Autosomal dominant macrothrombocytopenia,GP1BA,glycoprotein Ib platelet subunit alpha,17p13.2
140957,Autosomal dominant macrothrombocytopenia,TRPM7,transient receptor potential cation channel subfamily M member 7,15q21.2
140957,Autosomal dominant macrothrombocytopenia,GFI1B,growth factor independent 1B transcriptional repressor,9q34.13
140957,Autosomal dominant macrothrombocytopenia,GP1BB,glycoprotein Ib platelet subunit beta,22q11.21
140957,Autosomal dominant macrothrombocytopenia,TPM4,tropomyosin 4,19p13.12-p13.11
140957,Autosomal dominant macrothrombocytopenia,ITGA2B,integrin subunit alpha 2b,17q21.31
140957,Autosomal dominant macrothrombocytopenia,ITGB3,integrin subunit beta 3,17q21.32
140957,Autosomal dominant macrothrombocytopenia,TUBB1,tubulin beta 1 class VI,20q13.32
140957,Autosomal dominant macrothrombocytopenia,ACTN1,actinin alpha 1,14q24.1
140944,CLOVES syndrome,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
1555,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome,FGFR2,fibroblast growth factor receptor 2,10q26.13
140941,Short stature due to primary acid-labile subunit deficiency,IGFALS,insulin like growth factor binding protein acid labile subunit,16p13.3
1553,Curry-Jones syndrome,SMO,"smoothened, frizzled class receptor",7q32.1
140927,Self-limited neonatal-infantile epilepsy,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
140927,Self-limited neonatal-infantile epilepsy,KCNQ2,potassium voltage-gated channel subfamily Q member 2,20q13.33
140976,RHYNS syndrome,TMEM67,transmembrane protein 67,8q22.1
140969,Saldino-Mainzer syndrome,IFT140,intraflagellar transport 140,16p13.3
140969,Saldino-Mainzer syndrome,IFT172,intraflagellar transport 172,2p23.3
140966,"Palmoplantar keratoderma, Nagashima type",SERPINB7,serpin family B member 7,18q21.33
140963,Bilateral microtia-deafness-cleft palate syndrome,HOXA2,homeobox A2,7p15.2
382,Guanidinoacetate methyltransferase deficiency,GAMT,guanidinoacetate N-methyltransferase,19p13.3
742,Prolidase deficiency,PEPD,peptidase D,19q13.11
1571,Knobloch syndrome,PAK2,p21 (RAC1) activated kinase 2,3q29
1571,Knobloch syndrome,COL18A1,collagen type XVIII alpha 1 chain,21q22.3
1568,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome,AP1S2,adaptor related protein complex 1 subunit sigma 2,Xp22.2
1497,X-linked complicated corpus callosum dysgenesis,L1CAM,L1 cell adhesion molecule,Xq28
140436,Primary intraosseous venous malformation,ELMO2,engulfment and cell motility 2,20q13.12
1493,Vici syndrome,EPG5,ectopic P-granules 5 autophagy tethering factor,18q12.3-q21.1
1509,Coxopodopatellar syndrome,TBX4,T-box transcription factor 4,17q23.2
1507,Autosomal recessive Robinow syndrome,ROR2,receptor tyrosine kinase like orphan receptor 2,9q22.31
1507,Autosomal recessive Robinow syndrome,NXN,nucleoredoxin,17p13.3
1517,Cantú syndrome,ABCC9,ATP binding cassette subfamily C member 9,12p12.1
1517,Cantú syndrome,KCNJ8,potassium inwardly rectifying channel subfamily J member 8,12p12.1
1519,SPECC1L-related hypertelorism syndrome,SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1 like,22q11.23
1520,Craniofrontonasal dysplasia,EFNB1,ephrin B1,Xq13.1
1513,Craniodiaphyseal dysplasia,SOST,sclerostin,17q21.31
1513,Craniodiaphyseal dysplasia,SP7,Sp7 transcription factor,12q13.13
140481,Autosomal dominant slowed nerve conduction velocity,ARHGEF10,Rho guanine nucleotide exchange factor 10,8p23.3
1515,Cranioectodermal dysplasia,IFT122,intraflagellar transport 122,3q21.3-q22.1
1515,Cranioectodermal dysplasia,WDR35,WD repeat domain 35,2p24.1
1515,Cranioectodermal dysplasia,IFT43,intraflagellar transport 43,14q24.3
1515,Cranioectodermal dysplasia,WDR19,WD repeat domain 19,4p14
1515,Cranioectodermal dysplasia,IFT52,intraflagellar transport 52,20q13.12
1529,Craniofacial-deafness-hand syndrome,PAX3,paired box 3,2q36.1
1522,Craniometaphyseal dysplasia,ANKH,ANKH inorganic pyrophosphate transport regulator,5p15.2
1522,Craniometaphyseal dysplasia,GJA1,gap junction protein alpha 1,6q22.31
1525,Cranio-osteoarthropathy,HPGD,15-hydroxyprostaglandin dehydrogenase,4q34.1
1824,Lowry-Wood syndrome,RNU4ATAC,"RNA, U4atac small nuclear",2q14.2
1955,Spinocerebellar ataxia type 34,ELOVL4,ELOVL fatty acid elongase 4,6q14.1
2209,Maternal phenylketonuria syndrome,PAH,phenylalanine hydroxylase,12q23.2
1896,EEC syndrome,TP63,tumor protein p63,3q28
1897,EEM syndrome,CDH3,cadherin 3,16q22.1
1807,Focal facial dermal dysplasia type III,TWIST2,twist family bHLH transcription factor 2,2q37.3
1873,Jalili syndrome,CNNM4,cyclin and CBS domain divalent metal cation transport mediator 4,2q11.2
1879,Melorheostosis with osteopoikilosis,LEMD3,LEM domain containing 3,12q14.3
1872,Cone rod dystrophy,RPGR,retinitis pigmentosa GTPase regulator,Xp11.4
1872,Cone rod dystrophy,PRPH2,peripherin 2,6p21.1
1872,Cone rod dystrophy,CFAP410,cilia and flagella associated protein 410,21q22.3
1872,Cone rod dystrophy,PITPNM3,PITPNM family member 3,17p13.2-p13.1
1872,Cone rod dystrophy,OPN1MW,"opsin 1, medium wave sensitive",Xq28
1872,Cone rod dystrophy,CRX,cone-rod homeobox,19q13.33
1872,Cone rod dystrophy,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,1p36.22
1872,Cone rod dystrophy,CFAP418,cilia and flagella associated protein 418,8q22.1
1872,Cone rod dystrophy,CDHR1,cadherin related family member 1,10q23.1
1872,Cone rod dystrophy,ABCA4,ATP binding cassette subfamily A member 4,1p22.1
1872,Cone rod dystrophy,RIMS1,regulating synaptic membrane exocytosis 1,6q13
1872,Cone rod dystrophy,RPGRIP1,RPGR interacting protein 1,14q11.2
1872,Cone rod dystrophy,CACNA1F,calcium voltage-gated channel subunit alpha1 F,Xp11.23
1872,Cone rod dystrophy,CNGA3,cyclic nucleotide gated channel subunit alpha 3,2q11.2
1872,Cone rod dystrophy,AIPL1,AIP like 1 HSP90 co-chaperone,17p13.2
1872,Cone rod dystrophy,GUCA1A,guanylate cyclase activator 1A,6p21.1
1872,Cone rod dystrophy,GUCY2D,"guanylate cyclase 2D, retinal",17p13.1
1872,Cone rod dystrophy,OPN1LW,"opsin 1, long wave sensitive",Xq28
1872,Cone rod dystrophy,RAX2,retina and anterior neural fold homeobox 2,19p13.3
1872,Cone rod dystrophy,SEMA4A,semaphorin 4A,1q22
1872,Cone rod dystrophy,PROM1,prominin 1,4p15.32
1872,Cone rod dystrophy,CACNA2D4,calcium voltage-gated channel auxiliary subunit alpha2delta 4,12p13.33
1872,Cone rod dystrophy,ADAM9,ADAM metallopeptidase domain 9,8p11.22
1872,Cone rod dystrophy,UNC119,unc-119 lipid binding chaperone,17q11.2
1872,Cone rod dystrophy,RAB28,"RAB28, member RAS oncogene family",4p15.33
1872,Cone rod dystrophy,POC1B,POC1 centriolar protein B,12q21.33
1872,Cone rod dystrophy,DRAM2,DNA damage regulated autophagy modulator 2,1p13.3
1872,Cone rod dystrophy,TTLL5,tubulin tyrosine ligase like 5,14q24.3
1872,Cone rod dystrophy,TLCD3B,TLC domain containing 3B,16p11.2
1872,Cone rod dystrophy,UBAP1L,ubiquitin associated protein 1 like,15q22.31
1872,Cone rod dystrophy,ATF6,activating transcription factor 6,1q23.3
1871,Progressive cone dystrophy,PDE6C,phosphodiesterase 6C,10q23.33
1871,Progressive cone dystrophy,GNAT2,G protein subunit alpha transducin 2,1p13.3
1871,Progressive cone dystrophy,CNGB3,cyclic nucleotide gated channel subunit beta 3,8q21.3
1871,Progressive cone dystrophy,GUCA1A,guanylate cyclase activator 1A,6p21.1
1860,Thanatophoric dysplasia type 1,FGFR3,fibroblast growth factor receptor 3,4p16.3
1865,"Dyssegmental dysplasia, Silverman-Handmaker type",HSPG2,heparan sulfate proteoglycan 2,1p36.12
1830,Schimke immuno-osseous dysplasia,SMARCAL1,SNF2 related chromatin remodeling annealing helicase 1,2q35
1802,Ghosal hematodiaphyseal dysplasia,TBXAS1,thromboxane A synthase 1,7q34
2128,Isolated hemihyperplasia,IGF2,insulin like growth factor 2,11p15.5
2128,Isolated hemihyperplasia,H19,H19 imprinted maternally expressed transcript,11p15.5
2128,Isolated hemihyperplasia,KCNQ1OT1,KCNQ1 opposite strand/antisense transcript 1,11p15.5
2136,Hennekam syndrome,CCBE1,collagen and calcium binding EGF domains 1,18q21.32
2136,Hennekam syndrome,FAT4,FAT atypical cadherin 4,4q28.1
2136,Hennekam syndrome,ADAMTS3,ADAM metallopeptidase with thrombospondin type 1 motif 3,4q13.3
2138,"46,XX ovotesticular difference of sex development",SOX9,SRY-box transcription factor 9,17q24.3
2138,"46,XX ovotesticular difference of sex development",SRY,sex determining region Y,Yp11.2
2138,"46,XX ovotesticular difference of sex development",NR5A1,nuclear receptor subfamily 5 group A member 1,9q33.3
2143,Donnai-Barrow syndrome,LRP2,LDL receptor related protein 2,2q31.1
2148,Lissencephaly type 1 due to doublecortin gene mutation,DCX,doublecortin,Xq23
2108,Hallermann-Streiff syndrome,CHD6,chromodomain helicase DNA binding protein 6,20q12
2114,"Hip dysplasia, Beukes type",UFSP2,UFM1 specific peptidase 2,4q35.1
2117,Hartsfield syndrome,FGFR1,fibroblast growth factor receptor 1,8p11.23
376,Gordon syndrome,PIEZO2,piezo type mechanosensitive ion channel component 2,18p11.22-p11.21
2092,Focal dermal hypoplasia,PORCN,porcupine O-acyltransferase,Xp11.23
2098,"Acromesomelic dysplasia, Grebe type",BMPR1B,bone morphogenetic protein receptor type 1B,4q22.3
2098,"Acromesomelic dysplasia, Grebe type",GDF5,growth differentiation factor 5,20q11.22
380,Greig cephalopolysyndactyly syndrome,GLI3,GLI family zinc finger 3,7p14.1
2095,Gorlin-Chaudhry-Moss syndrome,SLC25A24,solute carrier family 25 member 24,1p13.3
157846,Neuroferritinopathy,FTL,ferritin light chain,19q13.33
2067,GAPO syndrome,ANTXR1,ANTXR cell adhesion molecule 1,2p13.3
2065,Galloway-Mowat syndrome,OSGEP,O-sialoglycoprotein endopeptidase,14q11.2
2065,Galloway-Mowat syndrome,TP53RK,TP53 regulating kinase,20q13.12
2065,Galloway-Mowat syndrome,WDR73,WD repeat domain 73,15q25.2
2065,Galloway-Mowat syndrome,NUP107,nucleoporin 107,12q15
2065,Galloway-Mowat syndrome,TPRKB,TP53RK binding protein,2p13.1
2065,Galloway-Mowat syndrome,LAGE3,L antigen family member 3,Xq28
2065,Galloway-Mowat syndrome,WDR4,WDR4 tRNA N7-guanosine methyltransferase non-catalytic subunit,21q22.3
2065,Galloway-Mowat syndrome,GON7,GON7 subunit of KEOPS complex,14q32.12
2065,Galloway-Mowat syndrome,NUP133,nucleoporin 133,1q42.13
2065,Galloway-Mowat syndrome,YRDC,yrdC N6-threonylcarbamoyltransferase domain containing,1p34.3
157941,Huntington disease-like 1,PRNP,prion protein (Kanno blood group),20p13
2072,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,GBA1,glucosylceramidase beta 1,1q22
157954,ANE syndrome,RBM28,RNA binding motif protein 28,7q32.1
157962,"Oculoauricular syndrome, Schorderet type",HMX1,H6 family homeobox 1,4p16.1
2078,Geroderma osteodysplastica,GORAB,"golgin, RAB6 interacting",1q24.2
2078,Geroderma osteodysplastica,PYCR1,pyrroline-5-carboxylate reductase 1,17q25.3
157949,Combined immunodeficiency with granulomatosis,INO80,INO80 complex ATPase subunit,15q15.1
157949,Combined immunodeficiency with granulomatosis,RAG1,recombination activating 1,11p12
157949,Combined immunodeficiency with granulomatosis,RAG2,recombination activating 2,11p12
157973,Congenital muscular dystrophy due to LMNA mutation,LMNA,lamin A/C,1q22
2084,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome,FBN1,fibrillin 1,15q21.1
157965,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome,SLC39A13,solute carrier family 39 member 13,11p11.2
1826,Frontometaphyseal dysplasia,MAP3K7,mitogen-activated protein kinase kinase kinase 7,6q15
1826,Frontometaphyseal dysplasia,FLNA,filamin A,Xq28
2050,Cole-Carpenter syndrome,P4HB,prolyl 4-hydroxylase subunit beta,17q25.3
2050,Cole-Carpenter syndrome,SEC24D,"SEC24 homolog D, COPII coat complex component",4q26
2050,Cole-Carpenter syndrome,CRTAP,cartilage associated protein,3p22.3
2059,Fryns syndrome,PIGN,phosphatidylinositol glycan anchor biosynthesis class N,18q21.33
2026,Gingival fibromatosis-hypertrichosis syndrome,ABCA5,ATP binding cassette subfamily A member 5,17q24.3
2028,Juvenile hyaline fibromatosis,ANTXR2,ANTXR cell adhesion molecule 2,4q21.21
2021,Fibrochondrogenesis,COL11A1,collagen type XI alpha 1 chain,1p21.1
2021,Fibrochondrogenesis,COL11A2,collagen type XI alpha 2 chain,6p21.32
2024,Hereditary gingival fibromatosis,GINGF2,"gingival fibromatosis, hereditary, 2",5q13-q22
2024,Hereditary gingival fibromatosis,SOS1,SOS Ras/Rac guanine nucleotide exchange factor 1,2p22.1
2024,Hereditary gingival fibromatosis,REST,RE1 silencing transcription factor,4q12
2044,Floating-Harbor syndrome,SRCAP,Snf2 related CREBBP activator protein,16p11.2
2036,Scalp-ear-nipple syndrome,KCTD1,potassium channel tetramerization domain containing 1,18q11.2
158769,Plaque-form urticaria pigmentosa,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
158766,Typical urticaria pigmentosa,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
158687,Lethal acantholytic erosive disorder,DSP,desmoplakin,6p24.3
158687,Lethal acantholytic erosive disorder,JUP,junction plakoglobin,17q21.2
158684,Epidermolysis bullosa simplex with pyloric atresia,PLEC,plectin,8q24.3
158684,Epidermolysis bullosa simplex with pyloric atresia,ITGB4,integrin subunit beta 4,17q25.1
158681,Epidermolysis bullosa simplex with circinate migratory erythema,KRT5,keratin 5,12q13.13
158676,"Localized dystrophic epidermolysis bullosa, nails only",COL7A1,collagen type VII alpha 1 chain,3p21.31
158673,"Localized dystrophic epidermolysis bullosa, acral form",COL7A1,collagen type VII alpha 1 chain,3p21.31
158668,Ectodermal dysplasia-skin fragility syndrome,PKP1,plakophilin 1,1q32.1
158778,Isolated bone marrow mastocytosis,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
158775,Smoldering systemic mastocytosis,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
158772,Nodular urticaria pigmentosa,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
1986,Gollop-Wolfgang complex,BHLHA9,basic helix-loop-helix family member a9,17p13.3
1980,Bilateral striopallidodentate calcinosis,NAA60,"N-alpha-acetyltransferase 60, NatF catalytic subunit",16p13.3
1980,Bilateral striopallidodentate calcinosis,CMPK2,cytidine/uridine monophosphate kinase 2,2p25.2
1980,Bilateral striopallidodentate calcinosis,JAM2,junctional adhesion molecule 2,21q21.3
1980,Bilateral striopallidodentate calcinosis,MYORG,myogenesis regulating glycosidase,9p13.3
1980,Bilateral striopallidodentate calcinosis,PDGFRB,platelet derived growth factor receptor beta,5q32
1980,Bilateral striopallidodentate calcinosis,PDGFB,platelet derived growth factor subunit B,22q13.1
1980,Bilateral striopallidodentate calcinosis,SLC20A2,solute carrier family 20 member 2,8p11.21
1980,Bilateral striopallidodentate calcinosis,XPR1,xenotropic and polytropic retrovirus receptor 1,1q25.3
1997,Blepharo-cheilo-odontic syndrome,CTNND1,catenin delta 1,11q12.1
1997,Blepharo-cheilo-odontic syndrome,CDH1,cadherin 1,16q22.1
2348,"Familial partial lipodystrophy, Dunnigan type",LMNA,lamin A/C,1q22
247768,Müllerian aplasia and hyperandrogenism,WNT4,Wnt family member 4,1p36.12
2353,Schilbach-Rott syndrome,PTCH1,patched 1,9q22.32
247790,FTH1-related iron overload,FTH1,ferritin heavy chain 1,11q12.3
247798,MUTYH-related polyposis,MUTYH,mutY DNA glycosylase,1p34.1
247794,Juvenile cataract-microcornea-renal glucosuria syndrome,SLC16A12,solute carrier family 16 member 12,10q23.31
247815,Autosomal recessive ataxia due to PEX10 deficiency,PEX10,peroxisomal biogenesis factor 10,1p36.32
2363,Lacrimoauriculodentodigital syndrome,FGF10,fibroblast growth factor 10,5p12
2363,Lacrimoauriculodentodigital syndrome,FGFR3,fibroblast growth factor receptor 3,4p16.3
2363,Lacrimoauriculodentodigital syndrome,FGFR2,fibroblast growth factor receptor 2,10q26.13
247691,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations,TREX1,three prime repair exonuclease 1,3p21.31
2340,Keratosis follicularis spinulosa decalvans,MBTPS2,"membrane bound transcription factor peptidase, site 2",Xp22.12
2340,Keratosis follicularis spinulosa decalvans,SAT1,spermidine/spermine N1-acetyltransferase 1,Xp22.11
2340,Keratosis follicularis spinulosa decalvans,LRP1,LDL receptor related protein 1,12q13.3
247685,Odontohypophosphatasia,ALPL,"alkaline phosphatase, biomineralization associated",1p36.12
2342,Haim-Munk syndrome,CTSC,cathepsin C,11q14.2
247709,Multiple endocrine neoplasia type 2B,RET,ret proto-oncogene,10q11.21
247698,Multiple endocrine neoplasia type 2A,RET,ret proto-oncogene,10q11.21
485,Kniest dysplasia,COL2A1,collagen type II alpha 1 chain,12q13.11
247585,Citrullinemia type II,SLC25A13,solute carrier family 25 member 13,7q21.3
247598,Neonatal intrahepatic cholestasis due to citrin deficiency,SLC25A13,solute carrier family 25 member 13,7q21.3
2332,KBG syndrome,ANKRD11,ankyrin repeat domain containing 11,16q24.3
247604,Juvenile primary lateral sclerosis,ALS2,alsin Rho guanine nucleotide exchange factor ALS2,2q33.1
247604,Juvenile primary lateral sclerosis,ERLIN2,ER lipid raft associated 2,8p11.23
247623,Perinatal lethal hypophosphatasia,ALPL,"alkaline phosphatase, biomineralization associated",1p36.12
247638,Prenatal benign hypophosphatasia,ALPL,"alkaline phosphatase, biomineralization associated",1p36.12
2337,"Diffuse palmoplantar keratoderma, Bothnian type",AQP5,aquaporin 5,12q13.12
247651,Infantile hypophosphatasia,ALPL,"alkaline phosphatase, biomineralization associated",1p36.12
247667,Childhood-onset hypophosphatasia,ALPL,"alkaline phosphatase, biomineralization associated",1p36.12
247676,Adult hypophosphatasia,ALPL,"alkaline phosphatase, biomineralization associated",1p36.12
494,Keratoderma hereditarium mutilans,GJB2,gap junction protein beta 2,13q12.11
2322,Kabuki syndrome,KMT2D,lysine methyltransferase 2D,12q13.12
2322,Kabuki syndrome,KDM6A,lysine demethylase 6A,Xp11.3
247378,Autosomal recessive secondary polycythemia not associated with VHL gene,BPGM,bisphosphoglycerate mutase,7q33
247511,Autosomal dominant secondary polycythemia,EPO,erythropoietin,7q22.1
247511,Autosomal dominant secondary polycythemia,EGLN1,egl-9 family hypoxia inducible factor 1,1q42.2
247511,Autosomal dominant secondary polycythemia,EPAS1,endothelial PAS domain protein 1,2p21
247511,Autosomal dominant secondary polycythemia,HBA1,hemoglobin subunit alpha 1,16p13.3
247511,Autosomal dominant secondary polycythemia,HBA2,hemoglobin subunit alpha 2,16p13.3
247511,Autosomal dominant secondary polycythemia,HBB,hemoglobin subunit beta,11p15.4
2323,Sanjad-Sakati syndrome,TBCE,tubulin folding cofactor E,1q42.3
247522,Primary ciliary dyskinesia-retinitis pigmentosa syndrome,RPGR,retinitis pigmentosa GTPase regulator,Xp11.4
247546,Acute neonatal citrullinemia type I,ASS1,argininosuccinate synthase 1,9q34.11
247573,Late-onset citrullinemia type I,ASS1,argininosuccinate synthase 1,9q34.11
2407,Laryngo-onycho-cutaneous syndrome,LAMA3,laminin subunit alpha 3,18q11.2
2412,Dislocation of the hip-dysmorphism syndrome,TRIM33,tripartite motif containing 33,1p13.2
248408,Familial hypodysfibrinogenemia,FGA,fibrinogen alpha chain,4q31.3
248408,Familial hypodysfibrinogenemia,FGB,fibrinogen beta chain,4q31.3
248408,Familial hypodysfibrinogenemia,FGG,fibrinogen gamma chain,4q32.1
2396,Encephalocraniocutaneous lipomatosis,FGFR1,fibroblast growth factor receptor 1,8p11.23
2396,Encephalocraniocutaneous lipomatosis,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
248340,Isolated delta-storage pool disease,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",11q24.3
2388,Choreoacanthocytosis,VPS13A,vacuolar protein sorting 13 homolog A,9q21.2
248111,Juvenile Huntington disease,HTT,huntingtin,4p16.3
2387,Leukonychia totalis,PLCD1,phospholipase C delta 1,3p22.2
2379,Early-onset parkinsonism-intellectual disability syndrome,RAB39B,"RAB39B, member RAS oncogene family",Xq28
247834,Occult macular dystrophy,RP1L1,RP1 like 1,8p23.1
247820,Ectodermal dysplasia-pili torti-cutaneous syndactyly syndrome,NECTIN4,nectin cell adhesion molecule 4,1q23.3
2378,Laurin-Sandrow syndrome,LMBR1,limb development membrane protein 1,7q36.3
247868,NLRP12-associated hereditary periodic fever syndrome,NLRP12,NLR family pyrin domain containing 12,19q13.42
2451,Mucocutaneous venous malformations,TEK,TEK receptor tyrosine kinase,9p21.2
244305,Dominant hypophosphatemia with nephrolithiasis or osteoporosis,SLC34A1,solute carrier family 34 member 1,5q35.3
244305,Dominant hypophosphatemia with nephrolithiasis or osteoporosis,NHERF1,NHERF family PDZ scaffold protein 1,17q25.1
244283,Biliary atresia with splenic malformation syndrome,CFC1,"cryptic, EGF-CFC family member 1",2q21.1
2440,Isolated split hand-split foot malformation,DLX6,distal-less homeobox 6,7q21.3
2440,Isolated split hand-split foot malformation,EPS15L1,epidermal growth factor receptor pathway substrate 15 like 1,19p13.11
2440,Isolated split hand-split foot malformation,TP63,tumor protein p63,3q28
2440,Isolated split hand-split foot malformation,SEM1,SEM1 26S proteasome subunit,7q21.3
2440,Isolated split hand-split foot malformation,WNT10B,Wnt family member 10B,12q13.12
2440,Isolated split hand-split foot malformation,DLX5,distal-less homeobox 5,7q21.3
2440,Isolated split hand-split foot malformation,BTRC,beta-transducin repeat containing E3 ubiquitin protein ligase,10q24.32
2440,Isolated split hand-split foot malformation,FBXW4,F-box and WD repeat domain containing 4,10q24.32
244310,RFT1-CDG,RFT1,RFT1 glycolipid translocator homolog,3p21.1
244242,HELLP syndrome,CD46,CD46 molecule,1q32.2
244242,HELLP syndrome,CFH,complement factor H,1q31.3
244242,HELLP syndrome,CFI,complement factor I,4q25
244242,HELLP syndrome,HELLPAR,HELLP associated long non-coding RNA,12q23.2
296,Ollier disease,PTH1R,parathyroid hormone 1 receptor,3p21.31
296,Ollier disease,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
296,Ollier disease,IDH1,isocitrate dehydrogenase (NADP(+)) 1,2q34
244275,De novo thrombotic microangiopathy after kidney transplantation,CFI,complement factor I,4q25
244275,De novo thrombotic microangiopathy after kidney transplantation,CFH,complement factor H,1q31.3
2438,Hand-foot-genital syndrome,HOXA13,homeobox A13,7p15.2
243343,Dimethylglycine dehydrogenase deficiency,DMGDH,dimethylglycine dehydrogenase,5q14.1
243367,Acute fatty liver of pregnancy,HADHA,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha,2p23.3
247353,Generalized pustular psoriasis,IL36RN,interleukin 36 receptor antagonist,2q14.1
247353,Generalized pustular psoriasis,AP1S3,adaptor related protein complex 1 subunit sigma 3,2q36.1
247262,Hyperphosphatasia-intellectual disability syndrome,PIGV,phosphatidylinositol glycan anchor biosynthesis class V,1p36.11
247262,Hyperphosphatasia-intellectual disability syndrome,PIGL,phosphatidylinositol glycan anchor biosynthesis class L,17p11.2
247262,Hyperphosphatasia-intellectual disability syndrome,PIGO,phosphatidylinositol glycan anchor biosynthesis class O,9p13.3
247262,Hyperphosphatasia-intellectual disability syndrome,PGAP2,post-GPI attachment to proteins 2,11p15.4
247262,Hyperphosphatasia-intellectual disability syndrome,PGAP3,post-GPI attachment to proteins phospholipase 3,17q12
247262,Hyperphosphatasia-intellectual disability syndrome,PIGW,phosphatidylinositol glycan anchor biosynthesis class W,17q12
247262,Hyperphosphatasia-intellectual disability syndrome,PIGY,phosphatidylinositol glycan anchor biosynthesis class Y,4q22.1
2484,Melnick-Needles syndrome,FLNA,filamin A,Xq28
247198,Progressive cerebello-cerebral atrophy,SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,4p15.2
247198,Progressive cerebello-cerebral atrophy,VPS53,VPS53 subunit of GARP complex,17p13.3
2477,Isolated megalencephaly,TBC1D7,TBC1 domain family member 7,6p24.1
2473,McKusick-Kaufman syndrome,MKKS,MKKS centrosomal shuttling protein,20p12.2
2470,Matthew-Wood syndrome,STRA6,signaling receptor and transporter of retinol STRA6,15q24.1
2470,Matthew-Wood syndrome,WNT7B,Wnt family member 7B,22q13.31
561,Marshall-Smith syndrome,NFIX,nuclear factor I X,19p13.13
559,Marinesco-Sjögren syndrome,SIL1,SIL1 nucleotide exchange factor,5q31.2
2462,Shprintzen-Goldberg syndrome,SKI,SKI proto-oncogene,1p36.33-p36.32
2462,Shprintzen-Goldberg syndrome,FBN1,fibrillin 1,15q21.1
2461,Marden-Walker syndrome,PIEZO2,piezo type mechanosensitive ion channel component 2,18p11.22-p11.21
251630,Anaplastic oligodendroglioma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251630,Anaplastic oligodendroglioma,POT1,protection of telomeres 1,7q31.33
251636,Ependymoma,ZFTA,zinc finger translocation associated,11q13.1
2176,Infantile systemic hyalinosis,ANTXR2,ANTXR cell adhesion molecule 2,4q21.21
251656,Oligoastrocytoma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251663,Anaplastic oligoastrocytoma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251671,Angiocentric glioma,MYB,"MYB proto-oncogene, transcription factor",6q23.3
251671,Angiocentric glioma,QKI,"QKI, KH domain containing RNA binding",6q26
2189,Hydrolethalus,HYLS1,HYLS1 centriolar and ciliogenesis associated,11q24.2
2189,Hydrolethalus,KIF7,kinesin family member 7,15q26.1
312,Autosomal dominant epidermolytic ichthyosis,KRT1,keratin 1,12q13.13
312,Autosomal dominant epidermolytic ichthyosis,KRT10,keratin 10,17q21.2
2196,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement,CLDN19,claudin 19,1p34.2
251576,Gliosarcoma,NFKBIA,NFKB inhibitor alpha,14q13.2
251576,Gliosarcoma,MGMT,O-6-methylguanine-DNA methyltransferase,10q26.3
251576,Gliosarcoma,EGFR,epidermal growth factor receptor,7p11.2
251576,Gliosarcoma,FGFR1,fibroblast growth factor receptor 1,8p11.23
251576,Gliosarcoma,FGFR3,fibroblast growth factor receptor 3,4p16.3
251576,Gliosarcoma,TP53,tumor protein p53,17p13.1
251576,Gliosarcoma,TACC3,transforming acidic coiled-coil containing protein 3,4p16.3
251576,Gliosarcoma,TACC1,transforming acidic coiled-coil containing protein 1,8p11.22
251576,Gliosarcoma,PPARG,peroxisome proliferator activated receptor gamma,3p25.2
251576,Gliosarcoma,LZTR1,leucine zipper like post translational regulator 1,22q11.21
251576,Gliosarcoma,SEPTIN14,septin 14,7p11.2
251576,Gliosarcoma,IDH1,isocitrate dehydrogenase (NADP(+)) 1,2q34
251579,Giant cell glioblastoma,ROS1,"ROS proto-oncogene 1, receptor tyrosine kinase",6q22.1
251579,Giant cell glioblastoma,PPARG,peroxisome proliferator activated receptor gamma,3p25.2
251579,Giant cell glioblastoma,NFKBIA,NFKB inhibitor alpha,14q13.2
251579,Giant cell glioblastoma,MGMT,O-6-methylguanine-DNA methyltransferase,10q26.3
251579,Giant cell glioblastoma,EGFR,epidermal growth factor receptor,7p11.2
251579,Giant cell glioblastoma,FGFR1,fibroblast growth factor receptor 1,8p11.23
251579,Giant cell glioblastoma,FGFR3,fibroblast growth factor receptor 3,4p16.3
251579,Giant cell glioblastoma,TP53,tumor protein p53,17p13.1
251579,Giant cell glioblastoma,TACC3,transforming acidic coiled-coil containing protein 3,4p16.3
251579,Giant cell glioblastoma,TACC1,transforming acidic coiled-coil containing protein 1,8p11.22
251579,Giant cell glioblastoma,IDH1,isocitrate dehydrogenase (NADP(+)) 1,2q34
251579,Giant cell glioblastoma,LZTR1,leucine zipper like post translational regulator 1,22q11.21
251579,Giant cell glioblastoma,SEPTIN14,septin 14,7p11.2
251589,Anaplastic astrocytoma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251598,Protoplasmic astrocytoma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251604,Gemistocytic astrocytoma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251601,Fibrillary astrocytoma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251615,Pilomyxoid astrocytoma,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
251615,Pilomyxoid astrocytoma,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
251615,Pilomyxoid astrocytoma,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",3p25.2
251615,Pilomyxoid astrocytoma,FGFR1,fibroblast growth factor receptor 1,8p11.23
251615,Pilomyxoid astrocytoma,SRGAP3,SLIT-ROBO Rho GTPase activating protein 3,3p25.3
251615,Pilomyxoid astrocytoma,NTRK2,neurotrophic receptor tyrosine kinase 2,9q21.33
251615,Pilomyxoid astrocytoma,KIAA1549,KIAA1549,7q34
251615,Pilomyxoid astrocytoma,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
251627,Oligodendroglioma,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
251627,Oligodendroglioma,POT1,protection of telomeres 1,7q31.33
2169,Methylcobalamin deficiency type cblE,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5p15.31
2228,Hypodontia-dysplasia of nails syndrome,MSX1,msh homeobox 1,4p16.2
2224,Hypertryptophanemia,TDO2,"tryptophan 2,3-dioxygenase",4q32.1
2229,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,LMNA,lamin A/C,1q22
2237,Hypoparathyroidism-sensorineural deafness-renal disease syndrome,GATA3,GATA binding protein 3,10p14
2199,Epidermolytic palmoplantar keratoderma,KRT1,keratin 1,12q13.13
2199,Epidermolytic palmoplantar keratoderma,KRT9,keratin 9,17q21.2
2199,Epidermolytic palmoplantar keratoderma,KRT16,keratin 16,17q21.2
251863,Desmoplastic/nodular medulloblastoma,SUFU,SUFU negative regulator of hedgehog signaling,10q24.32
2198,Palmoplantar keratoderma-esophageal carcinoma syndrome,RHBDF2,rhomboid 5 homolog 2,17q25.1
251858,Medulloblastoma with extensive nodularity,SUFU,SUFU negative regulator of hedgehog signaling,10q24.32
2202,Palmoplantar keratoderma-deafness syndrome,GJB2,gap junction protein beta 2,13q12.11
2202,Palmoplantar keratoderma-deafness syndrome,MT-TS1,mitochondrially encoded tRNA-Ser (UCN) 1,mitochondria
251899,Choroid plexus carcinoma,TP53,tumor protein p53,17p13.1
251019,2q32q33 deletion syndrome,SATB2,SATB homeobox 2,2q33.1
251028,SATB2-associated syndrome due to a chromosomal rearrangement,SATB2,SATB homeobox 2,2q33.1
672,Pallister-Hall syndrome,GLI3,GLI family zinc finger 3,7p14.1
455,Superficial epidermolytic ichthyosis,KRT2,keratin 2,12q13.13
251061,7q31 microdeletion syndrome,FOXP2,forkhead box P2,7q31.1
251066,8p11.2 deletion syndrome,ANK1,ankyrin 1,8p11.21
251071,8p23.1 microdeletion syndrome,GATA4,GATA binding protein 4,8p23.1
2273,Ichthyosis follicularis-alopecia-photophobia syndrome,MBTPS2,"membrane bound transcription factor peptidase, site 2",Xp22.12
139,CHILD syndrome,NSDHL,NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL,Xq28
457,Harlequin ichthyosis,ABCA12,ATP binding cassette subfamily A member 12,2q35
251056,6q25.2q25.3 microdeletion syndrome,ARID1B,AT-rich interaction domain 1B,6q25.3
2239,Familial isolated hypoparathyroidism due to agenesis of parathyroid gland,GCM2,glial cells missing transcription factor 2,6p24.2
2241,Megacystis-microcolon-intestinal hypoperistalsis syndrome,LMOD1,leiomodin 1,1q32.1
2241,Megacystis-microcolon-intestinal hypoperistalsis syndrome,MYH11,myosin heavy chain 11,16p13.11
2241,Megacystis-microcolon-intestinal hypoperistalsis syndrome,ACTG2,"actin gamma 2, smooth muscle",2p13.1
2241,Megacystis-microcolon-intestinal hypoperistalsis syndrome,MYLK,myosin light chain kinase,3q21.1
250984,Autosomal recessive Stickler syndrome,COL9A1,collagen type IX alpha 1 chain,6q13
250984,Autosomal recessive Stickler syndrome,COL9A2,collagen type IX alpha 2 chain,1p34.2
250984,Autosomal recessive Stickler syndrome,COL9A3,collagen type IX alpha 3 chain,20q13.33
250984,Autosomal recessive Stickler syndrome,LOXL3,lysyl oxidase like 3,2p13.1
250977,AICA-ribosiduria,ATIC,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,2q35
2250,Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome,SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,18p11.32
250923,Isolated aniridia,PAX6,paired box 6,11p13
250923,Isolated aniridia,TRIM44,tripartite motif containing 44,11p13
250923,Isolated aniridia,FOXC1,forkhead box C1,6p25.3
250972,Polymicrogyria with optic nerve hypoplasia,TUBA8,tubulin alpha 8,22q11.21
2255,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome,GATA6,GATA binding protein 6,18q11.2
251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HBB,hemoglobin subunit beta,11p15.4
251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,BCL11A,BCL11 transcription factor A,2p16.1
251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HBG1,hemoglobin subunit gamma 1,11p15.4
251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,HBG2,hemoglobin subunit gamma 2,11p15.4
251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,KLF1,KLF transcription factor 1,19p13.13
251383,CK syndrome,NSDHL,NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL,Xq28
251370,Sickle cell S-D Punjab disease,HBB,hemoglobin subunit beta,11p15.4
251375,Sickle cell S-E disease,HBB,hemoglobin subunit beta,11p15.4
251365,Sickle cell S-C disease,HBB,hemoglobin subunit beta,11p15.4
2319,Juberg-Hayward syndrome,ESCO2,establishment of sister chromatid cohesion N-acetyltransferase 2,8p21.1
251523,Hyperzincemia and hypercalprotectinemia,PSTPIP1,proline-serine-threonine phosphatase interacting protein 1,15q24.3
2315,Johanson-Blizzard syndrome,UBR1,ubiquitin protein ligase E3 component n-recognin 1,15q15.2
251510,"46,XY partial gonadal dysgenesis",DHX37,DEAH-box helicase 37,12q24.31
251510,"46,XY partial gonadal dysgenesis",WT1,WT1 transcription factor,11p13
251510,"46,XY partial gonadal dysgenesis",SOX9,SRY-box transcription factor 9,17q24.3
251510,"46,XY partial gonadal dysgenesis",SRY,sex determining region Y,Yp11.2
251510,"46,XY partial gonadal dysgenesis",WWOX,WW domain containing oxidoreductase,16q23.1-q23.2
251510,"46,XY partial gonadal dysgenesis",ZFPM2,"zinc finger protein, FOG family member 2",8q23
251510,"46,XY partial gonadal dysgenesis",GATA4,GATA binding protein 4,8p23.1
251510,"46,XY partial gonadal dysgenesis",NR0B1,nuclear receptor subfamily 0 group B member 1,Xp21.2
251510,"46,XY partial gonadal dysgenesis",NR5A1,nuclear receptor subfamily 5 group A member 1,9q33.3
251510,"46,XY partial gonadal dysgenesis",MAP3K1,mitogen-activated protein kinase kinase kinase 1,5q11.2
251510,"46,XY partial gonadal dysgenesis",VAMP7,vesicle associated membrane protein 7,Xq28 and Yq12
2309,Pachyonychia congenita,KRT16,keratin 16,17q21.2
2309,Pachyonychia congenita,KRT17,keratin 17,17q21.2
2309,Pachyonychia congenita,KRT6A,keratin 6A,12q13.13
2309,Pachyonychia congenita,KRT6B,keratin 6B,12q13.13
251393,Localized junctional epidermolysis bullosa,COL17A1,collagen type XVII alpha 1 chain,10q25.1
251393,Localized junctional epidermolysis bullosa,ITGB4,integrin subunit beta 4,17q25.1
2307,IVIC syndrome,SALL4,spalt like transcription factor 4,20q13.2
251295,Pigmented paravenous retinochoroidal atrophy,CRB1,crumbs cell polarity complex component 1,1q31.3
251290,Parietal foramina with clavicular hypoplasia,MSX2,msh homeobox 2,5q35.2
251287,Benign concentric annular macular dystrophy,IMPG1,interphotoreceptor matrix proteoglycan 1,6q14.1
251282,Autosomal dominant spastic ataxia type 1,VAMP1,vesicle associated membrane protein 1,12p13.31
251279,Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome,MFRP,membrane frizzled-related protein,11q23.3
251274,Familial hyperaldosteronism type III,KCNJ5,potassium inwardly rectifying channel subfamily J member 5,11q24.3
251262,Familial osteochondritis dissecans,ACAN,aggrecan,15q26.1
251347,Ataxia-telangiectasia-like disorder,MRE11,"MRE11 homolog, double strand break repair nuclease",11q21
2289,Neuronal intranuclear inclusion disease,NOTCH2NLC,notch 2 N-terminal like C,1q21.2
2290,Microvillus inclusion disease,MYO5B,myosin VB,18q21.1
2290,Microvillus inclusion disease,STX3,syntaxin 3,11q12.1
254857,Lethal infantile mitochondrial myopathy,MT-TT,mitochondrially encoded tRNA-Thr (ACN),mitochondria
2678,Familial isolated café-au-lait macules,LZTR1,leucine zipper like post translational regulator 1,22q11.21
254864,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency,TRMU,tRNA mitochondrial 2-thiouridylase,22q13.31
254864,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency,MT-TE,mitochondrially encoded tRNA-Glu (GAA/G),mitochondria
2662,Keipert syndrome,GPC4,glypican 4,Xq26.2
1475,Renal coloboma syndrome,PAX2,paired box 2,10q24.31
2670,Pierson syndrome,LAMB2,laminin subunit beta 2,3p21.31
254930,Combined oxidative phosphorylation defect type 7,MTRFR,mitochondrial translation release factor in rescue,12q24.31
254925,Combined oxidative phosphorylation defect type 4,TUFM,"Tu translation elongation factor, mitochondrial",16p11.2
2697,Arthrogryposis-renal dysfunction-cholestasis syndrome,VPS33B,VPS33B late endosome and lysosome associated,15q26.1
2697,Arthrogryposis-renal dysfunction-cholestasis syndrome,VIPAS39,"VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog",14q24.3
254920,Combined oxidative phosphorylation defect type 2,MRPS16,mitochondrial ribosomal protein S16,10q22.2
254913,Isolated ATP synthase deficiency,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,mitochondria
254913,Isolated ATP synthase deficiency,ATP5MK,ATP synthase membrane subunit k,10q24.33
254913,Isolated ATP synthase deficiency,MT-ATP8,mitochondrially encoded ATP synthase membrane subunit 8,mitochondria
254913,Isolated ATP synthase deficiency,ATPAF2,ATP synthase mitochondrial F1 complex assembly factor 2,17p11.2
254913,Isolated ATP synthase deficiency,ATP5F1E,ATP synthase F1 subunit epsilon,20q13.32
254913,Isolated ATP synthase deficiency,ATP5F1A,ATP synthase F1 subunit alpha,18q21.1
254913,Isolated ATP synthase deficiency,ATP5F1D,ATP synthase F1 subunit delta,19p13.3
255182,Pyruvate dehydrogenase E3-binding protein deficiency,PDHX,pyruvate dehydrogenase complex component X,11p13
2701,Noonan syndrome-like disorder with loose anagen hair,PPP1CB,protein phosphatase 1 catalytic subunit beta,2p23.2
2701,Noonan syndrome-like disorder with loose anagen hair,SHOC2,SHOC2 leucine rich repeat scaffold protein,10q25.2
255138,Pyruvate dehydrogenase E1-beta deficiency,PDHB,pyruvate dehydrogenase E1 subunit beta,3p14.3
255132,Adult-onset autosomal recessive sideroblastic anemia,GLRX5,glutaredoxin 5,14q32.13
2698,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome,GJB2,gap junction protein beta 2,13q12.11
254886,Autosomal recessive progressive external ophthalmoplegia,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
254886,Autosomal recessive progressive external ophthalmoplegia,TK2,thymidine kinase 2,16q21
254881,Spinocerebellar ataxia with epilepsy,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
254875,"Mitochondrial DNA depletion syndrome, myopathic form",TK2,thymidine kinase 2,16q21
254905,Isolated cytochrome C oxidase deficiency,COX10,cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10,17p12
254905,Isolated cytochrome C oxidase deficiency,MT-CO1,mitochondrially encoded cytochrome c oxidase I,mitochondria
254905,Isolated cytochrome C oxidase deficiency,MT-CO2,mitochondrially encoded cytochrome c oxidase II,mitochondria
254905,Isolated cytochrome C oxidase deficiency,MT-CO3,mitochondrially encoded cytochrome c oxidase III,mitochondria
254905,Isolated cytochrome C oxidase deficiency,COX6B1,cytochrome c oxidase subunit 6B1,19q13.12
254905,Isolated cytochrome C oxidase deficiency,COX14,cytochrome c oxidase assembly factor COX14,12q13.12
254905,Isolated cytochrome C oxidase deficiency,COX16,cytochrome c oxidase assembly factor COX16,14q24.2
254905,Isolated cytochrome C oxidase deficiency,COX4I1,cytochrome c oxidase subunit 4I1,16q24.1
254905,Isolated cytochrome C oxidase deficiency,COX20,cytochrome c oxidase assembly factor COX20,1q44
254905,Isolated cytochrome C oxidase deficiency,COA3,cytochrome c oxidase assembly factor 3,17q21.2
254905,Isolated cytochrome C oxidase deficiency,COX8A,cytochrome c oxidase subunit 8A,11q13.1
254905,Isolated cytochrome C oxidase deficiency,COX6A2,cytochrome c oxidase subunit 6A2,16p11.2
254905,Isolated cytochrome C oxidase deficiency,PET117,PET117 cytochrome c oxidase chaperone,20p11.23
254905,Isolated cytochrome C oxidase deficiency,COX5A,cytochrome c oxidase subunit 5A,15q24.2
254902,Renal tubulopathy-encephalopathy-liver failure syndrome,BCS1L,"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone",2q35
254898,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,PDSS1,decaprenyl diphosphate synthase subunit 1,10p12.1
254892,Autosomal dominant progressive external ophthalmoplegia,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
254892,Autosomal dominant progressive external ophthalmoplegia,POLG2,"DNA polymerase gamma 2, accessory subunit",17q23.3
254892,Autosomal dominant progressive external ophthalmoplegia,SLC25A4,solute carrier family 25 member 4,4q35.1
254892,Autosomal dominant progressive external ophthalmoplegia,TWNK,twinkle mtDNA helicase,10q24.31
254892,Autosomal dominant progressive external ophthalmoplegia,RRM2B,ribonucleotide reductase regulatory TP53 inducible subunit M2B,8q22.3
2712,Oculofaciocardiodental syndrome,BCOR,BCL6 corepressor,Xp11.4
2717,Oculotrichoanal syndrome,FREM1,FRAS1 related extracellular matrix 1,9p22.3
2704,Urofacial syndrome,HPSE2,heparanase 2 (inactive),10q24.2
2704,Urofacial syndrome,LRIG2,leucine rich repeats and immunoglobulin like domains 2,1p13.2
255210,Mitochondrial DNA-associated Leigh syndrome,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-ND2,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-ND3,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-TL1,mitochondrially encoded tRNA-Leu (UUA/G) 1,mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-TK,mitochondrially encoded tRNA-Lys (AAA/G),mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-TW,mitochondrially encoded tRNA-Trp (UGA/G),mitochondria
255210,Mitochondrial DNA-associated Leigh syndrome,MT-TV,mitochondrially encoded tRNA-Val (GUN),mitochondria
255229,Navajo neurohepatopathy,MPV17,mitochondrial inner membrane protein MPV17,2p23.3
2707,"Oculocerebrofacial syndrome, Kaufman type",UBE3B,ubiquitin protein ligase E3B,12q24.11
255235,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy",RRM2B,ribonucleotide reductase regulatory TP53 inducible subunit M2B,8q22.3
2710,Oculodentodigital dysplasia,GJA1,gap junction protein alpha 1,6q22.31
2721,Odonto-onycho-dermal dysplasia,WNT10A,Wnt family member 10A,2q35
260305,Autosomal recessive sideroblastic anemia,SLC25A38,solute carrier family 25 member 38,3p22.1
260305,Autosomal recessive sideroblastic anemia,HSPA9,heat shock protein family A (Hsp70) member 9,5q31.2
2754,Orofaciodigital syndrome type 6,FAM149B1,family with sequence similarity 149 member B1,10q22.2
2754,Orofaciodigital syndrome type 6,OFD1,OFD1 centriole and centriolar satellite protein,Xp22.2
2754,Orofaciodigital syndrome type 6,TMEM216,transmembrane protein 216,11q13.1
2754,Orofaciodigital syndrome type 6,KIF7,kinesin family member 7,15q26.1
2754,Orofaciodigital syndrome type 6,CPLANE1,ciliogenesis and planar polarity effector complex subunit 1,5p13.2
2754,Orofaciodigital syndrome type 6,TCTN3,tectonic family member 3,10q24.1
2754,Orofaciodigital syndrome type 6,PDE6D,phosphodiesterase 6D,2q37.1
2754,Orofaciodigital syndrome type 6,TMEM231,transmembrane protein 231,16q23.1
2754,Orofaciodigital syndrome type 6,TOPORS,"TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase",9p21.1
2754,Orofaciodigital syndrome type 6,KIAA0753,KIAA0753,17p13.1
2753,Orofaciodigital syndrome type 4,TCTN3,tectonic family member 3,10q24.1
2751,Orofaciodigital syndrome type 2,NEK1,NIMA related kinase 1,4q33
252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,SH3PXD2A,SH3 and PX domains 2A,10q24.33
252128,Malignant peripheral nerve sheath tumor with perineurial differentiation,HTRA1,HtrA serine peptidase 1,10q26.13
2750,Orofaciodigital syndrome type 1,OFD1,OFD1 centriole and centriolar satellite protein,Xp22.2
661,Congenital central hypoventilation syndrome,LBX1,ladybird homeobox 1,10q24.32
661,Congenital central hypoventilation syndrome,PHOX2B,paired like homeobox 2B,4p13
661,Congenital central hypoventilation syndrome,EDN3,endothelin 3,20q13.32
661,Congenital central hypoventilation syndrome,GDNF,glial cell derived neurotrophic factor,5p13.2
661,Congenital central hypoventilation syndrome,MYO1H,myosin IH,12q24.11
661,Congenital central hypoventilation syndrome,BDNF,brain derived neurotrophic factor,11p14.1
254361,Plectin-related limb-girdle muscular dystrophy R17,PLEC,plectin,8q24.3
2774,Multicentric carpo-tarsal osteolysis with or without nephropathy,MAFB,MAF bZIP transcription factor B,20q12
2770,Nasu-Hakola disease,TREM2,triggering receptor expressed on myeloid cells 2,6p21.1
2770,Nasu-Hakola disease,TYROBP,transmembrane immune signaling adaptor TYROBP,19q13.12
254343,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome,MTPAP,mitochondrial poly(A) polymerase,10p11.23
254334,Autosomal recessive intermediate Charcot-Marie-Tooth disease type B,KARS1,lysyl-tRNA synthetase 1,16q23.1
2762,Progressive osseous heteroplasia,GNAS,GNAS complex locus,20q13.32
252212,Malignant triton tumor,SH3PXD2A,SH3 and PX domains 2A,10q24.33
252212,Malignant triton tumor,HTRA1,HtrA serine peptidase 1,10q26.13
2763,Osteocraniostenosis,FAM111A,FAM111 trypsin like peptidase A,11q12.1
252206,Melanoma and neural system tumor syndrome,CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
252202,Constitutional mismatch repair deficiency syndrome,PMS2,"PMS1 homolog 2, mismatch repair system component",7p22.1
252202,Constitutional mismatch repair deficiency syndrome,MLH1,mutL homolog 1,3p22.2
252202,Constitutional mismatch repair deficiency syndrome,MSH2,mutS homolog 2,2p21-p16.3
252202,Constitutional mismatch repair deficiency syndrome,MSH6,mutS homolog 6,2p16.3
2792,Otofaciocervical syndrome,EYA1,EYA transcriptional coactivator and phosphatase 1,8q13.3
2792,Otofaciocervical syndrome,PAX1,paired box 1,20p11.22
254525,Temple syndrome due to paternal 14q32.2 microdeletion,MEG3,maternally expressed 3,14q32.2
254525,Temple syndrome due to paternal 14q32.2 microdeletion,DLK1,delta like non-canonical Notch ligand 1,14q32.2
254525,Temple syndrome due to paternal 14q32.2 microdeletion,RTL1,retrotransposon Gag like 1,14q32.2
2796,Pachydermoperiostosis,SLCO2A1,solute carrier organic anion transporter family member 2A1,3q22.1-q22.2
2796,Pachydermoperiostosis,HPGD,15-hydroxyprostaglandin dehydrogenase,4q34.1
254528,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion,RTL1,retrotransposon Gag like 1,14q32.2
254528,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion,MEG3,maternally expressed 3,14q32.2
254528,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion,DLK1,delta like non-canonical Notch ligand 1,14q32.2
2789,Lateral meningocele syndrome,NOTCH3,notch receptor 3,19p13.12
2788,Osteoporosis-pseudoglioma syndrome,LRP5,LDL receptor related protein 5,11q13.2
2791,Otodental syndrome,FGF3,fibroblast growth factor 3,11q13.3
2790,"Endosteal hyperostosis, Worth type",LRP5,LDL receptor related protein 5,11q13.2
2783,Autosomal dominant osteopetrosis type 1,LRP5,LDL receptor related protein 5,11q13.2
2780,Osteopathia striata-cranial sclerosis syndrome,AMER1,APC membrane recruitment protein 1,Xq11.2
2780,Osteopathia striata-cranial sclerosis syndrome,CTNNB1,catenin beta 1,3p22.1
667,Autosomal recessive malignant osteopetrosis,CLCN7,chloride voltage-gated channel 7,16p13.3
667,Autosomal recessive malignant osteopetrosis,TCIRG1,"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3",11q13.2
667,Autosomal recessive malignant osteopetrosis,TNFSF11,TNF superfamily member 11,13q14.11
667,Autosomal recessive malignant osteopetrosis,SNX10,sorting nexin 10,7p15.2
2805,Partial pancreatic agenesis,PTF1A,pancreas associated transcription factor 1a,10p12.2
2805,Partial pancreatic agenesis,PDX1,pancreatic and duodenal homeobox 1,13q12.2
254693,Partial hydatidiform mole,NLRP7,NLR family pyrin domain containing 7,19q13.42
254693,Partial hydatidiform mole,KHDC3L,"KH domain containing 3 like, subcortical maternal complex member",6q13
2807,Papilloma of choroid plexus,TP53,tumor protein p53,17p13.1
678,Papillon-Lefèvre syndrome,CTSC,cathepsin C,11q14.2
254704,Genetic hyperferritinemia without iron overload,FTL,ferritin light chain,19q13.33
254534,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation,DLK1,delta like non-canonical Notch ligand 1,14q32.2
254534,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation,MEG3,maternally expressed 3,14q32.2
254534,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation,RTL1,retrotransposon Gag like 1,14q32.2
2802,X-linked sideroblastic anemia and spinocerebellar ataxia,ABCB7,ATP binding cassette subfamily B member 7,Xq13.3
254531,Temple syndrome due to paternal 14q32.2 hypomethylation,RTL1,retrotransposon Gag like 1,14q32.2
254531,Temple syndrome due to paternal 14q32.2 hypomethylation,MEG3,maternally expressed 3,14q32.2
254531,Temple syndrome due to paternal 14q32.2 hypomethylation,DLK1,delta like non-canonical Notch ligand 1,14q32.2
254688,Complete hydatidiform mole,NLRP7,NLR family pyrin domain containing 7,19q13.42
254688,Complete hydatidiform mole,KHDC3L,"KH domain containing 3 like, subcortical maternal complex member",6q13
254688,Complete hydatidiform mole,MEI1,meiotic double-stranded break formation protein 1,22q13.2
254688,Complete hydatidiform mole,TOP6BL,TOP6B like initiator of meiotic double strand breaks,11q13.2
2498,Syndactyly type 8,FGF16,fibroblast growth factor 16,Xq21.1
2499,Metachondromatosis,PTPN11,protein tyrosine phosphatase non-receptor type 11,12q24.13
2500,Acrogeria,COL3A1,collagen type III alpha 1 chain,2q32.2
2501,"Metaphyseal chondrodysplasia, Spahr type",MMP13,matrix metallopeptidase 13,11q22.2
2504,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome,RUNX2,RUNX family transcription factor 2,6p21.1
2505,Multiple benign circumferential skin creases on limbs,MAPRE2,microtubule associated protein RP/EB family member 2,18q12.1-q12.2
2505,Multiple benign circumferential skin creases on limbs,TUBB,tubulin beta class I,6p21.33
2510,Micro syndrome,RAB3GAP1,RAB3 GTPase activating protein catalytic subunit 1,2q21.3
2510,Micro syndrome,RAB3GAP2,RAB3 GTPase activating non-catalytic protein subunit 2,1q41
2510,Micro syndrome,RAB18,"RAB18, member RAS oncogene family",10p12.1
2510,Micro syndrome,TBC1D20,TBC1 domain family member 20,20p13
2508,Corpus callosum agenesis-abnormal genitalia syndrome,ARX,aristaless related homeobox,Xp21.3
2514,Autosomal dominant primary microcephaly,DPP6,dipeptidyl peptidase like 6,7q36.2
2514,Autosomal dominant primary microcephaly,LMNB1,lamin B1,5q23.2
2518,Autosomal recessive chorioretinopathy-microcephaly syndrome,PLK4,polo like kinase 4,4q28.1
2518,Autosomal recessive chorioretinopathy-microcephaly syndrome,TUBGCP6,tubulin gamma complex component 6,22q13.33
2518,Autosomal recessive chorioretinopathy-microcephaly syndrome,TUBGCP4,tubulin gamma complex component 4,15q15.3
2524,Pontocerebellar hypoplasia type 2,TSEN15,tRNA splicing endonuclease subunit 15,1q25.3
2524,Pontocerebellar hypoplasia type 2,TSEN54,tRNA splicing endonuclease subunit 54,17q25.1
2524,Pontocerebellar hypoplasia type 2,TSEN34,tRNA splicing endonuclease subunit 34,19q13.42
2524,Pontocerebellar hypoplasia type 2,TSEN2,tRNA splicing endonuclease subunit 2,3p25.2
2524,Pontocerebellar hypoplasia type 2,SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,4p15.2
2526,Microcephaly-lymphedema-chorioretinopathy syndrome,KIF11,kinesin family member 11,10q23.33
2554,Ear-patella-short stature syndrome,ORC4,origin recognition complex subunit 4,2q23.1
2554,Ear-patella-short stature syndrome,ORC6,origin recognition complex subunit 6,16q11.2
2554,Ear-patella-short stature syndrome,CDT1,chromatin licensing and DNA replication factor 1,16q24.3
2554,Ear-patella-short stature syndrome,CDC6,cell division cycle 6,17q21.2
2554,Ear-patella-short stature syndrome,ORC1,origin recognition complex subunit 1,1p32.3
2554,Ear-patella-short stature syndrome,GMNN,geminin DNA replication inhibitor,6p22.3
2554,Ear-patella-short stature syndrome,CDC45,cell division cycle 45,22q11.21
2556,Microphthalmia with linear skin defects syndrome,HCCS,holocytochrome c synthase,Xp22.2
2556,Microphthalmia with linear skin defects syndrome,COX7B,cytochrome c oxidase subunit 7B,Xq21.1
2556,Microphthalmia with linear skin defects syndrome,NDUFB11,NADH:ubiquinone oxidoreductase subunit B11,Xp11.3
575,Muckle-Wells syndrome,NLRP3,NLR family pyrin domain containing 3,1q44
2573,Moyamoya disease,DIAPH1,diaphanous related formin 1,5q31.3
2573,Moyamoya disease,ACTA2,"actin alpha 2, smooth muscle",10q23.31
2573,Moyamoya disease,RNF213,ring finger protein 213,17q25.3
2570,Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome,GPKOW,G-patch domain and KOW motifs,Xp11.23
261183,15q11.2 microdeletion syndrome,NIPA1,NIPA magnesium transporter 1,15q11.2
261183,15q11.2 microdeletion syndrome,NIPA2,NIPA magnesium transporter 2,15q11.2
261183,15q11.2 microdeletion syndrome,TUBG1,tubulin gamma 1,17q21.31
2585,Ataxia-pancytopenia syndrome,SAMD9L,sterile alpha motif domain containing 9 like,7q21.2
261144,FOXG1 syndrome due to 14q12 microdeletion,FOXG1,forkhead box G1,14q12
2578,Mayer-Rokitansky-Küster-Hauser syndrome type 2,HNF1B,HNF1 homeobox B,17q12
2578,Mayer-Rokitansky-Küster-Hauser syndrome type 2,WNT4,Wnt family member 4,1p36.12
2576,Mulibrey nanism,TRIM37,tripartite motif containing 37,17q22
261222,Distal 16p11.2 microdeletion syndrome,SH2B1,SH2B adaptor protein 1,16p11.2
1359,Carney complex,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,17q24.2
1359,Carney complex,PDE11A,phosphodiesterase 11A,2q31.2
2593,Tubular aggregate myopathy,ORAI1,ORAI calcium release-activated calcium modulator 1,12q24.31
2593,Tubular aggregate myopathy,STIM1,stromal interaction molecule 1,11p15.4
2593,Tubular aggregate myopathy,CASQ1,calsequestrin 1,1q23.2
261229,14q11.2 microduplication syndrome,CHD8,chromodomain helicase DNA binding protein 8,14q11.2
261229,14q11.2 microduplication syndrome,SUPT16H,"SPT16 homolog, facilitates chromatin remodeling subunit",14q11.2
2590,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome,ASAH1,N-acylsphingosine amidohydrolase 1,8p22
2588,Myhre syndrome,SMAD4,SMAD family member 4,18q21.2
261190,Cleft palate-congenital heart defect-intellectual disability syndrome due to 15q14 microdeletion,MEIS2,Meis homeobox 2,15q14
261197,Proximal 16p11.2 microdeletion syndrome,SH2B1,SH2B adaptor protein 1,16p11.2
261295,20p12.3 microdeletion syndrome,BMP2,bone morphogenetic protein 2,20p12.3
261279,17q23.1q23.2 microdeletion syndrome,TBX4,T-box transcription factor 4,17q23.2
261265,17q12 microdeletion syndrome,HNF1B,HNF1 homeobox B,17q12
261265,17q12 microdeletion syndrome,LHX1,LIM homeobox 1,17q12
2616,3M syndrome,CUL7,cullin 7,6p21.1
2616,3M syndrome,OBSL1,obscurin like cytoskeletal adaptor 1,2q35
2616,3M syndrome,CCDC8,coiled-coil domain containing 8,19q13.32
261250,16q24.3 microdeletion syndrome,ANKRD11,ankyrin repeat domain containing 11,16q24.3
2613,Nail-patella-like renal disease,LMX1B,LIM homeobox transcription factor 1 beta,9q33.3
261257,Distal 17p13.3 microdeletion syndrome,YWHAE,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,17p13.3
2623,Geleophysic dysplasia,FBN1,fibrillin 1,15q21.1
2623,Geleophysic dysplasia,ADAMTSL2,ADAMTS like 2,9q34.2
2623,Geleophysic dysplasia,LTBP3,latent transforming growth factor beta binding protein 3,11q13.1
261330,Distal 22q11.2 microdeletion syndrome,BCR,BCR activator of RhoGEF and GTPase,22q11.23
261330,Distal 22q11.2 microdeletion syndrome,MAPK1,mitogen-activated protein kinase 1,22q11.22
261330,Distal 22q11.2 microdeletion syndrome,CRKL,"CRK like proto-oncogene, adaptor protein",22q11.21
261323,21q22.11q22.12 microdeletion syndrome,KIF15,kinesin family member 15,3p21.31
2639,Fibular aplasia-complex brachydactyly syndrome,BMPR1B,bone morphogenetic protein receptor type 1B,4q22.3
2639,Fibular aplasia-complex brachydactyly syndrome,GDF5,growth differentiation factor 5,20q11.22
261483,Xq27.3q28 duplication syndrome,FMR1,fragile X messenger ribonucleoprotein 1,Xq27.3
2632,Langer mesomelic dysplasia,SHOX,SHOX homeobox,Xp22.33 and Yp11.32
2645,Osteoglosphonic dysplasia,FGFR1,fibroblast growth factor receptor 1,8p11.23
261584,5q22 microdeletion syndrome,APC,APC regulator of WNT signaling pathway,5q22.2
261600,Alagille syndrome due to 20p12 microdeletion,JAG1,jagged canonical Notch ligand 1,20p12.2
261619,Alagille syndrome due to a JAG1 point mutation,JAG1,jagged canonical Notch ligand 1,20p12.2
261537,Mowat-Wilson syndrome due to monosomy 2q22,ZEB2,zinc finger E-box binding homeobox 2,2q22.3
261552,Mowat-Wilson syndrome due to a ZEB2 point mutation,ZEB2,zinc finger E-box binding homeobox 2,2q22.3
2636,Microcephalic osteodysplastic primordial dwarfism types I and III,RNU4ATAC,"RNA, U4atac small nuclear",2q14.2
2658,Lenz-Majewski hyperostotic dwarfism,PTDSS1,phosphatidylserine synthase 1,8q22.1
261629,Alagille syndrome due to a NOTCH2 point mutation,NOTCH2,notch receptor 2,1p12
261638,Okihiro syndrome due to 20q13 microdeletion,SALL4,spalt like transcription factor 4,20q13.2
261647,Okihiro syndrome due to a point mutation,SALL4,spalt like transcription factor 4,20q13.2
261652,Kleefstra syndrome due to a point mutation,KMT2C,lysine methyltransferase 2C,7q36.1
261652,Kleefstra syndrome due to a point mutation,EHMT1,euchromatic histone lysine methyltransferase 1,9q34.3
3057,Monoamine oxidase A deficiency,MAOA,monoamine oxidase A,Xp11.3
3047,"Blepharophimosis-intellectual disability syndrome, SBBYS type",KAT6B,lysine acetyltransferase 6B,10q22.2
3042,Intellectual disability-cataracts-calcified pinnae-myopathy syndrome,ZBTB20,zinc finger and BTB domain containing 20,3q13.31
263662,Familial multiple meningioma,SMARCB1,SWI/SNF related BAF chromatin remodeling complex subunit B1,22q11.23
263662,Familial multiple meningioma,SUFU,SUFU negative regulator of hedgehog signaling,10q24.32
263662,Familial multiple meningioma,SMARCE1,SWI/SNF related BAF chromatin remodeling complex subunit E1,17q21.2
263662,Familial multiple meningioma,MN1,"MN1 proto-oncogene, transcriptional regulator",22q12.1
263662,Familial multiple meningioma,PDGFB,platelet derived growth factor subunit B,22q13.1
263548,Peeling skin syndrome type A,FLG2,filaggrin 2,1q21.3
263548,Peeling skin syndrome type A,CHST8,carbohydrate sulfotransferase 8,19q13.11
263548,Peeling skin syndrome type A,SERPINB8,serpin family B member 8,18q22.1
263553,Peeling skin syndrome type B,CDSN,corneodesmosin,6p21.33
3032,NPHP3-related Meckel-like syndrome,NPHP3,nephrocystin 3,3q22.1
263534,Acral peeling skin syndrome,CSTA,cystatin A,3q21.1
263534,Acral peeling skin syndrome,TGM5,transglutaminase 5,15q15.2
263516,Progressive myoclonic epilepsy type 3,KCTD7,potassium channel tetramerization domain containing 7,7q11.21
263524,Acute necrotizing encephalopathy of childhood,CPT2,carnitine palmitoyltransferase 2,1p32.3
263524,Acute necrotizing encephalopathy of childhood,RANBP2,RAN binding protein 2,2q13
263501,COG4-CDG,COG4,component of oligomeric golgi complex 4,16q22.1
263508,COG1-CDG,COG1,component of oligomeric golgi complex 1,17q25.1
263482,"Spondyloepimetaphyseal dysplasia, Maroteaux type",TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
3021,RAPADILINO syndrome,RECQL4,RecQ like helicase 4,8q24.3
263494,DPM3-CDG,DPM3,"dolichyl-phosphate mannosyltransferase subunit 3, regulatory",1q22
263487,COG5-CDG,COG5,component of oligomeric golgi complex 5,7q22.3
263458,Hyperinsulinism due to INSR deficiency,INSR,insulin receptor,19p13.2
263455,Congenital hyperinsulinism due to HNF4A deficiency,HNF4A,hepatocyte nuclear factor 4 alpha,20q13.12
1832,Osteosclerotic bone dysplasia,FAM20C,FAM20C golgi associated secretory pathway kinase,7p22.3
3019,Ramon syndrome,ELMO2,engulfment and cell motility 2,20q13.12
263463,CHST3-related skeletal dysplasia,CHST3,carbohydrate sulfotransferase 3,10q22.1
263410,Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome,SLC19A3,solute carrier family 19 member 3,2q36.3
769,Rabson-Mendenhall syndrome,INSR,insulin receptor,19p13.2
3005,Pyle disease,SFRP4,secreted frizzled related protein 4,7p14.1
263347,MRCS syndrome,BEST1,bestrophin 1,11q12.3
2990,Autosomal recessive multiple pterygium syndrome,CHRNG,cholinergic receptor nicotinic gamma subunit,2q37.1
2990,Autosomal recessive multiple pterygium syndrome,MYH3,myosin heavy chain 3,17p13.1
263297,Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency,GYG1,glycogenin 1,3q24
3138,Ulnar-mammary syndrome,TBX3,T-box transcription factor 3,12q24.21
3144,Schneckenbecken dysplasia,SLC35D1,solute carrier family 35 member D1,1p31.3
3144,Schneckenbecken dysplasia,INPPL1,inositol polyphosphate phosphatase like 1,11q13.4
798,Schinzel-Giedion syndrome,SETBP1,SET binding protein 1,18q12.3
3115,Roussy-Lévy syndrome,PMP22,peripheral myelin protein 22,17p12
3115,Roussy-Lévy syndrome,MPZ,myelin protein zero,1q23.3
3102,Richieri Costa-Pereira syndrome,EIF4A3,eukaryotic translation initiation factor 4A3,17q25.3
3107,Autosomal dominant Robinow syndrome,DVL3,dishevelled segment polarity protein 3,3q27.1
3107,Autosomal dominant Robinow syndrome,WNT5A,Wnt family member 5A,3p14.3
3107,Autosomal dominant Robinow syndrome,DVL1,dishevelled segment polarity protein 1,1p36.33
3107,Autosomal dominant Robinow syndrome,FZD2,frizzled class receptor 2,17q21.31
3086,Autosomal dominant vitreoretinochoroidopathy,BEST1,bestrophin 1,11q12.3
3088,Revesz syndrome,TINF2,TERF1 interacting nuclear factor 2,14q12
3097,Meacham syndrome,WT1,WT1 transcription factor,11p13
3078,"Severe X-linked intellectual disability, Gustavson type",RBMX,RNA binding motif protein X-linked,Xq26.3
3077,X-linked intellectual disability-psychosis-macroorchidism syndrome,MECP2,methyl-CpG binding protein 2,Xq28
3063,"X-linked intellectual disability, Snyder type",SMS,spermine synthase,Xp22.11
2886,TARP syndrome,RBM10,RNA binding motif protein 10,Xp11.3
2884,Piebaldism,SNAI2,snail family transcriptional repressor 2,8q11.21
2884,Piebaldism,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
2879,"Phocomelia, Schinzel type",WNT7A,Wnt family member 7A,3p25.1
268882,Arnold-Chiari malformation type I,DKK1,dickkopf WNT signaling pathway inhibitor 1,10q21.1
268823,Occipital encephalocele,DACT1,dishevelled binding antagonist of beta catenin 1,14q23.1
2874,Phakomatosis pigmentokeratotica,HRAS,"HRas proto-oncogene, GTPase",11p15.5
2848,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,PRG4,proteoglycan 4,1q31.1
2854,Fuhrmann syndrome,WNT7A,Wnt family member 7A,3p25.1
708,Peters anomaly,FOXC1,forkhead box C1,6p25.3
708,Peters anomaly,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2p22.2
708,Peters anomaly,PITX2,paired like homeodomain 2,4q25
708,Peters anomaly,PAX6,paired box 6,11p13
708,Peters anomaly,FOXE3,forkhead box E3,1p33
2850,Alopecia-intellectual disability syndrome,ITGB6,integrin subunit beta 6,2q24.2
2850,Alopecia-intellectual disability syndrome,LSS,lanosterol synthase,21q22.3
2850,Alopecia-intellectual disability syndrome,AHSG,alpha 2-HS glycoprotein,3q27.3
268114,RAS-associated autoimmune leukoproliferative disease,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
268114,RAS-associated autoimmune leukoproliferative disease,NRAS,"NRAS proto-oncogene, GTPase",1p13.2
268129,Spheroid body myopathy,MYOT,myotilin,5q31.2
2822,Autosomal recessive spastic paraplegia type 11,SPG11,"SPG11 vesicle trafficking associated, spatacsin",15q21.1
268261,DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion,DYRK1A,dual specificity tyrosine phosphorylation regulated kinase 1A,21q22.13
2836,PEHO syndrome,ZNHIT3,zinc finger HIT-type containing 3,17q12
268162,Intermediate maple syrup urine disease,BCKDHA,branched chain keto acid dehydrogenase E1 subunit alpha,19q13.2
268162,Intermediate maple syrup urine disease,BCKDHB,branched chain keto acid dehydrogenase E1 subunit beta,6q14.1
268162,Intermediate maple syrup urine disease,DBT,dihydrolipoamide branched chain transacylase E2,1p21.2
268162,Intermediate maple syrup urine disease,PPM1K,"protein phosphatase, Mg2+/Mn2+ dependent 1K",4q22.1
268145,Classic maple syrup urine disease,BCKDHA,branched chain keto acid dehydrogenase E1 subunit alpha,19q13.2
268145,Classic maple syrup urine disease,BCKDHB,branched chain keto acid dehydrogenase E1 subunit beta,6q14.1
268145,Classic maple syrup urine disease,DBT,dihydrolipoamide branched chain transacylase E2,1p21.2
268184,Thiamine-responsive maple syrup urine disease,DBT,dihydrolipoamide branched chain transacylase E2,1p21.2
2833,Stiff skin syndrome,FBN1,fibrillin 1,15q21.1
2834,Wrinkly skin syndrome,ATP6V0A2,ATPase H+ transporting V0 subunit a2,12q24.31
268173,Intermittent maple syrup urine disease,BCKDHA,branched chain keto acid dehydrogenase E1 subunit alpha,19q13.2
268173,Intermittent maple syrup urine disease,BCKDHB,branched chain keto acid dehydrogenase E1 subunit beta,6q14.1
268173,Intermittent maple syrup urine disease,DBT,dihydrolipoamide branched chain transacylase E2,1p21.2
2969,Proteus-like syndrome,PTEN,phosphatase and tensin homolog,10q23.31
750,Pseudoachondroplasia,COMP,cartilage oligomeric matrix protein,19p13.11
1848,"Renal agenesis, bilateral",WNT9B,Wnt family member 9B,17q21.32
1848,"Renal agenesis, bilateral",GREB1L,GREB1 like retinoic acid receptor coactivator,18q11.1-q11.2
1848,"Renal agenesis, bilateral",RET,ret proto-oncogene,10q11.21
1848,"Renal agenesis, bilateral",ITGA8,integrin subunit alpha 8,10p13
1848,"Renal agenesis, bilateral",FGF20,fibroblast growth factor 20,8p22
1848,"Renal agenesis, bilateral",GFRA1,GDNF family receptor alpha 1,10q25.3
740,Hutchinson-Gilford progeria syndrome,ZMPSTE24,zinc metallopeptidase STE24,1p34.2
740,Hutchinson-Gilford progeria syndrome,LMNA,lamin A/C,1q22
2957,Guttmacher syndrome,HOXA13,homeobox A13,7p15.2
2924,Isolated polycystic liver disease,PRKCSH,PRKCSH beta subunit of glucosidase II,19p13.2
2924,Isolated polycystic liver disease,SEC63,"SEC63 homolog, protein translocation regulator",6q21
2924,Isolated polycystic liver disease,LRP5,LDL receptor related protein 5,11q13.2
2924,Isolated polycystic liver disease,ALG8,"ALG8 alpha-1,3-glucosyltransferase",11q14.1
2896,Pitt-Hopkins syndrome,TCF4,transcription factor 4,18q21.2
2896,Pitt-Hopkins syndrome,TCF4,transcription factor 4,18q21.2
2899,Brachyolmia-amelogenesis imperfecta syndrome,LTBP3,latent transforming growth factor beta binding protein 3,11q13.1
264580,Glycogen storage disease due to liver phosphorylase kinase deficiency,PHKA2,phosphorylase kinase regulatory subunit alpha 2,Xp22.13
264580,Glycogen storage disease due to liver phosphorylase kinase deficiency,PHKG2,phosphorylase kinase catalytic subunit gamma 2,16p11.2
2919,Orofaciodigital syndrome type 5,DDX59,DEAD-box helicase 59,1q32.1
264675,Hereditary pulmonary alveolar proteinosis,CSF2RB,colony stimulating factor 2 receptor subunit beta,22q12.3
264675,Hereditary pulmonary alveolar proteinosis,CSF2RA,colony stimulating factor 2 receptor subunit alpha,Xp22.32 and Yp11.3
3377,Trismus-pseudocamptodactyly syndrome,MYH8,myosin heavy chain 8,17p13.1
275777,Heritable pulmonary arterial hypertension,ATP13A3,ATPase 13A3,3q29
275777,Heritable pulmonary arterial hypertension,ACVRL1,activin A receptor like type 1,12q13.13
275777,Heritable pulmonary arterial hypertension,BMPR2,bone morphogenetic protein receptor type 2,2q33.1-q33.2
275777,Heritable pulmonary arterial hypertension,TBX4,T-box transcription factor 4,17q23.2
275777,Heritable pulmonary arterial hypertension,ENG,endoglin,9q34.11
275777,Heritable pulmonary arterial hypertension,CAV1,caveolin 1,7q31.2
275777,Heritable pulmonary arterial hypertension,SMAD9,SMAD family member 9,13q13.3
275777,Heritable pulmonary arterial hypertension,KCNK3,potassium two pore domain channel subfamily K member 3,2p23.3
275777,Heritable pulmonary arterial hypertension,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,15q15.1
275777,Heritable pulmonary arterial hypertension,GDF2,growth differentiation factor 2,10q11.22
275777,Heritable pulmonary arterial hypertension,SOX17,SRY-box transcription factor 17,8q11.23
275786,Drug- or toxin-induced pulmonary arterial hypertension,BMPR2,bone morphogenetic protein receptor type 2,2q33.1-q33.2
275798,Pulmonary arterial hypertension associated with connective tissue disease,HLA-B,"major histocompatibility complex, class I, B",6p21.33
3363,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome,PNPLA6,"patatin like domain 6, lysophospholipase",19p13.2
3366,Non-syndromic metopic craniosynostosis,FGFR1,fibroblast growth factor receptor 1,8p11.23
3366,Non-syndromic metopic craniosynostosis,FREM1,FRAS1 related extracellular matrix 1,9p22.3
276148,Benign epithelial tumor of salivary glands,PLAG1,PLAG1 zinc finger,8q12.1
276148,Benign epithelial tumor of salivary glands,HMGA2,high mobility group AT-hook 2,12q14.3
276145,Malignant epithelial tumor of salivary glands,PRKD1,protein kinase D1,14q12
3412,VACTERL with hydrocephalus,FANCB,FA complementation group B,Xp22.2
276152,Multiple endocrine neoplasia type 4,CDKN1B,cyclin dependent kinase inhibitor 1B,12p13.1
275872,Frontotemporal dementia with motor neuron disease,VCP,valosin containing protein,9p13.3
275872,Frontotemporal dementia with motor neuron disease,TARDBP,TAR DNA binding protein,1p36.22
275872,Frontotemporal dementia with motor neuron disease,FUS,FUS RNA binding protein,16p11.2
275872,Frontotemporal dementia with motor neuron disease,SQSTM1,sequestosome 1,5q35.3
275872,Frontotemporal dementia with motor neuron disease,C9ORF72,C9orf72-SMCR8 complex subunit,9p21.2
275872,Frontotemporal dementia with motor neuron disease,TBK1,TANK binding kinase 1,12q14.2
275872,Frontotemporal dementia with motor neuron disease,CHCHD10,coiled-coil-helix-coiled-coil-helix domain containing 10,22q11.23
3384,Common arterial trunk,TBX1,T-box transcription factor 1,22q11.21
3384,Common arterial trunk,NKX2-6,NK2 homeobox 6,8p21.2
3384,Common arterial trunk,PLXND1,plexin D1,3q22.1
275864,Behavioral variant of frontotemporal dementia,TMEM106B,transmembrane protein 106B,7p21.3
275864,Behavioral variant of frontotemporal dementia,PSEN1,presenilin 1,14q24.2
275864,Behavioral variant of frontotemporal dementia,CHMP2B,charged multivesicular body protein 2B,3p11.2
275864,Behavioral variant of frontotemporal dementia,TREM2,triggering receptor expressed on myeloid cells 2,6p21.1
275864,Behavioral variant of frontotemporal dementia,VCP,valosin containing protein,9p13.3
275864,Behavioral variant of frontotemporal dementia,MAPT,microtubule associated protein tau,17q21.31
275864,Behavioral variant of frontotemporal dementia,GRN,granulin precursor,17q21.31
275864,Behavioral variant of frontotemporal dementia,SQSTM1,sequestosome 1,5q35.3
275864,Behavioral variant of frontotemporal dementia,C9ORF72,C9orf72-SMCR8 complex subunit,9p21.2
3329,Tibial aplasia-ectrodactyly syndrome,BHLHA9,basic helix-loop-helix family member a9,17p13.3
3322,Hoyeraal-Hreidarsson syndrome,DKC1,dyskerin pseudouridine synthase 1,Xq28
3322,Hoyeraal-Hreidarsson syndrome,TERT,telomerase reverse transcriptase,5p15.33
3322,Hoyeraal-Hreidarsson syndrome,TINF2,TERF1 interacting nuclear factor 2,14q12
3322,Hoyeraal-Hreidarsson syndrome,RTEL1,regulator of telomere elongation helicase 1,20q13.33
3322,Hoyeraal-Hreidarsson syndrome,ACD,ACD shelterin complex subunit and telomerase recruitment factor,16q22.1
3322,Hoyeraal-Hreidarsson syndrome,PARN,poly(A)-specific ribonuclease,16p13.12
275555,Preeclampsia,FLT1,fms related receptor tyrosine kinase 1,13q12.3
275555,Preeclampsia,STOX1,storkhead box 1,10q22.1
275555,Preeclampsia,CORIN,"corin, serine peptidase",4p12
275517,Autoimmune lymphoproliferative syndrome-recurrent viral infections due to CASP8 deficiency,CASP8,caspase 8,2q33.1
3352,Tricho-dento-osseous syndrome,DLX3,distal-less homeobox 3,17q21.33
3342,Arterial tortuosity syndrome,SLC2A10,solute carrier family 2 member 10,20q13.12
3339,Oculoectodermal syndrome,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
3338,Toriello-Carey syndrome,DDX3X,DEAD-box helicase 3 X-linked,Xp11.4
3472,Yunis-Varon syndrome,FIG4,FIG4 phosphoinositide 5-phosphatase,6q21
3472,Yunis-Varon syndrome,VAC14,VAC14 component of PIKFYVE complex,16q22.1-q22.2
3319,Congenital amegakaryocytic thrombocytopenia,THPO,thrombopoietin,3q27.1
3319,Congenital amegakaryocytic thrombocytopenia,MPL,"MPL proto-oncogene, thrombopoietin receptor",1p34.2
3473,Zimmermann-Laband syndrome,KCNN3,potassium calcium-activated channel subfamily N member 3,1q21.3
3473,Zimmermann-Laband syndrome,ATP6V1B2,ATPase H+ transporting V1 subunit B2,8p21.3
3473,Zimmermann-Laband syndrome,KCNH1,potassium voltage-gated channel subfamily H member 1,1q32.2
3459,Wilson-Turner syndrome,HDAC8,histone deacetylase 8,Xq13.1
3459,Wilson-Turner syndrome,LAS1L,LAS1 like ribosome biogenesis factor,Xq12
2995,Baraitser-Winter cerebrofrontofacial syndrome,ACTB,actin beta,7p22.1
2995,Baraitser-Winter cerebrofrontofacial syndrome,ACTG1,actin gamma 1,17q25.3
3243,Sweet syndrome,PTPN6,protein tyrosine phosphatase non-receptor type 6,12p13.31
3243,Sweet syndrome,MEFV,"MEFV innate immunity regulator, pyrin",16p13.3
1827,Acromelic frontonasal dysplasia,ZSWIM6,zinc finger SWIM-type containing 6,5q12.1
268973,Isolated focal cortical dysplasia type Ia,SLC35A2,solute carrier family 35 member A2,Xp11.23
269008,Isolated focal cortical dysplasia type IIb,TSC2,TSC complex subunit 2,16p13.3
269008,Isolated focal cortical dysplasia type IIb,MTOR,mechanistic target of rapamycin kinase,1p36.22
269008,Isolated focal cortical dysplasia type IIb,TSC1,TSC complex subunit 1,9q34.13
269001,Isolated focal cortical dysplasia type IIa,TSC2,TSC complex subunit 2,16p13.3
269001,Isolated focal cortical dysplasia type IIa,MTOR,mechanistic target of rapamycin kinase,1p36.22
2460,Van den Ende-Gupta syndrome,SCARF2,scavenger receptor class F member 2,22q11.21
3416,Hyperostosis corticalis generalisata,LRP5,LDL receptor related protein 5,11q13.2
3416,Hyperostosis corticalis generalisata,SOST,sclerostin,17q21.31
3453,Autoimmune polyendocrinopathy type 1,AIRE,autoimmune regulator,21q22.3
3449,Weill-Marchesani syndrome,ADAMTS17,ADAM metallopeptidase with thrombospondin type 1 motif 17,15q26.3
3449,Weill-Marchesani syndrome,ADAMTS10,ADAM metallopeptidase with thrombospondin type 1 motif 10,19p13.2
3449,Weill-Marchesani syndrome,FBN1,fibrillin 1,15q21.1
3449,Weill-Marchesani syndrome,LTBP2,latent transforming growth factor beta binding protein 2,14q24.3
269510,Congenital non-communicating hydrocephalus,CCDC88C,coiled-coil domain containing 88C,14q32.11-q32.12
3454,Wieacker-Wolff syndrome,ZC4H2,zinc finger C4H2-type containing,Xq11.2
3455,Wiedemann-Rautenstrauch syndrome,POLR3A,RNA polymerase III subunit A,10q22.3
269505,Congenital communicating hydrocephalus,TRIM71,tripartite motif containing 71,3p22.3
269505,Congenital communicating hydrocephalus,MPDZ,multiple PDZ domain crumbs cell polarity complex component,9p23
269215,Isolated Dandy-Walker malformation without hydrocephalus,ZIC4,Zic family member 4,3q24
269215,Isolated Dandy-Walker malformation without hydrocephalus,NID1,nidogen 1,1q42.3
269215,Isolated Dandy-Walker malformation without hydrocephalus,ZIC1,Zic family member 1,3q24
269212,Isolated Dandy-Walker malformation with hydrocephalus,ZIC1,Zic family member 1,3q24
269212,Isolated Dandy-Walker malformation with hydrocephalus,ZIC4,Zic family member 4,3q24
1856,Spondyloperipheral dysplasia-short ulna syndrome,COL2A1,collagen type II alpha 1 chain,12q13.11
280333,Alpha-dystroglycan-related limb-girdle muscular dystrophy R16,DAG1,dystroglycan 1,3p21.31
280325,Distal deletion 12p syndrome,ERC1,ELKS/RAB6-interacting/CAST family member 1,12p13.33
280293,Pelizaeus-Merzbacher-like disease due to AIMP1 mutation,AIMP1,aminoacyl tRNA synthetase complex interacting multifunctional protein 1,4q24
280288,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation,HSPD1,heat shock protein family D (Hsp60) member 1,2q33.1
280365,Autosomal semi-dominant severe lipodystrophic laminopathy,LMNA,lamin A/C,1q22
3197,Hereditary hyperekplexia,ATAD1,ATPase family AAA domain containing 1,10q23.31
3197,Hereditary hyperekplexia,GLRA1,glycine receptor alpha 1,5q33.1
3197,Hereditary hyperekplexia,GLRB,glycine receptor beta,4q32.1
3197,Hereditary hyperekplexia,GPHN,gephyrin,14q23.3
3197,Hereditary hyperekplexia,SLC6A5,solute carrier family 6 member 5,11p15.1
3193,Supravalvular aortic stenosis,ELN,elastin,7q11.23
280356,PLIN1-related familial partial lipodystrophy,PLIN1,perilipin 1,15q26.1
280406,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,COQ6,"coenzyme Q6, monooxygenase",14q24.3
280384,Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome,ERLIN2,ER lipid raft associated 2,8p11.23
280397,Familial Alzheimer-like prion disease,PRNP,prion protein (Kanno blood group),20p13
280576,Nestor-Guillermo progeria syndrome,BANF1,barrier to autointegration nuclear assembly factor 1,11q13.1
3220,Deafness-enamel hypoplasia-nail defects syndrome,PEX1,peroxisomal biogenesis factor 1,7q21.2
3220,Deafness-enamel hypoplasia-nail defects syndrome,PEX6,peroxisomal biogenesis factor 6,6p21.1
280586,"Chondrodysplasia with joint dislocations, gPAPP type",BPNT2,"3'(2'), 5'-bisphosphate nucleotidase 2",8q12.1
280553,Fatal infantile hypertonic myofibrillar myopathy,CRYAB,crystallin alpha B,11q23.1
280558,Warsaw breakage syndrome,DDX11,DEAD/H-box helicase 11,12p11.21
647,Nijmegen breakage syndrome,NBN,nibrin,8q21.3
279943,Hereditary neutrophilia,CSF3R,colony stimulating factor 3 receptor,1p34.3
279934,"Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency",DGUOK,deoxyguanosine kinase,2p13.1
3152,Sclerosteosis,SOST,sclerostin,17q21.31
3152,Sclerosteosis,LRP4,LDL receptor related protein 4,11p11.2
280142,Severe combined immunodeficiency due to LCK deficiency,LCK,"LCK proto-oncogene, Src family tyrosine kinase",1p35.2
280133,Complement component 3 deficiency,C3,complement C3,19p13.3
3163,SHORT syndrome,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,5q13.1
1479,Atrial septal defect-atrioventricular conduction defects syndrome,NKX2-5,NK2 homeobox 5,5q35.1
3156,Senior-Loken syndrome,CEP290,centrosomal protein 290,12q21.32
3156,Senior-Loken syndrome,INVS,inversin,9q31.1
3156,Senior-Loken syndrome,IQCB1,IQ motif containing B1,3q13.33
3156,Senior-Loken syndrome,NPHP1,nephrocystin 1,2q13
3156,Senior-Loken syndrome,NPHP3,nephrocystin 3,3q22.1
3156,Senior-Loken syndrome,NPHP4,nephrocystin 4,1p36.31
3156,Senior-Loken syndrome,SDCCAG8,SHH signaling and ciliogenesis regulator SDCCAG8,1q43-q44
3156,Senior-Loken syndrome,WDR19,WD repeat domain 19,4p14
3156,Senior-Loken syndrome,CEP164,centrosomal protein 164,11q23.3
3156,Senior-Loken syndrome,TRAF3IP1,TRAF3 interacting protein 1,2q37.3
280071,ALG11-CDG,ALG11,"ALG11 alpha-1,2-mannosyltransferase",13q14.3
3157,Septo-optic dysplasia spectrum,PROKR2,prokineticin receptor 2,20p12.3
3157,Septo-optic dysplasia spectrum,SOX2,SRY-box transcription factor 2,3q26.33
3157,Septo-optic dysplasia spectrum,FGFR1,fibroblast growth factor receptor 1,8p11.23
3157,Septo-optic dysplasia spectrum,HESX1,HESX homeobox 1,3p14.3
3157,Septo-optic dysplasia spectrum,OTX2,orthodenticle homeobox 2,14q22.3
3157,Septo-optic dysplasia spectrum,SOX3,SRY-box transcription factor 3,Xq27.1
3157,Septo-optic dysplasia spectrum,ARNT2,aryl hydrocarbon receptor nuclear translocator 2,15q25.1
280210,"Pelizaeus-Merzbacher disease, connatal form",PLP1,proteolipid protein 1,Xq22.2
280219,"Pelizaeus-Merzbacher disease, classic form",PLP1,proteolipid protein 1,Xq22.2
280200,Microform holoprosencephaly,FGFR1,fibroblast growth factor receptor 1,8p11.23
280200,Microform holoprosencephaly,SUFU,SUFU negative regulator of hedgehog signaling,10q24.32
280200,Microform holoprosencephaly,PTCH1,patched 1,9q22.32
280200,Microform holoprosencephaly,SIX3,SIX homeobox 3,2p21
280200,Microform holoprosencephaly,TGIF1,TGFB induced factor homeobox 1,18p11.31
280200,Microform holoprosencephaly,ZIC2,Zic family member 2,13q32.3
280200,Microform holoprosencephaly,GLI2,GLI family zinc finger 2,2q14.2
280200,Microform holoprosencephaly,CRIPTO,"cripto, EGF-CFC family member",3p21.31
280200,Microform holoprosencephaly,FOXH1,forkhead box H1,8q24.3
280200,Microform holoprosencephaly,FGF8,fibroblast growth factor 8,10q24.32
280200,Microform holoprosencephaly,DISP1,dispatched RND transporter family member 1,1q41
280200,Microform holoprosencephaly,CDON,"cell adhesion associated, oncogene regulated",11q24.2
280200,Microform holoprosencephaly,NODAL,nodal growth differentiation factor,10q22.1
280200,Microform holoprosencephaly,DLL1,delta like canonical Notch ligand 1,6q27
280200,Microform holoprosencephaly,GAS1,growth arrest specific 1,9q21.33
280200,Microform holoprosencephaly,SHH,sonic hedgehog signaling molecule,7q36.3
3175,X-linked spasticity-intellectual disability-epilepsy syndrome,ARX,aristaless related homeobox,Xp21.3
280195,Septopreoptic holoprosencephaly,STIL,STIL centriolar assembly protein,1p33
280195,Septopreoptic holoprosencephaly,PTCH1,patched 1,9q22.32
280195,Septopreoptic holoprosencephaly,SHH,sonic hedgehog signaling molecule,7q36.3
280195,Septopreoptic holoprosencephaly,SIX3,SIX homeobox 3,2p21
280195,Septopreoptic holoprosencephaly,TGIF1,TGFB induced factor homeobox 1,18p11.31
280195,Septopreoptic holoprosencephaly,ZIC2,Zic family member 2,13q32.3
280195,Septopreoptic holoprosencephaly,GLI2,GLI family zinc finger 2,2q14.2
280195,Septopreoptic holoprosencephaly,CRIPTO,"cripto, EGF-CFC family member",3p21.31
280195,Septopreoptic holoprosencephaly,FOXH1,forkhead box H1,8q24.3
280195,Septopreoptic holoprosencephaly,FGF8,fibroblast growth factor 8,10q24.32
280195,Septopreoptic holoprosencephaly,DISP1,dispatched RND transporter family member 1,1q41
280195,Septopreoptic holoprosencephaly,CDON,"cell adhesion associated, oncogene regulated",11q24.2
280195,Septopreoptic holoprosencephaly,NODAL,nodal growth differentiation factor,10q22.1
280195,Septopreoptic holoprosencephaly,DLL1,delta like canonical Notch ligand 1,6q27
280195,Septopreoptic holoprosencephaly,GAS1,growth arrest specific 1,9q21.33
280183,Methylmalonic aciduria due to transcobalamin receptor defect,CD320,CD320 molecule,19p13.2
280282,Pelizaeus-Merzbacher-like disease due to GJC2 mutation,GJC2,gap junction protein gamma 2,1q42.13
280270,Pelizaeus-Merzbacher-like disease,MAL,"mal, T cell differentiation protein (MAL blood group)",2q11.1
280234,Null syndrome,PLP1,proteolipid protein 1,Xq22.2
1855,Spondyloenchondrodysplasia,ACP5,"acid phosphatase 5, tartrate resistant",19p13.2
280224,"Pelizaeus-Merzbacher disease, transitional form",PLP1,proteolipid protein 1,Xq22.2
1797,Autosomal dominant spondylocostal dysostosis,TBX6,T-box transcription factor 6,16p11.2
280229,Pelizaeus-Merzbacher disease in female carriers,PLP1,proteolipid protein 1,Xq22.2
276580,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
3258,Cenani-Lenz syndrome,APC,APC regulator of WNT signaling pathway,5q22.2
3258,Cenani-Lenz syndrome,LRP4,LDL receptor related protein 4,11p11.2
276575,Autosomal dominant hyperinsulinism due to SUR1 deficiency,ABCC8,ATP binding cassette subfamily C member 8,11p15.1
276598,Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency,ABCC8,ATP binding cassette subfamily C member 8,11p15.1
276603,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
276621,Sporadic pheochromocytoma/secreting paraganglioma,SDHD,succinate dehydrogenase complex subunit D,11q23.1
276621,Sporadic pheochromocytoma/secreting paraganglioma,SDHB,succinate dehydrogenase complex iron sulfur subunit B,1p36.13
276621,Sporadic pheochromocytoma/secreting paraganglioma,DNMT3A,DNA methyltransferase 3 alpha,2p23.3
276621,Sporadic pheochromocytoma/secreting paraganglioma,EPAS1,endothelial PAS domain protein 1,2p21
276621,Sporadic pheochromocytoma/secreting paraganglioma,VHL,von Hippel-Lindau tumor suppressor,3p25.3
276621,Sporadic pheochromocytoma/secreting paraganglioma,RET,ret proto-oncogene,10q11.21
276630,Symptomatic form of Coffin-Lowry syndrome in female carriers,RPS6KA3,ribosomal protein S6 kinase A3,Xp22.12
3275,Spondylocarpotarsal synostosis,MYH3,myosin heavy chain 3,17p13.1
3275,Spondylocarpotarsal synostosis,FLNB,filamin B,3p14.3
425,Apolipoprotein A-I deficiency,APOA1,apolipoprotein A1,11q23.3
425,Apolipoprotein A-I deficiency,ABCA1,ATP binding cassette subfamily A member 1,9q31.1
3301,Tetraamelia-multiple malformations syndrome,RSPO2,R-spondin 2,8q23.1
3301,Tetraamelia-multiple malformations syndrome,TBX4,T-box transcription factor 4,17q23.2
3301,Tetraamelia-multiple malformations syndrome,WNT3,Wnt family member 3,17q21.31-q21.32
276198,Spinocerebellar ataxia type 36,NOP56,NOP56 ribonucleoprotein,20p13
276193,Spinocerebellar ataxia type 35,TGM6,transglutaminase 6,20p13
276183,Spinocerebellar ataxia type 32,SCA32,spinocerebellar ataxia 32,7q32-q33
276238,Machado-Joseph disease type 1,ATXN3,ataxin 3,14q32.12
276234,Non-syndromic male infertility due to sperm motility disorder,CFAP251,cilia and flagella associated protein 251,12q24.31
276234,Non-syndromic male infertility due to sperm motility disorder,CFAP43,cilia and flagella associated protein 43,10q25.1
276234,Non-syndromic male infertility due to sperm motility disorder,CFAP44,cilia and flagella associated protein 44,3q13.2
276234,Non-syndromic male infertility due to sperm motility disorder,ARMC2,armadillo repeat containing 2,6q21
276234,Non-syndromic male infertility due to sperm motility disorder,TTC21A,tetratricopeptide repeat domain 21A,3p22.2
276234,Non-syndromic male infertility due to sperm motility disorder,AK7,adenylate kinase 7,14q32.2
276234,Non-syndromic male infertility due to sperm motility disorder,CFAP65,cilia and flagella associated protein 65,2q35
276234,Non-syndromic male infertility due to sperm motility disorder,CFAP69,cilia and flagella associated protein 69,7q21.13
276234,Non-syndromic male infertility due to sperm motility disorder,AKAP4,A-kinase anchoring protein 4,Xp11.22
276234,Non-syndromic male infertility due to sperm motility disorder,SPAG17,sperm associated antigen 17,1p12
276234,Non-syndromic male infertility due to sperm motility disorder,ACTL9,actin like 9,19p13.2
276234,Non-syndromic male infertility due to sperm motility disorder,USP26,ubiquitin specific peptidase 26,Xq26.2
276234,Non-syndromic male infertility due to sperm motility disorder,FSIP2,fibrous sheath interacting protein 2,2q32.1
276234,Non-syndromic male infertility due to sperm motility disorder,CFAP70,cilia and flagella associated protein 70,10q22.2
276234,Non-syndromic male infertility due to sperm motility disorder,TTC29,tetratricopeptide repeat domain 29,4q31.22
276234,Non-syndromic male infertility due to sperm motility disorder,CATSPER1,cation channel sperm associated 1,11q13.1
276234,Non-syndromic male infertility due to sperm motility disorder,SLC26A8,solute carrier family 26 member 8,6p21.31
276234,Non-syndromic male infertility due to sperm motility disorder,SEPTIN12,septin 12,16p13.3
276234,Non-syndromic male infertility due to sperm motility disorder,DNAH1,dynein axonemal heavy chain 1,3p21.1
276234,Non-syndromic male infertility due to sperm motility disorder,SSX1,SSX family member 1,Xp11.23
276234,Non-syndromic male infertility due to sperm motility disorder,DRC1,dynein regulatory complex subunit 1,2p23.3
276234,Non-syndromic male infertility due to sperm motility disorder,DNAH17,dynein axonemal heavy chain 17,17q25.3
276234,Non-syndromic male infertility due to sperm motility disorder,SPEF2,sperm flagellar 2,5p13.2
276223,"Mucopolysaccharidosis type 6, slowly progressing",ARSB,arylsulfatase B,5q14.1
276212,"Mucopolysaccharidosis type 6, rapidly progressing",ARSB,arylsulfatase B,5q14.1
276244,Machado-Joseph disease type 3,ATXN3,ataxin 3,14q32.12
276241,Machado-Joseph disease type 2,ATXN3,ataxin 3,14q32.12
276280,Hemihyperplasia-multiple lipomatosis syndrome,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
276399,Familial multinodular goiter,KEAP1,kelch like ECH associated protein 1,19p13.2
276399,Familial multinodular goiter,DICER1,"dicer 1, ribonuclease III",14q32.13
3238,Cardiospondylocarpofacial syndrome,MAP3K7,mitogen-activated protein kinase kinase kinase 7,6q15
3237,Multiple synostoses syndrome,GDF5,growth differentiation factor 5,20q11.22
3237,Multiple synostoses syndrome,NOG,noggin,17q22
3237,Multiple synostoses syndrome,FGF9,fibroblast growth factor 9,13q12.11
3237,Multiple synostoses syndrome,GDF6,growth differentiation factor 6,8q22.1
276405,Hyperbiliverdinemia,BLVRA,biliverdin reductase A,7p13
3250,Proximal symphalangism,GDF5,growth differentiation factor 5,20q11.22
3250,Proximal symphalangism,NOG,noggin,17q22
3255,Filippi syndrome,CKAP2L,cytoskeleton associated protein 2 like,2q14.1
276556,Hyperinsulinism due to UCP2 deficiency,UCP2,uncoupling protein 2,11q13.4
276432,Ogden syndrome,NAA10,"N-alpha-acetyltransferase 10, NatA catalytic subunit",Xq28
3253,Cleft lip/palate-ectodermal dysplasia syndrome,NECTIN1,nectin cell adhesion molecule 1,11q23.3
276435,Lower motor neuron syndrome with late-adult onset,CHCHD10,coiled-coil-helix-coiled-coil-helix domain containing 10,22q11.23
911,Combined immunodeficiency due to ZAP70 deficiency,ZAP70,zeta chain of T-cell receptor associated protein kinase 70,2q11.2
746,Mitochondrial trifunctional protein deficiency,HADHA,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha,2p23.3
746,Mitochondrial trifunctional protein deficiency,HADHB,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta,2p23.3
943,Malonic aciduria,MLYCD,malonyl-CoA decarboxylase,16q23.3
621,Hereditary methemoglobinemia,CYB5R3,cytochrome b5 reductase 3,22q13.2
621,Hereditary methemoglobinemia,CYB5A,cytochrome b5 type A,18q22.3
2089,Glycogen storage disease due to hepatic glycogen synthase deficiency,GYS2,glycogen synthase 2,12p12.1
412,Dysbetalipoproteinemia,APOE,apolipoprotein E,19q13.32
743,Severe hereditary thrombophilia due to congenital protein S deficiency,PROS1,protein S,3q11.1
424,Familial hyperthyroidism due to mutations in TSH receptor,TSHR,thyroid stimulating hormone receptor,14q24-q31
325,Congenital factor II deficiency,F2,"coagulation factor II, thrombin",11p11.2
343,Hyperimmunoglobulinemia D with periodic fever,MVK,mevalonate kinase,12q24.11
572,Immunodeficiency by defective expression of MHC class II,RFX5,regulatory factor X5,1q21.3
572,Immunodeficiency by defective expression of MHC class II,RFXANK,regulatory factor X associated ankyrin containing protein,19p13.11
572,Immunodeficiency by defective expression of MHC class II,RFXAP,regulatory factor X associated protein,13q13.3
572,Immunodeficiency by defective expression of MHC class II,CIITA,class II major histocompatibility complex transactivator,16p13.13
1930,Herpes simplex virus encephalitis,UNC93B1,"unc-93 homolog B1, TLR signaling regulator",11q13.2
1930,Herpes simplex virus encephalitis,TLR3,toll like receptor 3,4q35.1
1930,Herpes simplex virus encephalitis,TICAM1,TIR domain containing adaptor molecule 1,19p13.3
1930,Herpes simplex virus encephalitis,TRAF3,TNF receptor associated factor 3,14q32.32
1930,Herpes simplex virus encephalitis,TBK1,TANK binding kinase 1,12q14.2
158,Systemic primary carnitine deficiency,SLC22A5,solute carrier family 22 member 5,5q31.1
2056,Essential fructosuria,KHK,ketohexokinase,2p23.3
206436,Infantile Krabbe disease,PSAP,prosaposin,10q22.1
206436,Infantile Krabbe disease,GALC,galactosylceramidase,14q31.3
820,Sneddon syndrome,ADA2,adenosine deaminase 2,22q11.1
1945,Self-limited epilepsy with centrotemporal spikes,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,5q34
1945,Self-limited epilepsy with centrotemporal spikes,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,16p13.2
1945,Self-limited epilepsy with centrotemporal spikes,SRPX2,sushi repeat containing protein X-linked 2,Xq22.1
832,Succinyl-CoA:3-oxoacid CoA transferase deficiency,OXCT1,3-oxoacid CoA-transferase 1,5p13.1
6,3-methylcrotonyl-CoA carboxylase deficiency,MCCC1,methylcrotonyl-CoA carboxylase subunit 1,3q27.1
6,3-methylcrotonyl-CoA carboxylase deficiency,MCCC2,methylcrotonyl-CoA carboxylase subunit 2,5q13.2
20,3-hydroxy-3-methylglutaric aciduria,HMGCL,3-hydroxy-3-methylglutaryl-CoA lyase,1p36.11
714,Hemolytic anemia due to diphosphoglycerate mutase deficiency,BPGM,bisphosphoglycerate mutase,7q33
712,Hemolytic anemia due to glucophosphate isomerase deficiency,GPI,glucose-6-phosphate isomerase,19q13.11
206546,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers,DMD,dystrophin,Xp21.2-p21.1
206554,Fukutin-related limb-girdle muscular dystrophy R13,FKTN,fukutin,9q31.2
206549,Anoctamin-5-related limb-girdle muscular dystrophy R12,ANO5,anoctamin 5,11p14.3
206564,POMGNT1-related limb-girdle muscular dystrophy R15,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",1p34.1
206559,POMT2-related limb-girdle muscular dystrophy R14,POMT2,protein O-mannosyltransferase 2,14q24.3
206580,Autosomal recessive lower motor neuron disease with childhood onset,PLEKHG5,pleckstrin homology and RhoGEF domain containing G5,1p36.31
206443,Late-infantile/juvenile Krabbe disease,GALC,galactosylceramidase,14q31.3
206448,Adult Krabbe disease,GALC,galactosylceramidase,14q31.3
2680,Hypomyelination neuropathy-arthrogryposis syndrome,CNTNAP1,contactin associated protein 1,17q21.2
2680,Hypomyelination neuropathy-arthrogryposis syndrome,ADCY6,adenylate cyclase 6,12q13.12
2680,Hypomyelination neuropathy-arthrogryposis syndrome,LGI4,leucine rich repeat LGI family member 4,19q13.12
633,Laron syndrome,GHR,growth hormone receptor,5p13.1-p12
478,Kallmann syndrome,CCDC141,coiled-coil domain containing 141,2q31.2
478,Kallmann syndrome,PROK2,prokineticin 2,3p13
478,Kallmann syndrome,PROKR2,prokineticin receptor 2,20p12.3
478,Kallmann syndrome,CHD7,chromodomain helicase DNA binding protein 7,8q12.2
478,Kallmann syndrome,SOX10,SRY-box transcription factor 10,22q13.1
478,Kallmann syndrome,FGFR1,fibroblast growth factor receptor 1,8p11.23
478,Kallmann syndrome,HESX1,HESX homeobox 1,3p14.3
478,Kallmann syndrome,ANOS1,anosmin 1,Xp22.31
478,Kallmann syndrome,FGF8,fibroblast growth factor 8,10q24.32
478,Kallmann syndrome,WDR11,WD repeat domain 11,10q26.12
478,Kallmann syndrome,HS6ST1,heparan sulfate 6-O-sulfotransferase 1,2q14.3
478,Kallmann syndrome,SEMA3A,semaphorin 3A,7q21.11
478,Kallmann syndrome,IL17RD,interleukin 17 receptor D,3p14.3
478,Kallmann syndrome,FGF17,fibroblast growth factor 17,8p21.3
478,Kallmann syndrome,DUSP6,dual specificity phosphatase 6,12q21.33
478,Kallmann syndrome,SPRY4,sprouty RTK signaling antagonist 4,5q31.3
478,Kallmann syndrome,FLRT3,fibronectin leucine rich transmembrane protein 3,20p12.1
478,Kallmann syndrome,FEZF1,FEZ family zinc finger 1,7q31.32
478,Kallmann syndrome,DCC,DCC netrin 1 receptor,18q21.2
478,Kallmann syndrome,NDNF,neuron derived neurotrophic factor,4q27
478,Kallmann syndrome,TACR3,tachykinin receptor 3,4q24
478,Kallmann syndrome,CCDC141,coiled-coil domain containing 141,2q31.2
822,Hereditary spherocytosis,SLC4A1,solute carrier family 4 member 1 (Diego blood group),17q21.31
822,Hereditary spherocytosis,SPTA1,"spectrin alpha, erythrocytic 1",1q23.1
822,Hereditary spherocytosis,SPTB,"spectrin beta, erythrocytic",14q23.3
822,Hereditary spherocytosis,ANK1,ankyrin 1,8p11.21
822,Hereditary spherocytosis,EPB42,erythrocyte membrane protein band 4.2,15q15.2
910,Xeroderma pigmentosum,XPA,"XPA, DNA damage recognition and repair factor",9q22.33
910,Xeroderma pigmentosum,ERCC3,"ERCC excision repair 3, TFIIH core complex helicase subunit",2q14.3
910,Xeroderma pigmentosum,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3p25.1
910,Xeroderma pigmentosum,DDB2,damage specific DNA binding protein 2,11p11.2
910,Xeroderma pigmentosum,ERCC4,"ERCC excision repair 4, endonuclease catalytic subunit",16p13.12
910,Xeroderma pigmentosum,ERCC5,"ERCC excision repair 5, endonuclease",13q33.1
910,Xeroderma pigmentosum,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19q13.32
229,Familial aortic dissection,MYH11,myosin heavy chain 11,16p13.11
777,X-linked non-syndromic intellectual disability,STEEP1,STING1 ER exit protein 1,Xq24
777,X-linked non-syndromic intellectual disability,CASK,calcium/calmodulin dependent serine protein kinase,Xp11.4
777,X-linked non-syndromic intellectual disability,RPS6KA3,ribosomal protein S6 kinase A3,Xp22.12
777,X-linked non-syndromic intellectual disability,ARX,aristaless related homeobox,Xp21.3
777,X-linked non-syndromic intellectual disability,DMD,dystrophin,Xp21.2-p21.1
777,X-linked non-syndromic intellectual disability,FTSJ1,FtsJ RNA 2'-O-methyltransferase 1,Xp11.23
777,X-linked non-syndromic intellectual disability,GDI1,GDP dissociation inhibitor 1,Xq28
777,X-linked non-syndromic intellectual disability,MED12,mediator complex subunit 12,Xq13.1
777,X-linked non-syndromic intellectual disability,UPF3B,UPF3B regulator of nonsense mediated mRNA decay,Xq24
777,X-linked non-syndromic intellectual disability,AGTR2,angiotensin II receptor type 2,Xq23
777,X-linked non-syndromic intellectual disability,DLG3,discs large MAGUK scaffold protein 3,Xq13.1
777,X-linked non-syndromic intellectual disability,IL1RAPL1,interleukin 1 receptor accessory protein like 1,Xp21.3-p21.2
777,X-linked non-syndromic intellectual disability,TSPAN7,tetraspanin 7,Xp11.4
777,X-linked non-syndromic intellectual disability,ARHGEF6,Rac/Cdc42 guanine nucleotide exchange factor 6,Xq26.3
777,X-linked non-syndromic intellectual disability,ZNF81,zinc finger protein 81,Xp11.23
777,X-linked non-syndromic intellectual disability,SYP,synaptophysin,Xp11.23
777,X-linked non-syndromic intellectual disability,ZNF711,zinc finger protein 711,Xq21.1
777,X-linked non-syndromic intellectual disability,RAB39B,"RAB39B, member RAS oncogene family",Xq28
777,X-linked non-syndromic intellectual disability,HCFC1,host cell factor C1,Xq28
777,X-linked non-syndromic intellectual disability,ALG13,ALG13 UDP-N-acetylglucosaminyltransferase subunit,Xq23
777,X-linked non-syndromic intellectual disability,MID2,midline 2,Xq22.3
777,X-linked non-syndromic intellectual disability,PTCHD1,patched domain containing 1,Xp22.11
777,X-linked non-syndromic intellectual disability,USP9X,ubiquitin specific peptidase 9 X-linked,Xp11.4
777,X-linked non-syndromic intellectual disability,ACSL4,acyl-CoA synthetase long chain family member 4,Xq23
777,X-linked non-syndromic intellectual disability,MECP2,methyl-CpG binding protein 2,Xq28
777,X-linked non-syndromic intellectual disability,IQSEC2,IQ motif and Sec7 domain ArfGEF 2,Xp11.22
777,X-linked non-syndromic intellectual disability,SLC9A7,solute carrier family 9 member A7,Xp11.3
777,X-linked non-syndromic intellectual disability,CNKSR2,connector enhancer of kinase suppressor of Ras 2,Xp22.12
777,X-linked non-syndromic intellectual disability,FRMPD4,FERM and PDZ domain containing 4,Xp22.2
777,X-linked non-syndromic intellectual disability,USP27X,ubiquitin specific peptidase 27 X-linked,Xp11.23
777,X-linked non-syndromic intellectual disability,CLCN4,chloride voltage-gated channel 4,Xp22.2
766,Hemolytic anemia due to red cell pyruvate kinase deficiency,PKLR,pyruvate kinase L/R,1q22
206599,Isolated asymptomatic elevation of creatine phosphokinase,ANO5,anoctamin 5,11p14.3
206599,Isolated asymptomatic elevation of creatine phosphokinase,DAG1,dystroglycan 1,3p21.31
206599,Isolated asymptomatic elevation of creatine phosphokinase,CAV3,caveolin 3,3p25.3
3206,Stüve-Wiedemann syndrome,LIFR,LIF receptor subunit alpha,5p13.1
206583,Adult polyglucosan body disease,GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
65,Leber congenital amaurosis,USP45,ubiquitin specific peptidase 45,6q16.2
65,Leber congenital amaurosis,TUBB4B,tubulin beta 4B class IVb,9q34.3
65,Leber congenital amaurosis,SPATA7,spermatogenesis associated 7,14q31.3
65,Leber congenital amaurosis,GDF6,growth differentiation factor 6,8q22.1
65,Leber congenital amaurosis,IFT140,intraflagellar transport 140,16p13.3
65,Leber congenital amaurosis,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,1p36.22
65,Leber congenital amaurosis,RD3,RD3 regulator of GUCY2D,1q32.3
65,Leber congenital amaurosis,RDH12,retinol dehydrogenase 12,14q24.1
65,Leber congenital amaurosis,RPE65,retinoid isomerohydrolase RPE65,1p31.3
65,Leber congenital amaurosis,RPGRIP1,RPGR interacting protein 1,14q11.2
65,Leber congenital amaurosis,CEP290,centrosomal protein 290,12q21.32
65,Leber congenital amaurosis,AIPL1,AIP like 1 HSP90 co-chaperone,17p13.2
65,Leber congenital amaurosis,TULP1,TUB like protein 1,6p21.31
65,Leber congenital amaurosis,CRB1,crumbs cell polarity complex component 1,1q31.3
65,Leber congenital amaurosis,CRX,cone-rod homeobox,19q13.33
65,Leber congenital amaurosis,GUCY2D,"guanylate cyclase 2D, retinal",17p13.1
65,Leber congenital amaurosis,IMPDH1,inosine monophosphate dehydrogenase 1,7q32.1
65,Leber congenital amaurosis,IQCB1,IQ motif containing B1,3q13.33
65,Leber congenital amaurosis,LCA5,lebercilin LCA5,6q14.1
65,Leber congenital amaurosis,KCNJ13,potassium inwardly rectifying channel subfamily J member 13,2q37.1
65,Leber congenital amaurosis,LRAT,lecithin retinol acyltransferase,4q32.1
65,Leber congenital amaurosis,PCYT1A,"phosphate cytidylyltransferase 1A, choline",3q29
321,Multiple osteochondromas,EXT1,exostosin glycosyltransferase 1,8q24.11
321,Multiple osteochondromas,EXT2,exostosin glycosyltransferase 2,11p11.2
144,Lynch syndrome,MSH6,mutS homolog 6,2p16.3
144,Lynch syndrome,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
144,Lynch syndrome,PMS1,"PMS1 homolog 1, mismatch repair system component",2q32.2
144,Lynch syndrome,TGFBR2,transforming growth factor beta receptor 2,3p24.1
144,Lynch syndrome,MSH2,mutS homolog 2,2p21-p16.3
144,Lynch syndrome,EPCAM,epithelial cell adhesion molecule,2p21
144,Lynch syndrome,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
144,Lynch syndrome,PMS2,"PMS1 homolog 2, mismatch repair system component",7p22.1
144,Lynch syndrome,MLH1,mutL homolog 1,3p22.2
110,Bardet-Biedl syndrome,BBS1,Bardet-Biedl syndrome 1,11q13.2
110,Bardet-Biedl syndrome,BBS10,Bardet-Biedl syndrome 10,12q21.2
110,Bardet-Biedl syndrome,BBS2,Bardet-Biedl syndrome 2,16q13
110,Bardet-Biedl syndrome,BBS4,Bardet-Biedl syndrome 4,15q24.1
110,Bardet-Biedl syndrome,BBS5,Bardet-Biedl syndrome 5,2q31.1
110,Bardet-Biedl syndrome,BBS7,Bardet-Biedl syndrome 7,4q27
110,Bardet-Biedl syndrome,BBS9,Bardet-Biedl syndrome 9,7p14.3
110,Bardet-Biedl syndrome,CEP290,centrosomal protein 290,12q21.32
110,Bardet-Biedl syndrome,TRIM32,tripartite motif containing 32,9q33.1
110,Bardet-Biedl syndrome,TTC8,tetratricopeptide repeat domain 8,14q31.3
110,Bardet-Biedl syndrome,ARL6,ARF like GTPase 6,3q11.2
110,Bardet-Biedl syndrome,MKKS,MKKS centrosomal shuttling protein,20p12.2
110,Bardet-Biedl syndrome,MKS1,MKS transition zone complex subunit 1,17q22
110,Bardet-Biedl syndrome,NPHP1,nephrocystin 1,2q13
110,Bardet-Biedl syndrome,BBS12,Bardet-Biedl syndrome 12,4q27
110,Bardet-Biedl syndrome,SDCCAG8,SHH signaling and ciliogenesis regulator SDCCAG8,1q43-q44
110,Bardet-Biedl syndrome,WDPCP,WD repeat containing planar cell polarity effector,2p15
110,Bardet-Biedl syndrome,LZTFL1,leucine zipper transcription factor like 1,3p21.31
110,Bardet-Biedl syndrome,IFT172,intraflagellar transport 172,2p23.3
110,Bardet-Biedl syndrome,BBIP1,BBSome interacting protein 1,10q25.2
110,Bardet-Biedl syndrome,IFT27,intraflagellar transport 27,22q12.3
110,Bardet-Biedl syndrome,IFT74,intraflagellar transport 74,9p21.2
110,Bardet-Biedl syndrome,CEP19,centrosomal protein 19,3q29
110,Bardet-Biedl syndrome,SCAPER,S-phase cyclin A associated protein in the ER,15q24.3
110,Bardet-Biedl syndrome,CFAP418,cilia and flagella associated protein 418,8q22.1
110,Bardet-Biedl syndrome,SCLT1,sodium channel and clathrin linker 1,4q28.2
3095,Atypical Rett syndrome,MECP2,methyl-CpG binding protein 2,Xq28
3095,Atypical Rett syndrome,NTNG1,netrin G1,1p13.3
3095,Atypical Rett syndrome,CDKL5,cyclin dependent kinase like 5,Xp22.13
3095,Atypical Rett syndrome,SMC1A,structural maintenance of chromosomes 1A,Xp11.22
3095,Atypical Rett syndrome,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,9q22.33
1114,Aplasia cutis congenita,PLEC,plectin,8q24.3
1114,Aplasia cutis congenita,ITGB4,integrin subunit beta 4,17q25.1
1114,Aplasia cutis congenita,BMS1,BMS1 ribosome biogenesis factor,10q11.21
1114,Aplasia cutis congenita,DLL4,delta like canonical Notch ligand 4,15q15.1
1114,Aplasia cutis congenita,UBA2,ubiquitin like modifier activating enzyme 2,19q13.11
1272,Aymé-Gripp syndrome,MAF,MAF bZIP transcription factor,16q23.2
208513,Spinocerebellar ataxia type 29,ITPR1,"inositol 1,4,5-trisphosphate receptor type 1",3p26.1
208447,Bilateral generalized polymicrogyria,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,9q34.3
3051,Nicolaides-Baraitser syndrome,SMARCA2,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2,9p24.3
208441,Bilateral parasagittal parieto-occipital polymicrogyria,FIG4,FIG4 phosphoinositide 5-phosphatase,6q21
2963,"Progeroid syndrome, Petty type",SLC25A24,solute carrier family 25 member 24,1p13.3
1541,"Craniosynostosis, Boston type",MSX2,msh homeobox 2,5q35.2
1415,Hardikar syndrome,MED12,mediator complex subunit 12,Xq13.1
2151,Hirschsprung disease-ganglioneuroblastoma syndrome,PHOX2B,paired like homeobox 2B,4p13
209335,Autosomal dominant adult-onset proximal spinal muscular atrophy,VAPB,VAMP associated protein B and C,20q13.32
209341,DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy,DYNC1H1,dynein cytoplasmic 1 heavy chain 1,14q32.31
210110,Intermediate osteopetrosis,TCIRG1,"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3",11q13.2
210110,Intermediate osteopetrosis,CLCN7,chloride voltage-gated channel 7,16p13.3
210110,Intermediate osteopetrosis,PLEKHM1,pleckstrin homology and RUN domain containing M1,17q21.31
210115,Sterile multifocal osteomyelitis with periostitis and pustulosis,IL1RN,interleukin 1 receptor antagonist,2q14.1
209981,IRIDA syndrome,TMPRSS6,transmembrane serine protease 6,22q12.3
210122,Congenital alveolar capillary dysplasia,FOXF1,forkhead box F1,16q24.1
210128,Urocanic aciduria,UROC1,urocanate hydratase 1,3q21.3
2254,Pontocerebellar hypoplasia type 1,AGTPBP1,ATP/GTP binding carboxypeptidase 1,9q21.33
2254,Pontocerebellar hypoplasia type 1,VRK1,VRK serine/threonine kinase 1,14q32.2
2254,Pontocerebellar hypoplasia type 1,EXOSC3,exosome component 3,9p13.2
2254,Pontocerebellar hypoplasia type 1,EXOSC8,exosome component 8,13q13.3
2254,Pontocerebellar hypoplasia type 1,SLC25A46,solute carrier family 25 member 46,5q22.1
2254,Pontocerebellar hypoplasia type 1,EXOSC9,exosome component 9,4q27
209951,Autosomal spastic paraplegia type 18,ERLIN2,ER lipid raft associated 2,8p11.23
209967,Episodic ataxia type 6,SLC1A3,solute carrier family 1 member 3,5p13.2
209908,Isolated childhood apraxia of speech,FOXP2,forkhead box P2,7q31.1
209905,Brain-lung-thyroid syndrome,NKX2-1,NK2 homeobox 1,14q13.3
209902,Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency,CYP7A1,cytochrome P450 family 7 subfamily A member 1,8q12.1
209932,Cone dystrophy with supernormal rod response,KCNV2,potassium voltage-gated channel modifier subfamily V member 2,9p24.2
209916,Extraskeletal myxoid chondrosarcoma,TFG,trafficking from ER to golgi regulator,3q12.2
209916,Extraskeletal myxoid chondrosarcoma,EWSR1,EWS RNA binding protein 1,22q12.2
209916,Extraskeletal myxoid chondrosarcoma,TCF12,transcription factor 12,15q21.3
209916,Extraskeletal myxoid chondrosarcoma,NR4A3,nuclear receptor subfamily 4 group A member 3,9q31.1
209916,Extraskeletal myxoid chondrosarcoma,TAF15,TATA-box binding protein associated factor 15,17q12
209370,MECP2-related severe neonatal encephalopathy,MECP2,methyl-CpG binding protein 2,Xq28
209867,Autosomal dominant rhegmatogenous retinal detachment,COL2A1,collagen type II alpha 1 chain,12q13.11
210571,Dystonia 16,PRKRA,protein activator of interferon induced protein kinase EIF2AK2,2q31.2
3286,Catecholaminergic polymorphic ventricular tachycardia,CASQ2,calsequestrin 2,1p13.1
3286,Catecholaminergic polymorphic ventricular tachycardia,TRDN,triadin,6q22.31
3286,Catecholaminergic polymorphic ventricular tachycardia,RYR2,ryanodine receptor 2,1q43
3286,Catecholaminergic polymorphic ventricular tachycardia,CALM1,calmodulin 1,14q32.11
3286,Catecholaminergic polymorphic ventricular tachycardia,CALM2,calmodulin 2,2p21
3286,Catecholaminergic polymorphic ventricular tachycardia,CALM3,calmodulin 3,19q13.32
3286,Catecholaminergic polymorphic ventricular tachycardia,TECRL,"trans-2,3-enoyl-CoA reductase like",4q13.1
210548,Macrocephaly-intellectual disability-autism syndrome,PTEN,phosphatase and tensin homolog,10q23.31
210548,Macrocephaly-intellectual disability-autism syndrome,HEPACAM,hepatic and glial cell adhesion molecule,11q24.2
210159,Adult hepatocellular carcinoma,AXIN1,axin 1,16p13.3
210159,Adult hepatocellular carcinoma,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
210159,Adult hepatocellular carcinoma,CASP8,caspase 8,2q33.1
210159,Adult hepatocellular carcinoma,TP53,tumor protein p53,17p13.1
210159,Adult hepatocellular carcinoma,PDGFRL,platelet derived growth factor receptor like,8p22
210159,Adult hepatocellular carcinoma,CTNNB1,catenin beta 1,3p22.1
210159,Adult hepatocellular carcinoma,TSC2,TSC complex subunit 2,16p13.3
210159,Adult hepatocellular carcinoma,TSC1,TSC complex subunit 1,9q34.13
210159,Adult hepatocellular carcinoma,EGF,epidermal growth factor,4q25
210163,"Congenital lethal myopathy, Compton-North type",CNTN1,contactin 1,12q12
3240,Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome,KARS1,lysyl-tRNA synthetase 1,16q23.1
210141,Inherited congenital spastic tetraplegia,KANK1,KN motif and ankyrin repeat domains 1,9p24.3
210141,Inherited congenital spastic tetraplegia,GAD1,glutamate decarboxylase 1,2q31.1
210141,Inherited congenital spastic tetraplegia,ADD3,adducin 3,10q25.1-q25.2
210144,"Lethal polymalformative syndrome, Boissel type",FTO,FTO alpha-ketoglutarate dependent dioxygenase,16q12.2
1063,Tufted angioma,GNA14,G protein subunit alpha 14,9q21.2
211067,Episodic ataxia type 5,CACNB4,calcium voltage-gated channel auxiliary subunit beta 4,2q23.3
211017,Spinocerebellar ataxia type 30,SCA30,spinocerebellar ataxia 30,4q34.3-q35.1
656,Hereditary steroid-resistant nephrotic syndrome,MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",7q21.11
656,Hereditary steroid-resistant nephrotic syndrome,AVIL,advillin,12q14.1
656,Hereditary steroid-resistant nephrotic syndrome,DAAM2,dishevelled associated activator of morphogenesis 2,6p21.2
656,Hereditary steroid-resistant nephrotic syndrome,KANK2,KN motif and ankyrin repeat domains 2,19p13.2
656,Hereditary steroid-resistant nephrotic syndrome,LAMA5,laminin subunit alpha 5,20q13.33
656,Hereditary steroid-resistant nephrotic syndrome,ACTN4,actinin alpha 4,19q13.2
656,Hereditary steroid-resistant nephrotic syndrome,TRPC6,transient receptor potential cation channel subfamily C member 6,11q22.1
656,Hereditary steroid-resistant nephrotic syndrome,WT1,WT1 transcription factor,11p13
656,Hereditary steroid-resistant nephrotic syndrome,COL4A3,collagen type IV alpha 3 chain,2q36.3
656,Hereditary steroid-resistant nephrotic syndrome,NPHS1,"NPHS1 adhesion molecule, nephrin",19q13.12
656,Hereditary steroid-resistant nephrotic syndrome,NPHS2,"NPHS2 stomatin family member, podocin",1q25.2
656,Hereditary steroid-resistant nephrotic syndrome,PAX2,paired box 2,10q24.31
656,Hereditary steroid-resistant nephrotic syndrome,PLCE1,phospholipase C epsilon 1,10q23.33
656,Hereditary steroid-resistant nephrotic syndrome,INF2,"inverted formin, FH2 and WH2 domain containing",14q32.33
656,Hereditary steroid-resistant nephrotic syndrome,CD2AP,CD2 associated protein,6p12.3
656,Hereditary steroid-resistant nephrotic syndrome,MYO1E,myosin IE,15q22.2
656,Hereditary steroid-resistant nephrotic syndrome,PTPRO,protein tyrosine phosphatase receptor type O,12p12.3
656,Hereditary steroid-resistant nephrotic syndrome,ARHGAP24,Rho GTPase activating protein 24,4q21.23-q21.3
656,Hereditary steroid-resistant nephrotic syndrome,COQ8B,coenzyme Q8B,19q13.2
656,Hereditary steroid-resistant nephrotic syndrome,ANLN,"anillin, actin binding protein",7p14.2
656,Hereditary steroid-resistant nephrotic syndrome,CRB2,crumbs cell polarity complex component 2,9q33.3
656,Hereditary steroid-resistant nephrotic syndrome,NUP107,nucleoporin 107,12q15
656,Hereditary steroid-resistant nephrotic syndrome,NUP93,nucleoporin 93,16q13
656,Hereditary steroid-resistant nephrotic syndrome,NUP205,nucleoporin 205,7q33
656,Hereditary steroid-resistant nephrotic syndrome,GAPVD1,GTPase activating protein and VPS9 domains 1,9q33.3
656,Hereditary steroid-resistant nephrotic syndrome,NUP85,nucleoporin 85,17q25.1
656,Hereditary steroid-resistant nephrotic syndrome,NUP37,nucleoporin 37,12q23.2
656,Hereditary steroid-resistant nephrotic syndrome,NUP160,nucleoporin 160,11p11.2
656,Hereditary steroid-resistant nephrotic syndrome,NUP133,nucleoporin 133,1q42.13
656,Hereditary steroid-resistant nephrotic syndrome,TBC1D8B,TBC1 domain family member 8B,Xq22.3
656,Hereditary steroid-resistant nephrotic syndrome,ANKFY1,ankyrin repeat and FYVE domain containing 1,17p13.2
656,Hereditary steroid-resistant nephrotic syndrome,EMP2,epithelial membrane protein 2,16p13.13
656,Hereditary steroid-resistant nephrotic syndrome,ARHGDIA,Rho GDP dissociation inhibitor alpha,17q25.3
656,Hereditary steroid-resistant nephrotic syndrome,APOL1,apolipoprotein L1,22q12.3
2122,Kaposiform hemangioendothelioma,GNA14,G protein subunit alpha 14,9q21.2
2591,Infantile myofibromatosis,NOTCH3,notch receptor 3,19p13.12
2591,Infantile myofibromatosis,PDGFRB,platelet derived growth factor receptor beta,5q32
35,Propionic acidemia,PCCA,propionyl-CoA carboxylase subunit alpha,13q32.3
35,Propionic acidemia,PCCB,propionyl-CoA carboxylase subunit beta,3q22.3
663,Mitochondrial DNA-related progressive external ophthalmoplegia,MT-TS1,mitochondrially encoded tRNA-Ser (UCN) 1,mitochondria
663,Mitochondrial DNA-related progressive external ophthalmoplegia,MT-TL2,mitochondrially encoded tRNA-Leu (CUN) 2,mitochondria
663,Mitochondrial DNA-related progressive external ophthalmoplegia,MT-TN,mitochondrially encoded tRNA-Asn (AAU/C),mitochondria
663,Mitochondrial DNA-related progressive external ophthalmoplegia,MT-TL1,mitochondrially encoded tRNA-Leu (UUA/G) 1,mitochondria
220,Denys-Drash syndrome,WT1,WT1 transcription factor,11p13
5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,HADHA,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha,2p23.3
25,Glutaryl-CoA dehydrogenase deficiency,GCDH,glutaryl-CoA dehydrogenase,19p13.13
618,Familial melanoma,CDK4,cyclin dependent kinase 4,12q14.1
618,Familial melanoma,CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
618,Familial melanoma,MITF,melanocyte inducing transcription factor,3p13
618,Familial melanoma,TERT,telomerase reverse transcriptase,5p15.33
618,Familial melanoma,MC1R,melanocortin 1 receptor,16q24.3
618,Familial melanoma,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
618,Familial melanoma,CDKN2B,cyclin dependent kinase inhibitor 2B,9p21.3
618,Familial melanoma,MGMT,O-6-methylguanine-DNA methyltransferase,10q26.3
618,Familial melanoma,POT1,protection of telomeres 1,7q31.33
618,Familial melanoma,ACD,ACD shelterin complex subunit and telomerase recruitment factor,16q22.1
618,Familial melanoma,TERF2IP,TERF2 interacting protein,16q23.1
818,Smith-Lemli-Opitz syndrome,DHCR7,7-dehydrocholesterol reductase,11q13.4
213504,Adenocarcinoma of ovary,INHBA,inhibin subunit beta A,7p14.1
175,Cartilage-hair hypoplasia,RMRP,RNA component of mitochondrial RNA processing endoribonuclease,9p13.3
42,Medium chain acyl-CoA dehydrogenase deficiency,ACADM,acyl-CoA dehydrogenase medium chain,1p31.1
2066,Gamma-aminobutyric acid transaminase deficiency,ABAT,4-aminobutyrate aminotransferase,16p13.2
300,Bifunctional enzyme deficiency,HSD17B4,hydroxysteroid 17-beta dehydrogenase 4,5q23.1
300,Bifunctional enzyme deficiency,EHHADH,enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase,3q27.2
213726,Serous carcinoma of the corpus uteri,ERBB2,erb-b2 receptor tyrosine kinase 2,17q12
213711,Endometrial stromal sarcoma,YWHAE,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,17p13.3
213711,Endometrial stromal sarcoma,JAZF1,JAZF zinc finger 1,7p15.2-p15.1
213711,Endometrial stromal sarcoma,SUZ12,SUZ12 polycomb repressive complex 2 subunit,17q11.2
213711,Endometrial stromal sarcoma,NUTM2A,NUT family member 2A,10q23.2
213711,Endometrial stromal sarcoma,NUTM2B,NUT family member 2B,10q22.3
3261,Autoimmune lymphoproliferative syndrome,CASP10,caspase 10,2q33.1
3261,Autoimmune lymphoproliferative syndrome,FAS,Fas cell surface death receptor,10q23.31
3261,Autoimmune lymphoproliferative syndrome,FAS,Fas cell surface death receptor,10q23.31
3261,Autoimmune lymphoproliferative syndrome,FASLG,Fas ligand,1q24.3
2849,Perlman syndrome,DIS3L2,DIS3 like 3'-5' exoribonuclease 2,2q37.1
747,Autoimmune pulmonary alveolar proteinosis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
2953,Musculocontractural Ehlers-Danlos syndrome,CHST14,carbohydrate sulfotransferase 14,15q15.1
2953,Musculocontractural Ehlers-Danlos syndrome,DSE,dermatan sulfate epimerase,6q22.1
782,Axenfeld-Rieger syndrome,PITX2,paired like homeodomain 2,4q25
782,Axenfeld-Rieger syndrome,PITX2,paired like homeodomain 2,4q25
782,Axenfeld-Rieger syndrome,FOXC1,forkhead box C1,6p25.3
216718,Isolated congenitally uncorrected transposition of the great arteries,ZIC3,Zic family member 3,Xq26.3
216718,Isolated congenitally uncorrected transposition of the great arteries,GDF1,growth differentiation factor 1,19p13.11
216718,Isolated congenitally uncorrected transposition of the great arteries,MED13L,mediator complex subunit 13L,12q24.21
216718,Isolated congenitally uncorrected transposition of the great arteries,CFC1,"cryptic, EGF-CFC family member 1",2q21.1
216729,Congenitally uncorrected transposition of the great arteries with cardiac malformation,CFC1,"cryptic, EGF-CFC family member 1",2q21.1
882,Tyrosinemia type 1,FAH,fumarylacetoacetate hydrolase,15q25.1
216796,Osteogenesis imperfecta type 1,P4HB,prolyl 4-hydroxylase subunit beta,17q25.3
216796,Osteogenesis imperfecta type 1,SEC24D,"SEC24 homolog D, COPII coat complex component",4q26
216796,Osteogenesis imperfecta type 1,COL1A1,collagen type I alpha 1 chain,17q21.33
216796,Osteogenesis imperfecta type 1,COL1A2,collagen type I alpha 2 chain,7q21.3
216796,Osteogenesis imperfecta type 1,MBTPS2,"membrane bound transcription factor peptidase, site 2",Xp22.12
216804,Osteogenesis imperfecta type 2,COL1A1,collagen type I alpha 1 chain,17q21.33
216804,Osteogenesis imperfecta type 2,COL1A2,collagen type I alpha 2 chain,7q21.3
216804,Osteogenesis imperfecta type 2,P3H1,prolyl 3-hydroxylase 1,1p34.2
216804,Osteogenesis imperfecta type 2,CRTAP,cartilage associated protein,3p22.3
216804,Osteogenesis imperfecta type 2,PPIB,peptidylprolyl isomerase B,15q22.31
216804,Osteogenesis imperfecta type 2,MESD,mesoderm development LRP chaperone,15q25.1
216812,Osteogenesis imperfecta type 3,MBTPS2,"membrane bound transcription factor peptidase, site 2",Xp22.12
216812,Osteogenesis imperfecta type 3,COL1A1,collagen type I alpha 1 chain,17q21.33
216812,Osteogenesis imperfecta type 3,COL1A2,collagen type I alpha 2 chain,7q21.3
216812,Osteogenesis imperfecta type 3,P3H1,prolyl 3-hydroxylase 1,1p34.2
216812,Osteogenesis imperfecta type 3,CRTAP,cartilage associated protein,3p22.3
216812,Osteogenesis imperfecta type 3,CREB3L1,cAMP responsive element binding protein 3 like 1,11p11.2
216812,Osteogenesis imperfecta type 3,PPIB,peptidylprolyl isomerase B,15q22.31
216812,Osteogenesis imperfecta type 3,SERPINH1,serpin family H member 1,11q13.5
216812,Osteogenesis imperfecta type 3,FKBP10,FKBP prolyl isomerase 10,17q21.2
216812,Osteogenesis imperfecta type 3,SERPINF1,serpin family F member 1,17p13.3
216812,Osteogenesis imperfecta type 3,WNT1,Wnt family member 1,12q13.12
216812,Osteogenesis imperfecta type 3,TENT5A,terminal nucleotidyltransferase 5A,6q14.1
216812,Osteogenesis imperfecta type 3,BMP1,bone morphogenetic protein 1,8p21.3
216820,Osteogenesis imperfecta type 4,MBTPS2,"membrane bound transcription factor peptidase, site 2",Xp22.12
216820,Osteogenesis imperfecta type 4,TMEM38B,transmembrane protein 38B,9q31.2
216820,Osteogenesis imperfecta type 4,COL1A1,collagen type I alpha 1 chain,17q21.33
216820,Osteogenesis imperfecta type 4,COL1A2,collagen type I alpha 2 chain,7q21.3
216820,Osteogenesis imperfecta type 4,CRTAP,cartilage associated protein,3p22.3
216820,Osteogenesis imperfecta type 4,PPIB,peptidylprolyl isomerase B,15q22.31
216820,Osteogenesis imperfecta type 4,FKBP10,FKBP prolyl isomerase 10,17q21.2
216820,Osteogenesis imperfecta type 4,SP7,Sp7 transcription factor,12q13.13
216820,Osteogenesis imperfecta type 4,SERPINF1,serpin family F member 1,17p13.3
216820,Osteogenesis imperfecta type 4,WNT1,Wnt family member 1,12q13.12
216820,Osteogenesis imperfecta type 4,SPARC,secreted protein acidic and cysteine rich,5q33.1
216828,Osteogenesis imperfecta type 5,IFITM5,interferon induced transmembrane protein 5,11p15.5
3474,CHIME syndrome,PIGL,phosphatidylinositol glycan anchor biosynthesis class L,17p11.2
216866,Classic pantothenate kinase-associated neurodegeneration,PANK2,pantothenate kinase 2,20p13
216873,Atypical pantothenate kinase-associated neurodegeneration,PANK2,pantothenate kinase 2,20p13
216972,"Niemann-Pick disease type C, severe perinatal form",NPC1,NPC intracellular cholesterol transporter 1,18q11.2
216972,"Niemann-Pick disease type C, severe perinatal form",NPC2,NPC intracellular cholesterol transporter 2,14q24.3
216978,"Niemann-Pick disease type C, late infantile neurologic onset",NPC1,NPC intracellular cholesterol transporter 1,18q11.2
216978,"Niemann-Pick disease type C, late infantile neurologic onset",NPC2,NPC intracellular cholesterol transporter 2,14q24.3
361,Familial glucocorticoid deficiency,STAR,steroidogenic acute regulatory protein,8p11.23
361,Familial glucocorticoid deficiency,MC2R,melanocortin 2 receptor,18p11.21
361,Familial glucocorticoid deficiency,MRAP,melanocortin 2 receptor accessory protein,21q22.11
361,Familial glucocorticoid deficiency,TXNRD2,thioredoxin reductase 2,22q11.21
361,Familial glucocorticoid deficiency,NNT,nicotinamide nucleotide transhydrogenase,5p12
216975,"Niemann-Pick disease type C, severe early infantile neurologic onset",NPC1,NPC intracellular cholesterol transporter 1,18q11.2
216975,"Niemann-Pick disease type C, severe early infantile neurologic onset",NPC2,NPC intracellular cholesterol transporter 2,14q24.3
216986,"Niemann-Pick disease type C, adult neurologic onset",NPC1,NPC intracellular cholesterol transporter 1,18q11.2
216986,"Niemann-Pick disease type C, adult neurologic onset",NPC2,NPC intracellular cholesterol transporter 2,14q24.3
216981,"Niemann-Pick disease type C, juvenile neurologic onset",NPC1,NPC intracellular cholesterol transporter 1,18q11.2
216981,"Niemann-Pick disease type C, juvenile neurologic onset",NPC2,NPC intracellular cholesterol transporter 2,14q24.3
217012,Spinocerebellar ataxia type 31,BEAN1,brain expressed associated with NEDD4 1,16q21
2088,Fanconi-Bickel syndrome,SLC2A2,solute carrier family 2 member 2,3q26.2
217266,BNAR syndrome,FREM1,FRAS1 related extracellular matrix 1,9p22.3
179,Birdshot chorioretinopathy,HLA-A,"major histocompatibility complex, class I, A",6p22.1
2584,Classic mycosis fungoides,CTLA4,cytotoxic T-lymphocyte associated protein 4,2q33.2
2584,Classic mycosis fungoides,TNFRSF1B,TNF receptor superfamily member 1B,1p36.22
2584,Classic mycosis fungoides,CD28,CD28 molecule,2q33.2
217093,"Mucopolysaccharidosis type 2, attenuated form",IDS,iduronate 2-sulfatase,Xq28
3162,Sézary syndrome,CTLA4,cytotoxic T-lymphocyte associated protein 4,2q33.2
3162,Sézary syndrome,TNFRSF1B,TNF receptor superfamily member 1B,1p36.22
3162,Sézary syndrome,CD28,CD28 molecule,2q33.2
217085,"Mucopolysaccharidosis type 2, severe form",IDS,iduronate 2-sulfatase,Xq28
1451,CINCA syndrome,NLRP3,NLR family pyrin domain containing 3,1q44
217059,Isolated nail clubbing,HPGD,15-hydroxyprostaglandin dehydrogenase,4q34.1
217055,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A,GDAP1,ganglioside induced differentiation associated protein 1,8q21.11
217335,RIN2 syndrome,RIN2,Ras and Rab interactor 2,20p11.23
2745,Opitz GBBB syndrome,MID1,midline 1,Xp22.2
217330,REN-related autosomal dominant tubulointerstitial kidney disease,REN,renin,1q32.1
1171,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,ATP1A3,ATPase Na+/K+ transporting subunit alpha 3,19q13.2
217566,Chronic respiratory distress with surfactant metabolism deficiency,SFTPC,surfactant protein C,8p21.3
217563,Neonatal acute respiratory distress syndrome,SFTPB,surfactant protein B,2p11.2
217563,Neonatal acute respiratory distress syndrome,ABCA3,ATP binding cassette subfamily A member 3,16p13.3
217407,Hereditary hypotrichosis with recurrent skin vesicles,DSC3,desmocollin 3,18q12.1
217467,Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency,HRG,histidine rich glycoprotein,3q27.3
217390,Combined immunodeficiency due to DOCK8 deficiency,DOCK8,dedicator of cytokinesis 8,9p24.3
217385,17p13.3 microduplication syndrome,PAFAH1B1,platelet activating factor acetylhydrolase 1b regulatory subunit 1,17p13.3
217385,17p13.3 microduplication syndrome,YWHAE,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,17p13.3
217396,Progressive polyneuropathy with bilateral striatal necrosis,SLC25A19,solute carrier family 25 member 19,17q25.1
217371,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,TRMU,tRNA mitochondrial 2-thiouridylase,22q13.31
217382,Neurodegenerative syndrome due to cerebral folate transport deficiency,FOLR1,folate receptor 1,11q13.4
217377,Microduplication Xp11.22p11.23 syndrome,IQSEC2,IQ motif and Sec7 domain ArfGEF 2,Xp11.22
217622,Sensorineural deafness with dilated cardiomyopathy,EYA4,EYA transcriptional coactivator and phosphatase 4,6q23.2
331,Congenital factor XIII deficiency,F13A1,coagulation factor XIII A chain,6p25.1
331,Congenital factor XIII deficiency,F13B,coagulation factor XIII B chain,1q31.3
159,Carnitine-acylcarnitine translocase deficiency,SLC25A20,solute carrier family 25 member 20,3p21.31
79,Congenital alpha2-antiplasmin deficiency,SERPINF2,serpin family F member 2,17p13.3
2157,Histidinemia,HAL,histidine ammonia-lyase,12q23.1
220402,Limited cutaneous systemic sclerosis,CAV1,caveolin 1,7q31.2
220402,Limited cutaneous systemic sclerosis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
220402,Limited cutaneous systemic sclerosis,CCN2,cellular communication network factor 2,6q23.2
220402,Limited cutaneous systemic sclerosis,IRF5,interferon regulatory factor 5,7q32.1
220402,Limited cutaneous systemic sclerosis,KIAA0319L,KIAA0319 like,1p34.3
220402,Limited cutaneous systemic sclerosis,CCR6,C-C motif chemokine receptor 6,6q27
3124,Saccharopinuria,AASS,aminoadipate-semialdehyde synthase,7q31.32
220407,Limited systemic sclerosis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
220386,Semilobar holoprosencephaly,STAG2,STAG2 cohesin complex component,Xq25
220386,Semilobar holoprosencephaly,FGFR1,fibroblast growth factor receptor 1,8p11.23
220386,Semilobar holoprosencephaly,SMC1A,structural maintenance of chromosomes 1A,Xp11.22
220386,Semilobar holoprosencephaly,STIL,STIL centriolar assembly protein,1p33
220386,Semilobar holoprosencephaly,PTCH1,patched 1,9q22.32
220386,Semilobar holoprosencephaly,SHH,sonic hedgehog signaling molecule,7q36.3
220386,Semilobar holoprosencephaly,SIX3,SIX homeobox 3,2p21
220386,Semilobar holoprosencephaly,TGIF1,TGFB induced factor homeobox 1,18p11.31
220386,Semilobar holoprosencephaly,ZIC2,Zic family member 2,13q32.3
220386,Semilobar holoprosencephaly,GLI2,GLI family zinc finger 2,2q14.2
220386,Semilobar holoprosencephaly,CRIPTO,"cripto, EGF-CFC family member",3p21.31
220386,Semilobar holoprosencephaly,FOXH1,forkhead box H1,8q24.3
220386,Semilobar holoprosencephaly,FGF8,fibroblast growth factor 8,10q24.32
220386,Semilobar holoprosencephaly,DISP1,dispatched RND transporter family member 1,1q41
220386,Semilobar holoprosencephaly,CDON,"cell adhesion associated, oncogene regulated",11q24.2
220386,Semilobar holoprosencephaly,NODAL,nodal growth differentiation factor,10q22.1
220386,Semilobar holoprosencephaly,DLL1,delta like canonical Notch ligand 1,6q27
220386,Semilobar holoprosencephaly,GAS1,growth arrest specific 1,9q21.33
2203,Hyperlysinemia,AASS,aminoadipate-semialdehyde synthase,7q31.32
220393,Diffuse cutaneous systemic sclerosis,CAV1,caveolin 1,7q31.2
220393,Diffuse cutaneous systemic sclerosis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
220393,Diffuse cutaneous systemic sclerosis,CCN2,cellular communication network factor 2,6q23.2
220393,Diffuse cutaneous systemic sclerosis,IRF5,interferon regulatory factor 5,7q32.1
220393,Diffuse cutaneous systemic sclerosis,CCR6,C-C motif chemokine receptor 6,6q27
332,Congenital intrinsic factor deficiency,CBLIF,cobalamin binding intrinsic factor,11q12.1
220436,Quebec platelet disorder,PLAU,"plasminogen activator, urokinase",10q22.2
2195,Dicarboxylic aminoaciduria,SLC1A1,solute carrier family 1 member 1,9p24.2
220443,Bleeding diathesis due to thromboxane synthesis deficiency,TBXA2R,thromboxane A2 receptor,19p13.3
2170,Methylcobalamin deficiency type cblG,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,1q43
220295,Xeroderma pigmentosum-Cockayne syndrome complex,ERCC5,"ERCC excision repair 5, endonuclease",13q33.1
220295,Xeroderma pigmentosum-Cockayne syndrome complex,ERCC4,"ERCC excision repair 4, endonuclease catalytic subunit",16p13.12
220295,Xeroderma pigmentosum-Cockayne syndrome complex,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19q13.32
220295,Xeroderma pigmentosum-Cockayne syndrome complex,ERCC3,"ERCC excision repair 3, TFIIH core complex helicase subunit",2q14.3
414,Gyrate atrophy of choroid and retina,OAT,ornithine aminotransferase,10q26.13
927,Hyperammonemia due to N-acetylglutamate synthase deficiency,NAGS,N-acetylglutamate synthase,17q21.31
2880,Phosphoenolpyruvate carboxykinase deficiency,PCK1,phosphoenolpyruvate carboxykinase 1,20q13.31
2880,Phosphoenolpyruvate carboxykinase deficiency,PCK2,"phosphoenolpyruvate carboxykinase 2, mitochondrial",14q11.2-q12
941,D-glyceric aciduria,GLYCTK,glycerate kinase,3p21.2
220465,Laron syndrome with immunodeficiency,STAT5B,signal transducer and activator of transcription 5B,17q21.2
220460,Attenuated familial adenomatous polyposis,APC,APC regulator of WNT signaling pathway,5q22.2
2843,Pentosuria,DCXR,dicarbonyl and L-xylulose reductase,17q25.3
220497,Joubert syndrome with renal defect,NPHP1,nephrocystin 1,2q13
220497,Joubert syndrome with renal defect,RPGRIP1L,RPGRIP1 like,16q12.2
220497,Joubert syndrome with renal defect,TMEM237,transmembrane protein 237,2q33.1
212,Cystathioninuria,CTH,cystathionine gamma-lyase,1p31.1
220493,Joubert syndrome with ocular defect,AHI1,Abelson helper integration site 1,6q23.3
220493,Joubert syndrome with ocular defect,MKS1,MKS transition zone complex subunit 1,17q22
220493,Joubert syndrome with ocular defect,INPP5E,inositol polyphosphate-5-phosphatase E,9q34.3
220493,Joubert syndrome with ocular defect,CEP41,centrosomal protein 41,7q32.2
220493,Joubert syndrome with ocular defect,CEP120,centrosomal protein 120,5q23.2
470,Lysinuric protein intolerance,SLC7A7,solute carrier family 7 member 7,14q11.2
145,Hereditary breast and/or ovarian cancer syndrome,PTEN,phosphatase and tensin homolog,10q23.31
145,Hereditary breast and/or ovarian cancer syndrome,RAD51,RAD51 recombinase,15q15.1
145,Hereditary breast and/or ovarian cancer syndrome,BRCA2,BRCA2 DNA repair associated,13q13.1
145,Hereditary breast and/or ovarian cancer syndrome,BRIP1,BRCA1 interacting DNA helicase 1,17q23.2
145,Hereditary breast and/or ovarian cancer syndrome,CHEK2,checkpoint kinase 2,22q12.1
145,Hereditary breast and/or ovarian cancer syndrome,TP53,tumor protein p53,17p13.1
145,Hereditary breast and/or ovarian cancer syndrome,MRE11,"MRE11 homolog, double strand break repair nuclease",11q21
145,Hereditary breast and/or ovarian cancer syndrome,NBN,nibrin,8q21.3
145,Hereditary breast and/or ovarian cancer syndrome,PALB2,partner and localizer of BRCA2,16p12.2
145,Hereditary breast and/or ovarian cancer syndrome,BARD1,BRCA1 associated RING domain 1,2q35
145,Hereditary breast and/or ovarian cancer syndrome,RAD51C,RAD51 paralog C,17q22
145,Hereditary breast and/or ovarian cancer syndrome,RAD50,RAD50 double strand break repair protein,5q31.1
145,Hereditary breast and/or ovarian cancer syndrome,RAD51D,RAD51 paralog D,17q12
145,Hereditary breast and/or ovarian cancer syndrome,BRCA1,BRCA1 DNA repair associated,17q21.31
2965,Prolactinoma,CDH23,cadherin related 23,10q22.1
2965,Prolactinoma,MEN1,menin 1,11q13
2965,Prolactinoma,AIP,AHR interacting HSP90 co-chaperone,11q13.2
538,Lymphangioleiomyomatosis,TSC1,TSC complex subunit 1,9q34.13
538,Lymphangioleiomyomatosis,TSC2,TSC complex subunit 2,16p13.3
1578,Pterin-4 alpha-carbinolamine dehydratase deficiency,PCBD1,pterin-4 alpha-carbinolamine dehydratase 1,10q22.1
3208,Isolated succinate-CoQ reductase deficiency,SDHA,succinate dehydrogenase complex flavoprotein subunit A,5p15.33
3208,Isolated succinate-CoQ reductase deficiency,SDHB,succinate dehydrogenase complex iron sulfur subunit B,1p36.13
3208,Isolated succinate-CoQ reductase deficiency,SDHD,succinate dehydrogenase complex subunit D,11q23.1
3208,Isolated succinate-CoQ reductase deficiency,SDHAF1,succinate dehydrogenase complex assembly factor 1,19q13.12
221008,Rothmund-Thomson syndrome type 1,ANAPC1,anaphase promoting complex subunit 1,2q13
24,Fumaric aciduria,FH,fumarate hydratase,1q43
221016,Rothmund-Thomson syndrome type 2,RECQL4,RecQ like helicase 4,8q24.3
1561,Fatal infantile cytochrome C oxidase deficiency,SCO1,synthesis of cytochrome C oxidase 1,17p13.1
1561,Fatal infantile cytochrome C oxidase deficiency,SCO2,synthesis of cytochrome C oxidase 2,22q13.33
1561,Fatal infantile cytochrome C oxidase deficiency,COX15,cytochrome c oxidase assembly homolog COX15,10q24.2
1561,Fatal infantile cytochrome C oxidase deficiency,COA5,cytochrome c oxidase assembly factor 5,2q11.2
1561,Fatal infantile cytochrome C oxidase deficiency,COA6,cytochrome c oxidase assembly factor 6,1q42.2
1460,Isolated complex III deficiency,BCS1L,"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone",2q35
1460,Isolated complex III deficiency,MT-CYB,mitochondrially encoded cytochrome b,mitochondria
1460,Isolated complex III deficiency,UQCRQ,ubiquinol-cytochrome c reductase complex III subunit VII,5q31.1
1460,Isolated complex III deficiency,UQCRB,ubiquinol-cytochrome c reductase binding protein,8q22.1
1460,Isolated complex III deficiency,TTC19,tetratricopeptide repeat domain 19,17p12
1460,Isolated complex III deficiency,UQCRC2,ubiquinol-cytochrome c reductase core protein 2,16p12.2
1460,Isolated complex III deficiency,CYC1,cytochrome c1,8q24.3
1460,Isolated complex III deficiency,LYRM7,LYR motif containing 7,5q23.3-q31.1
1460,Isolated complex III deficiency,UQCC2,ubiquinol-cytochrome c reductase complex assembly factor 2,6p21.31
1460,Isolated complex III deficiency,UQCC3,ubiquinol-cytochrome c reductase complex assembly factor 3,11q12.3
1460,Isolated complex III deficiency,UQCRFS1,"ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1",19q12
851,Paris-Trousseau thrombocytopenia,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",11q24.3
221043,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome,FAM111B,FAM111 trypsin like peptidase B,11q12.1
221046,Poikiloderma with neutropenia,USB1,U6 snRNA biogenesis phosphodiesterase 1,16q21
745,Severe hereditary thrombophilia due to congenital protein C deficiency,PROC,"protein C, inactivator of coagulation factors Va and VIIIa",2q14.3
221061,Familial cerebral cavernous malformation,CCM2,CCM2 scaffold protein,7p13
221061,Familial cerebral cavernous malformation,KRIT1,KRIT1 ankyrin repeat containing,7q21.2
221061,Familial cerebral cavernous malformation,PDCD10,programmed cell death 10,3q26.1
221061,Familial cerebral cavernous malformation,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
849,Glanzmann thrombasthenia,ITGA2B,integrin subunit alpha 2b,17q21.31
849,Glanzmann thrombasthenia,ITGB3,integrin subunit beta 3,17q21.32
225154,Familial infantile bilateral striatal necrosis,NUP54,nucleoporin 54,4q21.1
225154,Familial infantile bilateral striatal necrosis,ADAR,adenosine deaminase RNA specific,1q21.3
225154,Familial infantile bilateral striatal necrosis,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,mitochondria
225154,Familial infantile bilateral striatal necrosis,NUP62,nucleoporin 62,19q13.33
225123,TFR2-related hemochromatosis,TFR2,transferrin receptor 2,7q22.1
221126,Fowler vasculopathy,FLVCR2,FLVCR choline and putative heme transporter 2,14q24.3
221139,Combined immunodeficiency with facio-oculo-skeletal anomalies,KNSTRN,kinetochore localized astrin (SPAG5) binding protein,15q15.1
221139,Combined immunodeficiency with facio-oculo-skeletal anomalies,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",1p36.22
221145,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",LTBP4,latent transforming growth factor beta binding protein 4,19q13.2
221145,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",LTBP4,latent transforming growth factor beta binding protein 4,19q13.2
228003,Severe combined immunodeficiency due to CORO1A deficiency,CORO1A,coronin 1A,16p11.2
228000,Idiopathic CD4 lymphocytopenia,UNC119,unc-119 lipid binding chaperone,17q11.2
842,Testicular seminomatous germ cell tumor,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
227976,"Autosomal recessive optic atrophy, OPA7 type",TMEM126A,transmembrane protein 126A,11q14.1
227796,Fundus albipunctatus,PRPH2,peripherin 2,6p21.1
227796,Fundus albipunctatus,RDH5,retinol dehydrogenase 5,12q13.2
227796,Fundus albipunctatus,RLBP1,retinaldehyde binding protein 1,15q26.1
389,Langerhans cell histiocytosis,MAP2K1,mitogen-activated protein kinase kinase 1,15q22.31
389,Langerhans cell histiocytosis,NRAS,"NRAS proto-oncogene, GTPase",1p13.2
389,Langerhans cell histiocytosis,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
228012,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,MYO6,myosin VI,6q14.1
543,Burkitt lymphoma,MYC,"MYC proto-oncogene, bHLH transcription factor",8q24.21
319,Skeletal Ewing sarcoma,ERG,ETS transcription factor ERG,21q22.2
319,Skeletal Ewing sarcoma,ETV1,ETS variant transcription factor 1,7p21.2
319,Skeletal Ewing sarcoma,EWSR1,EWS RNA binding protein 1,22q12.2
319,Skeletal Ewing sarcoma,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",11q24.3
319,Skeletal Ewing sarcoma,ETV4,ETS variant transcription factor 4,17q21.31
227535,Hereditary breast cancer,NQO2,N-ribosyldihydronicotinamide:quinone dehydrogenase 2,6p25.2
227535,Hereditary breast cancer,ATM,ATM serine/threonine kinase,11q22.3
227535,Hereditary breast cancer,CDH1,cadherin 1,16q22.1
227535,Hereditary breast cancer,BRCA1,BRCA1 DNA repair associated,17q21.31
227535,Hereditary breast cancer,BRCA2,BRCA2 DNA repair associated,13q13.1
227535,Hereditary breast cancer,PALB2,partner and localizer of BRCA2,16p12.2
227535,Hereditary breast cancer,XRCC2,X-ray repair cross complementing 2,7q36.1
227535,Hereditary breast cancer,KLLN,"killin, p53 regulated DNA replication inhibitor",10q23
227535,Hereditary breast cancer,RAD54L,RAD54 like,1p34.1
227535,Hereditary breast cancer,SLC67A1,solute carrier family 67 member 1,11p15.4
668,Osteosarcoma,CHEK2,checkpoint kinase 2,22q12.1
668,Osteosarcoma,RB1,RB transcriptional corepressor 1,13q14.2
668,Osteosarcoma,TP53,tumor protein p53,17p13.1
668,Osteosarcoma,TP53,tumor protein p53,17p13.1
227510,"Multiple system atrophy, cerebellar type",COQ2,"coenzyme Q2, polyprenyltransferase",4q21.23
2030,Fibrosarcoma,ETV6,ETS variant transcription factor 6,12p13.2
2030,Fibrosarcoma,NTRK3,neurotrophic receptor tyrosine kinase 3,15q25.3
2126,Solitary fibrous tumor,STAT6,signal transducer and activator of transcription 6,12q13.3
2126,Solitary fibrous tumor,NAB2,NGFI-A binding protein 2,12q13.3
758,Pseudoxanthoma elasticum,ABCC6,ATP binding cassette subfamily C member 6,16p13.11
758,Pseudoxanthoma elasticum,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,6q23.2
419,Hyperprolinemia type 1,PRODH,proline dehydrogenase 1,22q11.21
1501,Adrenocortical carcinoma,TP53,tumor protein p53,17p13.1
1501,Adrenocortical carcinoma,TP53,tumor protein p53,17p13.1
1501,Adrenocortical carcinoma,ZNRF3,zinc and ring finger 3,22q12.1
1501,Adrenocortical carcinoma,CTNNB1,catenin beta 1,3p22.1
1501,Adrenocortical carcinoma,CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
1501,Adrenocortical carcinoma,TERT,telomerase reverse transcriptase,5p15.33
1501,Adrenocortical carcinoma,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,17q24.2
226316,Genetic transient congenital hypothyroidism,DUOX2,dual oxidase 2,15q21.1
226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,POU1F1,POU class 1 homeobox 1,3p11.2
226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,PROP1,PROP paired-like homeobox 1,5q35.3
226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,HESX1,HESX homeobox 1,3p14.3
226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,LHX3,LIM homeobox 3,9q34.3
226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,LHX4,LIM homeobox 4,1q25.2
3273,Synovial sarcoma,SS18,SS18 subunit of BAF chromatin remodeling complex,18q11.2
3273,Synovial sarcoma,SSX1,SSX family member 1,Xp11.23
3273,Synovial sarcoma,SSX2,SSX family member 2,Xp11.22
503,Larsen syndrome,FLNB,filamin B,3p14.3
2478,Megalencephalic leukoencephalopathy with subcortical cysts,MLC1,modulator of VRAC current 1,22q13.33
2478,Megalencephalic leukoencephalopathy with subcortical cysts,HEPACAM,hepatic and glial cell adhesion molecule,11q24.2
3337,Primary Fanconi renotubular syndrome,EHHADH,enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase,3q27.2
3337,Primary Fanconi renotubular syndrome,GATM,glycine amidinotransferase,15q21.1
3337,Primary Fanconi renotubular syndrome,SLC34A1,solute carrier family 34 member 1,5q35.3
3337,Primary Fanconi renotubular syndrome,NDUFAF6,NADH:ubiquinone oxidoreductase complex assembly factor 6,8q22.1
223,Arginine vasopressin resistance,AVPR2,arginine vasopressin receptor 2,Xq28
223,Arginine vasopressin resistance,AQP2,aquaporin 2,12q13.12
228423,GATA2 deficiency spectrum,GATA2,GATA binding protein 2,3q21.3
521,Chronic myeloid leukemia,BCR,BCR activator of RhoGEF and GTPase,22q11.23
521,Chronic myeloid leukemia,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",9q34.12
521,Chronic myeloid leukemia,RUNX1,RUNX family transcription factor 1,21q22.12
228415,5q35 microduplication syndrome,NSD1,nuclear receptor binding SET domain protein 1,5q35.3
132,Hereditary butyrylcholinesterase deficiency,BCHE,butyrylcholinesterase,3q26.1
228426,Syndromic multisystem autoimmune disease due to Itch deficiency,ITCH,itchy E3 ubiquitin protein ligase,20q11.22
2345,Isolated Klippel-Feil syndrome,GDF3,growth differentiation factor 3,12p13.31
2345,Isolated Klippel-Feil syndrome,MEOX1,mesenchyme homeobox 1,17q21.31
2345,Isolated Klippel-Feil syndrome,GDF6,growth differentiation factor 6,8q22.1
1333,Familial pancreatic carcinoma,BRCA1,BRCA1 DNA repair associated,17q21.31
1333,Familial pancreatic carcinoma,BRCA2,BRCA2 DNA repair associated,13q13.1
1333,Familial pancreatic carcinoma,CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
1333,Familial pancreatic carcinoma,SMAD4,SMAD family member 4,18q21.2
1333,Familial pancreatic carcinoma,TP53,tumor protein p53,17p13.1
1333,Familial pancreatic carcinoma,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
1333,Familial pancreatic carcinoma,PALB2,partner and localizer of BRCA2,16p12.2
1333,Familial pancreatic carcinoma,PALLD,"palladin, cytoskeletal associated protein",4q32.3
1333,Familial pancreatic carcinoma,RABL3,"RAB, member of RAS oncogene family like 3",3q13.33
228429,Congenital generalized  lipodystrophy type 4,CAVIN1,caveolae associated protein 1,17q21.2
228387,Spondylo-megaepiphyseal-metaphyseal dysplasia,NKX3-2,NK3 homeobox 2,4p15.33
228390,Frontonasal dysplasia-alopecia-genital anomalies syndrome,ALX4,ALX homeobox 4,11p11.2
228402,2q23.1 microdeletion syndrome,MBD5,methyl-CpG binding domain protein 5,2q23.1
228366,CLN7 disease,MFSD8,major facilitator superfamily domain containing 8,4q28.2
228360,CLN5 disease,CLN5,CLN5 intracellular trafficking protein,13q22.3
228384,5q14.3 microdeletion syndrome,MEF2C,myocyte enhancer factor 2C,5q14.3
228374,Charcot-Marie-Tooth disease type 2B5,NEFL,neurofilament light chain,8p21.2
228343,CLN4 disease,DNAJC5,DnaJ heat shock protein family (Hsp40) member C5,20q13.33
228302,"Carnitine palmitoyl transferase II deficiency, myopathic form",CPT2,carnitine palmitoyltransferase 2,1p32.3
228305,"Carnitine palmitoyl transferase II deficiency, severe infantile form",CPT2,carnitine palmitoyltransferase 2,1p32.3
228308,"Carnitine palmitoyl transferase II deficiency, neonatal form",CPT2,carnitine palmitoyltransferase 2,1p32.3
3203,Overhydrated hereditary stomatocytosis,RHAG,Rh associated glycoprotein,6p12.3
3202,Dehydrated hereditary stomatocytosis,SLC4A1,solute carrier family 4 member 1 (Diego blood group),17q21.31
3202,Dehydrated hereditary stomatocytosis,PIEZO1,piezo type mechanosensitive ion channel component 1 (Er blood group),16q24.3
3202,Dehydrated hereditary stomatocytosis,KCNN4,potassium calcium-activated channel subfamily N member 4,19q13.31
228140,Idiopathic ventricular fibrillation,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
228140,Idiopathic ventricular fibrillation,DPP6,dipeptidyl peptidase like 6,7q36.2
1018,X-linked Alport syndrome-diffuse leiomyomatosis,COL4A6,collagen type IV alpha 6 chain,Xq22.3
1018,X-linked Alport syndrome-diffuse leiomyomatosis,COL4A5,collagen type IV alpha 5 chain,Xq22.3
306,Self-limited infantile epilepsy,SCN8A,sodium voltage-gated channel alpha subunit 8,12q13.13
306,Self-limited infantile epilepsy,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
306,Self-limited infantile epilepsy,KCNQ2,potassium voltage-gated channel subfamily Q member 2,20q13.33
306,Self-limited infantile epilepsy,KCNQ3,potassium voltage-gated channel subfamily Q member 3,8q24.22
306,Self-limited infantile epilepsy,PRRT2,proline rich transmembrane protein 2,16p11.2
328,Congenital factor X deficiency,F10,coagulation factor X,13q34
228174,Autosomal dominant Charcot-Marie-Tooth disease type 2N,AARS1,alanyl-tRNA synthetase 1,16q22.1
228169,Autosomal dominant striatal neurodegeneration,PDE8B,phosphodiesterase 8B,5q13.3
2132,Hemoglobin C disease,HBB,hemoglobin subunit beta,11p15.4
2133,Hemoglobin E disease,HBB,hemoglobin subunit beta,11p15.4
228179,Autosomal dominant Charcot-Marie-Tooth disease type 2M,DNM2,dynamin 2,19p13.2
288,Hereditary elliptocytosis,SPTA1,"spectrin alpha, erythrocytic 1",1q23.1
288,Hereditary elliptocytosis,SPTB,"spectrin beta, erythrocytic",14q23.3
288,Hereditary elliptocytosis,EPB41,erythrocyte membrane protein band 4.1,1p35.3
288,Hereditary elliptocytosis,GYPC,glycophorin C (Gerbich blood group),2q14.3
231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,DTNBP1,dystrobrevin binding protein 1,6p22.3
231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,BLOC1S5,biogenesis of lysosomal organelles complex 1 subunit 5,6p24.3
231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,BLOC1S3,biogenesis of lysosomal organelles complex 1 subunit 3,19q13.32
231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,BLOC1S6,biogenesis of lysosomal organelles complex 1 subunit 6,15q21.1
231512,Hermansky-Pudlak syndrome due to BLOC-2 deficiency,HPS3,HPS3 biogenesis of lysosomal organelles complex 2 subunit 1,3q24
231512,Hermansky-Pudlak syndrome due to BLOC-2 deficiency,HPS5,HPS5 biogenesis of lysosomal organelles complex 2 subunit 2,11p15.1
231512,Hermansky-Pudlak syndrome due to BLOC-2 deficiency,HPS6,HPS6 biogenesis of lysosomal organelles complex 2 subunit 3,10q24.32
256,Early-onset generalized limb-onset dystonia,TOR1A,torsin family 1 member A,9q34.11
256,Early-onset generalized limb-onset dystonia,EIF2AK2,eukaryotic translation initiation factor 2 alpha kinase 2,2p22.2
256,Early-onset generalized limb-onset dystonia,SHQ1,"SHQ1, H/ACA ribonucleoprotein assembly factor",3p13
231500,Hermansky-Pudlak syndrome due to BLOC-3 deficiency,HPS1,HPS1 biogenesis of lysosomal organelles complex 3 subunit 1,10q24.2
231500,Hermansky-Pudlak syndrome due to BLOC-3 deficiency,HPS4,HPS4 biogenesis of lysosomal organelles complex 3 subunit 2,22q12.1
2073,Narcolepsy type 1,HCRT,hypocretin neuropeptide precursor,17q21.2
2073,Narcolepsy type 1,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
2073,Narcolepsy type 1,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",6p21.32
2073,Narcolepsy type 1,MOG,myelin oligodendrocyte glycoprotein,6p22.1
2073,Narcolepsy type 1,TNFSF4,TNF superfamily member 4,1q25.1
2073,Narcolepsy type 1,P2RY11,purinergic receptor P2Y11,19p13.2
2073,Narcolepsy type 1,ZNF365,zinc finger protein 365,10q21.2
2073,Narcolepsy type 1,CTSH,cathepsin H,15q25.1
231401,Alpha-thalassemia-myelodysplastic syndrome,ATRX,ATRX chromatin remodeler,Xq21.1
231393,Beta-thalassemia-X-linked thrombocytopenia syndrome,GATA1,GATA binding protein 1,Xp11.23
1309,Medullary sponge kidney,HNF1B,HNF1 homeobox B,17q12
231249,Hemoglobin E-beta-thalassemia syndrome,HBB,hemoglobin subunit beta,11p15.4
231242,Hemoglobin C-beta-thalassemia syndrome,HBB,hemoglobin subunit beta,11p15.4
2197,Idiopathic hypercalciuria,ADCY10,adenylate cyclase 10,1q24.2
231237,Delta-beta-thalassemia,HBB,hemoglobin subunit beta,11p15.4
231237,Delta-beta-thalassemia,HBG1,hemoglobin subunit gamma 1,11p15.4
231237,Delta-beta-thalassemia,HBD,hemoglobin subunit delta,11p15.4
231226,Dominant beta-thalassemia,HBB,hemoglobin subunit beta,11p15.4
231222,Beta-thalassemia intermedia,HBB,hemoglobin subunit beta,11p15.4
231214,Beta-thalassemia major,HBB,hemoglobin subunit beta,11p15.4
2841,Hailey-Hailey disease,ATP2C1,ATPase secretory pathway Ca2+ transporting 1,3q22.1
231183,Usher syndrome type 3,CEP78,centrosomal protein 78,9q21.2
231183,Usher syndrome type 3,ARSG,arylsulfatase G,17q24.2
231183,Usher syndrome type 3,CLRN1,clarin 1,3q25.1
231183,Usher syndrome type 3,MT-TS2,mitochondrially encoded tRNA-Ser (AGU/C) 2,mitochondria
231183,Usher syndrome type 3,HARS1,histidyl-tRNA synthetase 1,5q31.3
347,Frasier syndrome,WT1,WT1 transcription factor,11p13
231178,Usher syndrome type 2,USH2A,usherin,1q41
231178,Usher syndrome type 2,ADGRV1,adhesion G protein-coupled receptor V1,5q14.3
231178,Usher syndrome type 2,MYO7A,myosin VIIA,11q13.5
231178,Usher syndrome type 2,WHRN,whirlin,9q32
231178,Usher syndrome type 2,PDZD7,PDZ domain containing 7,10q24.31
2596,Myopathy and diabetes mellitus,MT-TE,mitochondrially encoded tRNA-Glu (GAA/G),mitochondria
231154,Combined immunodeficiency due to partial RAG1 deficiency,RAG1,recombination activating 1,11p12
2966,Properdin deficiency,CFP,complement factor properdin,Xp11.23
231160,Familial cerebral saccular aneurysm,ANGPTL6,angiopoietin like 6,19p13.2
231160,Familial cerebral saccular aneurysm,COL3A1,collagen type III alpha 1 chain,2q32.2
231160,Familial cerebral saccular aneurysm,ENG,endoglin,9q34.11
231160,Familial cerebral saccular aneurysm,TGFBR3,transforming growth factor beta receptor 3,1p22.1
231160,Familial cerebral saccular aneurysm,THSD1,thrombospondin type 1 domain containing 1,13q14.3
231169,Usher syndrome type 1,USH1K,Usher syndrome 1K (autosomal recessive),10p11.21-q21.1
231169,Usher syndrome type 1,CDH23,cadherin related 23,10q22.1
231169,Usher syndrome type 1,USH1C,USH1 protein network component harmonin,11p15.1
231169,Usher syndrome type 1,USH1G,USH1 protein network component sans,17q25.1
231169,Usher syndrome type 1,MYO7A,myosin VIIA,11q13.5
231169,Usher syndrome type 1,PCDH15,protocadherin related 15,10q21.1
231169,Usher syndrome type 1,USH1E,"Usher syndrome 1E (autosomal recessive, severe)",21q21
231169,Usher syndrome type 1,USH1H,Usher syndrome 1H (autosomal recessive),15q22-q23
231169,Usher syndrome type 1,CIB2,calcium and integrin binding family member 2,15q25.1
231169,Usher syndrome type 1,ESPN,espin,1p36.31
231140,Silver-Russell syndrome due to an imprinting defect of 11p15,IGF2,insulin like growth factor 2,11p15.5
231140,Silver-Russell syndrome due to an imprinting defect of 11p15,H19,H19 imprinted maternally expressed transcript,11p15.5
231144,Silver-Russell syndrome due to 11p15 microduplication,H19,H19 imprinted maternally expressed transcript,11p15.5
231144,Silver-Russell syndrome due to 11p15 microduplication,IGF2,insulin like growth factor 2,11p15.5
231120,Beckwith-Wiedemann syndrome due to CDKN1C mutation,CDKN1C,cyclin dependent kinase inhibitor 1C,11p15.4
231127,Beckwith-Wiedemann syndrome due to 11p15 microdeletion,H19,H19 imprinted maternally expressed transcript,11p15.5
231108,Rhabdoid tumor predisposition syndrome,SMARCB1,SWI/SNF related BAF chromatin remodeling complex subunit B1,22q11.23
231108,Rhabdoid tumor predisposition syndrome,SMARCA4,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4,19p13.2
231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,H19,H19 imprinted maternally expressed transcript,11p15.5
231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,KCNQ1OT1,KCNQ1 opposite strand/antisense transcript 1,11p15.5
231117,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15,IGF2,insulin like growth factor 2,11p15.5
231040,Familial generalized lentiginosis,SASH1,SAM and SH3 domain containing 1,6q24.3-q25.1
3318,Essential thrombocythemia,TET2,tet methylcytosine dioxygenase 2,4q24
3318,Essential thrombocythemia,JAK2,Janus kinase 2,9p24.1
3318,Essential thrombocythemia,MPL,"MPL proto-oncogene, thrombopoietin receptor",1p34.2
3318,Essential thrombocythemia,CALR,calreticulin,19p13.13
3318,Essential thrombocythemia,SH2B3,SH2B adaptor protein 3,12q24.12
3318,Essential thrombocythemia,TP53,tumor protein p53,17p13.1
230857,Ehlers-Danlos/osteogenesis imperfecta syndrome,COL1A1,collagen type I alpha 1 chain,17q21.33
230857,Ehlers-Danlos/osteogenesis imperfecta syndrome,COL1A2,collagen type I alpha 2 chain,7q21.3
230851,Cardiac-valvular Ehlers-Danlos syndrome,COL1A2,collagen type I alpha 2 chain,7q21.3
82,Hereditary thrombophilia due to congenital antithrombin deficiency,SERPINC1,serpin family C member 1,1q25.1
230839,Classical-like Ehlers-Danlos syndrome type 1,TNXB,tenascin XB,6p21.33-p21.32
238269,AApoAII amyloidosis,APOA2,apolipoprotein A2,1q23.3
238446,15q11q13 microduplication syndrome,UBE3A,ubiquitin protein ligase E3A,15q11.2
238329,Severe X-linked mitochondrial encephalomyopathy,AIFM1,apoptosis inducing factor mitochondria associated 1,Xq26.1
231568,Autosomal dominant generalized dystrophic epidermolysis bullosa,COL7A1,collagen type VII alpha 1 chain,3p21.31
1900,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency,PLOD1,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",1p36.22
231671,Isolated growth hormone deficiency type IB,GH1,growth hormone 1,17q23.3
286,Vascular Ehlers-Danlos syndrome,COL3A1,collagen type III alpha 1 chain,2q32.2
231679,Isolated growth hormone deficiency type II,GH1,growth hormone 1,17q23.3
231679,Isolated growth hormone deficiency type II,POU1F1,POU class 1 homeobox 1,3p11.2
231662,Isolated growth hormone deficiency type IA,GH1,growth hormone 1,17q23.3
231662,Isolated growth hormone deficiency type IA,RNPC3,"RNA binding region (RNP1, RRM) containing 3",1p21.1
257,Epidermolysis bullosa simplex with muscular dystrophy,PLEC,plectin,8q24.3
1901,Dermatosparaxis Ehlers-Danlos syndrome,ADAMTS2,ADAM metallopeptidase with thrombospondin type 1 motif 2,5q35.3
1901,Dermatosparaxis Ehlers-Danlos syndrome,ADAMTSL2,ADAMTS like 2,9q34.2
231720,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome,LHX3,LIM homeobox 3,9q34.3
1899,Arthrochalasia Ehlers-Danlos syndrome,COL1A2,collagen type I alpha 2 chain,7q21.3
1899,Arthrochalasia Ehlers-Danlos syndrome,COL1A1,collagen type I alpha 1 chain,17q21.33
839,"Congenital nephrotic syndrome, Finnish type",NPHS1,"NPHS1 adhesion molecule, nephrin",19q13.12
531,Miller-Dieker syndrome,HIC1,HIC ZBTB transcriptional repressor 1,17p13.3
531,Miller-Dieker syndrome,YWHAE,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,17p13.3
531,Miller-Dieker syndrome,PAFAH1B1,platelet activating factor acetylhydrolase 1b regulatory subunit 1,17p13.3
452,X-linked lissencephaly with abnormal genitalia,ARX,aristaless related homeobox,Xp21.3
238763,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea,LTBP2,latent transforming growth factor beta binding protein 2,14q24.3
238722,Familial congenital mirror movements,DNAL4,dynein axonemal light chain 4,22q13.1
238722,Familial congenital mirror movements,RAD51,RAD51 recombinase,15q15.1
238722,Familial congenital mirror movements,DCC,DCC netrin 1 receptor,18q21.2
238722,Familial congenital mirror movements,NTN1,netrin 1,17p13.1
238769,1q44 microdeletion syndrome,HNRNPU,heterogeneous nuclear ribonucleoprotein U,1q44
238505,Combined immunodeficiency due to CD27 deficiency,CD27,CD27 molecule,12p13.31
238475,Familial hypercholanemia,EPHX1,epoxide hydrolase 1,1q42.12
238475,Familial hypercholanemia,TJP2,tight junction protein 2,9q21.11
238475,Familial hypercholanemia,BAAT,bile acid-CoA:amino acid N-acyltransferase,9q31.1
238475,Familial hypercholanemia,SLC10A1,solute carrier family 10 member 1,14q24.1
238455,Infantile dystonia-parkinsonism,SLC6A3,solute carrier family 6 member 3,5p15.33
238459,SLC35A1-CDG,SLC35A1,solute carrier family 35 member A1,6q15
238578,Familial clubfoot due to 17q23.1q23.2 microduplication,TBX4,T-box transcription factor 4,17q23.2
238557,Chuvash erythrocytosis,VHL,von Hippel-Lindau tumor suppressor,3p25.3
238569,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,IL10,interleukin 10,1q32.1
238569,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,IL10RA,interleukin 10 receptor subunit alpha,11q23.3
238569,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,IL10RB,interleukin 10 receptor subunit beta,21q22.11
238523,Atypical hypotonia-cystinuria syndrome,SLC3A1,solute carrier family 3 member 1,2p21
238523,Atypical hypotonia-cystinuria syndrome,PREPL,prolyl endopeptidase like,2p21
238523,Atypical hypotonia-cystinuria syndrome,CAMKMT,calmodulin-lysine N-methyltransferase,2p21
238613,Beckwith-Wiedemann syndrome due to NSD1 mutation,NSD1,nuclear receptor binding SET domain protein 1,5q35.3
238670,Isolated thyrotropin-releasing hormone deficiency,TRH,thyrotropin releasing hormone,3q22.1
240071,Classic progressive supranuclear palsy syndrome,MAPT,microtubule associated protein tau,17q21.31
240112,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome,MAPT,microtubule associated protein tau,17q21.31
240103,Progressive supranuclear palsy-corticobasal syndrome,MAPT,microtubule associated protein tau,17q21.31
240094,Progressive supranuclear palsy-pure akinesia with gait freezing syndrome,MAPT,microtubule associated protein tau,17q21.31
240085,Progressive supranuclear palsy-predominant parkinsonism syndrome,MAPT,microtubule associated protein tau,17q21.31
240760,Nijmegen breakage syndrome-like disorder,MRE11,"MRE11 homolog, double strand break repair nuclease",11q21
240760,Nijmegen breakage syndrome-like disorder,RAD50,RAD50 double strand break repair protein,5q31.1
331226,Susceptibility to infection due to TYK2 deficiency,TYK2,tyrosine kinase 2,19p13.2
331176,Severe congenital neutropenia due to G6PC3 deficiency,G6PC3,glucose-6-phosphatase catalytic subunit 3,17q21.31
331187,Immunodeficiency due to MASP-2 deficiency,MASP2,MBL associated serine protease 2,1p36.22
331190,Immunodeficiency due to ficolin3 deficiency,FCN3,ficolin 3,1p36.11
331206,Severe combined immunodeficiency due to complete RAG1/2 deficiency,RAG1,recombination activating 1,11p12
331206,Severe combined immunodeficiency due to complete RAG1/2 deficiency,RAG2,recombination activating 2,11p12
330032,Hemoglobin Lepore-beta-thalassemia syndrome,HBB,hemoglobin subunit beta,11p15.4
330032,Hemoglobin Lepore-beta-thalassemia syndrome,HBD,hemoglobin subunit delta,11p15.4
330041,Hemoglobin M disease,HBA2,hemoglobin subunit alpha 2,16p13.3
330041,Hemoglobin M disease,HBB,hemoglobin subunit beta,11p15.4
330041,Hemoglobin M disease,HBA1,hemoglobin subunit alpha 1,16p13.3
330050,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect,DNM1L,dynamin 1 like,12p11.21
330054,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome,GFER,"growth factor, augmenter of liver regeneration",16p13.3
329802,5p13 microduplication syndrome,NIPBL,NIPBL cohesin loading factor,5p13.2
329475,Spastic paraplegia-Paget disease of bone syndrome,VCP,valosin containing protein,9p13.3
329481,Lipoprotein glomerulopathy,APOE,apolipoprotein E,19q13.32
329478,Adult-onset distal myopathy due to VCP mutation,VCP,valosin containing protein,9p13.3
329931,C3 glomerulonephritis,CFHR1,complement factor H related 1,1q31.3
329931,C3 glomerulonephritis,CFHR5,complement factor H related 5,1q31.3
329931,C3 glomerulonephritis,CFHR3,complement factor H related 3,1q31.3
329931,C3 glomerulonephritis,CFHR2,complement factor H related 2,1q31.3
329971,Generalized juvenile polyposis/juvenile polyposis coli,BMPR1A,bone morphogenetic protein receptor type 1A,10q23.2
329971,Generalized juvenile polyposis/juvenile polyposis coli,ENG,endoglin,9q34.11
329971,Generalized juvenile polyposis/juvenile polyposis coli,SMAD4,SMAD family member 4,18q21.2
329967,Intermittent hydrarthrosis,MEFV,"MEFV innate immunity regulator, pyrin",16p13.3
329967,Intermittent hydrarthrosis,TNFRSF1A,TNF receptor superfamily member 1A,12p13.31
329903,Immunoglobulin-mediated membranoproliferative glomerulonephritis,CFH,complement factor H,1q31.3
329903,Immunoglobulin-mediated membranoproliferative glomerulonephritis,DGKE,diacylglycerol kinase epsilon,17q22
329308,Fatty acid hydroxylase-associated neurodegeneration,FA2H,fatty acid 2-hydroxylase,16q23.1
329314,Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency,DGUOK,deoxyguanosine kinase,2p13.1
329319,Thrombocythemia with distal limb defects,THPO,thrombopoietin,3q27.1
329284,Beta-propeller protein-associated neurodegeneration,WDR45,WD repeat domain 45,Xp11.23
329457,Distal arthrogryposis type 5D,ECEL1,endothelin converting enzyme like 1,2q37.1
329466,"Autosomal dominant focal dystonia, DYT25 type",GNAL,G protein subunit alpha L,18p11.21
329469,Acute megakaryoblastic leukemia in children without Down syndrome,GLIS2,GLIS family zinc finger 2,16p13.3
329469,Acute megakaryoblastic leukemia in children without Down syndrome,CBFA2T3,CBFA2/RUNX1 partner transcriptional co-repressor 3,16q24.3
329336,Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy,RRM2B,ribonucleotide reductase regulatory TP53 inducible subunit M2B,8q22.3
329336,Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy,RNASEH1,ribonuclease H1,2p25.3
329228,Microcephalic primordial dwarfism due to ZNF335 deficiency,ZNF335,zinc finger protein 335,20q13.12
329224,Schuurs-Hoeijmakers syndrome,PACS1,phosphofurin acidic cluster sorting protein 1,11q13.1-q13.2
329217,Cerebral sinovenous thrombosis,F2,"coagulation factor II, thrombin",11p11.2
329217,Cerebral sinovenous thrombosis,F5,coagulation factor V,1q24.2
329217,Cerebral sinovenous thrombosis,PROZ,"protein Z, vitamin K dependent plasma glycoprotein",13q34
329211,Autosomal dominant neovascular inflammatory vitreoretinopathy,CAPN5,calpain 5,11q13.5
329195,Developmental delay with autism spectrum disorder and gait instability,HERC2,HECT and RLD domain containing E3 ubiquitin protein ligase 2,15q13.1
329191,Tall stature-long halluces-multiple extra-epiphyses syndrome,NPR2,natriuretic peptide receptor 2,9p13.3
329178,Congenital muscular dystrophy with intellectual disability and severe epilepsy,DPM2,"dolichyl-phosphate mannosyltransferase subunit 2, regulatory",9q34.11
329258,Autosomal dominant Charcot-Marie-Tooth disease type 2Q,DHTKD1,dehydrogenase E1 and transketolase domain containing 1,10p14
329249,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency,SH2B1,SH2B adaptor protein 1,16p11.2
329242,Congenital chronic diarrhea with protein-losing enteropathy,PLVAP,plasmalemma vesicle associated protein,19p13.11
329242,Congenital chronic diarrhea with protein-losing enteropathy,DGAT1,diacylglycerol O-acyltransferase 1,8q24.3
329235,X-linked central congenital hypothyroidism with late-onset testicular enlargement,IGSF1,immunoglobulin superfamily member 1,Xq26.1
329173,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,RBCK1,RANBP2-type and C3HC4-type zinc finger containing 1,20p13
329173,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,RNF31,ring finger protein 31,14q12
329,Congenital factor XI deficiency,F11,coagulation factor XI,4q35.2
1243,Best vitelliform macular dystrophy,BEST1,bestrophin 1,11q12.3
325524,Classic congenital lipoid adrenal hyperplasia due to STAR deficency,STAR,steroidogenic acute regulatory protein,8p11.23
325448,Leydig cell hypoplasia due to LHB deficiency,LHB,luteinizing hormone subunit beta,19q13.33
325529,Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency,STAR,steroidogenic acute regulatory protein,8p11.23
324977,Proteasome-associated autoinflammatory syndrome,PSMB8,proteasome 20S subunit beta 8,6p21.32
324718,ABetaA21G amyloidosis,APP,amyloid beta precursor protein,21q21.3
324713,"ABeta amyloidosis, Italian type",APP,amyloid beta precursor protein,21q21.3
324737,SRD5A3-CDG,SRD5A3,steroid 5 alpha-reductase 3,4q12
324723,"ABeta amyloidosis, Arctic type",APP,amyloid beta precursor protein,21q21.3
324708,"ABeta amyloidosis, Iowa type",APP,amyloid beta precursor protein,21q21.3
324703,ABetaL34V amyloidosis,APP,amyloid beta precursor protein,21q21.3
324611,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation,KIF5A,kinesin family member 5A,12q13.3
324604,Classic multiminicore myopathy,SELENON,selenoprotein N,1p36.11
324604,Classic multiminicore myopathy,TTN,titin,2q31.2
324604,Classic multiminicore myopathy,MYH7,myosin heavy chain 7,14q11.2
324588,Familial dyskinesia and facial myokymia,ADCY5,adenylate cyclase 5,3q21.1
324601,X-linked cleft palate and ankyloglossia,TBX22,T-box transcription factor 22,Xq21.1
324581,Benign Samaritan congenital myopathy,RYR1,ryanodine receptor 1,19q13.2
324585,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain,MPZ,myelin protein zero,1q23.3
324569,Pontocerebellar hypoplasia type 8,CHMP1A,charged multivesicular body protein 1A,16q24.3
324575,Hyperinsulinism due to HNF1A deficiency,HNF1A,HNF1 homeobox A,12q24.31
324561,Hypopigmentation-punctate palmoplantar keratoderma syndrome,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,6q23.2
324530,Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation,PLCG2,phospholipase C gamma 2,16q24.1
324535,Combined oxidative phosphorylation defect type 11,RMND1,required for meiotic nuclear division 1 homolog,6q25.1
324525,Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation,MT-TL1,mitochondrially encoded tRNA-Leu (UUA/G) 1,mitochondria
324442,Autosomal recessive axonal neuropathy with neuromyotonia,HINT1,histidine triad nucleotide binding protein 1,5q23.3
324422,ALG13-CDG,ALG13,ALG13 UDP-N-acetylglucosaminyltransferase subunit,Xq23
324410,X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,CLIC2,chloride intracellular channel 2,Xq28
324321,Sinoatrial node dysfunction and deafness,CACNA1D,calcium voltage-gated channel subunit alpha1 D,3p21.1
324299,Multiple paragangliomas associated with polycythemia,EPAS1,endothelial PAS domain protein 1,2p21
324294,T-cell immunodeficiency with epidermodysplasia verruciformis,RHOH,ras homolog family member H,4p14
324290,PRDM8-related progressive myoclonus epilepsy,PRDM8,PR/SET domain 8,4q21.21
324262,Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency,GRM1,glutamate metabotropic receptor 1,6q24.3
320360,MT-ATP6-related mitochondrial spastic paraplegia,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,mitochondria
320355,Autosomal dominant spastic paraplegia type 41,SPG41,spastic paraplegia 41 (autosomal dominant),11p14.1-p11.2
320370,Autosomal recessive spastic paraplegia type 43,C19ORF12,chromosome 19 open reading frame 12,19q12
320365,Autosomal dominant spastic paraplegia type 36,SPG36,spastic paraplegia 36 (autosomal dominant),12q23-q24
320380,Autosomal recessive spastic paraplegia type 54,DDHD2,DDHD domain containing 2,8p11.23
320375,Autosomal recessive spastic paraplegia type 55,MTRFR,mitochondrial translation release factor in rescue,12q24.31
320391,Autosomal recessive spastic paraplegia type 46,GBA2,glucosylceramidase beta 2,9p13.3
320385,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,TECPR2,tectonin beta-propeller repeat containing 2,14q32.33
320401,Autosomal recessive spastic paraplegia type 44,GJC2,gap junction protein gamma 2,1q42.13
320396,Autosomal recessive spastic paraplegia type 45,NT5C2,"5'-nucleotidase, cytosolic II",10q24.32-q24.33
320411,Autosomal recessive spastic paraplegia type 56,CYP2U1,cytochrome P450 family 2 subfamily U member 1,4q25
320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,FLRT1,fibronectin leucine rich transmembrane protein 1,11q13.1
320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,KLC2,kinesin light chain 2,11q13.2
319547,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency,IFNGR2,interferon gamma receptor 2,21q22.11
319519,Combined oxidative phosphorylation defect type 14,FARS2,"phenylalanyl-tRNA synthetase 2, mitochondrial",6p25.1
319524,Combined oxidative phosphorylation defect type 15,MTFMT,mitochondrial methionyl-tRNA formyltransferase,15q22.31
319509,Combined oxidative phosphorylation defect type 9,MRPL3,mitochondrial ribosomal protein L3,3q22.1
319514,Combined oxidative phosphorylation defect type 13,PNPT1,polyribonucleotide nucleotidyltransferase 1,2p16.1
319589,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,IFNGR2,interferon gamma receptor 2,21q22.11
319595,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,STAT1,signal transducer and activator of transcription 1,2q32.2
319574,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,IFNGR2,interferon gamma receptor 2,21q22.11
319581,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,IFNGR1,interferon gamma receptor 1,6q23.3
319563,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,ISG15,ISG15 ubiquitin like modifier,1p36.33
319569,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,IFNGR1,interferon gamma receptor 1,6q23.3
319552,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,IL12RB1,interleukin 12 receptor subunit beta 1,19p13.11
319558,Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency,IL12B,interleukin 12B,5q33.3
319651,Constitutional megaloblastic anemia with severe neurologic disease,DHFR,dihydrofolate reductase,5q14.1
319646,PGM1-CDG,PGM1,phosphoglucomutase 1,1p31.3
319640,Retinal macular dystrophy type 2,PROM1,prominin 1,4p15.32
319635,Amyloidosis cutis dyschromia,GPNMB,glycoprotein nmb,7p15.3
319605,X-linked mendelian susceptibility to mycobacterial diseases,CYBB,cytochrome b-245 beta chain,Xp21.1-p11.4
319600,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,IRF8,interferon regulatory factor 8,16q24.1
319678,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,COQ9,coenzyme Q9,16q21
319678,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,COQ7,"coenzyme Q7, hydroxylase",16p12.3
319675,"Microcephalic primordial dwarfism, Dauber type",NIN,ninein,14q22.1
319671,Alazami syndrome,LARP7,"La ribonucleoprotein 7, transcriptional regulator",4q25
319298,Papillary renal cell carcinoma,MET,"MET proto-oncogene, receptor tyrosine kinase",7q31.2
319298,Papillary renal cell carcinoma,MITF,melanocyte inducing transcription factor,3p13
319303,Chromophobe renal cell carcinoma,HNF1A,HNF1 homeobox A,12q24.31
319308,MiT family translocation renal cell carcinoma,PRCC,proline rich mitotic checkpoint control factor,1q23.1
319308,MiT family translocation renal cell carcinoma,TFE3,transcription factor binding to IGHM enhancer 3,Xp11.23
319308,MiT family translocation renal cell carcinoma,ASPSCR1,"ASPSCR1 tether for SLC2A4, UBX domain containing",17q25.3
319308,MiT family translocation renal cell carcinoma,TFEB,transcription factor EB,6p21.1
319308,MiT family translocation renal cell carcinoma,CLTC,clathrin heavy chain,17q23.1
319308,MiT family translocation renal cell carcinoma,SFPQ,splicing factor proline and glutamine rich,1p34.3
319308,MiT family translocation renal cell carcinoma,NONO,non-POU domain containing octamer binding,Xq13.1
319332,Autosomal recessive myogenic arthrogryposis multiplex congenita,SYNE1,spectrin repeat containing nuclear envelope protein 1,6q25.2
319340,Carney complex-trismus-pseudocamptodactyly syndrome,MYH8,myosin heavy chain 8,17p13.1
319487,Familial papillary or follicular thyroid carcinoma,MINPP1,multiple inositol-polyphosphate phosphatase 1,10q23.2
319487,Familial papillary or follicular thyroid carcinoma,FOXE1,forkhead box E1,9q22.33
319487,Familial papillary or follicular thyroid carcinoma,HABP2,hyaluronan binding protein 2,10q25.3
319480,Acute myeloid leukemia with CEBPA somatic mutations,CEBPA,CCAAT enhancer binding protein alpha,19q13.11
319504,Combined oxidative phosphorylation defect type 8,AARS2,"alanyl-tRNA synthetase 2, mitochondrial",6p21.1
319465,Inherited acute myeloid leukemia,CEBPA,CCAAT enhancer binding protein alpha,19q13.11
319465,Inherited acute myeloid leukemia,TGM6,transglutaminase 6,20p13
319465,Inherited acute myeloid leukemia,ERCC6L2,ERCC excision repair 6 like 2,9q22.32
319462,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations,BRCA2,BRCA2 DNA repair associated,13q13.1
319199,Autosomal recessive spastic paraplegia type 53,VPS37A,VPS37A subunit of ESCRT-I,8p22
319160,Congenital myopathy with internal nuclei and atypical cores,CCDC78,coiled-coil domain containing 78,16p13.3
319189,Familial cortical myoclonus,NOL3,nucleolar protein 3,16q22.1
319192,Diencephalic-mesencephalic junction dysplasia,GSX2,GS homeobox 2,4q12
319192,Diencephalic-mesencephalic junction dysplasia,PCDH12,protocadherin 12,5q31.3
319182,Wiedemann-Steiner syndrome,KMT2A,lysine methyltransferase 2A,11q23.3
317428,Combined immunodeficiency due to ORAI1 deficiency,ORAI1,ORAI calcium release-activated calcium modulator 1,12q24.31
317425,Severe combined immunodeficiency due to DNA-PKcs deficiency,PRKDC,"protein kinase, DNA-activated, catalytic subunit",8q11.21
317430,Combined immunodeficiency due to STIM1 deficiency,STIM1,stromal interaction molecule 1,11p15.4
317473,Common variable immunodeficiency phenotype due to IKAROS functional haploinsufficiency,IKZF1,IKAROS family zinc finger 1,7p12.2
317476,XMEN,MAGT1,magnesium transporter 1,Xq21.1
315311,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form",CYP21A2,cytochrome P450 family 21 subfamily A member 2,6p21.33
315306,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",CYP21A2,cytochrome P450 family 21 subfamily A member 2,6p21.33
314978,X-linked non progressive cerebellar ataxia,ATP2B3,ATPase plasma membrane Ca2+ transporting 3,Xq28
314950,Primary hypereosinophilic syndrome,FGFR1,fibroblast growth factor receptor 1,8p11.23
314950,Primary hypereosinophilic syndrome,FIP1L1,factor interacting with PAPOLA and CPSF1,4q12
314950,Primary hypereosinophilic syndrome,PDGFRA,platelet derived growth factor receptor alpha,4q12
314950,Primary hypereosinophilic syndrome,PDGFRB,platelet derived growth factor receptor beta,5q32
314950,Primary hypereosinophilic syndrome,ETV6,ETS variant transcription factor 6,12p13.2
314918,Mild Canavan disease,ASPA,aspartoacylase,17p13.2
314911,Severe Canavan disease,ASPA,aspartoacylase,17p13.2
314679,Cerebrofacioarticular syndrome,DCHS1,dachsous cadherin-related 1,11p15.4
314679,Cerebrofacioarticular syndrome,FAT4,FAT atypical cadherin 4,4q28.1
314667,TMEM165-CDG,TMEM165,transmembrane protein 165,4q12
314689,Combined immunodeficiency due to STK4 deficiency,STK4,serine/threonine kinase 4,20q13.12
314652,Variant ABeta2M amyloidosis,B2M,beta-2-microglobulin,15q21.1
314647,Non-progressive cerebellar ataxia with intellectual disability,CAMTA1,calmodulin binding transcription activator 1,1p36.31-p36.23
314647,Non-progressive cerebellar ataxia with intellectual disability,POU4F1,POU class 4 homeobox 1,13q31.1
314662,Segmental progressive overgrowth syndrome with fibroadipose hyperplasia,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
314655,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion,PURA,purine rich element binding protein A,5q31.3
314629,CLN11 disease,GRN,granulin precursor,17q21.31
314637,Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency,MTO1,mitochondrial tRNA translation optimization 1,6q13
314632,CLN12 disease,ATP13A2,ATPase cation transporting 13A2,1p36.13
314802,Short stature due to partial GHR deficiency,GHR,growth hormone receptor,5p13.1-p12
314811,Short stature due to GHSR deficiency,GHSR,growth hormone secretagogue receptor,3q26.31
314777,Familial isolated pituitary adenoma,CDH23,cadherin related 23,10q22.1
314777,Familial isolated pituitary adenoma,AIP,AHR interacting HSP90 co-chaperone,11q13.2
314786,Silent pituitary adenoma,MEN1,menin 1,11q13
314786,Silent pituitary adenoma,AIP,AHR interacting HSP90 co-chaperone,11q13.2
314790,Null pituitary adenoma,MEN1,menin 1,11q13
314790,Null pituitary adenoma,AIP,AHR interacting HSP90 co-chaperone,11q13.2
314795,SHOX-related short stature,SHOX,SHOX homeobox,Xp22.33 and Yp11.32
314718,Lethal arteriopathy syndrome due to fibulin-4 deficiency,EFEMP2,EGF containing fibulin extracellular matrix protein 2,11q13.1
314721,Atypical dentin dysplasia due to SMOC2 deficiency,SMOC2,SPARC related modular calcium binding 2,6q27
370109,Ataxia-telangiectasia variant,ATM,ATM serine/threonine kinase,11q22.3
370103,"Primary dystonia, DYT17 type",DYT17,dystonia 17,20p11.22-q13.12
370097,Oculocutaneous albinism type 6,SLC24A5,solute carrier family 24 member 5,15q21.1
370396,Small cell carcinoma of the ovary,SMARCA4,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4,19p13.2
370348,Peripheral primitive neuroectodermal tumor,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",11q24.3
370334,Extraskeletal Ewing sarcoma,ERG,ETS transcription factor ERG,21q22.2
370334,Extraskeletal Ewing sarcoma,EWSR1,EWS RNA binding protein 1,22q12.2
370334,Extraskeletal Ewing sarcoma,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",11q24.3
370334,Extraskeletal Ewing sarcoma,SMARCA5,SNF2 related chromatin remodeling ATPase 5,4q31.21
370022,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,LAMA1,laminin subunit alpha 1,18p11.31
370026,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,CREBBP,CREB binding lysine acetyltransferase,16p13.3
370026,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,KAT6A,lysine acetyltransferase 6A,8p11.21
370015,"Spondyloepimetaphyseal dysplasia, Isidor-Toutain type",RPL13,ribosomal protein L13,16q24.3
370088,Acute infantile liver failure-multisystemic involvement syndrome,LARS1,leucyl-tRNA synthetase 1,5q32
370997,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,DAG1,dystroglycan 1,3p21.31
370921,STT3A-CDG,STT3A,STT3 oligosaccharyltransferase complex catalytic subunit A,11q24.2
370924,STT3B-CDG,STT3B,STT3 oligosaccharyltransferase complex catalytic subunit B,3p23
370927,SSR4-CDG,SSR4,signal sequence receptor subunit 4,Xq28
370930,XYLT1-CDG,XYLT1,xylosyltransferase 1,16p12.3
370959,Congenital muscular dystrophy with cerebellar involvement,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",1p34.1
370959,Congenital muscular dystrophy with cerebellar involvement,POMT1,protein O-mannosyltransferase 1,9q34.13
370959,Congenital muscular dystrophy with cerebellar involvement,POMT2,protein O-mannosyltransferase 2,14q24.3
370959,Congenital muscular dystrophy with cerebellar involvement,FKRP,fukutin related protein,19q13.32
370959,Congenital muscular dystrophy with cerebellar involvement,POMK,protein O-mannose kinase,8p11.21
370959,Congenital muscular dystrophy with cerebellar involvement,GMPPB,GDP-mannose pyrophosphorylase B,3p21.31
370968,Congenital muscular dystrophy with intellectual disability,POMT1,protein O-mannosyltransferase 1,9q34.13
370968,Congenital muscular dystrophy with intellectual disability,POMT2,protein O-mannosyltransferase 2,14q24.3
370968,Congenital muscular dystrophy with intellectual disability,FKRP,fukutin related protein,19q13.32
370968,Congenital muscular dystrophy with intellectual disability,LARGE1,LARGE xylosyl- and glucuronyltransferase 1,22q12.3
370968,Congenital muscular dystrophy with intellectual disability,GMPPB,GDP-mannose pyrophosphorylase B,3p21.31
370980,Congenital muscular dystrophy without intellectual disability,POMT1,protein O-mannosyltransferase 1,9q34.13
370980,Congenital muscular dystrophy without intellectual disability,FKTN,fukutin,9q31.2
370980,Congenital muscular dystrophy without intellectual disability,FKRP,fukutin related protein,19q13.32
370980,Congenital muscular dystrophy without intellectual disability,CRPPA,CDP-L-ribitol pyrophosphorylase A,7p21.2
370933,GM3 synthase deficiency,ST3GAL5,"ST3 beta-galactoside alpha-2,3-sialyltransferase 5",2p11.2
370943,Autism spectrum disorder-epilepsy-arthrogryposis syndrome,SLC35A3,solute carrier family 35 member A3,1p21.2
369929,Primary hyperaldosteronism-seizures-neurological abnormalities syndrome,CACNA1D,calcium voltage-gated channel subunit alpha1 D,3p21.1
369920,Pontocerebellar hypoplasia type 9,AMPD2,adenosine monophosphate deaminase 2,1p13.3
369942,CADDS,ABCD1,ATP binding cassette subfamily D member 1,Xq28
369942,CADDS,BCAP31,B cell receptor associated protein 31,Xq28
369939,Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,BCAP31,B cell receptor associated protein 31,Xq28
369955,"Methylmalonic acidemia with homocystinuria, type cblJ",ABCD4,ATP binding cassette subfamily D member 4,14q24.3
369970,Microcornea-myopic chorioretinal atrophy-telecanthus syndrome,ADAMTS18,ADAM metallopeptidase with thrombospondin type 1 motif 18,16q23.1
369962,"Methylmalonic acidemia with homocystinuria, type cblX",HCFC1,host cell factor C1,Xq28
369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,DSP,desmoplakin,6p24.3
369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,DSG1,desmoglein 1,18q12.1
370002,Focal palmoplantar keratoderma with joint keratoses,DSG1,desmoglein 1,18q12.1
369999,Diffuse palmoplantar keratoderma with painful fissures,DSG1,desmoglein 1,18q12.1
369837,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome,PIGT,phosphatidylinositol glycan anchor biosynthesis class T,20q13.12
369840,TRAPPC11-related limb-girdle muscular dystrophy R18,TRAPPC11,trafficking protein particle complex subunit 11,4q35.1
369847,Intellectual disability-hyperkinetic movement-truncal ataxia syndrome,TRAPPC11,trafficking protein particle complex subunit 11,4q35.1
369852,Congenital neutropenia-myelofibrosis-nephromegaly syndrome,VPS45,vacuolar protein sorting 45 homolog,1q21.2
369861,Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome,TRNT1,tRNA nucleotidyl transferase 1,3p26.2
369867,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,PLEKHG5,pleckstrin homology and RhoGEF domain containing G5,1p36.31
369873,Obesity due to SIM1 deficiency,SIM1,SIM bHLH transcription factor 1,6q16.3
369881,2p21 microdeletion syndrome without cystinuria,PREPL,prolyl endopeptidase like,2p21
369881,2p21 microdeletion syndrome without cystinuria,CAMKMT,calmodulin-lysine N-methyltransferase,2p21
369891,Developmental delay-facial dysmorphism syndrome due to MED13L deficiency,MED13L,mediator complex subunit 13L,12q24.21
369897,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies",FBXL4,F-box and leucine rich repeat protein 4,6q16.1-q16.2
369913,Combined oxidative phosphorylation defect type 17,ELAC2,elaC ribonuclease Z 2,17p12
364063,Infantile epileptic-dyskinetic encephalopathy,ARX,aristaless related homeobox,Xp21.3
364055,Severe early-childhood-onset retinal dystrophy,RPE65,retinoid isomerohydrolase RPE65,1p31.3
364055,Severe early-childhood-onset retinal dystrophy,LCA5,lebercilin LCA5,6q14.1
364055,Severe early-childhood-onset retinal dystrophy,LRAT,lecithin retinol acyltransferase,4q32.1
364055,Severe early-childhood-onset retinal dystrophy,SPATA7,spermatogenesis associated 7,14q31.3
364043,ALK-positive large B-cell lymphoma,ALK,ALK receptor tyrosine kinase,2p23.2-p23.1
364028,X-linked intellectual disability due to GRIA3 mutations,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,Xq25
772,Infantile Refsum disease,PEX2,peroxisomal biogenesis factor 2,8q21.13
772,Infantile Refsum disease,PEX1,peroxisomal biogenesis factor 1,7q21.2
772,Infantile Refsum disease,PEX10,peroxisomal biogenesis factor 10,1p36.32
772,Infantile Refsum disease,PEX12,peroxisomal biogenesis factor 12,17q12
772,Infantile Refsum disease,PEX13,peroxisomal biogenesis factor 13,2p15
772,Infantile Refsum disease,PEX14,peroxisomal biogenesis factor 14,1p36.22
772,Infantile Refsum disease,PEX16,peroxisomal biogenesis factor 16,11p11.2
772,Infantile Refsum disease,PEX19,peroxisomal biogenesis factor 19,1q23.2
772,Infantile Refsum disease,PEX26,peroxisomal biogenesis factor 26,22q11.21
772,Infantile Refsum disease,PEX3,peroxisomal biogenesis factor 3,6q24.2
772,Infantile Refsum disease,PEX5,peroxisomal biogenesis factor 5,12p13.31
772,Infantile Refsum disease,PEX6,peroxisomal biogenesis factor 6,6p21.1
772,Infantile Refsum disease,PEX11B,peroxisomal biogenesis factor 11 beta,1q21.1
1194,TMEM70-related mitochondrial encephalo-cardio-myopathy,TMEM70,transmembrane protein 70,8q21.11
363999,Non-immune hydrops fetalis,ANGPT2,angiopoietin 2,8p23.1
363999,Non-immune hydrops fetalis,THSD1,thrombospondin type 1 domain containing 1,13q14.3
363999,Non-immune hydrops fetalis,CALCRL,calcitonin receptor like receptor,2q32.1
363989,Familial benign flecked retina,PLA2G5,phospholipase A2 group V,1p36.13
363992,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome,ADAMTS17,ADAM metallopeptidase with thrombospondin type 1 motif 17,15q26.3
363992,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome,CERS3,ceramide synthase 3,15q26.3
363981,Charcot-Marie-Tooth disease type 4B3,SBF1,SET binding factor 1,22q13.33
363969,Autosomal recessive cerebral atrophy,TMPRSS4,transmembrane serine protease 4,11q23.3
363972,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia,CBL,Cbl proto-oncogene,11q23.3
363965,Koolen-De Vries syndrome due to a point mutation,KANSL1,KAT8 regulatory NSL complex subunit 1,17q21.31
363958,17q21.31 microdeletion syndrome,KANSL1,KAT8 regulatory NSL complex subunit 1,17q21.31
363727,X-linked dyserythropoietic anemia with abnormal platelets and neutropenia,GATA1,GATA binding protein 1,Xp11.23
363722,Alexander disease type II,GFAP,glial fibrillary acidic protein,17q21.31
363717,Alexander disease type I,GFAP,glial fibrillary acidic protein,17q21.31
363710,Spinocerebellar ataxia type 37,DAB1,DAB adaptor protein 1,1p32.2
363710,Spinocerebellar ataxia type 37,SCA37,spinocerebellar ataxia 37,1p32
363700,Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion,NF1,neurofibromin 1,17q11.2
363694,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome,SARS2,"seryl-tRNA synthetase 2, mitochondrial",19q13.2
363686,Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,GATAD2B,GATA zinc finger domain containing 2B,1q21.3
363677,Childhood-onset autosomal recessive myopathy with external ophthalmoplegia,MYH2,myosin heavy chain 2,17p13.1
363417,Temtamy preaxial brachydactyly syndrome,CHSY1,chondroitin sulfate synthase 1,15q26.3
363409,Fetal akinesia-cerebral and retinal hemorrhage syndrome,DNM2,dynamin 2,19p13.2
363412,Hypomyelination with brain stem and spinal cord involvement and leg spasticity,DARS1,aspartyl-tRNA synthetase 1,2q21.3
363432,Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency,GRID2,glutamate ionotropic receptor delta type subunit 2,4q22.1-q22.2
363424,Multiple mitochondrial dysfunctions syndrome type 3,IBA57,iron-sulfur cluster assembly factor IBA57,1q42.13
363396,High myopia-sensorineural deafness syndrome,SLITRK6,SLIT and NTRK like family member 6,13q31.1
363400,Progressive encephalopathy-severe neurodegeneration-lipodystrophy syndrome,BSCL2,"BSCL2 lipid droplet biogenesis associated, seipin",11q12.3
363618,LMNA-related cardiocutaneous progeria syndrome,LMNA,lamin A/C,1q22
363623,GMPPB-related limb-girdle muscular dystrophy R19,GMPPB,GDP-mannose pyrophosphorylase B,3p21.31
363649,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome,POLD1,"DNA polymerase delta 1, catalytic subunit",19q13.3
363654,X-linked parkinsonism-spasticity syndrome,ATP6AP2,ATPase H+ transporting accessory protein 2,Xp11.4
363665,Acroosteolysis-keloid-like lesions-premature aging syndrome,PDGFRB,platelet derived growth factor receptor beta,5q32
363540,Leukoencephalopathy with mild cerebellar ataxia and white matter edema,CLCN2,chloride voltage-gated channel 2,3q27.1
363549,Acute encephalopathy with biphasic seizures and late reduced diffusion,ADORA2A,adenosine A2a receptor,22q11.23
363611,CTCF-related neurodevelopmental disorder,CTCF,CCCTC-binding factor,16q22.1
363494,Non-seminomatous germ cell tumor of testis,KITLG,KIT ligand,12q21.32
363494,Non-seminomatous germ cell tumor of testis,SPRY4,sprouty RTK signaling antagonist 4,5q31.3
363523,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome,COG6,component of oligomeric golgi complex 6,13q14.11
363534,"Mitochondrial DNA depletion syndrome, hepatocerebrorenal form",TWNK,twinkle mtDNA helicase,10q24.31
363528,Intellectual disability-strabismus syndrome,ADAT3,adenosine deaminase tRNA specific 3,19p13.3
363444,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,THOC6,THO complex subunit 6,16p13.3
363454,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy,BICD2,BICD cargo adaptor 2,9q22.31
357329,Combined immunodeficiency due to IL21R deficiency,IL21R,interleukin 21 receptor,16p12.1
357237,Combined immunodeficiency due to CARD11 deficiency,CARD11,caspase recruitment domain family member 11,7p22.2
356978,"D,L-2-hydroxyglutaric aciduria",SLC25A1,solute carrier family 25 member 1,22q11.21
356961,SLC35A2-CDG,SLC35A2,solute carrier family 35 member A2,Xp11.23
357008,Hemolytic uremic syndrome with DGKE deficiency,DGKE,diacylglycerol kinase epsilon,17q22
356996,ANK3-related intellectual disability-sleep disturbance syndrome,ANK3,ankyrin 3,10q21.2
357043,Amyotrophic lateral sclerosis type 4,SETX,senataxin,9q34.13
357034,Non-hereditary retinoblastoma,RB1,RB transcriptional corepressor 1,13q14.2
357034,Non-hereditary retinoblastoma,MYCN,"MYCN proto-oncogene, bHLH transcription factor",2p24.3
357027,Hereditary retinoblastoma,RB1,RB transcriptional corepressor 1,13q14.2
357027,Hereditary retinoblastoma,MYCN,"MYCN proto-oncogene, bHLH transcription factor",2p24.3
357074,"Autosomal recessive cutis laxa type 2, classic type",ATP6V1E1,ATPase H+ transporting V1 subunit E1,22q11.21
357074,"Autosomal recessive cutis laxa type 2, classic type",ATP6V1A,ATPase H+ transporting V1 subunit A,3q13.31
357074,"Autosomal recessive cutis laxa type 2, classic type",ATP6V0A2,ATPase H+ transporting V0 subunit a2,12q24.31
357064,Autosomal recessive cutis laxa type 2B,PYCR1,pyrroline-5-carboxylate reductase 1,17q25.3
352654,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome,UCHL1,ubiquitin C-terminal hydrolase L1,4p13
352662,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome,NLRP1,NLR family pyrin domain containing 1,17p13
352641,Autosomal recessive cerebellar ataxia with late-onset spasticity,GBA2,glucosylceramidase beta 2,9p13.3
352649,Brain dopamine-serotonin vesicular transport disease,SLC18A2,solute carrier family 18 member A2,10q25.3
352596,Progressive myoclonic epilepsy with dystonia,TBC1D24,TBC1 domain family member 24,16p13.3
352577,Bainbridge-Ropers syndrome,ASXL3,ASXL transcriptional regulator 3,18q12.1
352587,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation,TBC1D24,TBC1 domain family member 24,16p13.3
352582,Familial infantile myoclonic epilepsy,CPLX1,complexin 1,4p16.3
352582,Familial infantile myoclonic epilepsy,TBC1D24,TBC1 domain family member 24,16p13.3
352734,Minimal pigment oculocutaneous albinism type 1,TYR,tyrosinase,11q14.3
352737,Temperature-sensitive oculocutaneous albinism type 1,TYR,tyrosinase,11q14.3
352709,CLN13 disease,CTSF,cathepsin F,11q13.2
352712,Facial dysmorphism-immunodeficiency-livedo-short stature syndrome,POLE,"DNA polymerase epsilon, catalytic subunit",12q24.33
352718,Progressive retinal dystrophy due to retinol transport defect,RBP4,retinol binding protein 4,10q23.33
352723,Attenuated Chédiak-Higashi syndrome,LYST,lysosomal trafficking regulator,1q42.3
352665,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion,HNRNPK,heterogeneous nuclear ribonucleoprotein K,9q21.32
352670,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F,GNB4,G protein subunit beta 4,3q26.33
352675,X-linked Charcot-Marie-Tooth disease type 6,PDK3,pyruvate dehydrogenase kinase 3,Xp22.11
352682,Cobblestone lissencephaly without muscular or ocular involvement,LAMB1,laminin subunit beta 1,7q31.1
353277,Rubinstein-Taybi syndrome due to CREBBP mutations,CREBBP,CREB binding lysine acetyltransferase,16p13.3
353220,Familial primary localized cutaneous amyloidosis,OSMR,oncostatin M receptor,5p13.1
353220,Familial primary localized cutaneous amyloidosis,IL31RA,interleukin 31 receptor A,5q11.2
353217,Epileptic encephalopathy with global cerebral demyelination,SLC25A12,solute carrier family 25 member 12,2q31.1
352745,Oculocutaneous albinism type 7,LRMDA,leucine rich melanocyte differentiation associated,10q22.2-q22.3
353320,"Pyruvate carboxylase deficiency, benign type",PC,pyruvate carboxylase,11q13.2
353327,Congenital myasthenic syndromes with glycosylation defect,ALG2,"ALG2 alpha-1,3/1,6-mannosyltransferase",9q22.33
353327,Congenital myasthenic syndromes with glycosylation defect,DPAGT1,dolichyl-phosphate N-acetylglucosaminephosphotransferase 1,11q23.3
353327,Congenital myasthenic syndromes with glycosylation defect,GFPT1,glutamine--fructose-6-phosphate transaminase 1,2p13.3
353327,Congenital myasthenic syndromes with glycosylation defect,ALG14,ALG14 UDP-N-acetylglucosaminyltransferase subunit,1p21.3
353327,Congenital myasthenic syndromes with glycosylation defect,GMPPB,GDP-mannose pyrophosphorylase B,3p21.31
353308,"Pyruvate carboxylase deficiency, infantile type",PC,pyruvate carboxylase,11q13.2
353314,"Pyruvate carboxylase deficiency, severe neonatal type",PC,pyruvate carboxylase,11q13.2
353298,Roifman syndrome,RNU4ATAC,"RNA, U4atac small nuclear",2q14.2
353281,Rubinstein-Taybi syndrome due to 16p13.3 microdeletion,CREBBP,CREB binding lysine acetyltransferase,16p13.3
353284,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,EP300,EP300 lysine acetyltransferase,22q13.2
352403,Spectrin-associated autosomal recessive cerebellar ataxia,SPTBN2,"spectrin beta, non-erythrocytic 2",11q13.2
352333,Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome,ELOVL4,ELOVL fatty acid elongase 4,6q14.1
352328,MEGDEL syndrome,SERAC1,serine active site containing 1,6q25.3
352447,Progressive external ophthalmoplegia-myopathy-emaciation syndrome,MGME1,mitochondrial genome maintenance exonuclease 1,20p11.23
352530,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,TRAPPC9,trafficking protein particle complex subunit 9,8q24.3
352563,Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency,MRPL44,mitochondrial ribosomal protein L44,2q36.1
352479,ISPD-related limb-girdle muscular dystrophy R20,CRPPA,CDP-L-ribitol pyrophosphorylase A,7p21.2
352470,DNA2-related mitochondrial DNA deletion syndrome,DNA2,DNA replication helicase/nuclease 2,10q21.3
352490,Autism spectrum disorder due to AUTS2 deficiency,AUTS2,activator of transcription and developmental regulator AUTS2,7q11.22
294415,Renal-hepatic-pancreatic dysplasia,NPHP3,nephrocystin 3,3q22.1
294415,Renal-hepatic-pancreatic dysplasia,NEK8,NIMA related kinase 8,17q11.2
294016,Microcephaly-capillary malformation syndrome,STAMBP,STAM binding protein,2p13.1
294023,Neonatal inflammatory skin and bowel disease,EGFR,epidermal growth factor receptor,7p11.2
294023,Neonatal inflammatory skin and bowel disease,ADAM17,ADAM metallopeptidase domain 17,2p25.1
293964,Hypoinsulinemic hypoglycemia and body hemihypertrophy,AKT2,AKT serine/threonine kinase 2,19q13.2
293978,Deficiency in anterior pituitary function-variable immunodeficiency syndrome,NFKB2,nuclear factor kappa B subunit 2,10q24.32
293955,Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,TPK1,thiamin pyrophosphokinase 1,7q35
293948,1p21.3 microdeletion syndrome,DPYD,dihydropyrimidine dehydrogenase,1p21.3
293936,EDICT syndrome,MIR184,microRNA 184,15q25.1
293925,Lethal occipital encephalocele-skeletal dysplasia syndrome,CYP26B1,cytochrome P450 family 26 subfamily B member 1,2p13.2
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",TTN,titin,2q31.2
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",PKP2,plakophilin 2,12p11.21
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",RYR2,ryanodine receptor 2,1q43
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",TGFB3,transforming growth factor beta 3,14q24.3
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",DSC2,desmocollin 2,18q12.1
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",DSG2,desmoglein 2,18q12.1
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",DSP,desmoplakin,6p24.3
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",JUP,junction plakoglobin,17q21.2
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",LDB3,LIM domain binding 3,10q23.2
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",LMNA,lamin A/C,1q22
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",TMEM43,transmembrane protein 43,3p25.1
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",CTNNA3,catenin alpha 3,10q21.3
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",PLN,phospholamban,6q22.31
293910,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant",CDH2,cadherin 2,18q12.1
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",TTN,titin,2q31.2
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",TMEM43,transmembrane protein 43,3p25.1
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",CTNNA3,catenin alpha 3,10q21.3
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",DSG2,desmoglein 2,18q12.1
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",PKP2,plakophilin 2,12p11.21
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",RYR2,ryanodine receptor 2,1q43
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",TGFB3,transforming growth factor beta 3,14q24.3
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",DSC2,desmocollin 2,18q12.1
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",DSP,desmoplakin,6p24.3
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",JUP,junction plakoglobin,17q21.2
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",LDB3,LIM domain binding 3,10q23.2
293899,"Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant",LMNA,lamin A/C,1q22
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",PKP2,plakophilin 2,12p11.21
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",DSC2,desmocollin 2,18q12.1
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",TTN,titin,2q31.2
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",TMEM43,transmembrane protein 43,3p25.1
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",RYR2,ryanodine receptor 2,1q43
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",TGFB3,transforming growth factor beta 3,14q24.3
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",DSG2,desmoglein 2,18q12.1
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",DSP,desmoplakin,6p24.3
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",JUP,junction plakoglobin,17q21.2
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",LDB3,LIM domain binding 3,10q23.2
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",LMNA,lamin A/C,1q22
293888,"Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant",CTNNA3,catenin alpha 3,10q21.3
293864,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome,RFX6,regulatory factor X6,6q22.1
293843,3MC syndrome,COLEC10,collectin subfamily member 10,8q24.12
293843,3MC syndrome,MASP1,MBL associated serine protease 1,3q27.3
293843,3MC syndrome,COLEC11,collectin subfamily member 11,2p25.3
293822,MITF-related melanoma and renal cell carcinoma predisposition syndrome,MITF,melanocyte inducing transcription factor,3p13
293825,Congenital dyserythropoietic anemia type IV,KLF1,KLF transcription factor 1,19p13.13
293707,"Blepharophimosis-intellectual disability syndrome, MKB type",MED12,mediator complex subunit 12,Xq13.1
293633,PYCR1-related De Barsy syndrome,PYCR1,pyrroline-5-carboxylate reductase 1,17q25.3
289891,Hypermethioninemia due to glycine N-methyltransferase deficiency,GNMT,glycine N-methyltransferase,6p21.1
289863,Atypical glycine encephalopathy,SLC6A9,solute carrier family 6 member 9,1p34.1
289863,Atypical glycine encephalopathy,AMT,aminomethyltransferase,3p21.31
289863,Atypical glycine encephalopathy,GCSH,glycine cleavage system protein H,16q23.2
289863,Atypical glycine encephalopathy,GLDC,glycine decarboxylase,9p24.1
289916,Vitamin B12-unresponsive methylmalonic acidemia type mut0,MMUT,methylmalonyl-CoA mutase,6p12.3
289857,Neonatal glycine encephalopathy,AMT,aminomethyltransferase,3p21.31
289857,Neonatal glycine encephalopathy,GCSH,glycine cleavage system protein H,16q23.2
289857,Neonatal glycine encephalopathy,GLDC,glycine decarboxylase,9p24.1
289860,Infantile glycine encephalopathy,SLC6A9,solute carrier family 6 member 9,1p34.1
289860,Infantile glycine encephalopathy,AMT,aminomethyltransferase,3p21.31
289860,Infantile glycine encephalopathy,GCSH,glycine cleavage system protein H,16q23.2
289860,Infantile glycine encephalopathy,GLDC,glycine decarboxylase,9p24.1
289846,Glutathione synthetase deficiency with 5-oxoprolinuria,GSS,glutathione synthetase,20q11.22
289849,Glutathione synthetase deficiency without 5-oxoprolinuria,GSS,glutathione synthetase,20q11.22
289560,Mitochondrial membrane protein-associated neurodegeneration,C19ORF12,chromosome 19 open reading frame 12,19q12
289548,Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,CYP11A1,cytochrome P450 family 11 subfamily A member 1,15q24.1
289539,BAP1-related tumor predisposition syndrome,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
289601,Hereditary arterial and articular multiple calcification syndrome,NT5E,5'-nucleotidase ecto,6q14.3
289586,Exfoliative ichthyosis,SERPINB8,serpin family B member 8,18q22.1
289586,Exfoliative ichthyosis,CSTA,cystatin A,3q21.1
293381,Epithelial recurrent erosion dystrophy,COL17A1,collagen type XVII alpha 1 chain,10q25.1
293603,Congenital hereditary endothelial dystrophy type II,SLC4A11,solute carrier family 4 member 11,20p13
811,Shwachman-Diamond syndrome,SBDS,SBDS ribosome maturation factor,7q11.21
811,Shwachman-Diamond syndrome,EFL1,elongation factor like GTPase 1,15q25.2
811,Shwachman-Diamond syndrome,DNAJC21,DnaJ heat shock protein family (Hsp40) member C21,5p13.2
293150,Familial clubfoot due to PITX1 point mutation,PITX1,paired like homeodomain 1,5q31.1
741,Familial mitral valve prolapse,DCHS1,dachsous cadherin-related 1,11p15.4
293144,Familial clubfoot due to 5q31 microdeletion,PITX1,paired like homeodomain 1,5q31.1
293168,Infantile-onset ascending hereditary spastic paralysis,ALS2,alsin Rho guanine nucleotide exchange factor ALS2,2q33.1
293165,Skin fragility-woolly hair-palmoplantar keratoderma syndrome,DSP,desmoplakin,6p24.3
428,Autosomal dominant hypocalcemia,CASR,calcium sensing receptor,3q13.33-q21.1
428,Autosomal dominant hypocalcemia,GNA11,G protein subunit alpha 11,19p13.3
293181,Epilepsy of infancy with migrating focal seizures,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
293181,Epilepsy of infancy with migrating focal seizures,KCNQ2,potassium voltage-gated channel subfamily Q member 2,20q13.33
293181,Epilepsy of infancy with migrating focal seizures,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,Xp22.2
293181,Epilepsy of infancy with migrating focal seizures,SCN1A,sodium voltage-gated channel alpha subunit 1,2q24.3
293181,Epilepsy of infancy with migrating focal seizures,SLC25A22,solute carrier family 25 member 22,11p15.5
293181,Epilepsy of infancy with migrating focal seizures,TBC1D24,TBC1 domain family member 24,16p13.3
293181,Epilepsy of infancy with migrating focal seizures,PLCB1,phospholipase C beta 1,20p12.3
293181,Epilepsy of infancy with migrating focal seizures,KCNT1,potassium sodium-activated channel subfamily T member 1,9q34.3
293181,Epilepsy of infancy with migrating focal seizures,SLC12A5,solute carrier family 12 member 5,20q13.12
293199,Pleomorphic rhabdomyosarcoma,TP53,tumor protein p53,17p13.1
293199,Pleomorphic rhabdomyosarcoma,NF1,neurofibromin 1,17q11.2
393,"46,XX testicular difference of sex development",SOX9,SRY-box transcription factor 9,17q24.3
393,"46,XX testicular difference of sex development",SRY,sex determining region Y,Yp11.2
393,"46,XX testicular difference of sex development",SOX3,SRY-box transcription factor 3,Xq27.1
393,"46,XX testicular difference of sex development",NR0B1,nuclear receptor subfamily 0 group B member 1,Xp21.2
393,"46,XX testicular difference of sex development",NR5A1,nuclear receptor subfamily 5 group A member 1,9q33.3
293284,Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria,PAH,phenylalanine hydroxylase,12q23.2
2394,Pyruvate dehydrogenase E3 deficiency,DLD,dihydrolipoamide dehydrogenase,7q31.1
2686,Cyclic neutropenia,ELANE,"elastase, neutrophil expressed",19p13.3
284414,"Glycerol kinase deficiency, adult form",GK,glycerol kinase,Xp21.2
284417,"Phosphoserine aminotransferase deficiency, infantile/juvenile form",PSAT1,phosphoserine aminotransferase 1,9q21.2
284426,Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency,LDHA,lactate dehydrogenase A,11p15.1
284435,Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency,LDHB,lactate dehydrogenase B,12p12.1
284973,Marfan syndrome type 2,TGFBR1,transforming growth factor beta receptor 1,9q22.33
284973,Marfan syndrome type 2,TGFBR2,transforming growth factor beta receptor 2,3p24.1
284963,Marfan syndrome type 1,FBN1,fibrillin 1,15q21.1
284984,Aneurysm-osteoarthritis syndrome,SMAD3,SMAD family member 3,15q22.33
284979,Neonatal Marfan syndrome,FBN1,fibrillin 1,15q21.1
289365,Familial vesicoureteral reflux,TNXB,tenascin XB,6p21.33-p21.32
289365,Familial vesicoureteral reflux,ROBO2,roundabout guidance receptor 2,3p12.3
289365,Familial vesicoureteral reflux,SOX17,SRY-box transcription factor 17,8q11.23
289377,Early-onset myopathy with fatal cardiomyopathy,TTN,titin,2q31.2
289380,Myosclerosis,COL6A2,collagen type VI alpha 2 chain,21q22.3
289290,Hypermethioninemia encephalopathy due to adenosine kinase deficiency,ADK,adenosine kinase,10q22.2
289266,Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,16p13.2
289307,Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency,ALDH6A1,aldehyde dehydrogenase 6 family member A1,14q24.3
289504,Combined malonic and methylmalonic acidemia,ACSF3,acyl-CoA synthetase family member 3,16q24.3
289499,Congenital cataract microcornea with corneal opacity,PXDN,peroxidasin,2p25.3
289499,Congenital cataract microcornea with corneal opacity,ATOH7,atonal bHLH transcription factor 7,10q21.3
289513,12q15q21 microdeletion syndrome,CNOT2,CCR4-NOT transcription complex subunit 2,12q15
289465,Isolated congenital adermatoglyphia,SMARCAD1,SNF2 related chromatin remodeling ATPase with DExD box 1,4q22.3
289478,PASH syndrome,NCSTN,nicastrin,1q23.2
289176,Autosomal recessive hypophosphatemic rickets,DMP1,dentin matrix acidic phosphoprotein 1,4q22.1
289176,Autosomal recessive hypophosphatemic rickets,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,6q23.2
289157,Hypocalcemic vitamin D-dependent rickets,CYP27B1,cytochrome P450 family 27 subfamily B member 1,12q14.1
289157,Hypocalcemic vitamin D-dependent rickets,CYP2R1,cytochrome P450 family 2 subfamily R member 1,11p15.2
281090,Syndromic recessive X-linked ichthyosis,STS,steroid sulfatase,Xp22.31
281190,Congenital reticular ichthyosiform erythroderma,KRT1,keratin 1,12q13.13
281190,Congenital reticular ichthyosiform erythroderma,KRT10,keratin 10,17q21.2
281201,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome,POMP,proteasome maturation protein,13q12.3
281139,Annular epidermolytic ichthyosis,KRT10,keratin 10,17q21.2
281139,Annular epidermolytic ichthyosis,KRT1,keratin 1,12q13.13
281122,Self-improving collodion baby,ALOX12B,"arachidonate 12-lipoxygenase, 12R type",17p13.1
281122,Self-improving collodion baby,ALOXE3,arachidonate epidermal lipoxygenase 3,17p13.1
281122,Self-improving collodion baby,TGM1,transglutaminase 1,14q12
281127,Acral self-healing collodion baby,TGM1,transglutaminase 1,14q12
280628,Familial progressive hyper- and hypopigmentation,KITLG,KIT ligand,12q21.32
280633,Multiple congenital anomalies-hypotonia-seizures syndrome,PIGN,phosphatidylinositol glycan anchor biosynthesis class N,18q21.33
280615,Hemoglobinopathy Toms River,HBG2,hemoglobin subunit gamma 2,11p15.4
280598,Hereditary sensorimotor neuropathy with hyperelastic skin,FBLN5,fibulin 5,14q32.12
280620,Progressive myoclonic epilepsy type 6,GOSR2,golgi SNAP receptor complex member 2,17q21.32
280671,Megaconial congenital muscular dystrophy,CHKB,choline kinase beta,22q13.33
280640,Occipital pachygyria and polymicrogyria,LAMC3,laminin subunit gamma 3,9q34.12
280654,Autosomal recessive nail dysplasia,FZD6,frizzled class receptor 6,8q22.3
280785,Bullous diffuse cutaneous mastocytosis,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
280794,Pseudoxanthomatous diffuse cutaneous mastocytosis,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
280679,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,BRCC3,BRCA1/BRCA2-containing complex subunit 3,Xq28
280763,Severe intellectual disability and progressive spastic paraplegia,AP4M1,adaptor related protein complex 4 subunit mu 1,7q22.1
280763,Severe intellectual disability and progressive spastic paraplegia,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15q21.2
280763,Severe intellectual disability and progressive spastic paraplegia,AP4B1,adaptor related protein complex 4 subunit beta 1,1p13.2
280763,Severe intellectual disability and progressive spastic paraplegia,AP4S1,adaptor related protein complex 4 subunit sigma 1,14q12
284149,Craniosynostosis-dental anomalies,IL11RA,interleukin 11 receptor subunit alpha,9p13.3
284139,"Larsen-like syndrome, B3GAT3 type",B3GAT3,"beta-1,3-glucuronyltransferase 3",11q12.3
284169,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion,WAC,WW domain containing adaptor with coiled-coil,10p12.1
284247,Familial retinal arterial macroaneurysm,IGFBP7,insulin like growth factor binding protein 7,4q12
284232,Autosomal dominant Charcot-Marie-Tooth disease type 2O,DYNC1H1,dynein cytoplasmic 1 heavy chain 1,14q32.31
284271,Autosomal recessive cerebellar ataxia-psychomotor delay syndrome,SYT14,synaptotagmin 14,1q32.2
284324,Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia,TPP1,tripeptidyl peptidase 1,11p15.4
284282,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency,WWOX,WW domain containing oxidoreductase,16q23.1-q23.2
284289,Adult-onset autosomal recessive cerebellar ataxia,ANO10,anoctamin 10,3p22.1-p21.33
284343,DICER1 tumor-predisposition syndrome,DICER1,"dicer 1, ribonuclease III",14q32.13
284339,Pontocerebellar hypoplasia type 7,TOE1,"target of EGR1, exonuclease",1p34.1
284339,Pontocerebellar hypoplasia type 7,MINPP1,multiple inositol-polyphosphate phosphatase 1,10q23.2
284411,"Glycerol kinase deficiency, juvenile form",GK,glycerol kinase,Xp21.2
282166,Inherited Creutzfeldt-Jakob disease,PRNP,prion protein (Kanno blood group),20p13
309854,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,SLC30A10,solute carrier family 30 member 10,1q41
309803,Rhizomelic chondrodysplasia punctata type 3,AGPS,alkylglycerone phosphate synthase,2q31.2
309789,Rhizomelic chondrodysplasia punctata type 1,PEX7,peroxisomal biogenesis factor 7,6q23.3
309796,Rhizomelic chondrodysplasia punctata type 2,GNPAT,glyceronephosphate O-acyltransferase,1q42.2
314029,High bone mass osteogenesis imperfecta,COL1A1,collagen type I alpha 1 chain,17q21.33
314029,High bone mass osteogenesis imperfecta,COL1A2,collagen type I alpha 2 chain,7q21.3
314029,High bone mass osteogenesis imperfecta,BMP1,bone morphogenetic protein 1,8p21.3
314022,Gastric adenocarcinoma and proximal polyposis of the stomach,APC,APC regulator of WNT signaling pathway,5q22.2
313892,Developmental and speech delay due to SOX5 deficiency,SOX5,SRY-box transcription factor 5,12p12.1
313884,12p12.1 microdeletion syndrome,SOX5,SRY-box transcription factor 5,12p12.1
313855,FGFR2-related bent bone dysplasia,FGFR2,fibroblast growth factor receptor 2,10q26.13
313850,Infantile cerebellar-retinal degeneration,ACO2,aconitase 2,22q13.2
313846,Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,ATR,ATR checkpoint kinase,3q23
313838,Coats plus syndrome,CTC1,CST telomere replication complex component 1,17p13.1
313838,Coats plus syndrome,STN1,STN1 subunit of CST complex,10q24.33
313800,Retinal dystrophy-optic nerve edema-splenomegaly-anhidrosis-migraine headache syndrome,ALPK1,alpha kinase 1,4q25
313808,Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia,AARS2,"alanyl-tRNA synthetase 2, mitochondrial",6p21.1
313808,Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia,CSF1R,colony stimulating factor 1 receptor,5q32
313795,Jawad syndrome,RBBP8,"RB binding protein 8, endonuclease",18q11.2
313772,Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome,AFG3L2,AFG3 like matrix AAA peptidase subunit 2,18p11.21
314603,Autosomal recessive spastic ataxia with leukoencephalopathy,MARS2,"methionyl-tRNA synthetase 2, mitochondrial",2q33.1
314597,Chudley-McCullough syndrome,GPSM2,G protein signaling modulator 2,1p13.3
314485,Young adult-onset distal hereditary motor neuropathy,DNAJB2,DnaJ heat shock protein family (Hsp40) member B2,2q35
314485,Young adult-onset distal hereditary motor neuropathy,VWA1,von Willebrand factor A domain containing 1,1p36.33
314555,Facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies syndrome,IRX5,iroquois homeobox 5,16q12.2
314394,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome,POC1A,POC1 centriolar protein A,3p21.2
314399,Autosomal dominant aplasia and myelodysplasia,SRP72,signal recognition particle 72,4q12
314404,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome,DNMT1,DNA methyltransferase 1,19p13.2
314373,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity,GUCY2C,guanylate cyclase 2C,12p12.3
314376,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency,GUCY2C,guanylate cyclase 2C,12p12.3
314381,Hereditary sensory and autonomic neuropathy type 6,DST,dystonin,6p12.1
314051,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome,EARS2,"glutamyl-tRNA synthetase 2, mitochondrial",16p12.2
306674,Kufor-Rakeb syndrome,ATP13A2,ATPase cation transporting 13A2,1p36.13
306734,"Primary dystonia, DYT21 type",DYT21,"dystonia 21, torsion (autosomal dominant)",2q14.3-q21.3
308380,Methylcobalamin deficiency type cblDv1,MMADHC,metabolism of cobalamin associated D,2q23.2
308386,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,MOCS1,molybdenum cofactor synthesis 1,6p21.2
308393,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B,MOCS2,molybdenum cofactor synthesis 2,5q11.2
308400,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C,GPHN,gephyrin,14q23.3
308410,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency,BCKDK,branched chain keto acid dehydrogenase kinase,16p11.2
308425,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,MCEE,methylmalonyl-CoA epimerase,2p13.3
308698,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form",GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
308712,"Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form",GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
308670,"Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form",GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
308684,"Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form",GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
309015,Familial lipoprotein lipase deficiency,LPL,lipoprotein lipase,8p21.3
309020,Familial apolipoprotein C-II deficiency,APOC2,apolipoprotein C2,19q13.32
308487,Generalized galactose epimerase deficiency,GALE,UDP-galactose-4-epimerase,1p36.11
178,Chordoma,PALB2,partner and localizer of BRCA2,16p12.2
178,Chordoma,BRCA2,BRCA2 DNA repair associated,13q13.1
178,Chordoma,TBXT,T-box transcription factor T,6q27
308473,Erythrocyte galactose epimerase deficiency,GALE,UDP-galactose-4-epimerase,1p36.11
2637,Microcephalic osteodysplastic primordial dwarfism type II,PCNT,pericentrin,21q22.3
308442,"Vitamin B12-responsive methylmalonic acidemia, type cblDv2",MMADHC,metabolism of cobalamin associated D,2q23.2
308655,"Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form",GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
308638,"Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form",GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
308621,"Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form",GBE1,"1,4-alpha-glucan branching enzyme 1",3p12.2
308552,"Glycogen storage disease due to acid maltase deficiency, infantile onset",GAA,alpha glucosidase,17q25.3
309271,"Metachromatic leukodystrophy, adult form",PSAP,prosaposin,10q22.1
309271,"Metachromatic leukodystrophy, adult form",ARSA,arylsulfatase A,22q13.33
309282,"Alpha-mannosidosis, infantile form",MAN2B1,mannosidase alpha class 2B member 1,19p13.13
309288,"Alpha-mannosidosis, adult form",MAN2B1,mannosidase alpha class 2B member 1,19p13.13
309246,"GM2 gangliosidosis, AB variant",GM2A,ganglioside GM2 activator,5q33.1
309252,Atypical Gaucher disease due to saposin C deficiency,PSAP,prosaposin,10q22.1
309256,"Metachromatic leukodystrophy, late infantile form",PSAP,prosaposin,10q22.1
309256,"Metachromatic leukodystrophy, late infantile form",ARSA,arylsulfatase A,22q13.33
309263,"Metachromatic leukodystrophy, juvenile form",PSAP,prosaposin,10q22.1
309263,"Metachromatic leukodystrophy, juvenile form",ARSA,arylsulfatase A,22q13.33
309324,"Free sialic acid storage disease, infantile form",SLC17A5,solute carrier family 17 member 5,6q13
309331,Intermediate severe Salla disease,SLC17A5,solute carrier family 17 member 5,6q13
309334,Salla disease,SLC17A5,solute carrier family 17 member 5,6q13
309297,Mucopolysaccharidosis type 4A,GALNS,galactosamine (N-acetyl)-6-sulfatase,16q24.3
309310,Mucopolysaccharidosis type 4B,GLB1,galactosidase beta 1,3p22.3
309185,"Tay-Sachs disease, juvenile form",HEXA,hexosaminidase subunit alpha,15q23
309178,"Tay-Sachs disease, infantile form",HEXA,hexosaminidase subunit alpha,15q23
309192,"Tay-Sachs disease, adult form",HEXA,hexosaminidase subunit alpha,15q23
309155,"Sandhoff disease, infantile form",HEXB,hexosaminidase subunit beta,5q13.3
309169,"Sandhoff disease, adult form",HEXB,hexosaminidase subunit beta,5q13.3
309162,"Sandhoff disease, juvenile form",HEXB,hexosaminidase subunit beta,5q13.3
300547,Autosomal recessive infantile hypercalcemia,CYP24A1,cytochrome P450 family 24 subfamily A member 1,20q13.2
300547,Autosomal recessive infantile hypercalcemia,SLC34A1,solute carrier family 34 member 1,5q35.3
300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,TUBB3,tubulin beta 3 class III,16q24.3
300573,Polymicrogyria due to TUBB2B mutation,TUBB2B,tubulin beta 2B class IIb,6p25.2
300496,Multiple congenital anomalies-hypotonia-seizures syndrome type 2,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,Xp22.2
300525,Pseudohypoaldosteronism type 2D,KLHL3,kelch like family member 3,5q31.2
300530,Pseudohypoaldosteronism type 2E,CUL3,cullin 3,2q36.2
300536,DDOST-CDG,DDOST,dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit,1p36.12
300865,Primary cutaneous anaplastic large cell lymphoma,TYK2,tyrosine kinase 2,19p13.2
300865,Primary cutaneous anaplastic large cell lymphoma,NPM1,nucleophosmin 1,5q35.1
300878,Hairy cell leukemia variant,IGHV4-34,immunoglobulin heavy variable 4-34,14q32.33
300895,ALK-positive anaplastic large cell lymphoma,ALK,ALK receptor tyrosine kinase,2p23.2-p23.1
300605,Juvenile amyotrophic lateral sclerosis,ALS2,alsin Rho guanine nucleotide exchange factor ALS2,2q33.1
300605,Juvenile amyotrophic lateral sclerosis,SPG11,"SPG11 vesicle trafficking associated, spatacsin",15q21.1
300605,Juvenile amyotrophic lateral sclerosis,SIGMAR1,sigma non-opioid intracellular receptor 1,9p13.3
300605,Juvenile amyotrophic lateral sclerosis,FUS,FUS RNA binding protein,16p11.2
300605,Juvenile amyotrophic lateral sclerosis,SPTLC1,serine palmitoyltransferase long chain base subunit 1,9q22.31
300751,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation,LMNA,lamin A/C,1q22
306550,FADD-related immunodeficiency,FADD,Fas associated via death domain,11q13.3
306542,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome,ALX1,ALX homeobox 1,12q21.31
306547,Porencephaly-microcephaly-bilateral congenital cataract syndrome,JAM3,junctional adhesion molecule 3,11q25
306530,Congenital hereditary facial paralysis-variable hearing loss syndrome,HOXB1,homeobox B1,17q21.32
306511,Autosomal recessive spastic paraplegia type 48,AP5Z1,adaptor related protein complex 5 subunit zeta 1,7p22.1
306504,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome,ITGA3,integrin subunit alpha 3,17q21.33
306661,Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome,FGF23,fibroblast growth factor 23,12p13.32
306661,Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome,GALNT3,polypeptide N-acetylgalactosaminyltransferase 3,2q24.3
306661,Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome,KL,klotho,13q13.1
306658,Familial normophosphatemic tumoral calcinosis,SAMD9,sterile alpha motif domain containing 9,7q21.2
306617,X-linked complicated spastic paraplegia type 1,L1CAM,L1 cell adhesion molecule,Xq28
306577,Hereditary sodium channelopathy-related small fibers neuropathy,SCN9A,sodium voltage-gated channel alpha subunit 9,2q24.3
306577,Hereditary sodium channelopathy-related small fibers neuropathy,SCN10A,sodium voltage-gated channel alpha subunit 10,3p22.2
306577,Hereditary sodium channelopathy-related small fibers neuropathy,SCN11A,sodium voltage-gated channel alpha subunit 11,3p22.2
306558,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome,IER3IP1,immediate early response 3 interacting protein 1,18q21.1
306558,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome,YIPF5,Yip1 domain family member 5,5q31.3
295195,Synpolydactyly type 1,HOXD13,homeobox D13,2q31.1
295191,Zygodactyly type 3,HOXD13,homeobox D13,2q31.1
295201,"Congenital vertical talus, unilateral",HOXD10,homeobox D10,2q31.1
295203,"Congenital vertical talus, bilateral",HOXD10,homeobox D10,2q31.1
295197,Synpolydactyly type 2,FBLN1,fibulin 1,22q13.31
295239,"Macrodactyly of fingers, unilateral",PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
295243,"Macrodactyly of toes, unilateral",PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
300179,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency,FKBP14,FKBP prolyl isomerase 14,7p14.3
300319,Autosomal dominant Charcot-Marie-Tooth disease type 2P,LRSAM1,leucine rich repeat and sterile alpha motif containing 1,9q33.3-q34.11
300324,Persistent polyclonal B-cell lymphocytosis,CARD11,caspase recruitment domain family member 11,7p22.2
300313,Congenital cataract-hearing loss-severe developmental delay syndrome,SLC33A1,solute carrier family 33 member 1,3q25.31
300298,Severe congenital hypochromic anemia with ringed sideroblasts,STEAP3,STEAP3 metalloreductase,2q14.2
300284,Connective tissue disorder due to lysyl hydroxylase-3 deficiency,PLOD3,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",7q22.1
300293,Transient infantile hypertriglyceridemia and hepatosteatosis,GPD1,glycerol-3-phosphate dehydrogenase 1,12q13.12
300293,Transient infantile hypertriglyceridemia and hepatosteatosis,CREB3L3,cAMP responsive element binding protein 3 like 3,19p13.3
300382,Progeroid and marfanoid aspect-lipodystrophy syndrome,FBN1,fibrillin 1,15q21.1
300345,Autosomal systemic lupus erythematosus,C1QA,complement C1q A chain,1p36.12
300345,Autosomal systemic lupus erythematosus,C4A,complement C4A (Chido/Rodgers blood group),6p21.33
300345,Autosomal systemic lupus erythematosus,DNASE1L3,deoxyribonuclease 1L3,3p14.3
300345,Autosomal systemic lupus erythematosus,C1R,complement C1r,12p13.31
300345,Autosomal systemic lupus erythematosus,DNASE1,deoxyribonuclease 1,16p13.3
300359,PLCG2-associated antibody deficiency and immune dysregulation,PLCG2,phospholipase C gamma 2,16q24.1
300333,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome,CD151,CD151 molecule (Raph blood group),11p15.5
464724,Fever-associated acute infantile liver failure syndrome,NBAS,NBAS subunit of NRZ tethering complex,2p24.3
464724,Fever-associated acute infantile liver failure syndrome,RINT1,RAD50 interactor 1,7q22.3
464738,Basel-Vanagaite-Smirin-Yosef syndrome,MED25,mediator complex subunit 25,19q13.33
464760,Familial cavitary optic disc anomaly,MMP19,matrix metallopeptidase 19,12q13.2
464756,Familial gastric type 1 neuroendocrine tumor,ATP4A,ATPase H+/K+ transporting subunit alpha,19q13.12
465508,Symptomatic form of HFE-related hemochromatosis,HFE,homeostatic iron regulator,6p22.2
465508,Symptomatic form of HFE-related hemochromatosis,BMP6,bone morphogenetic protein 6,6p24.3
464282,Spastic paraplegia-severe developmental delay-epilepsy syndrome,HACE1,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,6q16.3
464288,Short stature-brachydactyly-obesity-global developmental delay syndrome,PRMT7,protein arginine methyltransferase 7,16q22.1
464311,Intellectual disability syndrome due to a DYRK1A point mutation,DYRK1A,dual specificity tyrosine phosphorylation regulated kinase 1A,21q22.13
464366,NEK9-related lethal skeletal dysplasia,NEK9,NIMA related kinase 9,14q24.3
464336,BENTA disease,CARD11,caspase recruitment domain family member 11,7p22.2
464443,COG6-CGD,COG6,component of oligomeric golgi complex 6,13q14.11
464440,"Primary dystonia, DYT27 type",COL6A3,collagen type VI alpha 3 chain,2q37.3
464370,Neonatal alloimmune neutropenia,FCGR3B,Fc fragment of IgG receptor IIIb,1q23.3
456328,X-linked myotubular myopathy-abnormal genitalia syndrome,MAMLD1,mastermind like domain containing 1,Xq28
456328,X-linked myotubular myopathy-abnormal genitalia syndrome,MTM1,myotubularin 1,Xq28
456333,Hereditary neuroendocrine tumor of small intestine,IPMK,inositol polyphosphate multikinase,10q21.1
456312,Infantile multisystem neurologic-endocrine-pancreatic disease,PTRH2,peptidyl-tRNA hydrolase 2,17q23.1
456318,Hereditary sensory neuropathy-deafness-dementia syndrome,DNMT1,DNA methyltransferase 1,19p13.2
454840,NTHL1-related polyposis,NTHL1,nth like DNA glycosylase 1,16p13.3
454745,Kuru,PRNP,prion protein (Kanno blood group),20p13
453533,Polyendocrine-polyneuropathy syndrome,DMXL2,Dmx like 2,15q21.2
453521,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency,CWF19L1,CWF19 like cell cycle control factor 1,10q24.31
451612,Familial congenital nasolacrimal duct obstruction,IGSF3,immunoglobulin superfamily member 3,1p13.1
453504,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation,HNRNPK,heterogeneous nuclear ribonucleoprotein K,9q21.32
453510,Congenital insensitivity to pain with severe intellectual disability,CLTCL1,clathrin heavy chain like 1,22q11.21
448264,Isolated focal non-epidermolytic palmoplantar keratoderma,TRPV3,transient receptor potential cation channel subfamily V member 3,17p13.2
448264,Isolated focal non-epidermolytic palmoplantar keratoderma,KRT16,keratin 16,17q21.2
448251,Progressive autosomal recessive ataxia-deafness syndrome,SLC9A1,solute carrier family 9 member A1,1p36.11
448267,Regressive spondylometaphyseal dysplasia,LBR,lamin B receptor,1q42.12
448010,CAD-CDG,CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",2p23.3
447997,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,SLC1A4,solute carrier family 1 member 4,2p14
448242,Autosomal recessive brachyolmia,PAPSS2,3'-phosphoadenosine 5'-phosphosulfate synthase 2,10q23.2-q23.31
447977,Progressive scapulohumeroperoneal distal myopathy,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
447974,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,MYO18B,myosin XVIIIB,22q12.1
447980,19p13.3 microduplication syndrome,NFIX,nuclear factor I X,19p13.13
447954,Combined oxidative phosphorylation defect type 25,MARS2,"methionyl-tRNA synthetase 2, mitochondrial",2q33.1
447964,Autosomal dominant Charcot-Marie-Tooth disease type 2V,NAGLU,N-acetyl-alpha-glucosaminidase,17q21.2
447961,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome,SASH1,SAM and SH3 domain containing 1,6q24.3-q25.1
459033,Ataxia-oculomotor apraxia type 4,PNKP,polynucleotide kinase 3'-phosphatase,19q13.33
459051,"Spondyloepiphyseal dysplasia, Stanescu type",COL2A1,collagen type II alpha 1 chain,12q13.11
459061,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome,DPH1,diphthamide biosynthesis 1,17p13.3
459061,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome,DPH2,diphthamide biosynthesis 2,1p34.1
459056,Autosomal recessive spastic paraplegia type 75,MAG,myelin associated glycoprotein,19q13.1
459070,X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome,RPL10,ribosomal protein L10,Xq28
458798,Spinocerebellar ataxia type 41,TRPC3,transient receptor potential cation channel subfamily C member 3,4q27
458803,Spinocerebellar ataxia type 42,CACNA1G,calcium voltage-gated channel subunit alpha1 G,17q21.33
457485,Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,MTOR,mechanistic target of rapamycin kinase,1p36.22
457265,Progressive myoclonic epilepsy type 9,LMNB2,lamin B2,19p13.3
457279,Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome,PPP2R5D,protein phosphatase 2 regulatory subunit B'delta,6p21.1
457260,X-linked intellectual disability-hypotonia-movement disorder syndrome,DDX3X,DEAD-box helicase 3 X-linked,Xp11.4
457240,X-linked intellectual disability-short stature-overweight syndrome,THOC2,THO complex subunit 2,Xq25
457246,Clear cell sarcoma of kidney,BCOR,BCL6 corepressor,Xp11.4
457246,Clear cell sarcoma of kidney,YWHAE,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,17p13.3
457246,Clear cell sarcoma of kidney,NUTM2B,NUT family member 2B,10q22.3
457246,Clear cell sarcoma of kidney,NUTM2E,NUT family member 2E,10q22.3
457246,Clear cell sarcoma of kidney,TERT,telomerase reverse transcriptase,5p15.33
457246,Clear cell sarcoma of kidney,IRX2,iroquois homeobox 2,5p15.33
457395,Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome,RSPRY1,ring finger and SPRY domain containing 1,16q13
457406,Multiple mitochondrial dysfunctions syndrome type 4,ISCA2,iron-sulfur cluster assembly 2,14q24.3
457375,ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement,ITPA,inosine triphosphatase,20p13
457378,Complex lethal osteochondrodysplasia,TAPT1,transmembrane anterior posterior transformation 1,4p15.32
457359,Megalencephaly-severe kyphoscoliosis-overgrowth syndrome,HERC1,HECT and RLD domain containing E3 ubiquitin protein ligase family member 1,15q22.31
457284,Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,PPP2R1A,protein phosphatase 2 scaffold subunit Aalpha,19q13.41
457351,Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome,AFG2A,AFG2 AAA ATPase homolog A,4q28.1
457185,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,COQ4,coenzyme Q4,9q34.11
457088,Predisposition to invasive fungal disease due to CARD9 deficiency,CARD9,caspase recruitment domain family member 9,9q34.3
457223,Syndromic sensorineural deafness due to combined oxidative phosphorylation defect,MRPS7,mitochondrial ribosomal protein S7,17q25.1
457212,Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome,SLC6A17,solute carrier family 6 member 17,1p13.3
457193,KAT6-related intellectual disability-craniofacial anomalies-cardiac defects syndrome,KAT6A,lysine acetyltransferase 6A,8p11.21
456369,Polyglucosan body myopathy type 2,GYG1,glycogenin 1,3q24
457050,Autosomal dominant mitochondrial myopathy with exercise intolerance,CHCHD10,coiled-coil-helix-coiled-coil-helix domain containing 10,22q11.23
317,Erythrokeratodermia variabilis,GJA1,gap junction protein alpha 1,6q22.31
317,Erythrokeratodermia variabilis,GJB4,gap junction protein beta 4,1p34.3
317,Erythrokeratodermia variabilis,GJB3,gap junction protein beta 3,1p34.3
317,Erythrokeratodermia variabilis,KDSR,3-ketodihydrosphingosine reductase,18q21.33
629,Short stature due to growth hormone qualitative anomaly,GH1,growth hormone 1,17q23.3
632,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,BTK,Bruton tyrosine kinase,Xq22.1
632,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,ELF4,E74 like ETS transcription factor 4,Xq26.1
248,Autosomal recessive hypohidrotic ectodermal dysplasia,EDAR,ectodysplasin A receptor,2q13
248,Autosomal recessive hypohidrotic ectodermal dysplasia,EDARADD,EDAR associated via death domain,1q42.3-q43
248,Autosomal recessive hypohidrotic ectodermal dysplasia,WNT10A,Wnt family member 10A,2q35
248,Autosomal recessive hypohidrotic ectodermal dysplasia,CSTB,cystatin B,21q22.3
1810,Autosomal dominant hypohidrotic ectodermal dysplasia,EDAR,ectodysplasin A receptor,2q13
1810,Autosomal dominant hypohidrotic ectodermal dysplasia,EDARADD,EDAR associated via death domain,1q42.3-q43
1810,Autosomal dominant hypohidrotic ectodermal dysplasia,TRAF6,TNF receptor associated factor 6,11p12
1810,Autosomal dominant hypohidrotic ectodermal dysplasia,KDF1,keratinocyte differentiation factor 1,1p36.11
3437,Vogt-Koyanagi-Harada disease,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
3437,Vogt-Koyanagi-Harada disease,FAS,Fas cell surface death receptor,10q23.31
3437,Vogt-Koyanagi-Harada disease,PTPN22,protein tyrosine phosphatase non-receptor type 22,1p13.2
2032,Idiopathic pulmonary fibrosis,SFTPA1,surfactant protein A1,10q22.3
2032,Idiopathic pulmonary fibrosis,DSP,desmoplakin,6p24.3
2032,Idiopathic pulmonary fibrosis,TERT,telomerase reverse transcriptase,5p15.33
2032,Idiopathic pulmonary fibrosis,TERC,telomerase RNA component,3q26.2
2032,Idiopathic pulmonary fibrosis,MUC5B,"mucin 5B, oligomeric mucus/gel-forming",11p15.5
2032,Idiopathic pulmonary fibrosis,SFTPA2,surfactant protein A2,10q22.3
2032,Idiopathic pulmonary fibrosis,RTEL1,regulator of telomere elongation helicase 1,20q13.33
2032,Idiopathic pulmonary fibrosis,FAM13A,family with sequence similarity 13 member A,4q22.1
2032,Idiopathic pulmonary fibrosis,STN1,STN1 subunit of CST complex,10q24.33
2032,Idiopathic pulmonary fibrosis,ATP11A,ATPase phospholipid transporting 11A,13q34
2032,Idiopathic pulmonary fibrosis,DPP9,dipeptidyl peptidase 9,19p13.3
2032,Idiopathic pulmonary fibrosis,PARN,poly(A)-specific ribonuclease,16p13.12
2032,Idiopathic pulmonary fibrosis,SFTPC,surfactant protein C,8p21.3
2032,Idiopathic pulmonary fibrosis,ABCA3,ATP binding cassette subfamily A member 3,16p13.3
198,Occipital horn syndrome,ATP7A,ATPase copper transporting alpha,Xq21.1
891,Familial exudative vitreoretinopathy,CTNNB1,catenin beta 1,3p22.1
891,Familial exudative vitreoretinopathy,FZD4,frizzled class receptor 4,11q14.2
891,Familial exudative vitreoretinopathy,LRP5,LDL receptor related protein 5,11q13.2
891,Familial exudative vitreoretinopathy,NDP,norrin cystine knot growth factor NDP,Xp11.3
891,Familial exudative vitreoretinopathy,TSPAN12,tetraspanin 12,7q31.31
891,Familial exudative vitreoretinopathy,ZNF408,zinc finger protein 408,11p11.2
466688,Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome,FRMD4A,FERM domain containing 4A,10p13
466650,Exercise-induced malignant hyperthermia,RYR1,ryanodine receptor 1,19q13.2
466962,SMARCA4-deficient sarcoma of thorax,SMARCA4,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4,19p13.2
466950,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation,WAC,WW domain containing adaptor with coiled-coil,10p12.1
466926,Seizures-scoliosis-macrocephaly syndrome,EXT2,exostosin glycosyltransferase 2,11p11.2
466934,VPS11-related autosomal recessive hypomyelinating leukodystrophy,VPS11,VPS11 core subunit of CORVET and HOPS complexes,11q23.3
466921,Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome,TTN,titin,2q31.2
466806,Autosomal dominant thrombocytopenia with platelet secretion defect,SLFN14,schlafen family member 14,17q12
466794,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,SCYL1,SCY1 like pseudokinase 1,11q13.1
466791,Macrocephaly-intellectual disability-left ventricular non compaction syndrome,NONO,non-POU domain containing octamer binding,Xq13.1
466784,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect,SLC25A26,solute carrier family 25 member 26,3p14.1
466775,Autosomal recessive Charcot-Marie-Tooth disease type 2X,SPG11,"SPG11 vesicle trafficking associated, spatacsin",15q21.1
466768,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,MORC2,MORC family CW-type zinc finger 2,22q12.2
466729,Familial patent arterial duct,TFAP2B,transcription factor AP-2 beta,6p12.3
466729,Familial patent arterial duct,PRDM6,PR/SET domain 6,5q23.2
466722,Autosomal recessive spastic paraplegia type 77,FARS2,"phenylalanyl-tRNA synthetase 2, mitochondrial",6p25.1
466718,Martinique crinkled retinal pigment epitheliopathy,MAPKAPK3,MAPK activated protein kinase 3,3p21.2
466703,TMEM199-CDG,VMA12,vacuolar ATPase assembly factor VMA12,17q11.2
465824,Fetal encasement syndrome,CHUK,component of inhibitor of nuclear factor kappa B kinase complex,10q24.31
466026,Class I glucose-6-phosphate dehydrogenase deficiency,G6PD,glucose-6-phosphate dehydrogenase,Xq28
468620,Intellectual disability-epilepsy-extrapyramidal syndrome,DEAF1,DEAF1 transcription factor,11p15.5
468631,Microcephalic cortical malformations-short stature due to RTTN deficiency,RTTN,rotatin,18q22.2
467166,Tubulinopathy-associated dysgyria,TUBA1A,tubulin alpha 1a,12q13.12
467166,Tubulinopathy-associated dysgyria,TUBB2B,tubulin beta 2B class IIb,6p25.2
467166,Tubulinopathy-associated dysgyria,TUBB3,tubulin beta 3 class III,16q24.3
467176,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome,CCDC174,coiled-coil domain containing 174,3p25.1
468635,Cryptogenic multifocal ulcerous stenosing enteritis,PLA2G4A,phospholipase A2 group IVA,1q31.1
468641,Chronic enteropathy associated with SLCO2A1 gene,SLCO2A1,solute carrier organic anion transporter family member 2A1,3q22.1-q22.2
468661,Autosomal recessive spastic paraplegia type 74,IBA57,iron-sulfur cluster assembly factor IBA57,1q42.13
468666,Isolated generalized anhidrosis with normal sweat glands,ITPR2,"inositol 1,4,5-trisphosphate receptor type 2",12p11.23
468678,White-Sutton syndrome,POGZ,pogo transposable element derived with ZNF domain,1q21.3
468684,CCDC115-CDG,VMA22,vacuolar ATPase assembly factor VMA22,2q21.1
468672,Colobomatous macrophthalmia-microcornea syndrome,CRIM1,cysteine rich transmembrane BMP regulator 1,2p22.2
468726,Severe primary trimethylaminuria,FMO3,flavin containing dimethylaniline monoxygenase 3,1q24.3
468699,SLC39A8-CDG,SLC39A8,solute carrier family 39 member 8,4q24
468717,Rhizomelic chondrodysplasia punctata type 5,PEX5,peroxisomal biogenesis factor 5,12p13.31
401785,Autosomal recessive spastic paraplegia type 62,ERLIN1,ER lipid raft associated 1,10q24.31
401780,Autosomal recessive spastic paraplegia type 61,ARL6IP1,ARL6 interacting reticulophagy regulator 1,16p12.3
401800,Autosomal recessive spastic paraplegia type 60,WDR48,WD repeat domain 48,3p22.2
401795,Autosomal recessive spastic paraplegia type 59,USP8,ubiquitin specific peptidase 8,15q21.2
401768,Proximal myopathy with extrapyramidal signs,MICU1,mitochondrial calcium uptake 1,10q22.1
401764,Pancytopenia-developmental delay syndrome,ERCC6L2,ERCC excision repair 6 like 2,9q22.32
401777,Optic atrophy-intellectual disability syndrome,NR2F1,nuclear receptor subfamily 2 group F member 1,5q15
401830,Autosomal recessive spastic paraplegia type 69,RAB3GAP2,RAB3 GTPase activating non-catalytic protein subunit 2,1q41
401835,Autosomal recessive spastic paraplegia type 70,MARS1,methionyl-tRNA synthetase 1,12q13.3
401840,Autosomal recessive spastic paraplegia type 71,ZFR,zinc finger RNA binding protein,5p13.3
401805,Autosomal recessive spastic paraplegia type 63,AMPD2,adenosine monophosphate deaminase 2,1p13.3
401810,Autosomal recessive spastic paraplegia type 64,ENTPD1,ectonucleoside triphosphate diphosphohydrolase 1,10q24.1
401815,Autosomal recessive spastic paraplegia type 66,ARSI,arylsulfatase family member I,5q32
401820,Autosomal recessive spastic paraplegia type 67,PGAP1,post-GPI attachment to proteins inositol deacylase 1,2q33.1
401866,Childhood-onset spasticity with hyperglycinemia,GLRX5,glutaredoxin 5,14q32.13
401869,Multiple mitochondrial dysfunctions syndrome type 1,NFU1,NFU1 iron-sulfur cluster scaffold,2p13.3
401874,Multiple mitochondrial dysfunctions syndrome type 2,BOLA3,bolA family member 3,2p13.1
401849,Autosomal spastic paraplegia type 72,REEP2,receptor accessory protein 2,5q31.2
401859,Lipoic acid synthetase deficiency,LIAS,lipoic acid synthetase,4p14
401862,Lipoyl transferase 1 deficiency,LIPT1,lipoyltransferase 1,2q11.2
400025,Female infertility due to an implantation defect of genetic origin,ZFP36L2,ZFP36 ring finger protein like 2,2p21
401920,Fibrolamellar hepatocellular carcinoma,DNAJB1,DnaJ heat shock protein family (Hsp40) member B1,19p13.12
401920,Fibrolamellar hepatocellular carcinoma,PRKACA,protein kinase cAMP-activated catalytic subunit alpha,19p13.12
401911,AXIN2-related polyposis,AXIN2,axin 2,17q24.1
401901,Huntington disease-like syndrome due to C9ORF72 expansions,C9ORF72,C9orf72-SMCR8 complex subunit,9p21.2
401959,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome,KPNA7,karyopherin subunit alpha 7,7q22.1
401948,Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,CA5A,carbonic anhydrase 5A,16q24.2
401945,Moyamoya disease with early-onset achalasia,GUCY1A1,guanylate cyclase 1 soluble subunit alpha 1,4q32.1
401986,1p31p32 microdeletion syndrome,NFIA,nuclear factor I A,1p31.3
401979,"Autosomal recessive spondylometaphyseal dysplasia, Mégarbané type",PAM16,presequence translocase associated motor 16,16p13.3
401973,MEND syndrome,EBP,EBP cholestenol delta-isomerase,Xp11.23
401964,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons,DCAF8,DDB1 and CUL4 associated factor 8,1q23.2
402003,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering,KRT6C,keratin 6C,12q13.13
401996,Karyomegalic interstitial nephritis,FAN1,FANCD2 and FANCI associated nuclease 1,15q13.3
402017,Acute myeloid leukemia with t(9;11)(p22;q23),KMT2A,lysine methyltransferase 2A,11q23.3
402017,Acute myeloid leukemia with t(9;11)(p22;q23),MLLT3,MLLT3 super elongation complex subunit,9p21.3
402020,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2),MECOM,MDS1 and EVI1 complex locus,3q26.2
402020,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2),RPN1,ribophorin I,3q21.3
402014,Acute myeloid leukemia with t(6;9)(p23;q34),NUP214,nucleoporin 214,9q34.13
402014,Acute myeloid leukemia with t(6;9)(p23;q34),DEK,DEK proto-oncogene,6p22.3
402023,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),RBM15,RNA binding motif protein 15,1p13.3
402023,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),MRTFA,myocardin related transcription factor A,22q13.1-q13.2
402026,Acute myeloid leukemia with NPM1 somatic mutations,NPM1,nucleophosmin 1,5q35.1
402082,Progressive myoclonic epilepsy type 5,PRICKLE2,prickle planar cell polarity protein 2,3p14.1
402082,Progressive myoclonic epilepsy type 5,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
402364,Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly,MED17,mediator complex subunit 17,11q21
402041,Autosomal recessive distal renal tubular acidosis,FOXI1,forkhead box I1,5q35.1
402041,Autosomal recessive distal renal tubular acidosis,ATP6V0A4,ATPase H+ transporting V0 subunit a4,7q34
402041,Autosomal recessive distal renal tubular acidosis,ATP6V1B1,ATPase H+ transporting V1 subunit B1,2p13.3
402041,Autosomal recessive distal renal tubular acidosis,WDR72,WD repeat domain 72,15q21.3
402075,Familial bicuspid aortic valve,NKX2-5,NK2 homeobox 5,5q35.1
402075,Familial bicuspid aortic valve,GATA5,GATA binding protein 5,20q13.33
402075,Familial bicuspid aortic valve,NOTCH1,notch receptor 1,9q34.3
402075,Familial bicuspid aortic valve,SMAD6,SMAD family member 6,15q22.31
806,Scott syndrome,ANO6,anoctamin 6,12q12
404473,Intellectual disability-peripheral spasticity-exudative vitreoretinopathy syndrome,CTNNB1,catenin beta 1,3p22.1
404463,Multisystemic smooth muscle dysfunction syndrome,ACTA2,"actin alpha 2, smooth muscle",10q23.31
404466,Female infertility due to zona pellucida defect,ZP2,zona pellucida glycoprotein 2,16p12.3-p12.2
404466,Female infertility due to zona pellucida defect,ZP3,zona pellucida glycoprotein 3,7q11.23
404466,Female infertility due to zona pellucida defect,ZP1,zona pellucida glycoprotein 1,11q12.2
404451,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome,FBLN1,fibulin 1,22q13.31
404454,Alacrimia-choreoathetosis-liver dysfunction syndrome,NGLY1,N-glycanase 1,3p24.2
404443,Tatton-Brown-Rahman syndrome,DNMT3A,DNA methyltransferase 3 alpha,2p23.3
404448,ADNP syndrome,ADNP,activity dependent neuroprotector homeobox,20q13.13
404437,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome,QARS1,glutaminyl-tRNA synthetase 1,3p21.31
404560,Familial atypical multiple mole melanoma syndrome,CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
404553,Deficiency of adenosine deaminase 2,ADA2,adenosine deaminase 2,22q11.1
404546,DITRA,IL36RN,interleukin 36 receptor antagonist,2q14.1
404521,Spinal muscular atrophy with respiratory distress type 2,LAS1L,LAS1 like ribosome biogenesis factor,Xq12
404511,Clear cell papillary renal cell carcinoma,HNF1A,HNF1 homeobox A,12q24.31
404511,Clear cell papillary renal cell carcinoma,TMEM127,transmembrane protein 127,2q11.2
404511,Clear cell papillary renal cell carcinoma,MITF,melanocyte inducing transcription factor,3p13
404511,Clear cell papillary renal cell carcinoma,PBRM1,polybromo 1,3p21.1
404507,Chondromyxoid fibroma,GRM1,glutamate metabotropic receptor 1,6q24.3
404499,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency,RUBCN,rubicon autophagy regulator,3q29
404493,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency,TDP2,tyrosyl-DNA phosphodiesterase 2,6p22.3
404476,Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome,DICER1,"dicer 1, ribonuclease III",14q32.13
411536,Mild phosphoribosylpyrophosphate synthetase superactivity,PRPS1,phosphoribosyl pyrophosphate synthetase 1,Xq22.3
411543,Severe phosphoribosylpyrophosphate synthetase superactivity,PRPS1,phosphoribosyl pyrophosphate synthetase 1,Xq22.3
411590,Wolfram-like syndrome,WFS1,wolframin ER transmembrane glycoprotein,4p16.1
411602,Hereditary late-onset Parkinson disease,SNCA,synuclein alpha,4q22.1
411602,Hereditary late-onset Parkinson disease,GBA1,glucosylceramidase beta 1,1q22
411602,Hereditary late-onset Parkinson disease,LRRK2,leucine rich repeat kinase 2,12q12
411602,Hereditary late-onset Parkinson disease,EIF4G1,eukaryotic translation initiation factor 4 gamma 1,3q27.1
411602,Hereditary late-onset Parkinson disease,VPS35,VPS35 retromer complex component,16q11.2
411602,Hereditary late-onset Parkinson disease,DNAJC13,DnaJ heat shock protein family (Hsp40) member C13,3q22.1
411602,Hereditary late-onset Parkinson disease,GIGYF2,GRB10 interacting GYF protein 2,2q37.1
411629,Infantile nephropathic cystinosis,CTNS,"cystinosin, lysosomal cystine transporter",17p13.2
411493,Pontocerebellar hypoplasia type 10,CLP1,cleavage factor polyribonucleotide kinase subunit 1,11q12.1
411511,Angelman syndrome due to a point mutation,UBE3A,ubiquitin protein ligase E3A,15q11.2
411515,Angelman syndrome due to imprinting defect in 15q11-q13,SNRPN,small nuclear ribonucleoprotein polypeptide N,15q11.2
411515,Angelman syndrome due to imprinting defect in 15q11-q13,UBE3A,ubiquitin protein ligase E3A,15q11.2
411515,Angelman syndrome due to imprinting defect in 15q11-q13,ATP10A,ATPase phospholipid transporting 10A (putative),15q12
411712,Maternal riboflavin deficiency,SLC52A1,solute carrier family 52 member 1,17p13.2
411788,Familial isolated trichomegaly,FGF5,fibroblast growth factor 5,4q21.21
411986,Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome,DOCK7,dedicator of cytokinesis 7,1p31.3
412022,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome,ASPH,aspartate beta-hydroxylase,8q12.3
411641,Ocular cystinosis,CTNS,"cystinosin, lysosomal cystine transporter",17p13.2
411634,Juvenile nephropathic cystinosis,CTNS,"cystinosin, lysosomal cystine transporter",17p13.2
371428,Multicentric osteolysis-nodulosis-arthropathy spectrum,MMP2,matrix metallopeptidase 2,16q12.2
371428,Multicentric osteolysis-nodulosis-arthropathy spectrum,MMP14,matrix metallopeptidase 14,14q11.2
391677,Short stature-optic atrophy-Pelger-Huët anomaly syndrome,NBAS,NBAS subunit of NRZ tethering complex,2p24.3
391474,Frontorhiny,ALX3,ALX homeobox 3,1p13.3
391490,Adult-onset myasthenia gravis,TNFRSF11A,TNF receptor superfamily member 11a,18q21.33
391490,Adult-onset myasthenia gravis,CTLA4,cytotoxic T-lymphocyte associated protein 4,2q33.2
391490,Adult-onset myasthenia gravis,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",6p21.32
391487,STAT1-related autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome,STAT1,signal transducer and activator of transcription 1,2q32.2
391646,Feingold syndrome type 2,MIR17HG,miR-17-92a-1 cluster host gene,13q31.3
391641,Feingold syndrome type 1,MYCN,"MYCN proto-oncogene, bHLH transcription factor",2p24.3
391665,Homozygous familial hypercholesterolemia,ABCG5,ATP binding cassette subfamily G member 5,2p21
391665,Homozygous familial hypercholesterolemia,ABCG8,ATP binding cassette subfamily G member 8,2p21
391665,Homozygous familial hypercholesterolemia,APOB,apolipoprotein B,2p24.1
391665,Homozygous familial hypercholesterolemia,LDLRAP1,low density lipoprotein receptor adaptor protein 1,1p36.11
391665,Homozygous familial hypercholesterolemia,PCSK9,proprotein convertase subtilisin/kexin type 9,1p32.3
391665,Homozygous familial hypercholesterolemia,LDLR,low density lipoprotein receptor,19p13.2
391343,Fatal post-viral neurodegenerative disorder,PRF1,perforin 1,10q22.1
391348,Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome,SFXN4,sideroflexin 4,10q26.11
391351,SURF1-related Charcot-Marie-Tooth disease type 4,SURF1,SURF1 cytochrome c oxidase assembly factor,9q34.2
391366,Growth retardation-mild developmental delay-chronic hepatitis syndrome,SH2B3,SH2B adaptor protein 3,12q24.12
391372,FOXP1 Syndrome,FOXP1,forkhead box P1,3p13
391376,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome,ASNS,asparagine synthetase (glutamine-hydrolyzing),7q21.3
391389,Familial episodic pain syndrome with predominantly upper body involvement,TRPA1,transient receptor potential cation channel subfamily A member 1,8q21.11
391392,Familial episodic pain syndrome with predominantly lower limb involvement,SCN11A,sodium voltage-gated channel alpha subunit 11,3p22.2
391397,Hereditary sensory and autonomic neuropathy type 7,SCN11A,sodium voltage-gated channel alpha subunit 11,3p22.2
391408,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,PPP1R15B,protein phosphatase 1 regulatory subunit 15B,1q32.1
391408,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,TRMT10A,tRNA methyltransferase 10A,4q23
391411,Atypical juvenile parkinsonism,PODXL,podocalyxin like,7q32.3
391411,Atypical juvenile parkinsonism,DNAJC6,DnaJ heat shock protein family (Hsp40) member C6,1p31.3
391411,Atypical juvenile parkinsonism,SYNJ1,synaptojanin 1,21q22.11
391428,"HSD10 disease, infantile type",HSD17B10,hydroxysteroid 17-beta dehydrogenase 10,Xp11.22
391457,"HSD10 disease, neonatal type",HSD17B10,hydroxysteroid 17-beta dehydrogenase 10,Xp11.22
391307,Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome,TTI2,TELO2 interacting protein 2,8p12
391316,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,TNK2,tyrosine kinase non receptor 2,3q29
391311,Susceptibility to viral and mycobacterial infections due to STAT1 deficiency,STAT1,signal transducer and activator of transcription 1,2q32.2
391320,East Texas bleeding disorder,F5,coagulation factor V,1q24.2
391330,X-linked osteoporosis with fractures,PLS3,plastin 3,Xq23
397968,Charcot-Marie-Tooth disease type 2R,TRIM2,tripartite motif containing 2,4q31.3
397964,Combined immunodeficiency due to MALT1 deficiency,MALT1,MALT1 paracaspase,18q21.32
397959,TCR-alpha-beta-positive T-cell deficiency,TRAC,T-cell receptor alpha constant,14q11.2
397951,Microcephaly-thin corpus callosum-intellectual disability syndrome,TAF2,TATA-box binding protein associated factor 2,8q24.12
397946,Autosomal spastic paraplegia type 58,KIF1C,kinesin family member 1C,17p13.2
397941,MAN1B1-CDG,MAN1B1,mannosidase alpha class 1B member 1,9q34.3
397937,Polyglucosan body myopathy type 1,RBCK1,RANBP2-type and C3HC4-type zinc finger containing 1,20p13
397933,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome,IQSEC2,IQ motif and Sec7 domain ArfGEF 2,Xp11.22
397927,Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome,TBXT,T-box transcription factor T,6q27
397922,Ferro-cerebro-cutaneous syndrome,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,Xp22.2
397787,Combined immunodeficiency due to IKBKB deficiency,IKBKB,inhibitor of nuclear factor kappa B kinase subunit beta,8p11.21
397755,Periodic paralysis with transient compartment-like syndrome,CACNA1S,calcium voltage-gated channel subunit alpha1 S,1q32.1
397758,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies,ITM2B,integral membrane protein 2B,13q14.2
397744,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,MYH14,myosin heavy chain 14,19q13.33
397750,Periodic paralysis with later-onset distal motor neuropathy,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,mitochondria
397750,Periodic paralysis with later-onset distal motor neuropathy,MT-ATP8,mitochondrially encoded ATP synthase membrane subunit 8,mitochondria
397725,COASY protein-associated neurodegeneration,COASY,Coenzyme A synthase,17q21.2
397735,Autosomal dominant Charcot-Marie-Tooth disease type 2U,MARS1,methionyl-tRNA synthetase 1,12q13.3
397709,Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome,SNX14,sorting nexin 14,6q14.3
397715,Joubert syndrome with Jeune asphyxiating thoracic dystrophy,CSPP1,centrosome and spindle pole associated protein 1,8q13.1-q13.2
397715,Joubert syndrome with Jeune asphyxiating thoracic dystrophy,KIAA0586,KIAA0586,14q23.1
397692,Hereditary isolated aplastic anemia,THPO,thrombopoietin,3q27.1
397692,Hereditary isolated aplastic anemia,MPL,"MPL proto-oncogene, thrombopoietin receptor",1p34.2
397692,Hereditary isolated aplastic anemia,ACD,ACD shelterin complex subunit and telomerase recruitment factor,16q22.1
397623,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome,GSC,goosecoid homeobox,14q32.13
397685,Familial hyperprolactinemia,PRLR,prolactin receptor,5p13.2
397615,Obesity due to CEP19 deficiency,CEP19,centrosomal protein 19,3q29
397618,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome,SLC38A8,solute carrier family 38 member 8,16q23.3
397593,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,LYRM4,LYR motif containing 4,6p25.1
397593,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,NFS1,NFS1 cysteine desulfurase,20q11.22
397612,Macrocephaly-developmental delay syndrome,KPTN,"kaptin, actin binding protein",19q13.32
397606,PrP systemic amyloidosis,PRNP,prion protein (Kanno blood group),20p13
397590,Silver-Russell syndrome due to a point mutation,IGF2,insulin like growth factor 2,11p15.5
397590,Silver-Russell syndrome due to a point mutation,CDKN1C,cyclin dependent kinase inhibitor 1C,11p15.4
397590,Silver-Russell syndrome due to a point mutation,HMGA2,high mobility group AT-hook 2,12q14.3
397590,Silver-Russell syndrome due to a point mutation,PLAG1,PLAG1 zinc finger,8q12.1
394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",SLC25A32,solute carrier family 25 member 32,8q22.3
394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",FLAD1,flavin adenine dinucleotide synthetase 1,1q21.3
394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",ETFA,electron transfer flavoprotein subunit alpha,15q24.2-q24.3
394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",ETFB,electron transfer flavoprotein subunit beta,19q13.41
394532,"Multiple acyl-CoA dehydrogenase deficiency, mild type",ETFDH,electron transfer flavoprotein dehydrogenase,4q32.1
394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",ETFA,electron transfer flavoprotein subunit alpha,15q24.2-q24.3
394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",ETFB,electron transfer flavoprotein subunit beta,19q13.41
394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",ETFDH,electron transfer flavoprotein dehydrogenase,4q32.1
394529,"Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type",FLAD1,flavin adenine dinucleotide synthetase 1,1q21.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,SPAG17,sperm associated antigen 17,1p12
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,TEX14,"testis expressed 14, intercellular bridge forming factor",17q22
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,TDRD9,tudor domain containing 9,14q32.33
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,NANOS1,nanos C2HC-type zinc finger 1,10q26.11
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,FANCM,FA complementation group M,14q21.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,TEX15,"testis expressed 15, meiosis and synapsis associated",8p12
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,CT55,cancer/testis antigen 55,Xq26.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,RPL10L,ribosomal protein L10 like,14q21.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,GCNA,germ cell nuclear acidic peptidase,Xq13.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,CATIP,ciliogenesis associated TTC17 interacting protein,2q35
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,RNF212,ring finger protein 212,4p16.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,TERB1,telomere repeat binding bouquet formation protein 1,16q22.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,TERB2,telomere repeat binding bouquet formation protein 2,15q21.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,MOV10L1,Mov10 like RNA helicase 1,22q13.33
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,FBXO43,F-box protein 43,8q22.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,RPL10L,ribosomal protein L10 like,14q21.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,SHOC1,shortage in chiasmata 1,9q31.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,PNLDC1,PARN like ribonuclease domain containing exonuclease 1,6q25.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,DNAH10,dynein axonemal heavy chain 10,12q24.31
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,STAG3,STAG3 cohesin complex component,7q22.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,CFTR,CF transmembrane conductance regulator,7q31.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,NR5A1,nuclear receptor subfamily 5 group A member 1,9q33.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,TAF4B,TATA-box binding protein associated factor 4b,18q11.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,ZMYND15,zinc finger MYND-type containing 15,17p13.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,TEX11,testis expressed 11,Xq13.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,SYCP3,synaptonemal complex protein 3,12q23.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,SOHLH1,spermatogenesis and oogenesis specific basic helix-loop-helix 1,9q34.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,XRCC2,X-ray repair cross complementing 2,7q36.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,SYCE1,synaptonemal complex central element protein 1,10q26.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,MEIOB,meiosis specific with OB-fold,16p13.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,C14ORF39,chromosome 14 open reading frame 39,14q23.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,KLHL10,kelch like family member 10,17q21.2
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,CCDC34,coiled-coil domain containing 34,11p14.1
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,PDHA2,pyruvate dehydrogenase E1 subunit alpha 2,4q22.3
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,DNHD1,dynein heavy chain domain 1,11p15.4
399805,Male infertility with azoospermia or oligozoospermia due to single gene mutation,MSH5,mutS homolog 5,6p21.33
399058,Alpha-B crystallin-related late-onset myopathy,CRYAB,crystallin alpha B,11q23.1
398987,Malignant teratoma of ovary,BMP15,bone morphogenetic protein 15,Xp11.22
399086,HNRNPA1-related adult-onset distal myopathy,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,12q13.13
399081,KLHL9-related early-onset distal myopathy,KLHL9,kelch like family member 9,9p21.3
399103,Distal nebulin myopathy,NEB,nebulin,2q23.3
399096,Distal anoctaminopathy,ANO5,anoctamin 5,11p14.3
398189,Focal facial dermal dysplasia type IV,CYP26C1,cytochrome P450 family 26 subfamily C member 1,10q23.33
398069,Schaaf-Yang syndrome,MAGEL2,MAGE family member L2,15q11.2
398079,SIM1-related Prader-Willi-like syndrome,SIM1,SIM bHLH transcription factor 1,6q16.3
398088,Hereditary cryohydrocytosis with normal stomatin,SLC4A1,solute carrier family 4 member 1 (Diego blood group),17q21.31
435628,Keppen-Lubinsky syndrome,KCNJ6,potassium inwardly rectifying channel subfamily J member 6,21q22.13
435660,LIPE-related familial partial lipodystrophy,LIPE,"lipase E, hormone sensitive type",19q13.2
435651,CIDEC-related familial partial lipodystrophy,CIDEC,cell death inducing DFFA like effector c,3p25.3
435638,3p25.3 microdeletion syndrome,SETD5,SET domain containing 5,3p25.3
435638,3p25.3 microdeletion syndrome,BRPF1,bromodomain and PHD finger containing 1,3p25.3
435804,Short stature-advanced bone age-early-onset osteoarthritis syndrome,ACAN,aggrecan,15q26.1
435845,Lethal neonatal spasticity-epileptic encephalopathy syndrome,BRAT1,BRCA1 associated ATM activator 1,7p22.3
435930,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,SIX6,SIX homeobox 6,14q23.1
435819,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation,TFG,trafficking from ER to golgi regulator,3q12.2
435953,Progeroid features-hepatocellular carcinoma predisposition syndrome,SPRTN,SprT-like N-terminal domain,1q42.2
435988,Chronic atrial and intestinal dysrhythmia syndrome,SGO1,shugoshin 1,3p24.3
435934,COG2-CDG,COG2,component of oligomeric golgi complex 2,1q42.2
435938,X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome,RPL10,ribosomal protein L10,Xq28
436141,HIDEA syndrome,P4HTM,"prolyl 4-hydroxylase, transmembrane",3p21.31
436144,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome,CDKN1C,cyclin dependent kinase inhibitor 1C,11p15.4
435998,Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,COX6A1,cytochrome c oxidase subunit 6A1,12q24.31
436159,Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,CTLA4,cytotoxic T-lymphocyte associated protein 4,2q33.2
436151,Intellectual disability-expressive aphasia-facial dysmorphism syndrome,SETBP1,SET binding protein 1,18q12.3
436169,Thrombomodulin-related bleeding disorder,THBD,thrombomodulin,20p11.21
436166,Periodic fever-infantile enterocolitis-autoinflammatory syndrome,NLRC4,NLR family CARD domain containing 4,2p22.3
436182,Microcephalic primordial dwarfism-insulin resistance syndrome,NSMCE2,"NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase",8q24.13
436182,Microcephalic primordial dwarfism-insulin resistance syndrome,XRCC4,X-ray repair cross complementing 4,5q14.2
436174,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,IARS2,"isoleucyl-tRNA synthetase 2, mitochondrial",1q41
436245,Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome,RDH11,retinol dehydrogenase 11,14q24.1
436242,Hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease,TNNI3K,TNNI3 interacting kinase,1p31.1
436271,Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy,COA8,cytochrome c oxidase assembly factor 8,14q32.33
436252,Combined immunodeficiency-multiple intestinal atresia,TTC7A,tetratricopeptide repeat domain 7A,2p21
436252,Combined immunodeficiency-multiple intestinal atresia,PI4KA,phosphatidylinositol 4-kinase alpha,22q11.21
436274,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa,GGCX,gamma-glutamyl carboxylase,2p11.2
437552,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,FCGR3A,Fc fragment of IgG receptor IIIa,1q23.3
438178,Fatty acyl-CoA reductase 1 deficiency,FAR1,fatty acyl-CoA reductase 1,11p15.3
438159,STAT3-related early-onset multisystem autoimmune disease,STAT3,signal transducer and activator of transcription 3,17q21.2
438134,PCNA-related progressive neurodegenerative photosensitivity syndrome,PCNA,proliferating cell nuclear antigen,20p12.3
438117,Steel syndrome,COL27A1,collagen type XXVII alpha 1 chain,9q32
438114,RARS-related autosomal recessive hypomyelinating leukodystrophy,RARS1,arginyl-tRNA synthetase 1,5q34
438075,Ketoacidosis due to monocarboxylate transporter-1 deficiency,SLC16A1,solute carrier family 16 member 1,1p13.2
438274,GCGR-related hyperglucagonemia,GCGR,glucagon receptor,17q25.3
438216,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation,PURA,purine rich element binding protein A,5q31.3
438207,Severe autosomal recessive macrothrombocytopenia,PRKACG,protein kinase cAMP-activated catalytic subunit gamma,9q21.11
438207,Severe autosomal recessive macrothrombocytopenia,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,9p13.3
439212,Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome,MEGF10,multiple EGF like domains 10,5q23.2
439218,KCNQ2-related developmental and epileptic encephalopathy,KCNQ2,potassium voltage-gated channel subfamily Q member 2,20q13.33
439822,PDE4D haploinsufficiency syndrome,PDE4D,phosphodiesterase 4D,5q11.2-q12.1
439854,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease,PRKAG2,protein kinase AMP-activated non-catalytic subunit gamma 2,7q36.1
439897,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,KIF14,kinesin family member 14,1q32.1
440402,Interstitial lung disease due to ABCA3 deficiency,ABCA3,ATP binding cassette subfamily A member 3,16p13.3
440354,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome,COL11A1,collagen type XI alpha 1 chain,1p21.1
440392,Interstitial lung disease due to SP-C deficiency,SFTPC,surfactant protein C,8p21.3
440713,Isolated sedoheptulokinase deficiency,SHPK,sedoheptulokinase,17p13.2
440731,L-ferritin deficiency,FTL,ferritin light chain,19q13.33
440731,L-ferritin deficiency,FTL,ferritin light chain,19q13.33
440427,Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency,MARS1,methionyl-tRNA synthetase 1,12q13.3
440437,Familial colorectal cancer Type X,BMPR1A,bone morphogenetic protein receptor type 1A,10q23.2
440437,Familial colorectal cancer Type X,NPAT,"nuclear protein, coactivator of histone transcription",11q22.3
440437,Familial colorectal cancer Type X,MUTYH,mutY DNA glycosylase,1p34.1
440437,Familial colorectal cancer Type X,SEMA4A,semaphorin 4A,1q22
440437,Familial colorectal cancer Type X,RPS20,ribosomal protein S20,8q12.1
440437,Familial colorectal cancer Type X,POLE,"DNA polymerase epsilon, catalytic subunit",12q24.33
440437,Familial colorectal cancer Type X,POLD1,"DNA polymerase delta 1, catalytic subunit",19q13.3
440437,Familial colorectal cancer Type X,BRCA2,BRCA2 DNA repair associated,13q13.1
440437,Familial colorectal cancer Type X,ATM,ATM serine/threonine kinase,11q22.3
440437,Familial colorectal cancer Type X,CHEK2,checkpoint kinase 2,22q12.1
440706,Ribose-5-P isomerase deficiency,RPIA,ribose 5-phosphate isomerase A,2p11.2
441447,Early-onset posterior subcapsular cataract,LEMD2,LEM domain nuclear envelope protein 2,6p21.31
441447,Early-onset posterior subcapsular cataract,CRYBB2,crystallin beta B2,22q11.23
441447,Early-onset posterior subcapsular cataract,CHMP4B,charged multivesicular body protein 4B,20q11.22
441447,Early-onset posterior subcapsular cataract,EPHA2,EPH receptor A2,1p36.13
441447,Early-onset posterior subcapsular cataract,UNC45B,unc-45 myosin chaperone B,17q12
441452,Early-onset lamellar cataract,BFSP2,beaded filament structural protein 2,3q22.1
441452,Early-onset lamellar cataract,CRYAA,crystallin alpha A,21q22.3
441452,Early-onset lamellar cataract,CRYAB,crystallin alpha B,11q23.1
441452,Early-onset lamellar cataract,CRYBA1,crystallin beta A1,17q11.2
441452,Early-onset lamellar cataract,CRYBA4,crystallin beta A4,22q12.1
441452,Early-onset lamellar cataract,CRYGC,crystallin gamma C,2q33.3
441452,Early-onset lamellar cataract,CRYGD,crystallin gamma D,2q33.3
441452,Early-onset lamellar cataract,HSF4,heat shock transcription factor 4,16q22.1
441452,Early-onset lamellar cataract,MIP,major intrinsic protein of lens fiber,12q13.3
441452,Early-onset lamellar cataract,CRYGS,crystallin gamma S,3q27.3
441452,Early-onset lamellar cataract,CRYGB,crystallin gamma B,2q33.3
443057,Sporadic porphyria cutanea tarda,HFE,homeostatic iron regulator,6p22.2
443062,Familial porphyria cutanea tarda,UROD,uroporphyrinogen decarboxylase,1p34.1
443062,Familial porphyria cutanea tarda,HFE,homeostatic iron regulator,6p22.2
443073,Charcot-Marie-Tooth disease type 2S,IGHMBP2,immunoglobulin mu DNA binding protein 2,11q13.3
442835,Non-specific early-onset epileptic encephalopathy,ACTL6B,actin like 6B,7q22.1
442835,Non-specific early-onset epileptic encephalopathy,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,5q34
442835,Non-specific early-onset epileptic encephalopathy,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,4p12
442835,Non-specific early-onset epileptic encephalopathy,FZR1,fizzy and cell division cycle 20 related 1,19p13.3
442835,Non-specific early-onset epileptic encephalopathy,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5,15q12
442835,Non-specific early-onset epileptic encephalopathy,PACS2,phosphofurin acidic cluster sorting protein 2,14q32.33
442835,Non-specific early-onset epileptic encephalopathy,YWHAG,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma,7q11.23
442835,Non-specific early-onset epileptic encephalopathy,UBA5,ubiquitin like modifier activating enzyme 5,3q22.1
442835,Non-specific early-onset epileptic encephalopathy,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,19q13.33
442835,Non-specific early-onset epileptic encephalopathy,DALRD3,DALR anticodon binding domain containing 3,3p21.31
442835,Non-specific early-onset epileptic encephalopathy,TRAK1,trafficking kinesin protein 1,3p22.1
442835,Non-specific early-onset epileptic encephalopathy,SLC1A2,solute carrier family 1 member 2,11p13
442835,Non-specific early-onset epileptic encephalopathy,AP3B2,adaptor related protein complex 3 subunit beta 2,15q25.2
442835,Non-specific early-onset epileptic encephalopathy,ATP6V1A,ATPase H+ transporting V1 subunit A,3q13.31
442835,Non-specific early-onset epileptic encephalopathy,SCN3A,sodium voltage-gated channel alpha subunit 3,2q24.3
442835,Non-specific early-onset epileptic encephalopathy,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2,5q34
442835,Non-specific early-onset epileptic encephalopathy,CLTC,clathrin heavy chain,17q23.1
442835,Non-specific early-onset epileptic encephalopathy,NUS1,NUS1 dehydrodolichyl diphosphate synthase subunit,6q22.1
442835,Non-specific early-onset epileptic encephalopathy,CYFIP2,cytoplasmic FMR1 interacting protein 2,5q33.3
442835,Non-specific early-onset epileptic encephalopathy,FBXO28,F-box protein 28,1q42.11
442835,Non-specific early-onset epileptic encephalopathy,NTRK2,neurotrophic receptor tyrosine kinase 2,9q21.33
442835,Non-specific early-onset epileptic encephalopathy,KCNC2,potassium voltage-gated channel subfamily C member 2,12q21.1
442835,Non-specific early-onset epileptic encephalopathy,SLC38A3,solute carrier family 38 member 3,3p21.31
442835,Non-specific early-onset epileptic encephalopathy,FGF12,fibroblast growth factor 12,3q28-q29
442835,Non-specific early-onset epileptic encephalopathy,SZT2,SZT2 subunit of KICSTOR complex,1p34.2
442835,Non-specific early-onset epileptic encephalopathy,CELF2,CUGBP Elav-like family member 2,10p14
442835,Non-specific early-onset epileptic encephalopathy,DHDDS,dehydrodolichyl diphosphate synthase subunit,1p36.11
442835,Non-specific early-onset epileptic encephalopathy,PPP3CA,protein phosphatase 3 catalytic subunit alpha,4q24
442835,Non-specific early-onset epileptic encephalopathy,SYNJ1,synaptojanin 1,21q22.11
442835,Non-specific early-onset epileptic encephalopathy,FOXG1,forkhead box G1,14q12
442835,Non-specific early-onset epileptic encephalopathy,SYNGAP1,synaptic Ras GTPase activating protein 1,6p21.32
442835,Non-specific early-onset epileptic encephalopathy,SCN1A,sodium voltage-gated channel alpha subunit 1,2q24.3
442835,Non-specific early-onset epileptic encephalopathy,WWOX,WW domain containing oxidoreductase,16q23.1-q23.2
442835,Non-specific early-onset epileptic encephalopathy,AARS1,alanyl-tRNA synthetase 1,16q22.1
442835,Non-specific early-onset epileptic encephalopathy,SCN8A,sodium voltage-gated channel alpha subunit 8,12q13.13
442835,Non-specific early-onset epileptic encephalopathy,NECAP1,NECAP endocytosis associated 1,12p13.31
442835,Non-specific early-onset epileptic encephalopathy,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,5p12
442835,Non-specific early-onset epileptic encephalopathy,SLC13A5,solute carrier family 13 member 5,17p13.1
442835,Non-specific early-onset epileptic encephalopathy,KCNB1,potassium voltage-gated channel subfamily B member 1,20q13.13
442835,Non-specific early-onset epileptic encephalopathy,DNM1,dynamin 1,9q34.11
442835,Non-specific early-onset epileptic encephalopathy,KCNA2,potassium voltage-gated channel subfamily A member 2,1p13.3
442835,Non-specific early-onset epileptic encephalopathy,KCNA2,potassium voltage-gated channel subfamily A member 2,1p13.3
442835,Non-specific early-onset epileptic encephalopathy,EEF1A2,eukaryotic translation elongation factor 1 alpha 2,20q13.33
442835,Non-specific early-onset epileptic encephalopathy,CNKSR2,connector enhancer of kinase suppressor of Ras 2,Xp22.12
442835,Non-specific early-onset epileptic encephalopathy,PARS2,"prolyl-tRNA synthetase 2, mitochondrial",1p32.3
442835,Non-specific early-onset epileptic encephalopathy,ATP1A2,ATPase Na+/K+ transporting subunit alpha 2,1q23.2
442835,Non-specific early-onset epileptic encephalopathy,ATP1A3,ATPase Na+/K+ transporting subunit alpha 3,19q13.2
442835,Non-specific early-onset epileptic encephalopathy,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,9q22.33
442835,Non-specific early-onset epileptic encephalopathy,CACNA1B,calcium voltage-gated channel subunit alpha1 B,9q34.3
442835,Non-specific early-onset epileptic encephalopathy,CDK19,cyclin dependent kinase 19,6q21
442835,Non-specific early-onset epileptic encephalopathy,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
442835,Non-specific early-onset epileptic encephalopathy,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,7q21.11
443197,X-linked erythropoietic protoporphyria,ALAS2,5'-aminolevulinate synthase 2,Xp11.21
298,Mitochondrial neurogastrointestinal encephalomyopathy,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
298,Mitochondrial neurogastrointestinal encephalomyopathy,TYMP,thymidine phosphorylase,22q13.33
298,Mitochondrial neurogastrointestinal encephalomyopathy,RRM2B,ribonucleotide reductase regulatory TP53 inducible subunit M2B,8q22.3
298,Mitochondrial neurogastrointestinal encephalomyopathy,LIG3,DNA ligase 3,17q12
443236,Postural orthostatic tachycardia syndrome due to NET deficiency,SLC6A2,solute carrier family 6 member 2,16q12.2
552,MODY,ABCC8,ATP binding cassette subfamily C member 8,11p15.1
552,MODY,CEL,carboxyl ester lipase,9q34.13
552,MODY,GCK,glucokinase,7p13
552,MODY,HNF4A,hepatocyte nuclear factor 4 alpha,20q13.12
552,MODY,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
552,MODY,KLF11,KLF transcription factor 11,2p25.1
552,MODY,NEUROD1,neuronal differentiation 1,2q31.3
552,MODY,PDX1,pancreatic and duodenal homeobox 1,13q12.2
552,MODY,HNF1A,HNF1 homeobox A,12q24.31
552,MODY,INS,insulin,11p15.5
552,MODY,PAX4,paired box 4,7q32.1
552,MODY,BLK,"BLK proto-oncogene, Src family tyrosine kinase",8p23.1
552,MODY,APPL1,"adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1",3p14.3
443087,"46,XY difference of sex development due to testicular 17,20-desmolase deficiency",AKR1C2,aldo-keto reductase family 1 member C2,10p15.1
443087,"46,XY difference of sex development due to testicular 17,20-desmolase deficiency",AKR1C4,aldo-keto reductase family 1 member C4,10p15.1
443167,NUT midline carcinoma,NUTM1,NUT midline carcinoma family member 1,15q14
443167,NUT midline carcinoma,BRD4,bromodomain containing 4,19p13.12
130,Brugada syndrome,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,15q24.1
130,Brugada syndrome,ABCC9,ATP binding cassette subfamily C member 9,12p12.1
130,Brugada syndrome,CACNB2,calcium voltage-gated channel auxiliary subunit beta 2,10p12
130,Brugada syndrome,CACNA1C,calcium voltage-gated channel subunit alpha1 C,12p13.33
130,Brugada syndrome,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,7q21.11
130,Brugada syndrome,KCNE3,potassium voltage-gated channel subfamily E regulatory subunit 3,11q13.4
130,Brugada syndrome,GPD1L,glycerol-3-phosphate dehydrogenase 1 like,3p22.3
130,Brugada syndrome,KCND3,potassium voltage-gated channel subfamily D member 3,1p13.2
130,Brugada syndrome,SCN3B,sodium voltage-gated channel beta subunit 3,11q24.1
130,Brugada syndrome,TRPM4,transient receptor potential cation channel subfamily M member 4,19q13.33
130,Brugada syndrome,SCN10A,sodium voltage-gated channel alpha subunit 10,3p22.2
130,Brugada syndrome,SLMAP,sarcolemma associated protein,3p14.3
130,Brugada syndrome,SCN1B,sodium voltage-gated channel beta subunit 1,19q13.11
130,Brugada syndrome,AKAP9,A-kinase anchoring protein 9,7q21.2
130,Brugada syndrome,KCNE5,potassium voltage-gated channel subfamily E regulatory subunit 5,Xq23
130,Brugada syndrome,RANGRF,RAN guanine nucleotide release factor,17p13.1
130,Brugada syndrome,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
130,Brugada syndrome,SCNN1A,sodium channel epithelial 1 subunit alpha,12p13.31
130,Brugada syndrome,SEMA3A,semaphorin 3A,7q21.11
130,Brugada syndrome,SCN2B,sodium voltage-gated channel beta subunit 2,11q23.3
130,Brugada syndrome,KCNJ8,potassium inwardly rectifying channel subfamily J member 8,12p12.1
130,Brugada syndrome,PKP2,plakophilin 2,12p11.21
277,Severe combined immunodeficiency due to adenosine deaminase deficiency,ADA,adenosine deaminase,20q13.12
443162,NDE1-related microhydranencephaly,NDE1,nudE neurodevelopment protein 1,16p13.11
443811,PGM3-CDG,PGM3,phosphoglucomutase 3,6q14.1
443950,DNAJB2-related Charcot-Marie-Tooth disease type 2,DNAJB2,DnaJ heat shock protein family (Hsp40) member B2,2q35
443988,Ventriculomegaly-cystic kidney disease,CRB2,crumbs cell polarity complex component 2,9q33.3
444092,Autoimmune interstitial lung disease-arthritis syndrome,COPA,COPI coat complex subunit alpha,1q23.2
444099,Autosomal dominant spastic paraplegia type 73,CPT1C,carnitine palmitoyltransferase 1C,19q13.33
444138,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,CAST,calpastatin,5q15
443995,Mandibulofacial dysostosis with alopecia,EDNRA,endothelin receptor type A,4q31.22-q31.23
444048,"46,XX ovarian dysgenesis-short stature syndrome",MCM9,minichromosome maintenance 9 homologous recombination repair factor,6q22.31
444013,Combined oxidative phosphorylation defect type 23,GTPBP3,"GTP binding protein 3, mitochondrial",19p13.11
444069,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome,CENPF,centromere protein F,1q41
444077,Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome,AFF4,ALF transcription elongation factor 4,5q31.1
444072,Cerebellar-facial-dental syndrome,BRF1,BRF1 general transcription factor IIIB subunit,14q32.33
444463,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome due to TPP2 deficiency,TPP2,tripeptidyl peptidase 2,13q33.1
444458,Combined oxidative phosphorylation defect type 24,NARS2,"asparaginyl-tRNA synthetase 2, mitochondrial",11q14.1
445110,Limb-girdle muscular dystrophy due to POMK deficiency,POMK,protein O-mannose kinase,8p11.21
445062,Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome,DNAJC3,DnaJ heat shock protein family (Hsp40) member C3,13q32.1
445038,3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome,CLPB,ClpB family mitochondrial disaggregase,11q13.4
445018,Combined immunodeficiency due to LRBA deficiency,LRBA,LPS responsive beige-like anchor protein,4q31.3
447731,NIK deficiency,MAP3K14,mitogen-activated protein kinase kinase kinase 14,17q21.31
447737,Combined immunodeficiency due to DOCK2 deficiency,DOCK2,dedicator of cytokinesis 2,5q35.1
447740,Aggressive periodontitis,FPR1,formyl peptide receptor 1,19q13.41
447877,Polymerase proofreading-related polyposis,POLE,"DNA polymerase epsilon, catalytic subunit",12q24.33
447877,Polymerase proofreading-related polyposis,POLD1,"DNA polymerase delta 1, catalytic subunit",19q13.3
447896,Tremor-ataxia-central hypomyelination syndrome,POLR3A,RNA polymerase III subunit A,10q22.3
447893,Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome,POLR3A,RNA polymerase III subunit A,10q22.3
447784,Mitochondrial pyruvate carrier deficiency,MPC1,mitochondrial pyruvate carrier 1,6q27
447757,Autosomal dominant spastic paraplegia type 9B,ALDH18A1,aldehyde dehydrogenase 18 family member A1,10q24.1
447753,Autosomal dominant spastic paraplegia type 9A,ALDH18A1,aldehyde dehydrogenase 18 family member A1,10q24.1
447760,Autosomal recessive spastic paraplegia type 9B,ALDH18A1,aldehyde dehydrogenase 18 family member A1,10q24.1
412066,PRKAR1B-related neurodegenerative dementia with intermediate filaments,PRKAR1B,protein kinase cAMP-dependent type I regulatory subunit beta,7p22.3
412057,Autosomal recessive cerebellar ataxia due to STUB1 deficiency,STUB1,STIP1 homology and U-box containing protein 1,16p13.3
412181,Epidermolysis bullosa simplex due to BP230 deficiency,DST,dystonin,6p12.1
412069,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome,AHDC1,AT-hook DNA binding motif containing 1,1p36.11-p35.3
412189,Epidermolysis bullosa simplex due to exophilin 5 deficiency,EXPH5,exophilin 5,11q22.3
412206,Primary failure of tooth eruption,PTH1R,parathyroid hormone 1 receptor,3p21.31
420179,Malan overgrowth syndrome,NFIX,nuclear factor I X,19p13.13
420702,Autosomal recessive severe congenital neutropenia due to CSF3R deficiency,CSF3R,colony stimulating factor 3 receptor,1p34.3
420728,Combined oxidative phosphorylation defect type 20,VARS2,"valyl-tRNA synthetase 2, mitochondrial",6p21.33
420733,Combined oxidative phosphorylation defect type 21,TARS2,"threonyl-tRNA synthetase 2, mitochondrial",1q21.2
420741,RIDDLE syndrome,RNF168,ring finger protein 168,3q29
420492,"Adult-onset cervical dystonia, DYT23 type",CIZ1,CDKN1A interacting zinc finger protein 1,9q34.11
420485,Cranio-cervical dystonia with laryngeal and upper-limb involvement,ANO3,anoctamin 3,11p14.2
420429,"Glycogen storage disease due to acid maltase deficiency, late-onset",GAA,alpha glucosidase,17q25.3
420611,Transient myeloproliferative syndrome,GATA1,GATA binding protein 1,Xp11.23
420584,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome,GLI2,GLI family zinc finger 2,2q14.2
420699,Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency,CXCR2,C-X-C motif chemokine receptor 2,2q35
420686,Woolly hair-palmoplantar keratoderma syndrome,KANK2,KN motif and ankyrin repeat domains 2,19p13.2
420561,Temple-Baraitser syndrome,KCNH1,potassium voltage-gated channel subfamily H member 1,1q32.2
420573,Severe combined immunodeficiency due to CTPS1 deficiency,CTPS1,CTP synthase 1,1p34.2
420566,Bleeding disorder due to CalDAG-GEFI deficiency,RASGRP2,RAS guanyl releasing protein 2,11q13.1
423461,Mucolipidosis type III alpha/beta,GNPTAB,N-acetylglucosamine-1-phosphate transferase subunits alpha and beta,12q23.2
423470,Mucolipidosis type III gamma,GNPTG,N-acetylglucosamine-1-phosphate transferase subunit gamma,16p13.3
423454,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome,GRHL2,grainyhead like transcription factor 2,8q22.3
423384,Severe congenital neutropenia due to JAGN1 deficiency,JAGN1,jagunal homolog 1,3p25.3
423296,Spinocerebellar ataxia type 38,ELOVL5,ELOVL fatty acid elongase 5,6p12.1
423306,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome,QARS1,glutaminyl-tRNA synthetase 1,3p21.31
423479,X-linked intellectual disability-limb spasticity-retinal dystrophy-arginine vasopressin deficiency,PRPS1,phosphoribosyl pyrophosphate synthetase 1,Xq22.3
422526,Hereditary clear cell renal cell carcinoma,OGG1,8-oxoguanine DNA glycosylase,3p25.3
422526,Hereditary clear cell renal cell carcinoma,SLC49A4,solute carrier family 49 member 4,3q21.1
422526,Hereditary clear cell renal cell carcinoma,FLCN,folliculin,17p11.2
422526,Hereditary clear cell renal cell carcinoma,RNF139,ring finger protein 139,8q24.13
422526,Hereditary clear cell renal cell carcinoma,FHIT,fragile histidine triad diadenosine triphosphatase,3p14.2
422526,Hereditary clear cell renal cell carcinoma,HSPBAP1,HSPB1 associated protein 1,3q21.1
422526,Hereditary clear cell renal cell carcinoma,DIRC3,disrupted in renal carcinoma 3,2q35
423275,Spinocerebellar ataxia type 40,CCDC88C,coiled-coil domain containing 88C,14q32.11-q32.12
424107,Congenital myopathy with myasthenic-like onset,RYR1,ryanodine receptor 1,19q13.2
424099,Colobomatous microphthalmia-rhizomelic dysplasia syndrome,MAB21L2,mab-21 like 2,4q31.3
424261,TOR1AIP1-related limb-girdle muscular dystrophy,TOR1AIP1,torsin 1A interacting protein 1,1q25.2
424027,Progressive myoclonic epilepsy type 8,CERS1,ceramide synthase 1,19p13.11
423894,Microcephaly-complex motor and sensory axonal neuropathy syndrome,VRK1,VRK serine/threonine kinase 1,14q32.2
425120,STING-associated vasculopathy with onset in infancy,STING1,stimulator of interferon response cGAMP interactor 1,5q31.2
431361,Progressive encephalopathy with leukodystrophy due to DECR deficiency,NADK2,"NAD kinase 2, mitochondrial",5p13.2
431272,X-linked scapuloperoneal muscular dystrophy,FHL1,four and a half LIM domains 1,Xq26.3
431329,Autosomal recessive spastic paraplegia type 57,TFG,trafficking from ER to golgi regulator,3q12.2
431255,Scapuloperoneal spinal muscular atrophy,TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
431149,Combined immunodeficiency due to OX40 deficiency,TNFRSF4,TNF receptor superfamily member 4,1p36.33
431166,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,IFNAR2,interferon alpha and beta receptor subunit 2,21q22.11
431166,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,STAT2,signal transducer and activator of transcription 2,12q13.3
435438,Progressive myoclonic epilepsy type 7,KCNC1,potassium voltage-gated channel subfamily C member 1,11p15.1
435387,Autosomal dominant Charcot-Marie-Tooth disease type 2Y,VCP,valosin containing protein,9p13.3
434179,Orofaciodigital syndrome type 14,C2CD3,C2 domain containing 3 centriole elongation regulator,11q13.4
504476,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome,RFC1,replication factor C subunit 1,4p14
504523,Severe combined immunodeficiency due to LAT deficiency,LAT,linker for activation of T cells,16p11.2
504530,Combined immunodeficiency due to Moesin deficiency,MSN,moesin,Xq12
26793,Very long chain acyl-CoA dehydrogenase deficiency,ACADVL,acyl-CoA dehydrogenase very long chain,17p13.1
29072,Hereditary pheochromocytoma-paraganglioma,SLC25A11,solute carrier family 25 member 11,17p13.2
29072,Hereditary pheochromocytoma-paraganglioma,KIF1B,kinesin family member 1B,1p36.22
29072,Hereditary pheochromocytoma-paraganglioma,MDH2,malate dehydrogenase 2,7q11.23
29072,Hereditary pheochromocytoma-paraganglioma,DLST,dihydrolipoamide S-succinyltransferase,14q24.3
29072,Hereditary pheochromocytoma-paraganglioma,RET,ret proto-oncogene,10q11.21
29072,Hereditary pheochromocytoma-paraganglioma,SDHA,succinate dehydrogenase complex flavoprotein subunit A,5p15.33
29072,Hereditary pheochromocytoma-paraganglioma,SDHC,succinate dehydrogenase complex subunit C,1q23.3
29072,Hereditary pheochromocytoma-paraganglioma,SDHD,succinate dehydrogenase complex subunit D,11q23.1
29072,Hereditary pheochromocytoma-paraganglioma,FH,fumarate hydratase,1q43
29072,Hereditary pheochromocytoma-paraganglioma,SDHB,succinate dehydrogenase complex iron sulfur subunit B,1p36.13
29072,Hereditary pheochromocytoma-paraganglioma,TMEM127,transmembrane protein 127,2q11.2
29072,Hereditary pheochromocytoma-paraganglioma,MAX,MYC associated factor X,14q23.3
29072,Hereditary pheochromocytoma-paraganglioma,NF1,neurofibromin 1,17q11.2
29072,Hereditary pheochromocytoma-paraganglioma,VHL,von Hippel-Lindau tumor suppressor,3p25.3
29072,Hereditary pheochromocytoma-paraganglioma,SDHAF2,succinate dehydrogenase complex assembly factor 2,11q12.2
28378,Tyrosinemia type 2,TAT,tyrosine aminotransferase,16q22.2
29207,Reactive arthritis,HLA-B,"major histocompatibility complex, class I, B",6p21.33
29207,Reactive arthritis,HLA-B,"major histocompatibility complex, class I, B",6p21.33
29073,Multiple myeloma,CCND1,cyclin D1,11q13.3
320,Apparent mineralocorticoid excess,HSD11B2,hydroxysteroid 11-beta dehydrogenase 2,16q22.1
230,Dopamine beta-hydroxylase deficiency,DBH,dopamine beta-hydroxylase,9q34.2
725,Developmental and epileptic encephalopathy with spike-wave activation in sleep,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,16p13.2
725,Developmental and epileptic encephalopathy with spike-wave activation in sleep,FRRS1L,ferric chelate reductase 1 like,9q31.3
404,Familial hyperaldosteronism type II,CLCN2,chloride voltage-gated channel 2,3q27.1
162,Congenital cataract-anterior segment dysgenesis syndrome,PITX3,paired like homeodomain 3,10q24.32
545,Follicular lymphoma,BCL2,BCL2 apoptosis regulator,18q21.33
545,Follicular lymphoma,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
545,Follicular lymphoma,BCL6,BCL6 transcription repressor,3q27.3
545,Follicular lymphoma,IGH,immunoglobulin heavy locus,14q32.33
88,Idiopathic aplastic anemia,PRF1,perforin 1,10q22.1
88,Idiopathic aplastic anemia,SBDS,SBDS ribosome maturation factor,7q11.21
88,Idiopathic aplastic anemia,IFNG,interferon gamma,12q15
88,Idiopathic aplastic anemia,TERT,telomerase reverse transcriptase,5p15.33
88,Idiopathic aplastic anemia,TERC,telomerase RNA component,3q26.2
824,Primary myelofibrosis,JAK2,Janus kinase 2,9p24.1
824,Primary myelofibrosis,MPL,"MPL proto-oncogene, thrombopoietin receptor",1p34.2
824,Primary myelofibrosis,TET2,tet methylcytosine dioxygenase 2,4q24
824,Primary myelofibrosis,CALR,calreticulin,19p13.13
729,Polycythemia vera,JAK2,Janus kinase 2,9p24.1
25980,X-linked myopathy with excessive autophagy,VMA21,vacuolar ATPase assembly factor VMA21,Xq28
26106,Hereditary diffuse gastric cancer,CDH1,cadherin 1,16q22.1
26106,Hereditary diffuse gastric cancer,MAP3K6,mitogen-activated protein kinase kinase kinase 6,1p36.11
26106,Hereditary diffuse gastric cancer,CTNNA1,catenin alpha 1,5q31.2
26792,Short chain acyl-CoA dehydrogenase deficiency,ACADS,acyl-CoA dehydrogenase short chain,12q24.31
353,Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5,SGCG,sarcoglycan gamma,13q12.12
219,Delta-sarcoglycan-related limb-girdle muscular dystrophy R6,SGCD,sarcoglycan delta,5q33.2-q33.3
119,Beta-sarcoglycan-related limb-girdle muscular dystrophy R4,SGCB,sarcoglycan beta,4q12
603,"Distal myopathy, Welander type",TIA1,TIA1 cytotoxic granule associated RNA binding protein,2p13.3
603,"Distal myopathy, Welander type",SQSTM1,sequestosome 1,5q35.3
603,"Distal myopathy, Welander type",TIA1,TIA1 cytotoxic granule associated RNA binding protein,2p13.3
505227,Combined immunodeficiency due to GINS1 deficiency,GINS1,GINS complex subunit 1,20p11.21
505237,Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome,OTUD6B,OTU deubiquitinase 6B,8q21.3
588,Muscle-eye-brain disease,CRPPA,CDP-L-ribitol pyrophosphorylase A,7p21.2
588,Muscle-eye-brain disease,LARGE1,LARGE xylosyl- and glucuronyltransferase 1,22q12.3
588,Muscle-eye-brain disease,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",1p34.1
588,Muscle-eye-brain disease,POMT1,protein O-mannosyltransferase 1,9q34.13
588,Muscle-eye-brain disease,POMT2,protein O-mannosyltransferase 2,14q24.3
588,Muscle-eye-brain disease,FKTN,fukutin,9q31.2
588,Muscle-eye-brain disease,FKRP,fukutin related protein,19q13.32
588,Muscle-eye-brain disease,B3GALNT2,"beta-1,3-N-acetylgalactosaminyltransferase 2",1q42.3
588,Muscle-eye-brain disease,GMPPB,GDP-mannose pyrophosphorylase B,3p21.31
899,Walker-Warburg syndrome,COL4A1,collagen type IV alpha 1 chain,13q34
899,Walker-Warburg syndrome,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",1p34.1
899,Walker-Warburg syndrome,POMT1,protein O-mannosyltransferase 1,9q34.13
899,Walker-Warburg syndrome,POMT2,protein O-mannosyltransferase 2,14q24.3
899,Walker-Warburg syndrome,FKTN,fukutin,9q31.2
899,Walker-Warburg syndrome,FKRP,fukutin related protein,19q13.32
899,Walker-Warburg syndrome,LARGE1,LARGE xylosyl- and glucuronyltransferase 1,22q12.3
899,Walker-Warburg syndrome,DAG1,dystroglycan 1,3p21.31
899,Walker-Warburg syndrome,CRPPA,CDP-L-ribitol pyrophosphorylase A,7p21.2
899,Walker-Warburg syndrome,POMGNT2,"protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)",3p22.1
899,Walker-Warburg syndrome,RXYLT1,ribitol xylosyltransferase 1,12q14.2
899,Walker-Warburg syndrome,B3GALNT2,"beta-1,3-N-acetylgalactosaminyltransferase 2",1q42.3
899,Walker-Warburg syndrome,B4GAT1,"beta-1,4-glucuronyltransferase 1",11q13.2
899,Walker-Warburg syndrome,POMK,protein O-mannose kinase,8p11.21
505216,3-methylglutaconic aciduria type 9,TIMM50,translocase of inner mitochondrial membrane 50,19q13.2
272,"Congenital muscular dystrophy, Fukuyama type",FKTN,fukutin,9q31.2
505208,3-methylglutaconic aciduria type 8,HTRA2,HtrA serine peptidase 2,2p13.1
268,Dysferlin-related limb-girdle muscular dystrophy R2,DYSF,dysferlin,2p13.2
600,Vocal cord and pharyngeal distal myopathy,MATR3,matrin 3,5q31.2
505248,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders,VPS33A,VPS33A core subunit of CORVET and HOPS complexes,12q24.31
609,Tibial muscular dystrophy,TTN,titin,2q31.2
602,GNE myopathy,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,9p13.3
505242,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,SLC30A9,solute carrier family 30 member 9,4p13
508093,MEPAN syndrome,MECR,mitochondrial trans-2-enoyl-CoA reductase,1p35.3
508533,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome,EXTL3,exostosin like glycosyltransferase 3,8p21.1
508542,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,MYSM1,"Myb like, SWIRM and MPN domains 1",1p32.1
508512,Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome,RMI2,RecQ mediated genome instability 2,16p13.13
508512,Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome,TOP3A,DNA topoisomerase III alpha,17p11.2
508529,Intermediate epidermolysis bullosa simplex with cardiomyopathy,KLHL24,kelch like family member 24,3q27.1
508523,Hyperphenylalaninemia due to DNAJC12 deficiency,DNAJC12,DnaJ heat shock protein family (Hsp40) member C12,10q21.3
508488,8q24.3 microdeletion syndrome,PUF60,poly(U) binding splicing factor 60,8q24.3
508476,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome,HYAL2,hyaluronidase 2,3p21.31
508501,Oral-facial-digital syndrome with short stature and brachymesophalangy,IFT57,intraflagellar transport 57,3q13.12-q13.13
508498,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome,PUF60,poly(U) binding splicing factor 60,8q24.3
505652,CDKL5-deficiency disorder,CDKL5,cyclin dependent kinase like 5,Xp22.13
506334,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency,SGPL1,sphingosine-1-phosphate lyase 1,10q22.1
506307,Stromme syndrome,CENPF,centromere protein F,1q41
506358,Gabriele-de Vries syndrome,YY1,YY1 transcription factor,14q32.2
506353,Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction,SELENOI,selenoprotein I,2p23.3
495274,Charcot-Marie-Tooth disease type 2T,MME,membrane metalloendopeptidase,3q25.2
495844,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy,HIKESHI,heat shock protein nuclear import factor hikeshi,11q14.2
495818,9q33.3q34.11 microdeletion syndrome,LMX1B,LIM homeobox transcription factor 1 beta,9q33.3
495818,9q33.3q34.11 microdeletion syndrome,STXBP1,syntaxin binding protein 1,9q34.11
495875,Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome,MAB21L1,mab-21 like 1,13q13.3
496641,Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome,TBCD,tubulin folding cofactor D,17q25.3
496686,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome,KY,kyphoscoliosis peptidase,3q22.2
496689,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome,KY,kyphoscoliosis peptidase,3q22.2
496751,EVEN-plus syndrome,HSPA9,heat shock protein family A (Hsp70) member 9,5q31.2
496756,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome,TBCE,tubulin folding cofactor E,1q42.3
496790,Ocular anomalies-axonal neuropathy-developmental delay syndrome,ATAD3A,ATPase family AAA domain containing 3A,1p36.33
494433,MIRAGE syndrome,SAMD9,sterile alpha motif domain containing 9,7q21.2
494439,Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome,EXOSC2,exosome component 2,9q34.12
494444,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,DIAPH1,diaphanous related formin 1,5q31.3
494344,RERE-related neurodevelopmental syndrome,RERE,arginine-glutamic acid dipeptide repeats,1p36.23
494547,Squamous cell carcinoma of the hypopharynx,TNFRSF10B,TNF receptor superfamily member 10b,8p21.3
494547,Squamous cell carcinoma of the hypopharynx,PTEN,phosphatase and tensin homolog,10q23.31
494547,Squamous cell carcinoma of the hypopharynx,ING1,inhibitor of growth family member 1,13q34
494541,Childhood-onset benign chorea with striatal involvement,PDE10A,phosphodiesterase 10A,6q27
494526,Infantile-onset generalized dyskinesia with orofacial involvement,PDE10A,phosphodiesterase 10A,6q27
494550,Squamous cell carcinoma of the larynx,TNFRSF10B,TNF receptor superfamily member 10b,8p21.3
494550,Squamous cell carcinoma of the larynx,PTEN,phosphatase and tensin homolog,10q23.31
494550,Squamous cell carcinoma of the larynx,ING1,inhibitor of growth family member 1,13q34
500180,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder,UBTF,upstream binding transcription factor,17q21.31
500188,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome,GPRASP2,G protein-coupled receptor associated sorting protein 2,Xq22.1
500150,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome,SON,SON DNA and RNA binding protein,21q22.11
500159,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,RAC1,Rac family small GTPase 1,7p22.1
302,Inherited epidermodysplasia verruciformis,TMC6,transmembrane channel like 6,17q25.3
302,Inherited epidermodysplasia verruciformis,TMC8,transmembrane channel like 8,17q25.3
302,Inherited epidermodysplasia verruciformis,IL7,interleukin 7,8q21.13
302,Inherited epidermodysplasia verruciformis,CIB1,calcium and integrin binding 1,15q26.1
500166,SIN3-related intellectual disability syndrome due to a point mutation,SIN3A,SIN3 transcription regulator family member A,15q24.2
500166,SIN3-related intellectual disability syndrome due to a point mutation,SIN3B,SIN3 transcription regulator family member B,19p13.11
500135,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,CEP55,centrosomal protein 55,10q23.33
500144,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome,TRAPPC12,trafficking protein particle complex subunit 12,2p25.3
500055,Hao-Fountain syndrome due to 16p13.2 microdeletion,USP7,ubiquitin specific peptidase 7,16p13.2
500095,Tall stature-intellectual disability-renal anomalies syndrome,FIBP,FGF1 intracellular binding protein,11q13.1
500062,Infantile-onset periodic fever-panniculitis-dermatosis syndrome,OTULIN,OTU deubiquitinase with linear linkage specificity,5p15.2
123,Björnstad syndrome,BCS1L,"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone",2q35
898,Wagner disease,VCAN,versican,5q14.2-q14.3
500478,Squamous cell carcinoma of the oropharynx,TNFRSF10B,TNF receptor superfamily member 10b,8p21.3
500478,Squamous cell carcinoma of the oropharynx,PTEN,phosphatase and tensin homolog,10q23.31
500478,Squamous cell carcinoma of the oropharynx,ING1,inhibitor of growth family member 1,13q34
505,Graham Little-Piccardi-Lassueur syndrome,HLA-DRA,"major histocompatibility complex, class II, DR alpha",6p21.32
170,Woolly hair,LPAR6,lysophosphatidic acid receptor 6,13q14.2
170,Woolly hair,LIPH,lipase H,3q27.2
170,Woolly hair,KRT74,keratin 74,12q13.13
170,Woolly hair,KRT71,keratin 71,12q13.13
170,Woolly hair,KRT25,keratin 25,17q21.2
500548,Osteosclerotic metaphyseal dysplasia,LRRK1,leucine rich repeat kinase 1,15q26.3
500533,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome,STRADA,STE20 related adaptor alpha,17q23.3
500545,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract,NACC1,nucleus accumbens associated 1,19p13.13
500464,Squamous cell carcinoma of the nasal cavity and paranasal sinuses,TNFRSF10B,TNF receptor superfamily member 10b,8p21.3
500464,Squamous cell carcinoma of the nasal cavity and paranasal sinuses,PTEN,phosphatase and tensin homolog,10q23.31
500464,Squamous cell carcinoma of the nasal cavity and paranasal sinuses,ING1,inhibitor of growth family member 1,13q34
520,Acute promyelocytic leukemia,PML,PML nuclear body scaffold,15q24.1
520,Acute promyelocytic leukemia,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,17q24.2
520,Acute promyelocytic leukemia,RARA,retinoic acid receptor alpha,17q21.2
520,Acute promyelocytic leukemia,STAT5B,signal transducer and activator of transcription 5B,17q21.2
520,Acute promyelocytic leukemia,FIP1L1,factor interacting with PAPOLA and CPSF1,4q12
520,Acute promyelocytic leukemia,NPM1,nucleophosmin 1,5q35.1
520,Acute promyelocytic leukemia,NABP1,nucleic acid binding protein 1,2q32.3
520,Acute promyelocytic leukemia,ZBTB16,zinc finger and BTB domain containing 16,11q23.2
520,Acute promyelocytic leukemia,NUMA1,nuclear mitotic apparatus protein 1,11q13.4
520,Acute promyelocytic leukemia,TBL1XR1,TBL1X/Y related 1,3q26.32
520,Acute promyelocytic leukemia,IRF2BP2,interferon regulatory factor 2 binding protein 2,1q42.3
520,Acute promyelocytic leukemia,STAT3,signal transducer and activator of transcription 3,17q21.2
520,Acute promyelocytic leukemia,BCOR,BCL6 corepressor,Xp11.4
502363,Squamous cell carcinoma of the oral cavity,TNFRSF10B,TNF receptor superfamily member 10b,8p21.3
502363,Squamous cell carcinoma of the oral cavity,PTEN,phosphatase and tensin homolog,10q23.31
502363,Squamous cell carcinoma of the oral cavity,ING1,inhibitor of growth family member 1,13q34
502366,Squamous cell carcinoma of the lip,TNFRSF10B,TNF receptor superfamily member 10b,8p21.3
502366,Squamous cell carcinoma of the lip,PTEN,phosphatase and tensin homolog,10q23.31
502366,Squamous cell carcinoma of the lip,ING1,inhibitor of growth family member 1,13q34
502423,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,MSTO1,misato mitochondrial distribution and morphology regulator 1,1q22
502430,Weiss-Kruszka Syndrome,ZNF462,zinc finger protein 462,9q31.2
502434,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome,STAG1,STAG1 cohesin complex component,3q22.3
502444,Alkaline ceramidase 3 deficiency,ACER3,alkaline ceramidase 3,11q13.5
432,Normosmic congenital hypogonadotropic hypogonadism,NHLH2,nescient helix-loop-helix 2,1p13.1
432,Normosmic congenital hypogonadotropic hypogonadism,PROK2,prokineticin 2,3p13
432,Normosmic congenital hypogonadotropic hypogonadism,PROKR2,prokineticin receptor 2,20p12.3
432,Normosmic congenital hypogonadotropic hypogonadism,CHD7,chromodomain helicase DNA binding protein 7,8q12.2
432,Normosmic congenital hypogonadotropic hypogonadism,FGFR1,fibroblast growth factor receptor 1,8p11.23
432,Normosmic congenital hypogonadotropic hypogonadism,GNRHR,gonadotropin releasing hormone receptor,4q13.2
432,Normosmic congenital hypogonadotropic hypogonadism,KISS1R,KISS1 receptor,19p13.3
432,Normosmic congenital hypogonadotropic hypogonadism,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,9q34.3
432,Normosmic congenital hypogonadotropic hypogonadism,GNRH1,gonadotropin releasing hormone 1,8p21.2
432,Normosmic congenital hypogonadotropic hypogonadism,FGF8,fibroblast growth factor 8,10q24.32
432,Normosmic congenital hypogonadotropic hypogonadism,TAC3,tachykinin precursor 3,12q13.3
432,Normosmic congenital hypogonadotropic hypogonadism,TACR3,tachykinin receptor 3,4q24
432,Normosmic congenital hypogonadotropic hypogonadism,WDR11,WD repeat domain 11,10q26.12
432,Normosmic congenital hypogonadotropic hypogonadism,HS6ST1,heparan sulfate 6-O-sulfotransferase 1,2q14.3
432,Normosmic congenital hypogonadotropic hypogonadism,KISS1,KiSS-1 metastasis suppressor,1q32.1
432,Normosmic congenital hypogonadotropic hypogonadism,FGF17,fibroblast growth factor 17,8p21.3
432,Normosmic congenital hypogonadotropic hypogonadism,DUSP6,dual specificity phosphatase 6,12q21.33
432,Normosmic congenital hypogonadotropic hypogonadism,SPRY4,sprouty RTK signaling antagonist 4,5q31.3
91,Aromatase deficiency,CYP19A1,cytochrome P450 family 19 subfamily A member 1,15q21.2
785,Estrogen resistance syndrome,ESR1,estrogen receptor 1,6q25.1-q25.2
873,Desmoid tumor,CTNNB1,catenin beta 1,3p22.1
873,Desmoid tumor,APC,APC regulator of WNT signaling pathway,5q22.2
703,Bullous pemphigoid,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
703,Bullous pemphigoid,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",6p21.32
841,Sebocystomatosis,KRT17,keratin 17,17q21.2
867,Familial multiple trichoepithelioma,CYLD,CYLD lysine 63 deubiquitinase,16q12.1
735,Porokeratosis of Mibelli,MVK,mevalonate kinase,12q24.11
735,Porokeratosis of Mibelli,PMVK,phosphomevalonate kinase,1q21.3
497906,Childhood-onset basal ganglia degeneration syndrome,VAC14,VAC14 component of PIKFYVE complex,16q22.1-q22.2
659,Mutilating palmoplantar keratoderma with periorificial keratotic plaques,PERP,p53 apoptosis effector related to PMP22,6q23.3
659,Mutilating palmoplantar keratoderma with periorificial keratotic plaques,MBTPS2,"membrane bound transcription factor peptidase, site 2",Xp22.12
659,Mutilating palmoplantar keratoderma with periorificial keratotic plaques,TRPV3,transient receptor potential cation channel subfamily V member 3,17p13.2
523,Hereditary leiomyomatosis and renal cell cancer,FH,fumarate hydratase,1q43
497757,MME-related autosomal dominant Charcot Marie Tooth disease type 2,MME,membrane metalloendopeptidase,3q25.2
497764,Spinocerebellar ataxia type 43,MME,membrane metalloendopeptidase,3q25.2
530,Lipoid proteinosis,ECM1,extracellular matrix protein 1,1q21.2
734,Alpha delta granule deficiency,GFI1B,growth factor independent 1B transcriptional repressor,9q34.13
721,Gray platelet syndrome,NBEAL2,neurobeachin like 2,3p21.31
722,Hypoplasminogenemia,PLG,plasminogen,6q26
749,Congenital prekallikrein deficiency,KLKB1,kallikrein B1,4q35.2
853,Fetal and neonatal alloimmune thrombocytopenia,GP1BA,glycoprotein Ib platelet subunit alpha,17p13.2
853,Fetal and neonatal alloimmune thrombocytopenia,GP1BB,glycoprotein Ib platelet subunit beta,22q11.21
853,Fetal and neonatal alloimmune thrombocytopenia,ITGA2B,integrin subunit alpha 2b,17q21.31
853,Fetal and neonatal alloimmune thrombocytopenia,ITGB3,integrin subunit beta 3,17q21.32
853,Fetal and neonatal alloimmune thrombocytopenia,ITGA2,integrin subunit alpha 2,5q11.2
853,Fetal and neonatal alloimmune thrombocytopenia,CD109,CD109 molecule,6q13
483,Congenital high-molecular-weight kininogen deficiency,KNG1,kininogen 1,3q27.3
498359,Aquagenic palmoplantar keratoderma,CFTR,CF transmembrane conductance regulator,7q31.2
852,X-linked thrombocytopenia with normal platelets,WAS,WASP actin nucleation promoting factor,Xp11.23
465,Congenital plasminogen activator inhibitor type 1 deficiency,SERPINE1,serpin family E member 1,7q22.1
498251,Menstrual cycle-dependent periodic fever,HTR1A,5-hydroxytryptamine receptor 1A,5q12.3
143,Parathyroid carcinoma,CDC73,cell division cycle 73,1q31.2
786,Generalized glucocorticoid resistance syndrome,NR3C1,nuclear receptor subfamily 3 group C member 1,5q31.3
334,Hereditary atrial fibrillation,ABCC9,ATP binding cassette subfamily C member 9,12p12.1
334,Hereditary atrial fibrillation,PITX2,paired like homeodomain 2,4q25
334,Hereditary atrial fibrillation,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
334,Hereditary atrial fibrillation,GATA4,GATA binding protein 4,8p23.1
334,Hereditary atrial fibrillation,KCNE1,potassium voltage-gated channel subfamily E regulatory subunit 1,21q22.12
334,Hereditary atrial fibrillation,KCNE2,potassium voltage-gated channel subfamily E regulatory subunit 2,21q22.11
334,Hereditary atrial fibrillation,KCNJ2,potassium inwardly rectifying channel subfamily J member 2,17q24.3
334,Hereditary atrial fibrillation,KCNQ1,potassium voltage-gated channel subfamily Q member 1,11p15.5-p15.4
334,Hereditary atrial fibrillation,NKX2-5,NK2 homeobox 5,5q35.1
334,Hereditary atrial fibrillation,GJA5,gap junction protein alpha 5,1q21.2
334,Hereditary atrial fibrillation,SCN1B,sodium voltage-gated channel beta subunit 1,19q13.11
334,Hereditary atrial fibrillation,KCNJ3,potassium inwardly rectifying channel subfamily J member 3,2q24.1
334,Hereditary atrial fibrillation,MYL4,myosin light chain 4,17q21.32
334,Hereditary atrial fibrillation,TTN,titin,2q31.2
334,Hereditary atrial fibrillation,NKX2-6,NK2 homeobox 6,8p21.2
334,Hereditary atrial fibrillation,SCN4B,sodium voltage-gated channel beta subunit 4,11q23.3
334,Hereditary atrial fibrillation,KCNA5,potassium voltage-gated channel subfamily A member 5,12p13.32
334,Hereditary atrial fibrillation,NUP155,nucleoporin 155,5p13.2
334,Hereditary atrial fibrillation,NPPA,natriuretic peptide A,1p36.22
334,Hereditary atrial fibrillation,SCN3B,sodium voltage-gated channel beta subunit 3,11q24.1
334,Hereditary atrial fibrillation,GATA6,GATA binding protein 6,18q11.2
334,Hereditary atrial fibrillation,GATA5,GATA binding protein 5,20q13.33
334,Hereditary atrial fibrillation,SCN2B,sodium voltage-gated channel beta subunit 2,11q23.3
334,Hereditary atrial fibrillation,KCNJ5,potassium inwardly rectifying channel subfamily J member 5,11q24.3
615,Familial atrial myxoma,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,17q24.2
498497,Short rib-polydactyly syndrome type 5,WDR35,WD repeat domain 35,2p24.1
498693,MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome,MYBPC1,myosin binding protein C1,12q23.2
444,Marie Unna hereditary hypotrichosis,EPS8L3,EPS8 signaling adaptor L3,1p13.3
444,Marie Unna hereditary hypotrichosis,HR,HR lysine demethylase and nuclear receptor corepressor,8p21.3
498481,LRP5-related primary osteoporosis,LRP5,LDL receptor related protein 5,11q13.2
498481,LRP5-related primary osteoporosis,LRP5,LDL receptor related protein 5,11q13.2
573,Monilethrix,KRT86,keratin 86,12q13
573,Monilethrix,KRT83,keratin 83,12q13.13
573,Monilethrix,KRT81,keratin 81,12q13.13
573,Monilethrix,DSG4,desmoglein 4,18q12.1
840,Syringocystadenoma papilliferum,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
498494,Mirror-image polydactyly,PITX1,paired like homeodomain 1,5q31.1
384,Huriez syndrome,SMARCAD1,SNF2 related chromatin remodeling ATPase with DExD box 1,4q22.3
41,Dyschromatosis symmetrica hereditaria,ADAR,adenosine deaminase RNA specific,1q21.3
122,Birt-Hogg-Dubé syndrome,PRDM10,PR/SET domain 10,11q24.3
122,Birt-Hogg-Dubé syndrome,FLCN,folliculin,17p11.2
38,Acrokeratoelastoidosis of Costa,CCDC91,coiled-coil domain containing 91,12p11.22
241,Dyschromatosis universalis hereditaria,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
316,Progressive symmetric erythrokeratodermia,TRPM4,transient receptor potential cation channel subfamily M member 4,19q13.33
316,Progressive symmetric erythrokeratodermia,KRT83,keratin 83,12q13.13
316,Progressive symmetric erythrokeratodermia,KDSR,3-ketodihydrosphingosine reductase,18q21.33
316,Progressive symmetric erythrokeratodermia,LORICRIN,loricrin cornified envelope precursor protein,1q21.3
211,Familial cylindromatosis,CYLD,CYLD lysine 63 deubiquitinase,16q12.1
2908,Kindler epidermolysis bullosa,FERMT1,FERM domain containing kindlin 1,20p12.3
779,Reynolds syndrome,LBR,lamin B receptor,1q42.12
486811,Prenatal-onset spinal muscular atrophy with congenital bone fractures,ASCC1,activating signal cointegrator 1 complex subunit 1,10q22.1
486811,Prenatal-onset spinal muscular atrophy with congenital bone fractures,TRIP4,thyroid hormone receptor interactor 4,15q22.31
486815,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,TRIP4,thyroid hormone receptor interactor 4,15q22.31
485418,EMILIN-1-related connective tissue disease,EMILIN1,elastin microfibril interfacer 1,2p23.3
485421,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect,MFF,mitochondrial fission factor,2q36.3
485350,CLCN4-related X-linked intellectual disability syndrome,CLCN4,chloride voltage-gated channel 4,Xp22.2
485275,Acquired schizencephaly,EMX2,empty spiracles homeobox 2,10q26.11
485275,Acquired schizencephaly,SIX3,SIX homeobox 3,2p21
485275,Acquired schizencephaly,SHH,sonic hedgehog signaling molecule,7q36.3
482606,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome,FLNA,filamin A,Xq28
482601,Adenylosuccinate synthetase-like 1-related distal myopathy,ADSS1,adenylosuccinate synthase 1,14q32.33
480864,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome,TANGO2,transport and golgi organization 2 homolog,22q11.21
31837,Pulmonary venoocclusive disease,BMPR2,bone morphogenetic protein receptor type 2,2q33.1-q33.2
31837,Pulmonary venoocclusive disease,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,15q15.1
480907,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome,TAF1,TATA-box binding protein associated factor 1,Xq13.1
480898,Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome,EMC1,ER membrane protein complex subunit 1,1p36.13
480880,X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability,USP9X,ubiquitin specific peptidase 9 X-linked,Xp11.4
31740,Hypersensitivity pneumonitis,MUC5B,"mucin 5B, oligomeric mucus/gel-forming",11p15.5
480556,Isolated neonatal sclerosing cholangitis,DCDC2,doublecortin domain containing 2,6p22.3
480541,High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement,BCL6,BCL6 transcription repressor,3q27.3
480541,High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement,MYC,"MYC proto-oncogene, bHLH transcription factor",8q24.21
480541,High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement,BCL2,BCL2 apoptosis regulator,18q21.33
31709,Infantile convulsions and choreoathetosis,PDE2A,phosphodiesterase 2A,11q13.4
31709,Infantile convulsions and choreoathetosis,PRRT2,proline rich transmembrane protein 2,16p11.2
31709,Infantile convulsions and choreoathetosis,SCN8A,sodium voltage-gated channel alpha subunit 8,12q13.13
480851,Hereditary thrombocytopenia with early-onset myelofibrosis,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",20q11.23
480682,POGLUT1-related limb-girdle muscular dystrophy R21,POGLUT1,protein O-glucosyltransferase 1,3q13.33
481665,USP18 deficiency,USP18,ubiquitin specific peptidase 18,22q11.21
482077,HTRA1-related autosomal dominant cerebral small vessel disease,HTRA1,HtrA serine peptidase 1,10q26.13
481986,Familial schizencephaly,COL4A1,collagen type IV alpha 1 chain,13q34
481152,PYCR2-related microcephaly-progressive leukoencephalopathy,PYCR2,pyrroline-5-carboxylate reductase 2,1q42.12
481662,Familial Chilblain lupus,SAMHD1,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1,20q11.23
481662,Familial Chilblain lupus,TREX1,three prime repair exonuclease 1,3p21.31
481662,Familial Chilblain lupus,STING1,stimulator of interferon response cGAMP interactor 1,5q31.2
480476,Progressive familial intrahepatic cholestasis type 5,NR1H4,nuclear receptor subfamily 1 group H member 4,12q23.1
480491,MYO5B-related progressive familial intrahepatic cholestasis,MYO5B,myosin VB,18q21.1
480483,Progressive familial intrahepatic cholestasis type 4,TJP2,tight junction protein 2,9q21.11
480528,Lethal hydranencephaly-diaphragmatic hernia syndrome,PLAT,"plasminogen activator, tissue type",8p11.21
480536,MSH3-related polyposis,MSH3,mutS homolog 3,5q14.1
477814,Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,DIAPH1,diaphanous related formin 1,5q31.3
477787,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,PLA2G4A,phospholipase A2 group IVA,1q31.1
478029,Combined oxidative phosphorylation defect type 29,TXN2,thioredoxin 2,22q12.3
478042,Combined oxidative phosphorylation defect type 30,TRMT10C,"tRNA methyltransferase 10C, mitochondrial RNase P subunit",3q12.3
477993,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,KDM1A,lysine demethylase 1A,1p36.12
477857,Mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,RORC,RAR related orphan receptor C,1q21.3
477817,PMP22-RAI1 contiguous gene duplication syndrome,RAI1,retinoic acid induced 1,17p11.2
477831,Kosaki overgrowth syndrome,PDGFRB,platelet derived growth factor receptor beta,5q32
478049,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome,MIPEP,mitochondrial intermediate peptidase,13q12.12
478664,Hereditary sensory and autonomic neuropathy type 8,PRDM12,PR/SET domain 12,9q34.12
477661,IL21-related infantile inflammatory bowel disease,IL21,interleukin 21,4q27
477684,Combined oxidative phosphorylation defect type 26,TRMT5,tRNA methyltransferase 5,14q23.1
477673,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,GPT2,glutamic--pyruvic transaminase 2,16q11.2
477738,Pediatric multiple sclerosis,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",6p21.32
477738,Pediatric multiple sclerosis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
477749,Pontine autosomal dominant microangiopathy with leukoencephalopathy,COL4A1,collagen type IV alpha 1 chain,13q34
477742,Nodular fasciitis,USP6,ubiquitin specific peptidase 6,17p13.2
477742,Nodular fasciitis,MYH9,myosin heavy chain 9,22q12.3
477774,Combined oxidative phosphorylation defect type 27,CARS2,"cysteinyl-tRNA synthetase 2, mitochondrial",13q34
476119,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome,SHH,sonic hedgehog signaling molecule,7q36.3
476113,Combined immunodeficiency due to TFRC deficiency,TFRC,transferrin receptor,3q29
476126,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome,TRIO,trio Rho guanine nucleotide exchange factor,5p15.2
476406,Congenital generalized hypercontractile muscle stiffness syndrome,TPM3,tropomyosin 3,1q21.3
476394,PMP2-related Charcot-Marie-Tooth disease type 1,PMP2,peripheral myelin protein 2,8q21.13
493342,Vibratory urticaria,ADGRE2,adhesion G protein-coupled receptor E2,19p13.12
488642,TELO2-related intellectual disability-neurodevelopmental disorder,TELO2,telomere maintenance 2,16p13.3
488647,DDX41-related hematologic malignancy predisposition syndrome,DDX41,DEAD-box helicase 41,5q35.3
488650,"Distal myopathy, Tateyama type",CAV3,caveolin 3,3p25.3
488618,Transketolase deficiency,TKT,transketolase,3p21.1
488627,Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome,PUS3,pseudouridine synthase 3,11q24.2
488632,TBCK-related encephalopathy-severe hypotonia-craniofacial dysmorphism syndrome,TBCK,TBC1 domain containing kinase,4q24
488635,Early-onset epilepsy-intellectual disability-brain anomalies syndrome,PIGG,phosphatidylinositol glycan anchor biosynthesis class G (EMM blood group),4p16.3
488265,Osteofibrous dysplasia,MET,"MET proto-oncogene, receptor tyrosine kinase",7q31.2
488232,Split-foot malformation-mesoaxial polydactyly syndrome,MAP3K20,mitogen-activated protein kinase kinase kinase 20,2q31.1
488333,Autosomal dominant Charcot-Marie-Tooth disease type 2W,HARS1,histidyl-tRNA synthetase 1,5q31.3
488437,SIX2-related frontonasal dysplasia,SIX2,SIX homeobox 2,2p21
488613,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,GNB1,G protein subunit beta 1,1p36.33
488594,Autosomal recessive spastic paraplegia type 76,CAPN1,calpain 1,11q13.1
488197,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,MIR204,microRNA 204,9q21.12
488168,Microcephaly-congenital cataract-psoriasiform dermatitis syndrome,MSMO1,methylsterol monooxygenase 1,4q32.3
488191,Female infertility due to oocyte meiotic arrest,TLE6,"TLE family member 6, subcortical maternal complex member",19p13.3
488191,Female infertility due to oocyte meiotic arrest,WEE2,WEE2 oocyte meiosis inhibiting kinase,7q34
488191,Female infertility due to oocyte meiotic arrest,PANX1,pannexin 1,11q21
488191,Female infertility due to oocyte meiotic arrest,PATL2,PAT1 homolog 2,15q21.1
488191,Female infertility due to oocyte meiotic arrest,TUBB8,tubulin beta 8 class VIII,10p15.3
487796,Takenouchi-Kosaki syndrome,CDC42,cell division cycle 42,1p36.12
487814,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,DGAT2,diacylglycerol O-acyltransferase 2,11q13.5
487825,Pierpont syndrome,TBL1XR1,TBL1X/Y related 1,3q26.32
31150,Tangier disease,ABCA1,ATP binding cassette subfamily A member 1,9q31.1
31043,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement,CLDN16,claudin 16,3q28
31112,Dermatofibrosarcoma protuberans,COL1A1,collagen type I alpha 1 chain,17q21.33
31112,Dermatofibrosarcoma protuberans,PDGFB,platelet derived growth factor subunit B,22q13.1
30924,Primary hypomagnesemia with secondary hypocalcemia,TRPM6,transient receptor potential cation channel subfamily M member 6,9q21.13
30925,Hereditary arginine vasopressin deficiency,AVP,arginine vasopressin,20p13
476084,BVES-related limb-girdle muscular dystrophy,POPDC1,popeye domain cAMP effector 1,6q21
476096,Erythrokeratodermia-cardiomyopathy syndrome,DSP,desmoplakin,6p24.3
476093,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome,HSPB8,heat shock protein family B (small) member 8,12q24.23
71278,Congenital brain dysgenesis due to glutamine synthetase deficiency,GLUL,glutamate-ammonia ligase,1q25.3
71271,Split hand-split foot-deafness syndrome,DLX5,distal-less homeobox 5,7q21.3
71275,Rh deficiency syndrome,RHCE,Rh blood group CcEe antigens,1p36.11
71275,Rh deficiency syndrome,RHD,Rh blood group D antigen,1p36.11
71275,Rh deficiency syndrome,RHAG,Rh associated glycoprotein,6p12.3
71277,Classic glucose transporter type 1 deficiency syndrome,SLC2A1,solute carrier family 2 member 1,1p34.2
71212,Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,HADH,hydroxyacyl-CoA dehydrogenase,4q25
70592,Transient predisposition to invasive pyogenic bacterial infection,MYD88,MYD88 innate immune signal transduction adaptor,3p22.2
70592,Transient predisposition to invasive pyogenic bacterial infection,IRAK4,interleukin 1 receptor associated kinase 4,12q12
70595,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
70595,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome,TWNK,twinkle mtDNA helicase,10q24.31
70594,Dopa-responsive dystonia due to sepiapterin reductase deficiency,SPR,sepiapterin reductase,2p13.2
70573,Small cell lung cancer,RB1,RB transcriptional corepressor 1,13q14.2
70573,Small cell lung cancer,TP53,tumor protein p53,17p13.1
70573,Small cell lung cancer,TP73,tumor protein p73,1p36.32
70472,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type",LRPPRC,leucine rich pentatricopeptide repeat containing,2p21
70567,Cholangiocarcinoma,BRCA1,BRCA1 DNA repair associated,17q21.31
70567,Cholangiocarcinoma,BRCA2,BRCA2 DNA repair associated,13q13.1
70567,Cholangiocarcinoma,ROS1,"ROS proto-oncogene 1, receptor tyrosine kinase",6q22.1
70567,Cholangiocarcinoma,PTPN3,protein tyrosine phosphatase non-receptor type 3,9q31.3
69735,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome,SOX18,SRY-box transcription factor 18,20q13.33
69737,Bosley-Salih-Alorainy syndrome,HOXA1,homeobox A1,7p15.2
69739,Athabaskan brainstem dysgenesis syndrome,HOXA1,homeobox A1,7p15.2
69663,Low phospholipid-associated cholelithiasis,ABCB4,ATP binding cassette subfamily B member 4,7q21.12
69665,Intrahepatic cholestasis of pregnancy,NR1H4,nuclear receptor subfamily 1 group H member 4,12q23.1
69665,Intrahepatic cholestasis of pregnancy,ABCB11,ATP binding cassette subfamily B member 11,2q31.1
69665,Intrahepatic cholestasis of pregnancy,ABCB4,ATP binding cassette subfamily B member 4,7q21.12
69665,Intrahepatic cholestasis of pregnancy,ATP8B1,ATPase phospholipid transporting 8B1,18q21.31
69723,Tyrosinemia type 3,HPD,4-hydroxyphenylpyruvate dioxygenase,12q24.31
69126,PAPA syndrome,PSTPIP1,proline-serine-threonine phosphatase interacting protein 1,15q24.3
69087,Naegeli-Franceschetti-Jadassohn syndrome,KRT14,keratin 14,17q21.2
69088,Hypohidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome,IKBKG,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,Xq28
69085,Limb-mammary syndrome,TP63,tumor protein p63,3q28
69084,Pure hair and nail ectodermal dysplasia,KRT85,keratin 85,12q13.13
69084,Pure hair and nail ectodermal dysplasia,KRT74,keratin 74,12q13.13
69084,Pure hair and nail ectodermal dysplasia,HOXC13,homeobox C13,12q13.13
69076,Familial renal glucosuria,SLC5A2,solute carrier family 5 member 2,16p11.2
69063,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization,MME,membrane metalloendopeptidase,3q25.2
67046,3-methylglutaconic aciduria type 1,AUH,AU RNA binding methylglutaconyl-CoA hydratase,9q22.31
67047,3-methylglutaconic aciduria type 3,MICOS13,mitochondrial contact site and cristae organizing system subunit 13,19p13.3
67047,3-methylglutaconic aciduria type 3,OPA3,outer mitochondrial membrane lipid metabolism regulator OPA3,19q13.32
67044,Thrombocytopenia with congenital dyserythropoietic anemia,GATA1,GATA binding protein 1,Xp11.23
67045,X-linked intellectual disability with isolated growth hormone deficiency,SOX3,SRY-box transcription factor 3,Xq27.1
67042,Late-onset retinal degeneration,C1QTNF5,C1q and TNF related 5,11q23.3
67041,Hyaluronidase deficiency,HYAL1,hyaluronidase 1,3p21.31
67038,B-cell chronic lymphocytic leukemia,P2RX7,purinergic receptor P2X 7,12q24.31
67038,B-cell chronic lymphocytic leukemia,IGHV3-21,immunoglobulin heavy variable 3-21,14q32.33
67038,B-cell chronic lymphocytic leukemia,ATM,ATM serine/threonine kinase,11q22.3
67038,B-cell chronic lymphocytic leukemia,CCND1,cyclin D1,11q13.3
67038,B-cell chronic lymphocytic leukemia,TP53,tumor protein p53,17p13.1
67038,B-cell chronic lymphocytic leukemia,ARL11,ARF like GTPase 11,13q14.2
67038,B-cell chronic lymphocytic leukemia,IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),14q32.33
67038,B-cell chronic lymphocytic leukemia,POT1,protection of telomeres 1,7q31.33
67038,B-cell chronic lymphocytic leukemia,RPS15,ribosomal protein S15,19p13.3
67038,B-cell chronic lymphocytic leukemia,IKZF3,IKAROS family zinc finger 3,17q12-q21.1
67036,Autosomal dominant optic atrophy and cataract,OPA3,outer mitochondrial membrane lipid metabolism regulator OPA3,19q13.32
66637,Diaphanospondylodysostosis,BMPER,BMP binding endothelial regulator,7p14.3
66634,Dilated cardiomyopathy with ataxia,DNAJC19,DnaJ heat shock protein family (Hsp40) member C19,3q26.33
66631,CEDNIK syndrome,SNAP29,synaptosome associated protein 29,22q11.21
66629,Goldberg-Shprintzen megacolon syndrome,KIFBP,kinesin family binding protein,10q22.1
66628,Obesity due to congenital leptin deficiency,LEP,leptin,7q32.1
65282,Carvajal syndrome,DSP,desmoplakin,6p24.3
65285,Lhermitte-Duclos disease,PTEN,phosphatase and tensin homolog,10q23.31
65284,Biotin-thiamine-responsive basal ganglia disease,SLC19A3,solute carrier family 19 member 3,2q36.3
65287,Beta-ureidopropionase deficiency,UPB1,beta-ureidopropionase 1,22q11.23
65288,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,PTF1A,pancreas associated transcription factor 1a,10p12.2
65684,Monomelic amyotrophy,CPLANE1,ciliogenesis and planar polarity effector complex subunit 1,5p13.2
65684,Monomelic amyotrophy,CEP126,centrosomal protein 126,11q22.1
65748,Multiple self-healing squamous epithelioma,TGFBR1,transforming growth factor beta receptor 1,9q22.33
65743,Autosomal dominant multiple pterygium syndrome,MYH3,myosin heavy chain 3,17p13.1
65759,Carpenter syndrome,MEGF8,multiple EGF like domains 8,19q13.2
65759,Carpenter syndrome,RAB23,"RAB23, member RAS oncogene family",6p12.1-p11.2
64748,Dejerine-Sottas syndrome,PMP22,peripheral myelin protein 22,17p12
64748,Dejerine-Sottas syndrome,PRX,periaxin,19q13.2
64748,Dejerine-Sottas syndrome,EGR2,early growth response 2,10q21.3
64748,Dejerine-Sottas syndrome,MPZ,myelin protein zero,1q23.3
64751,Hereditary motor and sensory neuropathy type 5,MFN2,mitofusin 2,1p36.22
562509,Heme oxygenase-1 deficiency,HMOX1,heme oxygenase 1,22q12.3
64752,Hereditary sensory and autonomic neuropathy type 5,NTRK1,neurotrophic receptor tyrosine kinase 1,1q23.1
64752,Hereditary sensory and autonomic neuropathy type 5,NGF,nerve growth factor,1p13.2
64753,Spinocerebellar ataxia with axonal neuropathy type 2,SETX,senataxin,9q34.13
64753,Spinocerebellar ataxia with axonal neuropathy type 2,PIK3R5,phosphoinositide-3-kinase regulatory subunit 5,17p13.1
64754,Nevus comedonicus syndrome,NEK9,NIMA related kinase 9,14q24.3
562528,Congenital limbs-face contractures-hypotonia-developmental delay syndrome,NALCN,"sodium leak channel, non-selective",13q32.3-q33.1
64755,Becker nevus syndrome,ACTB,actin beta,7p22.1
562559,Anterior maxillary protrusion-strabismus-intellectual disability syndrome,SOBP,sine oculis binding protein homolog,6q21
562538,Autosomal recessive extra-oral halitosis,SELENBP1,selenium binding protein 1,1q21.3
562569,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome,TMEM94,transmembrane protein 94,17q25.1
64280,Childhood absence epilepsy,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,5q34
64280,Childhood absence epilepsy,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,5q34
64280,Childhood absence epilepsy,GABRB3,gamma-aminobutyric acid type A receptor subunit beta3,15q12
64280,Childhood absence epilepsy,CACNA1H,calcium voltage-gated channel subunit alpha1 H,16p13.3
64280,Childhood absence epilepsy,JRK,Jrk helix-turn-helix protein,8q24.3
64739,Ovarian hyperstimulation syndrome,FSHR,follicle stimulating hormone receptor,2p16.3
63269,Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis,POR,cytochrome p450 oxidoreductase,7q11.23
63260,Craniorachischisis,DACT1,dishevelled binding antagonist of beta catenin 1,14q23.1
63442,Angel-shaped phalango-epiphyseal dysplasia,GDF5,growth differentiation factor 5,20q11.22
63273,Distal myopathy with posterior leg and anterior hand involvement,FLNC,filamin C,7q32.1
63446,Acrocapitofemoral dysplasia,IHH,Indian hedgehog signaling molecule,2q35
60040,Megalencephaly-capillary malformation-polymicrogyria syndrome,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
60033,Idiopathic bronchiectasis,CFTR,CF transmembrane conductance regulator,7q31.2
60033,Idiopathic bronchiectasis,SCNN1A,sodium channel epithelial 1 subunit alpha,12p13.31
60033,Idiopathic bronchiectasis,SCNN1B,sodium channel epithelial 1 subunit beta,16p12.2
60033,Idiopathic bronchiectasis,SCNN1G,sodium channel epithelial 1 subunit gamma,16p12.2
59303,Neonatal ichthyosis-sclerosing cholangitis syndrome,CLDN1,claudin 1,3q28
59306,McLeod neuroacanthocytosis syndrome,XK,"X-linked Kx blood group antigen, Kell and VPS13A binding protein",Xp21.1
60015,Enlarged parietal foramina,ALX4,ALX homeobox 4,11p11.2
60015,Enlarged parietal foramina,MSX2,msh homeobox 2,5q35.2
60025,Pulmonary alveolar microlithiasis,SLC34A2,solute carrier family 34 member 2,4p15.2
564178,Primary hypomagnesemia-refractory seizures-intellectual disability syndrome,ATP1A1,ATPase Na+/K+ transporting subunit alpha 1,1p13.1
60030,Loeys-Dietz syndrome,TGFB2,transforming growth factor beta 2,1q41
60030,Loeys-Dietz syndrome,TGFB3,transforming growth factor beta 3,14q24.3
60030,Loeys-Dietz syndrome,SMAD2,SMAD family member 2,18q21.1
60030,Loeys-Dietz syndrome,SMAD3,SMAD family member 3,15q22.33
60030,Loeys-Dietz syndrome,IPO8,importin 8,12p11.21
60030,Loeys-Dietz syndrome,TGFBR1,transforming growth factor beta receptor 1,9q22.33
60030,Loeys-Dietz syndrome,TGFBR2,transforming growth factor beta receptor 2,3p24.1
563708,Syndromic congenital sodium diarrhea,SPINT2,"serine peptidase inhibitor, Kunitz type 2",19q13.2
59181,Sorsby pseudoinflammatory fundus dystrophy,TIMP3,TIMP metallopeptidase inhibitor 3,22q12.3
59135,Laing distal myopathy,MYH7,myosin heavy chain 7,14q11.2
58017,Classic hairy cell leukemia,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
57782,Mazabraud syndrome,GNAS,GNAS complex locus,20q13.32
55595,TNP03-related limb-girdle muscular dystrophy D2,TNPO3,transportin 3,7q32.1
55596,HNRNPDL-related limb-girdle muscular dystrophy D3,HNRNPDL,heterogeneous nuclear ribonucleoprotein D like,4q21.22
54595,Craniopharyngioma,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
54595,Craniopharyngioma,CTNNB1,catenin beta 1,3p22.1
56304,Atelosteogenesis type II,SLC26A2,solute carrier family 26 member 2,5q32
56305,Atelosteogenesis type III,FLNB,filamin B,3p14.3
563612,Isolated exencephaly,VANGL2,VANGL planar cell polarity protein 2,1q23.2
563612,Isolated exencephaly,MTHFR,methylenetetrahydrofolate reductase,1p36.22
563609,Isolated anencephaly,VANGL2,VANGL planar cell polarity protein 2,1q23.2
563609,Isolated anencephaly,MTHFR,methylenetetrahydrofolate reductase,1p36.22
55880,Chondrosarcoma,EXT1,exostosin glycosyltransferase 1,8q24.11
55654,Hypotrichosis simplex,LSS,lanosterol synthase,21q22.3
55654,Hypotrichosis simplex,LIPH,lipase H,3q27.2
55654,Hypotrichosis simplex,APCDD1,APC down-regulated 1,18p11.22
55654,Hypotrichosis simplex,RPL21,ribosomal protein L21,13q12.2
55654,Hypotrichosis simplex,SNRPE,small nuclear ribonucleoprotein polypeptide E,1q32.1
55654,Hypotrichosis simplex,LPAR6,lysophosphatidic acid receptor 6,13q14.2
55654,Hypotrichosis simplex,DSG4,desmoglein 4,18q12.1
565858,Craniosynostosis-microretrognathia-severe intellectual disability syndrome,PPP3CA,protein phosphatase 3 catalytic subunit alpha,4q24
565788,Infantile inflammatory bowel disease with neurological involvement,TGFB1,transforming growth factor beta 1,19q13.2
565909,Calpain-3-related limb-girdle muscular dystrophy D4,CAPN3,calpain 3,15q15.1
79233,Hypoxanthine guanine phosphoribosyltransferase partial deficiency,HPRT1,hypoxanthine phosphoribosyltransferase 1,Xq26.2-q26.3
79230,HJV or HAMP-related hemochromatosis,HJV,hemojuvelin BMP co-receptor,1q21.1
79230,HJV or HAMP-related hemochromatosis,HAMP,hepcidin antimicrobial peptide,19q13.12
79237,Galactokinase deficiency,GALK1,galactokinase 1,17q25.1
566067,CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome,CEBPE,CCAAT enhancer binding protein epsilon,14q11.2
79234,Crigler-Najjar syndrome type 1,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2q37.1
79235,Crigler-Najjar syndrome type 2,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2q37.1
565624,Combined oxidative phosphorylation defect type 39,GFM2,GTP dependent ribosome recycling factor mitochondrial 2,5q13.3
565612,Primary triglyceride deposit cardiomyovasculopathy,PNPLA2,"patatin like domain 2, triacylglycerol lipase",11p15.5
79157,2-methylbutyryl-CoA dehydrogenase deficiency,ACADSB,acyl-CoA dehydrogenase short/branched chain,10q26.13
79155,Hydroxykynureninuria,KYNU,kynureninase,2q22.2
79154,2-aminoadipic 2-oxoadipic aciduria,DHTKD1,dehydrogenase E1 and transketolase domain containing 1,10p14
79152,Disseminated superficial actinic porokeratosis,MVK,mevalonate kinase,12q24.11
79152,Disseminated superficial actinic porokeratosis,SLC17A9,solute carrier family 17 member 9,20q13.33
79152,Disseminated superficial actinic porokeratosis,MVD,mevalonate diphosphate decarboxylase,16q24.2
79152,Disseminated superficial actinic porokeratosis,FDPS,farnesyl diphosphate synthase,1q22
79151,Acrokeratosis verruciformis of Hopf,ATP2A2,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,12q24.11
79146,Familial progressive hyperpigmentation,KITLG,KIT ligand,12q21.32
79145,Dowling-Degos disease,PSENEN,"presenilin enhancer, gamma-secretase subunit",19q13.12
79145,Dowling-Degos disease,KRT5,keratin 5,12q13.13
79145,Dowling-Degos disease,POFUT1,protein O-fucosyltransferase 1,20q11.21
79145,Dowling-Degos disease,POGLUT1,protein O-glucosyltransferase 1,3q13.33
79159,Isobutyryl-CoA dehydrogenase deficiency,ACAD8,acyl-CoA dehydrogenase family member 8,11q25
79107,Developmental malformations-deafness-dystonia syndrome,ACTB,actin beta,7p22.1
566231,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha,THRA,thyroid hormone receptor alpha,17q21.1
79106,Eiken syndrome,PTH1R,parathyroid hormone 1 receptor,3p21.31
566243,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta,THRB,thyroid hormone receptor beta,3p24.2
79118,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome,GLIS3,GLIS family zinc finger 3,9p24.2
566393,Acute mast cell leukemia,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
79113,Mandibulofacial dysostosis-microcephaly syndrome,EFTUD2,elongation factor Tu GTP binding domain containing 2,17q21.31
79102,Thyrotoxic periodic paralysis,CACNA1S,calcium voltage-gated channel subunit alpha1 S,1q32.1
79102,Thyrotoxic periodic paralysis,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3,Xq28
79102,Thyrotoxic periodic paralysis,KCNJ18,potassium inwardly rectifying channel subfamily J member 18,17p11.2
79105,Myxofibrosarcoma,FUS,FUS RNA binding protein,16p11.2
79105,Myxofibrosarcoma,CREB3L2,cAMP responsive element binding protein 3 like 2,7q33
79105,Myxofibrosarcoma,CREB3L1,cAMP responsive element binding protein 3 like 1,11p11.2
79101,Hyperprolinemia type 2,ALDH4A1,aldehyde dehydrogenase 4 family member A1,1p36.13
566192,Congenital autosomal recessive small-platelet thrombocytopenia,FYB1,FYN binding protein 1,5p13.1
79100,Atrophoderma vermiculata,LRP1,LDL receptor related protein 1,12q13.3
79095,Congenital bile acid synthesis defect type 4,AMACR,alpha-methylacyl-CoA racemase,5p13.2
79094,Grange syndrome,YY1AP1,YY1 associated protein 1,1q22
566175,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome,CD55,CD55 molecule (Cromer blood group),1q32.2
79096,Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy,PNPO,pyridoxamine 5'-phosphate oxidase,17q21.32
79134,DEND syndrome,ABCC8,ATP binding cassette subfamily C member 8,11p15.1
79134,DEND syndrome,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
79134,DEND syndrome,NARS2,"asparaginyl-tRNA synthetase 2, mitochondrial",11q14.1
79137,Generalized epilepsy-paroxysmal dyskinesia syndrome,KCNMA1,potassium calcium-activated channel subfamily M alpha 1,10q22.3
79124,Hepatic veno-occlusive disease-immunodeficiency syndrome,SP110,SP110 nuclear body protein,2q37.1
566396,Chronic mast cell leukemia,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
77293,Chronic visceral acid sphingomyelinase deficiency,SMPD1,sphingomyelin phosphodiesterase 1,11p15.4
77295,Odontoleukodystrophy,POLR3A,RNA polymerase III subunit A,10q22.3
77261,Gaucher disease type 3,GBA1,glucosylceramidase beta 1,1q22
77292,Infantile neurovisceral acid sphingomyelinase deficiency,SMPD1,sphingomyelin phosphodiesterase 1,11p15.4
77298,Anophthalmia/microphthalmia-esophageal atresia syndrome,SOX2,SRY-box transcription factor 2,3q26.33
77297,Majeed syndrome,LPIN2,lipin 2,18p11.31
567502,B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome,TOP2B,DNA topoisomerase II beta,3p24.2
77301,Monosomy 9q22.3 syndrome,PTCH1,patched 1,9q22.32
79083,PPARG-related familial partial lipodystrophy,PPARG,peroxisome proliferator activated receptor gamma,3p25.2
79076,Juvenile polyposis of infancy,PTEN,phosphatase and tensin homolog,10q23.31
79076,Juvenile polyposis of infancy,BMPR1A,bone morphogenetic protein receptor type 1A,10q23.2
79087,Acquired partial lipodystrophy,LMNB2,lamin B2,19p13.3
79085,AKT2-related familial partial lipodystrophy,AKT2,AKT serine/threonine kinase 2,19q13.2
79084,"Familial partial lipodystrophy, Köbberling type",LMNA,lamin A/C,1q22
79091,Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome,MYH2,myosin heavy chain 2,17p13.1
75327,North Carolina macular dystrophy,DHS6S1,"DNase1 hypersensitivity, chromosome 6, site 1",6q16.2
75373,Progressive bifocal chorioretinal atrophy,DHS6S1,"DNase1 hypersensitivity, chromosome 6, site 1",6q16.2
75374,Bradyopsia,RGS9BP,regulator of G protein signaling 9 binding protein,19q13.11
75374,Bradyopsia,RGS9,regulator of G protein signaling 9,17q24.1
75376,Familial drusen,CFI,complement factor I,4q25
75376,Familial drusen,CFH,complement factor H,1q31.3
75376,Familial drusen,EFEMP1,EGF containing fibulin extracellular matrix protein 1,2p16.1
75377,Central areolar choroidal dystrophy,GUCA1A,guanylate cyclase activator 1A,6p21.1
75377,Central areolar choroidal dystrophy,PRPH2,peripherin 2,6p21.1
75377,Central areolar choroidal dystrophy,GUCY2D,"guanylate cyclase 2D, retinal",17p13.1
75382,Oguchi disease,SAG,S-antigen visual arrestin,2q37.1
75382,Oguchi disease,GRK1,G protein-coupled receptor kinase 1,13q34
75391,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency,MCM4,minichromosome maintenance complex component 4,8q11.21
75392,Periodontal Ehlers-Danlos syndrome,C1S,complement C1s,12p13.31
75392,Periodontal Ehlers-Danlos syndrome,C1R,complement C1r,12p13.31
75496,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome,B4GALT7,"beta-1,4-galactosyltransferase 7",5q35.3
75497,X-linked Ehlers-Danlos syndrome,FLNA,filamin A,Xq28
75563,X-linked sideroblastic anemia,ALAS2,5'-aminolevulinate synthase 2,Xp11.21
75564,Acquired idiopathic sideroblastic anemia,TET2,tet methylcytosine dioxygenase 2,4q24
75564,Acquired idiopathic sideroblastic anemia,SF3B1,splicing factor 3b subunit 1,2q33.1
75857,6q terminal deletion syndrome,ERMARD,ER membrane associated RNA degradation,6q27
75840,Ullrich congenital muscular dystrophy,COL6A1,collagen type VI alpha 1 chain,21q22.3
75840,Ullrich congenital muscular dystrophy,COL6A2,collagen type VI alpha 2 chain,21q22.3
75840,Ullrich congenital muscular dystrophy,COL6A3,collagen type VI alpha 3 chain,2q37.3
75840,Ullrich congenital muscular dystrophy,COL12A1,collagen type XII alpha 1 chain,6q13-q14.1
75858,MORM syndrome,INPP5E,inositol polyphosphate-5-phosphatase E,9q34.3
77258,Trichorhinophalangeal syndrome type 1,TRPS1,transcriptional repressor GATA binding 1,8q23.3
77260,Gaucher disease type 2,GBA1,glucosylceramidase beta 1,1q22
77259,Gaucher disease type 1,GBA1,glucosylceramidase beta 1,1q22
77259,Gaucher disease type 1,SCARB2,scavenger receptor class B member 2,4q21.1
569821,Congenital primary lymphedema of Gordon,VEGFC,vascular endothelial growth factor C,4q34.3
569816,CELSR1-related late-onset primary lymphedema,CELSR1,cadherin EGF LAG seven-pass G-type receptor 1,22q13.31
73272,Growth delay due to insulin-like growth factor type 1 deficiency,IGF1,insulin like growth factor 1,12q23.2
73273,Growth delay due to insulin-like growth factor I resistance,IGF1R,insulin like growth factor 1 receptor,15q26.3
75326,Familial isolated retinal arteriolar tortuosity,COL4A1,collagen type IV alpha 1 chain,13q34
75249,Familial isolated restrictive cardiomyopathy,FLNC,filamin C,7q32.1
75249,Familial isolated restrictive cardiomyopathy,KIF20A,kinesin family member 20A,5q31.2
75249,Familial isolated restrictive cardiomyopathy,TNNI3,"troponin I3, cardiac type",19q13.42
75249,Familial isolated restrictive cardiomyopathy,TNNT2,"troponin T2, cardiac type",1q32.1
75249,Familial isolated restrictive cardiomyopathy,MYPN,myopalladin,10q21.3
75234,Cholesteryl ester storage disease,LIPA,"lipase A, lysosomal acid type",10q23.31
75233,Wolman disease,LIPA,"lipase A, lysosomal acid type",10q23.31
568065,EPHB4-related lymphatic-related hydrops fetalis,EPHB4,EPH receptor B4,7q22.1
71290,Familial platelet disorder with associated myeloid malignancy,RUNX1,RUNX family transcription factor 1,21q22.12
568062,PIEZO1-related generalized lymphatic dysplasia with non-immune hydrops fetalis,PIEZO1,piezo type mechanosensitive ion channel component 1 (Er blood group),16q24.3
71493,Familial thrombocytosis,THPO,thrombopoietin,3q27.1
71493,Familial thrombocytosis,JAK2,Janus kinase 2,9p24.1
71493,Familial thrombocytosis,MPL,"MPL proto-oncogene, thrombopoietin receptor",1p34.2
568051,GJC2-related late-onset primary lymphedema,GJC2,gap junction protein gamma 2,1q42.13
71289,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome,MECOM,MDS1 and EVI1 complex locus,3q26.2
71289,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome,HOXA11,homeobox A11,7p15.2
71526,Obesity due to pro-opiomelanocortin deficiency,POMC,proopiomelanocortin,2p23.3
71528,Obesity due to prohormone convertase I deficiency,PCSK1,proprotein convertase subtilisin/kexin type 1,5q15
71529,Obesity due to melanocortin 4 receptor deficiency,MC4R,melanocortin 4 receptor,18q21.32
569164,Angiomatoid fibrous histiocytoma,CREB1,cAMP responsive element binding protein 1,2q33.3
569164,Angiomatoid fibrous histiocytoma,EWSR1,EWS RNA binding protein 1,22q12.2
71517,Rapid-onset dystonia-parkinsonism,ATP1A3,ATPase Na+/K+ transporting subunit alpha 3,19q13.2
71518,Benign paroxysmal torticollis of infancy,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
569274,Multiple mitochondrial dysfunctions syndrome type 5,ISCA1,iron-sulfur cluster assembly 1,9q21.33
569290,Multiple mitochondrial dysfunctions syndrome type 6,PMPCB,"peptidase, mitochondrial processing subunit beta",7q22.1
569248,Microcystic stromal tumor,CTNNB1,catenin beta 1,3p22.1
73229,HANAC syndrome,COL4A1,collagen type IV alpha 1 chain,13q34
73224,Kidney tubulopathy-dilated cardiomyopathy syndrome,RRAGD,Ras related GTP binding D,6q15
530849,Familial apolipoprotein A5 deficiency,APOA5,apolipoprotein A5,11q23.3
39041,Omenn syndrome,ADA,adenosine deaminase,20q13.12
39041,Omenn syndrome,RAG1,recombination activating 1,11p12
39041,Omenn syndrome,RAG2,recombination activating 2,11p12
39041,Omenn syndrome,CHD7,chromodomain helicase DNA binding protein 7,8q12.2
39041,Omenn syndrome,DCLRE1C,DNA cross-link repair 1C,10p13
39041,Omenn syndrome,IL2RG,interleukin 2 receptor subunit gamma,Xq13.1
39041,Omenn syndrome,LIG4,DNA ligase 4,13q33.3
39041,Omenn syndrome,RMRP,RNA component of mitochondrial RNA processing endoribonuclease,9p13.3
39041,Omenn syndrome,IL7R,interleukin 7 receptor,5p13.2
39041,Omenn syndrome,PSMB10,proteasome 20S subunit beta 10,16q22.1
530838,KRT1-related diffuse nonepidermolytic keratoderma,KRT1,keratin 1,12q13.13
39044,Uveal melanoma,CYSLTR2,cysteinyl leukotriene receptor 2,13q14.2
39044,Uveal melanoma,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
39044,Uveal melanoma,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
39044,Uveal melanoma,GNAQ,G protein subunit alpha q,9q21.2
39044,Uveal melanoma,GNA11,G protein subunit alpha 11,19p13.3
39044,Uveal melanoma,SF3B1,splicing factor 3b subunit 1,2q33.1
530792,RELA fusion-positive ependymoma,ZFTA,zinc finger translocation associated,11q13.1
530792,RELA fusion-positive ependymoma,RELA,"RELA proto-oncogene, NF-kB subunit",11q13.1
38874,Dihydropyrimidinuria,DPYS,dihydropyrimidinase,8q22.3
530303,Progressive dementia with neuroserpin inclusion bodies,SERPINI1,serpin family I member 1,3q26.1
37612,Episodic ataxia type 1,KCNA1,potassium voltage-gated channel subfamily A member 1,12p13.32
37553,Andersen-Tawil syndrome,KCNJ2,potassium inwardly rectifying channel subfamily J member 2,17q24.3
37553,Andersen-Tawil syndrome,KCNJ5,potassium inwardly rectifying channel subfamily J member 5,11q24.3
37042,Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,FOXP3,forkhead box P3,Xp11.23
36899,Myoclonus-dystonia syndrome,SGCE,sarcoglycan epsilon,7q21.3
36899,Myoclonus-dystonia syndrome,TOR1A,torsin family 1 member A,9q34.11
36899,Myoclonus-dystonia syndrome,DRD2,dopamine receptor D2,11q23.2
36899,Myoclonus-dystonia syndrome,DYT15,"dystonia 15, myoclonic",18p11
36899,Myoclonus-dystonia syndrome,KCTD17,potassium channel tetramerization domain containing 17,22q12.3
41751,Bietti crystalline dystrophy,CYP4V2,cytochrome P450 family 4 subfamily V member 2,4q35.1-q35.2
42062,Iminoglycinuria,SLC6A20,solute carrier family 6 member 20,3p21.31
42062,Iminoglycinuria,SLC36A2,solute carrier family 36 member 2,5q33.1
42062,Iminoglycinuria,SLC6A18,solute carrier family 6 member 18,5p15.33
42062,Iminoglycinuria,SLC6A19,solute carrier family 6 member 19,5p15.33
35706,Glutaric acidemia type 3,SUGCT,succinyl-CoA:glutarate-CoA transferase,7p14.1
35704,L-Arginine:glycine amidinotransferase deficiency,GATM,glycine amidinotransferase,15q21.1
35710,Glucose-galactose malabsorption,SLC5A1,solute carrier family 5 member 1,22q12.3
35737,Morning glory disc anomaly,PAX6,paired box 6,11p13
35708,Aromatic L-amino acid decarboxylase deficiency,DDC,dopa decarboxylase,7p12.2-p12.1
35689,Primary lateral sclerosis,SPG7,"SPG7 matrix AAA peptidase subunit, paraplegin",16q24.3
35701,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,HMGCS2,3-hydroxy-3-methylglutaryl-CoA synthase 2,1p12
35612,Nanophthalmos,MFRP,membrane frizzled-related protein,11q23.3
35612,Nanophthalmos,TMEM98,transmembrane protein 98,17q11.2
35612,Nanophthalmos,OTX2,orthodenticle homeobox 2,14q22.3
35612,Nanophthalmos,SIX6,SIX homeobox 6,14q23.1
35612,Nanophthalmos,RAX,retina and anterior neural fold homeobox,18q21.32
35612,Nanophthalmos,ALDH1A3,aldehyde dehydrogenase 1 family member A3,15q26.3
35612,Nanophthalmos,PRSS56,serine protease 56,2q37.1
35612,Nanophthalmos,SOX2,SRY-box transcription factor 2,3q26.33
35612,Nanophthalmos,BEST1,bestrophin 1,11q12.3
35612,Nanophthalmos,CRB1,crumbs cell polarity complex component 1,1q31.3
35173,X-linked dominant chondrodysplasia punctata,EBP,EBP cholestenol delta-isomerase,Xp11.23
35664,ALDH18A1-related De Barsy syndrome,ALDH18A1,aldehyde dehydrogenase 18 family member A1,10q24.1
35120,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency,NT5C3A,"5'-nucleotidase, cytosolic IIIA",7p14.3
35107,Desmosterolosis,DHCR24,24-dehydrocholesterol reductase,1p32.3
35099,Non-syndromic bicoronal craniosynostosis,FGFR3,fibroblast growth factor receptor 3,4p16.3
35099,Non-syndromic bicoronal craniosynostosis,ZIC1,Zic family member 1,3q24
35099,Non-syndromic bicoronal craniosynostosis,TCF12,transcription factor 12,15q21.3
35099,Non-syndromic bicoronal craniosynostosis,TWIST1,twist family bHLH transcription factor 1,7p21.1
35122,Congenital sucrase-isomaltase deficiency,SI,sucrase-isomaltase,3q26.1
36387,Genetic epilepsy with febrile seizure plus,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,5p12
36387,Genetic epilepsy with febrile seizure plus,FGF13,fibroblast growth factor 13,Xq26.3-q27.1
36387,Genetic epilepsy with febrile seizure plus,SCN1A,sodium voltage-gated channel alpha subunit 1,2q24.3
36387,Genetic epilepsy with febrile seizure plus,SCN1B,sodium voltage-gated channel beta subunit 1,19q13.11
36387,Genetic epilepsy with febrile seizure plus,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
36387,Genetic epilepsy with febrile seizure plus,SCN9A,sodium voltage-gated channel alpha subunit 9,2q24.3
36387,Genetic epilepsy with febrile seizure plus,GABRD,gamma-aminobutyric acid type A receptor subunit delta,1p36.33
36387,Genetic epilepsy with febrile seizure plus,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,5q34
36387,Genetic epilepsy with febrile seizure plus,STX1B,syntaxin 1B,16p11.2
36387,Genetic epilepsy with febrile seizure plus,CPA6,carboxypeptidase A6,8q13.2
36387,Genetic epilepsy with febrile seizure plus,PRRT2,proline rich transmembrane protein 2,16p11.2
36387,Genetic epilepsy with febrile seizure plus,ADGRV1,adhesion G protein-coupled receptor V1,5q14.3
36412,Hypocomplementemic urticarial vasculitis,DNASE1L3,deoxyribonuclease 1L3,3p14.3
36426,Stevens-Johnson syndrome,HLA-B,"major histocompatibility complex, class I, B",6p21.33
36426,Stevens-Johnson syndrome,IKZF1,IKAROS family zinc finger 1,7p12.2
36355,Bleeding disorder due to P2Y12 defect,P2RY12,purinergic receptor P2Y12,3q25.1
36367,Distal deletion 1q syndrome,ZBTB18,zinc finger and BTB domain containing 18,1q44
36383,COL4A1/2-related familial vascular leukoencephalopathy,COL4A1,collagen type IV alpha 1 chain,13q34
36383,COL4A1/2-related familial vascular leukoencephalopathy,COL4A2,collagen type IV alpha 2 chain,13q34
36386,Hereditary sensory and autonomic neuropathy type 1,ATL1,atlastin GTPase 1,14q22.1
36386,Hereditary sensory and autonomic neuropathy type 1,SPTLC1,serine palmitoyltransferase long chain base subunit 1,9q22.31
36386,Hereditary sensory and autonomic neuropathy type 1,SPTLC2,serine palmitoyltransferase long chain base subunit 2,14q24.3
36386,Hereditary sensory and autonomic neuropathy type 1,ATL3,atlastin GTPase 3,11q13.1
35878,Hyperinsulinism-hyperammonemia syndrome,GLUD1,glutamate dehydrogenase 1,10q23.2
35858,Imerslund-Gräsbeck syndrome,AMN,amnion associated transmembrane protein,14q32.32
35858,Imerslund-Gräsbeck syndrome,CUBN,cubilin,10p13
35909,Combined deficiency of factor V and factor VIII,MCFD2,"multiple coagulation factor deficiency 2, ER cargo receptor complex subunit",2p21
35909,Combined deficiency of factor V and factor VIII,LMAN1,"lectin, mannose binding 1",18q21.32
33572,5-oxoprolinase deficiency,OPLAH,"5-oxoprolinase, ATP-hydrolysing",8q24.3
33543,Kleine-Levin syndrome,TRANK1,tetratricopeptide repeat and ankyrin repeat containing 1,3p22.2
33445,Neuroectodermal melanolysosomal disease,MYO5A,myosin VA,15q21.2
535458,Familial GPIHBP1 deficiency,GPIHBP1,glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1,8q24.3
33402,Pediatric hepatocellular carcinoma,MET,"MET proto-oncogene, receptor tyrosine kinase",7q31.2
33402,Pediatric hepatocellular carcinoma,CTNNB1,catenin beta 1,3p22.1
34217,Naxos disease,JUP,junction plakoglobin,17q21.2
33574,Glutamate-cysteine ligase deficiency,GCLC,glutamate-cysteine ligase catalytic subunit,6p12.1
33573,Gamma-glutamyl transpeptidase deficiency,GGT1,gamma-glutamyltransferase 1,22q11.23
33110,Autosomal non-syndromic agammaglobulinemia,SPI1,Spi-1 proto-oncogene,11p11.2
33110,Autosomal non-syndromic agammaglobulinemia,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",1p36.22
33110,Autosomal non-syndromic agammaglobulinemia,IGHM,immunoglobulin heavy constant mu,14q32.33
33110,Autosomal non-syndromic agammaglobulinemia,IGLL1,immunoglobulin lambda like polypeptide 1,22q11.23
33110,Autosomal non-syndromic agammaglobulinemia,LRRC8A,leucine rich repeat containing 8 VRAC subunit A,9q34.11
33110,Autosomal non-syndromic agammaglobulinemia,TCF3,transcription factor 3,19p13.3
33110,Autosomal non-syndromic agammaglobulinemia,CD79A,CD79a molecule,19q13.2
33110,Autosomal non-syndromic agammaglobulinemia,CD79B,CD79b molecule,17q23.3
33110,Autosomal non-syndromic agammaglobulinemia,BLNK,B cell linker,10q24.1
33110,Autosomal non-syndromic agammaglobulinemia,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,5q13.1
33108,Lethal multiple pterygium syndrome,NEB,nebulin,2q23.3
33108,Lethal multiple pterygium syndrome,RAPSN,receptor associated protein of the synapse,11p11.2
33108,Lethal multiple pterygium syndrome,RYR1,ryanodine receptor 1,19q13.2
33108,Lethal multiple pterygium syndrome,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,2q31.1
33108,Lethal multiple pterygium syndrome,CHRND,cholinergic receptor nicotinic delta subunit,2q37.1
33108,Lethal multiple pterygium syndrome,CHRNG,cholinergic receptor nicotinic gamma subunit,2q37.1
33067,"Metaphyseal chondrodysplasia, Jansen type",PTH1R,parathyroid hormone 1 receptor,3p21.31
33069,Dravet syndrome,SCN1A,sodium voltage-gated channel alpha subunit 1,2q24.3
33069,Dravet syndrome,SCN1B,sodium voltage-gated channel beta subunit 1,19q13.11
33069,Dravet syndrome,SCN9A,sodium voltage-gated channel alpha subunit 9,2q24.3
33069,Dravet syndrome,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1,5q34
33069,Dravet syndrome,GABRG2,gamma-aminobutyric acid type A receptor subunit gamma2,5q34
33069,Dravet syndrome,PCDH19,protocadherin 19,Xq22.1
33069,Dravet syndrome,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
33001,Lymphedema-distichiasis syndrome,FOXC2,forkhead box C2,16q24.1
33355,Reticular dysgenesis,AK2,adenylate kinase 2,1p35.1
535453,Familial lipase maturation factor 1 deficiency,LMF1,lipase maturation factor 1,16p13.3
33364,Trichothiodystrophy,MPLKIP,M-phase specific PLK1 interacting protein,7p14.1
33364,Trichothiodystrophy,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19q13.32
33364,Trichothiodystrophy,GTF2H5,general transcription factor IIH subunit 5,6q25.3
33364,Trichothiodystrophy,ERCC3,"ERCC excision repair 3, TFIIH core complex helicase subunit",2q14.3
33364,Trichothiodystrophy,RNF113A,ring finger protein 113A,Xq24
33364,Trichothiodystrophy,GTF2E2,general transcription factor IIE subunit 2,8p12
33364,Trichothiodystrophy,TARS1,threonyl-tRNA synthetase 1,5p13.3
33364,Trichothiodystrophy,CARS1,cysteinyl-tRNA synthetase 1,11p15.4
33364,Trichothiodystrophy,AARS1,alanyl-tRNA synthetase 1,16q22.1
33226,Waldenström macroglobulinemia,MYD88,MYD88 innate immune signal transduction adaptor,3p22.2
35069,Infantile neuroaxonal dystrophy,PLA2G6,phospholipase A2 group VI,22q13.1
35093,Non-syndromic sagittal craniosynostosis,ALX4,ALX homeobox 4,11p11.2
35093,Non-syndromic sagittal craniosynostosis,TWIST1,twist family bHLH transcription factor 1,7p21.1
35078,T-B+ severe combined immunodeficiency due to JAK3 deficiency,JAK3,Janus kinase 3,19p13.11
34520,Congenital muscular dystrophy with integrin alpha-7 deficiency,ITGA7,integrin subunit alpha 7,12q13.2
34514,Telethonin-related limb-girdle muscular dystrophy R7,TCAP,titin-cap,17q12
34515,FKRP-related limb-girdle muscular dystrophy R9,FKRP,fukutin related protein,19q13.32
34516,DNAJB6-related limb-girdle muscular dystrophy D1,DNAJB6,DnaJ heat shock protein family (Hsp40) member B6,7q36.3
34587,Danon disease,LAMP2,lysosomal associated membrane protein 2,Xq24
34592,Immunodeficiency by defective expression of MHC class I,TAP2,"transporter 2, ATP binding cassette subfamily B member",6p21.32
34592,Immunodeficiency by defective expression of MHC class I,TAP1,"transporter 1, ATP binding cassette subfamily B member",6p21.32
34592,Immunodeficiency by defective expression of MHC class I,TAPBP,TAP binding protein,6p21.32
34592,Immunodeficiency by defective expression of MHC class I,B2M,beta-2-microglobulin,15q21.1
34528,Autosomal dominant primary hypomagnesemia with hypocalciuria,FXYD2,FXYD domain containing ion transport regulator 2,11q23.3
536516,Myopathic Ehlers-Danlos syndrome,COL12A1,collagen type XII alpha 1 chain,6q13-q14.1
536467,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome,B3GALT6,"beta-1,3-galactosyltransferase 6",1p36.33
536532,Classical-like Ehlers-Danlos syndrome type 2,AEBP1,AE binding protein 1,7p13
537072,PLG-related hereditary angioedema with normal C1Inh,PLG,plasminogen,6q26
32960,Tumor necrosis factor receptor 1 associated periodic syndrome,TNFRSF1A,TNF receptor superfamily member 1A,12p13.31
52530,Pseudo-von Willebrand disease,GP1BA,glycoprotein Ib platelet subunit alpha,17p13.2
52688,Myelodysplastic syndrome,TP53,tumor protein p53,17p13.1
52429,Branchiootic syndrome,EYA1,EYA transcriptional coactivator and phosphatase 1,8q13.3
52429,Branchiootic syndrome,SIX1,SIX homeobox 1,14q23.1
52503,X-linked creatine transporter deficiency,SLC6A8,solute carrier family 6 member 8,Xq28
52430,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,VCP,valosin containing protein,9p13.3
52430,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,HNRNPA2B1,heterogeneous nuclear ribonucleoprotein A2/B1,7p15.2
52430,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,12q13.13
52416,Mantle cell lymphoma,CCND1,cyclin D1,11q13.3
52416,Mantle cell lymphoma,ATM,ATM serine/threonine kinase,11q22.3
52416,Mantle cell lymphoma,IGH,immunoglobulin heavy locus,14q32.33
52427,Retinitis punctata albescens,PRPH2,peripherin 2,6p21.1
52427,Retinitis punctata albescens,RDH5,retinol dehydrogenase 5,12q13.2
52427,Retinitis punctata albescens,RHO,rhodopsin,3q22.1
52427,Retinitis punctata albescens,RLBP1,retinaldehyde binding protein 1,15q26.1
52417,MALT lymphoma,MALT1,MALT1 paracaspase,18q21.32
52417,MALT lymphoma,BIRC3,baculoviral IAP repeat containing 3,11q22.2
52417,MALT lymphoma,IGH,immunoglobulin heavy locus,14q32.33
52417,MALT lymphoma,FOXP1,forkhead box P1,3p13
52417,MALT lymphoma,BCL10,BCL10 immune signaling adaptor,1p22.3
52055,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,IGBP1,immunoglobulin binding protein 1,Xq13.1
52368,Mohr-Tranebjaerg syndrome,TIMM8A,translocase of inner mitochondrial membrane 8A,Xq22.1
53271,Muenke syndrome,FGFR3,fibroblast growth factor receptor 3,4p16.3
53347,Brody myopathy,ATP2A1,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1,16p11.2
53035,Caroli disease,PKHD1,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,6p12.3-p12.2
52901,Isolated follicle stimulating hormone deficiency,FSHB,follicle stimulating hormone subunit beta,11p14.1
53690,Congenital lactase deficiency,LCT,lactase,2q21.3
53689,Congenital chloride diarrhea,SLC26A3,solute carrier family 26 member 3,7q22.3-q31.1
538863,Classic pyoderma gangrenosum,PTPN6,protein tyrosine phosphatase non-receptor type 6,12p13.31
538574,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,KRT1,keratin 1,12q13.13
538574,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,MPZ,myelin protein zero,1q23.3
53583,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity,SLC2A1,solute carrier family 2 member 1,1p34.2
53540,Goldmann-Favre syndrome,NR2E3,nuclear receptor subfamily 2 group E member 3,15q23
53351,X-linked dystonia-parkinsonism,TAF1,TATA-box binding protein associated factor 1,Xq13.1
54260,Left ventricular noncompaction,PLEKHM2,pleckstrin homology and RUN domain containing M2,1p36.21
54260,Left ventricular noncompaction,TNNT2,"troponin T2, cardiac type",1q32.1
54260,Left ventricular noncompaction,PKP2,plakophilin 2,12p11.21
54260,Left ventricular noncompaction,ACTC1,actin alpha cardiac muscle 1,15q14
54260,Left ventricular noncompaction,TBX20,T-box transcription factor 20,7p14.2
54260,Left ventricular noncompaction,TPM1,tropomyosin 1,15q22.2
54260,Left ventricular noncompaction,DTNA,dystrobrevin alpha,18q12.1
54260,Left ventricular noncompaction,MYBPC3,myosin binding protein C3,11p11.2
54260,Left ventricular noncompaction,MYH7,myosin heavy chain 7,14q11.2
54260,Left ventricular noncompaction,LDB3,LIM domain binding 3,10q23.2
54260,Left ventricular noncompaction,LMNA,lamin A/C,1q22
54260,Left ventricular noncompaction,MIB1,MIB E3 ubiquitin protein ligase 1,18q11.2
54260,Left ventricular noncompaction,PRDM16,PR/SET domain 16,1p36.32
54260,Left ventricular noncompaction,MYH7B,myosin heavy chain 7B,20q11.22
54260,Left ventricular noncompaction,MIB2,MIB E3 ubiquitin protein ligase 2,1p36.33
538934,X-linked lymphoproliferative disease due to XIAP deficiency,XIAP,X-linked inhibitor of apoptosis,Xq25
538931,X-linked lymphoproliferative disease due to SAP deficiency,SH2D1A,SH2 domain containing 1A,Xq25
53696,Arthrogryposis-anterior horn cell disease syndrome,GLE1,GLE1 RNA export mediator,9q34.11
538872,Vegetative pyoderma gangrenosum,PTPN6,protein tyrosine phosphatase non-receptor type 6,12p13.31
53697,Gnathodiaphyseal dysplasia,ANO5,anoctamin 5,11p14.3
53691,Congenital cornea plana,KERA,keratocan,12q21.33
538869,Bullous pyoderma gangrenosum,PTPN6,protein tyrosine phosphatase non-receptor type 6,12p13.31
538866,Pustular pyoderma gangrenosum,PTPN6,protein tyrosine phosphatase non-receptor type 6,12p13.31
53693,GRACILE syndrome,BCS1L,"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone",2q35
48818,Aceruloplasminemia,CP,ceruloplasmin,3q24-q25.1
49382,Achromatopsia,PDE6C,phosphodiesterase 6C,10q23.33
49382,Achromatopsia,RPGR,retinitis pigmentosa GTPase regulator,Xp11.4
49382,Achromatopsia,CNGA3,cyclic nucleotide gated channel subunit alpha 3,2q11.2
49382,Achromatopsia,CNGB3,cyclic nucleotide gated channel subunit beta 3,8q21.3
49382,Achromatopsia,PDE6H,phosphodiesterase 6H,12p12.3
49382,Achromatopsia,GNAT2,G protein subunit alpha transducin 2,1p13.3
49382,Achromatopsia,ATF6,activating transcription factor 6,1q23.3
538958,Combined immunodeficiency due to CD70 deficiency,CD70,CD70 molecule,19p13.3
48431,Congenital cataracts-facial dysmorphism-neuropathy syndrome,CTDP1,CTD phosphatase subunit 1,18q23
538963,Combined immunodeficiency due to ITK deficiency,ITK,IL2 inducible T cell kinase,5q33.3
50814,Craniolenticulosutural dysplasia,SEC23A,"SEC23 homolog A, COPII coat complex component",14q21.1
49827,Thiamine-responsive megaloblastic anemia syndrome,SLC19A2,solute carrier family 19 member 2,1q24.2
50251,Pleural mesothelioma,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
50945,Blomstrand lethal chondrodysplasia,PTH1R,parathyroid hormone 1 receptor,3p21.31
50944,Schöpf-Schulz-Passarge syndrome,WNT10A,Wnt family member 10A,2q35
51083,Congenital short QT syndrome,SLC4A3,solute carrier family 4 member 3,2q35
51083,Congenital short QT syndrome,KCNJ2,potassium inwardly rectifying channel subfamily J member 2,17q24.3
51083,Congenital short QT syndrome,KCNH2,potassium voltage-gated channel subfamily H member 2,7q36.1
51083,Congenital short QT syndrome,KCNQ1,potassium voltage-gated channel subfamily Q member 1,11p15.5-p15.4
51083,Congenital short QT syndrome,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,7q21.11
50943,Keratolytic winter erythema,CTSB,cathepsin B,8p23.1
50942,Striate palmoplantar keratoderma,DSP,desmoplakin,6p24.3
50942,Striate palmoplantar keratoderma,KRT1,keratin 1,12q13.13
50942,Striate palmoplantar keratoderma,DSG1,desmoglein 1,18q12.1
52022,Potocki-Shaffer syndrome,ALX4,ALX homeobox 4,11p11.2
52022,Potocki-Shaffer syndrome,EXT2,exostosin glycosyltransferase 2,11p11.2
52022,Potocki-Shaffer syndrome,PHF21A,PHD finger protein 21A,11p11.2
51608,Generalized arterial calcification of infancy,ABCC6,ATP binding cassette subfamily C member 6,16p13.11
51608,Generalized arterial calcification of infancy,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,6q23.2
51188,Ethylmalonic encephalopathy,ETHE1,ETHE1 persulfide dioxygenase,19q13.31
541423,Growth delay-intellectual disability-hepatopathy syndrome,IARS1,isoleucyl-tRNA synthetase 1,9q22.31
51208,Formiminoglutamic aciduria,FTCD,formimidoyltransferase cyclodeaminase,21q22.3
51636,WHIM syndrome,CXCR4,C-X-C motif chemokine receptor 4,2q22.1
542306,GNB5-related intellectual disability-cardiac arrhythmia syndrome,GNB5,G protein subunit beta 5,15q21.2
542301,Combined immunodeficiency due to CARMIL2 deficiency,CARMIL2,capping protein regulator and myosin 1 linker 2,16q22.1
542310,Leukoencephalopathy with calcifications and cysts,SNORD118,"small nucleolar RNA, C/D box 118",17p13.1
42665,Tietz syndrome,MITF,melanocyte inducing transcription factor,3p13
542585,Auditory neuropathy-optic atrophy syndrome,FDXR,ferredoxin reductase,17q25.1
43115,Hereditary myopathy with lactic acidosis due to ISCU deficiency,ISCU,iron-sulfur cluster assembly enzyme,12q23.3
45448,Miyoshi myopathy,DYSF,dysferlin,2p13.2
543470,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome,FDXR,ferredoxin reductase,17q25.1
542657,Isolated hyperchlorhidrosis,CA12,carbonic anhydrase 12,15q22.2
44890,Gastrointestinal stromal tumor,PDGFRA,platelet derived growth factor receptor alpha,4q12
44890,Gastrointestinal stromal tumor,SDHA,succinate dehydrogenase complex flavoprotein subunit A,5p15.33
44890,Gastrointestinal stromal tumor,SDHB,succinate dehydrogenase complex iron sulfur subunit B,1p36.13
44890,Gastrointestinal stromal tumor,SDHC,succinate dehydrogenase complex subunit C,1q23.3
44890,Gastrointestinal stromal tumor,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
44890,Gastrointestinal stromal tumor,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
44890,Gastrointestinal stromal tumor,PDGFRA,platelet derived growth factor receptor alpha,4q12
45358,Congenital fibrosis of extraocular muscles,COL25A1,collagen type XXV alpha 1 chain,4q25
45358,Congenital fibrosis of extraocular muscles,TUBA1A,tubulin alpha 1a,12q13.12
45358,Congenital fibrosis of extraocular muscles,PHOX2A,paired like homeobox 2A,11q13.4
45358,Congenital fibrosis of extraocular muscles,KIF21A,kinesin family member 21A,12q12
45358,Congenital fibrosis of extraocular muscles,TUBB3,tubulin beta 3 class III,16q24.3
45358,Congenital fibrosis of extraocular muscles,TUBB2B,tubulin beta 2B class IIb,6p25.2
544254,SYNGAP1-related developmental and epileptic encephalopathy,SYNGAP1,synaptic Ras GTPase activating protein 1,6p21.32
46348,Paroxysmal extreme pain disorder,SCN10A,sodium voltage-gated channel alpha subunit 10,3p22.2
46348,Paroxysmal extreme pain disorder,SCN11A,sodium voltage-gated channel alpha subunit 11,3p22.2
46348,Paroxysmal extreme pain disorder,SCN9A,sodium voltage-gated channel alpha subunit 9,2q24.3
46059,Lathosterolosis,SC5D,sterol-C5-desaturase,11q23.3-q24.1
47044,Hereditary papillary renal cell carcinoma,MET,"MET proto-oncogene, receptor tyrosine kinase",7q31.2
46627,Char syndrome,TFAP2B,transcription factor AP-2 beta,6p12.3
46532,Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,HBB,hemoglobin subunit beta,11p15.4
46532,Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,HBG1,hemoglobin subunit gamma 1,11p15.4
46532,Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,HBG2,hemoglobin subunit gamma 2,11p15.4
46532,Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,KLF1,KLF transcription factor 1,19p13.13
544503,RNF13-related severe early-onset epileptic encephalopathy,RNF13,ring finger protein 13,3q25.1
544488,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome,ODC1,ornithine decarboxylase 1,2p25.1
544469,PRUNE1-related neurological syndrome,PRUNE1,prune exopolyphosphatase 1,1q21.3
544472,Atypical hemolytic uremic syndrome with complement gene abnormality,THBD,thrombomodulin,20p11.21
544472,Atypical hemolytic uremic syndrome with complement gene abnormality,C3,complement C3,19p13.3
544472,Atypical hemolytic uremic syndrome with complement gene abnormality,CD46,CD46 molecule,1q32.2
544472,Atypical hemolytic uremic syndrome with complement gene abnormality,CFB,complement factor B,6p21.33
544472,Atypical hemolytic uremic syndrome with complement gene abnormality,CFH,complement factor H,1q31.3
544472,Atypical hemolytic uremic syndrome with complement gene abnormality,CFI,complement factor I,4q25
47045,Familial cold urticaria,NLRP3,NLR family pyrin domain containing 3,1q44
544628,Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome,HNF4A,hepatocyte nuclear factor 4 alpha,20q13.12
544602,Congenital myopathy with reduced type 2 muscle fibers,MYL1,myosin light chain 1,2q34
555402,NAD(P)HX dehydratase deficiency,NAXD,NAD(P)HX dehydratase,13q34
555407,NAD(P)HX epimerase deficiency,NAXE,NAD(P)HX epimerase,1q22
555877,FLNA-related X-linked myxomatous valvular dysplasia,FLNA,filamin A,Xq28
556030,Early-onset familial hypoaldosteronism,CYP11B2,cytochrome P450 family 11 subfamily B member 2,8q24.3
556985,Early-onset calcifying leukoencephalopathy-skeletal dysplasia,CSF1R,colony stimulating factor 1 receptor,5q32
556955,Pancreatic agenesis-holoprosencephaly syndrome,CNOT1,CCR4-NOT transcription complex subunit 1,16q21
557064,Neonatal epileptic encephalopathy due to glutaminase deficiency,GLS,glutaminase,2q32.2
557056,Spastic ataxia-dysarthria due to glutaminase deficiency,GLS,glutaminase,2q32.2
557003,Oculoskeletodental syndrome,PIK3C2A,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha,11p15.1
519388,Autosomal recessive anterior segment dysgenesis,CPAMD8,C3 and PZP like alpha-2-macroglobulin domain containing 8,19p13.11
90050,Retinopathy of prematurity,LRP5,LDL receptor related protein 5,11q13.2
90050,Retinopathy of prematurity,FZD4,frizzled class receptor 4,11q14.2
90050,Retinopathy of prematurity,NDP,norrin cystine knot growth factor NDP,Xp11.3
90045,Hereditary folate malabsorption,SLC46A1,solute carrier family 46 member 1,17q11.2
90039,Hemoglobin D disease,HBB,hemoglobin subunit beta,11p15.4
90044,Familial pseudohyperkalemia,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
90042,Primary familial polycythemia,EPOR,erythropoietin receptor,19p13.2
90024,"Deafness with labyrinthine aplasia, microtia, and microdontia",FGF3,fibroblast growth factor 3,11q13.3
90023,Primary immunodeficiency syndrome due to P14/LAMTOR2 deficiency,LAMTOR2,"late endosomal/lysosomal adaptor, MAPK and MTOR activator 2",1q22
90020,Parkinson-dementia complex of Guam,PARK7,Parkinsonism associated deglycase,1p36.23
90020,Parkinson-dementia complex of Guam,TRPM7,transient receptor potential cation channel subfamily M member 7,15q21.2
90031,Non-spherocytic hemolytic anemia due to hexokinase deficiency,HK1,hexokinase 1,10q22.1
90026,Primary erythromelalgia,SCN9A,sodium voltage-gated channel alpha subunit 9,2q24.3
90026,Primary erythromelalgia,SCN10A,sodium voltage-gated channel alpha subunit 10,3p22.2
90026,Primary erythromelalgia,SCN11A,sodium voltage-gated channel alpha subunit 11,3p22.2
90030,Hemolytic anemia due to glutathione reductase deficiency,GSR,glutathione-disulfide reductase,8p12
89936,X-linked hypophosphatemia,PHEX,phosphate regulating endopeptidase X-linked,Xp22.11
89844,"Lissencephaly syndrome, Norman-Roberts type",NDE1,nudE neurodevelopment protein 1,16p13.11
89844,"Lissencephaly syndrome, Norman-Roberts type",KATNB1,katanin regulatory subunit B1,16q21
89844,"Lissencephaly syndrome, Norman-Roberts type",RELN,reelin,7q22.1
89843,Dystrophic epidermolysis bullosa pruriginosa,COL7A1,collagen type VII alpha 1 chain,3p21.31
89842,"Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form",COL7A1,collagen type VII alpha 1 chain,3p21.31
90001,X-linked cone dysfunction syndrome with myopia,OPN1MW,"opsin 1, medium wave sensitive",Xq28
90001,X-linked cone dysfunction syndrome with myopia,OPN1LW,"opsin 1, long wave sensitive",Xq28
89938,Bartter syndrome type 4,BSND,barttin CLCNK type accessory subunit beta,1p32.3
89938,Bartter syndrome type 4,CLCNKB,chloride voltage-gated channel Kb,1p36.13
89938,Bartter syndrome type 4,CLCNKA,chloride voltage-gated channel Ka,1p36.13
89937,Autosomal dominant hypophosphatemic rickets,FGF23,fibroblast growth factor 23,12p13.32
90340,Blau syndrome,NOD2,nucleotide binding oligomerization domain containing 2,16q12.1
90342,Xeroderma pigmentosum variant,POLH,DNA polymerase eta,6p21.1
90348,Autosomal dominant cutis laxa,ALDH18A1,aldehyde dehydrogenase 18 family member A1,10q24.1
90348,Autosomal dominant cutis laxa,FBLN5,fibulin 5,14q32.12
90348,Autosomal dominant cutis laxa,ELN,elastin,7q11.23
90349,Autosomal recessive cutis laxa type 1,EFEMP2,EGF containing fibulin extracellular matrix protein 2,11q13.1
90349,Autosomal recessive cutis laxa type 1,FBLN5,fibulin 5,14q32.12
90349,Autosomal recessive cutis laxa type 1,LTBP1,latent transforming growth factor beta binding protein 1,2p22.3
90354,Brittle cornea syndrome,ZNF469,zinc finger protein 469,16q24.2
90354,Brittle cornea syndrome,PRDM5,PR/SET domain 5,4q27
90308,Capillary-lymphatic-venous malformation with segmental distribution,AGGF1,angiogenic factor with G-patch and FHA domains 1,5q13.3
90308,Capillary-lymphatic-venous malformation with segmental distribution,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
90307,Parkes Weber syndrome,RASA1,RAS p21 protein activator 1,5q14.3
90322,Cockayne syndrome type 2,ERCC6,"ERCC excision repair 6, chromatin remodeling factor",10q11.23
90322,Cockayne syndrome type 2,ERCC8,"ERCC excision repair 8, CSA ubiquitin ligase complex subunit",5q12.1
90322,Cockayne syndrome type 2,ERCC1,"ERCC excision repair 1, endonuclease non-catalytic subunit",19q13.32
90321,Cockayne syndrome type 1,ERCC4,"ERCC excision repair 4, endonuclease catalytic subunit",16p13.12
90321,Cockayne syndrome type 1,ERCC6,"ERCC excision repair 6, chromatin remodeling factor",10q11.23
90321,Cockayne syndrome type 1,ERCC8,"ERCC excision repair 8, CSA ubiquitin ligase complex subunit",5q12.1
90324,Cockayne syndrome type 3,ERCC6,"ERCC excision repair 6, chromatin remodeling factor",10q11.23
90324,Cockayne syndrome type 3,ERCC8,"ERCC excision repair 8, CSA ubiquitin ligase complex subunit",5q12.1
90153,Mandibuloacral dysplasia with type A lipodystrophy,LMNA,lamin A/C,1q22
90154,Mandibuloacral dysplasia with type B lipodystrophy,ZMPSTE24,zinc metallopeptidase STE24,1p34.2
90186,Meige disease,EPHB4,EPH receptor B4,7q22.1
90118,Severe early-onset axonal neuropathy due to MFN2 deficiency,MFN2,mitofusin 2,1p36.22
90117,"Hereditary motor and sensory neuropathy, Okinawa type",TFG,trafficking from ER to golgi regulator,3q12.2
90120,Hereditary motor and sensory neuropathy type 6,SLC25A46,solute carrier family 25 member 46,5q22.1
90120,Hereditary motor and sensory neuropathy type 6,MFN2,mitofusin 2,1p36.22
88644,"Autosomal recessive ataxia, Beauce type",SYNE1,spectrin repeat containing nuclear envelope protein 1,6q25.2
88637,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,POLR3B,RNA polymerase III subunit B,12q23.3
88637,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,POLR1C,RNA polymerase I and III subunit C,6p21.1
88637,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,POLR3A,RNA polymerase III subunit A,10q22.3
88639,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,HIBCH,3-hydroxyisobutyryl-CoA hydrolase,2q32.2
88642,Congenital insensitivity to pain-anosmia-neuropathic arthropathy,SCN9A,sodium voltage-gated channel alpha subunit 9,2q24.3
88642,Congenital insensitivity to pain-anosmia-neuropathic arthropathy,SCN10A,sodium voltage-gated channel alpha subunit 10,3p22.2
88642,Congenital insensitivity to pain-anosmia-neuropathic arthropathy,SCN11A,sodium voltage-gated channel alpha subunit 11,3p22.2
88635,Vacuolar myopathy with sarcoplasmic reticulum protein aggregates,CASQ1,calsequestrin 1,1q23.2
88621,Ichthyosis-prematurity syndrome,SLC27A4,solute carrier family 27 member 4,9q34.11
88628,Posterior column ataxia-retinitis pigmentosa syndrome,FLVCR1,FLVCR choline and heme transporter 1,1q32.3
88629,Tritanopia,OPN1SW,"opsin 1, short wave sensitive",7q32.1
88630,Terminal osseous dysplasia-pigmentary defects syndrome,FLNA,filamin A,Xq28
88620,Isolated congenital anosmia,TENM1,teneurin transmembrane protein 1,Xq25
88620,Isolated congenital anosmia,CNGA2,cyclic nucleotide gated channel subunit alpha 2,Xq28
88619,Familial acute necrotizing encephalopathy,RANBP2,RAN binding protein 2,2q13
88618,S-adenosylhomocysteine hydrolase deficiency,AHCY,adenosylhomocysteinase,20q11.22
88616,Autosomal recessive non-syndromic intellectual disability,DCPS,"decapping enzyme, scavenger",11q24.2
88616,Autosomal recessive non-syndromic intellectual disability,B3GALNT2,"beta-1,3-N-acetylgalactosaminyltransferase 2",1q42.3
88616,Autosomal recessive non-syndromic intellectual disability,IMPA1,inositol monophosphatase 1,8q21.13
88616,Autosomal recessive non-syndromic intellectual disability,ABCA2,ATP binding cassette subfamily A member 2,9q34.3
88616,Autosomal recessive non-syndromic intellectual disability,CHKA,choline kinase alpha,11q13.2
88616,Autosomal recessive non-syndromic intellectual disability,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,5q33.2
88616,Autosomal recessive non-syndromic intellectual disability,CEP104,centrosomal protein 104,1p36.32
88616,Autosomal recessive non-syndromic intellectual disability,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,9q34.3
88616,Autosomal recessive non-syndromic intellectual disability,AIMP1,aminoacyl tRNA synthetase complex interacting multifunctional protein 1,4q24
88616,Autosomal recessive non-syndromic intellectual disability,UFSP2,UFM1 specific peptidase 2,4q35.1
88616,Autosomal recessive non-syndromic intellectual disability,CRBN,cereblon,3p26.2
88616,Autosomal recessive non-syndromic intellectual disability,TUSC3,tumor suppressor candidate 3,8p22
88616,Autosomal recessive non-syndromic intellectual disability,TECR,"trans-2,3-enoyl-CoA reductase",19p13.12
88616,Autosomal recessive non-syndromic intellectual disability,GRIK2,glutamate ionotropic receptor kainate type subunit 2,6q16.3
88616,Autosomal recessive non-syndromic intellectual disability,WASHC4,WASH complex subunit 4,12q23.3
88616,Autosomal recessive non-syndromic intellectual disability,TRAPPC9,trafficking protein particle complex subunit 9,8q24.3
88616,Autosomal recessive non-syndromic intellectual disability,PRSS12,serine protease 12,4q26
88616,Autosomal recessive non-syndromic intellectual disability,MED23,mediator complex subunit 23,6q23.2
88616,Autosomal recessive non-syndromic intellectual disability,CRADD,CARD and death domain containing adaptor protein,12q22
88616,Autosomal recessive non-syndromic intellectual disability,ZC3H14,zinc finger CCCH-type containing 14,14q31.3
88616,Autosomal recessive non-syndromic intellectual disability,NSUN2,NOP2/Sun RNA methyltransferase 2,5p15.31
88616,Autosomal recessive non-syndromic intellectual disability,LINS1,lines homolog 1,15q26.3
88616,Autosomal recessive non-syndromic intellectual disability,PGAP1,post-GPI attachment to proteins inositol deacylase 1,2q33.1
88616,Autosomal recessive non-syndromic intellectual disability,METTL23,"methyltransferase 23, arginine",17q25.2
88616,Autosomal recessive non-syndromic intellectual disability,CLIP1,CAP-Gly domain containing linker protein 1,12q24.31
88616,Autosomal recessive non-syndromic intellectual disability,FBXO31,F-box protein 31,16q24.2
88616,Autosomal recessive non-syndromic intellectual disability,NDST1,N-deacetylase and N-sulfotransferase 1,5q33.1
88616,Autosomal recessive non-syndromic intellectual disability,FMN2,formin 2,1q43
88616,Autosomal recessive non-syndromic intellectual disability,EDC3,enhancer of mRNA decapping 3,15q24.1
88616,Autosomal recessive non-syndromic intellectual disability,HNMT,histamine N-methyltransferase,2q22.1
88616,Autosomal recessive non-syndromic intellectual disability,EZR,ezrin,6q25.3
88616,Autosomal recessive non-syndromic intellectual disability,LMAN2L,"lectin, mannose binding 2 like",2q11.2
88616,Autosomal recessive non-syndromic intellectual disability,NEMF,nuclear export mediator factor,14q21.3
88616,Autosomal recessive non-syndromic intellectual disability,GRM7,glutamate metabotropic receptor 7,3p26.1
88616,Autosomal recessive non-syndromic intellectual disability,IQSEC1,IQ motif and Sec7 domain ArfGEF 1,3p25.2
88616,Autosomal recessive non-syndromic intellectual disability,TNIK,TRAF2 and NCK interacting kinase,3q26.2-q26.31
88616,Autosomal recessive non-syndromic intellectual disability,NCDN,neurochondrin,1p34.3
88616,Autosomal recessive non-syndromic intellectual disability,UBE4A,ubiquitination factor E4A,11q23.3
88616,Autosomal recessive non-syndromic intellectual disability,TTC5,tetratricopeptide repeat domain 5,14q11.2
88616,Autosomal recessive non-syndromic intellectual disability,PIGC,phosphatidylinositol glycan anchor biosynthesis class C,1q24.3
88616,Autosomal recessive non-syndromic intellectual disability,SLC45A1,solute carrier family 45 member 1,1p36.23
88616,Autosomal recessive non-syndromic intellectual disability,GEMIN5,gem nuclear organelle associated protein 5,5q33.2
88616,Autosomal recessive non-syndromic intellectual disability,FRRS1L,ferric chelate reductase 1 like,9q31.3
88616,Autosomal recessive non-syndromic intellectual disability,ALKBH8,"alkB homolog 8, tRNA methyltransferase",11q22.3
88616,Autosomal recessive non-syndromic intellectual disability,MBOAT7,membrane bound acylglycerophosphatidylinositol O-acyltransferase MBOAT7,19q13.42
88616,Autosomal recessive non-syndromic intellectual disability,FERRY3,FERRY endosomal RAB5 effector complex subunit 3,12p13.32
88616,Autosomal recessive non-syndromic intellectual disability,SARS1,seryl-tRNA synthetase 1,1p13.3
88616,Autosomal recessive non-syndromic intellectual disability,RSRC1,arginine and serine rich coiled-coil 1,3q25.32
88616,Autosomal recessive non-syndromic intellectual disability,MED25,mediator complex subunit 25,19q13.33
88616,Autosomal recessive non-syndromic intellectual disability,NAA20,"N-alpha-acetyltransferase 20, NatB catalytic subunit",20p11.23
88616,Autosomal recessive non-syndromic intellectual disability,CC2D1A,coiled-coil and C2 domain containing 1A,19p13.12
88616,Autosomal recessive non-syndromic intellectual disability,MAN1B1,mannosidase alpha class 1B member 1,9q34.3
88616,Autosomal recessive non-syndromic intellectual disability,TPR,"translocated promoter region, nuclear basket protein",1q31.1
88616,Autosomal recessive non-syndromic intellectual disability,KDM5B,lysine demethylase 5B,1q32.1
88616,Autosomal recessive non-syndromic intellectual disability,EEF1B2,eukaryotic translation elongation factor 1 beta 2,2q33.3
87503,Mal de Meleda,SLURP1,secreted LY6/PLAUR domain containing 1,8q24.3
86920,Dermatopathia pigmentosa reticularis,KRT14,keratin 14,17q21.2
522077,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome,SYT1,synaptotagmin 1,12q21.2
86911,Epilepsy with myoclonic absences,SLC2A1,solute carrier family 2 member 1,1p34.2
521450,LAMA5-related multisystemic syndrome,LAMA5,laminin subunit alpha 5,20q13.33
521445,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome,ADAMTSL1,ADAMTS like 1,9p22.2-p22.1
521438,Congenital vertebral-cardiac-renal anomalies syndrome,KYNU,kynureninase,2q22.2
521438,Congenital vertebral-cardiac-renal anomalies syndrome,NADSYN1,NAD synthetase 1,11q13.4
521438,Congenital vertebral-cardiac-renal anomalies syndrome,HAAO,"3-hydroxyanthranilate 3,4-dioxygenase",2p21
521432,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome,CYP51A1,cytochrome P450 family 51 subfamily A member 1,7q21.2
521426,PLAA-associated neurodevelopmental disorder,PLAA,phospholipase A2 activating protein,9p21.2
521414,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,ATP1A1,ATPase Na+/K+ transporting subunit alpha 1,1p13.1
521258,Xq25 microduplication syndrome,STAG2,STAG2 cohesin complex component,Xq25
521305,Proximal myopathy with focal depletion of mitochondria,CHKB,choline kinase beta,22q13.33
521390,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome,KIDINS220,kinase D interacting substrate 220,2p25.1
521406,Dystonia-parkinsonism-hypermanganesemia syndrome,SLC39A14,solute carrier family 39 member 14,8p21.3
89838,Autosomal recessive generalized epidermolysis bullosa simplex,KRT14,keratin 14,17q21.2
521411,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect,SCO2,synthesis of cytochrome C oxidase 2,22q13.33
88949,MUC1-related autosomal dominant tubulointerstitial kidney disease,MUC1,"mucin 1, cell surface associated",1q22
88950,UMOD-related autosomal dominant tubulointerstitial kidney disease,UMOD,uromodulin,16p12.3
88940,Pseudohypoaldosteronism type 2C,WNK1,WNK lysine deficient protein kinase 1,12p13.33
88939,Pseudohypoaldosteronism type 2B,WNK4,WNK lysine deficient protein kinase 4,17q21.2
88924,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,TSC2,TSC complex subunit 2,16p13.3
88924,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,PKD1,"polycystin 1, transient receptor potential channel interacting",16p13.3
88918,Autosomal dominant Alport syndrome,COL4A3,collagen type IV alpha 3 chain,2q36.3
88918,Autosomal dominant Alport syndrome,COL4A4,collagen type IV alpha 4 chain,2q36.3
88919,Autosomal recessive Alport syndrome,COL4A3,collagen type IV alpha 3 chain,2q36.3
88919,Autosomal recessive Alport syndrome,COL4A4,collagen type IV alpha 4 chain,2q36.3
88917,X-linked Alport syndrome,COL4A5,collagen type IV alpha 5 chain,Xq22.3
93256,Fragile X-associated tremor/ataxia syndrome,FMR1,fragile X messenger ribonucleoprotein 1,Xq27.3
528105,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome,CLDN10,claudin 10,13q32.1
528091,Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome,LARS2,"leucyl-tRNA synthetase 2, mitochondrial",3p21.31
528084,Non-specific syndromic intellectual disability,ZMIZ1,zinc finger MIZ-type containing 1,10q22.3
528084,Non-specific syndromic intellectual disability,PUS7,pseudouridine synthase 7,7q22.3
528084,Non-specific syndromic intellectual disability,TRAPPC4,trafficking protein particle complex subunit 4,11q23.3
528084,Non-specific syndromic intellectual disability,MAN2C1,mannosidase alpha class 2C member 1,15q24.2
528084,Non-specific syndromic intellectual disability,BAP1,BRCA1 associated deubiquitinase 1,3p21.1
528084,Non-specific syndromic intellectual disability,TRIP12,thyroid hormone receptor interactor 12,2q36.3
528084,Non-specific syndromic intellectual disability,ZNF526,zinc finger protein 526,19q13.2
528084,Non-specific syndromic intellectual disability,BCORL1,BCL6 corepressor like 1,Xq26.1
528084,Non-specific syndromic intellectual disability,CHD5,chromodomain helicase DNA binding protein 5,1p36.31
528084,Non-specific syndromic intellectual disability,PAK3,p21 (RAC1) activated kinase 3,Xq23
528084,Non-specific syndromic intellectual disability,BRWD3,bromodomain and WD repeat domain containing 3,Xq21.1
528084,Non-specific syndromic intellectual disability,TBR1,T-box brain transcription factor 1,2q24.2
528084,Non-specific syndromic intellectual disability,AGO1,argonaute RISC component 1,1p34.3
528084,Non-specific syndromic intellectual disability,KMT2E,lysine methyltransferase 2E (inactive),7q22.3
528084,Non-specific syndromic intellectual disability,SVBP,small vasohibin binding protein,1p34.2
528084,Non-specific syndromic intellectual disability,CERT1,ceramide transporter 1,5q13.3
528084,Non-specific syndromic intellectual disability,FBXW11,F-box and WD repeat domain containing 11,5q35.1
528084,Non-specific syndromic intellectual disability,ANKRD17,ankyrin repeat domain 17,4q13.3
528084,Non-specific syndromic intellectual disability,EMC10,ER membrane protein complex subunit 10,19q13.33
528084,Non-specific syndromic intellectual disability,SPTBN1,"spectrin beta, non-erythrocytic 1",2p16.2
528084,Non-specific syndromic intellectual disability,LMBRD2,LMBR1 domain containing 2,5p13.2
528084,Non-specific syndromic intellectual disability,TRMT1,tRNA methyltransferase 1,19p13.13
528084,Non-specific syndromic intellectual disability,CNOT1,CCR4-NOT transcription complex subunit 1,16q21
528084,Non-specific syndromic intellectual disability,CDK8,cyclin dependent kinase 8,13q12.13
528084,Non-specific syndromic intellectual disability,PGM2L1,phosphoglucomutase 2 like 1,11q13.4
528084,Non-specific syndromic intellectual disability,CTR9,"CTR9 homolog, Paf1/RNA polymerase II complex component",11p15.4
528084,Non-specific syndromic intellectual disability,RALA,RAS like proto-oncogene A,7p14.1
528084,Non-specific syndromic intellectual disability,NOVA2,NOVA alternative splicing regulator 2,19q13.32
528084,Non-specific syndromic intellectual disability,HNRNPC,heterogeneous nuclear ribonucleoprotein C,14q11.2
528084,Non-specific syndromic intellectual disability,ATP6V0A1,ATPase H+ transporting V0 subunit a1,17q21.2
528084,Non-specific syndromic intellectual disability,TAF4,TATA-box binding protein associated factor 4,20q13.33
528084,Non-specific syndromic intellectual disability,EIF4A2,eukaryotic translation initiation factor 4A2,3q27.3
528084,Non-specific syndromic intellectual disability,SCAF4,SR-related CTD associated factor 4,21q22.11
528084,Non-specific syndromic intellectual disability,CAPRIN1,cell cycle associated protein 1,11p13
528084,Non-specific syndromic intellectual disability,PPP2CA,protein phosphatase 2 catalytic subunit alpha,5q31.1
528084,Non-specific syndromic intellectual disability,TMEM222,transmembrane protein 222,1p36.11
528084,Non-specific syndromic intellectual disability,OTUD5,OTU deubiquitinase 5,Xp11.23
528084,Non-specific syndromic intellectual disability,SIAH1,siah E3 ubiquitin protein ligase 1,16q12.1
528084,Non-specific syndromic intellectual disability,RAC3,Rac family small GTPase 3,17q25.3
528084,Non-specific syndromic intellectual disability,FAM50A,family with sequence similarity 50 member A,Xq28
528084,Non-specific syndromic intellectual disability,ZMYM2,zinc finger MYM-type containing 2,13q12.11
528084,Non-specific syndromic intellectual disability,AP1G1,adaptor related protein complex 1 subunit gamma 1,16q22.2
528084,Non-specific syndromic intellectual disability,ATP9A,ATPase phospholipid transporting 9A (putative),20q13.2
528084,Non-specific syndromic intellectual disability,DOHH,deoxyhypusine hydroxylase,19p13.3
528084,Non-specific syndromic intellectual disability,ADGRL1,adhesion G protein-coupled receptor L1,19p13.12
528084,Non-specific syndromic intellectual disability,CSNK2A1,casein kinase 2 alpha 1,20p13
528084,Non-specific syndromic intellectual disability,TNRC6B,trinucleotide repeat containing adaptor 6B,22q13.1
528084,Non-specific syndromic intellectual disability,CUL3,cullin 3,2q36.2
528084,Non-specific syndromic intellectual disability,SETD5,SET domain containing 5,3p25.3
528084,Non-specific syndromic intellectual disability,SRCAP,Snf2 related CREBBP activator protein,16p11.2
528084,Non-specific syndromic intellectual disability,RNF2,ring finger protein 2,1q25.3
528084,Non-specific syndromic intellectual disability,SYNCRIP,synaptotagmin binding cytoplasmic RNA interacting protein,6q14.3
528084,Non-specific syndromic intellectual disability,GNB2,G protein subunit beta 2,7q22.1
528084,Non-specific syndromic intellectual disability,PRPF8,pre-mRNA processing factor 8,17p13.3
528084,Non-specific syndromic intellectual disability,NRCAM,neuronal cell adhesion molecule,7q31.1
528084,Non-specific syndromic intellectual disability,H4C5,H4 clustered histone 5,6p22.2
528084,Non-specific syndromic intellectual disability,TIAM1,TIAM Rac1 associated GEF 1,21q22.11
528084,Non-specific syndromic intellectual disability,CACNA1C,calcium voltage-gated channel subunit alpha1 C,12p13.33
528084,Non-specific syndromic intellectual disability,WDFY3,WD repeat and FYVE domain containing 3,4q21.23
528084,Non-specific syndromic intellectual disability,GRIK2,glutamate ionotropic receptor kainate type subunit 2,6q16.3
528084,Non-specific syndromic intellectual disability,NTNG1,netrin G1,1p13.3
528084,Non-specific syndromic intellectual disability,CNOT3,CCR4-NOT transcription complex subunit 3,19q13.42
528084,Non-specific syndromic intellectual disability,UBR7,ubiquitin protein ligase E3 component n-recognin 7,14q32.12
528084,Non-specific syndromic intellectual disability,WASF1,WASP family member 1,6q21
528084,Non-specific syndromic intellectual disability,ZNF142,zinc finger protein 142,2q35
528084,Non-specific syndromic intellectual disability,SETD1A,"SET domain containing 1A, histone lysine methyltransferase",16p11.2
528084,Non-specific syndromic intellectual disability,MADD,MAP kinase activating death domain,11p11.2
528084,Non-specific syndromic intellectual disability,NTNG2,netrin G2,9q34.13
528084,Non-specific syndromic intellectual disability,H4C3,H4 clustered histone 3,6p22.2
528084,Non-specific syndromic intellectual disability,CCDC32,coiled-coil domain containing 32,15q15.1
528084,Non-specific syndromic intellectual disability,PALS1,"protein associated with LIN7 1, MAGUK p55 family member",14q23.3
528084,Non-specific syndromic intellectual disability,KDM4B,lysine demethylase 4B,19p13.3
528084,Non-specific syndromic intellectual disability,ACTL6B,actin like 6B,7q22.1
528084,Non-specific syndromic intellectual disability,DLG4,discs large MAGUK scaffold protein 4,17p13.1
528084,Non-specific syndromic intellectual disability,DDX6,DEAD-box helicase 6,11q23.3
528084,Non-specific syndromic intellectual disability,DPYSL5,dihydropyrimidinase like 5,2p23.3
528084,Non-specific syndromic intellectual disability,MED27,mediator complex subunit 27,9q34.13
528084,Non-specific syndromic intellectual disability,HPDL,4-hydroxyphenylpyruvate dioxygenase like,1p34.1
528084,Non-specific syndromic intellectual disability,HS2ST1,heparan sulfate 2-O-sulfotransferase 1,1p22.3
528084,Non-specific syndromic intellectual disability,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,11q22.3
528084,Non-specific syndromic intellectual disability,MED13,mediator complex subunit 13,17q23.2
528084,Non-specific syndromic intellectual disability,TCF20,transcription factor 20,22q13.2
528084,Non-specific syndromic intellectual disability,TCF7L2,transcription factor 7 like 2,10q25.2-q25.3
528084,Non-specific syndromic intellectual disability,JARID2,jumonji and AT-rich interaction domain containing 2,6p22.3
528084,Non-specific syndromic intellectual disability,HUWE1,"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1",Xp11.22
528084,Non-specific syndromic intellectual disability,PTPN23,protein tyrosine phosphatase non-receptor type 23,3p21.31
528084,Non-specific syndromic intellectual disability,MAPK8IP3,mitogen-activated protein kinase 8 interacting protein 3,16p13.3
528084,Non-specific syndromic intellectual disability,TANC2,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2",17q23.2-q23.3
528084,Non-specific syndromic intellectual disability,EIF5A,eukaryotic translation initiation factor 5A,17p13.1
528084,Non-specific syndromic intellectual disability,ZNF699,zinc finger protein 699,19p13.2
528084,Non-specific syndromic intellectual disability,H4C9,H4 clustered histone 9,6p22.1
528084,Non-specific syndromic intellectual disability,DOCK3,dedicator of cytokinesis 3,3p21.2
528084,Non-specific syndromic intellectual disability,NAA15,"N-alpha-acetyltransferase 15, NatA auxiliary subunit",4q31.1
528084,Non-specific syndromic intellectual disability,RORA,RAR related orphan receptor A,15q22.2
528084,Non-specific syndromic intellectual disability,RLIM,"ring finger protein, LIM domain interacting",Xq13.2
528084,Non-specific syndromic intellectual disability,ACTL6A,actin like 6A,3q26.33
528084,Non-specific syndromic intellectual disability,CLCN3,chloride voltage-gated channel 3,4q33
528084,Non-specific syndromic intellectual disability,AGO2,"argonaute 2, RISC catalytic component",8q24.3
528084,Non-specific syndromic intellectual disability,KAT8,lysine acetyltransferase 8,16p11.2
528084,Non-specific syndromic intellectual disability,HTT,huntingtin,4p16.3
528084,Non-specific syndromic intellectual disability,ATP2B1,ATPase plasma membrane Ca2+ transporting 1,12q21.33
528084,Non-specific syndromic intellectual disability,PLXNA1,plexin A1,3q21.3
528084,Non-specific syndromic intellectual disability,KMT2B,lysine methyltransferase 2B,19q13.12
528084,Non-specific syndromic intellectual disability,PCDHGC4,"protocadherin gamma subfamily C, 4",5q31.3
528084,Non-specific syndromic intellectual disability,CPSF3,cleavage and polyadenylation specific factor 3,2p25.1
528084,Non-specific syndromic intellectual disability,MSL2,MSL complex subunit 2,3q22.3
528084,Non-specific syndromic intellectual disability,UPF1,UPF1 RNA helicase and ATPase,19p13.11
528084,Non-specific syndromic intellectual disability,FBXO11,F-box protein 11,2p16.3
528084,Non-specific syndromic intellectual disability,WARS1,tryptophanyl-tRNA synthetase 1,14q32.2
528084,Non-specific syndromic intellectual disability,PSMD12,"proteasome 26S subunit, non-ATPase 12",17q24.2
93262,Crouzon syndrome-acanthosis nigricans syndrome,FGFR3,fibroblast growth factor receptor 3,4p16.3
93260,Pfeiffer syndrome type 3,FGFR2,fibroblast growth factor receptor 2,10q26.13
93259,Pfeiffer syndrome type 2,FGFR2,fibroblast growth factor receptor 2,10q26.13
93258,Pfeiffer syndrome type 1,FGFR1,fibroblast growth factor receptor 1,8p11.23
93258,Pfeiffer syndrome type 1,FGFR2,fibroblast growth factor receptor 2,10q26.13
93271,"Short rib-polydactyly syndrome, Verma-Naumoff type",IFT80,intraflagellar transport 80,3q25.33
93271,"Short rib-polydactyly syndrome, Verma-Naumoff type",DYNC2H1,dynein cytoplasmic 2 heavy chain 1,11q22.3
93271,"Short rib-polydactyly syndrome, Verma-Naumoff type",WDR35,WD repeat domain 35,2p24.1
93271,"Short rib-polydactyly syndrome, Verma-Naumoff type",DYNC2I1,dynein 2 intermediate chain 1,7q36.3
93271,"Short rib-polydactyly syndrome, Verma-Naumoff type",DYNC2I2,dynein 2 intermediate chain 2,9q34.11
93269,"Short rib-polydactyly syndrome, Majewski type",TRAF3IP1,TRAF3 interacting protein 1,2q37.3
93269,"Short rib-polydactyly syndrome, Majewski type",DYNC2H1,dynein cytoplasmic 2 heavy chain 1,11q22.3
93269,"Short rib-polydactyly syndrome, Majewski type",NEK1,NIMA related kinase 1,4q33
93270,"Short rib-polydactyly syndrome, Saldino-Noonan type",DYNC2H1,dynein cytoplasmic 2 heavy chain 1,11q22.3
93268,"Short rib-polydactyly syndrome, Beemer-Langer type",IFT80,intraflagellar transport 80,3q25.33
93268,"Short rib-polydactyly syndrome, Beemer-Langer type",IFT122,intraflagellar transport 122,3q21.3-q22.1
93282,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",PAPSS2,3'-phosphoadenosine 5'-phosphosulfate synthase 2,10q23.2-q23.31
93283,"Spondyloepiphyseal dysplasia, Kimberley type",ACAN,aggrecan,15q26.1
93279,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis,COL2A1,collagen type II alpha 1 chain,12q13.11
93276,Polyostotic fibrous dysplasia,GNAS,GNAS complex locus,20q13.32
93277,Monostotic fibrous dysplasia,GNAS,GNAS complex locus,20q13.32
93274,Thanatophoric dysplasia type 2,FGFR3,fibroblast growth factor receptor 3,4p16.3
527497,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy,NKX6-2,NK6 homeobox 2,10q26.3
93110,Posterior urethral valve,BNC2,basonuclin zinc finger protein 2,9p22.3-p22.2
527450,Severe myopia-generalized joint laxity-short stature syndrome,GZF1,GDNF inducible zinc finger protein 1,20p11.21
93100,"Renal agenesis, unilateral",RET,ret proto-oncogene,10q11.21
93100,"Renal agenesis, unilateral",FRAS1,Fraser extracellular matrix complex subunit 1,4q21.21
93100,"Renal agenesis, unilateral",BMP4,bone morphogenetic protein 4,14q22.2
93100,"Renal agenesis, unilateral",FREM2,FRAS1 related extracellular matrix 2,13q13.3
93100,"Renal agenesis, unilateral",FREM1,FRAS1 related extracellular matrix 1,9p22.3
93100,"Renal agenesis, unilateral",UPK3A,uroplakin 3A,22q13.31
93100,"Renal agenesis, unilateral",DSTYK,dual serine/threonine and tyrosine protein kinase,1q32.1
93100,"Renal agenesis, unilateral",GREB1L,GREB1 like retinoic acid receptor coactivator,18q11.1-q11.2
527468,Diaphragmatic hernia-short bowel-asplenia syndrome,HLX,H2.0 like homeobox,1q41
92050,Congenital tufting enteropathy,EPCAM,epithelial cell adhesion molecule,2p21
92050,Congenital tufting enteropathy,PERCC1,proline and glutamate rich with coiled coil 1,16p13.3
93160,Hypocalcemic vitamin D-resistant rickets,VDR,vitamin D receptor,12q13.11
93114,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E,INF2,"inverted formin, FH2 and WH2 domain containing",14q32.33
93111,HNF1B-related autosomal dominant tubulointerstitial kidney disease,HNF1B,HNF1 homeobox B,17q12
93172,"Renal dysplasia, unilateral",HNF1B,HNF1 homeobox B,17q12
93173,"Renal dysplasia, bilateral",HNF1B,HNF1 homeobox B,17q12
93322,Isolated tibial hemimelia,GLI3,GLI family zinc finger 3,7p14.1
93321,Isolated radial hemimelia,LMBR1,limb development membrane protein 1,7q36.3
93321,Isolated radial hemimelia,SHH,sonic hedgehog signaling molecule,7q36.3
93325,Autosomal dominant Kenny-Caffey syndrome,FAM111A,FAM111 trypsin like peptidase A,11q12.1
93324,Autosomal recessive Kenny-Caffey syndrome,TBCE,tubulin folding cofactor E,1q42.3
93329,Autosomal recessive omodysplasia,GPC6,glypican 6,13q31.3-q32.1
93328,Autosomal dominant omodysplasia,FZD2,frizzled class receptor 2,17q21.31
93336,Polydactyly of a triphalangeal thumb,SHH,sonic hedgehog signaling molecule,7q36.3
93336,Polydactyly of a triphalangeal thumb,LMBR1,limb development membrane protein 1,7q36.3
93335,Postaxial polydactyly type B,GLI1,GLI family zinc finger 1,12q13.3
93335,Postaxial polydactyly type B,GLI3,GLI family zinc finger 3,7p14.1
93334,Postaxial polydactyly type A,GLI1,GLI family zinc finger 1,12q13.3
93334,Postaxial polydactyly type A,KIAA0825,KIAA0825,5q15
93334,Postaxial polydactyly type A,ZNF141,zinc finger protein 141,4p16.3
93334,Postaxial polydactyly type A,IQCE,IQ motif containing E,7p22.3
93334,Postaxial polydactyly type A,GLI3,GLI family zinc finger 3,7p14.1
93334,Postaxial polydactyly type A,CIBAR1,CBY1 interacting BAR domain containing 1,8q22.1
93333,Pelviscapular dysplasia,TBX15,T-box transcription factor 15,1p12
93339,Polydactyly of a biphalangeal thumb and/or hallux,GLI1,GLI family zinc finger 1,12q13.3
93338,Polysyndactyly,GLI3,GLI family zinc finger 3,7p14.1
93349,X-linked spondyloepimetaphyseal dysplasia,BGN,biglycan,Xq28
93346,"Spondyloepimetaphyseal dysplasia congenita, Strudwick type",COL2A1,collagen type II alpha 1 chain,12q13.11
93347,Anauxetic dysplasia,RMRP,RNA component of mitochondrial RNA processing endoribonuclease,9p13.3
93347,Anauxetic dysplasia,POP1,"POP1 homolog, ribonuclease P/MRP subunit",8q22.2
93347,Anauxetic dysplasia,RMP64,ribonuclease MRP subunit p64,3q13.2
93356,"Spondyloepimetaphyseal dysplasia, Missouri type",MMP13,matrix metallopeptidase 13,11q22.2
93352,"Spondyloepimetaphyseal dysplasia, Shohat type",DDRGK1,DDRGK domain containing 1,20p13
93284,Spondyloepiphyseal dysplasia tarda,TRAPPC2,trafficking protein particle complex subunit 2,Xp22.2
93296,Achondrogenesis type 2,COL2A1,collagen type II alpha 1 chain,12q13.11
93298,Achondrogenesis type 1B,SLC26A2,solute carrier family 26 member 2,5q32
93297,Hypochondrogenesis,COL2A1,collagen type II alpha 1 chain,12q13.11
93299,Achondrogenesis type 1A,TRIP11,thyroid hormone receptor interactor 11,14q32.12
93304,Autosomal dominant brachyolmia,TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
93307,Multiple epiphyseal dysplasia type 4,SLC26A2,solute carrier family 26 member 2,5q32
93308,Multiple epiphyseal dysplasia type 1,COMP,cartilage oligomeric matrix protein,19p13.11
93311,Multiple epiphyseal dysplasia type 5,MATN3,matrilin 3,2p24.1
93314,"Spondylometaphyseal dysplasia, Kozlowski type",TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
93315,"Spondylometaphyseal dysplasia, 'corner fracture' type",COL2A1,collagen type II alpha 1 chain,12q13.11
93315,"Spondylometaphyseal dysplasia, 'corner fracture' type",FN1,fibronectin 1,2q35
93316,"Spondylometaphyseal dysplasia, Schmidt type",COL2A1,collagen type II alpha 1 chain,12q13.11
93317,"Spondylometaphyseal dysplasia, Sedaghatian type",GPX4,glutathione peroxidase 4,19p13.3
529962,17q24.2 microdeletion syndrome,BPTF,bromodomain PHD finger transcription factor,17q24.2
529962,17q24.2 microdeletion syndrome,PSMD12,"proteasome 26S subunit, non-ATPase 12",17q24.2
90673,Hypothyroidism due to TSH receptor mutations,TSHR,thyroid stimulating hormone receptor,14q24-q31
90674,Isolated thyroid-stimulating hormone deficiency,TSHB,thyroid stimulating hormone subunit beta,1p13.2
529831,Letrozole toxicity,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19q13.2
90658,Charcot-Marie-Tooth disease type 1E,PMP22,peripheral myelin protein 22,17p12
90791,Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",1p12
529980,Inflammatory bowel disease-recurrent sinopulmonary infections syndrome,NFAT5,nuclear factor of activated T cells 5,16q22.1
529977,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome,RIPK1,receptor interacting serine/threonine kinase 1,6p25.2
90695,Non-acquired panhypopituitarism,SOX3,SRY-box transcription factor 3,Xq27.1
90695,Non-acquired panhypopituitarism,PROP1,PROP paired-like homeobox 1,5q35.3
529965,Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome,CHD1,chromodomain helicase DNA binding protein 1,5q15-q21.1
529970,Male infertility due to acephalic spermatozoa,PMFBP1,polyamine modulated factor 1 binding protein 1,16q22.2
529970,Male infertility due to acephalic spermatozoa,SUN5,Sad1 and UNC84 domain containing 5,20q11.21
90625,Rare X-linked non-syndromic sensorineural deafness type DFN,PRPS1,phosphoribosyl pyrophosphate synthetase 1,Xq22.3
90625,Rare X-linked non-syndromic sensorineural deafness type DFN,COL4A6,collagen type IV alpha 6 chain,Xq22.3
90625,Rare X-linked non-syndromic sensorineural deafness type DFN,SMPX,small muscle protein X-linked,Xp22.12
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,KITLG,KIT ligand,12q21.32
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,CENPP,centromere protein P,9q22.31
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,USP48,ubiquitin specific peptidase 48,1p36.12
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,SSBP1,single stranded DNA binding protein 1,7q34
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,TRRAP,transformation/transcription domain associated protein,7q22.1
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,PDE1C,phosphodiesterase 1C,7p14.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,ATP11A,ATPase phospholipid transporting 11A,13q34
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,SLC44A4,solute carrier family 44 member 4,6p21.33
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,POU4F3,POU class 4 homeobox 3,5q32
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,SIX1,SIX homeobox 1,14q23.1
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,TECTA,tectorin alpha,11q23.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,TMC1,transmembrane channel like 1,9q21.13
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,WFS1,wolframin ER transmembrane glycoprotein,4p16.1
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,COCH,cochlin,14q12
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,COL11A2,collagen type XI alpha 2 chain,6p21.32
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,GSDME,gasdermin E,7p15.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,COL11A1,collagen type XI alpha 1 chain,1p21.1
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,EYA4,EYA transcriptional coactivator and phosphatase 4,6q23.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,GJB2,gap junction protein beta 2,13q12.11
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,GJB3,gap junction protein beta 3,1p34.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,GJB6,gap junction protein beta 6,13q12.11
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,KCNQ4,potassium voltage-gated channel subfamily Q member 4,1p34.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MYH14,myosin heavy chain 14,19q13.33
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MYH9,myosin heavy chain 9,22q12.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MYO6,myosin VI,6q14.1
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MYO7A,myosin VIIA,11q13.5
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,CCDC50,coiled-coil domain containing 50,3q28
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,GRHL2,grainyhead like transcription factor 2,8q22.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,CRYM,crystallin mu,16p12.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,ACTG1,actin gamma 1,17q25.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,SLC17A8,solute carrier family 17 member 8,12q23.1
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MIR96,microRNA 96,7q32.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,TBC1D24,TBC1 domain family member 24,16p13.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,TJP2,tight junction protein 2,9q21.11
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,CEACAM16,"CEA cell adhesion molecule 16, tectorial membrane component",19q13.31-q13.32
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,DIAPH3,diaphanous related formin 3,13q21.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,DIABLO,diablo IAP-binding mitochondrial protein,12q24.31
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,P2RX2,purinergic receptor P2X 2,12q24.33
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,TNC,tenascin C,9q33.1
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MYO1C,myosin IC,17p13.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,OSBPL2,oxysterol binding protein like 2,20q13.33
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,HOMER2,homer scaffold protein 2,15q25.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MCM2,minichromosome maintenance complex component 2,3q21.3
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,CD164,CD164 molecule,6q21
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,ABCC1,ATP binding cassette subfamily C member 1 (ABCC1 blood group),16p13.11
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,PTPRQ,protein tyrosine phosphatase receptor type Q,12q21.31
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,PLS1,plastin 1,3q23
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MAP1B,microtubule associated protein 1B,5q13.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,DMXL2,Dmx like 2,15q21.2
90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,MYO1A,myosin IA,12q13.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,PPIP5K2,diphosphoinositol pentakisphosphate kinase 2,5q21.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TMEM132E,transmembrane protein 132E,17q12
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GRAP,GRB2 related adaptor protein,17p11.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,BDP1,BDP1 general transcription factor IIIB subunit,5q13.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,AFG2B,AFG2 AAA ATPase homolog B,15q21.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,CEACAM16,"CEA cell adhesion molecule 16, tectorial membrane component",19q13.31-q13.32
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,NARS2,"asparaginyl-tRNA synthetase 2, mitochondrial",11q14.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,ROR1,receptor tyrosine kinase like orphan receptor 1,1p31.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,WBP2,WW domain binding protein 2,17q25.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,EPS8L2,EPS8 signaling adaptor L2,11p15.5
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,SLC26A4,solute carrier family 26 member 4,7q22.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,BSND,barttin CLCNK type accessory subunit beta,1p32.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,CDH23,cadherin related 23,10q22.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TECTA,tectorin alpha,11q23.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TMC1,transmembrane channel like 1,9q21.13
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TMIE,transmembrane inner ear,3p21.31
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TMPRSS3,transmembrane serine protease 3,21q22.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,USH1C,USH1 protein network component harmonin,11p15.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,COL11A2,collagen type XI alpha 2 chain,6p21.32
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,ELMOD3,ELMO domain containing 3,2p11.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GJB2,gap junction protein beta 2,13q12.11
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GJB3,gap junction protein beta 3,1p34.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GJB6,gap junction protein beta 6,13q12.11
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MET,"MET proto-oncogene, receptor tyrosine kinase",7q31.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MYO15A,myosin XVA,17p11.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MYO6,myosin VI,6q14.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MYO7A,myosin VIIA,11q13.5
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,OTOF,otoferlin,2p23.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,PCDH15,protocadherin related 15,10q21.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,WHRN,whirlin,9q32
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,STRC,stereocilin,15q15.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TRIOBP,TRIO and F-actin binding protein,22q13.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,RDX,radixin,11q22.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,LHFPL5,LHFPL tetraspan subfamily member 5,6p21.31
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,ESPN,espin,1p36.31
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,ESRRB,estrogen related receptor beta,14q24.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MARVELD2,MARVEL domain containing 2,5q13.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MYO3A,myosin IIIA,10p12.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,SLC26A5,solute carrier family 26 member 5,7q22.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,OTOA,otoancorin,16p12.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,PJVK,pejvakin,2q31.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,CLDN14,claudin 14,21q22.13
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,LRTOMT,leucine rich transmembrane and O-methyltransferase domain containing,11q13.4
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,HGF,hepatocyte growth factor,7q21.11
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,LOXHD1,lipoxygenase homology PLAT domains 1,18q21.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GRXCR1,glutaredoxin and cysteine rich domain containing 1,4p13
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TPRN,taperin,9q34.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,PTPRQ,protein tyrosine phosphatase receptor type Q,12q21.31
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,SERPINB6,serpin family B member 6,6p25.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,TBC1D24,TBC1 domain family member 24,16p13.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GPSM2,G protein signaling modulator 2,1p13.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MSRB3,methionine sulfoxide reductase B3,12q14.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,ILDR1,immunoglobulin like domain containing receptor 1,3q13.33
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,KARS1,lysyl-tRNA synthetase 1,16q23.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GIPC3,GIPC PDZ domain containing family member 3,19p13.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,CIB2,calcium and integrin binding family member 2,15q25.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,CABP2,calcium binding protein 2,11q13.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,OTOG,otogelin,11p15.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,PNPT1,polyribonucleotide nucleotidyltransferase 1,2p16.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,OTOGL,otogelin like,12q21.31
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,SYNE4,spectrin repeat containing nuclear envelope family member 4,19q13.12
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,SLITRK6,SLIT and NTRK like family member 6,13q31.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GRXCR2,glutaredoxin and cysteine rich domain containing 2,5q32
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,EPS8,"EGFR pathway substrate 8, signaling adaptor",12p12.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,ADCY1,adenylate cyclase 1,7p12.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,CLIC5,chloride intracellular channel 5,6p21.1
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,RIPOR2,RHO family interacting cell polarization regulator 2,6p22.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,DCDC2,doublecortin domain containing 2,6p22.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,ATP2B2,ATPase plasma membrane Ca2+ transporting 2,3p25.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,S1PR2,sphingosine-1-phosphate receptor 2,19p13.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MPZL2,myelin protein zero like 2,11q23.3
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,CDC14A,cell division cycle 14A,1p21.2
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,GJA1,gap junction protein alpha 1,6q22.31
90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,MINAR2,membrane integral NOTCH2 associated receptor 2,5q23.3
529574,Duane retraction syndrome with congenital deafness,MAFB,MAF bZIP transcription factor B,20q12
90368,Hypotrichosis simplex of the scalp,KRT74,keratin 74,12q13.13
90368,Hypotrichosis simplex of the scalp,CDSN,corneodesmosin,6p21.33
90389,Telangiectasia macularis eruptiva perstans,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
90653,Stickler syndrome type 1,COL2A1,collagen type II alpha 1 chain,12q13.11
90652,Otopalatodigital syndrome type 2,FLNA,filamin A,Xq28
90654,Stickler syndrome type 2,COL11A1,collagen type XI alpha 1 chain,1p21.1
529665,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome,GPAA1,glycosylphosphatidylinositol anchor attachment 1,8q24.3
90647,Jervell and Lange-Nielsen syndrome,KCNE1,potassium voltage-gated channel subfamily E regulatory subunit 1,21q22.12
90647,Jervell and Lange-Nielsen syndrome,KCNQ1,potassium voltage-gated channel subfamily Q member 1,11p15.5-p15.4
90650,Otopalatodigital syndrome type 1,FLNA,filamin A,Xq28
90641,Rare mitochondrial non-syndromic sensorineural deafness,POU3F4,POU class 3 homeobox 4,Xq21.1
90641,Rare mitochondrial non-syndromic sensorineural deafness,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,mitochondria
90641,Rare mitochondrial non-syndromic sensorineural deafness,TFB1M,"transcription factor B1, mitochondrial",6q25.3
90641,Rare mitochondrial non-syndromic sensorineural deafness,TRMU,tRNA mitochondrial 2-thiouridylase,22q13.31
90641,Rare mitochondrial non-syndromic sensorineural deafness,MT-CO1,mitochondrially encoded cytochrome c oxidase I,mitochondria
90641,Rare mitochondrial non-syndromic sensorineural deafness,MT-RNR1,mitochondrially encoded 12S rRNA,mitochondria
90641,Rare mitochondrial non-syndromic sensorineural deafness,MT-TH,mitochondrially encoded tRNA-His (CAU/C),mitochondria
90641,Rare mitochondrial non-syndromic sensorineural deafness,MT-TS1,mitochondrially encoded tRNA-Ser (UCN) 1,mitochondria
91387,Familial thoracic aortic aneurysm and aortic dissection,FOXE3,forkhead box E3,1p33
91387,Familial thoracic aortic aneurysm and aortic dissection,THSD4,thrombospondin type 1 domain containing 4,15q23
91387,Familial thoracic aortic aneurysm and aortic dissection,SMAD2,SMAD family member 2,18q21.1
91387,Familial thoracic aortic aneurysm and aortic dissection,LOX,lysyl oxidase,5q23.1
91387,Familial thoracic aortic aneurysm and aortic dissection,MAT2A,methionine adenosyltransferase 2A,2p11.2
91387,Familial thoracic aortic aneurysm and aortic dissection,ELN,elastin,7q11.23
91387,Familial thoracic aortic aneurysm and aortic dissection,HEY2,hes related family bHLH transcription factor with YRPW motif 2,6q22.31
91387,Familial thoracic aortic aneurysm and aortic dissection,EFEMP2,EGF containing fibulin extracellular matrix protein 2,11q13.1
91387,Familial thoracic aortic aneurysm and aortic dissection,TGFB3,transforming growth factor beta 3,14q24.3
91387,Familial thoracic aortic aneurysm and aortic dissection,TGFBR1,transforming growth factor beta receptor 1,9q22.33
91387,Familial thoracic aortic aneurysm and aortic dissection,TGFBR2,transforming growth factor beta receptor 2,3p24.1
91387,Familial thoracic aortic aneurysm and aortic dissection,FBN1,fibrillin 1,15q21.1
91387,Familial thoracic aortic aneurysm and aortic dissection,ACTA2,"actin alpha 2, smooth muscle",10q23.31
91387,Familial thoracic aortic aneurysm and aortic dissection,MYLK,myosin light chain kinase,3q21.1
91387,Familial thoracic aortic aneurysm and aortic dissection,SMAD3,SMAD family member 3,15q22.33
91387,Familial thoracic aortic aneurysm and aortic dissection,PRKG1,protein kinase cGMP-dependent 1,10q11.23-q21.1
91387,Familial thoracic aortic aneurysm and aortic dissection,MFAP5,microfibril associated protein 5,12p13.31
91387,Familial thoracic aortic aneurysm and aortic dissection,TGFB2,transforming growth factor beta 2,1q41
91387,Familial thoracic aortic aneurysm and aortic dissection,SMAD4,SMAD family member 4,18q21.2
91387,Familial thoracic aortic aneurysm and aortic dissection,MYH11,myosin heavy chain 11,16p13.11
91411,Congenital ptosis,COL25A1,collagen type XXV alpha 1 chain,4q25
91411,Congenital ptosis,ZFHX4,zinc finger homeobox 4,8q21.13
91496,Snowflake vitreoretinal degeneration,KCNJ13,potassium inwardly rectifying channel subfamily J member 13,2q37.1
91495,Persistent hyperplastic primary vitreous,FZD4,frizzled class receptor 4,11q14.2
91495,Persistent hyperplastic primary vitreous,NDP,norrin cystine knot growth factor NDP,Xp11.3
91495,Persistent hyperplastic primary vitreous,ATOH7,atonal bHLH transcription factor 7,10q21.3
91481,Ring dermoid of cornea,PITX2,paired like homeodomain 2,4q25
91414,Pilomatrixoma,CTNNB1,catenin beta 1,3p22.1
91490,Isolated congenital sclerocornea,GJA8,gap junction protein alpha 8,1q21.2
91489,Isolated congenital megalocornea,CHRDL1,chordin like 1,Xq23
91483,Rieger anomaly,PITX2,paired like homeodomain 2,4q25
91483,Rieger anomaly,FOXC1,forkhead box C1,6p25.3
91130,Cardiomyopathy-hypotonia-lactic acidosis syndrome,SLC25A3,solute carrier family 25 member 3,12q23.1
91131,DK1-CDG,DOLK,dolichol kinase,9q34.11
91132,Ichthyosis-hypotrichosis syndrome,ST14,ST14 transmembrane serine protease matriptase,11q24.3
90793,Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency,CYP17A1,cytochrome P450 family 17 subfamily A member 1,10q24.32
90795,Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8q24.3
90796,"46,XY difference of sex development due to isolated 17,20-lyase deficiency",CYB5A,cytochrome b5 type A,18q22.3
90796,"46,XY difference of sex development due to isolated 17,20-lyase deficiency",CYP17A1,cytochrome P450 family 17 subfamily A member 1,10q24.32
90797,Partial androgen insensitivity syndrome,AR,androgen receptor,Xq12
91347,TSH-secreting pituitary adenoma,CDH23,cadherin related 23,10q22.1
91352,Germinoma of the central nervous system,JMJD1C,jumonji domain containing 1C,10q21.3
91135,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency,GGCX,gamma-glutamyl carboxylase,2p11.2
79396,"Autosomal dominant generalized epidermolysis bullosa simplex, severe form",KRT14,keratin 14,17q21.2
79396,"Autosomal dominant generalized epidermolysis bullosa simplex, severe form",KRT5,keratin 5,12q13.13
79397,Epidermolysis bullosa simplex with mottled pigmentation,KRT14,keratin 14,17q21.2
79397,Epidermolysis bullosa simplex with mottled pigmentation,KRT5,keratin 5,12q13.13
79394,Congenital ichthyosiform erythroderma,ABCA12,ATP binding cassette subfamily A member 12,2q35
79394,Congenital ichthyosiform erythroderma,ALOX12B,"arachidonate 12-lipoxygenase, 12R type",17p13.1
79394,Congenital ichthyosiform erythroderma,ALOXE3,arachidonate epidermal lipoxygenase 3,17p13.1
79394,Congenital ichthyosiform erythroderma,TGM1,transglutaminase 1,14q12
79394,Congenital ichthyosiform erythroderma,NIPAL4,NIPA like domain containing 4,5q33.3
79394,Congenital ichthyosiform erythroderma,PNPLA1,"patatin like domain 1, omega-hydroxyceramide transacylase",6p21.31
79394,Congenital ichthyosiform erythroderma,CERS3,ceramide synthase 3,15q26.3
79394,Congenital ichthyosiform erythroderma,SULT2B1,sulfotransferase family 2B member 1,19q13.33
79394,Congenital ichthyosiform erythroderma,SDR9C7,short chain dehydrogenase/reductase family 9C member 7,12q13.3
79395,Keratoderma hereditarium mutilans with ichthyosis,LORICRIN,loricrin cornified envelope precursor protein,1q21.3
79414,Woolly hair nevus,HRAS,"HRas proto-oncogene, GTPase",11p15.5
79399,"Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form",KRT14,keratin 14,17q21.2
79399,"Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form",KRT5,keratin 5,12q13.13
79401,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement,PLEC,plectin,8q24.3
79400,Localized epidermolysis bullosa simplex,KRT14,keratin 14,17q21.2
79400,Localized epidermolysis bullosa simplex,KRT5,keratin 5,12q13.13
79403,Junctional epidermolysis bullosa with pyloric atresia,ITGA6,integrin subunit alpha 6,2q31.1
79403,Junctional epidermolysis bullosa with pyloric atresia,ITGB4,integrin subunit beta 4,17q25.1
79402,Intermediate generalized junctional epidermolysis bullosa,COL17A1,collagen type XVII alpha 1 chain,10q25.1
79402,Intermediate generalized junctional epidermolysis bullosa,ITGB4,integrin subunit beta 4,17q25.1
79402,Intermediate generalized junctional epidermolysis bullosa,LAMA3,laminin subunit alpha 3,18q11.2
79402,Intermediate generalized junctional epidermolysis bullosa,LAMB3,laminin subunit beta 3,1q32.2
79402,Intermediate generalized junctional epidermolysis bullosa,LAMC2,laminin subunit gamma 2,1q25.3
79404,Severe generalized junctional epidermolysis bullosa,LAMB3,laminin subunit beta 3,1q32.2
79404,Severe generalized junctional epidermolysis bullosa,LAMC2,laminin subunit gamma 2,1q25.3
79404,Severe generalized junctional epidermolysis bullosa,LAMA3,laminin subunit alpha 3,18q11.2
79406,Late-onset junctional epidermolysis bullosa,COL17A1,collagen type XVII alpha 1 chain,10q25.1
79409,Recessive dystrophic epidermolysis bullosa inversa,COL7A1,collagen type VII alpha 1 chain,3p21.31
79408,"Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",COL7A1,collagen type VII alpha 1 chain,3p21.31
79408,"Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",MMP1,matrix metallopeptidase 1,11q22.2
79411,Self-improving dystrophic epidermolysis bullosa,COL7A1,collagen type VII alpha 1 chain,3p21.31
79410,"Localized dystrophic epidermolysis bullosa, pretibial form",COL7A1,collagen type VII alpha 1 chain,3p21.31
79452,Milroy disease,FLT4,fms related receptor tyrosine kinase 4,5q35.3
79455,Cutaneous mastocytoma,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
79435,Oculocutaneous albinism type 4,SLC45A2,solute carrier family 45 member 2,5p13.2
79434,Oculocutaneous albinism type 1B,TYR,tyrosinase,11q14.3
79433,Oculocutaneous albinism type 3,TYRP1,tyrosinase related protein 1,9p23
79432,Oculocutaneous albinism type 2,OCA2,OCA2 melanosomal transmembrane protein,15q12-q13.1
79432,Oculocutaneous albinism type 2,MC1R,melanocortin 1 receptor,16q24.3
79431,Oculocutaneous albinism type 1A,TYR,tyrosinase,11q14.3
79445,Pseudopseudohypoparathyroidism,GNAS,GNAS complex locus,20q13.32
79444,Pseudohypoparathyroidism type 1C,GNAS,GNAS complex locus,20q13.32
79443,Pseudohypoparathyroidism type 1A,GNAS,GNAS complex locus,20q13.32
79483,Phakomatosis cesioflammea,GNAQ,G protein subunit alpha q,9q21.2
79483,Phakomatosis cesioflammea,GNA11,G protein subunit alpha 11,19p13.3
79484,Phakomatosis cesiomarmorata,GNA11,G protein subunit alpha 11,19p13.3
79478,Griscelli syndrome type 3,MLPH,melanophilin,2q37.3
79478,Griscelli syndrome type 3,MYO5A,myosin VA,15q21.2
79474,Atypical Werner syndrome,LMNA,lamin A/C,1q22
79477,Griscelli syndrome type 2,RAB27A,"RAB27A, member RAS oncogene family",15q21.3
79476,Griscelli syndrome type 1,MYO5A,myosin VA,15q21.2
79473,Variegate porphyria,PPOX,protoporphyrinogen oxidase,1q23.3
79269,Sanfilippo syndrome type A,SGSH,N-sulfoglucosamine sulfohydrolase,17q25.3
79257,GM1 gangliosidosis type 3,GLB1,galactosidase beta 1,3p22.3
79256,GM1 gangliosidosis type 2,GLB1,galactosidase beta 1,3p22.3
79255,GM1 gangliosidosis type 1,GLB1,galactosidase beta 1,3p22.3
79254,Classic phenylketonuria,PAH,phenylalanine hydroxylase,12q23.2
79259,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,SLC37A4,solute carrier family 37 member 4,11q23.3
79258,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,G6PC1,glucose-6-phosphatase catalytic subunit 1,17q21.31
79246,Pyruvate dehydrogenase phosphatase deficiency,PDP1,pyruvate dehydrogenase phosphatase catalytic subunit 1,8q22.1
79253,Mild phenylketonuria,PAH,phenylalanine hydroxylase,12q23.2
79240,Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency,PHKB,phosphorylase kinase regulatory subunit beta,16q12.1
79241,Biotinidase deficiency,BTD,biotinidase,3p25.1
79239,Classic galactosemia,GALT,galactose-1-phosphate uridylyltransferase,9p13.3
79244,Pyruvate dehydrogenase E2 deficiency,DLAT,dihydrolipoamide S-acetyltransferase,11q23.1
79242,Holocarboxylase synthetase deficiency,HLCS,holocarboxylase synthetase,21q22.13
79243,Pyruvate dehydrogenase E1-alpha deficiency,PDHA1,pyruvate dehydrogenase E1 subunit alpha 1,Xp22.12
79243,Pyruvate dehydrogenase E1-alpha deficiency,LONP1,"lon peptidase 1, mitochondrial",19p13.2
79299,Congenital glucokinase-related hyperinsulinism,GCK,glucokinase,7p13
79301,Congenital bile acid synthesis defect type 1,HSD3B7,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7",16p11.2
79293,Familial LCAT deficiency,LCAT,lecithin-cholesterol acyltransferase,16q22.1
79292,Fish-eye disease,LCAT,lecithin-cholesterol acyltransferase,16q22.1
79278,Autosomal erythropoietic protoporphyria,FECH,ferrochelatase,18q21.31
79279,Alpha-N-acetylgalactosaminidase deficiency type 1,NAGA,alpha-N-acetylgalactosaminidase,22q13.2
79280,Alpha-N-acetylgalactosaminidase deficiency type 2,NAGA,alpha-N-acetylgalactosaminidase,22q13.2
79281,Alpha-N-acetylgalactosaminidase deficiency type 3,NAGA,alpha-N-acetylgalactosaminidase,22q13.2
79282,"Methylmalonic acidemia with homocystinuria, type cblC",MMACHC,metabolism of cobalamin associated C,1p34.1
79283,"Methylmalonic acidemia with homocystinuria, type cblD",MMADHC,metabolism of cobalamin associated D,2q23.2
79284,Methylmalonic acidemia with homocystinuria type cblF,LMBRD1,LMBR1 domain containing 1,6q13
79270,Sanfilippo syndrome type B,NAGLU,N-acetyl-alpha-glucosaminidase,17q21.2
79271,Sanfilippo syndrome type C,HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8p11.21-p11.1
79272,Sanfilippo syndrome type D,GNS,glucosamine (N-acetyl)-6-sulfatase,12q14.3
79273,Hereditary coproporphyria,CPOX,coproporphyrinogen oxidase,3q11.2
79276,Acute intermittent porphyria,HMBS,hydroxymethylbilane synthase,11q23.3
79277,Congenital erythropoietic porphyria,UROS,uroporphyrinogen III synthase,10q26.2
79277,Congenital erythropoietic porphyria,GATA1,GATA binding protein 1,Xp11.23
79333,COG7-CDG,COG7,component of oligomeric golgi complex 7,16p12.2
79332,B4GALT1-CDG,B4GALT1,"beta-1,4-galactosyltransferase 1",9p21.1
79330,MOGS-CDG,MOGS,mannosyl-oligosaccharide glucosidase,2p13.1
79329,MGAT2-CDG,MGAT2,"alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",14q21.3
79328,ALG9-CDG,ALG9,"ALG9 alpha-1,2-mannosyltransferase",11q23.1
79327,ALG1-CDG,ALG1,ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase,16p13.3
79326,ALG2-CDG,ALG2,"ALG2 alpha-1,3/1,6-mannosyltransferase",9q22.33
79325,ALG8-CDG,ALG8,"ALG8 alpha-1,3-glucosyltransferase",11q14.1
79324,ALG12-CDG,ALG12,"ALG12 alpha-1,6-mannosyltransferase",22q13.33
79323,MPDU1-CDG,MPDU1,mannose-P-dolichol utilization defect 1,17p13.1
79322,DPM1-CDG,DPM1,"dolichyl-phosphate mannosyltransferase subunit 1, catalytic",20q13.13
79321,ALG3-CDG,ALG3,"ALG3 alpha-1,3- mannosyltransferase",3q27.1
79320,ALG6-CDG,ALG6,"ALG6 alpha-1,3-glucosyltransferase",1p31.3
79319,MPI-CDG,MPI,mannose phosphate isomerase,15q24.1
79318,PMM2-CDG,PMM2,phosphomannomutase 2,16p13.2
79314,L-2-hydroxyglutaric aciduria,L2HGDH,L-2-hydroxyglutarate dehydrogenase,14q21.3
79315,D-2-hydroxyglutaric aciduria,D2HGDH,D-2-hydroxyglutarate dehydrogenase,2q37.3
79315,D-2-hydroxyglutaric aciduria,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
79312,Vitamin B12-unresponsive methylmalonic acidemia type mut-,MMUT,methylmalonyl-CoA mutase,6p12.3
79310,Vitamin B12-responsive methylmalonic acidemia type cblA,MMAA,metabolism of cobalamin associated A,4q31.21
79311,Vitamin B12-responsive methylmalonic acidemia type cblB,MMAB,metabolism of cobalamin associated B,12q24.11
79306,Progressive familial intrahepatic cholestasis type 1,MYO5B,myosin VB,18q21.1
79306,Progressive familial intrahepatic cholestasis type 1,ATP8B1,ATPase phospholipid transporting 8B1,18q21.31
79304,Progressive familial intrahepatic cholestasis type 2,ABCB11,ATP binding cassette subfamily B member 11,2q31.1
79305,Progressive familial intrahepatic cholestasis type 3,ABCB4,ATP binding cassette subfamily B member 4,7q21.12
79302,Congenital bile acid synthesis defect type 3,CYP7B1,cytochrome P450 family 7 subfamily B member 1,8q12.3
79303,Congenital bile acid synthesis defect type 2,AKR1D1,aldo-keto reductase family 1 member D1,7q33
79351,"3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form",PHGDH,phosphoglycerate dehydrogenase,1p12
79350,"3-phosphoserine phosphatase deficiency, infantile/juvenile form",PSPH,phosphoserine phosphatase,7p11.2
79345,Brachytelephalangic chondrodysplasia punctata,ARSL,arylsulfatase L,Xp22.33
85191,Singleton-Merten dysplasia,IFIH1,interferon induced with helicase C domain 1,2q24.2
85191,Singleton-Merten dysplasia,RIGI,RNA sensor RIG-I,9p21.1
85193,Idiopathic juvenile osteoporosis,WNT3A,Wnt family member 3A,1q42.13
85193,Idiopathic juvenile osteoporosis,DKK1,dickkopf WNT signaling pathway inhibitor 1,10q21.1
85193,Idiopathic juvenile osteoporosis,WNT1,Wnt family member 1,12q13.12
85195,Familial expansile osteolysis,TNFRSF11A,TNF receptor superfamily member 11a,18q21.33
85194,Spondylo-ocular syndrome,XYLT2,xylosyltransferase 2,17q21.33
85199,Craniosynostosis-anal anomalies-porokeratosis syndrome,RNU12,"RNA, U12 small nuclear",22q13.2
85198,Dysspondyloenchondromatosis,COL2A1,collagen type II alpha 1 chain,12q13.11
85201,Genitopatellar syndrome,KAT6B,lysine acetyltransferase 6B,10q22.2
85202,Keutel syndrome,MGP,matrix Gla protein,12p12.3
85212,Fetal Gaucher disease,GBA1,glucosylceramidase beta 1,1q22
85277,"X-linked intellectual disability, Cantagrel type",NEXMIF,neurite extension and migration factor,Xq13.3
85278,Christianson syndrome,SLC9A6,solute carrier family 9 member A6,Xq26.3
85279,KDM5C-related syndromic X-linked intellectual disability,KDM5C,lysine demethylase 5C,Xp11.22
85282,MEHMO syndrome,EIF2S3,eukaryotic translation initiation factor 2 subunit gamma,Xp22.11
85284,BRESEK syndrome,MBTPS2,"membrane bound transcription factor peptidase, site 2",Xp22.12
85286,"X-linked intellectual disability, Shashi type",RBMX,RNA binding motif protein X-linked,Xq26.3
85287,"X-linked intellectual disability, Siderius type",PHF8,PHD finger protein 8,Xp11.22
85288,"X-linked intellectual disability, Stocco Dos Santos type",SHROOM4,shroom family member 4,Xp11.22
85293,"X-linked intellectual disability, Cabezas type",CUL4B,cullin 4B,Xq24
85295,"HSD10 disease, atypical type",HSD17B10,hydroxysteroid 17-beta dehydrogenase 10,Xp11.22
85294,X-linked epilepsy-learning disabilities-behavior disorders syndrome,SYN1,synapsin I,Xp11.3-p11.23
85329,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome,AP1S2,adaptor related protein complex 1 subunit sigma 2,Xp22.2
85335,Fried syndrome,AP1S2,adaptor related protein complex 1 subunit sigma 2,Xp22.2
85410,Oligoarticular juvenile idiopathic arthritis,PTPN22,protein tyrosine phosphatase non-receptor type 22,1p13.2
85410,Oligoarticular juvenile idiopathic arthritis,STAT4,signal transducer and activator of transcription 4,2q32.2-q32.3
85410,Oligoarticular juvenile idiopathic arthritis,IL2RA,interleukin 2 receptor subunit alpha,10p15.1
85410,Oligoarticular juvenile idiopathic arthritis,CD247,CD247 molecule,1q24.2
85410,Oligoarticular juvenile idiopathic arthritis,PTPN2,protein tyrosine phosphatase non-receptor type 2,18p11.21
85410,Oligoarticular juvenile idiopathic arthritis,ANKRD55,ankyrin repeat domain 55,5q11.2
85410,Oligoarticular juvenile idiopathic arthritis,IL2RB,interleukin 2 receptor subunit beta,22q12.3
85414,Systemic-onset juvenile idiopathic arthritis,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
85414,Systemic-onset juvenile idiopathic arthritis,MIF,macrophage migration inhibitory factor,22q11.23
85414,Systemic-onset juvenile idiopathic arthritis,IL6,interleukin 6,7p15.3
85414,Systemic-onset juvenile idiopathic arthritis,LACC1,laccase domain containing 1,13q14.11
85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,PTPN22,protein tyrosine phosphatase non-receptor type 22,1p13.2
85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,STAT4,signal transducer and activator of transcription 4,2q32.2-q32.3
85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,IL2RA,interleukin 2 receptor subunit alpha,10p15.1
85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,CD247,CD247 molecule,1q24.2
85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,PTPN2,protein tyrosine phosphatase non-receptor type 2,18p11.21
85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,ANKRD55,ankyrin repeat domain 55,5q11.2
85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,IL2RB,interleukin 2 receptor subunit beta,22q12.3
85442,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,LHX4,LIM homeobox 4,1q25.2
85445,AA amyloidosis,SAA1,serum amyloid A1,11p15.1
85453,X-linked reticulate pigmentary disorder,POLA1,"DNA polymerase alpha 1, catalytic subunit",Xp22.11-p21.3
86788,X-linked severe congenital neutropenia,WAS,WASP actin nucleation promoting factor,Xp11.23
86309,DPAGT1-CDG,DPAGT1,dolichyl-phosphate N-acetylglucosaminephosphotransferase 1,11q23.3
85448,AGel amyloidosis,GSN,gelsolin,9q33.2
85447,ATTRV30M amyloidosis,TTR,transthyretin,18q12.1
85451,ATTRV122I amyloidosis,TTR,transthyretin,18q12.1
86812,POMT1-related limb-girdle muscular dystrophy R11,POMT1,protein O-mannosyltransferase 1,9q34.13
86813,Helicoid peripapillary chorioretinal degeneration,TEAD1,TEA domain transcription factor 1,11p15.3
86814,Familial adult myoclonic epilepsy,SAMD12,sterile alpha motif domain containing 12,8q24.11-q24.12
86814,Familial adult myoclonic epilepsy,YEATS2,YEATS domain containing 2,3q27.1
86814,Familial adult myoclonic epilepsy,CTNND2,catenin delta 2,5p15.2
86814,Familial adult myoclonic epilepsy,CNTN2,contactin 2,1q32.1
86814,Familial adult myoclonic epilepsy,ADRA2B,adrenoceptor alpha 2B,2q11.2
86814,Familial adult myoclonic epilepsy,MARCHF6,membrane associated ring-CH-type finger 6,5p15.2
86815,Aplasia of lacrimal and salivary glands,FGF10,fibroblast growth factor 10,5p12
86820,Familial avascular necrosis of femoral head,TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
86820,Familial avascular necrosis of femoral head,COL2A1,collagen type II alpha 1 chain,12q13.11
86816,Congenital analbuminemia,ALB,albumin,4q13.3
512017,Chronic lymphoproliferative disorder of natural killer cells,STAT3,signal transducer and activator of transcription 3,17q21.2
86817,Hemolytic anemia due to adenylate kinase deficiency,AK1,adenylate kinase 1,9q34.11
86818,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,KCNE5,potassium voltage-gated channel subfamily E regulatory subunit 5,Xq23
86818,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,ACSL4,acyl-CoA synthetase long chain family member 4,Xq23
86818,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,AMMECR1,AMMECR nuclear protein 1,Xq23
86819,Atrichia with papular lesions,HR,HR lysine demethylase and nuclear receptor corepressor,8p21.3
86841,Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality,RPS14,ribosomal protein S14,5q33.1
512103,Autosomal recessive epidermolytic ichthyosis,KRT10,keratin 10,17q21.2
86834,Juvenile myelomonocytic leukemia,RRAS,RAS related,19q13.33
86834,Juvenile myelomonocytic leukemia,PTPN11,protein tyrosine phosphatase non-receptor type 11,12q24.13
86834,Juvenile myelomonocytic leukemia,KRAS,"KRAS proto-oncogene, GTPase",12p12.1
86834,Juvenile myelomonocytic leukemia,NF1,neurofibromin 1,17q11.2
86834,Juvenile myelomonocytic leukemia,NRAS,"NRAS proto-oncogene, GTPase",1p13.2
86834,Juvenile myelomonocytic leukemia,CBL,Cbl proto-oncogene,11q23.3
86830,"Chronic myeloproliferative disease, unclassifiable",PDGFRB,platelet derived growth factor receptor beta,5q32
86829,Chronic neutrophilic leukemia,CSF3R,colony stimulating factor 3 receptor,1p34.3
512260,Congenital cerebellar ataxia due to RNU12 mutation,RNU12,"RNA, U12 small nuclear",22q13.2
86849,Acute basophilic leukemia,MYB,"MYB proto-oncogene, transcription factor",6q23.3
86849,Acute basophilic leukemia,GATA1,GATA binding protein 1,Xp11.23
86845,Acute myeloid leukaemia with myelodysplasia-related features,TET2,tet methylcytosine dioxygenase 2,4q24
86845,Acute myeloid leukaemia with myelodysplasia-related features,IDH1,isocitrate dehydrogenase (NADP(+)) 1,2q34
86845,Acute myeloid leukaemia with myelodysplasia-related features,IDH2,isocitrate dehydrogenase (NADP(+)) 2,15q26.1
86845,Acute myeloid leukaemia with myelodysplasia-related features,ASXL1,ASXL transcriptional regulator 1,20q11.21
86845,Acute myeloid leukaemia with myelodysplasia-related features,DNMT3A,DNA methyltransferase 3 alpha,2p23.3
86872,T-cell large granular lymphocyte leukemia,STAT3,signal transducer and activator of transcription 3,17q21.2
86884,Subcutaneous panniculitis-like T-cell lymphoma,HAVCR2,hepatitis A virus cellular receptor 2,5q33.3
79503,Ichthyosis hystrix of Curth-Macklin,KRT1,keratin 1,12q13.13
79495,X-linked congenital generalized hypertrichosis,SOX3,SRY-box transcription factor 3,Xq27.1
79499,Autosomal dominant deafness-onychodystrophy syndrome,ATP6V1B2,ATPase H+ transporting V1 subunit B2,8p21.3
79500,DOORS syndrome,ATP6V1B2,ATPase H+ transporting V1 subunit B2,8p21.3
79500,DOORS syndrome,TBC1D24,TBC1 domain family member 24,16p13.3
79501,Punctate palmoplantar keratoderma type 1,COL14A1,collagen type XIV alpha 1 chain,8q24.12
79501,Punctate palmoplantar keratoderma type 1,AAGAB,alpha and gamma adaptin binding protein,15q23
79643,Autosomal recessive hyperinsulinism due to SUR1 deficiency,ABCC8,ATP binding cassette subfamily C member 8,11p15.1
79651,Mild hyperphenylalaninemia,PAH,phenylalanine hydroxylase,12q23.2
79644,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
83330,Proximal spinal muscular atrophy type 1,SMN2,"survival of motor neuron 2, centromeric",5q13.2
83330,Proximal spinal muscular atrophy type 1,NAIP,NLR family apoptosis inhibitory protein,5q13.2
83330,Proximal spinal muscular atrophy type 1,SMN1,"survival of motor neuron 1, telomeric",5q13.2
83419,Proximal spinal muscular atrophy type 3,SMN2,"survival of motor neuron 2, centromeric",5q13.2
83419,Proximal spinal muscular atrophy type 3,NAIP,NLR family apoptosis inhibitory protein,5q13.2
83419,Proximal spinal muscular atrophy type 3,SMN1,"survival of motor neuron 1, telomeric",5q13.2
83420,Proximal spinal muscular atrophy type 4,SMN2,"survival of motor neuron 2, centromeric",5q13.2
83420,Proximal spinal muscular atrophy type 4,SMN1,"survival of motor neuron 1, telomeric",5q13.2
83418,Proximal spinal muscular atrophy type 2,SMN2,"survival of motor neuron 2, centromeric",5q13.2
83418,Proximal spinal muscular atrophy type 2,NAIP,NLR family apoptosis inhibitory protein,5q13.2
83418,Proximal spinal muscular atrophy type 2,SMN1,"survival of motor neuron 1, telomeric",5q13.2
83469,Desmoplastic small round cell tumor,WT1,WT1 transcription factor,11p13
83469,Desmoplastic small round cell tumor,EWSR1,EWS RNA binding protein 1,22q12.2
83465,Narcolepsy type 2,HCRT,hypocretin neuropeptide precursor,17q21.2
83465,Narcolepsy type 2,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",6p21.32
83465,Narcolepsy type 2,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",6p21.32
83465,Narcolepsy type 2,ZNF365,zinc finger protein 365,10q21.2
83473,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,PIK3R2,phosphoinositide-3-kinase regulatory subunit 2,19p13.11
83473,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,PIK3R2,phosphoinositide-3-kinase regulatory subunit 2,19p13.11
83473,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,CCND2,cyclin D2,12p13.32
83473,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,AKT3,AKT serine/threonine kinase 3,1q43-q44
83472,CAMOS syndrome,ZNF592,zinc finger protein 592,15q25.3
83472,CAMOS syndrome,WDR73,WD repeat domain 73,15q25.2
83471,T-cell immunodeficiency with thymic aplasia,FOXN1,forkhead box N1,17q11.2
83463,Microtia,HOXA2,homeobox A2,7p15.2
83461,Congenital primary aphakia,FOXE3,forkhead box E3,1p33
83454,Glomuvenous malformation,GLMN,"glomulin, FKBP associated protein",1p22.1
83620,Enteric anendocrinosis,NEUROG3,neurogenin 3,10q22.1
84081,Senior-Boichis syndrome,DCDC2,doublecortin domain containing 2,6p22.3
84081,Senior-Boichis syndrome,TMEM67,transmembrane protein 67,8q22.1
84090,Fibronectin glomerulopathy,FN1,fibronectin 1,2q35
84064,Syndromic diarrhea,SKIC3,SKI3 subunit of superkiller complex,5q15
84064,Syndromic diarrhea,SKIC2,SKI2 subunit of superkiller complex,6p21.33
513436,Autosomal recessive spastic paraplegia type 78,ATP13A2,ATPase cation transporting 13A2,1p36.13
83639,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,PIGM,phosphatidylinositol glycan anchor biosynthesis class M,1q23.2
83639,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,PIGW,phosphatidylinositol glycan anchor biosynthesis class W,17q12
83629,Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome,AIFM1,apoptosis inducing factor mitochondria associated 1,Xq26.1
513456,Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome,WDR26,WD repeat domain 26,1q42.11-q42.12
83642,Microcytic anemia with liver iron overload,SLC11A2,solute carrier family 11 member 2,12q13.12
85163,Hypomyelination-congenital cataract syndrome,HYCC1,hyccin PI4KA lipid kinase complex subunit 1,7p15.3
85164,Camptodactyly-tall stature-scoliosis-hearing loss syndrome,FGFR3,fibroblast growth factor receptor 3,4p16.3
85146,"Neurogenic scapuloperoneal syndrome, Kaeser type",DES,desmin,2q35
85128,Bothnia retinal dystrophy,RLBP1,retinaldehyde binding protein 1,15q26.1
85136,Cystic leukoencephalopathy without megalencephaly,NDUFA2,NADH:ubiquinone oxidoreductase subunit A2,5q31.3
85136,Cystic leukoencephalopathy without megalencephaly,RNASET2,ribonuclease T2,6q27
85112,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,RSPO1,R-spondin 1,1p34.3
84132,Desmin-related myopathy with Mallory body-like inclusions,SELENON,selenoprotein N,1p36.11
85186,Endosteal sclerosis-cerebellar hypoplasia syndrome,POLR3B,RNA polymerase III subunit B,12q23.3
85182,Diaphyseal medullary stenosis-bone malignancy syndrome,MTAP,methylthioadenosine phosphorylase,9p21.3
85179,Infantile osteopetrosis with neuroaxonal dysplasia,OSTM1,osteoclastogenesis associated transmembrane protein 1,6q21
85173,IMAGe syndrome,CDKN1C,cyclin dependent kinase inhibitor 1C,11p15.4
85173,IMAGe syndrome,POLE,"DNA polymerase epsilon, catalytic subunit",12q24.33
85172,"Microcephalic osteodysplastic dysplasia, Saul-Wilson type",COG4,component of oligomeric golgi complex 4,16q22.1
85169,Familial digital arthropathy-brachydactyly,TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
85167,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,PCYT1A,"phosphate cytidylyltransferase 1A, choline",3q29
85166,"Platyspondylic dysplasia, Torrance type",COL2A1,collagen type II alpha 1 chain,12q13.11
85165,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,FGFR3,fibroblast growth factor receptor 3,4p16.3
603448,Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome,VPS4A,vacuolar protein sorting 4 homolog A,16q23.1
603689,KLHL7-related Bohring-Opitz-like syndrome,KLHL7,kelch like family member 7,7p15.3
603684,KLHL7-related Bohring-Opitz-like and Crisponi/Cold-induced sweating-like overlap syndrome,KLHL7,kelch like family member 7,7p15.3
603694,KLHL7-related Crisponi/cold-induced sweating-like syndrome,KLHL7,kelch like family member 7,7p15.3
610573,CLCN6-related childhood-onset progressive neurodegeneration-peripheral neuropathy syndrome,CLCN6,chloride voltage-gated channel 6,1p36.22
610569,KIAA1109-related early lethal congenital brain malformations-arthrogryposis syndrome,BLTP1,bridge-like lipid transfer protein family member 1,4q27
611201,Oculogastrointestinal-neurodevelopmental syndrome,CAPN15,calpain 15,16p13.3
600668,CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome,CCNK,cyclin K,14q32.2
600663,NRXN1-related severe neurodevelopmental disorder-motor stereotypies-chronic constipation-sleep-wake cycle disturbance,NRXN1,neurexin 1,2p16.3
97244,Rigid spine syndrome,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
97244,Rigid spine syndrome,SELENON,selenoprotein N,1p36.11
97249,Pontocerebellar hypoplasia type 3,PCLO,piccolo presynaptic cytomatrix protein,7q21.11
97279,Insulinoma,YY1,YY1 transcription factor,14q32.2
97279,Insulinoma,MEN1,menin 1,11q13
97286,Carney-Stratakis syndrome,SDHB,succinate dehydrogenase complex iron sulfur subunit B,1p36.13
97286,Carney-Stratakis syndrome,SDHC,succinate dehydrogenase complex subunit C,1q23.3
97286,Carney-Stratakis syndrome,SDHD,succinate dehydrogenase complex subunit D,11q23.1
97297,Bohring-Opitz syndrome,ASXL1,ASXL transcriptional regulator 1,20q11.21
97338,Melanoma of soft tissue,EWSR1,EWS RNA binding protein 1,22q12.2
97338,Melanoma of soft tissue,ATF1,activating transcription factor 1,12q13.12
97338,Melanoma of soft tissue,CREB1,cAMP responsive element binding protein 1,2q33.3
97346,ADan amyloidosis,ITM2B,integral membrane protein 2B,13q14.2
97345,ABri amyloidosis,ITM2B,integral membrane protein 2B,13q14.2
97362,"Renal hypoplasia, bilateral",PAX2,paired box 2,10q24.31
97362,"Renal hypoplasia, bilateral",PBX1,PBX homeobox 1,1q23.3
97363,Unilateral multicystic dysplastic kidney,HNF1B,HNF1 homeobox B,17q12
97364,Bilateral multicystic dysplastic kidney,HNF1B,HNF1 homeobox B,17q12
97369,Renal tubular dysgenesis of genetic origin,ACE,angiotensin I converting enzyme,17q23.3
97369,Renal tubular dysgenesis of genetic origin,AGT,angiotensinogen,1q42.2
97369,Renal tubular dysgenesis of genetic origin,REN,renin,1q32.1
97369,Renal tubular dysgenesis of genetic origin,AGTR1,angiotensin II receptor type 1,3q24
97548,Right sided atrial isomerism,GDF1,growth differentiation factor 1,19p13.11
96182,Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7,GRB10,growth factor receptor bound protein 10,7p12.1
96191,Paternal uniparental disomy of chromosome 6 syndrome,HYMAI,hydatidiform mole associated and imprinted,6q24.2
96191,Paternal uniparental disomy of chromosome 6 syndrome,PLAGL1,PLAG1 like zinc finger 1,6q24.2
96184,Temple syndrome due to maternal uniparental disomy of chromosome 14,MEG3,maternally expressed 3,14q32.2
96184,Temple syndrome due to maternal uniparental disomy of chromosome 14,DLK1,delta like non-canonical Notch ligand 1,14q32.2
96184,Temple syndrome due to maternal uniparental disomy of chromosome 14,RTL1,retrotransposon Gag like 1,14q32.2
96253,Cushing disease,CDH23,cadherin related 23,10q22.1
96253,Cushing disease,USP48,ubiquitin specific peptidase 48,1p36.12
96253,Cushing disease,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",7q34
96253,Cushing disease,USP8,ubiquitin specific peptidase 8,15q21.2
96253,Cushing disease,NR3C1,nuclear receptor subfamily 3 group C member 1,5q31.3
96253,Cushing disease,TP53,tumor protein p53,17p13.1
96253,Cushing disease,ATRX,ATRX chromatin remodeler,Xq21.1
96266,Leydig cell hypoplasia due to partial LH resistance,LHCGR,luteinizing hormone/choriogonadotropin receptor,2p16.3
96265,Leydig cell hypoplasia due to complete LH resistance,LHCGR,luteinizing hormone/choriogonadotropin receptor,2p16.3
96334,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,MEG3,maternally expressed 3,14q32.2
96334,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,DLK1,delta like non-canonical Notch ligand 1,14q32.2
96334,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,RTL1,retrotransposon Gag like 1,14q32.2
97234,Glycogen storage disease due to phosphoglycerate mutase deficiency,PGAM2,phosphoglycerate mutase 2,7p13
97238,Rippling muscle disease,CAV3,caveolin 3,3p25.3
97239,Reducing body myopathy,FHL1,four and a half LIM domains 1,Xq26.3
97240,Zebra body myopathy,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
600194,Factor V Atlanta bleeding disorder,F5,coagulation factor V,1q24.2
97685,17q11 microdeletion syndrome,NF1,neurofibromin 1,17q11.2
95706,Non-syndromic posterior hypospadias,AR,androgen receptor,Xq12
95706,Non-syndromic posterior hypospadias,MAMLD1,mastermind like domain containing 1,Xq28
95702,X-linked adrenal hypoplasia congenita,NR0B1,nuclear receptor subfamily 0 group B member 1,Xp21.2
95716,Familial thyroid dyshormonogenesis,SLC5A5,solute carrier family 5 member 5,19p13.11
95716,Familial thyroid dyshormonogenesis,TPO,thyroid peroxidase,2p25.3
95716,Familial thyroid dyshormonogenesis,DUOX2,dual oxidase 2,15q21.1
95716,Familial thyroid dyshormonogenesis,DUOXA2,dual oxidase maturation factor 2,15q21.1
95716,Familial thyroid dyshormonogenesis,TG,thyroglobulin,8q24.22
95716,Familial thyroid dyshormonogenesis,IYD,iodotyrosine deiodinase,6q25.1
95713,Athyreosis,FOXE1,forkhead box E1,9q22.33
95713,Athyreosis,NKX2-1,NK2 homeobox 1,14q13.3
95713,Athyreosis,SLC26A4,solute carrier family 26 member 4,7q22.3
95713,Athyreosis,TSHR,thyroid stimulating hormone receptor,14q24-q31
95713,Athyreosis,NKX2-5,NK2 homeobox 5,5q35.1
95713,Athyreosis,PAX8,paired box 8,2q14.1
95712,Thyroid ectopia,NKX2-5,NK2 homeobox 5,5q35.1
95712,Thyroid ectopia,PAX8,paired box 8,2q14.1
95699,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,POR,cytochrome p450 oxidoreductase,7q11.23
95496,Pituitary stalk interruption syndrome,WDR11,WD repeat domain 11,10q26.12
95496,Pituitary stalk interruption syndrome,ROBO1,roundabout guidance receptor 1,3p12.3
95496,Pituitary stalk interruption syndrome,PROKR2,prokineticin receptor 2,20p12.3
95496,Pituitary stalk interruption syndrome,HESX1,HESX homeobox 1,3p14.3
95496,Pituitary stalk interruption syndrome,LHX4,LIM homeobox 4,1q25.2
95496,Pituitary stalk interruption syndrome,CDON,"cell adhesion associated, oncogene regulated",11q24.2
95496,Pituitary stalk interruption syndrome,GPR161,G protein-coupled receptor 161,1q24.2
95494,"Combined pituitary hormone deficiencies, genetic forms",FOXA2,forkhead box A2,20p11.21
95494,"Combined pituitary hormone deficiencies, genetic forms",POU1F1,POU class 1 homeobox 1,3p11.2
95494,"Combined pituitary hormone deficiencies, genetic forms",PROP1,PROP paired-like homeobox 1,5q35.3
95494,"Combined pituitary hormone deficiencies, genetic forms",HESX1,HESX homeobox 1,3p14.3
95494,"Combined pituitary hormone deficiencies, genetic forms",OTX2,orthodenticle homeobox 2,14q22.3
95494,"Combined pituitary hormone deficiencies, genetic forms",LHX4,LIM homeobox 4,1q25.2
95494,"Combined pituitary hormone deficiencies, genetic forms",GLI2,GLI family zinc finger 2,2q14.2
95433,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome,PEX6,peroxisomal biogenesis factor 6,6p21.1
95434,Autosomal recessive cerebellar ataxia-movement disorder syndrome,VPS41,VPS41 subunit of HOPS complex,7p14.1
95434,Autosomal recessive cerebellar ataxia-movement disorder syndrome,VPS13D,vacuolar protein sorting 13 homolog D,1p36.22-p36.21
95232,Lissencephaly due to LIS1 mutation,PAFAH1B1,platelet activating factor acetylhydrolase 1b regulatory subunit 1,17p13.3
95159,Hepatoerythropoietic porphyria,UROD,uroporphyrinogen decarboxylase,1p34.1
95428,COG8-CDG,COG8,component of oligomeric golgi complex 8,16q22.1
94122,"Cerebellar ataxia, Cayman type",ATCAY,ATCAY kinesin light chain interacting caytaxin,19p13.3
94124,Spinocerebellar ataxia with axonal neuropathy type 1,TDP1,tyrosyl-DNA phosphodiesterase 1,14q32.11
94125,Recessive mitochondrial ataxia syndrome,POLG,"DNA polymerase gamma, catalytic subunit",15q26.1
94147,Spinocerebellar ataxia type 7,ATXN7,ataxin 7,3p14.1
94150,Anonychia congenita totalis,RSPO4,R-spondin 4,20p13
94064,Deafness-infertility syndrome,CATSPER2,cation channel sperm associated 2,15q15.3
94064,Deafness-infertility syndrome,STRC,stereocilin,15q15.3
94063,12q14 microdeletion syndrome,LEMD3,LEM domain containing 3,12q14.3
94063,12q14 microdeletion syndrome,HMGA2,high mobility group AT-hook 2,12q14.3
94065,15q24 microdeletion syndrome,SIN3A,SIN3 transcription regulator family member A,15q24.2
94068,Spondyloepiphyseal dysplasia congenita,COL2A1,collagen type II alpha 1 chain,12q13.11
94083,Partington syndrome,ARX,aristaless related homeobox,Xp21.3
94088,Hereditary renal hypouricemia,SLC22A12,solute carrier family 22 member 12,11q13.1
94088,Hereditary renal hypouricemia,SLC2A9,solute carrier family 2 member 9,4p16.1
94089,Pseudohypoparathyroidism type 1B,GNAS,GNAS complex locus,20q13.32
94089,Pseudohypoparathyroidism type 1B,STX16,syntaxin 16,20q13.32
96148,Distal deletion 10q syndrome,EBF3,EBF transcription factor 3,10q26.3
96147,Kleefstra syndrome due to 9q34 microdeletion,EHMT1,euchromatic histone lysine methyltransferase 1,9q34.3
95720,Thyroid hypoplasia,SLC26A4,solute carrier family 26 member 4,7q22.3
95720,Thyroid hypoplasia,TSHR,thyroid stimulating hormone receptor,14q24-q31
95720,Thyroid hypoplasia,PAX8,paired box 8,2q14.1
597623,IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome,IRF2BPL,interferon regulatory factor 2 binding protein like,14q24.3
597733,Oculocutaneous albinism type 8,DCT,dopachrome tautomerase,13q32.1
597738,Luscan-Lumish syndrome,SETD2,"SET domain containing 2, histone lysine methyltransferase",3p21.31
597887,ALPI-related inflammatory bowel disease,ALPI,"alkaline phosphatase, intestinal",2q37.1
597939,Euthyroid dysprealbuminemic hyperthyroxinemia,TTR,transthyretin,18q12.1
597743,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,SETD2,"SET domain containing 2, histone lysine methyltransferase",3p21.31
93552,Pediatric systemic lupus erythematosus,SAT1,spermidine/spermine N1-acetyltransferase 1,Xp22.11
93552,Pediatric systemic lupus erythematosus,STAT4,signal transducer and activator of transcription 4,2q32.2-q32.3
93552,Pediatric systemic lupus erythematosus,SPP1,secreted phosphoprotein 1,4q22.1
93552,Pediatric systemic lupus erythematosus,IRAK1,interleukin 1 receptor associated kinase 1,Xq28
597874,MTHFS-related developmental delay-microcephaly-short stature-epilepsy syndrome,MTHFS,methenyltetrahydrofolate synthetase,15q25.1
93562,AFib amyloidosis,FGA,fibrinogen alpha chain,4q31.3
598603,Facial dysmorphism-hypertrichosis-epilepsy-intellectual disability/developmental delay-gingival overgrowth syndrome,KCNK4,potassium two pore domain channel subfamily K member 4,11q13.1
598164,FOXG1 syndrome due to intragenic alteration,FOXG1,forkhead box G1,14q12
93560,AApoAI amyloidosis,APOA1,apolipoprotein A1,11q23.3
93561,ALys amyloidosis,LYZ,lysozyme,12q15
93571,Dense deposit disease,CFH,complement factor H,1q31.3
93571,Dense deposit disease,CFHR1,complement factor H related 1,1q31.3
597201,TRIM22-related inflammatory bowel disease,TRIM22,tripartite motif containing 22,11p15.4
93474,Scheie syndrome,IDUA,alpha-L-iduronidase,4p16.3
93476,Hurler-Scheie syndrome,IDUA,alpha-L-iduronidase,4p16.3
93473,Hurler syndrome,IDUA,alpha-L-iduronidase,4p16.3
93399,Juvenile sialidosis type 2,NEU1,neuraminidase 1,6p21.33
93400,Congenital sialidosis type 2,NEU1,neuraminidase 1,6p21.33
599373,STXBP1-related encephalopathy,STXBP1,syntaxin binding protein 1,9q34.11
599376,Hypomyelination of early myelinating structures,PLP1,proteolipid protein 1,Xq22.2
93405,Syndactyly type 4,SHH,sonic hedgehog signaling molecule,7q36.3
93405,Syndactyly type 4,LMBR1,limb development membrane protein 1,7q36.3
599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,ANGPT1,angiopoietin 1,8q23.1
599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,MYOF,myoferlin,10q23.33
599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,KNG1,kininogen 1,3q27.3
599418,Hereditary angioedema with normal C1Inh not related to F12 or PLG variant,HS3ST6,heparan sulfate-glucosamine 3-sulfotransferase 6,16p13.3
93404,Syndactyly type 3,GJA1,gap junction protein alpha 1,6q22.31
93406,Syndactyly type 5,HOXD13,homeobox D13,2q31.1
93409,"Brachydactyly-syndactyly, Zhao type",HOXD13,homeobox D13,2q31.1
599579,Factor V Amsterdam bleeding disorder,F5,coagulation factor V,1q24.2
93360,"Spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type",KIF22,kinesin family member 22,16p11.2
93358,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,DDR2,discoidin domain receptor tyrosine kinase 2,1q23.3
93357,SPONASTRIME dysplasia,TONSL,"tonsoku like, DNA repair protein",8q24.3
599082,CHD3-related developmental delay-speech delay-intellectual disability-abnormalities of vision-facial dysmorphism syndrome,CHD3,chromodomain helicase DNA binding protein 3,17p13.1
93372,Familial hypocalciuric hypercalcemia type 1,CASR,calcium sensing receptor,3q13.33-q21.1
93387,Brachydactyly type E,HOXD13,homeobox D13,2q31.1
93387,Brachydactyly type E,PTHLH,parathyroid hormone like hormone,12p11.22
93388,Brachydactyly type A1,BMPR1B,bone morphogenetic protein receptor type 1B,4q22.3
93388,Brachydactyly type A1,GDF5,growth differentiation factor 5,20q11.22
93388,Brachydactyly type A1,IHH,Indian hedgehog signaling molecule,2q35
93384,Brachydactyly type C,BMPR1B,bone morphogenetic protein receptor type 1B,4q22.3
93384,Brachydactyly type C,GDF5,growth differentiation factor 5,20q11.22
93396,Brachydactyly type A2,BMP2,bone morphogenetic protein 2,20p12.3
93396,Brachydactyly type A2,GDF5,growth differentiation factor 5,20q11.22
93396,Brachydactyly type A2,BMPR1B,bone morphogenetic protein receptor type 1B,4q22.3
93932,FG syndrome type 1,MED12,mediator complex subunit 12,Xq13.1
93930,Classic bladder exstrophy,TP63,tumor protein p63,3q28
93930,Classic bladder exstrophy,ISL1,ISL LIM homeobox 1,5q11.1
93926,Midline interhemispheric variant of holoprosencephaly,STIL,STIL centriolar assembly protein,1p33
93926,Midline interhemispheric variant of holoprosencephaly,PTCH1,patched 1,9q22.32
93926,Midline interhemispheric variant of holoprosencephaly,SHH,sonic hedgehog signaling molecule,7q36.3
93926,Midline interhemispheric variant of holoprosencephaly,SIX3,SIX homeobox 3,2p21
93926,Midline interhemispheric variant of holoprosencephaly,TGIF1,TGFB induced factor homeobox 1,18p11.31
93926,Midline interhemispheric variant of holoprosencephaly,ZIC2,Zic family member 2,13q32.3
93926,Midline interhemispheric variant of holoprosencephaly,GLI2,GLI family zinc finger 2,2q14.2
93926,Midline interhemispheric variant of holoprosencephaly,CRIPTO,"cripto, EGF-CFC family member",3p21.31
93926,Midline interhemispheric variant of holoprosencephaly,FOXH1,forkhead box H1,8q24.3
93926,Midline interhemispheric variant of holoprosencephaly,FGF8,fibroblast growth factor 8,10q24.32
93926,Midline interhemispheric variant of holoprosencephaly,DISP1,dispatched RND transporter family member 1,1q41
93926,Midline interhemispheric variant of holoprosencephaly,CDON,"cell adhesion associated, oncogene regulated",11q24.2
93926,Midline interhemispheric variant of holoprosencephaly,NODAL,nodal growth differentiation factor,10q22.1
93926,Midline interhemispheric variant of holoprosencephaly,DLL1,delta like canonical Notch ligand 1,6q27
93926,Midline interhemispheric variant of holoprosencephaly,GAS1,growth arrest specific 1,9q21.33
93924,Lobar holoprosencephaly,STIL,STIL centriolar assembly protein,1p33
93924,Lobar holoprosencephaly,FGFR1,fibroblast growth factor receptor 1,8p11.23
93924,Lobar holoprosencephaly,PTCH1,patched 1,9q22.32
93924,Lobar holoprosencephaly,SHH,sonic hedgehog signaling molecule,7q36.3
93924,Lobar holoprosencephaly,SIX3,SIX homeobox 3,2p21
93924,Lobar holoprosencephaly,TGIF1,TGFB induced factor homeobox 1,18p11.31
93924,Lobar holoprosencephaly,ZIC2,Zic family member 2,13q32.3
93924,Lobar holoprosencephaly,GLI2,GLI family zinc finger 2,2q14.2
93924,Lobar holoprosencephaly,CRIPTO,"cripto, EGF-CFC family member",3p21.31
93924,Lobar holoprosencephaly,FOXH1,forkhead box H1,8q24.3
93924,Lobar holoprosencephaly,FGF8,fibroblast growth factor 8,10q24.32
93924,Lobar holoprosencephaly,DISP1,dispatched RND transporter family member 1,1q41
93924,Lobar holoprosencephaly,CDON,"cell adhesion associated, oncogene regulated",11q24.2
93924,Lobar holoprosencephaly,NODAL,nodal growth differentiation factor,10q22.1
93924,Lobar holoprosencephaly,DLL1,delta like canonical Notch ligand 1,6q27
93924,Lobar holoprosencephaly,GAS1,growth arrest specific 1,9q21.33
93925,Alobar holoprosencephaly,STIL,STIL centriolar assembly protein,1p33
93925,Alobar holoprosencephaly,PLCH1,phospholipase C eta 1,3q25.31
93925,Alobar holoprosencephaly,STAG2,STAG2 cohesin complex component,Xq25
93925,Alobar holoprosencephaly,PTCH1,patched 1,9q22.32
93925,Alobar holoprosencephaly,SHH,sonic hedgehog signaling molecule,7q36.3
93925,Alobar holoprosencephaly,SIX3,SIX homeobox 3,2p21
93925,Alobar holoprosencephaly,TGIF1,TGFB induced factor homeobox 1,18p11.31
93925,Alobar holoprosencephaly,ZIC2,Zic family member 2,13q32.3
93925,Alobar holoprosencephaly,GLI2,GLI family zinc finger 2,2q14.2
93925,Alobar holoprosencephaly,CRIPTO,"cripto, EGF-CFC family member",3p21.31
93925,Alobar holoprosencephaly,FOXH1,forkhead box H1,8q24.3
93925,Alobar holoprosencephaly,FGF8,fibroblast growth factor 8,10q24.32
93925,Alobar holoprosencephaly,DISP1,dispatched RND transporter family member 1,1q41
93925,Alobar holoprosencephaly,CDON,"cell adhesion associated, oncogene regulated",11q24.2
93925,Alobar holoprosencephaly,NODAL,nodal growth differentiation factor,10q22.1
93925,Alobar holoprosencephaly,DLL1,delta like canonical Notch ligand 1,6q27
93925,Alobar holoprosencephaly,GAS1,growth arrest specific 1,9q21.33
93921,Full schwannomatosis,NF2,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",22q12.2
93921,Full schwannomatosis,SMARCB1,SWI/SNF related BAF chromatin remodeling complex subunit B1,22q11.23
93921,Full schwannomatosis,COQ6,"coenzyme Q6, monooxygenase",14q24.3
93921,Full schwannomatosis,LZTR1,leucine zipper like post translational regulator 1,22q11.21
93952,"X-linked intellectual disability, Hedera type",ATP6AP2,ATPase H+ transporting accessory protein 2,Xp11.4
595109,Atypical Timothy syndrome,CACNA1C,calcium voltage-gated channel subunit alpha1 C,12p13.33
93950,"X-linked intellectual disability, Sutherland-Haan type",PQBP1,polyglutamine binding protein 1,Xp11.23
595098,Timothy syndrome type 1,CACNA1C,calcium voltage-gated channel subunit alpha1 C,12p13.33
93947,"X-linked intellectual disability, Golabi-Ito-Hall type",PQBP1,polyglutamine binding protein 1,Xp11.23
595105,Timothy syndrome type 2,CACNA1C,calcium voltage-gated channel subunit alpha1 C,12p13.33
93946,Hamel cerebro-palato-cardiac syndrome,PQBP1,polyglutamine binding protein 1,Xp11.23
93945,"X-linked intellectual disability, Porteous type",PQBP1,polyglutamine binding protein 1,Xp11.23
93616,Hemoglobin H disease,HBA2,hemoglobin subunit alpha 2,16p13.3
93616,Hemoglobin H disease,HBA1,hemoglobin subunit alpha 1,16p13.3
93622,Dent disease type 1,CLCN5,chloride voltage-gated channel 5,Xp11.23
93623,Dent disease type 2,OCRL,OCRL inositol polyphosphate-5-phosphatase,Xq26.1
93591,Infantile nephronophthisis,NPHP3,nephrocystin 3,3q22.1
93591,Infantile nephronophthisis,INVS,inversin,9q31.1
93591,Infantile nephronophthisis,NEK8,NIMA related kinase 8,17q11.2
93591,Infantile nephronophthisis,TTC21B,tetratricopeptide repeat domain 21B,2q24.3
93591,Infantile nephronophthisis,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,9q22.33
93591,Infantile nephronophthisis,CEP83,centrosomal protein 83,12q22
93591,Infantile nephronophthisis,ZNF423,zinc finger protein 423,16q12.1
93592,Juvenile nephronophthisis,NPHP1,nephrocystin 1,2q13
93592,Juvenile nephronophthisis,NPHP4,nephrocystin 4,1p36.31
93592,Juvenile nephronophthisis,GLIS2,GLIS family zinc finger 2,16p13.3
93592,Juvenile nephronophthisis,WDR19,WD repeat domain 19,4p14
93592,Juvenile nephronophthisis,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,9q22.33
93592,Juvenile nephronophthisis,MAPKBP1,mitogen-activated protein kinase binding protein 1,15q15.1
93592,Juvenile nephronophthisis,ADAMTS9,ADAM metallopeptidase with thrombospondin type 1 motif 9,3p14.1
93589,Late-onset nephronophthisis,NPHP3,nephrocystin 3,3q22.1
93589,Late-onset nephronophthisis,XPNPEP3,X-prolyl aminopeptidase 3,22q13.2
93589,Late-onset nephronophthisis,MAPKBP1,mitogen-activated protein kinase binding protein 1,15q15.1
93598,Primary hyperoxaluria type 1,AGXT,alanine--glyoxylate aminotransferase,2q37.3
596008,Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis,FGFR2,fibroblast growth factor receptor 2,10q26.13
93583,Congenital thrombotic thrombocytopenic purpura,ADAMTS13,ADAM metallopeptidase with thrombospondin type 1 motif 13,9q34.2
93610,Distal renal tubular acidosis with anemia,SLC4A1,solute carrier family 4 member 1 (Diego blood group),17q21.31
596759,Combined immunodeficiency due to RELA haploinsufficiency,RELA,"RELA proto-oncogene, NF-kB subunit",11q13.1
93608,Autosomal dominant distal renal tubular acidosis,SLC4A1,solute carrier family 4 member 1 (Diego blood group),17q21.31
93607,Autosomal recessive proximal renal tubular acidosis,SLC4A4,solute carrier family 4 member 4,4q13.3
93613,Cystinuria type B,SLC7A9,solute carrier family 7 member 9,19q13.11
93612,Cystinuria type A,SLC3A1,solute carrier family 3 member 1,2p21
93602,Xanthinuria type II,MOCOS,molybdenum cofactor sulfurase,18q12.2
93601,Xanthinuria type I,XDH,xanthine dehydrogenase,2p23.1
93600,Primary hyperoxaluria type 3,HOGA1,4-hydroxy-2-oxoglutarate aldolase 1,10q24.2
93599,Primary hyperoxaluria type 2,GRHPR,glyoxylate and hydroxypyruvate reductase,9p13.2
93606,Nephrogenic syndrome of inappropriate antidiuresis,AVPR2,arginine vasopressin receptor 2,Xq28
596753,VEXAS syndrome,UBA1,ubiquitin like modifier activating enzyme 1,Xp11.3
93605,Bartter syndrome type 3,CLCNKB,chloride voltage-gated channel Kb,1p36.13
99068,Complete atrioventricular septal defect-tetralogy of Fallot,NR2F2,nuclear receptor subfamily 2 group F member 2,15q26.2
99068,Complete atrioventricular septal defect-tetralogy of Fallot,GATA4,GATA binding protein 4,8p23.1
99068,Complete atrioventricular septal defect-tetralogy of Fallot,CRELD1,cysteine rich with EGF like domains 1,3p25.3
99067,Complete atrioventricular septal defect with ventricular hypoplasia,NR2F2,nuclear receptor subfamily 2 group F member 2,15q26.2
99067,Complete atrioventricular septal defect with ventricular hypoplasia,GATA6,GATA binding protein 6,18q11.2
99067,Complete atrioventricular septal defect with ventricular hypoplasia,CRELD1,cysteine rich with EGF like domains 1,3p25.3
99067,Complete atrioventricular septal defect with ventricular hypoplasia,GATA4,GATA binding protein 4,8p23.1
99106,"Atrial septal defect, ostium primum type",TLL1,tolloid like 1,4q32.3
99105,"Atrial septal defect, sinus venosus type",CITED2,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2,6q24.1
99103,"Atrial septal defect, ostium secundum type",ACTC1,actin alpha cardiac muscle 1,15q14
99103,"Atrial septal defect, ostium secundum type",GATA4,GATA binding protein 4,8p23.1
99103,"Atrial septal defect, ostium secundum type",MYH6,myosin heavy chain 6,14q11.2
99103,"Atrial septal defect, ostium secundum type",NKX2-5,NK2 homeobox 5,5q35.1
99103,"Atrial septal defect, ostium secundum type",TBX20,T-box transcription factor 20,7p14.2
99103,"Atrial septal defect, ostium secundum type",TBX20,T-box transcription factor 20,7p14.2
99103,"Atrial septal defect, ostium secundum type",TLL1,tolloid like 1,4q32.3
99103,"Atrial septal defect, ostium secundum type",CITED2,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2,6q24.1
99103,"Atrial septal defect, ostium secundum type",GATA6,GATA binding protein 6,18q11.2
99141,Lymphedema-posterior choanal atresia syndrome,PTPN14,protein tyrosine phosphatase non-receptor type 14,1q32.3-q41
99361,Isolated familial medullary thyroid carcinoma,ESR2,estrogen receptor 2,14q23.2-q23.3
99361,Isolated familial medullary thyroid carcinoma,NTRK1,neurotrophic receptor tyrosine kinase 1,1q23.1
99361,Isolated familial medullary thyroid carcinoma,RET,ret proto-oncogene,10q11.21
99657,"Primary dystonia, DYT2 type",HPCA,hippocalcin,1p35.1
99429,Complete androgen insensitivity syndrome,AR,androgen receptor,Xq12
99646,Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria,IDH1,isocitrate dehydrogenase (NADP(+)) 1,2q34
592574,Menke-Hennekam syndrome,CREBBP,CREB binding lysine acetyltransferase,16p13.3
592564,GNAO1-related developmental delay-seizures-movement disorder spectrum,GNAO1,G protein subunit alpha o1,16q13
592570,TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome,TRAF7,TNF receptor associated factor 7,16p13.3
99718,Leber plus disease,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,mitochondria
99718,Leber plus disease,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,mitochondria
99718,Leber plus disease,MT-ND3,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3,mitochondria
99725,Pituitary gigantism,AIP,AHR interacting HSP90 co-chaperone,11q13.2
99725,Pituitary gigantism,MEN1,menin 1,11q13
589821,Congenital-onset Steinert myotonic dystrophy,DMPK,DM1 protein kinase,19q13.32
589827,Juvenile-onset Steinert myotonic dystrophy,DMPK,DM1 protein kinase,19q13.32
589824,Childhood-onset Steinert myotonic dystrophy,DMPK,DM1 protein kinase,19q13.32
589833,Late-onset Steinert myotonic dystrophy,DMPK,DM1 protein kinase,19q13.32
589830,Adult-onset Steinert myotonic dystrophy,DMPK,DM1 protein kinase,19q13.32
99704,Early-onset obesity-hyperphagia-severe developmental delay syndrome,NTRK2,neurotrophic receptor tyrosine kinase 2,9q21.33
589905,PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome,PHIP,PHIP subunit of CUL4-Ring ligase complex,6q14.1
589856,Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome,KMT2D,lysine methyltransferase 2D,12q13.12
99749,Kostmann syndrome,HAX1,HCLS1 associated protein X-1,1q21.3
99757,Embryonal rhabdomyosarcoma,SLC67A1,solute carrier family 67 member 1,11p15.4
99757,Embryonal rhabdomyosarcoma,TP53,tumor protein p53,17p13.1
99757,Embryonal rhabdomyosarcoma,NF1,neurofibromin 1,17q11.2
99757,Embryonal rhabdomyosarcoma,DICER1,"dicer 1, ribonuclease III",14q32.13
99756,Alveolar rhabdomyosarcoma,FOXO1,forkhead box O1,13q14.11
99756,Alveolar rhabdomyosarcoma,PAX3,paired box 3,2q36.1
99756,Alveolar rhabdomyosarcoma,PAX7,paired box 7,1p36.13
99756,Alveolar rhabdomyosarcoma,NF1,neurofibromin 1,17q11.2
99756,Alveolar rhabdomyosarcoma,TP53,tumor protein p53,17p13.1
99734,Myotonia fluctuans,SCN4A,sodium voltage-gated channel alpha subunit 4,17q23.3
99731,Isolated sulfite oxidase deficiency,SUOX,sulfite oxidase,12q13.2
99735,Myotonia permanens,SCN4A,sodium voltage-gated channel alpha subunit 4,17q23.3
99736,Acetazolamide-responsive myotonia,SCN4A,sodium voltage-gated channel alpha subunit 4,17q23.3
99741,King-Denborough syndrome,RYR1,ryanodine receptor 1,19q13.2
99742,Amish lethal microcephaly,SLC25A19,solute carrier family 25 member 19,17q25.1
98820,Familial focal epilepsy with variable foci,DEPDC5,"DEP domain containing 5, GATOR1 subcomplex subunit",22q12.2-q12.3
98820,Familial focal epilepsy with variable foci,NPRL2,"NPR2 like, GATOR1 complex subunit",3p21.31
98820,Familial focal epilepsy with variable foci,NPRL3,"NPR3 like, GATOR1 complex subunit",16p13.3
98818,Landau-Kleffner syndrome,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,16p13.2
98813,Hypohidrotic ectodermal dysplasia with immunodeficiency,IKBKG,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,Xq28
98813,Hypohidrotic ectodermal dysplasia with immunodeficiency,NFKBIA,NFKB inhibitor alpha,14q13.2
98811,Paroxysmal exertion-induced dyskinesia,SLC2A1,solute carrier family 2 member 1,1p34.2
98811,Paroxysmal exertion-induced dyskinesia,PRRT2,proline rich transmembrane protein 2,16p11.2
98810,Paroxysmal non-kinesigenic dyskinesia,PNKD,PNKD metallo-beta-lactamase domain containing,2q35
98810,Paroxysmal non-kinesigenic dyskinesia,PRRT2,proline rich transmembrane protein 2,16p11.2
98809,Paroxysmal kinesigenic dyskinesia,PRRT2,proline rich transmembrane protein 2,16p11.2
98809,Paroxysmal kinesigenic dyskinesia,KCNA1,potassium voltage-gated channel subfamily A member 1,12p13.32
98809,Paroxysmal kinesigenic dyskinesia,KCNJ10,potassium inwardly rectifying channel subfamily J member 10,1q23.2
98808,Autosomal dominant dopa-responsive dystonia,GCH1,GTP cyclohydrolase 1,14q22.2
98808,Autosomal dominant dopa-responsive dystonia,NR4A2,nuclear receptor subfamily 4 group A member 2,2q24.1
98808,Autosomal dominant dopa-responsive dystonia,IMPDH2,inosine monophosphate dehydrogenase 2,3p21.31
98807,"Primary dystonia, DYT13 type",DYT13,"dystonia 13, torsion",1p36
98838,Primary mediastinal large B-cell lymphoma,BCL6,BCL6 transcription repressor,3q27.3
98838,Primary mediastinal large B-cell lymphoma,XPO1,exportin 1,2p15
98835,Acute undifferentiated leukemia,KMT2A,lysine methyltransferase 2A,11q23.3
98833,Acute myeloblastic leukemia without maturation,FLT3,fms related receptor tyrosine kinase 3,13q12.2
98833,Acute myeloblastic leukemia without maturation,NPM1,nucleophosmin 1,5q35.1
98834,Acute myeloblastic leukemia with maturation,FLT3,fms related receptor tyrosine kinase 3,13q12.2
98834,Acute myeloblastic leukemia with maturation,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
98834,Acute myeloblastic leukemia with maturation,NPM1,nucleophosmin 1,5q35.1
98831,Acute myeloid leukemia with 11q23 abnormalities,KMT2A,lysine methyltransferase 2A,11q23.3
98832,Acute myeloid leukemia with minimal differentiation,FLT3,fms related receptor tyrosine kinase 3,13q12.2
98829,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),FLT3,fms related receptor tyrosine kinase 3,13q12.2
98829,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),MYH11,myosin heavy chain 11,16p13.11
98829,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),CBFB,core-binding factor subunit beta,16q22.1
98829,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
98826,Myelodysplastic neoplasm with low blasts,TET2,tet methylcytosine dioxygenase 2,4q24
98823,Chronic myelomonocytic leukemia,ETV6,ETS variant transcription factor 6,12p13.2
98823,Chronic myelomonocytic leukemia,ASXL1,ASXL transcriptional regulator 1,20q11.21
98823,Chronic myelomonocytic leukemia,SRSF2,serine and arginine rich splicing factor 2,17q25.2
98824,Atypical chronic myeloid leukemia,CSF3R,colony stimulating factor 3 receptor,1p34.3
98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,LMNA,lamin A/C,1q22
98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,SYNE1,spectrin repeat containing nuclear envelope protein 1,6q25.2
98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,TMEM43,transmembrane protein 43,3p25.1
98853,Autosomal dominant Emery-Dreifuss muscular dystrophy,SYNE2,spectrin repeat containing nuclear envelope protein 2,14q23.2
98850,Aggressive systemic mastocytosis,TET2,tet methylcytosine dioxygenase 2,4q24
98850,Aggressive systemic mastocytosis,SRSF2,serine and arginine rich splicing factor 2,17q25.2
98850,Aggressive systemic mastocytosis,ASXL1,ASXL transcriptional regulator 1,20q11.21
98850,Aggressive systemic mastocytosis,RUNX1,RUNX family transcription factor 1,21q22.12
98850,Aggressive systemic mastocytosis,CBL,Cbl proto-oncogene,11q23.3
98849,Systemic mastocytosis with associated hematologic neoplasm,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
98849,Systemic mastocytosis with associated hematologic neoplasm,TET2,tet methylcytosine dioxygenase 2,4q24
98849,Systemic mastocytosis with associated hematologic neoplasm,SRSF2,serine and arginine rich splicing factor 2,17q25.2
98849,Systemic mastocytosis with associated hematologic neoplasm,ASXL1,ASXL transcriptional regulator 1,20q11.21
98843,"Classic Hodgkin lymphoma, nodular sclerosis type",KLHDC8B,kelch domain containing 8B,3p21.31
98839,Intravascular large B-cell lymphoma,BCL6,BCL6 transcription repressor,3q27.3
98839,Intravascular large B-cell lymphoma,BCL2,BCL2 apoptosis regulator,18q21.33
98842,Lymphomatoid papulosis,TYK2,tyrosine kinase 2,19p13.2
98842,Lymphomatoid papulosis,NPM1,nucleophosmin 1,5q35.1
589608,"Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies",RHOA,ras homolog family member A,3p21.31
589595,Mixed phenotype acute leukemia with t(v;11q23.3),FLT3,fms related receptor tyrosine kinase 3,13q12.2
589595,Mixed phenotype acute leukemia with t(v;11q23.3),KMT2A,lysine methyltransferase 2A,11q23.3
589595,Mixed phenotype acute leukemia with t(v;11q23.3),AFF1,ALF transcription elongation factor 1,4q21.3-q22.1
98868,Southeast Asian ovalocytosis,SLC4A1,solute carrier family 4 member 1 (Diego blood group),17q21.31
98869,Congenital dyserythropoietic anemia type I,CDAN1,codanin 1,15q15.2
98869,Congenital dyserythropoietic anemia type I,CDIN1,CDAN1 interacting nuclease 1,15q14
589618,Dystonia 28,KMT2B,lysine methyltransferase 2B,19q13.12
98870,Congenital dyserythropoietic anemia type III,KIF23,kinesin family member 23,15q23
98870,Congenital dyserythropoietic anemia type III,RACGAP1,Rac GTPase activating protein 1,12q13.12
589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),FLT3,fms related receptor tyrosine kinase 3,13q12.2
589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),KMT2A,lysine methyltransferase 2A,11q23.3
98863,X-linked Emery-Dreifuss muscular dystrophy,EMD,emerin,Xq28
98863,X-linked Emery-Dreifuss muscular dystrophy,FHL1,four and a half LIM domains 1,Xq26.3
589527,Spinocerebellar ataxia type 45,FAT2,FAT atypical cadherin 2,5q33.1
589547,"GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder",GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,12p13.1
589442,Short stature-skeletal dysplasia-retinal degeneration-intellectual disability-sensorineural hearing loss syndrome,PISD,phosphatidylserine decarboxylase,22q12.2
589435,Spondylometaphyseal dysplasia-corneal dystrophy syndrome,PLCB3,phospholipase C beta 3,11q13.1
589522,Spinocerebellar ataxia type 46,PLD3,phospholipase D family member 3,19q13.2
589515,PUM1-associated developmental disability-ataxia-seizure syndrome,PUM1,pumilio RNA binding family member 1,1p35.2
98855,Autosomal recessive Emery-Dreifuss muscular dystrophy,LMNA,lamin A/C,1q22
98856,Charcot-Marie-Tooth disease type 2B1,LMNA,lamin A/C,1q22
98881,Familial dysfibrinogenemia,FGA,fibrinogen alpha chain,4q31.3
98881,Familial dysfibrinogenemia,FGB,fibrinogen beta chain,4q31.3
98881,Familial dysfibrinogenemia,FGG,fibrinogen gamma chain,4q32.1
98880,Familial afibrinogenemia,FGA,fibrinogen alpha chain,4q31.3
98880,Familial afibrinogenemia,FGB,fibrinogen beta chain,4q31.3
98880,Familial afibrinogenemia,FGG,fibrinogen gamma chain,4q32.1
98885,Bleeding diathesis due to glycoprotein VI deficiency,GP6,glycoprotein VI platelet,19q13.42
98873,Congenital dyserythropoietic anemia type II,SEC23B,"SEC23 homolog B, COPII coat complex component",20p11.23
98897,Oculopharyngodistal myopathy,NOTCH2NLC,notch 2 N-terminal like C,1q21.2
98897,Oculopharyngodistal myopathy,LRP12,LDL receptor related protein 12,8q22.3
98897,Oculopharyngodistal myopathy,GIPC1,GIPC PDZ domain containing family member 1,19p13.12
98897,Oculopharyngodistal myopathy,ABCD3,ATP binding cassette subfamily D member 3,1p21.3
98897,Oculopharyngodistal myopathy,NUTM2B-AS1,NUTM2B antisense RNA 1,10q22.3
98897,Oculopharyngodistal myopathy,RILPL1,Rab interacting lysosomal protein like 1,12q24.31
98895,Becker muscular dystrophy,DMD,dystrophin,Xp21.2-p21.1
98896,Duchenne muscular dystrophy,DMD,dystrophin,Xp21.2-p21.1
98896,Duchenne muscular dystrophy,LTBP4,latent transforming growth factor beta binding protein 4,19q13.2
98902,Amish nemaline myopathy,TNNT1,"troponin T1, slow skeletal type",19q13.42
98889,Bilateral perisylvian polymicrogyria,SRPX2,sushi repeat containing protein X-linked 2,Xq22.1
98889,Bilateral perisylvian polymicrogyria,ADGRG1,adhesion G protein-coupled receptor G1,16q21
98889,Bilateral perisylvian polymicrogyria,PI4KA,phosphatidylinositol 4-kinase alpha,22q11.21
98890,Early-onset X-linked optic atrophy,OPA2,optic atrophy 2 (obscure),Xp11.4-p11.2
98892,Periventricular nodular heterotopia,ARFGEF2,ARF guanine nucleotide exchange factor 2,20q13.13
98892,Periventricular nodular heterotopia,FLNA,filamin A,Xq28
98892,Periventricular nodular heterotopia,ERMARD,ER membrane associated RNA degradation,6q27
98892,Periventricular nodular heterotopia,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18q21.31
98892,Periventricular nodular heterotopia,TMTC3,transmembrane O-mannosyltransferase targeting cadherins 3,12q21.32
98892,Periventricular nodular heterotopia,ARF1,ARF GTPase 1,1q42.13
98892,Periventricular nodular heterotopia,MAP1B,microtubule associated protein 1B,5q13.2
98912,"Late-onset distal myopathy, Markesbery-Griggs type",LDB3,LIM domain binding 3,10q23.2
98911,Distal myotilinopathy,MYOT,myotilin,5q31.2
98914,Presynaptic congenital myasthenic syndromes,CHAT,choline O-acetyltransferase,10q11.23
98914,Presynaptic congenital myasthenic syndromes,AGRN,agrin,1p36.33
98914,Presynaptic congenital myasthenic syndromes,SLC25A1,solute carrier family 25 member 1,22q11.21
98914,Presynaptic congenital myasthenic syndromes,SNAP25,synaptosome associated protein 25,20p12.2
98914,Presynaptic congenital myasthenic syndromes,SYT2,synaptotagmin 2,1q32.1
98914,Presynaptic congenital myasthenic syndromes,MYO9A,myosin IXA,15q23
98914,Presynaptic congenital myasthenic syndromes,SLC5A7,solute carrier family 5 member 7,2q12.3
98914,Presynaptic congenital myasthenic syndromes,VAMP1,vesicle associated membrane protein 1,12p13.31
98914,Presynaptic congenital myasthenic syndromes,SLC18A3,solute carrier family 18 member A3,10q11.23
98914,Presynaptic congenital myasthenic syndromes,COL13A1,collagen type XIII alpha 1 chain,10q22.1
98913,Postsynaptic congenital myasthenic syndromes,RAPSN,receptor associated protein of the synapse,11p11.2
98913,Postsynaptic congenital myasthenic syndromes,SCN4A,sodium voltage-gated channel alpha subunit 4,17q23.3
98913,Postsynaptic congenital myasthenic syndromes,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,2q31.1
98913,Postsynaptic congenital myasthenic syndromes,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,2q31.1
98913,Postsynaptic congenital myasthenic syndromes,CHRNB1,cholinergic receptor nicotinic beta 1 subunit,17p13.1
98913,Postsynaptic congenital myasthenic syndromes,CHRNB1,cholinergic receptor nicotinic beta 1 subunit,17p13.1
98913,Postsynaptic congenital myasthenic syndromes,CHRND,cholinergic receptor nicotinic delta subunit,2q37.1
98913,Postsynaptic congenital myasthenic syndromes,CHRND,cholinergic receptor nicotinic delta subunit,2q37.1
98913,Postsynaptic congenital myasthenic syndromes,CHRNE,cholinergic receptor nicotinic epsilon subunit,17p13.2
98913,Postsynaptic congenital myasthenic syndromes,CHRNE,cholinergic receptor nicotinic epsilon subunit,17p13.2
98913,Postsynaptic congenital myasthenic syndromes,DOK7,docking protein 7,4p16.3
98913,Postsynaptic congenital myasthenic syndromes,MUSK,muscle associated receptor tyrosine kinase,9q31.3
98913,Postsynaptic congenital myasthenic syndromes,LRP4,LDL receptor related protein 4,11p11.2
98913,Postsynaptic congenital myasthenic syndromes,AGRN,agrin,1p36.33
98913,Postsynaptic congenital myasthenic syndromes,AK9,adenylate kinase 9,6q21
98913,Postsynaptic congenital myasthenic syndromes,COL13A1,collagen type XIII alpha 1 chain,10q22.1
98916,Acute inflammatory demyelinating polyradiculoneuropathy,PMP22,peripheral myelin protein 22,17p12
98915,Synaptic congenital myasthenic syndromes,COLQ,collagen like tail subunit of asymmetric acetylcholinesterase,3p25.1
98915,Synaptic congenital myasthenic syndromes,LAMB2,laminin subunit beta 2,3p21.31
98904,Congenital myopathy with excess of thin filaments,ACTA1,"actin alpha 1, skeletal muscle",1q42.13
98905,Congenital multicore myopathy with external ophthalmoplegia,RYR1,ryanodine receptor 1,19q13.2
98908,Neutral lipid storage disease with myopathy,PNPLA2,"patatin like domain 2, triacylglycerol lipase",11p15.5
98907,Neutral lipid storage disease with ichthyosis,ABHD5,"abhydrolase domain containing 5, lysophosphatidic acid acyltransferase",3p21.33
98909,Desminopathy,DES,desmin,2q35
98933,"Multiple system atrophy, parkinsonian type",COQ2,"coenzyme Q2, polyprenyltransferase",4q21.23
98934,Huntington disease-like 2,JPH3,junctophilin 3,16q24.2
98920,Spinal muscular atrophy with respiratory distress type 1,IGHMBP2,immunoglobulin mu DNA binding protein 2,11q13.3
98942,Coloboma of choroid and retina,ACTG1,actin gamma 1,17q25.3
98942,Coloboma of choroid and retina,FZD5,frizzled class receptor 5,2q33.3
98942,Coloboma of choroid and retina,SALL2,spalt like transcription factor 2,14q11.2
98942,Coloboma of choroid and retina,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
98942,Coloboma of choroid and retina,PAX6,paired box 6,11p13
98938,Colobomatous microphthalmia,SHH,sonic hedgehog signaling molecule,7q36.3
98938,Colobomatous microphthalmia,STRA6,signaling receptor and transporter of retinol STRA6,15q24.1
98938,Colobomatous microphthalmia,VSX2,visual system homeobox 2,14q24.3
98938,Colobomatous microphthalmia,GDF6,growth differentiation factor 6,8q22.1
98938,Colobomatous microphthalmia,GDF3,growth differentiation factor 3,12p13.31
98938,Colobomatous microphthalmia,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
98938,Colobomatous microphthalmia,TENM3,teneurin transmembrane protein 3,4q34.3-q35.1
98938,Colobomatous microphthalmia,RBP4,retinol binding protein 4,10q23.33
98938,Colobomatous microphthalmia,SOX2,SRY-box transcription factor 2,3q26.33
98938,Colobomatous microphthalmia,SIX6,SIX homeobox 6,14q23.1
98938,Colobomatous microphthalmia,OTX2,orthodenticle homeobox 2,14q22.3
98938,Colobomatous microphthalmia,RAX,retina and anterior neural fold homeobox,18q21.32
98938,Colobomatous microphthalmia,ALDH1A3,aldehyde dehydrogenase 1 family member A3,15q26.3
98938,Colobomatous microphthalmia,PORCN,porcupine O-acyltransferase,Xp11.23
98949,Complete cryptophthalmia,FREM2,FRAS1 related extracellular matrix 2,13q13.3
98947,Coloboma of optic disc,FZD5,frizzled class receptor 5,2q33.3
98947,Coloboma of optic disc,SALL2,spalt like transcription factor 2,14q11.2
98947,Coloboma of optic disc,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
98947,Coloboma of optic disc,PAX6,paired box 6,11p13
98945,Coloboma of macula,FZD5,frizzled class receptor 5,2q33.3
98945,Coloboma of macula,SALL2,spalt like transcription factor 2,14q11.2
98945,Coloboma of macula,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
98945,Coloboma of macula,PAX6,paired box 6,11p13
98946,Coloboma of eyelid,FZD5,frizzled class receptor 5,2q33.3
98946,Coloboma of eyelid,SALL2,spalt like transcription factor 2,14q11.2
98946,Coloboma of eyelid,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
98946,Coloboma of eyelid,PAX6,paired box 6,11p13
98943,Coloboma of eye lens,FZD5,frizzled class receptor 5,2q33.3
98943,Coloboma of eye lens,SALL2,spalt like transcription factor 2,14q11.2
98943,Coloboma of eye lens,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
98943,Coloboma of eye lens,PAX6,paired box 6,11p13
98944,Coloboma of iris,ACTG1,actin gamma 1,17q25.3
98944,Coloboma of iris,FZD5,frizzled class receptor 5,2q33.3
98944,Coloboma of iris,SALL2,spalt like transcription factor 2,14q11.2
98944,Coloboma of iris,ABCB6,ATP binding cassette subfamily B member 6 (LAN blood group),2q35
98944,Coloboma of iris,PAX6,paired box 6,11p13
98957,Gelatinous drop-like corneal dystrophy,TACSTD2,tumor associated calcium signal transducer 2,1p32.1
98956,Epithelial basement membrane dystrophy,TGFBI,transforming growth factor beta induced,5q31.1
98954,Meesmann corneal dystrophy,KRT12,keratin 12,17q21.2
98954,Meesmann corneal dystrophy,KRT3,keratin 3,12q13.13
98964,Lattice corneal dystrophy type I,TGFBI,transforming growth factor beta induced,5q31.1
98963,Granular corneal dystrophy type II,TGFBI,transforming growth factor beta induced,5q31.1
98962,Granular corneal dystrophy type I,TGFBI,transforming growth factor beta induced,5q31.1
98961,Reis-Bücklers corneal dystrophy,TGFBI,transforming growth factor beta induced,5q31.1
98960,Thiel-Behnke corneal dystrophy,TGFBI,transforming growth factor beta induced,5q31.1
98973,Posterior polymorphous corneal dystrophy,VSX1,visual system homeobox 1,20p11.21
98973,Posterior polymorphous corneal dystrophy,ZEB1,zinc finger E-box binding homeobox 1,10p11.22
98973,Posterior polymorphous corneal dystrophy,COL8A2,collagen type VIII alpha 2 chain,1p34.3
98973,Posterior polymorphous corneal dystrophy,OVOL2,ovo like zinc finger 2,20p11.23
98973,Posterior polymorphous corneal dystrophy,GRHL2,grainyhead like transcription factor 2,8q22.3
98974,Fuchs endothelial corneal dystrophy,SLC4A11,solute carrier family 4 member 11,20p13
98974,Fuchs endothelial corneal dystrophy,ZEB1,zinc finger E-box binding homeobox 1,10p11.22
98974,Fuchs endothelial corneal dystrophy,COL8A2,collagen type VIII alpha 2 chain,1p34.3
98974,Fuchs endothelial corneal dystrophy,TCF4,transcription factor 4,18q21.2
98974,Fuchs endothelial corneal dystrophy,AGBL1,AGBL carboxypeptidase 1,15q25.3
98967,Schnyder corneal dystrophy,UBIAD1,UbiA prenyltransferase domain containing 1,1p36.22
98969,Macular corneal dystrophy,CHST6,carbohydrate sulfotransferase 6,16q23.1
98970,Fleck corneal dystrophy,PIKFYVE,"phosphoinositide kinase, FYVE-type zinc finger containing",2q34
98976,Congenital glaucoma,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2p22.2
98976,Congenital glaucoma,MYOC,myocilin,1q24.3
98976,Congenital glaucoma,LTBP2,latent transforming growth factor beta binding protein 2,14q24.3
98976,Congenital glaucoma,TEK,TEK receptor tyrosine kinase,9p21.2
98977,Juvenile glaucoma,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2p22.2
98977,Juvenile glaucoma,MYOC,myocilin,1q24.3
98977,Juvenile glaucoma,EFEMP1,EGF containing fibulin extracellular matrix protein 1,2p16.1
98978,Axenfeld anomaly,PITX2,paired like homeodomain 2,4q25
98978,Axenfeld anomaly,FOXC1,forkhead box C1,6p25.3
98988,Early-onset anterior polar cataract,CRYAA,crystallin alpha A,21q22.3
98988,Early-onset anterior polar cataract,CRYBB3,crystallin beta B3,22q11.23
98988,Early-onset anterior polar cataract,CRYGB,crystallin gamma B,2q33.3
98988,Early-onset anterior polar cataract,CRYBA2,crystallin beta A2,2q35
98990,Coralliform cataract,CRYGD,crystallin gamma D,2q33.3
98989,Cerulean cataract,CRYBB2,crystallin beta B2,22q11.23
98989,Cerulean cataract,CRYGD,crystallin gamma D,2q33.3
98989,Cerulean cataract,MIP,major intrinsic protein of lens fiber,12q13.3
98989,Cerulean cataract,MAF,MAF bZIP transcription factor,16q23.2
98984,Pulverulent cataract,BFSP2,beaded filament structural protein 2,3q22.1
98984,Pulverulent cataract,CRYBB2,crystallin beta B2,22q11.23
98984,Pulverulent cataract,CRYGC,crystallin gamma C,2q33.3
98984,Pulverulent cataract,CRYGD,crystallin gamma D,2q33.3
98984,Pulverulent cataract,GJA3,gap junction protein alpha 3,13q12.11
98984,Pulverulent cataract,GJA8,gap junction protein alpha 8,1q21.2
98984,Pulverulent cataract,CRYBB1,crystallin beta B1,22q12.1
98984,Pulverulent cataract,MAF,MAF bZIP transcription factor,16q23.2
98984,Pulverulent cataract,VIM,vimentin,10p13
98985,Early-onset sutural cataract,BFSP2,beaded filament structural protein 2,3q22.1
98985,Early-onset sutural cataract,CRYBA1,crystallin beta A1,17q11.2
98985,Early-onset sutural cataract,CRYBB2,crystallin beta B2,22q11.23
98985,Early-onset sutural cataract,GJA8,gap junction protein alpha 8,1q21.2
98985,Early-onset sutural cataract,MIP,major intrinsic protein of lens fiber,12q13.3
98985,Early-onset sutural cataract,CRYGS,crystallin gamma S,3q27.3
98991,Early-onset nuclear cataract,WFS1,wolframin ER transmembrane glycoprotein,4p16.1
98991,Early-onset nuclear cataract,CRYAA,crystallin alpha A,21q22.3
98991,Early-onset nuclear cataract,CRYAB,crystallin alpha B,11q23.1
98991,Early-onset nuclear cataract,CRYBA1,crystallin beta A1,17q11.2
98991,Early-onset nuclear cataract,CRYBB2,crystallin beta B2,22q11.23
98991,Early-onset nuclear cataract,CRYBB3,crystallin beta B3,22q11.23
98991,Early-onset nuclear cataract,CRYGC,crystallin gamma C,2q33.3
98991,Early-onset nuclear cataract,CRYGD,crystallin gamma D,2q33.3
98991,Early-onset nuclear cataract,GJA3,gap junction protein alpha 3,13q12.11
98991,Early-onset nuclear cataract,GJA8,gap junction protein alpha 8,1q21.2
98991,Early-onset nuclear cataract,MIP,major intrinsic protein of lens fiber,12q13.3
98991,Early-onset nuclear cataract,CRYBB1,crystallin beta B1,22q12.1
98991,Early-onset nuclear cataract,NHS,NHS actin remodeling regulator,Xp22.2-p22.13
98991,Early-onset nuclear cataract,BFSP1,beaded filament structural protein 1,20p12.1
98991,Early-onset nuclear cataract,EPHA2,EPH receptor A2,1p36.13
98991,Early-onset nuclear cataract,FYCO1,FYVE and coiled-coil domain autophagy adaptor 1,3p21.31
98991,Early-onset nuclear cataract,UNC45B,unc-45 myosin chaperone B,17q12
98991,Early-onset nuclear cataract,CRYBA2,crystallin beta A2,2q35
98994,Total early-onset cataract,CRYAA,crystallin alpha A,21q22.3
98994,Total early-onset cataract,CRYBB2,crystallin beta B2,22q11.23
98994,Total early-onset cataract,GJA8,gap junction protein alpha 8,1q21.2
98994,Total early-onset cataract,HSF4,heat shock transcription factor 4,16q22.1
98994,Total early-onset cataract,MIP,major intrinsic protein of lens fiber,12q13.3
98994,Total early-onset cataract,NHS,NHS actin remodeling regulator,Xp22.2-p22.13
98994,Total early-onset cataract,LIM2,lens intrinsic membrane protein 2,19q13.41
98994,Total early-onset cataract,EPHA2,EPH receptor A2,1p36.13
98994,Total early-onset cataract,FYCO1,FYVE and coiled-coil domain autophagy adaptor 1,3p21.31
98994,Total early-onset cataract,AGK,acylglycerol kinase,7q34
98994,Total early-onset cataract,CRYGB,crystallin gamma B,2q33.3
98994,Total early-onset cataract,GCNT2,glucosaminyl (N-acetyl) transferase 2 (I blood group),6p24.3-p24.2
98994,Total early-onset cataract,LSS,lanosterol synthase,21q22.3
98994,Total early-onset cataract,PGRMC1,progesterone receptor membrane component 1,Xq24
98994,Total early-onset cataract,LEMD2,LEM domain nuclear envelope protein 2,6p21.31
98994,Total early-onset cataract,DNMBP,dynamin binding protein,10q24.2
98994,Total early-onset cataract,SIPA1L3,signal induced proliferation associated 1 like 3,19q13.13-q13.2
98993,Early-onset posterior polar cataract,PITX3,paired like homeodomain 3,10q24.32
98993,Early-onset posterior polar cataract,CRYAB,crystallin alpha B,11q23.1
98993,Early-onset posterior polar cataract,CRYBA1,crystallin beta A1,17q11.2
98993,Early-onset posterior polar cataract,GJA3,gap junction protein alpha 3,13q12.11
98993,Early-onset posterior polar cataract,MIP,major intrinsic protein of lens fiber,12q13.3
98993,Early-onset posterior polar cataract,CHMP4B,charged multivesicular body protein 4B,20q11.22
98993,Early-onset posterior polar cataract,EPHA2,EPH receptor A2,1p36.13
98993,Early-onset posterior polar cataract,PANK4,pantothenate kinase 4 (inactive),1p36.32
99001,Butterfly-shaped pigment dystrophy,PRPH2,peripherin 2,6p21.1
99001,Butterfly-shaped pigment dystrophy,OTX2,orthodenticle homeobox 2,14q22.3
99001,Butterfly-shaped pigment dystrophy,CTNNA1,catenin alpha 1,5q31.2
99002,Reticular dystrophy of the retinal pigment epithelium,RCBTB1,RCC1 and BTB domain containing protein 1,13q14.2
99000,Adult-onset foveomacular vitelliform dystrophy,PRPH2,peripherin 2,6p21.1
99000,Adult-onset foveomacular vitelliform dystrophy,BEST1,bestrophin 1,11q12.3
99000,Adult-onset foveomacular vitelliform dystrophy,IMPG2,interphotoreceptor matrix proteoglycan 2,3q12.3
99000,Adult-onset foveomacular vitelliform dystrophy,IMPG1,interphotoreceptor matrix proteoglycan 1,6q14.1
99003,Multifocal pattern dystrophy simulating fundus flavimaculatus,PRPH2,peripherin 2,6p21.1
99013,Spastic paraplegia type 7,SPG7,"SPG7 matrix AAA peptidase subunit, paraplegin",16q24.3
99014,X-linked Charcot-Marie-Tooth disease type 5,PRPS1,phosphoribosyl pyrophosphate synthetase 1,Xq22.3
99015,Spastic paraplegia type 2,PLP1,proteolipid protein 1,Xq22.2
585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,PDGFRA,platelet derived growth factor receptor alpha,4q12
585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,FOXP1,forkhead box P1,3p13
585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",9q34.12
585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),BCR,BCR activator of RhoGEF and GTPase,22q11.23
585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),IKZF1,IKAROS family zinc finger 1,7p12.2
585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),TP53,tumor protein p53,17p13.1
585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),FLT3,fms related receptor tyrosine kinase 3,13q12.2
585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),HLA-C,"major histocompatibility complex, class I, C",6p21.33
585936,B-lymphoblastic leukemia/lymphoma with hyperdiploidy,GATA3,GATA binding protein 3,10p14
585936,B-lymphoblastic leukemia/lymphoma with hyperdiploidy,PIP4K2A,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha,10p12.2
585918,B-lymphoblastic leukemia/lymphoma with t(v;11q23.3),KMT2A,lysine methyltransferase 2A,11q23.3
585929,B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1),ETV6,ETS variant transcription factor 6,12p13.2
99027,Adult-onset autosomal dominant leukodystrophy,LMNB1,lamin B1,5q23.2
585956,B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3),TCF3,transcription factor 3,19p13.3
585956,B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3),PBX1,PBX homeobox 1,1q23.3
585948,B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3),IGH,immunoglobulin heavy locus,14q32.33
99042,Congenitally uncorrected transposition of the great arteries with coarctation,CFC1,"cryptic, EGF-CFC family member 1",2q21.1
98676,Autosomal recessive isolated optic atrophy,YME1L1,YME1 like 1 ATPase,10p12.1
98676,Autosomal recessive isolated optic atrophy,ACO2,aconitase 2,22q13.2
98676,Autosomal recessive isolated optic atrophy,RTN4IP1,reticulon 4 interacting protein 1,6q21
98676,Autosomal recessive isolated optic atrophy,MCAT,malonyl-CoA-acyl carrier protein transacylase,22q13.2
98673,"Autosomal dominant optic atrophy, classic form",OPA1,OPA1 mitochondrial dynamin like GTPase,3q29
98673,"Autosomal dominant optic atrophy, classic form",DNM1L,dynamin 1 like,12p11.21
98619,Rare isolated myopia,SLC39A5,solute carrier family 39 member 5,12q13.3
98619,Rare isolated myopia,SCO2,synthesis of cytochrome C oxidase 2,22q13.33
98619,Rare isolated myopia,P3H2,prolyl 3-hydroxylase 2,3q28
98619,Rare isolated myopia,LRPAP1,LDL receptor related protein associated protein 1,4p16.3
583602,Neu-Laxova syndrome due to phosphoserine aminotransferase deficiency,PSAT1,phosphoserine aminotransferase 1,9q21.2
583607,Neu-Laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency,PHGDH,phosphoglycerate dehydrogenase,1p12
583612,Neu-Laxova syndrome due to 3-phosphoserine phosphatase deficiency,PSPH,phosphoserine phosphatase,7p11.2
98795,Angelman syndrome due to paternal uniparental disomy of chromosome 15,UBE3A,ubiquitin protein ligase E3A,15q11.2
98794,Angelman syndrome due to maternal 15q11q13 deletion,UBE3A,ubiquitin protein ligase E3A,15q11.2
98794,Angelman syndrome due to maternal 15q11q13 deletion,OCA2,OCA2 melanosomal transmembrane protein,15q12-q13.1
98791,Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,HBA2,hemoglobin subunit alpha 2,16p13.3
98791,Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,HBA1,hemoglobin subunit alpha 1,16p13.3
98806,"Primary dystonia, DYT6 type",THAP1,THAP domain containing 1,8p11.21
98805,"Primary dystonia, DYT4 type",TUBB4A,tubulin beta 4A class IVa,19p13.3
98784,Sleep-related hypermotor epilepsy,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,20q13.33
98784,Sleep-related hypermotor epilepsy,CHRNA2,cholinergic receptor nicotinic alpha 2 subunit,8p21.2
98784,Sleep-related hypermotor epilepsy,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,1q21.3
98784,Sleep-related hypermotor epilepsy,KCNT1,potassium sodium-activated channel subfamily T member 1,9q34.3
98784,Sleep-related hypermotor epilepsy,DEPDC5,"DEP domain containing 5, GATOR1 subcomplex subunit",22q12.2-q12.3
98784,Sleep-related hypermotor epilepsy,CRH,corticotropin releasing hormone,8q13.1
98784,Sleep-related hypermotor epilepsy,CABP4,calcium binding protein 4,11q13.2
98764,Spinocerebellar ataxia type 27A,FGF14,fibroblast growth factor 14,13q33.1
98763,Spinocerebellar ataxia type 14,PRKCG,protein kinase C gamma,19q13.42
98766,Spinocerebellar ataxia type 5,SPTBN2,"spectrin beta, non-erythrocytic 2",11q13.2
98765,Spinocerebellar ataxia type 4,PLEKHG4,pleckstrin homology and RhoGEF domain containing G4,16q22.1
98760,Spinocerebellar ataxia type 8,ATXN8,ataxin 8,13q21.33
98760,Spinocerebellar ataxia type 8,ATXN8OS,ATXN8 opposite strand lncRNA,13q21.33
98759,Spinocerebellar ataxia type 17,TBP,TATA-box binding protein,6q27
98762,Spinocerebellar ataxia type 12,PPP2R2B,protein phosphatase 2 regulatory subunit Bbeta,5q32
98761,Spinocerebellar ataxia type 10,ATXN10,ataxin 10,22q13.31
98772,Spinocerebellar ataxia type 19/22,KCND3,potassium voltage-gated channel subfamily D member 3,1p13.2
98771,Spinocerebellar ataxia type 18,IFRD1,interferon related developmental regulator 1,7q31.1
98773,Spinocerebellar ataxia type 21,TMEM240,transmembrane protein 240,1p36.33
98768,Spinocerebellar ataxia type 13,KCNC3,potassium voltage-gated channel subfamily C member 3,19q13.33
98767,Spinocerebellar ataxia type 11,TTBK2,tau tubulin kinase 2,15q15.2
98769,Spinocerebellar ataxia type 15/16,ITPR1,"inositol 1,4,5-trisphosphate receptor type 1",3p26.1
580940,QRICH1-related intellectual disability-chondrodysplasia syndrome,QRICH1,glutamine rich 1,3p21.31
580933,Lethal brain and heart developmental defects,SIRT6,sirtuin 6,19p13.3
98755,Spinocerebellar ataxia type 1,ATXN1,ataxin 1,6p22.3
98756,Spinocerebellar ataxia type 2,ATXN2,ataxin 2,12q24.12
98758,Spinocerebellar ataxia type 6,CACNA1A,calcium voltage-gated channel subunit alpha1 A,19p13.13
581271,Cramp-fasciculation syndrome,TRPA1,transient receptor potential cation channel subfamily A member 1,8q21.11
98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,SNRPN,small nuclear ribonucleoprotein polypeptide N,15q11.2
98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,MAGEL2,MAGE family member L2,15q11.2
98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,NDN,"necdin, MAGE family member",15q11.2
98754,Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15,OCA2,OCA2 melanosomal transmembrane protein,15q12-q13.1
576232,Partial atrioventricular septal defect with ventricular hypoplasia,GATA4,GATA binding protein 4,8p23.1
576235,Partial atrioventricular septal defect without ventricular hypoplasia,CRELD1,cysteine rich with EGF like domains 1,3p25.3
576227,Complete atrioventricular septal defect without ventricular hypoplasia,MEF2C,myocyte enhancer factor 2C,5q14.3
575553,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy,CTSA,cathepsin A,20q13.12
576349,NLRC4-related familial cold autoinflammatory syndrome,NLRC4,NLR family CARD domain containing 4,2p22.3
576283,SATB2-associated syndrome due to a pathogenic variant,SATB2,SATB homeobox 2,2q33.1
574957,Mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency,JAK1,Janus kinase 1,1p31.3
574918,Predisposition to severe viral infection due to IRF7 deficiency,IRF7,interferon regulatory factor 7,11p15.5
572385,Brachydactyly type B1,ROR2,receptor tyrosine kinase like orphan receptor 2,9q22.31
572361,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2,FOXL2,forkhead box L2,3q22.3
572428,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia,OAS1,2'-5'-oligoadenylate synthetase 1,12q24.13
98434,Hereditary combined deficiency of vitamin K-dependent clotting factors,GGCX,gamma-glutamyl carboxylase,2p11.2
98434,Hereditary combined deficiency of vitamin K-dependent clotting factors,VKORC1,vitamin K epoxide reductase complex subunit 1,16p11.2
572543,RFVT2-related riboflavin transporter deficiency,SLC52A2,solute carrier family 52 member 2,8q24.3
572550,RFVT3-related riboflavin transporter deficiency,SLC52A3,solute carrier family 52 member 3,20p13
572773,Microcephaly-short stature-limb abnormalities syndrome,DONSON,DNA replication fork stabilization factor DONSON,21q22.11
572798,WARS2-related combined oxidative phosphorylation defect,WARS2,"tryptophanyl tRNA synthetase 2, mitochondrial",1p12
572768,Microcephaly-micromelia syndrome,DONSON,DNA replication fork stabilization factor DONSON,21q22.11
572013,Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome,MACF1,microtubule actin crosslinking factor 1,1p34.3
572013,Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome,CEP85L,centrosomal protein 85L,6q22.31
572333,Blepharophimosis-ptosis-epicanthus inversus syndrome plus,FOXL2,forkhead box L2,3q22.3
572354,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1,FOXL2,forkhead box L2,3q22.3
570491,QRSL1-related combined oxidative phosphorylation defect,QRSL1,glutaminyl-tRNA amidotransferase subunit QRSL1,6q21
570422,Galactose mutarotase deficiency,GALM,galactose mutarotase,2p22.1
570371,Bartter syndrome type 5,MAGED2,MAGE family member D2,Xp11.21
694963,Inflammatory breast cancer,BRCA1,BRCA1 DNA repair associated,17q21.31
694963,Inflammatory breast cancer,BRCA2,BRCA2 DNA repair associated,13q13.1
694946,Alazami-Yuan syndrome,TAF6,TATA-box binding protein associated factor 6,7q22.1
694956,Intellectual disability-lymphoid hypertrophy-macrocephaly syndrome,ZBTB7A,zinc finger and BTB domain containing 7A,19p13.3
694356,ADAR-related hereditary spastic paraplegia,ADAR,adenosine deaminase RNA specific,1q21.3
694937,Intellectual disability-peripheral neuropathy-corpus callosum abnormalities syndrome due to nudix hydrolase 2 deficiency,NUDT2,nudix hydrolase 2,9p13.3
694922,Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome,ADPRS,ADP-ribosylserine hydrolase,1p34.3
693912,EPHB4-related capillary malformation-arteriovenous malformation,EPHB4,EPH receptor B4,7q22.1
693907,RASA1-related capillary malformation-arteriovenous malformation,RASA1,RAS p21 protein activator 1,5q14.3
694308,ZMYND11-related developmental delay-speech delay-seizures-behavioral abnormalities-craniofacial dysmorphism syndrome due to a point mutation,ZMYND11,zinc finger MYND-type containing 11,10p15.3
696189,Congenital generalized lipodystrophy type 1,AGPAT2,1-acylglycerol-3-phosphate O-acyltransferase 2,9q34.3
696206,Congenital generalized lipodystrophy type 3,CAV1,caveolin 1,7q31.2
696242,PPARG-associated congenital generalized lipodystrophy,PPARG,peroxisome proliferator activated receptor gamma,3p25.2
696289,Congenital generalized lipodystrophy type 2,BSCL2,"BSCL2 lipid droplet biogenesis associated, seipin",11q12.3
695783,EDEM3-CDG,EDEM3,ER degradation enhancing alpha-mannosidase like protein 3,1q25.3
695807,Immunodeficiency-systemic inflammation-lymphoma predisposition syndrome,SYK,spleen associated tyrosine kinase,9q22.2
696063,PLIN4-related distal myopathy,PLIN4,perilipin 4,19p13.3
695147,Sickle cell-beta plus-thalassemia,HBB,hemoglobin subunit beta,11p15.4
695183,Late-onset combined immunodeficiency due to ICOS deficiency,ICOS,inducible T cell costimulator,2q33.2
695172,Combined immunodeficiency due to dimerization defective IKAROS mutation,IKZF1,IKAROS family zinc finger 1,7p12.2
695191,Late-onset combined immunodeficiency due to ICOSL deficiency,ICOSLG,inducible T cell costimulator ligand,21q22.3
695110,MAN2B2-CDG,MAN2B2,mannosidase alpha class 2B member 2,4p16.1
695140,Sickle cell-beta zero-thalassemia,HBB,hemoglobin subunit beta,11p15.4
104077,Myopathic intestinal pseudoobstruction,ACTG2,"actin gamma 2, smooth muscle",2p13.1
697067,Global developmental delay-intellectual disability-microcephaly-short stature-brain iron accumulation syndrome,BCAS3,BCAS3 microtubule associated cell migration factor,17q23.2
696942,Childhood-onset common variable immunodeficiency due to ARHGEF1 deficiency,ARHGEF1,Rho guanine nucleotide exchange factor 1,19q13.2
696945,X-linked common variable immunodeficiency phenotype due to SH3KBP1 deficiency,SH3KBP1,SH3 domain containing kinase binding protein 1,Xp22.12
696931,Common variable immunodeficiency phenotype due to TWEAK deficiency,TNFSF12,TNF superfamily member 12,17p13.1
696925,Adult-onset common variable immunodeficiency due to BAFF-receptor deficiency,TNFRSF13C,TNF receptor superfamily member 13C,22q13.2
696907,Common variable immunodeficiency phenotype due to homozygous TACI deficiency,TNFRSF13B,TNF receptor superfamily member 13B,17p11.2
103918,Tropical pancreatitis,SPINK1,serine peptidase inhibitor Kazal type 1,5q32
103918,Tropical pancreatitis,CTRC,chymotrypsin C,1p36.21
696904,Common variable immunodeficiency phenotype due to IRF2BP2 deficiency,IRF2BP2,interferon regulatory factor 2 binding protein 2,1q42.3
696894,Common variable immunodeficiency phenotype due to CD21 deficiency,CR2,complement C3d receptor 2,1q32.2
103908,Congenital sodium diarrhea,GUCY2C,guanylate cyclase 2C,12p12.3
103908,Congenital sodium diarrhea,SLC9A3,solute carrier family 9 member A3,5p15.33
696881,Common variable immunodeficiency phenotype due to CD19/CD81 deficiency,CD19,CD19 molecule,16p11.2
696881,Common variable immunodeficiency phenotype due to CD19/CD81 deficiency,CD81,CD81 molecule,11p15.5
103909,Trehalase deficiency,TREH,trehalase,11q23.3
696874,NFKB1-related immune dysregulation,NFKB1,nuclear factor kappa B subunit 1,4q24
102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,RUNX1,RUNX family transcription factor 1,21q22.12
102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,FLT3,fms related receptor tyrosine kinase 3,13q12.2
102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,CEBPA,CCAAT enhancer binding protein alpha,19q13.11
102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,RUNX1T1,RUNX1 partner transcriptional co-repressor 1,8q21.3
102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4q12
697764,Intellectual disability-nasal speech-craniofacial dysmorphism syndrome due to CNOT2 mutation,CNOT2,CCR4-NOT transcription complex subunit 2,12q15
697414,Early-onset combined immunodeficiency with low Ig due to dominant negative IKAROS mutation,IKZF1,IKAROS family zinc finger 1,7p12.2
697734,ST3GAL3-CDG,ST3GAL3,"ST3 beta-galactoside alpha-2,3-sialyltransferase 3",1p34.1
697417,Common variable immunodeficiency phenotype due to SEC61A1 deficiency,SEC61A1,SEC61 translocon subunit alpha 1,3q21.3
697394,Combined immunodeficiency due to c-REL deficiency,REL,"REL proto-oncogene, NF-kB subunit",2p16.1
697403,Combined immunodeficiency-hypogammaglobulinemia-skeletal anomalies syndrome due to IKBKA deficiency,CHUK,component of inhibitor of nuclear factor kappa B kinase complex,10q24.31
697389,Combined immunodeficiency due to HELIOS deficiency,IKZF2,IKAROS family zinc finger 2,2q34
697160,Infantile epileptic spasms syndrome,SCN2A,sodium voltage-gated channel alpha subunit 2,2q24.3
697160,Infantile epileptic spasms syndrome,CDKL5,cyclin dependent kinase like 5,Xp22.13
697160,Infantile epileptic spasms syndrome,ARX,aristaless related homeobox,Xp21.3
697160,Infantile epileptic spasms syndrome,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,Xp22.2
697160,Infantile epileptic spasms syndrome,SPTAN1,"spectrin alpha, non-erythrocytic 1",9q34.11
697160,Infantile epileptic spasms syndrome,PLCB1,phospholipase C beta 1,20p12.3
697160,Infantile epileptic spasms syndrome,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,12p13.1
697160,Infantile epileptic spasms syndrome,WDR45,WD repeat domain 45,Xp11.23
697160,Infantile epileptic spasms syndrome,NTRK2,neurotrophic receptor tyrosine kinase 2,9q21.33
697160,Infantile epileptic spasms syndrome,SIK1,salt inducible kinase 1,21q22.3
697160,Infantile epileptic spasms syndrome,GUF1,GTP binding elongation factor GUF1,4p12
697160,Infantile epileptic spasms syndrome,CNPY3,canopy FGF signaling regulator 3,6p21.1
697160,Infantile epileptic spasms syndrome,PHACTR1,phosphatase and actin regulator 1,6p24.1
699593,Combined immunodeficiency-lymphopenia-cancer predisposing syndrome due to AIOLOS deficiency,IKZF3,IKAROS family zinc finger 3,17q12-q21.1
699605,NEMO deleted exon 5 autoinflammatory syndrome,IKBKG,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,Xq28
699599,ICHAD syndrome,IKZF2,IKAROS family zinc finger 2,2q34
699618,Severe mendelian susceptibility to mycobacterial diseases due to complete IFNG deficiency,IFNG,interferon gamma,12q15
699615,Severe mendelian susceptibility to mycobacterial diseases due to complete IRF1 deficiency,IRF1,interferon regulatory factor 1,5q31.1
698085,Global developmental delay-intellectual disability-facial dysmorphism-pseudo-Pelger-Huët anomaly syndrome,TMEM147,transmembrane protein 147,19q13.12
698090,Ophthalmological abnormalities-facial dysmorphism-intellectual disability syndrome,BRPF1,bromodomain and PHD finger containing 1,3p25.3
699822,Sickle cell S-Lepore disease,HBB,hemoglobin subunit beta,11p15.4
699822,Sickle cell S-Lepore disease,HBD,hemoglobin subunit delta,11p15.4
699850,2p25.3 microduplication syndrome,MYT1L,myelin transcription factor 1 like,2p25.3
699850,2p25.3 microduplication syndrome,PXDN,peroxidasin,2p25.3
700090,Sickle cell S-O Arab disease,HBB,hemoglobin subunit beta,11p15.4
700111,Homozygous hemoglobin O Arab disease,HBB,hemoglobin subunit beta,11p15.4
700107,Sickle cell S-other specified hemoglobin variant,HBB,hemoglobin subunit beta,11p15.4
700124,Autosomal recessive hereditary chronic pancreatitis,SPINK1,serine peptidase inhibitor Kazal type 1,5q32
700124,Autosomal recessive hereditary chronic pancreatitis,CFTR,CF transmembrane conductance regulator,7q31.2
699708,CLN14 disease,KCTD7,potassium channel tetramerization domain containing 7,7q11.21
699718,Infantile CLN1 disease,PPT1,palmitoyl-protein thioesterase 1,1p34.2
699734,Late infantile CLN1 disease,PPT1,palmitoyl-protein thioesterase 1,1p34.2
699739,Juvenile CLN1 disease,PPT1,palmitoyl-protein thioesterase 1,1p34.2
699745,Adult CLN1 disease,PPT1,palmitoyl-protein thioesterase 1,1p34.2
699751,Infantile CLN2 disease,TPP1,tripeptidyl peptidase 1,11p15.4
699761,Late infantile CLN2 disease,TPP1,tripeptidyl peptidase 1,11p15.4
699769,Juvenile CLN2 disease,TPP1,tripeptidyl peptidase 1,11p15.4
699780,Juvenile CLN3 disease,CLN3,"CLN3 lysosomal/endosomal transmembrane protein, battenin",16p12.1
699796,Protracted juvenile CLN3 disease,CLN3,"CLN3 lysosomal/endosomal transmembrane protein, battenin",16p12.1
699802,Late infantile CLN5 disease,CLN5,CLN5 intracellular trafficking protein,13q22.3
699807,Juvenile CLN5 disease,CLN5,CLN5 intracellular trafficking protein,13q22.3
699812,Adult CLN5 disease,CLN5,CLN5 intracellular trafficking protein,13q22.3
700508,Distal muscle weakness-foot deformity-elevated sorbitol level-hereditary motor neuropathy,SORD,sorbitol dehydrogenase,15q21.1
700497,Juvenile CLN10 disease,CTSD,cathepsin D,11p15.5
700492,Late infantile CLN10 disease,CTSD,cathepsin D,11p15.5
700487,Congenital CLN10 disease,CTSD,cathepsin D,11p15.5
700484,Late infantile CLN8 disease,CLN8,CLN8 transmembrane ER and ERGIC protein,8p23.3
700477,Adult CLN6 disease,CLN6,CLN6 transmembrane ER protein,15q23
700472,Juvenile CLN6 disease,CLN6,CLN6 transmembrane ER protein,15q23
700188,Calf-predominant weakness-gastrocnemius medialis atrophy-distal myopathy,RYR1,ryanodine receptor 1,19q13.2
101351,Familial isolated congenital asplenia,NKX2-5,NK2 homeobox 5,5q35.1
101351,Familial isolated congenital asplenia,RPSA,ribosomal protein SA,3p22.1
700170,Asymetric thumb-handgrip weakness-distal myopathy,DNAJB4,DnaJ heat shock protein family (Hsp40) member B4,1p31.1
700163,SMPX-related distal myopathy,SMPX,small muscle protein X-linked,Xp22.12
700154,TARDBP-related predominantly upper-limb distal myopathy,TARDBP,TAR DNA binding protein,1p36.22
700467,Late infantile CLN6 disease,CLN6,CLN6 transmembrane ER protein,15q23
700333,Hypotonia-speech impairment-severe cognitive delay syndrome due to UNC80 deficiency,UNC80,"unc-80 homolog, NALCN channel complex subunit",2q34
700336,Hypotonia-speech impairment-severe cognitive delay syndrome due to NALCN deficiency,NALCN,"sodium leak channel, non-selective",13q32.3-q33.1
700325,NKAP-related intellectual disability-facial dysmorphism-marfanoid habitus-scoliosis syndrome,NKAP,NFKB activating protein,Xq24
700205,Combined immunodeficiency due to IKBKB gain-of-function mutation,IKBKB,inhibitor of nuclear factor kappa B kinase subunit beta,8p11.21
664511,"Early-onset severe Hermansky-Pudlak syndrome with hearing loss, due to AP3D1 deficiency",AP3D1,adaptor related protein complex 3 subunit delta 1,19p13.3
101150,Autosomal recessive dopa-responsive dystonia,TH,tyrosine hydroxylase,11p15.5
101150,Autosomal recessive dopa-responsive dystonia,TSPOAP1,TSPO associated protein 1,17q22
664500,Hermansky-Pudlak syndrome due to AP3B1 deficiency,AP3B1,adaptor related protein complex 3 subunit beta 1,5q14.1
101111,Spinocerebellar ataxia type 25,SCA25,spinocerebellar ataxia 25,2p21-p15
101111,Spinocerebellar ataxia type 25,PNPT1,polyribonucleotide nucleotidyltransferase 1,2p16.1
101112,Spinocerebellar ataxia type 26,EEF2,eukaryotic translation elongation factor 2,19p13.3
101109,Spinocerebellar ataxia type 28,AFG3L2,AFG3 like matrix AAA peptidase subunit 2,18p11.21
664438,Gingival fibromatosis-aortic root dilatation-facial dysmorphism-intellectual disability syndrome,KCNMA1,potassium calcium-activated channel subfamily M alpha 1,10q22.3
101110,Spinocerebellar ataxia type 20,SCA20,spinocerebellar ataxia 20,11q12
101108,Spinocerebellar ataxia type 23,PDYN,prodynorphin,20p13
664430,Neurodevelopmental disorder-slit-like lateral ventricles-intellectual disability syndrome,SLC4A10,solute carrier family 4 member 10,2q24.2
664416,Brain abnormalities-severe developmental delay-facial dysmorphism-intellectual disability syndrome due to MEF2C mutation,MEF2C,myocyte enhancer factor 2C,5q14.3
664729,EBV-induced lymphoproliferative disease due to TET2 deficiency,TET2,tet methylcytosine dioxygenase 2,4q24
664726,EBV-induced lymphoproliferative disease due to CD137 deficiency,TNFRSF9,TNF receptor superfamily member 9,1p36.23
664711,EBV-induced lymphoproliferative disease due to PRKCD deficiency,PRKCD,protein kinase C delta,3p21.1
664699,EBV-induced lymphoproliferative disease due to RASGRP1 deficiency,RASGRP1,RAS guanyl releasing protein 1,15q14
101085,Charcot-Marie-Tooth disease type 1F,NEFL,neurofilament light chain,8p21.2
101088,X-linked hyper-IgM syndrome,CD40LG,CD40 ligand,Xq26.3
101081,Charcot-Marie-Tooth disease type 1A,PMP22,peripheral myelin protein 22,17p12
101082,Charcot-Marie-Tooth disease type 1B,MPZ,myelin protein zero,1q23.3
101083,Charcot-Marie-Tooth disease type 1C,LITAF,lipopolysaccharide induced TNF factor,16p13.13
101084,Charcot-Marie-Tooth disease type 1D,EGR2,early growth response 2,10q21.3
101078,X-linked Charcot-Marie-Tooth disease type 4,AIFM1,apoptosis inducing factor mitochondria associated 1,Xq26.1
662234,Neurodevelopmental delay-congenital heart defects-intellectual disability syndrome,SPEN,spen family transcriptional repressor,1p36.21-p36.13
662367,NESCAV syndrome,KIF1A,kinesin family member 1A,2q37.3
662216,Mucopolysaccharidosis type 10,ARSK,arylsulfatase family member K,5q15
662207,Neurodevelopmental delay-brain malformations-skeletal defects-intellectual disability syndrome,HNRNPH1,heterogeneous nuclear ribonucleoprotein H1,5q35.3
101075,X-linked Charcot-Marie-Tooth disease type 1,GJB1,gap junction protein beta 1,Xq13.1
101102,Charcot-Marie-Tooth disease type 2H,GDAP1,ganglioside induced differentiation associated protein 1,8q21.11
664401,Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to TAB2 mutation,TAB2,TGF-beta activated kinase 1 (MAP3K7) binding protein 2,6q25.1
101101,Charcot-Marie-Tooth disease type 2B2,PNKP,polynucleotide kinase 3'-phosphatase,19q13.33
664404,6q25.1 microdeletion syndrome,TAB2,TGF-beta activated kinase 1 (MAP3K7) binding protein 2,6q25.1
101097,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness,GDAP1,ganglioside induced differentiation associated protein 1,8q21.11
662762,Motor delay-microcephaly-speech impairment-ocular abnormalities syndrome,ARPC4,actin related protein 2/3 complex subunit 4,3p25.3
101090,Hyper-IgM syndrome type 3,CD40,CD40 molecule,20q13.12
101089,Hyper-IgM syndrome type 2,AICDA,activation induced cytidine deaminase,12p13.31
662829,Intellectual disability-speech delay-dysmorphic features-T cell abnormalities syndrome,BCL11B,BCL11 transcription factor B,14q32.2
101092,Hyper-IgM syndrome type 5,UNG,uracil DNA glycosylase,12q24.11
675359,Anastomosing haemangioma,GNAQ,G protein subunit alpha q,9q21.2
675359,Anastomosing haemangioma,GNA14,G protein subunit alpha 14,9q21.2
675359,Anastomosing haemangioma,GNA11,G protein subunit alpha 11,19p13.3
675216,Spinocerebellar ataxia type 27B,FGF14,fibroblast growth factor 14,13q33.1
101049,Familial hypocalciuric hypercalcemia type 2,GNA11,G protein subunit alpha 11,19p13.3
101050,Familial hypocalciuric hypercalcemia type 3,AP2S1,adaptor related protein complex 2 subunit sigma 1,19q13.32
101041,Familial hypofibrinogenemia,FGA,fibrinogen alpha chain,4q31.3
101041,Familial hypofibrinogenemia,FGB,fibrinogen beta chain,4q31.3
101041,Familial hypofibrinogenemia,FGG,fibrinogen gamma chain,4q32.1
101046,Epilepsy with auditory features,RELN,reelin,7q22.1
101046,Epilepsy with auditory features,LGI1,leucine rich glioma inactivated 1,10q23.33
101046,Epilepsy with auditory features,DEPDC5,"DEP domain containing 5, GATOR1 subcomplex subunit",22q12.2-q12.3
101068,Congenital stromal corneal dystrophy,DCN,decorin,12q21.33
101068,Congenital stromal corneal dystrophy,SPARCL1,SPARC like 1,4q22.1
675767,Severe congenital neutropenia-developmental delay syndrome due to SRP54 deficiency,SRP54,signal recognition particle 54,14q13.2
101070,Bilateral frontoparietal polymicrogyria,ADGRG1,adhesion G protein-coupled receptor G1,16q21
675396,Epithelioid hemangioma,FOSB,"FosB proto-oncogene, AP-1 transcription factor subunit",19q13.32
675396,Epithelioid hemangioma,ZFP36L2,ZFP36 ring finger protein like 2,2p21
675396,Epithelioid hemangioma,LMNA,lamin A/C,1q22
675396,Epithelioid hemangioma,VIM,vimentin,10p13
675396,Epithelioid hemangioma,FOS,"Fos proto-oncogene, AP-1 transcription factor subunit",14q24.3
675628,TLR8-related inflammation-severe neutropenia-bone marrow failure-lymphoproliferation syndrome,TLR8,toll like receptor 8,Xp22.2
101063,Situs inversus totalis,ANKS3,ankyrin repeat and sterile alpha motif domain containing 3,16p13.3
101063,Situs inversus totalis,NME7,NME/NM23 family member 7,1q24.2
101063,Situs inversus totalis,CITED2,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2,6q24.1
101063,Situs inversus totalis,NODAL,nodal growth differentiation factor,10q22.1
101063,Situs inversus totalis,CFAP53,cilia and flagella associated protein 53,18q21.1
101063,Situs inversus totalis,CFAP52,cilia and flagella associated protein 52,17p13.1
101063,Situs inversus totalis,MMP21,matrix metallopeptidase 21,10q26.2
101063,Situs inversus totalis,PKD1L1,"polycystin 1 like 1, transient receptor potential channel interacting",7p12.3
101063,Situs inversus totalis,DNAH9,dynein axonemal heavy chain 9,17p12
101063,Situs inversus totalis,CIROP,ciliated left-right organizer metallopeptidase,14q11.2
667662,Breast implant-associated anaplastic large cell lymphoma,JAK1,Janus kinase 1,1p31.3
667662,Breast implant-associated anaplastic large cell lymphoma,JAK2,Janus kinase 2,9p24.1
667662,Breast implant-associated anaplastic large cell lymphoma,STAT3,signal transducer and activator of transcription 3,17q21.2
101023,Cleft hard palate,GRHL3,grainyhead like transcription factor 3,1p36.11
101023,Cleft hard palate,UBB,ubiquitin B,17p11.2
101009,Autosomal dominant spastic paraplegia type 29,SPG29,spastic paraplegia 29 (autosomal dominant),1p31.1-p21.1
101010,Autosomal spastic paraplegia type 30,KIF1A,kinesin family member 1A,2q37.3
101011,Autosomal dominant spastic paraplegia type 31,REEP1,receptor accessory protein 1,2p11.2
101016,Romano-Ward syndrome,TRDN,triadin,6q22.31
101016,Romano-Ward syndrome,KCNH2,potassium voltage-gated channel subfamily H member 2,7q36.1
101016,Romano-Ward syndrome,KCNQ1,potassium voltage-gated channel subfamily Q member 1,11p15.5-p15.4
101016,Romano-Ward syndrome,CAV3,caveolin 3,3p25.3
101016,Romano-Ward syndrome,ANK2,ankyrin 2,4q25-q26
101016,Romano-Ward syndrome,KCNE1,potassium voltage-gated channel subfamily E regulatory subunit 1,21q22.12
101016,Romano-Ward syndrome,KCNE2,potassium voltage-gated channel subfamily E regulatory subunit 2,21q22.11
101016,Romano-Ward syndrome,SCN5A,sodium voltage-gated channel alpha subunit 5,3p22.2
101016,Romano-Ward syndrome,AKAP9,A-kinase anchoring protein 9,7q21.2
101016,Romano-Ward syndrome,SCN4B,sodium voltage-gated channel beta subunit 4,11q23.3
101016,Romano-Ward syndrome,SNTA1,syntrophin alpha 1,20q11.21
101016,Romano-Ward syndrome,KCNJ5,potassium inwardly rectifying channel subfamily J member 5,11q24.3
101016,Romano-Ward syndrome,NOS1AP,nitric oxide synthase 1 adaptor protein,1q23.3
101016,Romano-Ward syndrome,CALM1,calmodulin 1,14q32.11
101016,Romano-Ward syndrome,CALM2,calmodulin 2,2p21
101016,Romano-Ward syndrome,SCN10A,sodium voltage-gated channel alpha subunit 10,3p22.2
101016,Romano-Ward syndrome,TBX5,T-box transcription factor 5,12q24.21
101016,Romano-Ward syndrome,CACNA1C,calcium voltage-gated channel subunit alpha1 C,12p13.33
101016,Romano-Ward syndrome,CALM3,calmodulin 3,19q13.32
674653,Actinomyopathy-associated syndromic thrombocytopenia,ACTB,actin beta,7p22.1
674762,Early-onset autoinflammatory syndrome due to A20 haploinsufficiency,TNFAIP3,TNF alpha induced protein 3,6q23.3
101039,Female restricted epilepsy with intellectual disability,PCDH19,protocadherin 19,Xq22.1
101028,Transaldolase deficiency,TALDO1,transaldolase 1,11p15.5
673556,Pseudomyogenic hemangioendothelioma,FOSB,"FosB proto-oncogene, AP-1 transcription factor subunit",19q13.32
673556,Pseudomyogenic hemangioendothelioma,ACTB,actin beta,7p22.1
673556,Pseudomyogenic hemangioendothelioma,WWTR1,WW domain containing transcription regulator 1,3q25.1
673556,Pseudomyogenic hemangioendothelioma,SERPINE1,serpin family E member 1,7q22.1
100984,Autosomal dominant spastic paraplegia type 3,ATL1,atlastin GTPase 1,14q22.1
685067,Hypodontia-scalp hypotrichosis-facial dysmorphism syndrome,TSPEAR,thrombospondin type laminin G domain and EAR repeats,21q22.3
685082,Pediatric acute respiratory distress syndrome,ABCA3,ATP binding cassette subfamily A member 3,16p13.3
685082,Pediatric acute respiratory distress syndrome,SFTPB,surfactant protein B,2p11.2
685082,Pediatric acute respiratory distress syndrome,SFTPC,surfactant protein C,8p21.3
685017,Combined immunodeficiency due to TBX1 deficiency,TBX1,T-box transcription factor 1,22q11.21
100991,Autosomal dominant spastic paraplegia type 10,KIF5A,kinesin family member 5A,12q13.3
100989,Autosomal dominant spastic paraplegia type 8,WASHC5,WASH complex subunit 5,8q24.13
100988,Autosomal dominant spastic paraplegia type 6,NIPA1,NIPA magnesium transporter 1,15q11.2
100986,Autosomal recessive spastic paraplegia type 5A,CYP7B1,cytochrome P450 family 7 subfamily B member 1,8q12.3
100985,Autosomal dominant spastic paraplegia type 4,SPAST,spastin,2p22.3
687424,ZMYND11-related developmental delay-speech delay-seizures-behavioral abnormalities-craniofacial dysmorphism syndrome due to 10p15.3 microdeletion,ZMYND11,zinc finger MYND-type containing 11,10p15.3
100999,Autosomal dominant spastic paraplegia type 19,SPG19,spastic paraplegia 19 (autosomal dominant),9q33-q34
101000,Autosomal recessive spastic paraplegia type 20,SPART,spartin,13q13.3
686999,Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome,PLAAT3,phospholipase A and acyltransferase 3,11q12.3-q13.1
100997,X-linked spastic paraplegia type 16,SPG16,"spastic paraplegia 16 (complicated, X-linked recessive)",Xq11.2
100998,Autosomal dominant spastic paraplegia type 17,BSCL2,"BSCL2 lipid droplet biogenesis associated, seipin",11q12.3
100995,Autosomal recessive spastic paraplegia type 14,SPG14,spastic paraplegia 14 (autosomal recessive),3q27-q28
686495,MADD-related developmental delay-endocrine dysfunction-hypohemoglobinemia syndrome,MADD,MAP kinase activating death domain,11p11.2
100996,Autosomal recessive spastic paraplegia type 15,ZFYVE26,zinc finger FYVE-type containing 26,14q24.1
686488,RNU4-2-related neurodevelopmental disorder-facial dysmorphism-white matter abnormalities-short stature syndrome,RNU4-2,"RNA, U4 small nuclear 2",12q24.31
100993,Autosomal dominant spastic paraplegia type 12,UBAP1,ubiquitin associated protein 1,9p13.3
100993,Autosomal dominant spastic paraplegia type 12,RTN2,reticulon 2,19q13.32
686482,BPTF-related intellectual disability-facial dysmorphism-skeletal anomalies syndrome,BPTF,bromodomain PHD finger transcription factor,17q24.2
100994,Autosomal dominant spastic paraplegia type 13,HSPD1,heat shock protein family D (Hsp60) member 1,2q33.1
101007,Autosomal recessive spastic paraplegia type 27,SPG27,spastic paraplegia 27 (autosomal recessive),10q22.1-q24.1
688543,Reticular dysgenesis-like severe combined immunodeficiency,RAC2,Rac family small GTPase 2,22q13.1
101008,Autosomal recessive spastic paraplegia type 28,DDHD1,DDHD domain containing 1,14q22.1
101005,Autosomal recessive spastic paraplegia type 25,SPG25,"spastic paraplegia 25 (autosomal recessive, with disc herniation)",6q23-q24.1
101006,Autosomal recessive spastic paraplegia type 26,B4GALNT1,"beta-1,4-N-acetyl-galactosaminyltransferase 1",12q13.3
101003,Autosomal recessive spastic paraplegia type 23,DSTYK,dual serine/threonine and tyrosine protein kinase,1q32.1
101003,Autosomal recessive spastic paraplegia type 23,SPG23,spastic paraplegia 23 (autosomal recessive),1q24-q32
101004,Autosomal recessive spastic paraplegia type 24,SPG24,spastic paraplegia 24 (autosomal recessive),13q14
101001,Autosomal recessive spastic paraplegia type 21,SPG21,"SPG21 abhydrolase domain containing, maspardin",15q22.31
675775,Severe congenital myelofibrosis-pancytopenia-intellectual disability-neurologic and ophthalmic abnormalities syndrome,RBSN,"rabenosyn, RAB effector",3p25.1
675782,Progressive hypotonia-intellectual disability-facial dysmorphism syndrome due to FYVE-defective RBSN,RBSN,"rabenosyn, RAB effector",3p25.1
676039,Combined immunodeficiency due to FOXN1 haploinsufficiency,FOXN1,forkhead box N1,17q11.2
676125,X-linked immune dysregulation with inflammatory bowel disease due to ELF4 deficiency,ELF4,E74 like ETS transcription factor 4,Xq26.1
100093,Carcinoid syndrome,SDHD,succinate dehydrogenase complex subunit D,11q23.1
100924,Porphyria due to ALA dehydratase deficiency,ALAD,aminolevulinate dehydratase,9q32
684216,Intellectual disability-facial dysmorphism-joint hypermobility-hearing loss syndrome,TET3,tet methylcytosine dioxygenase 3,2p13.1
684305,Neurooculocardiogenitourinary syndrome,WDR37,WD repeat domain 37,10p15.3
100973,FRAXE intellectual disability,AFF2,ALF transcription elongation factor 2,Xq28
100973,FRAXE intellectual disability,FMR3,fragile X mental retardation associated 3,Xq28
100974,FRAXF syndrome,TMEM185A,transmembrane protein 185A,Xq28
684742,2q13 microdeletion syndrome,FBLN7,fibulin 7,2q13
684742,2q13 microdeletion syndrome,TMEM87B,transmembrane protein 87B,2q13
100976,Bathing suit ichthyosis,TGM1,transglutaminase 1,14q12
684232,Intellectual disability-épilepsy-dental anomalies-facial dysmorphism syndrome,SATB1,SATB homeobox 1,3p24.3
684226,Intellectual disability-hypotonia-facial dysmorphism-macrocephaly syndrome,KMT5B,lysine methyltransferase 5B,11q13.2
684247,Isolated growth hormone deficiency type IV,GHRHR,growth hormone releasing hormone receptor,7p14.3
684240,Neurodevelopmental disorder-spasticity-movement disorder-epileptic syndrome,YIF1B,"Yip1 interacting factor homolog B, membrane trafficking protein",19q13.2
100054,F12-related hereditary angioedema with normal C1Inh,F12,coagulation factor XII,5q35.3
100051,Hereditary angioedema type 2,SERPING1,serpin family G member 1,11q12.1
100057,Renin-angiotensin-aldosterone system-blocker-induced angioedema,XPNPEP2,X-prolyl aminopeptidase 2,Xq26.1
692173,Marbach-Schaaf neurodevelopmental syndrome,PRKAR1B,protein kinase cAMP-dependent type I regulatory subunit beta,7p22.3
692193,CHAMP1-related intellectual disability-facial dysmorphism-behavioral abnormalities syndrome,CHAMP1,chromosome alignment maintaining phosphoprotein 1,13q34
692812,RAC2-related combined immunodeficiency-bronchiectasis-cancer-predisposing syndrome,RAC2,Rac family small GTPase 2,22q13.1
693549,Facial dysmorphism-Intellectual disability-rhombencephalosynapsis syndrome,MN1,"MN1 proto-oncogene, transcriptional regulator",22q12.1
692790,ATP6AP1-CDG,ATP6AP1,ATPase H+ transporting accessory protein 1,Xq28
100069,Semantic dementia,PSEN1,presenilin 1,14q24.2
100069,Semantic dementia,TMEM106B,transmembrane protein 106B,7p21.3
100069,Semantic dementia,CHMP2B,charged multivesicular body protein 2B,3p11.2
100069,Semantic dementia,TREM2,triggering receptor expressed on myeloid cells 2,6p21.1
100069,Semantic dementia,MAPT,microtubule associated protein tau,17q21.31
100069,Semantic dementia,GRN,granulin precursor,17q21.31
100069,Semantic dementia,C9ORF72,C9orf72-SMCR8 complex subunit,9p21.2
693627,Agammaglobulinemia-skin involvement-failure to thrive syndrome,SLC39A7,solute carrier family 39 member 7,6p21.32
100070,Progressive non-fluent aphasia,TMEM106B,transmembrane protein 106B,7p21.3
100070,Progressive non-fluent aphasia,PSEN1,presenilin 1,14q24.2
100070,Progressive non-fluent aphasia,CHMP2B,charged multivesicular body protein 2B,3p11.2
100070,Progressive non-fluent aphasia,TREM2,triggering receptor expressed on myeloid cells 2,6p21.1
100070,Progressive non-fluent aphasia,VCP,valosin containing protein,9p13.3
100070,Progressive non-fluent aphasia,MAPT,microtubule associated protein tau,17q21.31
100070,Progressive non-fluent aphasia,GRN,granulin precursor,17q21.31
100070,Progressive non-fluent aphasia,C9ORF72,C9orf72-SMCR8 complex subunit,9p21.2
693681,Activated PI3K-delta syndrome 2,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,5q13.1
100075,Neuroendocrine tumor of stomach,ATRX,ATRX chromatin remodeler,Xq21.1
693661,Activated PI3K-delta syndrome 1,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",1p36.22
693647,Agammaglobulinemia-early-onset hypertrophic cardiomyopathy-neutropenia syndrome,FNIP1,folliculin interacting protein 1,5q31.1
100020,Myelodysplastic neoplasm with increased blasts type 2,TET2,tet methylcytosine dioxygenase 2,4q24
100019,Myelodysplastic neoplasm with increased blasts type 1,TET2,tet methylcytosine dioxygenase 2,4q24
688581,Midface hypoplasia-hearing impairment-elliptocytosis-nephrocalcinosis syndrome,AMMECR1,AMMECR nuclear protein 1,Xq23
688594,Combined immunodeficiency due to RELB deficiency,RELB,"RELB proto-oncogene, NF-kB subunit",19q13.32
688642,Turnpenny-Fry syndrome,PCGF2,polycomb group ring finger 2,17q12
689021,Asymptomatic hyperCKemia-myalgia-rhabdomyolysis syndrome,ANO5,anoctamin 5,11p14.3
100032,Hypocalcified amelogenesis imperfecta,FAM83H,family with sequence similarity 83 member H,8q24.3
100032,Hypocalcified amelogenesis imperfecta,SLC24A4,solute carrier family 24 member 4,14q32.12
100032,Hypocalcified amelogenesis imperfecta,ITGB6,integrin subunit beta 6,2q24.2
100032,Hypocalcified amelogenesis imperfecta,AMTN,amelotin,4q13.3
100031,Hypoplastic amelogenesis imperfecta,ACP4,acid phosphatase 4,19q13.33
100031,Hypoplastic amelogenesis imperfecta,SP6,Sp6 transcription factor,17q21.32
100031,Hypoplastic amelogenesis imperfecta,RELT,RELT TNF receptor,11q13.4
100031,Hypoplastic amelogenesis imperfecta,ENAM,enamelin,4q13.3
100031,Hypoplastic amelogenesis imperfecta,LAMB3,laminin subunit beta 3,1q32.2
100031,Hypoplastic amelogenesis imperfecta,ITGB6,integrin subunit beta 6,2q24.2
100031,Hypoplastic amelogenesis imperfecta,AMBN,ameloblastin,4q13.3
100034,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism,DLX3,distal-less homeobox 3,17q21.33
100033,Hypomaturation amelogenesis imperfecta,GPR68,G protein-coupled receptor 68,14q32.11
100033,Hypomaturation amelogenesis imperfecta,AMELX,amelogenin X-linked,Xp22.2
100033,Hypomaturation amelogenesis imperfecta,KLK4,kallikrein related peptidase 4,19q13.41
100033,Hypomaturation amelogenesis imperfecta,MMP20,matrix metallopeptidase 20,11q22.2
100033,Hypomaturation amelogenesis imperfecta,WDR72,WD repeat domain 72,15q21.3
100033,Hypomaturation amelogenesis imperfecta,ODAPH,odontogenesis associated phosphoprotein,4q21.1
100033,Hypomaturation amelogenesis imperfecta,SLC24A4,solute carrier family 24 member 4,14q32.12
689231,IFIH1-related hereditary spastic paraplegia,IFIH1,interferon induced with helicase C domain 1,2q24.2
689234,RNASEH2B-related hereditary spastic paraplegia,RNASEH2B,ribonuclease H2 subunit B,13q14.3
689397,Poirier-Bienvenu neurodevelopmental syndrome,CSNK2B,casein kinase 2 beta,6p21.33
689408,Shashi-Pena syndrome,ASXL2,ASXL transcriptional regulator 2,2p23.3
689430,Adenoid ameloblastoma,CTNNB1,catenin beta 1,3p22.1
100044,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B,DNM2,dynamin 2,19p13.2
100045,Autosomal dominant intermediate Charcot-Marie-Tooth disease type C,YARS1,tyrosyl-tRNA synthetase 1,1p35.1
689829,Microphthalmia-motor delay-language delay-brain anomalies-diaphragmatic hernia syndrome,RARB,retinoic acid receptor beta,3p24.2
100046,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D,MPZ,myelin protein zero,1q23.3
689822,Structural heart defects-renal anomalies syndrome,TMEM260,transmembrane protein 260,14q22.3
100050,Hereditary angioedema type 1,SERPING1,serpin family G member 1,11q12.1
647667,Mandibuloacral dysplasia associated to MTX2,MTX2,metaxin 2,2q31.1
647676,Multiple epiphyseal dysplasia type 7,CANT1,calcium activated nucleotidase 1,17q25.3
646113,Intermediate collagen VI-related muscular dystrophy,COL6A1,collagen type VI alpha 1 chain,21q22.3
646113,Intermediate collagen VI-related muscular dystrophy,COL6A2,collagen type VI alpha 2 chain,21q22.3
646113,Intermediate collagen VI-related muscular dystrophy,COL6A3,collagen type VI alpha 3 chain,2q37.3
646278,CDK13-related developmental delay-intellectual disability-facial dysmorphism-congenital heart defects syndrome,CDK13,cyclin dependent kinase 13,7p14.1
100008,ACys amyloidosis,CST3,cystatin C,20p11.21
100006,"ABeta amyloidosis, Dutch type",APP,amyloid beta precursor protein,21q21.3
99989,Intermediate DEND syndrome,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
99977,Squamous cell carcinoma of the esophagus,WWOX,WW domain containing oxidoreductase,16q23.1-q23.2
99977,Squamous cell carcinoma of the esophagus,RNF6,ring finger protein 6,13q12.13
99977,Squamous cell carcinoma of the esophagus,TGFBR2,transforming growth factor beta receptor 2,3p24.1
99977,Squamous cell carcinoma of the esophagus,DLEC1,DLEC1 cilia and flagella associated protein,3p22.2
99976,Adenocarcinoma of the oesophagus and oesophagogastric junction,ERBB2,erb-b2 receptor tyrosine kinase 2,17q12
99971,Well-differentiated liposarcoma,CDK4,cyclin dependent kinase 4,12q14.1
99971,Well-differentiated liposarcoma,HMGA2,high mobility group AT-hook 2,12q14.3
99971,Well-differentiated liposarcoma,MDM2,MDM2 proto-oncogene,12q15
99970,Dedifferentiated liposarcoma,CDK4,cyclin dependent kinase 4,12q14.1
99970,Dedifferentiated liposarcoma,HMGA2,high mobility group AT-hook 2,12q14.3
99970,Dedifferentiated liposarcoma,MDM2,MDM2 proto-oncogene,12q15
99967,Myxoid/round cell liposarcoma,FUS,FUS RNA binding protein,16p11.2
99967,Myxoid/round cell liposarcoma,DDIT3,DNA damage inducible transcript 3,12q13.3
99966,Atypical teratoid rhabdoid tumor,SMARCB1,SWI/SNF related BAF chromatin remodeling complex subunit B1,22q11.23
99961,Benign recurrent intrahepatic cholestasis type 2,ABCB11,ATP binding cassette subfamily B member 11,2q31.1
99960,Benign recurrent intrahepatic cholestasis type 1,ATP8B1,ATPase phospholipid transporting 8B1,18q21.31
643538,Hao-Fountain syndrome due to USP7 mutation,USP7,ubiquitin specific peptidase 7,16p13.2
643503,Marfanoid habitus-facial dysmorphism-skeletal abnormality-heart defect syndrome,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",9q34.12
99955,Charcot-Marie-Tooth disease type 4B1,MTMR2,myotubularin related protein 2,11q21
99956,Charcot-Marie-Tooth disease type 4B2,SBF2,SET binding factor 2,11p15.4
99948,Charcot-Marie-Tooth disease type 4A,GDAP1,ganglioside induced differentiation associated protein 1,8q21.11
99947,Autosomal dominant Charcot-Marie-Tooth disease type 2A2,MFN2,mitofusin 2,1p36.22
99950,Charcot-Marie-Tooth disease type 4D,NDRG1,N-myc downstream regulated 1,8q24.22
99949,Charcot-Marie-Tooth disease type 4C,SH3TC2,SH3 domain and tetratricopeptide repeats 2,5q32
99952,Charcot-Marie-Tooth disease type 4F,PRX,periaxin,19q13.2
99951,Charcot-Marie-Tooth disease type 4E,EGR2,early growth response 2,10q21.3
99954,Charcot-Marie-Tooth disease type 4H,FGD4,"FYVE, RhoGEF and PH domain containing 4",12p11.21
99953,Charcot-Marie-Tooth disease type 4G,HK1,hexokinase 1,10q22.1
99940,Autosomal dominant Charcot-Marie-Tooth disease type 2F,HSPB1,heat shock protein family B (small) member 1,7q11.23
99939,Autosomal dominant Charcot-Marie-Tooth disease type 2E,NEFL,neurofilament light chain,8p21.2
99942,Autosomal dominant Charcot-Marie-Tooth disease type 2I,MPZ,myelin protein zero,1q23.3
99944,Autosomal dominant Charcot-Marie-Tooth disease type 2K,GDAP1,ganglioside induced differentiation associated protein 1,8q21.11
99943,Autosomal dominant Charcot-Marie-Tooth disease type 2J,MPZ,myelin protein zero,1q23.3
99946,Autosomal dominant Charcot-Marie-Tooth disease type 2A1,KIF1B,kinesin family member 1B,1p36.22
99945,Autosomal dominant Charcot-Marie-Tooth disease type 2L,HSPB8,heat shock protein family B (small) member 8,12q24.23
99936,Autosomal dominant Charcot-Marie-Tooth disease type 2B,RAB7A,"RAB7A, member RAS oncogene family",3q21.3
99937,Autosomal dominant Charcot-Marie-Tooth disease type 2C,TRPV4,transient receptor potential cation channel subfamily V member 4,12q24.11
99938,Autosomal dominant Charcot-Marie-Tooth disease type 2D,GARS1,glycyl-tRNA synthetase 1,7p14.3
648562,Ferroportin disease,SLC40A1,solute carrier family 40 member 1,2q32.2
648581,Digenic hemochromatosis,HFE,homeostatic iron regulator,6p22.2
648581,Digenic hemochromatosis,HJV,hemojuvelin BMP co-receptor,1q21.1
648581,Digenic hemochromatosis,HAMP,hepcidin antimicrobial peptide,19q13.12
648581,Digenic hemochromatosis,TFR2,transferrin receptor 2,7q22.1
99916,Malignant Sertoli-Leydig cell tumor of the ovary,DICER1,"dicer 1, ribonuclease III",14q32.13
99915,Malignant granulosa cell tumor of the ovary,FOXL2,forkhead box L2,3q22.3
99915,Malignant granulosa cell tumor of the ovary,DICER1,"dicer 1, ribonuclease III",14q32.13
99914,Gynandroblastoma,DICER1,"dicer 1, ribonuclease III",14q32.13
647815,Keratitis fugax hereditaria,NLRP3,NLR family pyrin domain containing 3,1q44
99901,Acyl-CoA dehydrogenase 9 deficiency,ACAD9,acyl-CoA dehydrogenase family member 9,3q21.3
647811,Cardiac-urogenital syndrome,MYRF,myelin regulatory factor,11q12.2
647804,Combined immunodeficiency due to FCHO1 deficiency,FCHO1,FCH and mu domain containing endocytic adaptor 1,19p13.11
647834,SLC40A1-related hemochromatosis,SLC40A1,solute carrier family 40 member 1,2q32.2
647772,Isolated primary pigmented nodular adrenocortical disease,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,17q24.2
647772,Isolated primary pigmented nodular adrenocortical disease,PDE11A,phosphodiesterase 11A,2q31.2
647681,Craniosynostosis-facial dysmorphism-Chiari-1 malformation-developmental and language delay syndrome,ERF,ETS2 repressor factor,19q13.2
647799,MYT1L-related developmental delay-intellectual disability-obesity syndrome,MYT1L,myelin transcription factor 1 like,2p25.3
99898,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency,IFNGR1,interferon gamma receptor 1,6q23.3
647788,Neurodevelopmental delay-intellectual disability-ataxia-feeding difficulty syndrome,DHX30,DExH-box helicase 30,3p21.31
647782,Isolated micronodular adrenocortical disease,PDE11A,phosphodiesterase 11A,2q31.2
647782,Isolated micronodular adrenocortical disease,PDE8B,phosphodiesterase 8B,5q13.3
99879,Familial isolated hyperparathyroidism,GCM2,glial cells missing transcription factor 2,6p24.2
99879,Familial isolated hyperparathyroidism,CDC73,cell division cycle 73,1q31.2
99879,Familial isolated hyperparathyroidism,MEN1,menin 1,11q13
656283,Autosomal recessive combined immunodeficiency due to complete IL6ST deficiency,IL6ST,interleukin 6 cytokine family signal transducer,5q11.2
656279,1p36.33 duplication syndrome,ATAD3A,ATPase family AAA domain containing 3A,1p36.33
656279,1p36.33 duplication syndrome,ATAD3B,ATPase family AAA domain containing 3B,1p36.33
656279,1p36.33 duplication syndrome,ATAD3C,ATPase family AAA domain containing 3C,1p36.33
99880,Hyperparathyroidism-jaw tumor syndrome,CDC73,cell division cycle 73,1q31.2
656313,Autosomal dominant combined immunodeficiency due to partial IL6ST deficiency,IL6ST,interleukin 6 cytokine family signal transducer,5q11.2
656300,Autosomal recessive combined immunodeficiency due to partial IL6ST deficiency,IL6ST,interleukin 6 cytokine family signal transducer,5q11.2
656130,PBX1-related congenital anomalies of kidney-urinary tract syndrome,PBX1,PBX homeobox 1,1q23.3
656135,Intellectual disability-cupped ears syndrome,POU3F3,POU class 3 homeobox 3,2q12.1
99887,Acute megakaryoblastic leukemia in children with Down syndrome,GATA1,GATA binding protein 1,Xp11.23
656912,Autosomal dominant combined immunodeficiency due to ERBIN deficiency,ERBIN,erbb2 interacting protein,5q12.3
656326,Autosomal recessive combined immunodeficiency due to IL6R deficiency,IL6R,interleukin 6 receptor,1q21.3
99885,Isolated permanent neonatal diabetes mellitus,STAT3,signal transducer and activator of transcription 3,17q21.2
99885,Isolated permanent neonatal diabetes mellitus,GCK,glucokinase,7p13
99885,Isolated permanent neonatal diabetes mellitus,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
99885,Isolated permanent neonatal diabetes mellitus,PDX1,pancreatic and duodenal homeobox 1,13q12.2
99885,Isolated permanent neonatal diabetes mellitus,INS,insulin,11p15.5
99885,Isolated permanent neonatal diabetes mellitus,ABCC8,ATP binding cassette subfamily C member 8,11p15.1
99886,Transient neonatal diabetes mellitus,ABCC8,ATP binding cassette subfamily C member 8,11p15.1
99886,Transient neonatal diabetes mellitus,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11p15.1
99886,Transient neonatal diabetes mellitus,HYMAI,hydatidiform mole associated and imprinted,6q24.2
99886,Transient neonatal diabetes mellitus,PLAGL1,PLAG1 like zinc finger 1,6q24.2
99886,Transient neonatal diabetes mellitus,ZFP57,ZFP57 zinc finger protein,6p22.1
653712,CHD4-related neurodevelopmental disorder,CHD4,chromodomain helicase DNA binding protein 4,12p13.31
653722,Digenic Alport syndrome,COL4A3,collagen type IV alpha 3 chain,2q36.3
653722,Digenic Alport syndrome,COL4A4,collagen type IV alpha 4 chain,2q36.3
653722,Digenic Alport syndrome,COL4A5,collagen type IV alpha 5 chain,Xq22.3
653725,"Autosomal recessive limb-girdle muscular dystrophy, type 28",HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5q13.3
653728,"Congenital insensitivity to pain syndrome, Marsili type",ZFHX2,zinc finger homeobox 2,14q11.2
99861,Precursor T-cell acute lymphoblastic leukemia,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",9q34.12
99861,Precursor T-cell acute lymphoblastic leukemia,SET,SET nuclear proto-oncogene,9q34.11
99861,Precursor T-cell acute lymphoblastic leukemia,NUP214,nucleoporin 214,9q34.13
99861,Precursor T-cell acute lymphoblastic leukemia,ZBTB16,zinc finger and BTB domain containing 16,11q23.2
99861,Precursor T-cell acute lymphoblastic leukemia,SALL2,spalt like transcription factor 2,14q11.2
99861,Precursor T-cell acute lymphoblastic leukemia,TRA,T-cell receptor alpha locus,14q11.2
99861,Precursor T-cell acute lymphoblastic leukemia,BCR,BCR activator of RhoGEF and GTPase,22q11.23
99861,Precursor T-cell acute lymphoblastic leukemia,CDKN2A,cyclin dependent kinase inhibitor 2A,9p21.3
99861,Precursor T-cell acute lymphoblastic leukemia,TAL1,"TAL bHLH transcription factor 1, erythroid differentiation factor",1p33
99861,Precursor T-cell acute lymphoblastic leukemia,FLT3,fms related receptor tyrosine kinase 3,13q12.2
99861,Precursor T-cell acute lymphoblastic leukemia,MYC,"MYC proto-oncogene, bHLH transcription factor",8q24.21
99861,Precursor T-cell acute lymphoblastic leukemia,STIL,STIL centriolar assembly protein,1p33
99861,Precursor T-cell acute lymphoblastic leukemia,MYB,"MYB proto-oncogene, transcription factor",6q23.3
99861,Precursor T-cell acute lymphoblastic leukemia,TRB,T-cell receptor beta locus,7q34
99861,Precursor T-cell acute lymphoblastic leukemia,TRD,T-cell receptor delta locus,14q11.2
99861,Precursor T-cell acute lymphoblastic leukemia,TRG,T-cell receptor gamma locus,7p14
99861,Precursor T-cell acute lymphoblastic leukemia,TCL1A,TCL1 family AKT coactivator A,14q32.13
99861,Precursor T-cell acute lymphoblastic leukemia,TLX1,T cell leukemia homeobox 1,10q24.31
99861,Precursor T-cell acute lymphoblastic leukemia,TLX3,T cell leukemia homeobox 3,5q35.1
99861,Precursor T-cell acute lymphoblastic leukemia,CNOT3,CCR4-NOT transcription complex subunit 3,19q13.42
99861,Precursor T-cell acute lymphoblastic leukemia,MLLT10,MLLT10 histone lysine methyltransferase DOT1L cofactor,10p12.31
99861,Precursor T-cell acute lymphoblastic leukemia,DDX3X,DEAD-box helicase 3 X-linked,Xp11.4
99861,Precursor T-cell acute lymphoblastic leukemia,PICALM,phosphatidylinositol binding clathrin assembly protein,11q14.2
653709,Cone rod dystrophy-short stature syndrome,CFAP410,cilia and flagella associated protein 410,21q22.3
653751,X-linked combined immunodeficiency due to SASH3 deficiency,SASH3,SAM and SH3 domain containing 3,Xq26.1
653767,Jansen-de Vries syndrome,PPM1D,"protein phosphatase, Mg2+/Mn2+ dependent 1D",17q23.3
653880,Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency,ECHS1,"enoyl-CoA hydratase, short chain 1",10q26.3
99849,Glycogen storage disease due to muscle beta-enolase deficiency,ENO3,enolase 3,17p13.2
652487,Developmental delay-overweight-facial dysmorphism-behavioral abnormalities syndrome,SRRM2,serine/arginine repetitive matrix 2,16p13.3
99845,Genetic recurrent myoglobinuria,MT-CO1,mitochondrially encoded cytochrome c oxidase I,mitochondria
99845,Genetic recurrent myoglobinuria,MT-CO3,mitochondrially encoded cytochrome c oxidase III,mitochondria
99845,Genetic recurrent myoglobinuria,LPIN1,lipin 1,2p25.1
99845,Genetic recurrent myoglobinuria,OBSCN,"obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF",1q42.13
99843,Leukocyte adhesion deficiency type II,SLC35C1,solute carrier family 35 member C1,11p11.2
99844,Leukocyte adhesion deficiency type III,FERMT3,FERM domain containing kindlin 3,11q13.1
99853,Ovarioleukodystrophy,EIF2B1,eukaryotic translation initiation factor 2B subunit alpha,12q24.31
99853,Ovarioleukodystrophy,EIF2B2,eukaryotic translation initiation factor 2B subunit beta,14q24.3
99853,Ovarioleukodystrophy,EIF2B3,eukaryotic translation initiation factor 2B subunit gamma,1p34.1
99853,Ovarioleukodystrophy,EIF2B4,eukaryotic translation initiation factor 2B subunit delta,2p23.3
99853,Ovarioleukodystrophy,EIF2B5,eukaryotic translation initiation factor 2B subunit epsilon,3q27.1
99853,Ovarioleukodystrophy,AARS2,"alanyl-tRNA synthetase 2, mitochondrial",6p21.1
652532,Adult-onset progressive leukoencephalopathy-early-onset deafness,KARS1,lysyl-tRNA synthetase 1,16q23.1
99854,Cree leukoencephalopathy,EIF2B1,eukaryotic translation initiation factor 2B subunit alpha,12q24.31
99854,Cree leukoencephalopathy,EIF2B2,eukaryotic translation initiation factor 2B subunit beta,14q24.3
99854,Cree leukoencephalopathy,EIF2B3,eukaryotic translation initiation factor 2B subunit gamma,1p34.1
99854,Cree leukoencephalopathy,EIF2B4,eukaryotic translation initiation factor 2B subunit delta,2p23.3
99854,Cree leukoencephalopathy,EIF2B5,eukaryotic translation initiation factor 2B subunit epsilon,3q27.1
99852,Ravine syndrome,SLC7A2-IT1,SLC7A2 intronic transcript 1,8p22
652522,Periodic fever-immunodeficiency-thrombocytopenia syndrome,WDR1,WD repeat domain 1,4p16.1
99832,Resistance to thyrotropin-releasing hormone syndrome,TRHR,thyrotropin releasing hormone receptor,8q23.1
99842,Leukocyte adhesion deficiency type I,ITGB2,integrin subunit beta 2,21q22.3
650097,Genetic central precocious puberty in male,MKRN3,makorin ring finger protein 3,15q11.2
650097,Genetic central precocious puberty in male,DLK1,delta like non-canonical Notch ligand 1,14q32.2
650097,Genetic central precocious puberty in male,KISS1R,KISS1 receptor,19p13.3
650097,Genetic central precocious puberty in male,KISS1,KiSS-1 metastasis suppressor,1q32.1
650077,Genetic central precocious puberty in female,MKRN3,makorin ring finger protein 3,15q11.2
650077,Genetic central precocious puberty in female,DLK1,delta like non-canonical Notch ligand 1,14q32.2
650077,Genetic central precocious puberty in female,KISS1R,KISS1 receptor,19p13.3
99811,Neuronal intestinal pseudoobstruction,FLNA,filamin A,Xq28
660012,Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to a NR4A2 point mutation,NR4A2,nuclear receptor subfamily 4 group A member 2,2q24.1
99812,LIG4 syndrome,XRCC4,X-ray repair cross complementing 4,5q14.2
99812,LIG4 syndrome,LIG4,DNA ligase 4,13q33.3
660021,Orofacial clefting-cardiac anomalies-facial dysmorphism syndrome,AMOTL1,angiomotin like 1,11q21
661526,MBD4-related tumor predisposition syndrome,MBD4,"methyl-CpG binding domain 4, DNA glycosylase",3q21.3
662172,Phelan-McDermid syndrome due to SHANK3 mutation,SHANK3,SH3 and multiple ankyrin repeat domains 3,22q13.33
99819,Familial gestational hyperthyroidism,TSHR,thyroid stimulating hormone receptor,14q24-q31
662169,Phelan-McDermid syndrome due to 22q13.3 deletion,SHANK3,SH3 and multiple ankyrin repeat domains 3,22q13.33
662179,Microcephaly-hearing loss-facial dysmorphism-intellectual disability syndrome,SPOP,speckle type BTB/POZ protein,17q21.33
662175,Macrocephaly-congenital heart disease-facial dysmorphism-intellectual disability syndrome,SPOP,speckle type BTB/POZ protein,17q21.33
662189,Neurodevelopmental disorder-brain malformation-facial dysmorphism-brachydactyly syndrome,HNRNPR,heterogeneous nuclear ribonucleoprotein R,1p36.12
662184,Congenital muscular dystrophy-cataract-intellectual disability syndrome,INPP5K,inositol polyphosphate-5-phosphatase K,17p13.3
662198,Neurodevelopmental delay-intellectual disability-skeletal defects syndrome,HNRNPH2,heterogeneous nuclear ribonucleoprotein H2,Xq22.1
99796,Subcortical band heterotopia,DCX,doublecortin,Xq23
99796,Subcortical band heterotopia,PAFAH1B1,platelet activating factor acetylhydrolase 1b regulatory subunit 1,17p13.3
99796,Subcortical band heterotopia,EML1,EMAP like 1,14q32.2
99798,Oligodontia,SUMO1,small ubiquitin like modifier 1,2q33.1
99798,Oligodontia,EDA,ectodysplasin A,Xq13.1
99798,Oligodontia,EDARADD,EDAR associated via death domain,1q42.3-q43
99798,Oligodontia,FGFR1,fibroblast growth factor receptor 1,8p11.23
99798,Oligodontia,IRF6,interferon regulatory factor 6,1q32.2
99798,Oligodontia,WNT10A,Wnt family member 10A,2q35
99798,Oligodontia,MSX1,msh homeobox 1,4p16.2
99798,Oligodontia,PAX9,paired box 9,14q13.3
99798,Oligodontia,TGFA,transforming growth factor alpha,2p13.3
99798,Oligodontia,LRP6,LDL receptor related protein 6,12p13.2
99798,Oligodontia,GREM2,"gremlin 2, DAN family BMP antagonist",1q43
99798,Oligodontia,WNT10B,Wnt family member 10B,12q13.12
99802,Hemimegalencephaly,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",3q26.32
99802,Hemimegalencephaly,AKT3,AKT serine/threonine kinase 3,1q43-q44
99802,Hemimegalencephaly,MTOR,mechanistic target of rapamycin kinase,1p36.22
659873,Wormian bones-micrognathia-abnormal dentition-progeroid syndrome,LEMD2,LEM domain nuclear envelope protein 2,6p21.31
99803,Haddad syndrome,PHOX2B,paired like homeobox 2B,4p13
99803,Haddad syndrome,RET,ret proto-oncogene,10q11.21
99803,Haddad syndrome,ASCL1,achaete-scute family bHLH transcription factor 1,12q23.2
99806,Oculootodental syndrome,FGF3,fibroblast growth factor 3,11q13.3
99806,Oculootodental syndrome,FADD,Fas associated via death domain,11q13.3
659904,Multiple congenital anomalies-neurodevelopmental delay-ocular abnormalities syndrome,PRR12,proline rich 12,19q13.33
99807,PEHO-like syndrome,CCDC88A,coiled-coil domain containing 88A,2p16.1
99810,Familial porencephaly,COL4A1,collagen type IV alpha 1 chain,13q34
99810,Familial porencephaly,COL4A2,collagen type IV alpha 2 chain,13q34
99810,Familial porencephaly,COLGALT1,collagen beta(1-O)galactosyltransferase 1,19p13.11
659975,Sensorineural hearing loss-spastic quadriplegia-intellectual disability syndrome,AFG2B,AFG2 AAA ATPase homolog B,15q21.1
659396,Cohen-Gibson syndrome,EED,embryonic ectoderm development,11q14.2
658951,Early-onset immune dysregulation due to DOCK11 complete deficiency,DOCK11,dedicator of cytokinesis 11,Xq24
659609,Facial dysmorphism-global developmental delay-hypotonia-polymicrogyria syndrome,RAC3,Rac family small GTPase 3,17q25.3
659463,Imagawa-Matsumoto syndrome,SUZ12,SUZ12 polycomb repressive complex 2 subunit,17q11.2
659672,Harderoporphyria,CPOX,coproporphyrinogen oxidase,3q11.2
99789,Dentin dysplasia type I,SSUH2,ssu-2 homolog,3p25.3
99789,Dentin dysplasia type I,DSPP,dentin sialophosphoprotein,4q22.1
99789,Dentin dysplasia type I,VPS4B,vacuolar protein sorting 4 homolog B,18q21.33
659702,Intrauterine growth retardation-micrognathia-short stature-facial dysmorphism-rhizomelic shortening syndrome,ARCN1,archain 1,11q23.3
99791,Dentin dysplasia type II,DSPP,dentin sialophosphoprotein,4q22.1
658778,COQ7-related distal hereditary motor neuropathy,COQ7,"coenzyme Q7, hydroxylase",16p12.3
658595,DNMT3A-related microcephalic dwarfism,DNMT3A,DNA methyltransferase 3 alpha,2p23.3
658813,Combined immunodeficiency-megaloblastic anemia due to methylenetetrahydrofolate dehydrogenase 1 deficiency,MTHFD1,"methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1",14q23.3
658843,Developmental delay-ataxia-hypotonia-facial dysmorphism syndrome,EBF3,EBF transcription factor 3,10q26.3
99772,Cleft velum,GRHL3,grainyhead like transcription factor 3,1p36.11
99772,Cleft velum,UBB,ubiquitin B,17p11.2
99771,Bifid uvula,UBB,ubiquitin B,17p11.2
99771,Bifid uvula,GRHL3,grainyhead like transcription factor 3,1p36.11
658946,Early-onset immune dysregulation with autoimmunity due to DOCK11 partial deficiency,DOCK11,dedicator of cytokinesis 11,Xq24
631073,Autosomal recessive spastic paraplegia type 82,PCYT2,"phosphate cytidylyltransferase 2, ethanolamine",17q25.3
631076,Autosomal recessive spastic paraplegia type 83,HPDL,4-hydroxyphenylpyruvate dioxygenase like,1p34.1
631079,Autosomal recessive spastic paraplegia type 84,PI4KA,phosphatidylinositol 4-kinase alpha,22q11.21
631082,Autosomal recessive spastic paraplegia type 85,RNF170,ring finger protein 170,8p11.21
631068,Autosomal dominant spastic paraplegia type 80,UBAP1,ubiquitin associated protein 1,9p13.3
631106,Spinocerebellar ataxia type 49,SAMD9L,sterile alpha motif domain containing 9 like,7q21.2
631103,Spinocerebellar ataxia type 48,STUB1,STIP1 homology and U-box containing protein 1,16p13.3
631095,Spinocerebellar ataxia type 44,GRM1,glutamate metabotropic receptor 1,6q24.3
631088,Autosomal recessive spastic paraplegia type 87,TMEM63C,transmembrane protein 63C,14q24.3
631085,Autosomal recessive spastic paraplegia type 86,ABHD16A,"abhydrolase domain containing 16A, phospholipase",6p21.33
631248,Mitchell Syndrome,ACOX1,acyl-CoA oxidase 1,17q25.1
634475,Mosaic NF2-related schwannomatosis,NF2,"NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor",22q12.2
636970,Autosomal recessive myosin storage myopathy,MYH7,myosin heavy chain 7,14q11.2
636965,Autosomal dominant myosin storage myopathy,MYH7,myosin heavy chain 7,14q11.2
637013,SMARCA2-related blepharophimosis-intellectual disability syndrome,SMARCA2,SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2,9p24.3
636941,Vascular Ehlers-Danlos-polymicrogyria syndrome,COL3A1,collagen type III alpha 1 chain,2q32.2
641375,B-lymphoblastic leukemia/lymphoma with t(17;19),HLF,"HLF transcription factor, PAR bZIP family member",17q22
641375,B-lymphoblastic leukemia/lymphoma with t(17;19),TCF3,transcription factor 3,19p13.3
641368,Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency,ZNF341,zinc finger protein 341,20q11.22
641372,B-lymphoblastic leukemia/lymphoma with t(7;9)(q11.2;p13.2),PAX5,paired box 5,9p13.2
641372,B-lymphoblastic leukemia/lymphoma with t(7;9)(q11.2;p13.2),AUTS2,activator of transcription and developmental regulator AUTS2,7q11.22
641353,Infantile neurodegeneration-progressive spasticity-intellectual disability-white matter lesions syndrome,HPDL,4-hydroxyphenylpyruvate dioxygenase like,1p34.1
641361,Neurodevelopmental delay-hypotonia-cerebellar ataxia-cardiac conduction defects syndrome,EXOSC5,exosome component 5,19q13.2
642976,Perrault syndrome type 2,PRORP,protein only RNase P catalytic subunit,14q13.2
642976,Perrault syndrome type 2,CLPP,caseinolytic mitochondrial matrix peptidase proteolytic subunit,19p13.3
642976,Perrault syndrome type 2,ERAL1,Era like 12S mitochondrial rRNA chaperone 1,17q11.2
642976,Perrault syndrome type 2,HARS2,"histidyl-tRNA synthetase 2, mitochondrial",5q31.3
642976,Perrault syndrome type 2,HSD17B4,hydroxysteroid 17-beta dehydrogenase 4,5q23.1
642976,Perrault syndrome type 2,LARS2,"leucyl-tRNA synthetase 2, mitochondrial",3p21.31
642976,Perrault syndrome type 2,TWNK,twinkle mtDNA helicase,10q24.31
642976,Perrault syndrome type 2,GGPS1,geranylgeranyl diphosphate synthase 1,1q42.3
642976,Perrault syndrome type 2,RMND1,required for meiotic nuclear division 1 homolog,6q25.1
642965,Autosomal recessive ataxia due to PEX2 deficiency,PEX2,peroxisomal biogenesis factor 2,8q21.13
642954,Autosomal recessive ataxia due to PEX16 deficiency,PEX16,peroxisomal biogenesis factor 16,11p11.2
642945,Perrault syndrome type 1,PRORP,protein only RNase P catalytic subunit,14q13.2
642945,Perrault syndrome type 1,CLPP,caseinolytic mitochondrial matrix peptidase proteolytic subunit,19p13.3
642945,Perrault syndrome type 1,ERAL1,Era like 12S mitochondrial rRNA chaperone 1,17q11.2
642945,Perrault syndrome type 1,HARS2,"histidyl-tRNA synthetase 2, mitochondrial",5q31.3
642945,Perrault syndrome type 1,HSD17B4,hydroxysteroid 17-beta dehydrogenase 4,5q23.1
642945,Perrault syndrome type 1,LARS2,"leucyl-tRNA synthetase 2, mitochondrial",3p21.31
642945,Perrault syndrome type 1,TWNK,twinkle mtDNA helicase,10q24.31
642945,Perrault syndrome type 1,GGPS1,geranylgeranyl diphosphate synthase 1,1q42.3
642945,Perrault syndrome type 1,RMND1,required for meiotic nuclear division 1 homolog,6q25.1
642763,Autosomal dominant intellectual disability-craniofacial dysmorphism-macrocephaly-hypotonia syndrome due to H1-4 mutation,H1-4,"H1.4 linker histone, cluster member",6p22.2
642747,PUM1-related cerebellar ataxia,PUM1,pumilio RNA binding family member 1,1p35.2
642691,Fragile X-associated primary ovarian insufficiency,FMR1,fragile X messenger ribonucleoprotein 1,Xq27.3
642675,CHD8 overgrowth syndrome,CHD8,chromodomain helicase DNA binding protein 8,14q11.2
642671,Familial hyperaldosteronism type IV,CACNA1H,calcium voltage-gated channel subunit alpha1 H,16p13.3
642099,"Spondyloepimetaphyseal dysplasia with joint laxity, Beighton type",B3GALT6,"beta-1,3-galactosyltransferase 6",1p36.33
642085,EXOC6B-related spondyloepimetaphyseal dysplasia with joint laxity,EXOC6B,exocyst complex component 6B,2p13.2
632603,Mesomelic dysplasia-digital anomalies-intellectual disability syndrome,AFF3,ALF transcription elongation factor 3,2q11.2
633021,SLC12A2-related autosomal recessive neonatal-developmental delay-intellectual disability-feeding difficulty-sensorineural deafness syndrome,SLC12A2,solute carrier family 12 member 2,5q23.3
633024,SLC12A2-related autosomal dominant infantile-developmental delay-intellectual disability-sensorineural deafness syndrome,SLC12A2,solute carrier family 12 member 2,5q23.3
633004,KDM3B-related intellectual disability-facial dysmorphism-short stature syndrome,KDM3B,lysine demethylase 3B,5q31.2
633035,Intellectual disability-early-onset cataract-microcephaly syndrome,COPB1,COPI coat complex subunit beta 1,11p15.2
633028,CPE-related Prader-Willi-like syndrome,CPE,carboxypeptidase E,4q32.3
615938,Spastic paraparesis-cataracts-speech delay syndrome,FAR1,fatty acyl-CoA reductase 1,11p15.3
615986,Lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due to biallelic deletions in the ATAD3 gene cluster,ATAD3A,ATPase family AAA domain containing 3A,1p36.33
615983,Lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due to a point mutation,ATAD3A,ATPase family AAA domain containing 3A,1p36.33
621758,Fibrosis-neurodegeneration-cerebral angiomatosis syndrome,NHLRC2,NHL repeat containing 2,10q25.3
620371,Gitelman-like kidney tubulopathy due to mitochondrial DNA mutation,MT-TF,mitochondrially encoded tRNA-Phe (UUU/C),mitochondria
620371,Gitelman-like kidney tubulopathy due to mitochondrial DNA mutation,MT-TI,mitochondrially encoded tRNA-Ile (AUU/C),mitochondria
620368,EGF-related primary hypomagnesemia with intellectual disability,EGF,epidermal growth factor,4q25
620363,Primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome,CNNM2,cyclin and CBS domain divalent metal cation transport mediator 2,10q24.32
620220,Bartter syndrome type 2,KCNJ1,potassium inwardly rectifying channel subfamily J member 1,11q24.3
620158,Non-syndromic non-specific multisutural craniosynostosis,FUZ,fuzzy planar cell polarity protein,19q13.33
623695,MIR140-related spondyloepiphyseal dysplasia,MIR140,microRNA 140,16q22.1
622925,X-linked severe syndromic thoracic aortic aneurysm and dissection,BGN,biglycan,Xq28
622934,SBDS-related severe neonatal spondylometaphyseal dysplasia,SBDS,SBDS ribosome maturation factor,7q11.21
617919,F12-associated cold autoinflammatory syndrome,F12,coagulation factor XII,5q35.3
619941,Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency,MRTFA,myocardin related transcription factor A,22q13.1-q13.2
619367,SAMD9L-associated autoinflammatory syndrome,SAMD9L,sterile alpha motif domain containing 9 like,7q21.2
619953,Familial hyperinflammatory lymphoproliferative immunodeficiency,NCKAP1L,NCK associated protein 1 like,12q13.13-q13.2
619948,Early-onset autoimmunity-autoinflammation-immunodeficiency syndrome due to SOCS1 haploinsufficiency,SOCS1,suppressor of cytokine signaling 1,16p13.13
619979,Developmental delay-immunodeficiency-leukoencephalopathy-hypohomocysteinemia syndrome,NFE2L2,NFE2 like bZIP transcription factor 2,2q31.2
619972,CADINS disease,CARD11,caspase recruitment domain family member 11,7p22.2
619363,NOCARH syndrome,CDC42,cell division cycle 42,1p36.12
619233,Hereditary persistence of fetal hemoglobin-intellectual disability syndrome,BCL11A,BCL11 transcription factor A,2p16.1
